A0_Samples	A18_Sex	A1_OS	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A3_T	A4_N	A5_M	A6_Stage	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	additional_studies.additional_study.disease_code	additional_studies.additional_study.project_code	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivisions.anatomic_neoplasm_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	bcr_patient_barcode	bcr_patient_uuid	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator	day_of_form_completion	days_to_birth	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	distant_metastasis_present_ind2	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	er_detection_method_text	er_level_cell_percentage_category	ethnicity	first_nonlymph_node_metastasis_anatomic_sites.metastatic_site_at_diagnosis	first_nonlymph_node_metastasis_anatomic_sites.metastatic_site_at_diagnosis_other	fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range	follow_ups.follow_up.additional_pharmaceutical_therapy	follow_ups.follow_up.additional_radiation_therapy	follow_ups.follow_up.additional_surgery_locoregional_procedure	follow_ups.follow_up.additional_surgery_metastatic_procedure	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.breast_carcinoma_estrogen_receptor_status	follow_ups.follow_up.breast_carcinoma_immunohistochemistry_pos_cell_score	follow_ups.follow_up.breast_carcinoma_progesterone_receptor_status	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_additional_surgery_locoregional_procedure	follow_ups.follow_up.days_to_additional_surgery_metastatic_procedure	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.days_to_last_known_alive	follow_ups.follow_up.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.er_detection_method_text	follow_ups.follow_up.er_level_cell_percentage_category	follow_ups.follow_up.fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.her2_and_centromere_17_positive_finding_other_measurement_scale_text	follow_ups.follow_up.her2_erbb_method_calculation_method_text	follow_ups.follow_up.her2_erbb_pos_finding_cell_percent_category	follow_ups.follow_up.her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	follow_ups.follow_up.her2_immunohistochemistry_level_result	follow_ups.follow_up.her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count	follow_ups.follow_up.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	follow_ups.follow_up.her2_neu_breast_carcinoma_copy_analysis_input_total_number	follow_ups.follow_up.her2_neu_chromosone_17_signal_ratio_value	follow_ups.follow_up.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	follow_ups.follow_up.immunohistochemistry_positive_cell_score	follow_ups.follow_up.lab_proc_her2_neu_immunohistochemistry_receptor_status	follow_ups.follow_up.lab_procedure_her2_neu_in_situ_hybrid_outcome_type	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	follow_ups.follow_up.metastatic_breast_carcinoma_estrogen_receptor_status	follow_ups.follow_up.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	follow_ups.follow_up.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	follow_ups.follow_up.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type	follow_ups.follow_up.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	follow_ups.follow_up.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	follow_ups.follow_up.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	follow_ups.follow_up.metastatic_breast_carcinoma_progesterone_receptor_status	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_neoplasm_event_type	follow_ups.follow_up.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	follow_ups.follow_up.new_tumor_events.new_tumor_event.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_status	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	follow_ups.follow_up.new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_status	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.pgr_detection_method_text	follow_ups.follow_up.pos_finding_her2_erbb2_other_measurement_scale_text	follow_ups.follow_up.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	follow_ups.follow_up.pos_finding_progesterone_receptor_other_measurement_scale_text	follow_ups.follow_up.positive_finding_estrogen_receptor_other_measurement_scale_text	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.progesterone_receptor_level_cell_percent_category	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	her2_and_centromere_17_positive_finding_other_measurement_scale_text	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count	her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	histological_type	histological_type_other	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	immunohistochemistry_positive_cell_score	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	metastatic_breast_carcinoma_progesterone_receptor_status	month_of_form_completion	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	new_tumor_events.new_tumor_event.her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_estrogen_receptor_status	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	new_tumor_events.new_tumor_event.metastatic_breast_carcinoma_progesterone_receptor_status	new_tumor_events.new_tumor_event.new_neoplasm_event_occurrence_anatomic_site	new_tumor_events.new_tumor_event.new_neoplasm_event_type	new_tumor_events.new_tumor_event.new_neoplasm_occurrence_anatomic_site_text	new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	new_tumor_events.new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	other_dx	patient_id	person_neoplasm_cancer_status	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	postoperative_rx_tx	primary_lymph_node_presentation_assessment	progesterone_receptor_level_cell_percent_category	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	surgical_procedure_purpose_other_text	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	tumor_tissue_site_other	vital_status	year_of_form_completion	year_of_initial_pathologic_diagnosis
TCGA-D8-A1JJ	FEMALE	611	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	611			TUMOR FREE				54	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1JJ	f7ab565c-83b5-4988-b9be-8a46f65dca8c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	29	-19966	Not Applicable	0	274	Not Available	Not Available	TCGA-D8-A1JJ-D20752;TCGA-D8-A1JJ-D65328	1B097076-CB3B-448F-A602-0212DC8246E8;FC68628D-E031-42D2-9D8F-4D34ACDEEC56	Not Available;Not Available	19;22	143;143	137;137	doxorubicine;cyclophosphamide	Not Available;Not Available	1;9	4;Not Available	108.6;Not Available	mg/m2/day;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	434.4;Not Available	mg;Not Available	Not Available;NO	2012;2014	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JJ-F20754	2586900A-76A7-44D0-9D02-828DF5F321CD				19		Not Available	Not Applicable	611		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	DAKOHercepTest TM	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JJ	TUMOR FREE	manual counting	10-75%	Not Available	10-75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-D8-A1JJ-R20753	765626E2-B396-481B-8720-E2A148CA748A	Not Available	19	207	189	Not Available	1	25+1 boost 1500cGy	6500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	breast conserving therapy	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A5J0	FEMALE	715	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	715			TUMOR FREE				63	Left	Not Available	Not Available	TCGA-BH-A5J0	DB55D9D9-DD56-4CA9-B1F1-0D929697B280	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	13	-23072	Not Applicable	0	225	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A5J0-F63664	10B16ACD-2E32-4414-99E9-3838D5692CFB				14			Not Applicable	715																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5J0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2014	2012
TCGA-A8-A09A	FEMALE	304	Infiltrating Ductal Carcinoma	Breast	Alive	T2	NX	M0	Stage X	1				WITH TUMOR				40	Left	Not Available	Not Available	TCGA-A8-A09A	b205bba0-1870-4458-9088-8817e20389fe	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-14883	Not Applicable	0	304	Not Available	Not Available	TCGA-A8-A09A-D37802;TCGA-A8-A09A-D37803;TCGA-A8-A09A-D37804;TCGA-A8-A09A-D37805;TCGA-A8-A09A-D37806	CD73A61D-093A-4D49-B667-77B33D535F5B;88F900CF-4B32-407F-8868-F0C403EDE587;0AF1F61C-EA80-4E11-91D7-55B88B1E1B3D;4C782B94-02AD-4D3A-AC10-A300BDDC79D7;92C7BE24-ECD6-4492-AD23-374F8B00872A	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	31;31;31;182;Not Available	Not Available;Not Available;Not Available;Not Available;243	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Tamoxifen	Unknown;Unknown;Unknown;Unknown;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09A-F40551	6D20EF32-98F7-497A-B6E9-A40607FF1FF7				23			Not Applicable	304																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09A	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09A-R38166	42E57A30-DD55-4E80-A902-D6DA091B49FD	Not Available	11	212	182	Unknown	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	NX	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A28O	FEMALE	1120	Infiltrating Lobular Carcinoma	Breast	Alive	T3a	N3	M0	Stage IIIC	0	1120			TUMOR FREE				50	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A28O	84B7CCF2-8AB3-4B21-96DE-800D231BC072	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	2	-18501	Not Applicable	0	324	Not Available	NO	TCGA-BH-A28O-D64238;TCGA-BH-A28O-D64239	CAD6922D-31F1-401F-AAA4-FCD9176D8DE1;103854BD-AAE1-4387-84DC-33377016C730	Not Available;Not Available	27;27	430;430	338;338	Cytoxan;Doxorubicin	Complete Response;Complete Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A28O-F64237	78078E02-494D-4954-BA84-31674011235A				27			Not Applicable	1120																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	14	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	14	Not Available	No	A28O	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T3a	Segmental mastectomy	YES	NO	BH	Breast	Not Applicable	Alive	2012	2010
TCGA-A2-A0CL	FEMALE	3015	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	0	3015			TUMOR FREE				37	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0CL	5c8983f2-9788-4dfa-971c-3ec457b6166e	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-13556	Not Applicable	0	1827	Not Available	Not Available	TCGA-A2-A0CL-D7408;TCGA-A2-A0CL-D7409;TCGA-A2-A0CL-D7415;TCGA-A2-A0CL-D7411;TCGA-A2-A0CL-D7417;TCGA-A2-A0CL-D7412;TCGA-A2-A0CL-D39784	6e17a5be-5bf0-4bf3-8e88-caab1ca38aed;7f7f933f-bab0-42a9-b14f-e3b8eaee2866;9ded5455-e05f-4b38-b10a-0accda9fdabb;68e80464-73a4-4094-9487-d45dc4d516d7;8844d562-a5b6-4ebb-9006-a8eba7177d29;c002a4ce-ae2a-4c04-9941-a4fa99d93666;3CD728D5-9818-47B3-AED9-099463BAC77E	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Antimetabolite	31;31;31;31;31;31;1	168;112;Not Available;112;Not Available;504;168	126;69;505;69;752;269;126	Taxol;Cytoxan;Arimidex;Adriamycin;Zometa;Tamoxifen;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Complete Response	1;1;1;1;1;1;2	4;4;Not Available;4;Not Available;Not Available;Not Available	230-298;1020;1;102;4;10;Not Available	mg;mg;mg;mg;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Maintenance (for osteopenia);Not Applicable;Not Applicable	1;2;5;3;6;4;Not Available	IV;IV;PO;IV;IV;PO;Not Available	NO;NO;YES;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Other, specify in notes;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Bisphosphonate;Not Available;Not Available	1006;4080;Not Available;408;Not Available;Not Available;Not Available	mg;mg;Not Available;mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;YES	2011;2011;2011;2011;2011;2011;2013	Not Available	20-29%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0CL-F14457;TCGA-A2-A0CL-F59313	CE691542-B93E-4911-B72C-B246A8887DA1;EC083639-8177-453D-8451-0BF534DE6082				9;8		Not Available;None	Not Applicable;Not Applicable	1964;3015		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	14	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	9	0	No	A0CL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-A2-A0CL-R7419	5579f19f-ae39-4394-8043-dd64e58b60f8	1	31	255	206	Not Available	1	61	11080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2006
TCGA-EW-A6SD	FEMALE	1010	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1010			TUMOR FREE				32	Left;Left Upper Outer Quadrant	Not Available	Not Available	TCGA-EW-A6SD	42378DBC-A123-4CF9-8502-165E89FDA271	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	14	-12006	Not Applicable	0	1010	Not Available	Not Available	TCGA-EW-A6SD-D71030	8617823B-CDC1-4292-A1A7-F1D9B9ABBA73	Not Available	14	198	86	TCH	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2015	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	31	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	No	A6SD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-EW-A6SD-R71031	DD24B5DA-6930-49C2-80AD-BC5FF24B767B	Not Available	14	288	239	Not Available	3	23	46	NO	External	Not Applicable	Not Available	Not Available	Not Available	2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	EW	Breast	Not Applicable	Alive	2015	2012
TCGA-AC-A6IW	FEMALE	413	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	413			TUMOR FREE				73	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A6IW	8183F0FB-2303-4D7B-BCCD-55E5031FC7DF	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-26896	Not Applicable	0	21	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A6IW-F64106	A62988AE-F527-4DAB-B4F0-F6FD96DC156F				26			Not Applicable	413																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A6IW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2013
TCGA-BH-A0DI	FEMALE	912	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	912			TUMOR FREE				63	Right	Not Available	Not Available	TCGA-BH-A0DI	27ba717a-5cd8-440a-9345-4ae086f6efca	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	11	-23327	Not Applicable	0	673	Not Available	NO	TCGA-BH-A0DI-D58707;TCGA-BH-A0DI-D58708;TCGA-BH-A0DI-D58709	062DAD22-5616-49FF-9EE5-1C0763405FEE;CD0C2F47-0F49-4143-8B90-4DD1AEF83C03;443925EA-94E1-4E24-96E1-9D9EAC2A280A	Not Available;Not Available;Not Available	22;22;22	194;194;319	131;131;215	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0DI-F58698	31AD28DA-0E4B-4F0D-95BF-E74BE74D8070				22			Not Applicable	912																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	3	Not Available	No	A0DI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site;Primary Tumor Field	TCGA-BH-A0DI-R58701;TCGA-BH-A0DI-R58704;TCGA-BH-A0DI-R58706	F056AB35-31BF-4599-ABE9-440E2C255424;67811850-0D4F-4182-8CBF-45970A1F7B64;638AB258-DB1B-4910-9106-5FA88FB73D59	Not Available;Not Available;Not Available	22;22;22	402;357;369	362;322;363	Complete Response;Complete Response;Complete Response	4;4;4	28;25;5	50;45;10	NO;NO;NO	External;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Gy;Gy;Gy	2014;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2009
TCGA-C8-A1HJ	FEMALE	5	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	5			TUMOR FREE				53	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HJ	a855c228-a263-44df-87a0-cbc32187e3f5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	1	-19629	Not Applicable	0	5	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	10	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	Not Available	Not Available	No	A1HJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0SY	FEMALE	1347	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1	M0	Stage IIIA	0	1347			TUMOR FREE				62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0SY	dc696e3c-f448-468f-a576-f4429be0338a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	12	-22928	Not Applicable	0	1154	Not Available	Not Available	TCGA-A2-A0SY-D3394;TCGA-A2-A0SY-D3401;TCGA-A2-A0SY-D3408;TCGA-A2-A0SY-D3399;TCGA-A2-A0SY-D3397	25d2f8f4-0b06-4677-b483-998d03b900e1;03bf9c75-4ae4-4747-a8b1-e1823ce91368;75561abb-f715-4b09-b607-0ebecf96ca9f;ee88474f-8a2d-4902-9de7-f016aac05379;c8d31da4-4cdc-4236-9aff-f8004227981c	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;256;Not Available;Not Available	Taxotere;Herceptin;Arimidex;Cytoxan;Adriamycin	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	4;Not Available;Not Available;4;4	Not Available;Not Available;1;Not Available;Not Available	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;4;5;3;2	IV;IV;PO;IV;IV	NO;NO;YES;NO;NO	Chemotherapy;Targeted Molecular therapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0SY-F13943	F8198FBA-D635-4B1C-82E7-56851120B8B6				18		Not Available	Not Applicable	1347		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified	Not Available	60	Not Available	Not Available	4.8	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Positive	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	1	0	No	A0SY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0SY-R3410	39a5f3b7-96ba-4021-8108-609f4a14186f	1	12	263	216	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2007
TCGA-BH-A42U	FEMALE	3364	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	3364			Unknown				80	Right	Not Available	Not Available	TCGA-BH-A42U	2DC1CEC9-925A-417F-9E21-3C2143E711B4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	1	-29330	Not Applicable	0	3324	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A42U-F61923	19515634-4B7A-46FC-8FFD-C9C2EB15C93A				10			Not Applicable	3364																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A42U	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2012	2004
TCGA-E2-A15L	FEMALE	626	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	626			TUMOR FREE				65	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A15L	37242f5a-25ae-4b1f-9ce6-09ce1dc92539	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	13	-23845	Not Applicable	0	331	Not Available	NO	TCGA-E2-A15L-D18887	50C9B52E-A733-4A39-89C6-A845EDDC1CC5	Not Available	15	Not Available	45	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15L-F18885	CA37A855-FA95-4FBE-A554-B8424DF1544F				15		Not Available	Not Applicable	626		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	30-39%	Not Available	2+	Not Available	Not Available	Not Available	0.9	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15L	TUMOR FREE	Allred score 5+3 = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-GM-A2DM	FEMALE	3226	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3226			TUMOR FREE				57	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DM	753D5D49-3B40-4737-9D4C-B1EC29CC2692	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	30	-21160	Not Applicable	0	2331	Not Available	NO	TCGA-GM-A2DM-D47106;TCGA-GM-A2DM-D47107;TCGA-GM-A2DM-D47108;TCGA-GM-A2DM-D47109;TCGA-GM-A2DM-D47110	AADE02DF-74F2-4DD1-A0AE-1429B9186906;140AE260-F266-41E9-9467-8C7E03D3AB54;873034B7-62ED-4DD0-AD5C-84DAB7801B20;7C8F3B47-B784-4B27-9FB2-7B466008E490;B5B25354-BF47-47EA-B68D-748265329F82	Not Available;Not Available;Not Available;Not Available;Not Available	22;22;22;22;22	169;218;218;218;772	81;176;176;176;279	Taxol;Fluorouracil;Epirubicin;Cytoxan;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;NO	2013;2013;2013;2013;2013	Not Available	40-49%	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A2DM-F47104	3ACB5CDD-7AFC-45D0-9145-0EC2DD8EE8E0				22			Not Applicable	3226																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2DM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	30-39%	WHITE	Not Available	Primary Tumor Field	TCGA-GM-A2DM-R47105	8493586C-8C86-4027-959A-2E8975783875	Not Available	22	273	237	Complete Response	8	26	52	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2004
TCGA-BH-A0H6	FEMALE	747	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	NX	M0	Stage I	0	747			TUMOR FREE				82	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right	No axillary staging	Not Available	TCGA-BH-A0H6	aeb6a3a6-b57a-4c53-90e6-e833777dd2a1	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	10	-30125	Not Applicable	0	747	Not Available	Not Available																								H-SCORE 230	50-59%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0H6-F4711	529564A6-8E4A-4B86-A79C-43009E0AB551	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	747	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	0	No	A0H6	TUMOR FREE	H-SCORE 250	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	60-69%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0H6-R4707	30C78395-364D-4EDC-97D5-D54F53759758	1	22	97	64	Not Available	11	20	5208	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	NX	T1b	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-AR-A1AX	FEMALE	2629	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	2629			Not Available				64	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AX	f72c1d69-da35-459f-8542-59bfd6c09c23	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	14	-23507	Not Applicable	0	1103	Not Available	Not Available	TCGA-AR-A1AX-D22145;TCGA-AR-A1AX-D22147;TCGA-AR-A1AX-D22144;TCGA-AR-A1AX-D22143;TCGA-AR-A1AX-D22146;TCGA-AR-A1AX-D22142	8B22C59E-5DAE-4372-A2A9-CD57D6D84D53;B73644E2-BE84-462A-8A8A-7DD3B1096370;34AD7E93-C4C1-4D25-AB5B-2DB9F3864B85;9E6B462C-33CD-4914-B565-BF5F728AA385;D3CAF54C-B16D-4B4C-BB7E-85033DB79E0E;EBFA7185-C765-4E3A-95B6-F841E01AD17C	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1	482;Not Available;160;Not Available;295;Not Available	117;341;Not Available;54;249;54	Trastuzumab;Letrozole;Paclitaxel;Cytoxan;Exemestane;Doxorubicin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	Not Available;Not Available;4;4;Not Available;4	2;2.5;Not Available;Not Available;25;Not Available	mg/kg;mg/day;Not Available;Not Available;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;4;1;1;3;1	IV;PO;Not Available;Not Available;PO;Not Available	NO;YES;NO;NO;NO;NO	Immunotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A1AX-F22140;TCGA-AR-A1AX-F49480;TCGA-AR-A1AX-F71720	ED2AD3DF-F314-4146-A0BA-B3C01F970ED9;3C2C45B7-1BAB-4945-8691-5213ECC2496A;1A4724BC-BF17-4BE0-B7A2-9BD4E3960306				1;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1103;1890;2629		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	3;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AX-R22141	FD178C27-E6A3-460C-95B5-BB1D1CC94E82	1	1	242	194	Not Available	3	33	6060	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-E9-A1R6	FEMALE	339	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	339			TUMOR FREE				63	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1R6	4842bac3-abaa-4900-871f-f2c3ba6457f5	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	28	-23347	Not Applicable	0	84	Not Available	NO	TCGA-E9-A1R6-D30848	04E8410B-36AD-4102-B74E-60586DD6717C	Not Available	17	Not Available	66	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1R6-F30847;TCGA-E9-A1R6-F39520	9F411262-22A5-4C5D-952D-6F805D9C2FCA;60A76A6C-E151-40D3-8D86-79F68C50F4E4				25;24		Not Available;None	Not Applicable;Not Applicable	339;339		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	9;1	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2013;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1R6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A1R6-R30849	CB247066-616B-43C5-8432-131360C166F1	1	17	125	96	Not Available	4	23	4600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A12D	FEMALE	2515	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	2515			TUMOR FREE				43	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A12D	2fe854b4-bac9-4801-9a1c-ee99388e8082	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	8	-15774	Not Applicable	0	1948	Not Available	Not Available	TCGA-AO-A12D-D5974;TCGA-AO-A12D-D5973;TCGA-AO-A12D-D5971;TCGA-AO-A12D-D5972	9e959e52-721e-4948-8ebb-0b025e5cf4a5;67744251-ab75-4c28-8782-6df6f473f4ed;cc8a523b-e65b-4413-95b9-ee3bb5e88e41;6c48065e-2a03-4fe6-a4d7-d5ceaba2cc5f	Not Available;Not Available;Not Available;Not Available	10;10;10;10	503;212;128;128	170;149;65;65	Trastuzumab;Albumin-Bound Paclitaxel;Cyclophosphamide;Doxorubicin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	17;4;4;4	6;200;600;60	mg/kg;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;1728;3984;400	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	66	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;None;None	TCGA-AO-A12D-F5892;TCGA-AO-A12D-F19429;TCGA-AO-A12D-F43438	4E3E7D26-A688-4A6A-9F05-FDD4D6B7978B;357AAC1A-1D70-4199-85AD-44F31A28AEFB;497D877B-0253-4505-92FD-BD836D1444F6	Not Available;None;None	Not Available;None;None	Not Available;None;None	8;12;21	Not Available;None;None	Not Available;Not Available;None	Not Applicable;Not Applicable;Not Applicable	1948;2151;2515	Not Available;None;None	Not Available;Not Applicable;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;Scheduled Follow-up Submission;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;None;NO	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	12;12;5	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;NO;None	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;NO	TUMOR FREE;Not Available;TUMOR FREE	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	YES;YES;YES	Not Available;None;None	YES;YES;YES	Alive;Alive;Alive	2010;2011;2013	FEMALE	Not Available	3+ Positive	90-99%	>=2.0 Positive	3+	32	Not Available	441	6.7	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	0	No	A12D	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A12D-R5893	be918525-d872-4c32-9a3b-104e79637323	1	8	316	282	Not Available	12	25	10000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2005
TCGA-BH-A1FC	FEMALE	3472	Medullary Carcinoma	Breast	Dead	T1c	N1b	M0	Stage IIA	0	3472			TUMOR FREE				78	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FC	b97bf89a-7a85-4eef-ae7e-f787aead1f0a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	8	-28706	3472	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Available	23	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1FC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T1c	localized segmental mastectomy with axillary node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-A8-A08S	FEMALE	1004	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	M0	Stage IIA	0	1004			TUMOR FREE				71	Left	Not Available	Not Available	TCGA-A8-A08S	2779fa01-ac93-4e80-a997-3385f72172c3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-25994	Not Applicable	0	580	Not Available	Not Available	TCGA-A8-A08S-D37747	F9B9A52B-AF15-41B3-9116-D18A681DCB1B	n/a	6	Not Available	62	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08S-F40560	A5D239B1-ABC3-4829-A371-345C8E7AA795				24			Not Applicable	1004																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A08S	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08S-R38153	AEAE8ED5-C523-482A-A2FA-F1B611263248	Not Available	11	62	31	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Surgical resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-5L-AAT1	FEMALE	1471	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M1	Stage IV	0	1471			WITH TUMOR				63	Left	Other (specify)	Level 1 clearance	TCGA-5L-AAT1	16FC3677-0393-4ED1-AD3F-C8355F056369	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	15	-23225	Not Applicable	0	1471	Not Available	Not Available	TCGA-5L-AAT1-D63716	747059AE-DC7B-409F-9178-2DD683C19A6F	Not Available	15	Not Available	46	Letrozol	Not Applicable	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	80-89%	HISPANIC OR LATINO	Bone	Not Available	Not Available																																																																																																									FEMALE	Not Available	CISH	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	Yes	AAT1	WITH TUMOR	Not Available	CISH	Not Available	Not Available	Not Available	YES	YES	10-19%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M1	N0	T2	Not Available	NO	YES	5L	Breast	Not Applicable	Alive	2014	2010
TCGA-3C-AAAU	FEMALE	4047	Infiltrating Lobular Carcinoma	Breast	Alive	TX	NX	MX	Stage X	1	1808.0	Lung	Distant Metastasis	WITH TUMOR				55	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-3C-AAAU	6E7D5EC6-A469-467C-B748-237353C23416	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	13	-20211	Not Applicable	0	3767	Not Available	Not Available	TCGA-3C-AAAU-D60350	B8C5D175-54E9-4659-A630-DC1EA2BBD315	Not Available	6	Not Available	1828	Zoladex	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	YES	2014	Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-3C-AAAU-F68069;TCGA-3C-AAAU-F71341	238F65F8-617D-4508-B006-20A31E09D1C6;D7B0BC51-D86F-4554-939E-EA9A24DE581D				13;24			Not Applicable;Not Applicable	3928;4047																				NO;NO																						11;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	1808;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Lung;Not Available	Distant Metastasis;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;NO	WITH TUMOR;WITH TUMOR						YES;NO		NO;NO	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Not Evaluated	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	Not Available	No	AAAU	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	50-59%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	NX	TX	Not Available	NO	YES	3C	Breast	Not Applicable	Alive	2014	2004
TCGA-A2-A25E	FEMALE	3204	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	1	2989.0	Other, specify	Locoregional Recurrence	TUMOR FREE				34	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A25E	ba89cb4f-cd63-47b1-9550-76fdaff89f2e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-12601	Not Applicable	0	2511	Not Available	NO	TCGA-A2-A25E-D14568;TCGA-A2-A25E-D14569;TCGA-A2-A25E-D14564;TCGA-A2-A25E-D14567;TCGA-A2-A25E-D14570;TCGA-A2-A25E-D14565;TCGA-A2-A25E-D44981	189903E4-A8AF-4AE4-A953-0928F10646D2;335FCDB6-340C-4A4F-B08B-F509B2B0DEF5;019B2AA1-9E61-4BE6-BDE1-B885EEE5589B;0D2DEFB3-3E8B-4761-8BD1-897AB03EFA98;029F44F2-9A34-45CF-8E9F-2AFEB11BE5CD;63600442-2336-493D-BC5F-CECB9800FD53;99D343A1-BE9A-407D-80DC-45B049932EE1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;22;2	136;136;601;242;Not Available;2155;Not Available	67;67;250;158;2380;334;3055	Cytoxan;Adriamycin;Herceptin;Taxol;Goserelin;Tamoxifen;Anastrozole	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Applicable	7;7;7;7;7;7;7	4;4;47;12;Not Available;Not Available;Not Available	900;90;98-196;120;3.6;10;Not Available	mg;mg;mg;mg;mg;mg/m2/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Preventative;Not Applicable;Not Applicable	4;5;1;3;6;2;Not Available	IV;IV;IV;IV;SC;PO;Not Available	NO;NO;NO;NO;YES;NO;YES	Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3600;360;5142;1440;Not Available;Not Available;Not Available	mg;mg;mg;mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;NO	2011;2011;2011;2011;2011;2011;2013	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A25E-F31056;TCGA-A2-A25E-F44982	9F95AA80-AEE0-46FA-8B16-BB4787BD8D32;6AAA3968-F33A-48E5-AFBE-404BF56B0F02				23;2		Not Available;None	Not Applicable;Not Applicable	2796;3204		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;7	Not Available;None	Not Available;None	Not Available;None	NO;None	None;YES	None;NO	None;3024	None;2989	None;Not Available	None;Not Available	None;1+	None;Not Available	None;90-99%	None;Positive	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;3+	None;3 Point Scale	None;2+	None;3 Point Scale	None;Negative	None;Not Evaluated	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;<10%	None;Positive	None;Other, specify	None;Locoregional Recurrence	None;Left Chest Wall	None;YES	None;Not Available	None;YES	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	2.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Equivocal	Equivocal	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	6	Not Available	No	A25E	TUMOR FREE	Not Available	Not Available	Not Available	Strong, using scale of Weak, Moderate and Strong	Moderate using scale of Weak, Moderate, Strong	Not Available	YES	60-69%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-A2-A25E-R14572	5A937750-CD3F-454B-99C4-779547CF9062	1	21	333	292	Not Available	7	84	10640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2004
TCGA-BH-A0DL	FEMALE	2381	Other, specify	Breast	Alive	T2	N0	M0	Stage IIA	0	2381			TUMOR FREE				64	Left	Not Available	Not Available	TCGA-BH-A0DL	ba39bfbc-5cac-4f6c-b55c-4eee3466ee93	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	11	-23628	Not Applicable	0	1467	Not Available	NO	TCGA-BH-A0DL-D60392;TCGA-BH-A0DL-D60393	ED098E0D-9D8B-45CE-BCD7-8583BBCAAE58;31BEEEBA-90EE-411E-AD7B-89ABD5BE59B9	Not Available;Not Available	9;9	121;205	58;58	Cytoxan;Taxotere	Complete Response;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0DL-F60389	68E48067-EBC1-4A4C-90F4-73945B7413AD				9			Not Applicable	2381																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Infiltrating ductal carcinoma with metaplastic carcinoma and focal apocrine features	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0DL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DL-R60391	1BDA7B8A-1E8C-4A96-832E-5D9489A9F1AD	Not Available	9	205	154	Complete Response	6	36	6640	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-B6-A0RH	FEMALE	6456	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	1	2165.0	Other, specify	Locoregional Disease	TUMOR FREE				51	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RH	c3148e68-1739-4334-abda-1dcbc2166846	Negative	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	15	-18759	Not Applicable	0	5749	Not Available	Not Available																								Immunohistochemistry	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;None	YES;None	YES;None		TCGA-B6-A0RH-F13794;TCGA-B6-A0RH-F71512	7C07AC9E-BAE5-4C5C-9BCB-956AAEB7A12C;8AD42059-F3DB-4B45-B375-F6321BA31CCF				12;26		2268;None	Not Applicable;6456	5749;Not Available		2165;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Evaluated;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Evaluated;None	Not Evaluated;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Evaluated;None	7;3	Other, specify;None	Locoregional Disease;None	Chest Wall;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Dead	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Not Evaluated	Not Evaluated	23	Positive	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0RH	TUMOR FREE	Immunohistochemistry	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2011	1991
TCGA-A8-A06U	FEMALE	883	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1a	M0	Stage IIB	0	883			TUMOR FREE				80	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A06U	6bc4c56d-aac5-49a2-9913-9538d06d898f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-29525	883	0	Not Available	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A06U-F40817	B73596BB-A8E2-4419-A10A-5FB43A34299B				2			883	Not Available																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A06U	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Dead	2011	2008
TCGA-AO-A03T	FEMALE	2124	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2124			TUMOR FREE				42	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A03T	dd6b64a8-d546-4fd1-bbbd-ac9703791cae	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	19	-15540	Not Applicable	0	1187	Not Available	Not Available	TCGA-AO-A03T-D3059;TCGA-AO-A03T-D3061;TCGA-AO-A03T-D3062;TCGA-AO-A03T-D3065;TCGA-AO-A03T-D3070;TCGA-AO-A03T-D3068	b907f99e-3495-43b4-b00a-67573ac72ce9;febd5704-d4cd-477f-8be2-22d0c03c0826;faee37a8-911b-420f-a9a3-de6d58ef9583;ab1ed21c-89e2-4211-8db0-501a91fcb91d;89f9ff00-958d-462b-9439-712c34271b9b;02ff28ad-6659-4062-8dd8-45461526756a	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;19;19;19;19;19	122;122;178;1095;Not Available;Not Available	80;80;136;232;1095;1130	CYCLOPHOSPHAMIDE;DOXORUBICIN;PACLITAXEL;TAMOXIFEN (NOVADEX);LUPRON;LETROZOLE (FEMARA)	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9	4;4;4;Not Available;Not Available;Not Available	600;60;175;20;7.5;2.5	mg/m2;mg/m2;mg/m2;mg/day;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2;3;3	IV;IV;IV;PO;IM;PO	NO;NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4032;404;1176;Not Available;Not Available;Not Available	mg;mg;mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;None;None	TCGA-AO-A03T-F3255;TCGA-AO-A03T-F15475;TCGA-AO-A03T-F43476	25D19A8C-2173-4BC0-815E-256998CB4135;2331CB7A-6AD6-4EE4-93E8-FC79C2F2E561;7BFCB10D-E59D-4D33-92A0-B27E4BE856C9	Not Available;None;None	Not Available;None;None	Not Available;None;None	19;22;22	Not Available;None;None	Not Available;Not Available;None	Not Applicable;Not Applicable;Not Applicable	1187;1456;2124	Not Available;None;None	Not Available;Not Applicable;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;Scheduled Follow-up Submission;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;None;NO	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	9;8;5	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;NO;None	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;NO	TUMOR FREE;Not Available;TUMOR FREE	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	YES;YES;YES	Not Available;None;None	NO;YES;NO	Alive;Alive;Alive	2010;2011;2013	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A03T	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2007
TCGA-A2-A0CX	FEMALE	1728	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1728			TUMOR FREE				52	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CX	c744fc13-3aca-4245-9e24-abd368cc8bef	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	10	-19152	Not Applicable	0	1303	Not Available	Not Available	TCGA-A2-A0CX-D1966;TCGA-A2-A0CX-D1963;TCGA-A2-A0CX-D1962;TCGA-A2-A0CX-D1964;TCGA-A2-A0CX-D1965;TCGA-A2-A0CX-D1967;TCGA-A2-A0CX-D1968	f97daa85-db58-457f-9c18-66c61a97cfcf;dcb6e770-4623-4b7b-81dc-ed8d4d0a0f44;76481ee3-1221-4453-8712-e377d62dadcc;b6f6197b-da60-4a3c-8ad3-684df50b6dfa;f31ba050-8c08-4914-b20d-75d85501bb13;7eae7122-ba45-4ed8-86c7-0b0b15f5a9e8;aa0d58a3-07f6-4683-b664-53d0eec5ffcf	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13	Not Available;127;127;169;367;Not Available;1273	601;64;64;148;162;686;1184	Zoladex;Adriamycin;Cytoxan;Taxol;Herceptin;Letrozole;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9	Not Available;4;4;4;Not Available;Not Available;Not Available	3.6;126;1250;165;200-600;2.5;20 mg daily	mg;mg;mg;mg;mg;mg;mg	OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Given to induce menopause;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	5;2;1;3;4;6;7	IM;IV;IV;IV;IV;PO;PO	NO;NO;NO;NO;NO;YES;NO	Other, specify in notes;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Hormone Therapy;Hormone Therapy	Given to induce menopause;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;504;5000;660;Not Available;Not Available;Not Available	Not Available;mg;mg;mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0CX-F13721	2A0B12FB-64F9-49DF-ACC6-22D1110B827C				10		Not Available	Not Applicable	1728		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0CX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Not Available	TCGA-A2-A0CX-R1969	69e31ee3-a4ba-40bf-b722-f1a229006582	1	13	305	Not Available	Not Available	9	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2006
TCGA-AC-A3W6	FEMALE	0	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1	MX	Stage IIIA	0	0			TUMOR FREE				90	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A3W6	1B4CFAD1-E353-4411-97B6-2B7B9309E95E	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	24	-32872	Not Applicable	0	0	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3W6-F57046	533C3FB1-7B9B-41B8-8BC4-63C503E2A3EF				28			Not Applicable	0																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	3	Yes	A3W6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	20-29%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2012
TCGA-A1-A0SQ	FEMALE	554	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	MX	Stage IIB	0	554			TUMOR FREE				45	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SQ	08de63a2-7b76-43c3-80dc-df748b1d81bc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	30	-16458	Not Applicable	0	554	Not Available	NO	TCGA-A1-A0SQ-D15541;TCGA-A1-A0SQ-D15544;TCGA-A1-A0SQ-D15542	6EF5104B-825D-4C69-94C9-85CB727D5457;CC54C460-ED66-4313-9C2B-BA4816081388;DE1DD233-6EE9-4C5D-8CAB-CF9336114C4A	Not Available;Not Available;Not Available	24;24;24	Not Available;Not Available;237	148;299;Not Available	ac;tamoxifen;taxol	Not Available;Not Available;Not Available	8;8;8	4;Not Available;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A0SQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A1-A0SQ-R15543	DB4CABEB-052D-429F-ACF7-B550C6495F80	Not Available	24	329	268	Not Available	8	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2011	2007
TCGA-D8-A1XY	FEMALE	503	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	503			TUMOR FREE				74	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XY	0130d616-885e-4a6c-9d03-2f17dd692a05	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	9	-27106	Not Applicable	0	81	Not Available	NO	TCGA-D8-A1XY-D29995	4983452A-0399-4CBE-BCDF-9F09A21FC698	Not Available	31	Not Available	421	Tamoxifen	Not Available	3	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XY-F29994	85C03FE0-C6F1-4428-A4D2-749634FC006D				31		Not Available	Not Applicable	503		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	HerceptTest TM Dako	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Evaluated	3	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1XY	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0RX	FEMALE	170	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	170			TUMOR FREE				59	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0RX	e828455d-4680-41b2-8a1c-1582e3790d62	Not Available	Negative	Not Available	0	Not Available	Not Evaluated	Negative	Other	Not Applicable	NO	11	-21857	Not Applicable	0	170	Not Available	Not Available	TCGA-BH-A0RX-D4873;TCGA-BH-A0RX-D4872;TCGA-BH-A0RX-D4874	5D132A06-F3D4-4E01-ACBA-37EBA9BACD22;CBEF5FFD-0B68-4780-939F-C001E4A34CCB;A90F4DFB-A730-4F63-B6A4-BDC3570C9474	Not Available;Not Available;Not Available	18;18;18	155;155;155	50;50;50	Fluorouracil;Cyclophosphamide;Methotrexate	Not Available;Not Available;Not Available	11;11;11	6;6;6	1122;1122;75	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	6808;6808;447	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	H-Score 0	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	Not Available	TCGA-BH-A0RX-F4875	4CFEECD1-12BC-496C-9B8E-2E006F072A1E	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	170	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0RX	TUMOR FREE	H-Score 0	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2010
TCGA-AR-A5QQ	FEMALE	322	Other, specify	Breast	Dead	T3	N1	M0	Stage IIIA	1	301.0	Other, specify	Locoregional Recurrence	TUMOR FREE				68	Right	Axillary lymph node dissection alone	Not Available	TCGA-AR-A5QQ	3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	15	-24841	322	0	Not Available	Not Available	Not Available	TCGA-AR-A5QQ-D43954;TCGA-AR-A5QQ-D43955;TCGA-AR-A5QQ-D43958;TCGA-AR-A5QQ-D43960;TCGA-AR-A5QQ-D43962;TCGA-AR-A5QQ-D43964	1E5134F3-A59A-400F-B7B0-64A9497A1897;BE51B815-9DB6-447D-8819-873D08EDAB68;A25A87ED-0EBE-4D81-AE56-A8F243B5743B;7E77E139-F8F0-4B5C-8487-8CAAF7C8D746;DD9E6CBF-F1BB-4B39-AEBA-AA7A777C9EEC;64A6D9AB-D9A7-47AE-BB5D-FC484F6E56ED	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10	91;91;143;143;143;143	69;69;119;119;119;119	Carboplatin;Taxol;Ifosfamide;MESNA-1;MESNA-2;VP-16	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Ancillary;Ancillary;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A5QQ-F42734	8318BD8E-9128-4A44-AB63-98E5A2459230				10			322	Not Available																				NO																						6					Not Available	Not Available	Not Available	301	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Lung	Distant Metastasis	Liver, bone, chest wall, adrenal glands	Not Available	Not Available	YES	WITH TUMOR						YES		YES	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Squamous (metaplastic) carcinoma	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	24	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	301;301;301;301;301	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Other, specify;Lung;Liver;Bone;Other, specify	Locoregional Recurrence;Distant Metastasis;Distant Metastasis;Distant Metastasis;Distant Metastasis	chestwall;Not Available;Not Available;Not Available;Adrenal glands	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES	1	Not Available	No	A5QQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-AR-A5QQ-R42765	36D43FF0-8472-4D18-9916-39F7D4FAF10C	Not Available	10	233	Not Available	Not Available	6	34	6120	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2013	2011
TCGA-A7-A4SC	FEMALE	446	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	446			TUMOR FREE				62	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A7-A4SC	EC0AB947-9341-4FFF-BDA4-FDFB9434D508	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	20	-23008	Not Applicable	0	215	Not Available	Not Available	TCGA-A7-A4SC-D40466;TCGA-A7-A4SC-D40469	4CDA31F3-7B21-4B73-9B41-8406C9958051;D20C10DB-BE58-4536-9BE0-3547209715C7	Not Available;Not Available	21;21	139;Not Available	61;169	TAMOXIFEN;TAMOXIFEN	Unknown;Not Applicable	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.2					TCGA-A7-A4SC-F49714	E86BB295-DEB8-4683-9676-D7244DFA8E00				8			Not Applicable	446																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA Probe kit	3+	303	Not Available	2.4	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4SC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field;Regional site	TCGA-A7-A4SC-R40460;TCGA-A7-A4SC-R40463	70B29690-4181-48E2-A7CC-FC358B2090F8;FA5C4F6B-BC17-4C50-A49D-9985D4D9ABDC	Not Available;Not Available	21;21	168;166	130;130	Complete Response;Complete Response	2;2	28;26	5040;4680	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-E9-A22B	FEMALE	1167	Mixed Histology (please specify)	Breast	Alive	T1c	N0	M0	Stage IA	0	1167			TUMOR FREE				71	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A22B	b956df1b-bc77-4bdb-a5bd-5dda7b4c8da7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	YES	2	-26278	Not Applicable	0	0	Not Available	NO	TCGA-E9-A22B-D30663	39291295-C212-4E0E-8B9F-08F63DD0A88F	Not Available	13	Not Available	50	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	7240	mg	Not Available	2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A22B-F30662;TCGA-E9-A22B-F39786;TCGA-E9-A22B-F64425	73E4C2B9-86C7-4A6F-8CB5-AAF19812E59E;9E2ED482-C9F8-4510-9A4A-BFA94732EE48;6867212E-A944-4228-844E-00D426464E1F				21;1;2		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	315;692;1167		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	7;2;9	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2014;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A22B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-EW-A1OZ	FEMALE	1229	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1229			TUMOR FREE				56	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1OZ	8f912a40-3251-4e1f-ae65-1f93d71f9881	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Other	Not Applicable	YES	11	-20664	Not Applicable	0	941	Not Available	NO	TCGA-EW-A1OZ-D30296;TCGA-EW-A1OZ-D30295;TCGA-EW-A1OZ-D30293;TCGA-EW-A1OZ-D30297;TCGA-EW-A1OZ-D30292	39ED2156-1E5E-4477-ACB2-C08C764C86FB;AABA0EBE-E734-4D86-883A-695AB14363E4;D68A7ED2-A4F6-4C19-A54D-7340BF471708;3E70EEE7-3272-4696-9D31-32FA4D397B05;4D0A2FAD-1E7F-4624-B437-150EF0D4E686	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	487;291;228;Not Available;186	144;256;144;301;144	Trastuzumab;Paclitaxel;Carboplatin;Aromasin;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	17;5;4;Not Available;3	516;152;552;25;142	mg;mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2;1	IV;IV;IV;PO;IV	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	8772;599;1961;Not Available;426	mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2	Not Available	Not Available	Not Available		TCGA-EW-A1OZ-F29098	652D6657-335D-47DD-B917-8793B786C736				8		Not Available	Not Applicable	1229		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	20-29%	Not Available	2+	40	Not Available	Not Available	2.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1OZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	total mastectomy	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-C8-A1HK	FEMALE	366	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	366			TUMOR FREE				53	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HK	52c35691-efca-42f5-a03e-02c9f872275c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	1	Not Available	Not Applicable	0	7	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A1HK-F19100	A1CA0508-80BE-4CA1-A509-E54F50DEB1A9				2		Not Available	Not Applicable	366		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Positive	Not Evaluated	8	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	Not Available	Not Available	No	A1HK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A5ZX	FEMALE	336	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	336			TUMOR FREE				48	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A5ZX	BA80DB4E-D899-4DA4-AE49-5263D98E1530	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	13	-17683	Not Applicable	0	132	Not Available	Not Available	TCGA-A7-A5ZX-D51332;TCGA-A7-A5ZX-D51333;TCGA-A7-A5ZX-D51334;TCGA-A7-A5ZX-D52815	9C29891D-CFA8-48D4-A646-C3AD561F20DA;F5C792BC-E5C5-4C56-9434-A746E1B17038;46461AEB-BAB0-45F1-A893-FCD00A28BBEA;056878FC-D30B-4BF4-8BD2-972B61510B2D	Not Available;Not Available;Not Available;Not Available	15;15;15;6	118;118;174;Not Available	76;76;132;268	Doxorubicin;Cyclophosphamide;Paclitaxel;Tamoxifen	Complete Response;Complete Response;Complete Response;Complete Response	11;11;11;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A5ZX-F52721	4168828D-E26A-4495-896F-2164A95A9FC2				6			Not Applicable	336																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	24	Unknown	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	21	Not Available	Yes	A5ZX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO	Primary Tumor Field;Regional site	TCGA-A7-A5ZX-R51335;TCGA-A7-A5ZX-R51336	0352DA94-E095-4DB4-96EE-242B04B52219;F1E49549-94E9-4C73-BEE1-843F26ACAF97	Not Available;Not Available	15;15	263;263	227;227	Complete Response;Complete Response	11;11	28;28	5040;5040	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders.	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-B6-A0RM	FEMALE	2373	Infiltrating Ductal Carcinoma	Breast	Dead	TX	NX	MX	Stage X	0	2373			TUMOR FREE				57	Left	No axillary staging	Not Available	TCGA-B6-A0RM	151f3677-6854-4265-9126-d92c646c67ae	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	NO	2	-21047	2373	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0RM-F13797	FAE88C3C-4AE1-4274-B83F-EDF870D50E59				12		Not Available	2373	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	0	Not Available	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	Not Available	Not Available	No	A0RM	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	MX	NX	TX	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1993
TCGA-A1-A0SM	MALE	242	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	242			TUMOR FREE				77	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SM	784de7ac-8424-42eb-83d4-a1bebaa42b97	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	6	-28198	Not Applicable	0	242	Not Available	Not Available																								Not Available	20-29%	NOT HISPANIC OR LATINO	Not Available	Not Available	2																																																																																																									MALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	21	11	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	3	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	No	A0SM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2010	2007
TCGA-BH-A0C1	FEMALE	1411	Infiltrating Lobular Carcinoma	Breast	Dead	T3	N2a	M0	Stage IIIA	1	1123.0	Bone	Distant Metastasis	WITH TUMOR				61	Right	Not Available	Not Available	TCGA-BH-A0C1	d10a4887-373b-4726-a61d-126f950e4a06	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	11	-22377	Not Applicable	0	1339	Not Available	YES	TCGA-BH-A0C1-D63401;TCGA-BH-A0C1-D63402	61C5552F-F0F5-40A2-9749-2A2F13D9FFDA;5104D7EB-AA20-495D-B052-EA95B8DB9658	Not Available;Not Available	7;7	1167;1167	119;119	Adriamycin;Cytoxan	Clinical Progressive Disease;Clinical Progressive Disease	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0C1-F63399	CD476A7D-DDD8-4815-98A8-9F82F7F0D480				7			1411	Not Available																				NO																						8					Not Available	Not Available	Not Available	1123	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Bone	Distant Metastasis	Not Available	Not Available	Not Available	YES	WITH TUMOR						YES		YES	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	8	Not Available	No	A0C1	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-BH-A0C1-R63403	B71FD2B6-D242-4DE7-8DCC-A78C429010F1	Not Available	7	101	84	Radiographic Progressive Disease	8	14	3500	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-AQ-A1H2	FEMALE	475	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	475			TUMOR FREE				84	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AQ-A1H2	4d120899-9a80-4736-b097-285e9e261bcb	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-30958	Not Applicable	0	230	Not Available	NO	TCGA-AQ-A1H2-D19898;TCGA-AQ-A1H2-D19899;TCGA-AQ-A1H2-D19897	BB2A1345-F78E-4367-87E6-5C17B4221F19;C7DE7726-8978-4819-B64A-71AE48B4A1FF;94375318-4D27-4A4B-A198-FD922F5A1BA1	Not Available;Not Available;Not Available	3;3;3	462;Not Available;182	98;378;98	Herceptin;Arimidex;Taxol	Not Available;Not Available;Not Available	1;1;1	Not Available;Not Available;12	2;1;80	mg/kg;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AQ-A1H2-F19896	BA3554E9-F416-4973-B66A-513126BBBB98				3		Not Available	Not Applicable	475		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	2.7	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Indeterminate	Positive	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	13	Not Available	No	A1H2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-AQ-A1H2-R19901;TCGA-AQ-A1H2-R19902	DB2A4469-F942-4E92-90EE-E8434E806487;D33D7E94-096B-44C0-BFB7-7CCA8794CE55	1;1	4;4	246;243	208;208	Not Available;Not Available	1;1	28;25	5900;5000	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	YES	NO	AQ	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0ER	FEMALE	2263	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IB	0	2263			TUMOR FREE				63	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0ER	7455d832-ad66-40df-85d7-3a7051c4498d	Negative	Positive	Not Available	Not Available	Not Available	Lumpectomy	Positive	Lumpectomy	Not Applicable	YES	13	-23021	Not Applicable	0	1903	Not Available	Not Available	TCGA-A2-A0ER-D1981;TCGA-A2-A0ER-D1980;TCGA-A2-A0ER-D1978;TCGA-A2-A0ER-D1979;TCGA-A2-A0ER-D1982	51090311-5909-4760-bf5a-1cefb8292222;72972060-56c4-4ffe-971d-d5772839072a;81147c8f-47a7-4712-8495-8af0047c51d9;e44399f3-f0fc-40bf-8966-a2644119679e;72844d5d-8e7f-4b64-80a5-ee6e676e0b32	Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;10	154;Not Available;140;140;615	154;183;98;98;327	Docetaxel;Arimidex;Cytoxan;Adriamycin;E-75	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;9	1;Not Available;4;4;7	173;1;1038;104;1000	mg;mg;mg;mg;ug	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Cancer Vaccine Trial	4;3;1;2;5	IV;PO;IV;IV;Not Available	NO;YES;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	173;Not Available;4152;416;7000	mg;Not Available;mg;mg;ug	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0ER-F13719	1D5FC55A-1B4C-4319-89BB-1B2DF2C3FE55				13		Not Available	Not Applicable	2263		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	14	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	0	No	A0ER	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0ER-R1983	a18a9176-c998-41d5-b7b2-07d966053c74	1	13	246	200	Not Available	8	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2005
TCGA-BH-A0BF	FEMALE	1324	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1mi	M0	Stage IIB	0	1324			TUMOR FREE				56	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0BF	e6b79d7a-ed6b-459a-b040-d142616e7ab4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	5	-20691	Not Applicable	0	782	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BF-F59142	F0AF0BD4-A367-46F9-8059-CBDFB34BE1B8				1			1324	Not Available																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	Not Available	No	A0BF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Total mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2009
TCGA-C8-A3M8	FEMALE	394	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	394			TUMOR FREE				68	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-C8-A3M8	C1E704D6-A33B-4891-90BD-992B0040C075	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	6	-24877	Not Applicable	0	7	Not Available	NO	TCGA-C8-A3M8-D70780	1A0AC881-C2A3-4989-8D7D-837481DF0F5B	Not Available	9	Not Available	79	Tamoxifen	Complete Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A3M8-F70779	36BA9AA0-FB67-44C6-8E4E-E8BDB8C92DB5				9			Not Applicable	394																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	Not Available	Not Available	No	A3M8	TUMOR FREE	Not Available	Dako	Not Available	Allred	Allred	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2012	2011
TCGA-AC-A23C	FEMALE	585	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	MX	Stage IIB	0	585			Not Available				62	Left	Not Available	Not Available	TCGA-AC-A23C	dfd0b7ba-c7d3-498e-b455-346301865452	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	14	-22751	Not Applicable	0	29	Not Available	NO	TCGA-AC-A23C-D43236	76E26F66-B516-401D-8620-D4CEF98B70D2	Not Available	15	204	77	Chemo, NOS	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available					TCGA-AC-A23C-F43235	37E3974F-7A96-4CFC-B4DF-D9C320C34423				15			Not Applicable	585																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	1	Not Available	No	A23C	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	50-59%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A1XD	FEMALE	522	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	522			TUMOR FREE				36	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XD	c4699748-f01d-4b30-9c74-1ca77fb84ac1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-13510	Not Applicable	0	155	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XD-F29440	CA295FC1-24C4-40F5-AF2F-AF0B56CE9B37				19		Not Available	Not Applicable	522		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Available	Discrepancy	Negative	Not Evaluated	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	6	Not Available	No	A1XD	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XD-R29441	EFC43768-3277-4FD5-8328-112033D69DF4	Not Available	19	138	109	Not Available	3	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A1RB	FEMALE	976	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	976			TUMOR FREE				40	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RB	94b95984-b2fb-4e42-8887-45e7086c3179	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	28	-14755	Not Applicable	0	21	Not Available	NO	TCGA-E9-A1RB-D30858;TCGA-E9-A1RB-D30856;TCGA-E9-A1RB-D30857;TCGA-E9-A1RB-D30859	ED42B1AF-E7F0-4598-9EFE-12B6AEA180C3;25429B7D-51F9-4C70-AC60-B8148B735388;5E138DC3-70C8-4195-8DF7-2EFC4FA27407;27022DC0-5FA3-4EB4-B968-C35A4655475D	Not Available;Not Available;Not Available;Not Available	17;17;17;17	Not Available;107;107;107	15;11;11;11	Tamoxifen;Methotrexate;5-Fluorouracil;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	4;4;4;4	Not Available;5;5;5	20;100;2000;2000	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;500;10000;10000	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1RB-F30854;TCGA-E9-A1RB-F39530	D5AED3F9-5484-41CC-B13E-8B9FD4CBB938;EEE00A97-63CE-4A0A-A552-0F2F2D98CCC8				17;24		Not Available;None	Not Applicable;976	633;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;1	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Dead	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	0	No	A1RB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-B6-A408	FEMALE	2072	Mixed Histology (please specify)	Breast	Alive	T2	N3a	M0	Stage IIIC	0	2072			TUMOR FREE				55	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A408	9964F447-92AD-4D1E-AF20-11CF84FAB7B0	Not Available	Positive	4 Point Scale	3+	4 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	20	-20102	Not Applicable	0	1519	Not Available	Not Available	TCGA-B6-A408-D41046;TCGA-B6-A408-D41049;TCGA-B6-A408-D41050	921E7A16-C072-47C3-8810-22048A5B72E7;0ED2B906-7178-435B-9882-692FBAA62DC0;2ABDCF82-F819-4FBE-9C37-623C5AC08467	Not Available;Not Available;Not Available	11;11;11	163;163;163	55;58;58	Cyclophosphamide;Docetaxel;Doxorubicin	Unknown;Unknown;Unknown	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.6					TCGA-B6-A408-F59666	3C48974E-14E5-44BF-B964-C5E7C18FF99F				3			Not Applicable	2072																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	20-29%	Not Available	2+	60	Not Available	2.9	1.2	Not Available	Mixed Histology (please specify)	ductal and lobular	No	C50.9	8522/3	C50.9	3+	YES	Not Applicable	Tumor resection	Equivocal	Negative	23	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	10	Not Available	No	A408	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	60-69%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-B6-A408-R41053	A2EEA4E4-5B15-4FB4-A169-6ABF975476FF	Not Available	11	244	208	Unknown	3	24	4800	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	2008
TCGA-AN-A0XR	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	10			Not Available				55	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A0XR	f51af6db-2655-47fb-9ffc-83a503a728ea	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	Not Available	25	-20381	Not Applicable	0	10	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XR-F56951	B7A4A241-84FC-4828-8CEA-3BA465FDF1CA				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	7	Not Available	No	A0XR	Not Available	Not Available	Not Available	Not Available	0	160	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A0JA	FEMALE	655	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	1	143.0	Bone	Distant Metastasis	WITH TUMOR				36	Right Upper Inner Quadrant;Right Lower Inner Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JA	86b7b206-8e69-432d-acc9-bccce710955e	Not Available	Positive	Not Available	1+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	19	-13307	Not Applicable	0	346	Not Available	Not Available	TCGA-AO-A0JA-D3170;TCGA-AO-A0JA-D3168;TCGA-AO-A0JA-D3169;TCGA-AO-A0JA-D3167	357e7201-60df-425e-9cab-dd4722ff6b34;3e3ada60-dd5a-4b4e-8cf2-53587263d938;bdf4593a-cafd-4db8-b132-eb1d37a76eee;3c735330-523e-41f1-9fad-ef714a373d23	Not Available;Not Available;Not Available;Not Available	19;19;19;19	Not Available;Not Available;Not Available;242	292;166;166;166	PACLITAXEL;LEUPROLIDE ACETATE (LUPRON);ZOLEDRONIC ACID;TAMOXIFEN	Not Available;Not Available;Not Available;Not Available	9;9;9;9	7;Not Available;6;Not Available	80;7.5;4;20	mg/m2;mg;mg;mg/day	PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IM;IV;PO	YES;YES;YES;NO	Chemotherapy;Hormone Therapy;Other, specify in notes;Hormone Therapy	Not Available;Not Available;BISPHOSPHONATE;Not Available	980;Not Available;24;Not Available	mg;Not Available;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;Not Available	NO;Not Available	YES;NO	Not Available;None	TCGA-AO-A0JA-F3166;TCGA-AO-A0JA-F15484	9712413C-70D3-4935-AD00-BE1C76671568;DE973A94-D71D-421F-9511-557735C21273	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	143;Not Available	Not Applicable;Not Applicable	346;655	Not Available;None	143;143	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		1+;1+	Not Available;Not Available	<10%;Not Available	Negative;Negative	Not Available;Not Available	3+ POSITIVE;Not Available	<10%;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;4 Point Scale	2+;Not Available	None;4 Point Scale	Negative;Negative	Not Evaluated;Not Available	Not Available;3 Point Scale	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	70-79%;70-79%	Positive;Positive	9;8	None;Bone	None;Distant Metastasis	None;Not Available	None;YES																																		WITH TUMOR;WITH TUMOR	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	NO;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	11	Not Available	No	A0JA	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009
TCGA-B6-A40C	FEMALE	2164	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	0	2164			TUMOR FREE				51	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-B6-A40C	FD0B1B8B-1A76-480A-B61C-D176E4E02C6B	Not Available	Positive	4 Point Scale	3+	4 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	20	-18852	Not Applicable	0	1673	Not Available	Not Available	TCGA-B6-A40C-D41040;TCGA-B6-A40C-D41041;TCGA-B6-A40C-D41043	0EE50169-85A2-4749-923E-DC70257C063A;AF65E574-4989-44B0-B73C-85E950DF1BC6;93C4C94A-4713-49E3-85A0-2D02AF47B8E8	Not Available;Not Available;Not Available	11;11;11	107;107;170	37;37;128	Cyclophosphamide;Doxorubicin;Paclitaxel	Unknown;Unknown;Unknown	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-B6-A40C-F59660	3C1BA7E3-2F4E-4FE3-B558-91284B51CC4E				3			Not Applicable	2164																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A40C	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field	TCGA-B6-A40C-R41044	2765DB95-8665-4445-B94B-390902724055	Not Available	11	254	218	Unknown	3	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	2005
TCGA-C8-A275	FEMALE	1	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	1			TUMOR FREE				56	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-C8-A275	ce887e90-0660-4f44-a3a4-b3b894cb7eda	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Other	Not Applicable	Not Available	21	-20774	Not Applicable	0	1	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A275	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0HQ	FEMALE	1121	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	1121			TUMOR FREE				56	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0HQ	f31c21b6-0f7f-435b-9e24-97c909755c36	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Other	Not Applicable	YES	11	-20719	Not Applicable	0	1121	Not Available	Not Available	TCGA-BH-A0HQ-D4790	BA4DBB81-7F70-4C31-9A0A-D7FEB14DA787	Not Available	17	Not Available	70	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HQ-F4795	3116F5DA-E215-4E25-808D-988778A6B552	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	1121	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0HQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0HQ-R4793	71993FAC-819D-407E-A24D-9460EFFB2804	1	17	156	104	Not Available	11	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-EW-A1OV	FEMALE	789	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	789			TUMOR FREE				56	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1OV	ac68d219-5670-4ddd-8df6-8aa7ad59e5c7	Negative	Negative	3 Point Scale	Not Available	3 Point Scale	Modified radical mastectomy	Negative	Lumpectomy	Not Applicable	YES	27	-20764	Not Applicable	0	523	Not Available	NO	TCGA-EW-A1OV-D30309;TCGA-EW-A1OV-D30310;TCGA-EW-A1OV-D30308;TCGA-EW-A1OV-D29120	A35B4531-1DC9-46D1-A861-9056798B1594;D43BD34B-E399-4B01-9711-CFC5C3099BB2;438AC993-E582-4312-9218-95B3B4AF3C80;0F1217D3-7BF4-4145-9240-DE1C87BE3F50	Not Available;Not Available;Not Available;Not Available	7;7;7;8	252;314;252;252	203;273;203;203	Epirubicin;Docetaxel;Cyclophosphamide;Fluorouracil	Not Available;Not Available;Not Available;Not Available	3;3;3;3	3;3;3;3	178;180;890;890	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	538;545;2690;2690	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1OV-F29119	803F6927-592D-459C-AC6D-DBEB52CA6344				8		Not Available	Not Applicable	789		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	1.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	6	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	1	No	A1OV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-E2-A108	FEMALE	837	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	1				Not Available				64	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-E2-A108	4f04bd10-9902-4a23-b15d-4f4409d79499	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	11	-23530	Not Applicable	0	124	Not Available	Not Available	TCGA-E2-A108-D7774;TCGA-E2-A108-D7776;TCGA-E2-A108-D17424;TCGA-E2-A108-D17915	b5112aa6-5ae8-4f62-9901-d9fb84775ddd;0e5f203f-3c34-4cb7-be76-4901295154cf;D2DB5EB8-9FA3-4CF9-88B7-0FEEDE0C2122;478FCF8A-98C5-4614-BAF3-0E937EBBF1C5	Not Available;Not Available;Not Available;Not Available	14;14;28;27	144;187;Not Available;Not Available	102;151;244;95	Adriamycin;Taxol;Femara;Cytoxan	Not Available;Not Available;Not Available;Not Available	2;2;9;10	4;12;Not Available;Not Available	Not Available;Not Available;2.5;Not Available	Not Available;Not Available;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;3;1	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 7 (outside facility)	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A108-F17423	A33B2D82-E56A-4069-9F2E-D9EED8EEAFBA				28		Not Available	Not Applicable	837		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		WITH TUMOR			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	No	A108	Not Available	Allred score 7 per outside facility report	Not Available	Not Available	Allred score 7 per outside facility report	Allred score 7 (per outside facility)	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field;Primary Tumor Field	TCGA-E2-A108-R17426;TCGA-E2-A108-R17427;TCGA-E2-A108-R17425	3898256B-7709-4AD8-A5F1-C015BE2F2D7C;33202687-94BA-4A4A-840C-2AEEB9DBAABB;D1EF94C7-3632-4BEA-A17F-C2AD0BD214B4	2;2;02	28;28;28	313;306;306	307;266;264	Not Available;Not Available;Not Available	9;9;9	5;Not Available;Not Available	1000;4860;5040	NO;NO;NO	EXTERNAL BEAM;EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;ADJUVANT;ADJUVANT	Not Available;Not Available;Not Available	cGy;cGy;cGy	2011;2011;2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-D8-A141	FEMALE	626	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	M0		0	626			Not Available				40	Right	Axillary lymph node dissection alone	Not Available	TCGA-D8-A141	42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	27	-14626	Not Applicable	0	113	Not Available	Not Available	TCGA-D8-A141-D20735;TCGA-D8-A141-D64903;TCGA-D8-A141-D64904	A15AAA0F-A203-4D17-AC59-C7871CF733F8;F8D4FFC9-CAC1-4BF7-8524-0962257D22E0;885E2338-5CEA-43F7-A449-B6C3AB636165	Not Available;Not Available;Not Available	14;15;15	113;113;113	50;50;50	doxorubicine;cyclophosphamide;tamoxifen	Not Available;Not Available;Not Available	1;9;9	4;Not Available;Not Available	101.4;Not Available;Not Available	mg/m2;Not Available;Not Available	ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	405.6;Not Available;Not Available	mg/m2;Not Available;Not Available	Not Available;NO;NO	2012;2014;2014	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A141-F20734	3A9C552D-4EB1-455F-A421-E364643E5041				14		Not Available	Not Applicable	626		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	15	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	Not Available	No	A141	Not Available	manual counting	Hercep Test  TM Dako	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A12N	FEMALE	358	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	358			TUMOR FREE				58	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12N	b8a615f9-d19b-4b09-8ec8-0674e5c648cd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	12	-21428	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12N-F20264	96DF27E9-D48D-4A01-8961-1CFFC6B18408				9		Not Available	Not Applicable	358		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A12N	TUMOR FREE	Not Available	Not Available	Not Available	Allread Score 8	Allred Score 8	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A13F	FEMALE	765	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	765			TUMOR FREE				44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A13F	2cf68894-168b-458b-af4f-53cad72989a8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-16363	Not Applicable	0	196	Not Available	Not Available	TCGA-A7-A13F-D8659;TCGA-A7-A13F-D8657;TCGA-A7-A13F-D8658;TCGA-A7-A13F-D17813;TCGA-A7-A13F-D17801	16003a88-4c4e-4f56-ad98-b6e02346fe51;ff50db3d-c7d9-4aca-8616-bd68d8d81157;a3494e0e-47ac-4bf1-8911-42330fdda6fe;22203C82-11A9-45F7-A172-B99BE2FC855D;D0D604CB-1045-4D02-AC97-F5AE8513DA0F	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;25;25	175;91;91;210;Not Available	105;49;49;179;358	Docetaxel;Doxorubicin;Cyclophosphamide;Tamoxifen;Arimidex	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;10;10	4;4;4;Not Available;Not Available	198-200;121-123;1200-1230;20;1	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;2	IV;IV;IV;PO;PO	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	798;487;4854;Not Available;106	mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	2.8	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A13F-F17799;TCGA-A7-A13F-F39779	A1C9EECF-7FF9-4670-AF8A-053EE9F885D6;C0C53386-68E4-4D29-ABF4-1C85462AE7DD				25;1		Not Available;None	Not Applicable;Not Applicable	387;765		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	10;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2013	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA Probe Kit	2+	403	Not Available	3.0	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	3	Not Available	No	A13F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-A7-A13F-R17800;TCGA-A7-A13F-R17807	B1FB7AD8-B216-495A-9411-64F6A0D451E5;DB4D2F46-F9F4-4A31-92E4-B09C3567DBA0	1;1	25;25	248;246	211;211	Not Available;Not Available	10;10	28;26	5040;4680	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0DV	FEMALE	2064	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	2064			TUMOR FREE				54	Left Upper Inner Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Not Available	Not Available	TCGA-BH-A0DV	96b9c7db-1be1-4b60-b47c-26b654c3d64c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	2	-19781	Not Applicable	0	1374	Not Available	NO	TCGA-BH-A0DV-D63673;TCGA-BH-A0DV-D63674;TCGA-BH-A0DV-D63675	C3346CC5-8B94-4A86-A119-C6A580D232C8;6D3D306F-FA11-4AED-93F7-6388AEE8F089;BB94428A-1E62-47AC-BB42-8CA90FF6F1BD	Not Available;Not Available;Not Available	15;15;15	176;177;177	48;48;48	Taxotere;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-BH-A0DV-F63672	39C1B260-0C00-4D1C-93D1-6F57AB835DD1				15			Not Applicable	2064																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	9	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	9	Not Available	No	A0DV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DV-R63676	4BEA7C33-55A3-42B7-97E0-D43F494C6B9D	Not Available	15	223	177	Complete Response	8	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-A2-A0YM	FEMALE	965	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	965			TUMOR FREE				67	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node biopsy and non-sentinel lymph node biopsy	TCGA-A2-A0YM	5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	8	-24831	Not Applicable	0	662	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YM-F15767	5A91256B-618E-4365-9DE5-864FDFC51EE4				30		Not Available	Not Applicable	965		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified	Not Available	60	Not Available	Not Available	1.08	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0YM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YM-R5680	9d0ac647-5f1f-4321-8e4f-dc1703bd5159	1	8	126	80	Not Available	12	31	5520	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-BH-A0B4	MALE	1191	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	1191			TUMOR FREE				65	Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0B4	c710f4ab-fbd9-42ed-95d4-4e6d51207f38	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	4	-23980	Not Applicable	0	1191	Not Available	Not Available	TCGA-BH-A0B4-D15436;TCGA-BH-A0B4-D15437	E5C444DF-3662-4062-B553-FB8DE188EE81;E2E65D25-78D3-4CEC-B111-4B60F152B128	Not Available;Not Available	4;4	797;Not Available	692;211	Docetaxel;Tamoxifen	Not Available;Not Available	11;11	6;Not Available	130;20	mg;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;PO	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	785;Not Available	mg;Not Available	Not Available;Not Available	2010;2010	Not Available	80-89%	Not Available	Not Available	Not Available	2.0	Not Available	Not Available	Not Available		TCGA-BH-A0B4-F15435	AE2D2C86-0F6F-4CD9-9D52-361A471B6676				4		Not Available	Not Applicable	1191		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	MALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	5.65	2.83	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	10	Negative	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	No	A0B4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50-59%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-AN-A0XL	FEMALE	163	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	163			TUMOR FREE				61	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A0XL	4649dee3-b668-44cd-ab97-3834de3ef8f8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	25	-22341	Not Applicable	0	10	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XL-F68955	3060F448-5814-4CF8-B2CF-AB1B70F1098B				23			Not Applicable	163																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0XL	TUMOR FREE	Not Available	Not Available	Not Available	60	130	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A14O	FEMALE	1359	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	1359			TUMOR FREE				76	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14O	fb356957-f620-4d99-b675-1355a1d9f932	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	31	-27837	Not Applicable	0	1173	Not Available	NO	TCGA-E2-A14O-D18524	4F298221-2D3F-4F83-8DBB-15844934BAA0	Not Available	20	Not Available	53	Arimidex	Not Available	10	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14O-F18521	D8933DE8-A517-4142-9C1D-E9CB01F4932F				19		Not Available	Not Applicable	1359		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	50-59%	Not Available	2+	Not Available	Not Available	Not Available	1.65	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	2	Not Available	No	A14O	TUMOR FREE	Allred score 5+2 = 7	Not Available	Not Available	Allred score = 7	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A14O-R18525	C94602E4-7139-4008-BDC3-9058B35B1E21	1	20	105	68	Not Available	10	Not Available	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A10B	FEMALE	1141	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	1	195.0	Lung	New Primary Tumor	TUMOR FREE				67	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A10B	f801aeed-dc43-49d7-a319-84c8851979d9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	22	-24577	Not Applicable	0	748	Not Available	Not Available	TCGA-E2-A10B-D7778;TCGA-E2-A10B-D17414;TCGA-E2-A10B-D17415;TCGA-E2-A10B-D17413;TCGA-E2-A10B-D17412;TCGA-E2-A10B-D17371	22a0ab43-d0fb-443a-9af6-411f57558645;7A8C4891-71FD-4118-BEB4-84AC3D858FBC;970F3CF2-E642-4E3C-8819-541DF6437E4E;0FEBDEAC-7A64-4F2D-A282-2BB6ADA48DF4;4513E452-531B-4CB3-A85B-9B4267CABF91;011EFEBF-C10E-4C0F-871E-99C7222B06B2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;19;19;19;19;19	Not Available;398;398;301;748;Not Available	232;252;252;301;657;230	Arimidex;Paclitaxel;Carboplatin;Bevacizumab;Pemetrexed;Arimidex	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;9;9;9;9;9	Not Available;8;7;1;4;Not Available	1;312;Not Available;840;624;1	mg/day;mg;mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;2;3;4;1	PO;IV;IV;IV;IV;PO	YES;NO;NO;NO;NO;YES	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1556;1922;840;2484;Not Available	mg/day;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011	Allred score 5+3= 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	YES	YES		TCGA-E2-A10B-F17370	276DD2FD-D528-42EF-A703-FD3CC598295E				19		195	Not Applicable	1141		195				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	9	Lung	New Primary Tumor	Not Available	YES																																		Not Available			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	1.11	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	28	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	2	0	No	A10B	TUMOR FREE	Allred score 5+3= 8	Not Available	Not Available	Allred score 8	Allred score 8	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A10B-R17417	7DB115F8-D3D7-46CF-8652-9C5C37F11FAC	1	19	413	368	Not Available	9	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-AC-A3W7	FEMALE	471	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	471			TUMOR FREE				66	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A3W7	2481A671-760B-428C-968D-42E25FD42AC5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	17	-24327	Not Applicable	0	192	Not Available	Not Available	TCGA-AC-A3W7-D57848	99F4E33A-B847-43FF-98B1-80EBFB1944E9	Not Available	27	Not Available	65	Femara	Not Applicable	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3W7-F57847	51E87969-0929-4751-8663-2FB10328655B				27			Not Applicable	471																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A3W7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2012
TCGA-AR-A0U3	FEMALE	4080	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	4080			Not Available				59	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0U3	c5f00132-1c6b-4337-af6f-596c652665cc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	25	-21755	Not Applicable	0	2317	Not Available	Not Available	TCGA-AR-A0U3-D19028;TCGA-AR-A0U3-D19034;TCGA-AR-A0U3-D19031;TCGA-AR-A0U3-D19033	8B7D25A5-DF6C-4F1F-9018-189E343500BB;3AB2189D-3925-4831-B00A-1E7791363CF8;13CF7E01-51DD-4494-8E95-4C20C42A3E50;0E604F50-B14A-4467-953D-6DDF69361452	Not Available;Not Available;Not Available;Not Available	12;12;12;12	69;2015;69;137	41;166;41;95	Doxorubicin;Anastrozole;Cytoxan;Paclitaxel	Not Available;Not Available;Not Available;Not Available	12;12;12;12	3;Not Available;3;4	60;1;600;175	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	420;Not Available;4160;1590	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	10-19%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0U3-F18482;TCGA-AR-A0U3-F49481;TCGA-AR-A0U3-F71712	1FED9C55-51D0-4ED5-8150-2A0DDD73D8FF;AABD784B-86D7-4F0B-B4BC-E08E71337DD7;679643AA-E34B-4B54-B79A-C34ECCF1DD86				12;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	2317;3468;4080		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	Not Available	No	A0U3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A0U3-R18476	E1B639A5-3CE0-4F0C-8250-286B8927236C	1	12	210	171	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2004
TCGA-B6-A0IH	FEMALE	2965	Infiltrating Lobular Carcinoma	Breast	Dead	T3	N1b	M0	Stage IIIA	0	2965			Not Available				81	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IH	2476dda9-da2a-4242-9642-b92b8b9b1c79	Negative	Positive	Not Available	Not Available	Not Available	Modified radical mastectomy	Positive	Other	Not Applicable	NO	15	-29907	2965	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0IH-F12617	A5FE44D8-EFB4-473A-B201-4E3502C030D9				2		Not Available	2965	Not Available		Not Available				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available																																		Not Available			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	27	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	25	Not Available	No	A0IH	Not Available	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T3	Excisional biopsy	NO	YES	B6	Breast	Not Applicable	Dead	2011	1995
TCGA-A2-A0YH	FEMALE	659	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	659			TUMOR FREE				53	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0YH	298d33da-15af-48cb-b30f-eaf54e7baa43	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	14	-19596	Not Applicable	0	379	Not Available	Not Available	TCGA-A2-A0YH-D5437;TCGA-A2-A0YH-D5440;TCGA-A2-A0YH-D5441;TCGA-A2-A0YH-D5435	80f9e542-473a-4608-9e1c-491b215c50d7;599117f8-1d3d-4e44-bf96-83aaba1b8ca7;cbf163a4-c78e-463e-8de3-c0981fefd6f9;e60cd9fa-5849-49a5-8bb1-69491f0379a1	Not Available;Not Available;Not Available;Not Available	14;14;14;14	179;179;Not Available;60	74;74;Not Available;60	Taxotere;Cytoxan;Arimidex;Adriamycin	Not Available;Not Available;Not Available;Not Available	12;12;12;12	6;6;Not Available;1	138;1100;Not Available;Not Available	mg;mg;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;3;4;1	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	828;6600;Not Available;Not Available	mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YH-F16752	72D0FFE4-4FE3-4846-A658-E195AE00FAE0				16		Not Available	Not Applicable	659		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	5	Not Available	No	A0YH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YH-R5442	7446a50c-47f9-4fab-84f9-78ee16a151d5	1	14	264	214	Not Available	12	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-B6-A1KI	FEMALE	2236	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	2236			TUMOR FREE				63	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-B6-A1KI	1dafdd64-527d-4d46-bbdf-7a97774f881b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	19	-23031	Not Applicable	0	1463	Not Available	NO																								image cytometry	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	3.1	Not Available	Not Available	Not Available		TCGA-B6-A1KI-F15737	59D24E41-B9FE-49F2-8B2C-08589B98F220				29		Not Available	Not Applicable	2236		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	90-99%	Not Available	2+	60	Not Available	3.8	1.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1KI	TUMOR FREE	image cytometry	Not Available	Not Available	70 fmol/mg	288 fmol/mg	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Excisional biospy	NO	YES	B6	Breast	Not Applicable	Alive	2011	2003
TCGA-A2-A3XY	FEMALE	1093	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1a	M0	Stage IIB	1	802.0	Lung	Distant Metastasis	TUMOR FREE				49	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A3XY	DEBA32E4-0E68-4711-941B-3B63BD965AFB	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	14	-18059	Not Applicable	0	786	Not Available	NO	TCGA-A2-A3XY-D34406;TCGA-A2-A3XY-D34407;TCGA-A2-A3XY-D34408;TCGA-A2-A3XY-D34409;TCGA-A2-A3XY-D34411;TCGA-A2-A3XY-D43312;TCGA-A2-A3XY-D43313;TCGA-A2-A3XY-D43314;TCGA-A2-A3XY-D43315	CBE5F428-42AB-4719-A28B-3D8E9903B596;E7F46F97-06FB-49A1-B9B2-DC0F211325DC;2BB3150F-2130-4FA5-9E80-A2F76E236D3C;385416B0-05A4-45C0-A807-DDFFE65C59EE;6B22D335-A270-451A-93F4-A11F8A4875A6;4620C49F-B2FE-4FBD-8CD3-C2CAFBD9EEA4;89205666-328A-4D84-8355-E8627C761EC5;D2AD9346-11EA-432E-94D0-DC4429648DC1;D420260B-7367-4532-AC11-A5A0966EBCBC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14;16;16;16;16	149;149;170;170;254;913;1019;1061;1058	86;86;170;170;184;816;816;1040;816	Adriamycin;Cyclophosphamide;Adriamycin;Cyclophosphamide;Paclitaxel;Carboplatin;Gemcitabine;Docetaxel;Denosumab	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;NO;NO;NO;NO	2012;2012;2012;2012;2012;2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3XY-F43311;TCGA-A2-A3XY-F55836	02379C43-DB21-44A9-AE3C-0A268B0FAB40;9C95F754-39EE-4F59-AF2D-7F215716D933				16;16			Not Applicable;1093	1064;Not Available																				NO;NO																						5;1					YES;YES;NO	NO;NO;YES	Not Available;Not Available;Not Available	802;813;1072	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Evaluated	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Evaluated	Not Available;Not Available;Not Evaluated	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Evaluated	Lung;Other, specify;Brain	Distant Metastasis;Locoregional Recurrence;Distant Metastasis	Not Available;Mediastinal and Supraclavicular Lymph Nodes;Not Available	NO;NO;NO	Not Available;Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR						YES;YES		YES;YES	Alive;Dead	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.13	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	3	Not Available	No	A3XY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Unknown;Distant site	TCGA-A2-A3XY-R34405;TCGA-A2-A3XY-R55837	7A7E240A-DBB4-4389-ABD4-1836FA872FF7;0F6362E1-CAE1-405E-9935-8D0EB86AF3EF	Not Available;Not Available	14;16	366;1082	Not Available;1074	Complete Response;Radiographic Progressive Disease	8;1	Not Available;6	Not Available;1800	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;cGy	2012;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2012	2010
TCGA-A7-A5ZV	FEMALE	368	Infiltrating Carcinoma NOS	Breast	Alive	T2	N0	M0	Stage IIA	0	368			TUMOR FREE				62	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A5ZV	0EC70E40-07DF-461D-8FF9-351240A0D454	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	14	-22966	Not Applicable	0	210	Not Available	Not Available	TCGA-A7-A5ZV-D43178;TCGA-A7-A5ZV-D43179;TCGA-A7-A5ZV-D43180	8F1125F3-DBBB-47BC-BACF-5CE4963DC966;EADD43A7-E14F-4643-A3BE-C251663F4AA0;52DC65F2-30C0-4BDD-89AC-641853A9E429	Not Available;Not Available;Not Available	14;14;14	137;137;193	95;95;151	Doxorubicin;Cyclophosphamide;Paclitaxel	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	2.5					TCGA-A7-A5ZV-F51143	135338BE-7C95-4141-AF1A-A7515A8E065D				8			Not Applicable	368																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA Probe Kit	2+	40	Not Available	3.8	1.5	Not Available	Infiltrating Carcinoma NOS	Not Applicable	No	C50.9	8010/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5ZV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-A7-A5ZV-R51144	D208F7C1-8594-4935-AAA9-D798639B925F	Not Available	8	316	270	Complete Response	11	33	6100	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-AR-A1AU	FEMALE	2868	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	2868			Not Available				39	Right Upper Inner Quadrant;Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AU	36220587-1c1c-4f92-b177-3b2155e7e273	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	14	-14564	Not Applicable	0	1409	Not Available	Not Available	TCGA-AR-A1AU-D21864;TCGA-AR-A1AU-D21871;TCGA-AR-A1AU-D21866;TCGA-AR-A1AU-D21869	AA98F6B4-F95F-42BE-8DC4-9453156E46D9;42C369BB-5B2B-41E6-AFEB-DD07F763415A;E590785D-CACD-47BA-B643-8C232EC60A72;04058D52-264A-4E9D-80C7-5F003B9F48C6	Not Available;Not Available;Not Available;Not Available	28;28;28;28	85;Not Available;85;141	43;157;43;99	Doxorubicin;Tamoxifen;Cytoxan;Paclitaxel	Not Available;Not Available;Not Available;Not Available	2;2;2;2	4;Not Available;4;4	60;20;600;175	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	460;Not Available;4540;1320	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A1AU-F21858;TCGA-AR-A1AU-F49472;TCGA-AR-A1AU-F71744	A71CFC53-16BF-448A-8B79-F8053B635F03;2EF8415E-95BD-4EEF-9529-267C05B3273E;CA3498DB-9604-4BDE-90A0-B890E45357A9				27;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1409;2318;2868		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	2;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	37	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	4	Not Available	No	A1AU	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AU-R21860	5E3D53C1-AE5A-4CFE-94E9-C0B9F51931A0	1	27	202	159	Not Available	2	16	4680	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Total Mastectomy	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-Z7-A8R5	FEMALE	3287	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1a	MX	Stage IIIA	1	181.0		Locoregional Recurrence	TUMOR FREE				61	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-Z7-A8R5	23F438BD-1DBB-4D46-972F-1E8E74DDBD37	Not Available	Positive	4 Point Scale	1+	4 Point Scale	Unknown	Positive	Other	Not Applicable	YES	9	-22280	Not Applicable	0	3042	Not Available	Not Available	TCGA-Z7-A8R5-D58759;TCGA-Z7-A8R5-D58761;TCGA-Z7-A8R5-D58762	08450109-B43A-47C4-8D73-9711DF983444;3B9407D6-8ECF-44E6-A3C8-821C5FF3B17A;975E7C8D-AADD-4A83-8053-CDE2D86B1A5A	Not Available;Not Available;Not Available	9;9;9	181;181;181	61;61;61	Adriamycin;Cytoxan;Taxol	Stable Disease;Stable Disease;Stable Disease	7;7;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-Z7-A8R5-F58763	9849E8B7-D2F4-4C6A-B5A4-06D7FB7212B0				9			Not Applicable	3287																				NO																						7					Not Available	Unknown	Not Available	3287	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Bone	Locoregional Recurrence	Not Available	Unknown	Not Available	YES	WITH TUMOR						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	YES	NO	181	181	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Locoregional Recurrence	Not Available	YES	Not Available	YES	3	3	Yes	A8R5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Segmental Mastectomy	NO	YES	Z7	Breast	Not Applicable	Alive	2014	2005
TCGA-C8-A1HE	FEMALE	375	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	375			TUMOR FREE				59	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HE	b26d41cd-393b-4cd4-8925-a9488f7de576	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	24	Not Available	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A1HE-F20269	16CB3317-31C3-4E95-9B3B-0EBE48FFF665				9		Not Available	Not Applicable	375		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Equivocal	Not Evaluated	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A1HE	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 4	Allred Score 7	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-GM-A2DI	FEMALE	2590	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i+)	M0	Stage I	0	2590			TUMOR FREE				52	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DI	66FA504C-4AE4-49AC-9355-1E063776DC0D	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	29	-19030	Not Applicable	0	1883	Not Available	NO	TCGA-GM-A2DI-D47090;TCGA-GM-A2DI-D47091;TCGA-GM-A2DI-D47092;TCGA-GM-A2DI-D47093	7B5D9D98-20F4-4180-8CAC-4343CFA7FCD3;5CFA2517-8901-4EA6-A4C7-92DA88C6C423;7D31035E-0AC6-403A-B734-CA72E210C75F;2D81179B-0BEB-492F-8B9F-5FA57D8F59D0	Not Available;Not Available;Not Available;Not Available	22;22;22;22	133;217;217;217	70;154;154;154	Taxotere;Fluorouracil;Epirubicin;Cytoxan	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	3.33					TCGA-GM-A2DI-F47089	64BBFF53-4A07-4474-8016-57DEE132EC2E				22			Not Applicable	2590																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	3.53	1.06	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	1	No	A2DI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2005
TCGA-A7-A4SE	FEMALE	644	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	644			TUMOR FREE				54	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A4SE	DBF6F981-15CC-40AD-91AC-A66360405FBD	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	22	-20080	Not Applicable	0	371	Not Available	Not Available	TCGA-A7-A4SE-D41891;TCGA-A7-A4SE-D41892;TCGA-A7-A4SE-D41893	8C1D4FAD-B3C5-4009-94B8-51BE6B474423;B8237736-7799-4490-A1CA-2A15E2985B17;5FA600E2-E487-4345-A4BE-E4A7AD3738EB	Not Available;Not Available;Not Available	2;2;2	91;91;154	49;49;105	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A4SE-F50162	EA17641D-048D-48C9-8C6F-24D1888E0196				16			Not Applicable	644																				YES																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4SE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2011
TCGA-D8-A27V	FEMALE	381	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	381			TUMOR FREE				62	Right Upper Outer Quadrant;Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A27V	AD6D26AB-6568-40DB-BFB0-394D40E801CF	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	21	-22958	Not Applicable	0	73	Not Available	NO	TCGA-D8-A27V-D30106	C90BB84D-E867-45CE-BBAF-7A25BE220C0E	Not Available	2	Not Available	48	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27V-F30105	E413E78A-B9CB-4D48-8CA1-3F5C41E8E3B0				29		Not Available	Not Applicable	381		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Venten	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A27V	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	>75%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A08B	FEMALE	1156	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1156			TUMOR FREE				52	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A08B	d8d7a6c2-6427-4f47-968c-6c3affba4617	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-19114	Not Applicable	0	702	Not Available	Not Available	TCGA-A8-A08B-D37819;TCGA-A8-A08B-D37820;TCGA-A8-A08B-D37821;TCGA-A8-A08B-D37822;TCGA-A8-A08B-D37823;TCGA-A8-A08B-D37824	61251669-19D4-4215-A0A6-13B53CB464EC;DD7BF60D-0661-4F71-8217-FBA9068C17CB;D7E15D1C-7E0D-4F82-86A7-8411A4207C23;E1FC34BF-AF83-49E2-9FB0-6CE574F0AAE7;4E401259-435D-4C0B-AD8D-33361A32FEE6;D84A4E44-43BA-4E63-8B8E-8CA529809BC3	n/a;n/a;n/a;n/a;n/a;n/a	6;6;6;6;6;6	122;122;122;883;579;Not Available	31;31;31;214;214;914	5-Fluorouracil;Epirubicin;Cyclophosphamide;Tamoxifen;Trastuzumab;Letrozole	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Targeted Molecular therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08B-F40841	B37E2409-548D-421A-A840-34803C923738				2			Not Applicable	1156																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08B-R38171	05C8AF27-7A23-4CF3-8294-437ABD8EE4C1	Not Available	11	184	122	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A1IU	FEMALE	337	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (mol+)	M0	Stage IA	0	337			TUMOR FREE				60	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IU	001cef41-ff86-4d3f-a140-a647ac4b10a1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	29	-22279	Not Applicable	0	127	Not Available	NO	TCGA-E2-A1IU-D19975	6BB85C8B-BED1-4F0D-B330-2307404DA314	Not Available	4	Not Available	36	Arimidex	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1IU-F19974	24CBF8D6-4B40-4569-A40F-F3C906BEEA9D				4		Not Available	Not Applicable	337		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1IU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (mol+)	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A2LN	FEMALE	1161	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1161			Not Available				65	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LN	A076F135-BE82-40FA-8516-285ED355C965	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	12	-23992	Not Applicable	0	520	Not Available	NO	TCGA-AR-A2LN-D37541	CECA734C-34EE-4E7A-BE8F-82D7437D58FB	Not Available	6	Not Available	15	Letrozole	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LN-F37537;TCGA-AR-A2LN-F49496	31DA3189-1539-4BBF-8C9F-E5EB069F3D56;E7D8079A-0AC5-4D0D-8B52-2FF1367C2892				6;2			Not Applicable;Not Applicable	997;1161																				NO;Not Available																						12;10					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	Not Available;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	Not Available	No	A2LN	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Mastectomy	NO	YES	AR	Breast	Not Applicable	Alive	2012	2010
TCGA-A8-A07L	FEMALE	975	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	975			TUMOR FREE				58	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07L	e89a9deb-6321-4e61-b412-b4993d4277dd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-21428	Not Applicable	0	518	Not Available	Not Available	TCGA-A8-A07L-D37866;TCGA-A8-A07L-D37867	F05105AD-1CB2-444A-9701-65ECDF294EC2;F35579B1-B246-4D73-899D-43A1DAB766AD	Not Available;Not Available	6;6	122;Not Available	31;184	Not Available;Anastrozole	Complete Response;Not Applicable	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07L-F40830	E992C9F9-BF33-4063-A892-5ECD2958B1E6				2			Not Applicable	975																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07L	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07L-R38185	A5E63D28-1725-4DCC-9576-232B048E4C4C	Not Available	11	184	153	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-EW-A1P4	FEMALE	907	Medullary Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	907			TUMOR FREE				43	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1P4	521e2140-ae5b-456f-8699-97398d009687	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	11	-15989	Not Applicable	0	501	Not Available	NO	TCGA-EW-A1P4-D29687;TCGA-EW-A1P4-D29689	79E0A6AE-A364-45A1-9ED5-E0FBDD00DAA9;E8073733-F67A-40F9-88DA-22013C8ED597	Not Available;Not Available	26;26	144;144	73;73	Docetaxel;Cyclophosphamide	Not Available;Not Available	3;3	4;4	75;600	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	TC;TC	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1P4-F29684	45EAB7C6-BFBF-48EC-B18C-19642B61C70E				26		Not Available	Not Applicable	907		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1P4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1P4-R29685	1B09106F-D19A-436A-AE7E-6DE51BA1A9B4	1	26	263	208	Not Available	3	Not Available	15,900	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-E9-A249	FEMALE	217	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	217			TUMOR FREE				45	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A249	fb3607eb-858e-4ecd-8477-95140658c6d2	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	22	-16689	Not Applicable	0	29	Not Available	NO	TCGA-E9-A249-D31246;TCGA-E9-A249-D31248;TCGA-E9-A249-D31249;TCGA-E9-A249-D39725	A0F0004B-8C6B-4412-B770-39EB7B0401E6;ECDD44B4-F229-4DD5-80B7-0AF3F66BE1EC;7A8EA282-7B3B-4CB3-9B6F-F35946CED74A;877690E5-008F-454B-9C29-5210E3FCA338	Not Available;Not Available;Not Available;Not Available	25;25;25;31	100;100;Not Available;100	28;28;28;28	Cyclophosphamide;Cyclophosphamide;Tamoxifen;Doxorubicin	Not Available;Not Available;Not Available;Unknown	4;4;4;1	1;3;Not Available;Not Available	1200;1000;20;Not Available	mg;mg;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;PO;Not Available	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1200;3000;Not Available;Not Available	mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;NO	2012;2012;2012;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A249-F31245;TCGA-E9-A249-F49108	EC37D95B-4379-46EA-A8F9-E46E14298215;7E07DC42-0F43-488D-9ED8-EBA590B0B5FC				25;25		Not Available;None	Not Applicable;Not Applicable	217;217		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;9	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A249	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A249-R31250	1F1A22C3-9307-4C5F-8EA2-A29C7D429E58	1	25	155	128	Not Available	4	Not Available	13500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AC-A2QI	FEMALE	588	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1a	MX	Stage IIIA	0	588			TUMOR FREE				76	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A2QI	C57835BE-77AB-4CF5-9B23-62C11A7B2EAF	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	18	-27865	Not Applicable	0	28	Not Available	NO	TCGA-AC-A2QI-D57049;TCGA-AC-A2QI-D57050;TCGA-AC-A2QI-D57051	7AE4D249-9E5B-463E-9352-BB540E0FD3AB;811FCC91-6880-400D-B7BB-C848DF5A5C23;ED0E149B-307C-4202-9AD7-09B21CE8FAB9	Not Available;Not Available;Not Available	28;28;28	275;275;275	100;100;100	Cytoxan;5-FU;Methotrexate	Complete Response;Complete Response;Complete Response	2;2;2	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2QI-F57047	6AA0381B-1A09-4E7E-A968-8065C44EB313				28			Not Applicable	588																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	2	Not Available	No	A2QI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A2QI-R57048	67D9DBB7-C7EE-49D0-9D87-3DA5AD405CFF	Not Available	28	355	309	Complete Response	2	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Total Mastectomy	YES	NO	AC	Breast	Not Applicable	Alive	2011	2011
TCGA-D8-A1X5	FEMALE	565	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	MX	Stage IIIC	0	565			TUMOR FREE				81	Right Upper Outer Quadrant;Right Lower Inner Quadrant;Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1X5	eb93df3d-9e25-4e4c-9a5d-350f296e5acf	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	9	-29734	Not Applicable	0	171	Not Available	NO	TCGA-D8-A1X5-D29935;TCGA-D8-A1X5-D30115	9E4AF981-5926-4017-BB6E-25B7554E7645;972E329F-848E-4B00-AB12-F25F7C073C6A	Not Available;Not Available	30;2	Not Available;Not Available	55;55	Tamoxifen;Tamoxifen	Not Available;Not Available	3;4	14;Not Available	20;20	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	PO;PO	YES;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	280;Not Available	mg;mg	Not Available;Not Available	2012;2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1X5-F29934	EB83DACE-75EE-47C9-A706-ED4628EBAC90				30		Not Available	Not Applicable	565		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Hercep Test  TM Dako	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	14	Not Available	No	A1X5	TUMOR FREE	manual counting	Not Available	Not Available	10-75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1X5-R29936	E2E68231-4608-4580-8B41-5293428ED8EB	Not Available	30	140	113	Not Available	3	45	9000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A14V	FEMALE	1042	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1042			TUMOR FREE				53	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14V	3144f1fb-4342-4079-bfe8-940da4bfd88e	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	6	-19643	Not Applicable	0	748	Not Available	NO	TCGA-E2-A14V-D18889;TCGA-E2-A14V-D18891;TCGA-E2-A14V-D18914;TCGA-E2-A14V-D18872;TCGA-E2-A14V-D18886	AE8D09DE-A05B-4A3B-99CC-4CE7A88E8DF1;3DFEAA7A-286F-4E35-840E-F22E6ABF302F;BB18FBCE-4921-4FD2-B7C0-CDA67CCD1AF5;AF33F97A-5569-496E-8D09-EE256571D9C4;A22C1AFA-B014-42F4-BAE1-B26AA885A2D4	Not Available;Not Available;Not Available;Not Available;Not Available	1;7;7;7;7	97;195;468;Not Available;97	55;118;118;304;55	cyclophosphamide;paclitaxel;lapatinib;arimidex;doxorubicin	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	4;4;Not Available;Not Available;4	1128;152;1500;1;112	mg;mg;mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;2;3;1	IV;IV;PO;PO;IV	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	4512;1499;571500;Not Available;448	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14V-F18870	FFA983CC-57D9-4557-B5BB-BCD3D09CB1CE				4		Not Available	Not Applicable	1042		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	3	Not Available	No	A14V	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A14V-R18918	79735EF6-10DC-4DF6-B729-8C11B3A5D417	1	4	303	253	Not Available	11	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-LL-A6FQ	FEMALE	80	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	80			Unknown				77	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-LL-A6FQ	92B842C5-F71B-4EF7-BA86-358D28E0966F	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	30	-28375	Not Applicable	0	80	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A6FQ-F58204	804405B3-E0C3-4F4D-985A-1AF09F39E17F				2			Not Applicable	80																				YES																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	7	0	No	A6FQ	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	80-89%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-A8-A06R	FEMALE	547	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	547			TUMOR FREE				69	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A06R	f3ba71f9-25f3-4784-bf2d-3aa522a0cba8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-25477	Not Applicable	0	547	Not Available	Not Available	TCGA-A8-A06R-D37825;TCGA-A8-A06R-D37826;TCGA-A8-A06R-D37827;TCGA-A8-A06R-D37828	D8FE6469-6DAB-4BCB-9DF8-8AD53DF522F2;02116C14-0DE0-40A5-9224-0A2BBC4D0DEB;24AF886F-B700-4E8D-91FA-5A62222090E4;A8ADA003-4EDE-4F08-BD6D-033E139A8077	n/a;n/a;n/a;n/a	6;6;6;6	151;151;151;334	59;59;59;243	5-Fluorouracil;Doxorubicin;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Complete Response	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A06R-F40815	AB298BD7-3CA2-44B2-8FA0-1DB436A3375F				2			Not Applicable	547																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06R	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A06R-R38172	3F996702-1D58-4178-BBF8-51E62724C215	Not Available	11	212	181	Complete Response	12	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-EW-A3E8	FEMALE	1035	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	1035			TUMOR FREE				60	Left;Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A3E8	C0B7B798-3383-4A45-A455-9ECA5810739E	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	8	-21922	Not Applicable	0	647	Not Available	Not Available	TCGA-EW-A3E8-D39996	6D645F63-EEF8-43F6-AC29-34CBBEC01722	Not Available	8	Not Available	196	Anastrozole	Not Applicable	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-EW-A3E8-F57617	71B7D2CC-2481-4609-94CB-593371E7EE7D				18			Not Applicable	1035																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A3E8	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-EW-A3E8-R39993	91E4B957-C918-4E13-B0E0-48ECCA77D430	Not Available	8	196	165	Complete Response	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	YES	NO	EW	Breast	Not Applicable	Alive	2013	2011
TCGA-C8-A26Y	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE				90	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-C8-A26Y	4d51159f-ab2f-40e3-a363-847c3654431e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	21	-32872	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A26Y-F70791	D698E40F-5055-4DF2-962D-C3BE9150CBE3				9			Not Applicable	0																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A26Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0B5	FEMALE	2136	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	2136			TUMOR FREE				40	Left	Not Available	Not Available	TCGA-BH-A0B5	9da462b0-93c2-4305-89f6-7199a30399a7	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	2	-14920	Not Applicable	0	1471	Not Available	NO	TCGA-BH-A0B5-D59183;TCGA-BH-A0B5-D59184;TCGA-BH-A0B5-D59185	17D3063F-CC13-421E-A738-803D7C558475;05D47456-5206-4EA3-A5A3-8CF061849DEF;C9BF525E-EE34-4064-99CD-996F6EB4C09E	Not Available;Not Available;Not Available	2;2;2	Not Available;Not Available;257	63;63;Not Available	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0B5-F59182	994E9DC9-8CDF-461E-A2DB-C42A64512AE8				2			Not Applicable	2136																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Available	24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	5	Not Available	No	A0B5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site;Primary Tumor Field	TCGA-BH-A0B5-R59186;TCGA-BH-A0B5-R59187;TCGA-BH-A0B5-R59188	0B41A50F-764D-4D7C-BC17-E313C18AA5F6;B7B2EE6E-695B-4760-8724-30655D22136D;814C435B-99BC-4D04-AD11-C90E47DEBE5F	Not Available;Not Available;Not Available	2;2;2	302;302;304	257;257;300	Complete Response;Complete Response;Complete Response	5;5;5	28;43;6	5040;5936;100	NO;NO;NO	External;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;Gy	2014;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-EW-A1P0	FEMALE	1251	Other, specify	Breast	Alive	T2	N1b	MX	Stage IIB	1	1094.0	Other, specify	Distant Metastasis	WITH TUMOR				55	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A1P0	81e32f39-3aa0-468b-87ed-dd2eb6165ddf	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	10	-20107	Not Applicable	0	1121	Not Available	YES	TCGA-EW-A1P0-D29668	82BB1AF4-6610-45A8-BCFE-5A38D177760E	Not Available	8	1245	1033	Arimidex	Not Available	3	Not Available	1	mg/day	ADJUVANT	Not Applicable	Not Available	PO	NO	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	YES		TCGA-EW-A1P0-F29105	14E24F35-F5DD-4CE1-B35A-7E14ED9BFFBB				8		1105	Not Applicable	1251		1094				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	3	Other, specify	Distant Metastasis	mediastinal lymph node	YES																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	IDC+ mucinous carcinoma	No	C50.9	8523/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1+	Not Available	90-99%	Positive	Not Available	Not Available	<10%	Not Available	Not Available	3+	1+	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Negative	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1+	Not Available	90-99%	Positive	Not Available	Not Available	<10%	Not Available	Not Available	3+	3 Point Scale	1+	3 Point Scale	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A1P0	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1b	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A1AM	FEMALE	2991	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1	M0	Stage IIIA	0	2991			TUMOR FREE				52	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-AR-A1AM	EBD1512A-4865-4193-97B3-F599D555759A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	20	-19123	Not Applicable	0	1903	Not Available	Not Available	TCGA-AR-A1AM-D36899;TCGA-AR-A1AM-D36913;TCGA-AR-A1AM-D36914;TCGA-AR-A1AM-D63948	66305035-0C04-4F78-9827-C6945903CB21;A6043E89-02FF-41DB-B796-E31AA6778A1F;A2E5EB14-9F26-47D5-86B5-95B3B1E65039;1F367D89-FCE1-484D-B3CA-93FF5FE8F4E0	Not Available;Not Available;Not Available;Not Available	20;20;20;21	97;314;336;97	55;127;314;55	Adriamycin;Tamoxifen;Anastrozole;cytoxan	Not Available;Not Available;Not Available;Unknown	11;11;11;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A1AM-F36898;TCGA-AR-A1AM-F49467;TCGA-AR-A1AM-F71733	45E8106C-259E-4F9D-9FDA-FFCDE4772117;C59D857B-7316-4208-A40A-0A040A69E09B;4ECA877E-6675-4BE9-9D8E-962797C4E435				20;2;30			Not Applicable;Not Applicable;Not Applicable	1903;2315;2991																				NO;NO;NO																						11;10;3					Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE						YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A1AM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2012	2006
TCGA-E9-A5UO	FEMALE	785	Mucinous Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	785			TUMOR FREE				41	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A5UO	ED2617C3-5D3B-4688-9283-0F8A10E0B10D	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Other	Not Applicable	NO	23	-15050	Not Applicable	0	7	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A5UO-F56481;TCGA-E9-A5UO-F70210	8F3F5F6D-C479-4BDE-AAE8-93351797E3DA;30B02ABC-CC95-48D0-985F-42DAC16CAC58				10;30			Not Applicable;Not Applicable	420;785																				NO;NO																						2;1					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						NO;NO		NO;NO	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	Not Available	No	A5UO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Partial mastectomy	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012
TCGA-B6-A0X4	FEMALE	860	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	1	716.0	Bone	Distant Metastasis	WITH TUMOR				62	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0X4	4e42fdc5-2a8b-49e9-87ef-6db7a6692d08	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	14	-22688	860	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	YES	NO		TCGA-B6-A0X4-F15723	29FCF3A8-AC74-45DF-8A7F-9B4EABACE410				29		Not Available	860	Not Available		716				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Bone	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Not Evaluated	Not Evaluated	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0X4	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1996
TCGA-BH-A8FZ	FEMALE	574	Infiltrating Lobular Carcinoma	Breast	Alive	T1b	N0	M0	Stage IA	0	574			TUMOR FREE				58	Left	Not Available	Not Available	TCGA-BH-A8FZ	1CC30842-4A5B-4F07-B36F-5B84CEAA5662	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	25	-21343	Not Applicable	0	144	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A8FZ-F63679	11E8283A-157A-43A1-8DB4-8F21080D28C5				27			Not Applicable	574																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A8FZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-BH-A8FZ-R57777	A3520120-DE20-49A6-A0A8-DC098E7076DC	Not Available	26	125	81	Complete Response	3	33	10	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1b	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2014	2012
TCGA-EW-A1PH	FEMALE	607	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	607			TUMOR FREE				52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1PH	4da999a0-ef41-4a0b-b1d1-446b39cc855a	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	27	-19073	Not Applicable	0	140	Not Available	NO	TCGA-EW-A1PH-D30304;TCGA-EW-A1PH-D30306;TCGA-EW-A1PH-D29111;TCGA-EW-A1PH-D30305;TCGA-EW-A1PH-D29113	2DDB37C1-2B90-4032-8C74-3AB053366DB0;8C772D08-80AB-49A9-9CAC-40EEADDB8D31;E98E3894-4A1F-4559-AA6C-977995AAADD4;3C59E6BD-8791-41EF-A738-A127DA2E0088;CE3771B3-13A0-460B-B9C7-C17BAA64C06A	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	140;161;140;140;271	98;161;98;98;215	Cyclophosphamide;Docetaxel;Fluorouracil;Epirubicin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	3;1;3;3;8	835;169;835;167;124	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;2	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	2505;169;2505;501;992	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-EW-A1PH-F29110;TCGA-EW-A1PH-F41145	7268DC2D-2021-4105-BF63-E0D421464BDB;1D45F7E0-49FF-4FE9-AB11-639270B50BAF				8;12		Not Available;None	Not Applicable;Not Applicable	425;607		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	0	No	A1PH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1PH-R32259	B13D295F-A310-4C1A-9812-BFC67F771E56	1	20	322	276	Not Available	4	34	6120	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A131	FEMALE	411	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	411			TUMOR FREE				82	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A131	c49e3b18-fd88-48f4-8b01-300692ceb367	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	15	-29966	Not Applicable	0	14	Not Available	NO	TCGA-C8-A131-D70828;TCGA-C8-A131-D70829;TCGA-C8-A131-D70830	D5B3D28A-4333-4455-9FCB-220B0A14A5FB;FF1D85A6-7EFA-489D-B455-FF6D8C7D3E33;F291DB2B-45ED-4BD2-98A3-63F012802AC3	Not Available;Not Available;Not Available	9;9;9	57;57;57	34;34;34	5-Flourouracil;Doxorubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A131-F19083;TCGA-C8-A131-F70827	1EFBD51F-B7D9-44A2-9EB5-A651DD80FDC4;FD18DE54-343A-43E7-9EA3-010208D98744				2;9		Not Available;None	Not Applicable;Not Applicable	68;411		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2010;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	4	Not Available	No	A131	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A5QM	FEMALE	2231	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	968.0	Other, specify	New Primary Tumor	TUMOR FREE				62	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A5QM	9C895825-D6F6-4D14-A662-23212200F6E5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	15	-22780	Not Applicable	0	1440	Not Available	Not Available	TCGA-AR-A5QM-D43857	D7CB0EED-DFD0-48DF-AE12-84DB425177EF	Not Available	10	Not Available	36	Anastrozole	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A5QM-F43848;TCGA-AR-A5QM-F69264	075D1C9B-74C2-4011-925E-872B1109BD5F;798F4A44-D7B5-4E57-901C-EDE79F981BE7				10;31			Not Applicable;Not Applicable	1665;2231																				NO;NO																						6;12					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	968;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Other, specify;Not Available	New Primary Tumor;Not Available	Malignant melanoma;Not Available	Not Available;Not Available	Not Available;Not Available	YES;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Available	9	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	968	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	New Primary Tumor	malignant melanoma	Not Available	Not Available	YES	0	Not Available	Yes	A5QM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-AR-A5QM-R43856	5B7461B2-C13C-47B1-B736-33437677102C	Not Available	10	82	36	Not Available	6	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Wide Excision	NO	YES	AR	Breast	Not Applicable	Alive	2013	2008
TCGA-B6-A0RE	FEMALE	7777	Infiltrating Ductal Carcinoma	Breast	Alive	TX	N0 (i-)	M0	Stage X	0	7777			TUMOR FREE				61	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RE	08da7c4c-3067-4bcf-9d7a-78566df72e69	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	2	-22449	Not Applicable	0	6435	Not Available	Not Available																								Unknown	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0RE-F13792;TCGA-B6-A0RE-F71507	E5211DCF-42C5-4A93-8ED4-0BF0E83E5F30;68A0A63C-7D7B-433D-AA9F-84E7F9365EA8				12;26		Not Available;None	Not Applicable;Not Applicable	6435;7777		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;NO		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Unknown	Other method, specify:	Not Evaluated	Not Available	14	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0RE	TUMOR FREE	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	TX	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1989
TCGA-AN-A0XN	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	10			TUMOR FREE				68	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-AN-A0XN	4e3699da-4367-4a43-9d66-a117d3ad460d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	25	-25029	Not Applicable	0	10	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XN-F68956	00AF090C-547A-493B-9220-2FEF43822FD0				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A0XN	TUMOR FREE	Not Available	0	Not Available	170	0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A1LI	FEMALE	3121	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	3121			TUMOR FREE				57	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1LI	3558dec7-eae3-4a41-a217-266c6a4535fb	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	3	-21064	Not Applicable	0	2750	Not Available	NO	TCGA-E2-A1LI-D20625;TCGA-E2-A1LI-D20624	8E4821F1-29B2-4F8E-B282-225C81946E03;EDBA2340-0F7F-49B5-9FBD-5B68A1F31507	Not Available;Not Available	12;12	112;112	42;42	Adriamycin;Cytoxan	Not Available;Not Available	1;1	4;4	60;600	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	240;2400	mg/m2;mg/m2	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1LI-F20623	8BAE43AC-77BB-4AC6-9756-C0A746B794DC				12		Not Available	Not Applicable	3121		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.21	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1LI	TUMOR FREE	Not Available	ACIS	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1LI-R20626	B73909E2-58E4-42C3-AFFF-2F8746177C50	1	12	194	152	Not Available	1	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2003
TCGA-D8-A1XQ	FEMALE	499	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	499			TUMOR FREE				69	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XQ	3886b4fb-ba22-4a50-b11a-a6893951f170	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	16	-25345	Not Applicable	0	177	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XQ-F29449	E3365AFC-09F9-4524-A456-5208C249283D				26		Not Available	Not Applicable	499		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	0%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0BM	FEMALE	1876	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1876			TUMOR FREE				54	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0BM	c2aeee6c-ba10-4cf9-b560-c739580f7bf3	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	8	-20049	Not Applicable	0	1117	Not Available	Not Available	TCGA-BH-A0BM-D4484;TCGA-BH-A0BM-D4481;TCGA-BH-A0BM-D4483	07017073-10D9-4DD4-878C-E519D915D613;3C72F82E-10E8-4A73-AAA4-B3074877D2B1;E9AF4E21-72D8-4812-B417-6233FC2911FF	Not Available;Not Available;Not Available	15;15;15	229;138;138	164;80;80	TAXOTERE;ADRIAMYCIN;CYTOXAN	Not Available;Not Available;Not Available	11;11;11	12;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0BM-F34064	23464ADF-8E8E-4359-AA9A-0D6C5E3A3BBD				29		Not Available	Not Applicable	1876		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	No	A0BM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-A8-A08O	FEMALE	943	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M1	Stage IV	1	762.0			WITH TUMOR				45	Right	Not Available	Not Available	TCGA-A8-A08O	5f5964a8-8e07-4620-98f0-93d162dbc31e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-16681	Not Applicable	0	943	Not Available	Not Available	TCGA-A8-A08O-D37779;TCGA-A8-A08O-D37780;TCGA-A8-A08O-D37781;TCGA-A8-A08O-D37782;TCGA-A8-A08O-D37783;TCGA-A8-A08O-D37784	985B0E53-6F65-4082-B0F8-813791E8AFC3;4301A8E9-4F7C-4D4F-BD1B-6ACEB2E8A058;11802BE2-DDBF-48C1-A327-EDE548A2FF37;6AA48F49-4040-4A21-B74C-DACF035A783D;AF51E7FE-12FB-4680-9277-972D6F241035;A70656EE-B142-4029-AB38-FAC922222B5A	n/a;n/a;n/a;n/a;n/a;n/a	6;6;6;6;6;6	121;790;397;Not Available;335;Not Available	31;790;366;943;60;60	Docetaxel;Vinorelbine;Anastrozole;Tamoxifen;Bevacizumab;Ibandronate	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable;Clinical Progressive Disease;Not Applicable	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Targeted Molecular therapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08O-F40848	A5B49570-AA8E-44E1-9B60-EF845AFFDC60				2			Not Applicable	943																				NO																						3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	762;762	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES	WITH TUMOR						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08O	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M1	N3a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-AN-A0FJ	FEMALE	242	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M1	Stage IV	0	242			TUMOR FREE				59	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FJ	546248b0-22a0-4b70-a437-76fb0a238a0d	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	27	-21910	Not Applicable	0	242	Not Available	Not Available																								dextran coated charcoal	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FJ-F68950	6A061E72-8985-4C17-AB5A-BAE6F2AAEB10				23			Not Applicable	242																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	40-49%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	14	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	8	0	No	A0FJ	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M1	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-A1-A0SF	FEMALE	1463	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1463			TUMOR FREE				54	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SF	4b620966-b4c7-4615-bf58-ca9d3226b9bd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	24	-19731	Not Applicable	0	1463	Not Available	NO	TCGA-A1-A0SF-D12156;TCGA-A1-A0SF-D12154;TCGA-A1-A0SF-D12152	7D85A866-4109-48A5-A927-6B9F5C64BD59;8B91D294-5433-4D18-A271-253430DDD871;911C7AF6-25C0-4A50-BE12-4E139C861AC0	Not Available;Not Available;Not Available	24;24;24	Not Available;918;126	1010;157;65	arimidex;tamoxifen;tc	Not Available;Not Available;Not Available	5;5;5	Not Available;Not Available;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	PO;PO;IV	YES;NO;NO	Other, specify in notes;Hormone Therapy;Chemotherapy	Aromatase Inhibitor;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	Not Available	No	A0SF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2011	2006
TCGA-D8-A13Z	FEMALE	635	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0		0	635			Not Available				51	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A13Z	5a17dcd9-5ced-4a69-8069-23c7fd0649d1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	27	-18942	Not Applicable	0	210	Not Available	Not Available	TCGA-D8-A13Z-D20732;TCGA-D8-A13Z-D65313;TCGA-D8-A13Z-D65314	CB4478D0-5504-4268-A2E9-9EFE2B5C293F;7EBDCBDC-E474-41D4-8D9F-2B99158B6829;D08EFDD4-5EBB-4816-910D-C6EAC35DE992	Not Available;Not Available;Not Available	14;22;22	157;157;157	52;52;52	doxorubicine;cyclophosphamide;tamoxifen	Not Available;Not Available;Not Available	1;9;9	6;Not Available;Not Available	6x97.8;Not Available;Not Available	mg/m2;Not Available;Not Available	ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	586.8;Not Available;Not Available	mg;Not Available;Not Available	Not Available;NO;NO	2012;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A13Z-F20731	444554B2-937F-4327-A7CC-E6A2B5BDC2B7				14		Not Available	Not Applicable	635		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	9	Not Available	No	A13Z	Not Available	Not Available	Hercep Test  TM Dako	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-D8-A13Z-R20733	022E96E7-CD23-4434-A287-97397DC0002B	Not Available	14	210	184	Not Available	1	18	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0DG	FEMALE	2041	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2041			TUMOR FREE				30	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0DG	0bc5744c-5fa3-45bb-87d0-70a02068b392	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	2	-11204	Not Applicable	0	713	Not Available	NO	TCGA-BH-A0DG-D63659;TCGA-BH-A0DG-D63660;TCGA-BH-A0DG-D63661	9B494472-AB4F-4900-8EA9-FBFB49E1C6A9;3BDFD427-B336-4AB3-A362-7E6587C297E7;B7B05AD1-68C3-489B-A7EB-F57176297F1B	Not Available;Not Available;Not Available	14;14;14	166;166;166	48;48;48	Taxotere;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0DG-F63658	8C3A54AE-5BD9-4011-ACE6-99D5A1D02FE2				14			Not Applicable	2041																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0DG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-BH-A0DG-R63662	16BBF746-9D23-4F90-94B5-7C620BC39CFA	Not Available	14	181	166	Complete Response	8	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Total mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-D8-A1JL	FEMALE	611	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	611			TUMOR FREE				72	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JL	aa4244a8-0454-4247-a1c3-357fd51746fa	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	29	-26484	Not Applicable	0	265	Not Available	Not Available																								manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JL-F20747	DCA53598-A604-4C2E-BC24-67A6AD8B8D49				15		Not Available	Not Applicable	611		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	DAKOHercepTest TM	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JL	TUMOR FREE	manual counting	Not Available	Not Available	0%	0%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A14P	FEMALE	1246	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	0	1246			TUMOR FREE				79	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A14P	e4fc0909-f284-4471-866d-d8967b6adcbc	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	31	-28923	Not Applicable	0	487	Not Available	NO	TCGA-E2-A14P-D18847	1097E387-AF7B-476A-AE90-ECF89836F10D	Not Available	20	396	39	Trastuzumab	Not Available	10	3	570	mg	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	10568	mg	Not Available	2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14P-F18846	28693AEC-5F7F-45B2-BEA4-2250E4909DBE				20		Not Available	Not Applicable	1246		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			NO		YES	Alive	2011	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	10	Not Available	No	A14P	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A14P-R18848	6DC4F0B6-6E08-4D24-9535-30E94160D27B	1	20	90	47	Not Available	10	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A0EA	FEMALE	991	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N1a	M0	Stage IIA	0	991			TUMOR FREE				72	Left	Not Available	Not Available	TCGA-BH-A0EA	1f601832-eee3-48fb-acf5-80c4a454f26e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	11	-26548	991	0	Not Available	Not Available	NO	TCGA-BH-A0EA-D58578;TCGA-BH-A0EA-D58581	90419813-A572-48FF-972A-949B5811D2F8;FECD8A5A-10AD-4DB7-91F2-08A6B16C19B9	Not Available;Not Available	14;14	363;522	84;363	Taxotere;Cytoxan	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0EA-F58566	4E9DAD81-E003-4EE4-88B8-99136572258C				14			991	Not Available																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	2	Not Available	Yes	A0EA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Total mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2008
TCGA-E9-A1NG	FEMALE	786	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	786			TUMOR FREE				62	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1NG	659b0170-e914-45ff-aa55-fcb8d3dc7b8a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	23	-22896	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1NG-D39776;TCGA-E9-A1NG-D39777	0D22B7CA-FD4C-4FB1-BC8D-AC7B958AE6E6;8D15500A-996F-42AD-9B5C-4B59FBEB68D6	Not Available;Not Available	1;1	Not Available;786	34;34	Letrozole;Tamoxifen	Not Applicable;Complete Response	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1NG-F29212;TCGA-E9-A1NG-F39774	CF8E81EE-644C-447C-8659-32AF571CBD47;B3EEEE00-5B8E-436F-80FE-7412C969BF0C				12;1		Not Available;None	Not Applicable;786	656;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Dead	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1NG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A9RU	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	MX	Stage IIIC	0	0			TUMOR FREE				90	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A9RU	6F18F96E-C0C9-4CC4-9FB2-CBA8949D5402	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	16	-32873	Not Applicable	0	0	Not Available	Not Available	TCGA-E2-A9RU-D60754	E37A508B-E21A-488A-B8D1-9927AA86305A	Not Available	16	Not Available	0	Arimidex	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E2-A9RU-F67578;TCGA-E2-A9RU-F70313	0E1468D5-13FF-4DA9-B3E2-19E5F062869A;BF7D4093-2A5D-4A9B-A257-7303FD2DD6E5				6;9			Not Applicable;Not Applicable	0;0																				NO;NO																						11;2					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	12	Not Available	No	A9RU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Allred Score 6	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Regional site;Primary Tumor Field	TCGA-E2-A9RU-R60755;TCGA-E2-A9RU-R60756	97D7F63A-20AB-4935-8123-943CFF3853D2;4068FAFC-865C-49DB-8D79-51CEA29F727F	Not Available;Not Available	16;16	0;0	0;0	Complete Response;Complete Response	6;6	Not Available;5	50.4;10	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2014	2013
TCGA-A2-A0SV	FEMALE	825	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2a	M1	Stage IV	0	825			WITH TUMOR				63	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0SV	ad01259b-d858-40bc-a6ba-0bb06e996afb	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	NO	15	-23126	825	0	Not Available	Not Available	Not Available	TCGA-A2-A0SV-D3723;TCGA-A2-A0SV-D3724;TCGA-A2-A0SV-D3725;TCGA-A2-A0SV-D3726	dffb0d8f-27a1-4dc6-855e-0fb99d5c4584;5207293a-a541-4268-9200-ec61f261433f;ff55eeb9-fb43-4b8c-915b-c74dc4195ffe;93f9d2f6-5376-40a2-b368-fc89e4e8650c	Not Available;Not Available;Not Available;Not Available	15;15;15;15	253;168;223;Not Available	65;79;170;304	Zometa;Arimidex;Fulvestrant;Xeloda	Not Available;Not Available;Not Available;Not Available	11;11;11;11	7;Not Available;5;Not Available	4;1;250-500;3000	mg;mg/day;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;3;4	IV;PO;IM;PO	NO;NO;NO;NO	Other, specify in notes;Hormone Therapy;Hormone Therapy;Chemotherapy	Bisphosphonate therapy;Not Available;Not Available;Not Available	16;Not Available;1250;Not Available	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Bone	Not Available	Not Available	YES	NO	Not Available	NO	TCGA-A2-A0SV-F3755	94723553-D507-4FCD-98BB-176F2233F930	Not Available	Not Available	Not Available	22	Not Available	Not Available	825	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11																																						WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Dead	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	No	A0SV	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0SV-R3727	e12b8a6f-2881-4d70-8abb-c5f2944d4ae7	1	15	141	108	Not Available	11	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M1	N2a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2006
TCGA-AR-A24X	FEMALE	3004	Mixed Histology (please specify)	Breast	Alive	T2	N0	M0	Stage IIA	0	3004			Not Available				52	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24X	491d5ebb-e9ab-4b17-acb8-630ff9fef0f2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	30	-19030	Not Applicable	0	1465	Not Available	Not Available	TCGA-AR-A24X-D31644;TCGA-AR-A24X-D31645;TCGA-AR-A24X-D31646	4A49DB24-6D72-4CF9-A396-F9FEC2E3A3FF;D805353E-47A2-4282-9237-2CAC88D2665E;5D4ED2DA-2DBA-474E-911D-6EFAE11A411B	Not Available;Not Available;Not Available	21;21;21	Not Available;Not Available;1926	Not Available;Not Available;130	Doxorubicin;Cytoxan;Tamoxifen	Not Available;Not Available;Not Available	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	80-89%	Not Available	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24X-F31643;TCGA-AR-A24X-F49505;TCGA-AR-A24X-F71741	D38579DD-B26E-4ACC-AD09-47DCCB6A47A4;6283A368-C360-4D7E-B284-5AB8F0FE43D6;D8FB489C-76DF-4D1D-9D2A-3DB704F0E1E3				7;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1465;2548;3004		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24X	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-E2-A1IO	FEMALE	1855	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1855			TUMOR FREE				37	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IO	71fc8941-4cfb-47ea-a533-873d38f8c95c	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	29	-13671	Not Applicable	0	498	Not Available	NO	TCGA-E2-A1IO-D20320;TCGA-E2-A1IO-D20319;TCGA-E2-A1IO-D20321	BFC8334A-C530-4EE0-860A-3473046CCE9F;5CAD1231-055C-4E7F-AA97-689B30AEE887;07023BDC-054F-4A18-BA92-A01D49FC2F1D	Not Available;Not Available;Not Available	4;4;4	147;147;Not Available	84;84;266	Docetaxel;Cyclophosphamide;Tamoxifen	Not Available;Not Available;Not Available	1;1;1	4;4;Not Available	115.5;924;20	mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;2	IV;IV;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	462;3696;20	mg;mg;mg/day	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1IO-F20318;TCGA-E2-A1IO-F70391	3AD0463E-614D-4388-ACC7-44A21F87E0EB;E33C2350-FCFD-48B6-9444-E29E22BB64DD				4;16		Not Available;None	Not Applicable;Not Applicable	687;1855		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	30-39%	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1IO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1IO-R20322	F2339939-5A10-4BDB-A1F4-6DBF9094FF35	1	4	220	175	Not Available	1	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-B6-A0I1	FEMALE	2361	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	1	1120.0	Lung	Distant Metastasis	TUMOR FREE				73	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0I1	5DD423E8-FEAA-4568-A750-500948C41D6C	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	11	-26902	2361	0	Not Available	Not Available	Not Available																								image cytometry	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-B6-A0I1-F38909	31CBA550-5941-49DB-B716-73F9F87BA3E9				3			2361	Not Available																				NO																						1					NO	NO	1120	1120	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Lung	Distant Metastasis	Not Available	YES	Not Available	YES	TUMOR FREE						NO		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Not Evaluated	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	Not Available	No	A0I1	TUMOR FREE	image cytometry	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2012	1998
TCGA-OL-A5D7	FEMALE	1780	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	1780			TUMOR FREE				70	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A5D7	C8F39325-5382-447C-9291-A6915FC978B8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Unknown	19	-25643	Not Applicable	0	1416	Not Available	Not Available	TCGA-OL-A5D7-D65248;TCGA-OL-A5D7-D65249	3B824D33-1415-4513-BD99-B3D2EB3268E0;34732C91-371D-4928-9C31-6B8D6A5D76CB	Not Available;Not Available	24;24	104;104	41;41	Cytoxan;Taxotere	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A5D7-F55439	81E1B508-543A-4E66-856F-86048DFAF64A				10			Not Applicable	1780																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.36	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	0	No	A5D7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A5D7-R65250	737BD5F1-6E92-4485-96EE-BA831B7A24C9	Not Available	24	550	134	Complete Response	9	Not Available	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2009
TCGA-A1-A0SN	FEMALE	1196	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	MX	Stage IIA	0	1196			TUMOR FREE				50	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SN	0dc337fa-da8b-42c4-b9a7-fb76d81c161f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	23	-18401	Not Applicable	0	1196	Not Available	Not Available	TCGA-A1-A0SN-D12066;TCGA-A1-A0SN-D12067;TCGA-A1-A0SN-D12157	46FC4D8A-2EEC-454B-BC8F-447030B0D761;6BE7B34C-4BFD-4AFD-B4FA-EF6DFA0CA6D0;4E133864-9EDE-40C9-91C3-E5E05D9D8545	Not Available;Not Available;Not Available	23;23;24	179;270;879	87;179;179	ac;taxol;herceptin	Not Available;Not Available;Not Available	5;5;5	4;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	4	Not Available	No	A0SN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	60-69%	WHITE	Not Available	Not Available	TCGA-A1-A0SN-R12068	C407753A-0959-403F-A289-925E56F5B012	Not Available	23	361	331	Not Available	5	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1	T1c	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2011	2007
TCGA-A8-A094	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE				75	Left	Not Available	Not Available	TCGA-A8-A094	993103b1-e5a1-4c33-8629-be53ebc41d64	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-27729	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A094	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-GM-A2DF	FEMALE	2155	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	2155			TUMOR FREE				53	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-GM-A2DF	D6F7AFC0-1558-43AD-ACB1-2B5311ED2264	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	29	-19614	Not Applicable	0	1299	Not Available	NO	TCGA-GM-A2DF-D47077;TCGA-GM-A2DF-D47078;TCGA-GM-A2DF-D47079;TCGA-GM-A2DF-D47080	9309E85C-511C-4D64-A9FD-153D7D059F76;BD3CED99-2972-42AC-A40F-65D713B00CF1;9759BFEA-6BA0-47F3-8697-D4BE5FD98515;0DE09D9B-CDA0-4E1C-A438-47238333BAF8	Not Available;Not Available;Not Available;Not Available	22;22;22;22	159;229;229;229	82;166;166;166	Taxol;Fluorouracil;Epirubicin;Cytoxan	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.40					TCGA-GM-A2DF-F47074	5EA23820-4945-4615-B3D5-2407C809951B				22			Not Applicable	2155																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	1.57	1.12	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A2DF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-GM-A2DF-R47076	097C40A5-1D8D-4E81-8D6E-2BCBC0783E3E	Not Available	22	294	250	Complete Response	8	32	64	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2007
TCGA-A2-A3XU	FEMALE	912	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1mi	M0	Stage IIB	1	596.0	Other, specify	Locoregional Recurrence	WITH TUMOR				35	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A3XU	A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	29	-13046	912	0	Not Available	Not Available	Not Available	TCGA-A2-A3XU-D34706;TCGA-A2-A3XU-D34707;TCGA-A2-A3XU-D34708;TCGA-A2-A3XU-D34709;TCGA-A2-A3XU-D34710	F99B1711-2441-4D81-BE35-E77D8DB5DD5C;22884654-200E-40BD-8E0D-C5BB2915AC39;BF14305C-8340-470C-B0C2-57AD71B8C1DE;D7667385-C63A-4D90-AE37-D95D1BC45AD5;45C67643-FF02-4C5B-874F-3D7D85A8FE9D	Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28	155;155;155;718;902	Not Available;Not Available;Not Available;596;657	Adriamycin;Cytoxan;Taxotere;Arimidex;Xeloda	Unknown;Unknown;Unknown;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	1.5					TCGA-A2-A3XU-F34704	71CBE6D1-7840-4A7C-AB59-CCDF29432FFA				30			912	Not Available																				NO																						8					YES;YES;YES;Not Available	NO;YES;NO;Not Available	Not Available;Not Available;Not Available;Not Available	596;596;574;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Positive;Negative;Not Evaluated;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Evaluated;Negative;Not Evaluated;Not Available	Not Evaluated;Not Evaluated;Not Evaluated;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Positive;Negative;Not Evaluated;Not Available	Other, specify;Other, specify;Bone;Not Available	Locoregional Recurrence;Locoregional Recurrence;Distant Metastasis;Not Available	Breast;Chest wall, Breast Recurrence;Not Available;Not Available	NO;NO;NO;Not Available	Not Available;Not Available;Not Available;Not Available	YES	WITH TUMOR						YES		YES	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	1.66	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Negative	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	YES;YES;YES	NO;YES;NO	596;Not Available;Not Available	Not Available;667;574	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Evaluated;Negative;Not Evaluated	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Evaluated;Negative;Not Evaluated	Not Evaluated;Not Evaluated;Not Evaluated	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Evaluated;Negative;Not Evaluated	Other, specify;Other, specify;Bone	Locoregional Recurrence;Locoregional Recurrence;Distant Metastasis	Breast recurrence;Chest wall;Not Available	YES;NO;NO	Not Available;Not Available;Not Available	YES	3	0	No	A3XU	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Regional site	TCGA-A2-A3XU-R34705	02DB7B9E-B9A1-471B-A309-5BFE13679395	Not Available	28	Not Available	Not Available	Unknown	8	20	4000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2012	2006
TCGA-BH-A0B8	FEMALE	1569	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0 (i-)	M0	Stage I	0	1569			TUMOR FREE				64	Right Upper Inner Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0B8	d3a75976-67d3-40fa-9f6f-cf2a3d7b773c	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	3	-23380	Not Applicable	0	1569	Not Available	Not Available	TCGA-BH-A0B8-D15443	00C007B0-1048-4B35-B0C6-48FD9B881A51	Not Available	3	Not Available	114	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0B8-F15442	2CC2206F-9B64-41BB-A290-4AC1379C77B6				3		Not Available	Not Applicable	1569		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.29	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0B8	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30-39%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0B8-R15444	48351B36-41DF-4E03-839A-F3968397A16A	1	3	114	63	Not Available	11	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1b	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2006
TCGA-AC-A6NO	FEMALE	51	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	51			TUMOR FREE				43	Right	Axillary lymph node dissection alone	Not Available	TCGA-AC-A6NO	8D9B50D1-139B-4447-AE9C-E54764D9E2A7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	10	-15996	Not Applicable	0	51	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	16	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	No	A6NO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2011
TCGA-A2-A0ET	FEMALE	1066	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	1066			TUMOR FREE				58	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0ET	96f23d8a-be0f-4925-ba00-805dc293414c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	20	-21464	Not Applicable	0	807	Not Available	Not Available	TCGA-A2-A0ET-D1869;TCGA-A2-A0ET-D1872;TCGA-A2-A0ET-D1873;TCGA-A2-A0ET-D1871	27062a5c-294b-42b5-83d5-4823fa303cf6;2b5d05ab-12db-4d8a-b19d-bfadbd0be27f;f4c9aca2-477b-48f3-8c8c-8bff0959670c;595833d0-af3e-4038-80c4-3f798f222a6d	Not Available;Not Available;Not Available;Not Available	20;20;20;20	169;169;Not Available;225	101;101;282;183	Cytoxan;Adriamycin;Anastrozole;Taxol	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;4;Not Available;4	1140-1170;114-117;1 mg daily;341-342	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;4;2	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	4650;464;Not Available;1367	mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0ET-F13713	ADFE6D4E-59FC-4293-AB60-DC1F69907AEE				10		Not Available	Not Applicable	1066		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.09	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	5	0	No	A0ET	TUMOR FREE	Not Available	Not Available	Not Available	Intensity=Strong	Intensity=Strong	Not Available	Not Available	70-79%	WHITE	Not Available	Not Available	TCGA-A2-A0ET-R1874	771405be-178c-469b-9e42-e26011660284	1	20	Not Available	Not Available	Not Available	9	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-AC-A3QP	FEMALE	675	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	675			TUMOR FREE				79	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A3QP	6F4C8D30-47FB-47DF-9EB7-4E5881E3711E	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	5	-29113	Not Applicable	0	286	Not Available	NO	TCGA-AC-A3QP-D56162	112B1EE9-F2CE-42E6-9BAF-6648ACB7226D	Not Available	29	Not Available	115	Femara	Not Applicable	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.2					TCGA-AC-A3QP-F56161	C88A67C7-BD93-497B-9C15-0C721BDE4168				29			Not Applicable	675																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	30	Not Available	2.6	1.2	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	1	1	No	A3QP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A3QP-R56164	611045A0-C19E-40FE-8A67-7170568A99B2	Not Available	29	108	62	Complete Response	1	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-A2-A04P	FEMALE	548	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N3c	M0	Stage IIIC	1	179.0	Other, specify	Locoregional Recurrence	WITH TUMOR				36	Left	Axillary lymph node dissection alone	Not Available	TCGA-A2-A04P	ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21	Positive	Negative	Not Available	Not Available	Not Available	Mastectomy NOS	Negative	Lumpectomy	Not Applicable	NO	26	-13238	548	0	Not Available	Not Available	Not Available	TCGA-A2-A04P-D2663;TCGA-A2-A04P-D2658;TCGA-A2-A04P-D2660;TCGA-A2-A04P-D2662;TCGA-A2-A04P-D2661;TCGA-A2-A04P-D2656;TCGA-A2-A04P-D2657;TCGA-A2-A04P-D2659	3a1d9f6f-f1ca-46c5-b2a8-de1975c543bc;82ad8e80-6818-481d-83da-17868130a545;365f5d4a-5bca-494e-82fa-3648ee6acfaa;021fbfcb-44dd-4dcd-952e-486a8aa9ecd0;17d09ea1-32bc-4cc2-998e-e9368e472335;355b6e7c-0b78-4127-8a9b-218b7e9c260b;8779d88c-d7d4-492c-b46f-bebb3650f0e8;2af268e5-309a-4cc6-8239-5fad8fe2c4e1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27;27	Not Available;303;424;424;424;180;242;303	424;242;303;424;424;69;180;242	Exemestane;TAXOTERE;ADRIAMYCIN;NAVELBINE;Cisplatin;TAXOL;XELODA;GEMZAR	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;1;1;12;Not Available;Not Available	25;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	8;3;5;7;6;1;2;4	PO;IV;IV;IV;IV;IV;PO;IV	NO;NO;NO;NO;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	YES;NO;None	YES;NO;None	YES;NO;None	NO;NO;None	TCGA-A2-A04P-F2652;TCGA-A2-A04P-F10241;TCGA-A2-A04P-F71021	0D1BD57A-F783-438D-9F39-8A75193DDDCC;1966A070-7389-434A-BE2F-01ABFB19B3AB;4B4F5FA2-A9FE-49A8-914E-F8256897A51A	Negative;Not Available;None	Not Available;Not Available;None	Negative;Not Available;None	26;18;13	179;Not Available;None	Not Available;Not Available;None	548;548;548	Not Available;Not Available;Not Available	Not Available;Not Available;None	179;180;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None		Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	1.0;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Evaluated;Not Available;None	Negative;Not Available;None	None;None;NO	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None		Not Available;Not Available;None		Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	8;3;3					None;None;YES;YES;YES;YES	None;None;YES;YES;NO;NO	None;None;179;Not Available;Not Available;Not Available	None;None;179;102;180;313	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Negative;Not Evaluated;Not Evaluated;Not Evaluated	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;1.0;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Evaluated;Not Evaluated;Not Evaluated;Not Evaluated	None;None;Negative;Not Evaluated;Not Evaluated;Not Evaluated	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Not Available;Not Available;Not Available;Not Available	None;None;Negative;Not Evaluated;Not Evaluated;Not Evaluated	None;None;Other, specify;Bone;Lung;Liver	None;None;Locoregional Recurrence;Distant Metastasis;Distant Metastasis;Distant Metastasis	None;None;Axilla;Not Available;Not Available;Not Available	None;None;YES;NO;NO;NO	None;None;Not Available;Not Available;Not Available;Not Available	None;None;YES	WITH TUMOR;WITH TUMOR;WITH TUMOR	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	YES;YES;YES	Not Available;Not Available;None	YES;YES;YES	Dead;Dead;Dead	2010;2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Negative	20	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	18	0	No	A04P	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Local Recurrence;Distant Recurrence;Primary Tumor Field	TCGA-A2-A04P-R2654;TCGA-A2-A04P-R2655;TCGA-A2-A04P-R2653	c8ef8b75-f636-4aa7-be8c-fa7dc58b779c;87499c44-a2db-4134-9bcf-76dfea4a507c;8cb52952-9ade-48ce-84fc-1ec9cece1fc5	Not Available;Not Available;Not Available	27;27;27	237;237;237	Not Available;193;193	Not Available;Not Available;Not Available	8;8;8	3;23;59	900;4393;10620	NO;NO;NO	EXTERNAL BEAM;EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable;Not Applicable	RECURRENCE;PROGRESSION;ADJUVANT	Not Available;Not Available;Not Available	cGy;cGy;cGy	2010;2010;2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3c	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2003
TCGA-A7-A5ZW	FEMALE	326	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	326			TUMOR FREE				47	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A7-A5ZW	523E24A2-51B9-4658-BE2F-42E5FCCEBB17	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-17529	Not Applicable	0	134	Not Available	Not Available	TCGA-A7-A5ZW-D50165;TCGA-A7-A5ZW-D50166;TCGA-A7-A5ZW-D50168	4AF33B96-C484-42DE-8F9B-AAB6DC4E168D;C795DC4E-1F39-460D-9E49-17CB3709BE9E;D46476DA-66D7-47D9-9AAA-19A388D19BAA	Not Available;Not Available;Not Available	16;16;16	176;176;Not Available	71;71;269	Cyclophosphamide;Taxotere;Tamoxifen	Complete Response;Complete Response;Not Applicable	10;10;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A5ZW-F51509	99C27BED-2BF4-4438-BFF1-18A08C754731				19			Not Applicable	326																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5ZW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	80-89%	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-A7-A5ZW-R50179	2208C54F-FD2C-457C-A3A5-E5433888EA9E	Not Available	16	252	207	Complete Response	10	33	6100	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-EW-A1PB	FEMALE	608	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	MX	Stage IIIA	0	608			TUMOR FREE				70	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A1PB	88db1340-e4bf-451a-87c0-6e9168296f5e	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	18	-25770	Not Applicable	0	608	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PB-F29107	3AAF57DA-E30C-45A6-B7DD-53CC5EA84417				8		Not Available	Not Applicable	608		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	Not Available	No	A1PB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-AO-A1KT	FEMALE	541	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	541			TUMOR FREE				78	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A1KT	1f8f87cb-8a0b-474c-97fb-c71b4fd88d97	Not Available	Positive	4 Point Scale	4+	4 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	1	-28660	Not Applicable	0	541	Not Available	NO	TCGA-AO-A1KT-D9910;TCGA-AO-A1KT-D9907;TCGA-AO-A1KT-D9909;TCGA-AO-A1KT-D9908	9e5254ab-c0ac-4253-bf73-2858ca59bc89;4daf246a-634a-4387-94f0-f90e6ef5ed43;6667d908-2ed7-4435-b5ed-adee0dae9f78;8515c4c8-a540-40dd-a831-e564158b5a23	Not Available;Not Available;Not Available;Not Available	1;1;1;1	Not Available;209;209;209	323;62;62;62	Arimidex;Fluorouracil;Methotrexate;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	4;4;4;4	Not Available;8;8;8	1;600;40;600	mg/day;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;8448;560;8448	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.7	Not Available	Not Available	Not Available	Not Available	TCGA-AO-A1KT-F9905	F0B207F5-C16E-4C68-98E9-69D908E9DFB5	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Applicable	541	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2011	FEMALE	Not Available	Not Available	10-19%	>2.2 Positive	2+	40	Not Available	2.4	1.4	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	1	Discrepancy	A1KT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A1KT-R9906	e031925b-8fc6-4d32-9a26-d3fdf0ae7662	1	1	280	238	Not Available	4	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2009
TCGA-EW-A1P3	FEMALE	1611	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	1611			TUMOR FREE				48	Right Lower Outer Quadrant	Other (specify)	SN+1 non sentinel node	TCGA-EW-A1P3	1ff85ada-3cdd-4afb-b311-2c7befb52702	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	10	-17637	Not Applicable	0	987	Not Available	NO	TCGA-EW-A1P3-D32283;TCGA-EW-A1P3-D32284;TCGA-EW-A1P3-D32279;TCGA-EW-A1P3-D32280;TCGA-EW-A1P3-D32281;TCGA-EW-A1P3-D32282	ADEE31EE-3558-4B60-9FB9-AE7031EEA45D;2DF181FE-A297-4584-BC96-62221AB5790D;E96674F2-DD8B-48F7-A5FF-D00715D4FC07;7C343140-68DC-4876-A592-603D0A985E0E;83B4A268-34F3-48DE-8F37-38D69F993505;0E200A24-933F-4B50-8382-45D54BFC5B59	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;30;30;30;30	1175;Not Available;147;147;147;233	261;1181;105;105;105;167	Tamoxifen;Femara;Fluorouracil;Epirubicin;Cyclophosphamide;Paclitaxel	Stable Disease;Not Applicable;Unknown;Unknown;Unknown;Stable Disease	5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;YES;NO;NO;NO;NO	Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-EW-A1P3-F32277;TCGA-EW-A1P3-F41142	EDE411CE-6185-490D-B7D9-9B2FCBE02D96;C361F496-F694-4201-844C-066F444499C3				15;12		Not Available;None	Not Applicable;Not Applicable	1260;1611		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	5;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	Yes	A1P3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-E9-A226	FEMALE	1048	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2	M0	Stage IIIA	1	790.0	Liver	Distant Metastasis	TUMOR FREE				45	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A226	dd67408e-46ba-4573-9415-d4814e9f84de	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	3	-16511	Not Applicable	0	16	Not Available	NO	TCGA-E9-A226-D29957;TCGA-E9-A226-D29956;TCGA-E9-A226-D29954;TCGA-E9-A226-D29955;TCGA-E9-A226-D55887	7D35CA2D-3C41-4DC3-BFFD-515E87E17963;DC196A0E-9253-4AAA-9BAB-196614D5855F;23AD3108-BB86-4392-9D2B-0F09E09F978D;63D2FA20-DF70-4A44-AF1C-A0C2D389F79A;2C88B47F-36AA-43AF-95BB-33939622235F	Not Available;Not Available;Not Available;Not Available;Not Available	30;30;30;30;17	Not Available;205;205;205;937	13;13;13;13;790	Tamoxifen;Cyclophosphamide;5-Fluorouracil;Doxorubicin;Pamidronate	Not Available;Not Available;Not Available;Not Available;Partial Response	3;3;3;3;1	Not Available;6;6;6;Not Available	20;1600;2000;100;Not Available	mg/day;mg;Not Available;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	PO;IV;IV;IV;Not Available	YES;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;9600;7000;500;Not Available	Not Available;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;NO	2012;2012;2012;2012;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A226-F29953;TCGA-E9-A226-F39536;TCGA-E9-A226-F70682	13947F51-BAED-4F88-969D-895B7BFFB55D;2E5DFE54-8DD8-45DF-AAE0-4C72C600C8A0;EFB0AAEA-6DB2-48ED-AB3F-020003E15D87				17;24;2		Not Available;None;None	Not Applicable;Not Applicable;1048	628;1038;Not Available		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	1;1;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;YES;YES;Not Available	None;NO;NO;Not Available	None;Not Available;Not Available;Not Available	None;790;790;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Bone;Liver;Not Available	None;Distant Metastasis;Distant Metastasis;Not Available	None;Not Available;Not Available;Not Available	None;NO;NO;Not Available	None;Not Available;Not Available;Not Available	None;YES;NO	TUMOR FREE;WITH TUMOR;WITH TUMOR			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Dead	2013;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	6	Not Available	No	A226	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A226-R29958	0516AC70-E0BC-4A79-B7E7-95CC9ED41DE0	Not Available	30	117	94	Not Available	3	20	4000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-S3-A6ZG	FEMALE	562	Mixed Histology (please specify)	Breast	Alive	T2	N1	M0	Stage IIB	0	562			TUMOR FREE				71	Left;Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-S3-A6ZG	1A679332-30A3-4495-A2E5-39D299E14333	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	12	-26141	Not Applicable	0	207	Not Available	Not Available	TCGA-S3-A6ZG-D51088;TCGA-S3-A6ZG-D51089;TCGA-S3-A6ZG-D51090;TCGA-S3-A6ZG-D63649;TCGA-S3-A6ZG-D64188	4FFDEFCC-4989-4FE3-9F8C-2F66D9CD5EF8;9C1469D0-34BE-4520-A928-C8222B9AA84A;592DBC73-6BBC-49B6-8C4D-DE2812D431D8;9E65EFA0-05D8-47EB-A1E0-6E44A31DBA3D;CE65FD9A-E5F7-42B1-8603-9979F90ABD5F	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;27;27	100;100;221;Not Available;100	52;52;116;256;52	Doxorubicin;Cytoxan;Taxol;Anastrozole;NEULASTA	Complete Response;Complete Response;Complete Response;Not Applicable;Complete Response	11;11;11;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;NO	2013;2013;2013;2014;2014	CAP scoring guideline 2010	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-S3-A6ZG-F63645;TCGA-S3-A6ZG-F70438	17174B64-048E-4778-9D5E-70492306C048;CF08A13B-D885-4AB3-A818-92AC66A01A70				27;26			Not Applicable;Not Applicable	399;562																				NO;NO																						8;2					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	CAP scoring guidelines 2010	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Invasive mixed ductal and lobular carcinoma	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	0	No	A6ZG	TUMOR FREE	CAP scoring guideline 2010	Not Available	Not Available	Moderate	Moderate	YES	YES	80-89%	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-S3-A6ZG-R63648	2C875BB6-139D-4B69-95DF-8D8F732E4308	Not Available	27	326	269	Complete Response	8	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2013	2013
TCGA-BH-A0H0	FEMALE	461	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	461			TUMOR FREE				69	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0H0	96457ebf-ae88-41f4-97e5-cdc3163418aa	Not Available	Positive	Not Available	2+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	10	-25223	Not Applicable	0	461	Not Available	Not Available	TCGA-BH-A0H0-D4700	A14326DB-605D-438E-8A8A-4F5740293909	Not Available	17	Not Available	67	ARIMIDEX	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-SCORE 190	50-59%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0H0-F4704	F6601BA3-50AC-41E2-B50D-CC6128A123B6	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	461	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0H0	TUMOR FREE	H-SCORE 7	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0H0-R4702	BDB65034-26A9-4FFC-B432-29CCD467D1FD	1	17	148	97	Not Available	11	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-GM-A3XG	FEMALE	1330	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	1330			TUMOR FREE				46	Right;Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-GM-A3XG	6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	1	-16948	Not Applicable	0	982	Not Available	Not Available	TCGA-GM-A3XG-D35512;TCGA-GM-A3XG-D35515;TCGA-GM-A3XG-D35516;TCGA-GM-A3XG-D35519;TCGA-GM-A3XG-D41971;TCGA-GM-A3XG-D41972	E32E194C-8D7D-4B56-BB63-4D33F4B1082A;40EF982A-EAA8-4F0A-A86D-5ED6DA2150F7;53DCF90D-749C-447D-BA77-62545A2CCAAA;34EC610D-426F-433C-94ED-1FB1BC4FF569;D44E9F6A-E7B4-4C08-BF20-B6A744CD1C78;1E050AB5-3F95-403F-9CD2-15E62549A9B0	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;8;8	247;324;324;324;473;843	163;261;261;261;434;813	Paclitaxel;Fluorouracil;Adriamycin;Cytoxan;Tamoxifen;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Complete Response	10;10;10;10;4;4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.67					TCGA-GM-A3XG-F46963	9CCD1072-5A2E-4CCA-AA65-DAEFDFE36A3A				20			Not Applicable	1330																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	1.73	1.04	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	0	No	A3XG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field	TCGA-GM-A3XG-R35511	2085DEFE-099C-42C0-92EF-DF939B5A7AEF	Not Available	1	415	372	Complete Response	10	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2012	2009
TCGA-C8-A12P	FEMALE	358	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	358			TUMOR FREE				55	Left	Not Available	Not Available	TCGA-C8-A12P	abdc76db-f85e-4337-a57e-6d098789da03	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	13	-20332	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12P-F20267	E314B6FE-D28B-4608-B290-CC684F3A2B1A				9		Not Available	Not Applicable	358		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Positive	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12P	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A1IE	FEMALE	2362	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	1	1810.0	Liver	Distant Metastasis	TUMOR FREE				61	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IE	2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	26	-22510	Not Applicable	0	983	Not Available	NO	TCGA-E2-A1IE-D19971;TCGA-E2-A1IE-D19965;TCGA-E2-A1IE-D19967;TCGA-E2-A1IE-D19968;TCGA-E2-A1IE-D19970;TCGA-E2-A1IE-D70374;TCGA-E2-A1IE-D70375;TCGA-E2-A1IE-D70376;TCGA-E2-A1IE-D70377	FF2B7E21-B246-498D-8B7B-4B91A0FB3425;F1068428-E9F7-419B-B5A1-1C52A1E42A8E;65CC9CCD-D919-4BCD-96BF-619424B8D8BE;21FD6890-254A-4F5F-B112-8D1EB3C23341;D27CB74E-89DC-4859-81F9-CBA4A807E9E8;FC87038A-95A3-4E05-9442-79BF251AF39F;6A7EB17B-231B-4C2C-B1B0-8825B0BD71CA;7325CF50-8976-4A43-9E2F-6FA667BC428C;07C275AD-3B22-436C-89C9-CCB6FD3D2B2E	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;16;16;16;16	Not Available;104;104;171;437;1928;2187;Not Available;Not Available	500;62;62;118;252;1844;1928;2187;2187	Tamoxifen;Doxorubicin;Cyclophosphamide;Paclitaxel;Arimidex;Femara;Faslodex;Exemestane;Everolimus	Not Available;Not Available;Not Available;Not Available;Not Available;Clinical Progressive Disease;Clinical Progressive Disease;Not Applicable;Not Applicable	12;12;12;12;12;3;3;3;3	Not Available;4;4;4;Not Available;Not Available;Not Available;Not Available;Not Available	20;118;1182;341;1;Not Available;Not Available;Not Available;Not Available	mg/day;mg;mg;mg;mg/day;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;1;1;2;3;Not Available;Not Available;Not Available;Not Available	PO;IV;IM;IV;IV;PO;Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO;NO;NO;NO;YES;YES	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;472;4728;1364;185;Not Available;Not Available;Not Available;Not Available	mg/day;mg;mg;mg;mg;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;NO;NO;NO;NO	2011;2011;2011;2011;2011;2015;2015;2015;2015	allred score 5 + 3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1IE-F19964;TCGA-E2-A1IE-F70297	D2C1D1D2-94EC-4BD9-9EF5-0F7C2604F6EE;2D1B9C9B-B501-4643-91F8-FBF1D4B0A90C				21;16		Not Available;None	Not Applicable;Not Applicable	1165;2362		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;YES	None;NO	None;Not Available	None;1810	None;200	None;2.1	None;Not Available	None;Not Available	None;Not Available	None;Positive	None;2.2	None;Not Available	None;Not Available	None;Not Available	None;1.0	None;3+	None;3 Point Scale	None;3+	None;3 Point Scale	None;Not Available	None;Negative	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Positive	None;Liver	None;Distant Metastasis	None;Not Available	None;NO	None;Not Available	None;YES	TUMOR FREE;WITH TUMOR			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	20-29%	Not Available	2+	Not Available	Not Available	Not Available	1.05	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A1IE	TUMOR FREE	allred score 3 + 3 = 6	Not Available	Not Available	allred score = 6	allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A1IE-R19972	03BCA171-2C59-4E91-93E2-0BCEBAD1E9F7	1	21	251	200	Not Available	12	33	6080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-LL-A7SZ	FEMALE	594	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	594			TUMOR FREE				49	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-LL-A7SZ	09A5E9FD-D816-4F8C-BAA9-0E40BA607B16	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	7	-18161	Not Applicable	0	170	Not Available	Not Available	TCGA-LL-A7SZ-D55457;TCGA-LL-A7SZ-D55458;TCGA-LL-A7SZ-D55460;TCGA-LL-A7SZ-D66976	A3E71F68-6309-4BB8-BF4D-BE485E3E1A0D;5B4EB4C7-43B4-486D-92BD-4B7E69E4413D;329A77EB-2FCC-4B16-9067-24F677050B03;7B392814-A441-40A9-8A1B-24106473A188	Not Available;Not Available;TAXOL;Not Available	7;7;7;29	104;104;209;Not Available	62;62;132;237	ADRIAMYCIN;CYTOXAN;Not Available;TAMOXIFEN	Complete Response;Complete Response;Complete Response;Not Applicable	1;1;1;10	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES	2014;2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A7SZ-F66973	1D00374C-84A6-4DC5-97F4-0C60D6ADA5BE				29			Not Applicable	594																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	No	A7SZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	BLACK OR AFRICAN AMERICAN	NO	Regional site;Primary Tumor Field	TCGA-LL-A7SZ-R66974;TCGA-LL-A7SZ-R66975	4C950E6E-B651-4FE5-842B-46976BEF8BC8;73EF3361-48B3-4F10-A4CF-137ACCA6B8C8	Not Available;Not Available	29;29	275;275	239;239	Complete Response;Complete Response	10;10	28;28	45;50.4	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	SKIN SPARING RADICAL MASTECTOMY	YES	NO	LL	Breast	Not Applicable	Alive	2014	2013
TCGA-LL-A73Z	FEMALE	227	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	NX	M1	Stage IV	1	192.0	Brain	Distant Metastasis	WITH TUMOR				55	Left;Left Lower Inner Quadrant	No axillary staging	Not Available	TCGA-LL-A73Z	3E637872-F5E5-49D3-BB0D-9C16B8713382	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Evaluated	Positive	Lumpectomy	Not Applicable	NO	15	-20118	Not Applicable	0	137	Not Available	Not Available	TCGA-LL-A73Z-D51324;TCGA-LL-A73Z-D51326;TCGA-LL-A73Z-D51327;TCGA-LL-A73Z-D51328	7720FC0E-5AB6-4C6A-8EE4-97B0882078E7;C1E53020-8C36-4C1C-89EB-FFA09DCF92E6;3E79EC05-9045-43FC-94DB-E1CD163B0D88;D00B1B78-354F-4C0A-BA7A-27A54ECC394D	Not Available;Not Available;Not Available;Not Available	15;15;15;15	60;60;109;179	18;18;74;123	Adriamycin;Cytoxan;taxol;faslodex	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	11;11;11;11	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	10-19%	NOT HISPANIC OR LATINO	Other, specify	skin	2.2					TCGA-LL-A73Z-F64983	C93234C7-BF07-45D1-B6C1-80938475F7B5				16			227	Not Available																				NO																						9					NO;Not Available	NO;Not Available	Not Available;Not Available	192;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Brain;Not Available	Distant Metastasis;Not Available	Not Available;Not Available	NO;Not Available	Not Available;Not Available	YES	WITH TUMOR						YES		YES	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	243	Not Available	2.5	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Excisional Biopsy	Equivocal	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A73Z	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	NO	<10%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-LL-A73Z-R51329	D11B1721-EDD8-4F57-98D6-8B5F3BBE1EEF	Not Available	15	151	125	Radiographic Progressive Disease	11	16	42.72	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M1	NX	T1c	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-LD-A66U	FEMALE	646	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	646			TUMOR FREE				44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-LD-A66U	38DC3E09-0B0E-4A29-B318-CC0352013DAE	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	27	-16101	Not Applicable	0	252	Not Available	Not Available	TCGA-LD-A66U-D44826;TCGA-LD-A66U-D44784;TCGA-LD-A66U-D44824;TCGA-LD-A66U-D58447	26C2F6EB-DFF2-4C2A-A095-98A2434C36EF;7A18D472-645D-49A3-B32B-E960EF3D6FC1;0938D350-5A79-457E-B8EA-2BCF27413DDE;F33118FA-3D18-420A-8F4A-2B5ECD06BE24	Not Available;Not Available;Not Available;Not Available	27;27;27;10	183;127;127;Not Available	141;85;85;278	Taxol;Adriamycin;Cytoxan;Tamoxifen	Unknown;Unknown;Unknown;Not Applicable	6;6;6;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LD-A66U-F58445;TCGA-LD-A66U-F63067	90F609AB-BB7D-47BD-B55F-10F4F655C783;6AA69A72-7696-47F4-B184-4F5F74969DDD				10;30			Not Applicable;Not Applicable	422;646																				NO;NO																						4;7					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	15	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	No	A66U	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field	TCGA-LD-A66U-R44783	EF712C6A-231E-4FEA-B371-DFBEF41B049B	Not Available	26	Not Available	231	Not Applicable	6	28	4680	YES	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	YES	NO	LD	Breast	Not Applicable	Alive	2013	2012
TCGA-AQ-A1H3	FEMALE	989	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	MX	Stage IIIC	0	989			TUMOR FREE				49	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AQ-A1H3	82ec33dd-e783-4c74-9a87-797a699e11df	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-18177	Not Applicable	0	162	Not Available	NO	TCGA-AQ-A1H3-D19918;TCGA-AQ-A1H3-D19909;TCGA-AQ-A1H3-D19919;TCGA-AQ-A1H3-D19910	80735D66-0D8E-43E8-A65D-695327350EBC;49FE2EE4-C3CA-449E-9041-AADDB7B2789D;98F948E1-A62A-41F8-8B73-54326F302C9F;A00FC9E3-5B49-4A54-A683-C81D3B869DAD	Not Available;Not Available;Not Available;Not Available	4;4;4;4	162;106;Not Available;106	120;64;239;64	Taxol;Adriamycin;Tamoxifen;Cytoxan	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;4;Not Available;4	175;60;20;600	mg/m2;mg/m2;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AQ-A1H3-F19908;TCGA-AQ-A1H3-F50661	C0E98003-E4EE-4BE5-A95E-AEDA30278AC0;98A7EDE4-CB1F-4A84-AD74-E1F4C96ABF53				4;28		Not Available;None	Not Applicable;Not Applicable	402;989		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	14	Not Available	No	A1H3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	80-89%	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-AQ-A1H3-R19911;TCGA-AQ-A1H3-R19912	DD693829-5BDE-49CE-AA8B-42D8FFE43469;A77D9CB5-BE36-4F5B-A97C-A8A048732921	1;1	4;4	233;226	188;188	Not Available;Not Available	1;1	33;28	6040;5040	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T2	Not Available	YES	NO	AQ	Breast	Not Applicable	Alive	2011	2010
TCGA-AN-A0FT	FEMALE	214	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	214			TUMOR FREE				63	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FT	baf5e81f-2322-41ec-9053-b9559a7993bc	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-23300	Not Applicable	0	183	Not Available	Not Available																								dextran coated charcoal	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FT-F68964	A4DE618B-9DF9-4C32-89BA-4C48D4E00DEE				24			Not Applicable	214																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	0	No	A0FT	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	230	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-E9-A1NC	FEMALE	1203	Mixed Histology (please specify)	Breast	Alive	T2	N1	M0	Stage IIB	0	1203			TUMOR FREE				61	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1NC	e74aea7c-ca14-49df-b5cf-dacb839ac27a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	23	-22355	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1NC-D32903;TCGA-E9-A1NC-D32906;TCGA-E9-A1NC-D32908;TCGA-E9-A1NC-D32909	E78A504B-9523-4183-AF5D-ACF86478BB82;86434E5A-26BE-4F46-AF34-769FA7208481;DDF2090C-2AB2-4A9F-A37C-2D6945B8AA8E;A78DF706-2990-4314-934D-7EFD5C578BD5	Not Available;Not Available;Not Available;Not Available	15;15;15;15	122;122;122;708	10;10;10;134	Doxorubicin;5-Fluorouracil;Cyclophosphane;Tamoxifen	Complete Response;Complete Response;Complete Response;Complete Response	6;6;6;6	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1NC-F29162;TCGA-E9-A1NC-F40639	13CA0108-5056-4497-AB23-DD66AF372D8A;9D94E73F-C799-4D60-8226-7DEEBDA60156				4;26		Not Available;None	Not Applicable;Not Applicable	708;1203		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2014;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	0	No	A1NC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0AV	FEMALE	1820	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1820			TUMOR FREE				52	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A0AV	790ff5db-b7f3-4946-aaed-305f66b1dd6a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	2	-19314	Not Applicable	0	1180	Not Available	NO	TCGA-BH-A0AV-D59175;TCGA-BH-A0AV-D59176	3FC0BA35-5F5A-4C4B-B4F7-34A5A6C872EF;BA9B227E-1B4A-469B-BCC4-E008C2CA2DAA	Not Available;Not Available	2;2	259;259	146;146	Taxotere;Cytoxan	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-BH-A0AV-F59174	F2F9895E-1F5D-4A27-9394-24906331E464				2			Not Applicable	1820																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Negative	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0AV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-BH-A0AV-R59177	1E9BDB6B-495D-4881-8264-4717B2630D9B	Not Available	2	308	259	Complete Response	5	36	66.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Segmental mastectomy with left axillary lymph node dissection	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-B6-A0RT	FEMALE	2721	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1	M0	Stage IIIA	0	2721			TUMOR FREE				39	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RT	4bf50455-9ab7-4521-a791-089f66d3b877	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	3	-14374	Not Applicable	0	2721	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0RT-F13789	1E4F30E1-0F1A-4FD6-A858-B54D79689792				12		Not Available	Not Applicable	2721		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Available	23	Close	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	1	Not Available	No	A0RT	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1996
TCGA-EW-A1IW	FEMALE	371	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	371			TUMOR FREE				80	Right Lower Inner Quadrant;Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1IW	5e2cbc56-97f9-4b94-ade2-a3f739bcc7be	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	27	-29529	Not Applicable	0	252	Not Available	NO	TCGA-EW-A1IW-D21178	6E6AFF49-706F-44B0-8ED2-F4AB626A5491	Not Available	10	Not Available	71	Aromasin	Not Available	2	6	25	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1IW-F21380	F2B8499E-0A1A-45DA-86EA-531D38617555				6		Not Available	Not Applicable	371		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	+ or -	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	0	No	A1IW	TUMOR FREE	Not Available	CISH	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	total mastectomy	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A3Q9	FEMALE	1001	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3	M0	Stage IIIC	0	1001			TUMOR FREE				78	Right Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A3Q9	E36E985D-2C44-4E14-854A-7DBCA4BB0304	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	30	-28715	Not Applicable	0	31	Not Available	NO	TCGA-E9-A3Q9-D40591;TCGA-E9-A3Q9-D40592;TCGA-E9-A3Q9-D40593;TCGA-E9-A3Q9-D40594	1D3313F6-A11D-433B-9DE9-C6710E726905;EE1ADBED-9135-4EE3-84F2-42AB43FA667F;E7C7F8BC-C6B2-4F17-9D8B-484C4B903746;8925146E-CA92-4C23-9610-AA8FAADEC1D3	Not Available;Not Available;Not Available;Not Available	25;25;25;25	51;51;51;Not Available	28;28;28;108	Cyclophosphane;Mitoxantrone;5-Fluorouracil;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	2;2;2;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	40-49%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A3Q9-F40589;TCGA-E9-A3Q9-F59741	685D54DA-6242-4E70-A7EA-0C22A6BA84B3;0902FC35-0AAF-4110-9F64-887922B8B914				25;20			Not Applicable;Not Applicable	560;1001																				NO;NO																						2;5					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Indeterminate	Not Evaluated	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	22	0	No	A3Q9	TUMOR FREE	Not Available	Not Available	Not Available	8	8	Not Available	YES	40-49%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T3	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2012	2011
TCGA-AC-A8OS	FEMALE	70	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	70			TUMOR FREE				71	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A8OS	D5E655FE-3FBC-47B0-BA23-1D1DD01D591C	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-26248	Not Applicable	0	70	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	10-19%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A8OS	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2013
TCGA-B6-A0I6	FEMALE	991	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N1	M0	Stage IIA	1	859.0	Other, specify	Distant Metastasis	WITH TUMOR				49	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0I6	045c13ef-3db7-4adf-b0a3-23338f0479f3	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	2	-18014	991	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	NO		TCGA-B6-A0I6-F12605	DCA585A3-16B1-4A99-9C5A-AEB6183E3C9E				1		Not Available	991	Not Available		859				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	6	Other, specify	Distant Metastasis	Skin and bone	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	32	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	6	Not Available	No	A0I6	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1990
TCGA-S3-AA12	FEMALE	574	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	MX	Stage IIIA	0	574			TUMOR FREE				82	Left;Left Upper Inner Quadrant;Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-S3-AA12	2BCACFD1-6A45-4B96-9B80-2AD569B1AB45	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	18	-30101	Not Applicable	0	259	Not Available	Not Available	TCGA-S3-AA12-D58368	1212862C-4FC4-424A-AE86-4464B10A60B1	Not Available	18	Not Available	58	ANASTROZOLE	Not Applicable	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	CAP SCORING GUIDELINE 2010	90-99%	NOT HISPANIC OR LATINO	Lung;Other, specify	left adrenal gland	Not Available					TCGA-S3-AA12-F67620;TCGA-S3-AA12-F70442	51D6062C-FC35-4A9F-8888-CF19EC5BD0AC;C4900549-569B-42AF-A29A-0C7466A08071				7;26			Not Applicable;Not Applicable	467;574																				NO;NO																						11;2					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2014;2015	FEMALE	Not Available	CAP SCORING GUIDELINE 2010	Not Available	CAP SCORING GUIDELINE 2007	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	Yes	AA12	TUMOR FREE	CAP SCORING GUIDELINE 2010	Not Available	Not Available	MODERATE	MODERATE	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013
TCGA-B6-A0WX	FEMALE	639	Other, specify	Breast	Dead	T3	N1b	M0	Stage IIIA	1	563.0	Bone	Distant Metastasis	WITH TUMOR				40	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0WX	a482fc4c-ff1d-46a0-a968-7df06422cc4b	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	14	-14784	639	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	NO		TCGA-B6-A0WX-F15729	BA8B9EFE-3133-40B3-9336-0CD5C63B5D0A				29		Not Available	639	Not Available		563				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Bone	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Pleomorphic/lobular	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Evaluated	21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	9	Not Available	No	A0WX	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1998
TCGA-E2-A1II	FEMALE	1025	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1025			TUMOR FREE				51	Left	Sentinel node biopsy alone	Not Available	TCGA-E2-A1II	0fe1419e-a005-407c-8ae7-15c4c1579539	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	28	-18788	Not Applicable	0	850	Not Available	NO	TCGA-E2-A1II-D19957;TCGA-E2-A1II-D19955;TCGA-E2-A1II-D19956	E52E0CD6-6BA3-4B19-B9A1-B64D2D70C333;32F5916B-52FE-4FD3-8F7D-FAFD84F63E02;7F620EE0-F7E5-41C9-9E7F-E47843DBB6EC	Not Available;Not Available;Not Available	21;21;21	171;115;115	129;73;73	Paclitaxel;Doxorubicin;Cyclophosphamide	Not Available;Not Available;Not Available	12;12;12	4;4;4	328;116;1164	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1312;460;4656	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	allred score 0 + 0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1II-F19954	27975FD4-6AE6-4CF8-B70D-97A5D77F33F1				21		Not Available	Not Applicable	1025		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1II	TUMOR FREE	allred score 2+2 = 4	Not Available	Not Available	allred score = 4	allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1II-R19959	0C04CF63-CC3C-4E0B-A37F-CAF63097FBAB	1	21	236	181	Not Available	12	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-S3-AA17	FEMALE	424	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi		Stage IIB	0	424			TUMOR FREE				64	Right;Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-S3-AA17	49A2FD48-744D-4D88-B9B4-8C778D4F48FD	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	21	-23642	Not Applicable	0	119	Not Available	Not Available	TCGA-S3-AA17-D58375	61D5661A-D46E-4B24-8512-602DE23D1373	Not Available	21	Not Available	99	ANASTROZOLE	Not Applicable	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	CAP SCORING GUIDELINE 2010	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	35					TCGA-S3-AA17-F67708	47914404-6847-4D22-91E8-F2BA8618EE3E				11			Not Applicable	424																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	CAP SCORING GUIDELINE 2010	Not Available	CAP SCORING GUIDELINE 2010	2+	20	Not Available	61	1.7	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	1	Yes	AA17	TUMOR FREE	CAP SCORING GUIDELINE 2010	Not Available	Not Available	MODERATE	STRONG	YES	YES	70-79%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-S3-AA17-R58374	FBDFCCD6-FB33-4827-8C3D-BA9F05070849	Not Available	18	162	119	Complete Response	4	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	cM0 (i+)	N1mi	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013
TCGA-C8-A3M7	FEMALE	1034	Infiltrating Lobular Carcinoma	Breast	Dead	T4b	N0	M0	Stage IIIB	1	1034.0		Locoregional Recurrence	TUMOR FREE				60	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-C8-A3M7	959FF069-8A49-4C9B-85C2-5291CAC0ACFF	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	6	-22096	Not Applicable	0	1	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A3M7-F70838	BFE6A7FF-9238-485C-836E-9BE96855EF6D				9			1034	Not Available																				NO																						3					NO	NO	Not Available	1034	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Locoregional Recurrence	Not Available	NO	Not Available	YES	WITH TUMOR						YES		YES	Dead	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A3M7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T4b	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2012	2010
TCGA-E9-A1ND	FEMALE	1266	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1266			TUMOR FREE				75	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1ND	f06f09f3-8133-4a92-ac86-fbe64295e0d8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	YES	23	-27400	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1ND-D30738;TCGA-E9-A1ND-D30736	FE127B51-D86A-4837-BD0A-0BE45831808C;C52B4951-6F14-4E15-850F-E75D2A3B32AC	Not Available;Not Available	16;16	Not Available;78	31;31	Aromasin;Tamoxifen	Not Available;Not Available	4;4	Not Available;Not Available	25;20	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	YES;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A1ND-F29163;TCGA-E9-A1ND-F55570;TCGA-E9-A1ND-F62586	84404451-1487-4C94-8B63-BB1DDD0B95D9;71D7CEFF-D60F-4294-8529-C2647A2961D0;20D9D392-E622-4E6B-9D2D-1D2616A9F585				9;9;21		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	383;838;1266		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	3;1;7	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2012;2014;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	0	No	A1ND	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A7-A13E	FEMALE	614	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1	MX	Stage IIB	1	556.0	Other, specify	Distant Metastasis	TUMOR FREE		FPPP	TCGA	62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A13E	8c7e74e0-71ef-49b8-9217-94b8ef740ef9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	28	-22690	Not Applicable	0	287	Not Available	Not Available	TCGA-A7-A13E-D8481;TCGA-A7-A13E-D8387;TCGA-A7-A13E-D8384;TCGA-A7-A13E-D8385;TCGA-A7-A13E-D8386;TCGA-A7-A13E-D30411;TCGA-A7-A13E-D30410	6b9ba4ba-7f9d-4756-b32b-d5bc244ed7e7;2a1cd4f5-b57f-4701-a524-65a4c933838e;ab9b71e4-bef4-4ef9-aee1-f529cd48d75e;dacbe1fe-726e-49ea-807c-c058a56849ab;d8fde920-62a6-411b-8bb4-b2d156e504c4;17FFDC6B-E84C-4E5B-999D-D68ED4BF7881;983433D3-76A3-4F8C-9397-6496805CDAB0	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;21;21;21;21;9;9	Not Available;193;108;108;207;574;589	211;67;67;67;123;574;211	Arimidex;Bevacizumab;Doxorubicin;Cyclophosphamide;Paclitaxel;Taxol;Anastrozole	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;3;3;3;3;4;4	Not Available;8;4;4;4;1;Not Available	1;914-1364;120-122;1200-1230;158-160;157;1	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;PALLIATIVE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1;2;1	PO;IV;IV;IV;IV;IV;PO	YES;NO;NO;NO;NO;NO;NO	Hormone Therapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;9136;486;4848;1908;157;379	Not Available;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2012;2012	Not Available	20-29%	NOT HISPANIC OR LATINO	Not Available	Not Available	3.0	Not Available;YES	Not Available;YES	Not Available;NO	Not Available;None	TCGA-A7-A13E-F9345;TCGA-A7-A13E-F30405	624C544A-EABA-4615-9912-C86A62D148EA;10F815AF-1701-4E90-A5B7-C9A30984BF5E	Not Available;None	Not Available;None	Not Available;None	21;9	Not Available;None	Not Available;Not Available	Not Applicable;614	326;Not Available	Not Available;None	Not Available;556	Not Available;None	Not Available;None	Not Available;None	None;Additional New Tumor Event	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;1+	Not Available;Not Available	Not Available;Not Available	Not Available;Negative	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Negative	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Negative	3;4	None;Other, specify	None;Distant Metastasis	None;Lung, Bone, Liver, Brain and Skin Nodules	None;YES																																		TUMOR FREE;WITH TUMOR	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;NO	Alive;Dead	2011;2012	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA Probe Kit	2+	561	Not Available	3.2	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	2	Not Available	No	A13E	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field;Distant site;Distant site	TCGA-A7-A13E-R8473;TCGA-A7-A13E-R30409;TCGA-A7-A13E-R30408	d0e25ccc-163e-4d8e-822f-3703bdff238e;B6E2B338-90E5-4321-A73B-84030A994930;6001F2EF-D19E-42B5-8DB5-91084F93BFB8	1;3;2	28;9;9	287;598;563	238;584;557	Not Available;Not Available;Not Available	2;4;4	33;10;5	6100;3000;2000	NO;NO;NO	EXTERNAL BEAM;EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;PALLIATIVE;PALLIATIVE	Not Available;Not Available;Not Available	cGy;cGy;cGy	2011;2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A12U	FEMALE	385	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	385			TUMOR FREE				46	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12U	97b5f490-1cd9-4833-b903-5f4c6e45670d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	13	-17045	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12U-F20249	06835152-B8AC-4FE9-A8E6-873E5B07FD48				9		Not Available	Not Applicable	385		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12U	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 3	Allred Score 5	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0D0	FEMALE	2048	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2048			TUMOR FREE				60	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0D0	324bcba2-f6a4-45a6-807c-215bdffcca21	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	16	-22115	Not Applicable	0	643	Not Available	Not Available	TCGA-A2-A0D0-D1851;TCGA-A2-A0D0-D1852	f423013c-d03a-46bf-9df8-4261396bdc99;e74bfde2-3653-4de9-bff3-80e8d53d150d	Not Available;Not Available	16;16	125;125	62;62	Cytoxan;Docetaxel	Not Available;Not Available	9;9	4;4	1230;153	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4920;612	mg;mg	Not Available;Not Available	2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0D0-F13729;TCGA-A2-A0D0-F59399	4F4DEDB3-173C-4B24-B46B-D1DDCB67A318;D16C3023-B057-4408-8F50-C78DEA6876E1				9;12		Not Available;None	Not Applicable;Not Applicable	643;2048		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	TUMOR FREE;Unknown			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	1.17	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Negative	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0D0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-A2-A0D2	FEMALE	1027	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	1027			TUMOR FREE				45	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0D2	99e32c59-aa73-43fa-88c9-399ddadb2c72	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	16	-16623	Not Applicable	0	761	Not Available	Not Available	TCGA-A2-A0D2-D1822;TCGA-A2-A0D2-D1823;TCGA-A2-A0D2-D1824	0b7ae681-1762-4598-b9c5-79d77a5f208a;956680fa-6dc8-437e-8529-32d884b2e572;ef46d977-60f0-4915-9438-4c3e9c7e66d8	Not Available;Not Available;Not Available	17;17;17	123;123;179	74;74;137	Adriamycin;Cytoxan;Taxol	Not Available;Not Available;Not Available	9;9;9	4;4;4	108-109;1086;325-329	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	435;4344;1308	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0D2-F14458	76B9C470-A143-4376-92CB-58317C2C3764				9		Not Available	Not Applicable	1027		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	1.05	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Negative	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	4	No	A0D2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site;Regional site	TCGA-A2-A0D2-R1825;TCGA-A2-A0D2-R70743	a912f4e0-99c5-408c-b321-73e7f5d077e0;12036BDE-8D83-40CA-AA13-7AFEFCF03DD5	1;Not Available	17;3	270;270	230;230	Not Available;Complete Response	9;3	28;28	5040;5040	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;cGy	2010;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-B6-A40B	FEMALE	3152	Infiltrating Lobular Carcinoma	Breast	Alive	T1b	N0 (i-)	M0	Stage I	0	3152			TUMOR FREE				76	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-B6-A40B	8539E15F-BA40-4219-AAEB-08D0AB101311	Not Available	Positive	4 Point Scale	3+	4 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	20	-27811	Not Applicable	0	2521	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-B6-A40B-F59661	B9D049E2-D4B2-495F-A644-3E44E9C01D0C				3			Not Applicable	3152																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A40B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	90-99%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1b	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	2005
TCGA-A2-A04X	FEMALE	1686	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1686			TUMOR FREE				34	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A04X	733a2a0f-b37a-4b81-b49e-3c0f30d1eb37	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	9	-12642	Not Applicable	0	1349	Not Available	Not Available	TCGA-A2-A04X-D2682;TCGA-A2-A04X-D2681;TCGA-A2-A04X-D2684;TCGA-A2-A04X-D2683;TCGA-A2-A04X-D2685	b94cdbfc-4069-4d6a-8d85-c6b17dbc5d93;9e16caf0-b8c7-4aed-a2d9-5a2494cafed1;b8724add-8494-4d41-af82-b8a8e396c6df;ca766a09-75f1-4329-9994-9dd95f79c497;a4d66c51-5221-4ab9-aa36-900913040d4b	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	122;122;383;210;490	80;80;133;133;352	ADRIAMYCIN;CYTOXAN;HERCEPTIN;TAXOL;TAMOXIFEN	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	4;4;20;12;Not Available	114;1140;154-500;154-156;10	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	456;4560;6471.5;1858;Not Available	mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	80-89%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-A2-A04X-F9335	BA0997F8-5C6A-44FB-9BC5-B6F5C5DFCFC8	Not Available	Not Available	Not Available	18	Not Available	Not Available	Not Applicable	1686	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	3.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A04X	TUMOR FREE	Not Available	Not Available	Not Available	MODERATE	STRONG	Not Available	Not Available	50-59%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2006
TCGA-GI-A2C8	FEMALE	225	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N0	MX	Stage IIIB	0	225			Not Available				63	Right	Sentinel node biopsy alone	Not Available	TCGA-GI-A2C8	33fe5833-d7a0-43d7-a03d-56985ea448a6	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-23103	Not Applicable	0	225	Not Available	NO	TCGA-GI-A2C8-D29371;TCGA-GI-A2C8-D33311;TCGA-GI-A2C8-D33386	D1A3A8E4-3C2D-46EE-B5D8-1C3994DF7365;0857F66A-898E-4DBC-8D79-4B31F0552BC4;8750F85E-D2A1-4936-AE36-C090AA8D373C	Not Available;Not Available;Not Available	8;29;29	166;166;166	Not Available;Not Available;Not Available	Adriamycin;Cytoxen;Taxotere	Not Available;Not Available;Not Available	5;6;6	4;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	OTHER, SPECIFY IN NOTES;Not Available;Not Available	neoadjuvant;Not Applicable;Not Applicable	Unknown;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;NO;NO	2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-GI-A2C8-F21661	89C2725E-FFD1-4357-A966-FD0DBFB12860				8		Not Available	Not Applicable	225		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Not Available	Negative	Negative	10	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	Not Available	No	A2C8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T4b	Not Available	NO	YES	GI	Breast	Not Applicable	Alive	2011	2004
TCGA-A8-A07G	FEMALE	577	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	577			TUMOR FREE				65	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07G	8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-23926	Not Applicable	0	577	Not Available	Not Available	TCGA-A8-A07G-D37879;TCGA-A8-A07G-D37880;TCGA-A8-A07G-D37881;TCGA-A8-A07G-D37882	0211068A-96FE-4994-9F2A-BA4918363F47;28A905FA-0749-46CF-9381-CFD29F1403E3;E2B01A91-364F-43EC-ACE7-587DA7947387;EF6F7284-A441-4DE8-BD6E-C34BC40D261E	Not Available;Not Available;Not Available;Not Available	6;6;6;6	181;181;181;Not Available	59;59;59;243	5-Fluorouracil;Methotrexate;Cyclophosphamide;Letrozole	Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07G-F40827	11CBA9E4-00D9-4227-964C-1681DBE988ED				2			Not Applicable	577																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07G-R38188	30302E30-CC2F-48C2-8021-CF4C619A5E21	Not Available	11	212	181	Complete Response	12	Not Available	Not Available	Not Available	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-OL-A5D6	FEMALE	1104	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	MX	Stage IIA	0	1104			TUMOR FREE				71	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A5D6	C3A981C7-F148-4252-BD50-AF8A49EC0DF8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Unknown	19	-26052	Not Applicable	0	385	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A5D6-F55437	9B1D5A06-6684-47E7-B1BC-96A9FFE8BA2A				10			1104	Not Available																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.13	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	0	No	A5D6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2009
TCGA-A2-A0EV	FEMALE	968	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	968			TUMOR FREE				80	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0EV	7032ec9c-e96b-4642-a7b6-d0aee7a3add2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	11	-29285	Not Applicable	0	545	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0EV-F13712	785B386C-75E3-49AA-A871-A8DD80C39466				10		Not Available	Not Applicable	968		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	1.40	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A0EV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-AN-A0FK	FEMALE	213	Infiltrating Ductal Carcinoma	Breast	Alive	T4	N0	M0	Stage IIIB	0	213			TUMOR FREE				88	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FK	2f4cbedf-ed7e-45a2-bf34-f1d1e696bdde	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-32462	Not Applicable	0	213	Not Available	Not Available																								dextran coated charcoal	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FK-F68951	F72119D9-67B0-4548-B682-73E6069E2D9A				23			Not Applicable	213																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	20-29%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FK	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	230	230	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T4	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-BH-A18V	FEMALE	1556	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	1556			Not Available				48	Right	Axillary lymph node dissection alone	Not Available	TCGA-BH-A18V	6b960b58-28e1-41c6-bd6e-7e669c6aa4ef	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	2	-17682	1556	0	Not Available	Not Available	YES																								Not Available	Not Available	NOT HISPANIC OR LATINO	Other, specify	axilaary node negative but intrammary node positive	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.4	8500/3	C50.4	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	25	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A18V	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Modified radical mastectomy with left breast biopsy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2001
TCGA-D8-A1XZ	FEMALE	466	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	MX	Stage IIIA	0	466			TUMOR FREE				81	Right Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XZ	2c90d5e3-ac8c-4c86-a06f-42ccc064eb49	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	9	-29916	Not Applicable	0	121	Not Available	NO	TCGA-D8-A1XZ-D30078	3B8B3BD1-028D-4001-B58C-D0CE9C68CF27	Not Available	2	Not Available	94	tamoxiphene+anastrozolum	Not Available	4	Not Available	20+1	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XZ-F30077	5898E4E8-0E20-482D-BF42-11B375146742				2		Not Available	Not Applicable	466		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	6	Not Available	No	A1XZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XZ-R30079	C8844127-DA9B-42AF-8D57-3B1CE257E1A5	Not Available	2	93	69	Not Available	4	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AQ-A04L	FEMALE	3957	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	3957			TUMOR FREE				48	Right	Sentinel node biopsy alone	Not Available	TCGA-AQ-A04L	78582fbc-dcc7-48ae-9f95-5271c9bc5b72	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	15	-17759	Not Applicable	0	3359	Not Available	Not Available	TCGA-AQ-A04L-D5777;TCGA-AQ-A04L-D5902;TCGA-AQ-A04L-D5900	8cfa2f3b-c536-46a5-ae5e-d9045e765e11;d5c327db-f7d5-4cd6-b90d-ea1ac1999f6a;f935f513-a1e9-4ada-87c4-07d532acd756	Not Available;Not Available;Not Available	6;10;10	111;1957;111	48;141;48	Adriamycin;Tamoxifen;Cytoxan	Not Available;Not Available;Not Available	1;1;1	4;1;4	101;Not Available;1014	mg;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;PO;IV	NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	404;Not Available;4056	mg;Not Available;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-AQ-A04L-F4908;TCGA-AQ-A04L-F35324	3CE88760-4A4B-436E-87CE-465B430365BB;34C3837D-DC46-481C-B853-6E2BD80C7466	Not Available;None	Not Available;None	Not Available;None	15;24	Not Available;None	Not Available;None	Not Applicable;Not Applicable	3359;3957	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;9					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Evaluated	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	No	A04L	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	NO	YES	AQ	Breast	Not Applicable	Alive	2010	2001
TCGA-EW-A1IZ	FEMALE	554	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	554			TUMOR FREE				53	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A1IZ	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	11	-19706	Not Applicable	0	260	Not Available	NO	TCGA-EW-A1IZ-D21547;TCGA-EW-A1IZ-D21573;TCGA-EW-A1IZ-D29260;TCGA-EW-A1IZ-D29261	748A06A9-BBDF-473E-A546-C7831FAD5211;31800857-4883-46B8-B764-56614F4F4DD8;F8E114ED-A2E9-45CF-8C5D-262BC6C1502D;8F111407-47A7-4A8E-AAFB-EB76FC42375C	Not Available;Not Available;Not Available;Not Available	15;15;13;13	176;Not Available;176;176	70;199;70;70	Taxotere;Femara;Adriamycin;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	2;2;3;3	6;Not Available;6;6	139;2.5;69;694	mg;mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	TAC;Not Available;TAC;TAC	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	834;Not Available;414;4164	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1IZ-F21543	78FCD753-17E1-4043-8A55-B3DB082E3A80				6		Not Available	Not Applicable	554		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	stereotactic biopsy	Other method, specify:	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	5	Not Available	No	A1IZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Local Recurrence	TCGA-EW-A1IZ-R21549	FA7E93F3-A23C-4264-83BF-68B207E736B2	1	15	261	197	Not Available	2	8	6,100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A0A9	FEMALE	822	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	822			TUMOR FREE				80	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A0A9	7b605fb6-d077-401e-b870-b87ddf505f82	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-29370	Not Applicable	0	396	Not Available	Not Available	TCGA-A8-A0A9-D37904	9728FE30-70C8-4399-84BC-DCE88562667E	Not Available	6	Not Available	31	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A0A9-F40323	2268A2C4-38E4-4EAA-AE4D-4454ED86BB07				16			Not Applicable	822																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0A9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A0A9-R38194	89CEC5DA-77F7-448B-9CC1-9A2DE6F37364	Not Available	11	153	123	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-A2-A0T2	FEMALE	255	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N3	M1	Stage IV	0	255			WITH TUMOR				66	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0T2	128d198e-9b22-427c-90db-3714455f3a17	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	12	-24235	255	0	Not Available	Not Available	Not Available	TCGA-A2-A0T2-D3707	374f0db8-26b8-4cd4-828d-1250a5a81df3	Not Available	12	225	105	Xeloda	Not Available	11	4	3	g/day	ADJUVANT	Not Applicable	1	PO	NO	Chemotherapy	Not Available	Not Available	g/day	Not Available	2010	Not Available	<10%	NOT HISPANIC OR LATINO	Liver	Abdomen	Not Available	NO	NO	Not Available	NO	TCGA-A2-A0T2-F3706	A366E180-A36C-447C-BDDE-931193A02AA4	Not Available	Not Available	Not Available	12	Not Available	Not Available	255	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11																																						WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	NO	Dead	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	No	A0T2	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-A2-A0T2-R3708	86535c68-8c55-421f-ad89-586c8d68c5ed	1	12	199	179	Not Available	11	12	3000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M1	N3	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2009
TCGA-LL-A5YP	FEMALE	450	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	450			Unknown				49	Right;Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-LL-A5YP	6D24E675-2FA4-4102-861F-7516650B3049	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	20	-18041	Not Applicable	0	99	Not Available	Not Available	TCGA-LL-A5YP-D43371;TCGA-LL-A5YP-D43372;TCGA-LL-A5YP-D59324;TCGA-LL-A5YP-D59325	BC6B458B-5E1E-406F-B8B0-210BAEFD3919;A1DC4722-1400-4337-B4EF-0797D7BC8602;AB4E3D99-82DD-4221-A645-BAD1768BAEC1;F5B3F5A9-5B54-4D89-94D1-B44F2A5E2881	Not Available;Not Available;Not Available;Not Available	20;20;8;8	92;92;457;Not Available	50;50;113;302	Cytoxan;Adriamycin;herceptin;arimidex	Unknown;Unknown;Unknown;Not Applicable	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Immunotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2014;2014	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	35					TCGA-LL-A5YP-F59323	447B3E95-78F4-48F2-86F1-C67294C4D37C				8			Not Applicable	450																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	20	Not Available	118	3.4	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Positive	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	Yes	A5YP	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-LL-A5YP-R59327	1B2D1DFE-6C4A-47FD-98BA-CAF7E1D38BE3	Not Available	8	266	225	Unknown	5	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-AC-A23H	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	NX	M0	Stage IIA	1				TUMOR FREE				90	Right Upper Inner Quadrant;Right Lower Inner Quadrant	Not Available	Not Available	TCGA-AC-A23H	7dcf550c-90ce-4f63-aecd-0e46897e2a3e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	13	-32873	Not Applicable	0	0	Not Available	NO																								Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A23H-F45572	9E725427-00DE-4C87-ADEE-5B6A3EC1902C				17			0	Not Available																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						NO		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A23H	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	NX	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2009
TCGA-A8-A07S	FEMALE	243	Mixed Histology (please specify)	Breast	Alive	T2	N0	M0	Stage IIA	1				WITH TUMOR				73	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07S	a20fa2c4-a502-47e3-bfaa-2ec4cce3a859	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-26998	Not Applicable	0	243	Not Available	Not Available	TCGA-A8-A07S-D37858	D07D6350-F930-4F58-9B82-9257EC76316B	n/a	6	Not Available	151	Tamoxifen	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07S-F40833	78B6AD18-7DC4-47A4-908E-5490DAE3A3B9				2			Not Applicable	243																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	lobular/ductal	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07S	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07S-R38181	DA0CEEAB-4453-45D1-810B-36039944F72C	Not Available	11	151	121	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-B6-A0IM	FEMALE	3873	Other, specify	Breast	Dead	T3	N0 (i-)	M0	Stage IIB	0	3873			TUMOR FREE				75	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IM	5a4b7098-1f6a-49e9-b364-29d6d34f5bd5	Negative	Positive	Not Available	Not Available	Not Available	Modified radical mastectomy	Positive	Lumpectomy	Not Applicable	NO	2	-27557	Not Applicable	0	3836	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0IM-F12623	2BD40A19-71A1-4898-94DA-8EFD7FC2F2A2				2		Not Available	3873	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal/cribiform	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Available	9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0IM	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1997
TCGA-AR-A2LE	FEMALE	5062	Infiltrating Lobular Carcinoma	Breast	Alive	T1	N0	M0	Stage I	1	4203.0	Other, specify	New Primary Tumor	Not Available				69	Right	Sentinel node biopsy alone	Not Available	TCGA-AR-A2LE	E3FCBF94-D3EF-4A37-AA45-5297F96AF9EB	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	12	-25499	Not Applicable	0	3913	Not Available	NO	TCGA-AR-A2LE-D37189	D5991C24-5B04-45B5-B05F-7F2C6C1167C2	Not Available	6	1869	17	Tamoxifen	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LE-F35164;TCGA-AR-A2LE-F49486;TCGA-AR-A2LE-F71711	D8AE0195-68C0-4365-B4AE-30D683A89E3F;49DFF8F1-B277-4E3B-A5EE-6B53EB73107E;EFEB125E-2F60-48BB-9A7B-CFB8A1E7F38F				6;2;30			Not Applicable;Not Applicable;Not Applicable	4239;4356;5062																				NO;Not Available;NO																						12;10;3					Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	4203;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Other, specify;Not Available;Not Available	New Primary Tumor;Not Available;Not Available	Endometrium;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;NO;NO	Not Available;TUMOR FREE;TUMOR FREE						YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	Not Available	No	A2LE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LE-R37190	56389EF6-0220-40E9-B0B0-1CAB2EDF58DB	Not Available	6	84	42	Not Available	12	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Excision	NO	YES	AR	Breast	Not Applicable	Alive	2012	2001
TCGA-E9-A1NA	FEMALE	1112	Mixed Histology (please specify)	Breast	Alive	T2	N0	M0	Stage IIA	0	1112			TUMOR FREE				58	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1NA	af577366-0258-49e7-b6af-e70056c081a4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	23	-21397	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1NA-D32899;TCGA-E9-A1NA-D32900;TCGA-E9-A1NA-D32901	728F3086-1CBF-46B3-8113-1355961E96B6;2A162745-964D-4B44-90CE-6DA163CD3A01;2D437D87-3612-4B26-B16A-AF426B729C67	Not Available;Not Available;Not Available	15;15;15	148;148;Not Available	12;12;206	Cyclophosphamide;Carboplatin;Letrozole	Not Available;Not Available;Not Applicable	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1NA-F29159;TCGA-E9-A1NA-F39782	0DA884CF-F3AE-4AD9-AEE0-EF79534486D5;7D959C11-6F61-40A8-B8E3-A80F62DFE74A				9;1		Not Available;None	Not Applicable;Not Applicable	654;1112		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1NA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1NA-R29161	698F1492-8386-44E8-9271-29109BBA6FCC	Not Available	9	95	58	Not Available	3	23	4600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-GI-A2C9	FEMALE	3342	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	3342			TUMOR FREE				58	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-GI-A2C9	9F6BE944-83DE-42AB-8738-F0022F475E61	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	21	-21534	Not Applicable	0	711	Not Available	NO	TCGA-GI-A2C9-D21685	EDBFE34C-5F81-4C58-B519-A7D28AB60B38	Not Available	8	3349	Discrepancy	Not Available	Not Available	5	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-GI-A2C9-F21663	C2067CDA-E620-41E9-9545-34875B29BC1F				8		Not Available	Not Applicable	3342		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A2C9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-GI-A2C9-R21683	817932FB-2657-4409-8D5B-35D4DDD5E017	Not Available	8	3342	Discrepancy	Not Available	5	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	NO	YES	GI	Breast	Not Applicable	Alive	2011	2003
TCGA-OL-A66P	FEMALE	428	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	428			Unknown				75	Right	Sentinel node biopsy alone	Not Available	TCGA-OL-A66P	F81AC8A2-4CE6-439E-B027-1C0BFC88CEAA	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Unknown	11	-27489	Not Applicable	0	58	Not Available	Not Available	TCGA-OL-A66P-D64493;TCGA-OL-A66P-D65245	1BB36628-3326-4CF1-B898-053AE55A2C10;D827B0B7-5809-4FDC-BA64-92F84625B855	Not Available;Not Available	24;24	162;162	71;71	Cytoxan;Taxotere	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A66P-F58494	09B7FC8E-A0C0-4ECB-B6D4-A185043F7DAF				11			Not Applicable	428																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.13	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A66P	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2013
TCGA-AO-A0J7	FEMALE	618	Other, specify	Breast	Alive	T2	N1	M0	Stage IIB	0	618			TUMOR FREE				71	Left Upper Inner Quadrant;Left Lower Inner Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0J7	9536bec0-dae0-4d63-a1b3-956741835243	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	19	-26281	Not Applicable	0	261	Not Available	Not Available	TCGA-AO-A0J7-D3114;TCGA-AO-A0J7-D3118;TCGA-AO-A0J7-D3113;TCGA-AO-A0J7-D3116	304050e5-dfd9-48ce-aab0-49d8d7f731a0;926f18ae-e779-45e5-b100-5edfc2e97133;c6d2fa6c-c6bb-4696-9ffd-3cada015a624;99f7ae0d-d072-40fc-be36-42be73a600e5	Not Available;Not Available;Not Available;Not Available	19;19;19;19	140;Not Available;140;195	97;202;97;154	DOXORUBICIN;ANASTROZOLE (ARIMIDEX);CYCLOPHOSPHAMIDE;PACLITAXEL	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;Not Available;4;4	60;1;600;175	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	440;Not Available;4400;1280	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J7-F3109;TCGA-AO-A0J7-F15480	A6013BFD-2B91-4245-90CB-81BED5DF1764;39B5539A-E3E4-4585-9081-D1FDC294262F	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	261;618	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal & Mucinous	No	C50.9	8523/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	3	0	No	A0J7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A0J7-R3111	2efb0bf7-1bbb-4da2-a353-3eef4c2f4b18	1	19	Not Available	258	Not Available	9	17	3060	YES	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009
TCGA-GM-A2DB	FEMALE	2406	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2406			TUMOR FREE				62	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DB	6E6B7742-A562-490B-BB72-04A5653852E4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	28	-22883	Not Applicable	0	1616	Not Available	NO	TCGA-GM-A2DB-D47159;TCGA-GM-A2DB-D47161;TCGA-GM-A2DB-D47162;TCGA-GM-A2DB-D47163	FCDFC8F4-07C3-4F53-A0E4-135FC08A31D6;8109884C-3338-42A4-8167-9ABEF5678D23;9C452D7D-4120-4BFE-B788-AEF890F1DA60;9DB393BE-D1F8-4423-BE3A-1201B189B8E6	Not Available;Not Available;Not Available;Not Available	22;22;22;22	167;248;248;248	91;181;181;181	Taxol;Fluorouracil;Epirubicin;Cytoxan	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.50					TCGA-GM-A2DB-F47156	5F9BC2B1-50F3-4A6F-9B76-6BE7330FCA84				22			Not Applicable	2406																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	1.67	1.11	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2DB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-GM-A2DB-R47157	D6AC4D25-3614-447E-8DF4-09A1DBE09817	Not Available	22	317	271	Complete Response	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2006
TCGA-C8-A9FZ	FEMALE	592	Mixed Histology (please specify)	Breast	Alive	T2	N1	M0	Stage IIB	0	592			TUMOR FREE				49	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A9FZ	726C6892-0DCE-4869-A7A7-CC44C26FE843	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	29	-18038	Not Applicable	0	7	Not Available	Not Available	TCGA-C8-A9FZ-D69967;TCGA-C8-A9FZ-D69968;TCGA-C8-A9FZ-D69969;TCGA-C8-A9FZ-D69970	5EE9E222-CE90-4A1B-91F3-2A38CF4DC1ED;F8280902-5A96-471B-9127-AA1A6C7235C8;614A0F5A-4696-4BB3-8D04-8673AD02C486;B038BA42-8ECD-4542-84B8-B748DBC4FA52	Not Available;Not Available;Not Available;Not Available	23;23;23;23	99;99;99;Not Available	29;29;29;169	Doxorubicin;5-Flourouracil;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	1;1;1;1	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2015;2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A9FZ-F69966	48655EEB-7E9F-4726-9820-88FFF609A953				23			Not Applicable	592																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating Tubulo-Lobular Carcinoma	No	C50.9	8524/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	Not Available	No	A9FZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	NO	Regional site	TCGA-C8-A9FZ-R69971	3D376E22-7CAA-4664-A6AC-505C83C6D30B	Not Available	23	155	119	Complete Response	1	2	44	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2014	2013
TCGA-A2-A0EW	FEMALE	1884	Infiltrating Lobular Carcinoma	Breast	Dead	T1b	N3a	M0	Stage IIIC	1	1353.0	Bone	Distant Metastasis	TUMOR FREE				53	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0EW	8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	YES	5	-19413	Not Applicable	0	770	Not Available	Not Available	TCGA-A2-A0EW-D6797;TCGA-A2-A0EW-D6794;TCGA-A2-A0EW-D6754;TCGA-A2-A0EW-D6795;TCGA-A2-A0EW-D59516;TCGA-A2-A0EW-D59517;TCGA-A2-A0EW-D59518;TCGA-A2-A0EW-D59519;TCGA-A2-A0EW-D59520;TCGA-A2-A0EW-D59521;TCGA-A2-A0EW-D59522;TCGA-A2-A0EW-D59523	29e822b5-c5e4-453f-9c1b-a7e30508d9e2;fd289cfd-fcaf-4acb-8fc0-5ca6b1ab340b;e9277ae6-b3a0-4b3b-a966-f019eda5e035;d456b88f-f515-4180-8cd6-ff63d245e198;435F5BFB-5046-4569-B0B6-57857326B73A;9978CD5C-428A-4871-B65B-A055D9325955;086CE23B-765A-4665-BD7E-9CD16396B4B9;69429F28-2A38-4B0B-9306-59A9133230D7;1071A37F-0128-473D-8BA3-2DBF3AD5953E;01259757-DD3D-4DF9-9686-9CB07AE8A150;C89E1F88-A478-4697-9540-2AC63A295747;9FAAE45E-9014-4CD8-BBBA-F327C60E65D7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;14;14;14;14;14;14;14;14	812;127;127;184;903;1001;1365;1422;1562;1718;1722;1787	221;85;85;141;813;904;1002;1158;1366;1425;1618;1696	Arimidex;Adriamycin;Cytoxan;Taxol;Letrozole;Arimidex;Exemestane;Zoledronic Acid;Fulvestrant;Denosumab;Tamoxifen;Doxorubicin Liposome	Not Available;Not Available;Not Available;Not Available;Complete Response;Complete Response;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	1;1;1;1;5;5;5;5;5;5;5;5	Not Available;4;4;4;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;115-116;1158;334-338;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;2;1;3;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PO;IV;IV;IV;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy;Ancillary;Hormone Therapy;Ancillary;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;463;4632;1344;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;mg;mg;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;NO;NO;NO;NO;NO;NO;NO;NO	2009;2011;2011;2011;2014;2014;2014;2014;2014;2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0EW-F13724;TCGA-A2-A0EW-F59511	09B81A25-DC34-48EB-9651-B0ACA113E04D;195DBE0F-C593-40A4-A0EC-3B0CCBD34DE5				10;14		Not Available;None	Not Applicable;1884	905;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;YES	None;YES	None;Not Available	None;1353	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Bone	None;Distant Metastasis	None;Not Available	None;NO	None;Not Available	None;YES	TUMOR FREE;WITH TUMOR			Not Available;None			YES;YES		NO;YES	Alive;Dead	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	1.33	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	26	0	No	A0EW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	WHITE	Not Available	Primary Tumor Field;Regional site;Primary Tumor Field;Distant site	TCGA-A2-A0EW-R59512;TCGA-A2-A0EW-R59513;TCGA-A2-A0EW-R59514;TCGA-A2-A0EW-R59515	F5F06A88-0642-4AA7-B9EF-9BA4A71E0677;221162DC-64B5-485A-98E8-BA764D594EE0;970E4073-9905-472F-B638-04E9643AA8B2;1208B130-7049-48E8-9340-9D4B26754D03	Not Available;Not Available;Not Available;Not Available	14;14;14;14	249;246;256;1480	211;211;252;1466	Complete Response;Complete Response;Complete Response;Radiographic Progressive Disease	5;5;5;5	Not Available;Not Available;Not Available;Not Available	5040;4500;1000;3000	NO;NO;NO;NO	External;External;External;External	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	cGy;cGy;Not Available;cGy	2014;2014;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T1b	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2008
TCGA-EW-A6SB	FEMALE	760	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage II	0	760			TUMOR FREE				62	Left;Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A6SB	5C59028F-B8FA-4811-8314-BE3EAED5F364	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	12	-22844	Not Applicable	0	760	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A6SB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	Not Available	Not Available	EW	Breast	Not Applicable	Alive	2015	2012
TCGA-E2-A150	FEMALE	1935	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1935			TUMOR FREE				48	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A150	4ac693e9-10f3-46b3-9d46-df3af7b0d259	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	6	-17580	Not Applicable	0	591	Not Available	NO	TCGA-E2-A150-D18517;TCGA-E2-A150-D18518;TCGA-E2-A150-D18516	DBDE6E37-20B6-4FD1-9ADE-F324268AEF35;34429660-1923-46C7-9C89-A412C2A9DE79;6E72775A-C321-47EC-B622-DD6248D502F6	Not Available;Not Available;Not Available	7;7;7	96;129;66	24;80;24	Doxorubicin;Paclitaxel (Protein-Bound);Cyclophosphamide	Not Available;Not Available;Not Available	11;11;11	4;4;4	122;398;1218	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	488;1719;4872	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A150-F18515;TCGA-E2-A150-F71066	38FBBD18-BAE7-4FA6-89D9-DD317944D96B;F53AF7A3-7480-40A2-99D1-87493C41A28F				7;18		Not Available;None	Not Applicable;Not Applicable	773;1935		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	10;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A150	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A150-R18519	D82259A3-46D2-4F2F-A3B4-42F0AF6342D8	1	7	202	154	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-AR-A250	FEMALE	2707	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2707			TUMOR FREE				58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A250	a0963e93-b63e-4de2-86c1-81302e271d3e	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Negative	Other	Not Applicable	Not Available	30	-21309	Not Applicable	0	1708	Not Available	Not Available	TCGA-AR-A250-D31673;TCGA-AR-A250-D31675;TCGA-AR-A250-D31676;TCGA-AR-A250-D31677;TCGA-AR-A250-D31678;TCGA-AR-A250-D31681;TCGA-AR-A250-D31682	2BB4B137-AA4E-42D6-876B-C9DE7B910372;28A6AC67-90F8-4C77-8281-C9887C7E6E72;677A72C5-4625-4239-A896-2AB4FCD7EB83;6C28195A-B380-475E-A6D9-97FBEAA7FE7F;DBBFBEC9-088D-4F94-9353-A06600586DF8;7E468399-B2D5-45FC-A528-0CC24445CD24;90EABCF1-AA20-4EB3-B2A9-B65F7B1C21F3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;21;21	88;88;179;102;179;466;Not Available	45;45;102;102;109;193;194	Doxorubicin;Cytoxan;Paclitaxel;Trastuzumab;Trustuzumab;Trastuzumab;Anastrozole	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Immunotherapy;Immunotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A250-F31671;TCGA-AR-A250-F49508;TCGA-AR-A250-F65794	E37895EF-CEFD-4679-99E6-58D11D96C6C9;6501DF95-37C6-4C3A-952A-F585726826C1;34C8A220-2C5D-4707-85EF-7585564FB291				8;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1708;2274;2707		Not Applicable;None;None				Not Available;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;9	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2012;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A250	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Wide local excision and simple mastectomy	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-LL-A5YL	FEMALE	519	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	519			Unknown				64	Right;Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-LL-A5YL	1D75E89D-4B01-443C-BE54-749C7A667BF4	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	3	-23395	Not Applicable	0	169	Not Available	Not Available	TCGA-LL-A5YL-D43410;TCGA-LL-A5YL-D43411;TCGA-LL-A5YL-D43750;TCGA-LL-A5YL-D43751;TCGA-LL-A5YL-D59653	8706E99F-7547-4F58-918E-66A8EA5EB237;4F99E58A-D90D-4DE0-9ABD-37B777EE111F;31AEC785-42C5-479C-B46B-3AB5E1479898;98BC7928-4B13-46C1-AADD-C2FC86C0BB51;8E7139E6-B6EF-403D-ABDE-AF79BD55D833	Not Available;Not Available;Not Available;Not Available;Not Available	21;21;3;3;19	150;150;246;Not Available;Not Available	78;78;169;169;341	Adriamycin;Cytoxan;Paclitaxel;Herceptin;ARIMIDEX	Unknown;Unknown;Unknown;Not Applicable;Not Applicable	5;5;6;6;5	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2013;2013;2013;2013;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.9					TCGA-LL-A5YL-F59650	0FBEAAC5-77A9-4E92-9B8F-E11AA2F05535				19			Not Applicable	519																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	65	Not Available	2.6	0.9	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Negative	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	0	No	A5YL	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	WHITE	NO	Primary Tumor Field;Regional site	TCGA-LL-A5YL-R59651;TCGA-LL-A5YL-R59652	42CD0077-F207-40F2-B347-0485C089500B;041DB4FA-27B4-4F06-B997-A6B2D1B2CC15	Not Available;Not Available	19;19	315;315	273;273	Unknown;Unknown	5;5	28;28	50.4;50.4	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2012
TCGA-A8-A07E	FEMALE	608	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N3a	MX	Stage X	0	608			TUMOR FREE				81	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07E	853456d8-2367-404e-abc9-020fe8bbd209	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-29800	Not Applicable	0	608	Not Available	Not Available	TCGA-A8-A07E-D37761	4C0CE1A6-BDC8-4C9A-8A4B-C562220040B4	n/a	6	Not Available	0	Letrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07E-F40825	E36B92B8-AA12-4750-B2DC-517C7ABB7C81				2			Not Applicable	608																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A07E	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N3a	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-A8-A092	FEMALE	942	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	942			TUMOR FREE				48	Left	Not Available	Not Available	TCGA-A8-A092	38a8b734-9acc-42f9-b5b7-e51b0dfc6504	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-17807	Not Applicable	0	487	Not Available	Not Available	TCGA-A8-A092-D37793;TCGA-A8-A092-D37794;TCGA-A8-A092-D37795;TCGA-A8-A092-D37796	3BB14198-BDE6-4F06-85E6-41F6C1519A1E;7DEE3F98-1E1E-41EF-A92F-77AE88709E27;5EC320E1-3655-436C-B8CC-5E65353FEC34;2E5FD555-117E-45B5-BD9D-9F6653236007	n/a;n/a;n/a;n/a	6;6;6;6	91;153;153;Not Available	30;30;30;181	Paclitaxel;Epirubicin;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A092-F40556	08BBC200-9E93-4FC1-8382-1CBF2310477F				23			Not Applicable	942																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A092	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A092-R38164	CF613056-FC7D-4604-89E3-ABBBC28E70AD	Not Available	11	273	181	Complete Response	12	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A5QP	FEMALE	1185	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1185			TUMOR FREE				54	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A5QP	3C275152-D04B-440C-9621-2FC05EA977B6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	15	-19805	Not Applicable	0	439	Not Available	Not Available	TCGA-AR-A5QP-D43914	8150DA11-23B1-4826-AD05-FFB7FBE8410D	Not Available	10	Not Available	46	Tamoxifen	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A5QP-F43875;TCGA-AR-A5QP-F69266	8273D0A2-FA6A-44B5-B288-5F1049F5C9E5;E98992F8-020A-46A2-A019-DC50F9C178C3				10;31			Not Applicable;Not Applicable	622;1185																				NO;NO																						6;12					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Equivocal	Not Available	40	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5QP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-AR-A5QP-R43913	CF61419A-FE99-4501-84F5-3EAFB9324AFB	Not Available	10	70	42	Not Available	6	20	5256	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2013	2011
TCGA-E9-A24A	FEMALE	747	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	M0	Stage IIA	0	747			TUMOR FREE				69	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A24A	9f3cc92b-fa22-478e-a2e4-6b4c8afb93d6	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	NO	22	-25370	Not Applicable	0	11	Not Available	NO	TCGA-E9-A24A-D31257	64424F2D-62A0-41E3-AC8A-8D4380E0149C	Not Available	25	Not Available	9	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A24A-F31256;TCGA-E9-A24A-F39541	BC9E264C-D8AE-4A8A-B55A-DCE0DAB97FBB;CE71B1A0-DB97-48A0-913F-05CD15EED1C9				25;24		Not Available;None	Not Applicable;Not Applicable	322;747		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;1	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Lumpectomy	Other method, specify:	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A24A	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A24A-R31258	048982EB-6799-422D-B7D8-045CE8B2D032	1	25	65	35	Not Available	4	20	4000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-E9-A1N9	FEMALE	1101	Mixed Histology (please specify)	Breast	Alive	T2	N0	M0	Stage IIA	0	1101			TUMOR FREE				58	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1N9	994ca1f5-ad10-44ec-aa21-71fc2940653b	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	23	-21228	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1N9-D32897;TCGA-E9-A1N9-D32898	D16DD4A4-E874-49EE-82FB-2A247DCE61BD;378CC11C-A4AA-4803-B2C1-FD7C98CB5DAA	Not Available;Not Available	15;15	91;Not Available	14;119	Doxorubicin;Tamoxifen	Not Available;Not Available	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1N9-F29157;TCGA-E9-A1N9-F58373	54014DFF-CDF9-49F0-B5A6-6F722416420B;07EB2A9C-A934-44A1-9FD2-C1580160C002				9;8		Not Available;None	Not Applicable;Not Applicable	399;1101		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1N9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A09D	FEMALE	1522	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1522			TUMOR FREE				47	Right Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A09D	36449392-de76-4ee9-bc09-627a07e18727	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-17440	Not Applicable	0	396	Not Available	Not Available	TCGA-A8-A09D-D37763;TCGA-A8-A09D-D37764;TCGA-A8-A09D-D37765;TCGA-A8-A09D-D37766;TCGA-A8-A09D-D37767	7501154C-AB3E-4BCF-8170-83C79CD130EF;2832D3CB-D8F2-4D5E-BCF9-1352FF358AE8;58419487-BBD7-4BC3-A34A-1791CFFDFD05;B4C8E610-F345-484B-BC53-E1B72842ABE2;3CE1FDD7-6CB8-4FEB-9A0A-D9C352B117AF	n/a;n/a;n/a;n/a;n/a	6;6;6;6;6	92;92;153;1400;Not Available	0;0;92;274;1400	Doxorubicin;Cyclophosphamide;Paclitaxel;Tamoxifen;Anastrozole	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09D-F40549	A2B31F29-0E1F-4F7F-B705-1B6F0312A9F4				23			Not Applicable	1522																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09D	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09D-R38157	31E1897B-65F4-4842-8B8A-B76F8482942E	Not Available	11	274	214	Complete Response	12	Not Available	67	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-LL-A9Q3	FEMALE	532	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3a	MX	Stage IIIC	0	532			Unknown				69	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-LL-A9Q3	6AF6D256-A753-46D2-B611-E4094FF265AA	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	21	-25477	Not Applicable	0	224	Not Available	Not Available	TCGA-LL-A9Q3-D59662;TCGA-LL-A9Q3-D59663;TCGA-LL-A9Q3-D67101	637C53B9-68C5-43C6-802C-B9ACAD0B95E6;4DEAD1ED-B25F-493F-81D1-E0AF2833ACA3;B225CCB0-5441-4D39-98BE-00AAA257CE40	Not Available;Not Available;Not Available	19;19;30	531;216;Not Available	118;118;273	HERCEPTIN;TAXOL;ARIMIDEX	Complete Response;Unknown;Not Applicable	5;5;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Immunotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A9Q3-F67103	21E69907-81F4-4C83-ACCC-E79FFE88B38C				30			Not Applicable	532																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	28	0	No	A9Q3	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	WHITE	NO	Primary Tumor Field	TCGA-LL-A9Q3-R67102	F10086C3-8DB8-4FE5-ACD6-E85CC15E25F9	Not Available	30	290	251	Complete Response	10	28	50.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T3	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2014	2013
TCGA-AR-A24Z	FEMALE	3001	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	3001			Not Available				57	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24Z	9fefbe7c-f66a-4940-843e-285cb7b392c1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	30	-20900	Not Applicable	0	1574	Not Available	Not Available	TCGA-AR-A24Z-D31665;TCGA-AR-A24Z-D31668;TCGA-AR-A24Z-D31667	24B6AA72-F2AB-4E43-84F8-C9EBEDE6978B;CEF63E08-B78B-4BE0-BD0B-1A62629A45AA;00E48087-B371-4EB8-93D4-4F9C4E366C28	Not Available;Not Available;Not Available	21;21;21	91;91;1912	49;49;133	Doxorubicin;Cytoxan;Anastrozole	Not Available;Not Available;Not Available	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24Z-F31664;TCGA-AR-A24Z-F49507;TCGA-AR-A24Z-F71743	A77B894E-2A15-4FCD-8DDD-28769F257CE3;DEBAA1B0-B174-41E1-BAE2-2B5E069C17E3;4F1B7892-51A0-4396-8B71-2847EE22CBEF				8;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1574;2403;3001		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24Z	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Total mastectomy	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-GM-A3NY	FEMALE	1162	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1162			TUMOR FREE				72	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-GM-A3NY	BD5374C9-7F36-457F-B66B-7CC7FF64224E	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	3	-26642	Not Applicable	0	743	Not Available	NO	TCGA-GM-A3NY-D40405	907FA230-9311-4125-9C9D-FA54ED976D6C	Not Available	19	Not Available	160	Arimidex	Not Applicable	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A3NY-F40403	055BBB55-226C-4908-8773-39A4E65A9E37				19			Not Applicable	1162																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	1	0	No	A3NY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	20-29%	WHITE	Not Available	Primary Tumor Field	TCGA-GM-A3NY-R40404	7B29BB47-1F8A-4F98-ADD3-B16DEDB079F6	Not Available	19	124	82	Stable Disease	2	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2012	2009
TCGA-D8-A1XM	FEMALE	538	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	538			TUMOR FREE				57	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1XM	92529232-8504-4541-b7e2-4df8f497c413	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	16	-21056	Not Applicable	0	218	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XM-F29445	581291C6-5F3C-4477-A478-0A083B71FC3A				19		Not Available	Not Applicable	538		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XM	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XM-R29446	D5715E1F-01E5-428C-BFBF-115F0D3438BB	Not Available	19	93	61	Not Available	3	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0AW	FEMALE	622	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	622			TUMOR FREE				56	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0AW	c5891c7a-fd24-4891-8f51-373967e4a6dd	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Negative	Lumpectomy	Not Applicable	NO	3	-20468	Not Applicable	0	622	Not Available	Not Available	TCGA-BH-A0AW-D15447;TCGA-BH-A0AW-D15448;TCGA-BH-A0AW-D15449;TCGA-BH-A0AW-D15446;TCGA-BH-A0AW-D15450	B2148FF1-940F-45EC-8B2C-74F5951B58D1;6D34C697-F428-4E3B-BD07-BB9E156CC9AB;1D5E80DC-168A-47F1-BF39-F8031C065626;D6D6F047-A44A-41C1-A02C-277B2B508E08;2D1B4C2D-D268-45BF-9ABD-22F9D99DAB07	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	150;515;150;410;Not Available	53;200;53;53;543	Carboplatin;Arimidex;Taxotere;Herceptin;Aromasin	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	Not Available;Not Available;6;Not Available;Not Available	6;1;75;6;50	AUC;mg/day;mg/m2;mg/kg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1	IV;PO;IV;IV;PO	NO;NO;NO;NO;YES	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	ER Positive H-Score 95	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0AW-F15445	179764C8-B58C-4FF9-9AB7-830D6A91DEF9				3		Not Available	Not Applicable	622		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	0	No	A0AW	TUMOR FREE	PR Negative H-Score 0	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0AW-R15451	2E78F368-4AD6-4F12-A487-FC57001C95A9	1	3	252	201	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-E9-A22A	FEMALE	1189	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1189			TUMOR FREE				74	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A22A	4aacbc42-5ac5-4339-b9fa-c6e812084837	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	YES	2	-27288	Not Applicable	0	0	Not Available	NO	TCGA-E9-A22A-D29838	5D55C0D5-040F-4184-A845-1D4A4FEB2ADC	Not Available	29	Not Available	111	Tamoxifen	Not Available	3	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	7240	mg	Not Available	2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A22A-F29837;TCGA-E9-A22A-F39785	6E69F7F7-D400-40B0-8969-107D3F5EC94C;0A926351-9B94-4D55-9D38-4EB8CBCBB2D3				27;1		Not Available;None	Not Applicable;Not Applicable	713;1189		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	5;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2014;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A22A	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A15H	FEMALE	393	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IIA	0	393			TUMOR FREE				38	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15H	5580b21a-2cdb-4777-ad79-6e06654144f5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-13985	Not Applicable	0	42	Not Available	NO	TCGA-E2-A15H-D18923	A307776F-37AE-46FE-A3D1-D0E79E1D73A8	Not Available	14	Not Available	83	Herceptin	Not Available	11	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15H-F18916	4D718A1D-4604-4750-AC77-52E35846B82E				14		Not Available	Not Applicable	393		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Positive	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A15H	TUMOR FREE	Not Available	Not Available	Not Available	Allred score = 8	Allred Score = 7	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-D8-A1XA	FEMALE	839	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	839			TUMOR FREE				64	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1XA	739cb132-51e9-41be-8064-311a13da0d74	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	18	-23387	Not Applicable	0	274	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XA-F29434	23F14C5F-A612-4176-9B70-83C685679F1E				3		Not Available	Not Applicable	839		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Equivocal	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XA	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XA-R29435	D72884C9-451B-40F9-A7FE-C1FA19833923	Not Available	19	185	140	Not Available	3	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A1R5	FEMALE	92	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	92			TUMOR FREE				63	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1R5	23c21dea-3713-408f-ba56-f7c586e9f206	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	28	-23116	Not Applicable	0	42	Not Available	NO	TCGA-E9-A1R5-D30843	D4023E14-4199-48D4-A1ED-0B85D63C7BA4	Not Available	17	Not Available	24	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1R5-F30840;TCGA-E9-A1R5-F48700	0D7066DE-52E0-4A17-8F0F-17ADEF0BAE8C;05A3A194-C053-42E5-BC72-38C2C5BFDD8D				17;19		Not Available;None	Not Applicable;Not Applicable	92;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;9	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		YES;Not Available	Alive;Not Available	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1R5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A1R5-R30845	98C41B70-3054-4029-8DA9-02E2B870A48C	1	17	92	65	Not Available	4	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0H7	FEMALE	702	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	702			TUMOR FREE				65	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0H7	2021ed1f-dc75-4701-b8b8-1386466e4802	Not Available	Positive	Not Available	2+	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	10	-23972	Not Applicable	0	702	Not Available	Not Available	TCGA-BH-A0H7-D4715;TCGA-BH-A0H7-D4717;TCGA-BH-A0H7-D4728;TCGA-BH-A0H7-D4726;TCGA-BH-A0H7-D4719	3A96F8DB-2BB6-4F01-A332-0CC10127499B;0D085B7B-5316-41F0-9FF4-0EF4C547C459;8C760D86-7F32-4842-8DB0-ADAFD53EA414;C42E6C62-C1C9-46D9-B3BB-217B83E7D2ED;F4A15B10-F974-4196-AC98-13A14F2D6621	Not Available;Not Available;Not Available;Not Available;Not Available	17;18;18;18;18	Not Available;148;232;246;148	298;85;85;169;85	ARIMIDEX;DOXORUBICIN;BEVACIZUMAB (AVASTIN)/PLACEBO PROVIDED BY STUDY;PACLITAXEL;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	Not Available;4;8;12;4	1;86;765;115;860	mg/day;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1	PO;IV;IV;IV;IV	YES;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;344;6120;1380;3440	Not Available;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	H-SCORE 255	70-79%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0H7-F4737	A652B449-0747-4A34-B758-A6E67A1000F6	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	702	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	No	A0H7	TUMOR FREE	H-SCORE 150	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	30-39%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0H7-R4736	8B3F8793-8DF3-477C-BFB8-CA5F68C9C608	1	17	314	274	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-B6-A0X7	FEMALE	1781	Mixed Histology (please specify)	Breast	Dead	T1c	NX	MX	Stage X	1	1104.0	Other, specify	New Primary Tumor	Not Available				62	Right	No axillary staging	Not Available	TCGA-B6-A0X7	5b9a5cd2-5ec8-48a0-b9f2-da9bede0b089	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	NO	14	-22723	1781	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	YES		TCGA-B6-A0X7-F15714	407D3BEE-E689-48D3-BD64-8C07564E2AD9				29		1104	1781	Not Available		1104				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Other, specify	New Primary Tumor	colon	YES																																		TUMOR FREE			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Ductal/Lobular	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Evaluated	0	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A0X7	Not Available	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	MX	NX	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1994
TCGA-AN-A0AL	FEMALE	227	Infiltrating Ductal Carcinoma	Breast	Alive	T4	N0	M0	Stage IIIB	0	227			TUMOR FREE				41	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0AL	3e9f93c0-aa79-4b4c-bd6c-b3325912362a	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	21	-15286	Not Applicable	0	198	Not Available	Not Available																								dextran coated charcoal	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AL-F68944	02C99963-3C0B-4888-BD6F-F1C920E08720				23			Not Applicable	227																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AL	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T4	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-AR-A2LJ	FEMALE	2632	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1	MX	Stage IIIA	0	2632			Not Available				40	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LJ	738E1ACC-1F0C-4A96-9C8A-222727EF5AF8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	12	-14723	Not Applicable	0	1359	Not Available	NO	TCGA-AR-A2LJ-D37263;TCGA-AR-A2LJ-D37264;TCGA-AR-A2LJ-D37265;TCGA-AR-A2LJ-D37696;TCGA-AR-A2LJ-D37697	40A4371F-CF9D-4587-93C3-21D91D80BB9A;46FEDD0F-87E6-4C31-AB41-4B1DA8FAD929;5D6D171A-7CB5-4A45-B2B7-EAAF05E65A29;74F13BD2-4E94-41A3-885F-6E52D52D7446;5C63D548-84D8-4253-AC3F-91CB50B0178B	Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7	84;84;175;465;Not Available	42;42;98;98;190	Adriamycin;Cytoxan;Paclitaxel;Trastuzumab;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LJ-F35167;TCGA-AR-A2LJ-F49490;TCGA-AR-A2LJ-F71721	B4BFC81E-8655-457D-93D0-43609FAF7A31;8B02FE2E-1AD4-4C80-A4D5-973A8BF7D516;3502778E-0BFA-4CEE-A207-74D9CAE57F6A				7;2;30			Not Applicable;Not Applicable;Not Applicable	1865;1912;2632																				NO;Not Available;NO																						12;10;3					Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Not Available;TUMOR FREE;TUMOR FREE						YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	1	Not Available	No	A2LJ	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LJ-R37266	97483A09-7652-4CE8-940E-A82D5C9F5E30	Not Available	7	231	196	Not Available	12	25	5000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1	T3	Total Mastectomy	NO	YES	AR	Breast	Not Applicable	Alive	2012	2007
TCGA-AN-A0FS	FEMALE	210	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	210			TUMOR FREE				55	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FS	10c9be1e-2cc0-45e4-8d2c-c013ea63ef05	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	20	-20352	Not Applicable	0	191	Not Available	Not Available																								dextran coated charcoal	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FS-F68954	80A52799-160B-4844-83FC-F6D6F06E60C4				23			Not Applicable	210																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	20-29%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	14	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FS	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	230	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-A2-A0EN	FEMALE	4088	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	4088			TUMOR FREE				70	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A0EN	5e670fec-8992-44bf-8657-f7f9a272306b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	27	-25771	Not Applicable	0	4088	Not Available	Not Available	TCGA-A2-A0EN-D2544;TCGA-A2-A0EN-D2543	b71d60f7-798d-44c2-8d89-f63514233b1e;4d55dd20-b5b7-40c3-8015-41a32a417673	Not Available;Not Available	12;12	Not Available;1926	1985;64	Anastrozole;Tamoxifen	Not Available;Not Available	10;10	Not Available;Not Available	1;20	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	YES;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0EN-F13725	78F26CBF-3BA6-4DB3-80C7-C632F90A271B				10		Not Available	Not Applicable	2718		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.4	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	1	No	A0EN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50-59%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0EN-R2545	7820e82d-3f7c-446c-ad1a-a7f9dd967440	1	12	134	91	Not Available	10	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2015	2003
TCGA-EW-A423	FEMALE	533	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	533			TUMOR FREE				75	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A423	BDD08EC8-8892-4273-8F21-6FDE0F23C52D	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	4	-27627	Not Applicable	0	309	Not Available	Not Available	TCGA-EW-A423-D38933	C3B35A80-A856-4049-B06A-02E765F87BD0	Not Available	4	Not Available	205	Anastrozole	Not Applicable	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	50-59%	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-EW-A423-F38895;TCGA-EW-A423-F42558	6E8F6BDC-E908-4D9C-94E3-779F98588303;CCAFBC43-EDB6-41CB-90F2-65B874EBD3E2				26;18			Not Applicable;Not Applicable	309;533																				NO;YES																						3;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;Discrepancy		YES;Discrepancy	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A423	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	WHITE	YES	Primary Tumor Field	TCGA-EW-A423-R38936	8A98C19C-07DE-43E1-8391-6975D585C793	Not Available	4	162	52	Complete Response	1	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	EW	Breast	Not Applicable	Alive	2013	2012
TCGA-GM-A5PX	FEMALE	551	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1mi	M0	Stage IIB	0	551			TUMOR FREE				65	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-GM-A5PX	F7064D01-29D8-49A2-AD60-1E0C5F148F3E	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	12	-23753	Not Applicable	0	551	Not Available	Not Available	TCGA-GM-A5PX-D42160;TCGA-GM-A5PX-D42161;TCGA-GM-A5PX-D42163	D2BD571D-6658-48CB-88FE-77DAC9870F9C;761DB280-F416-45BF-B1C0-88A1E9EFA3EF;2713B9D0-0CB9-4FD7-B75B-3ED4DEC296C4	Not Available;Not Available;Not Available	12;12;12	236;339;Not Available	112;265;340	Arimidex;Aromasin;Tamoxifen	Complete Response;Complete Response;Not Applicable	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.78																																																																																																									FEMALE	Not Available	Not Available	30-39%	Not Available	1+	60	Not Available	1.98	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	2	No	A5PX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2013	2011
TCGA-BH-A0W7	FEMALE	1363	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	1363			TUMOR FREE				49	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A0W7	9f80649b-a249-4fb5-97ad-059a30e13fea	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	15	-17996	Not Applicable	0	558	Not Available	Not Available	TCGA-BH-A0W7-D34074;TCGA-BH-A0W7-D34075;TCGA-BH-A0W7-D34076;TCGA-BH-A0W7-D34077	0A4EE347-EE11-4426-A666-055E6317A805;1D1011B2-5862-44A0-8E76-C71A08C733ED;47152466-BCD7-423E-ACBE-8E1CC909F134;F892639C-D682-4FC7-AE4B-6FF21F295085	Not Available;Not Available;Not Available;Not Available	29;29;29;29	138;138;1233;1324	76;76;168;1171	Taxotere;Cytoxan;Tamoxifen;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response	7;7;7;7	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0W7-F34073	F6B25172-02C5-489E-9061-B951EE902CB0				29		Not Available	Not Applicable	1363		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	0	No	A0W7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0W7-R34078	BEFB5D3C-A0C6-4F5D-8E1A-C0561BEFCEB9	Not Available	29	229	168	Complete Response	7	36	1600	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A0CS	FEMALE	2348	Infiltrating Ductal Carcinoma	Breast	Dead	T4b	N3a	M1	Stage IV	0	2348			TUMOR FREE				73	Left	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0CS	d071c16b-7cee-45ed-8ec9-612418143815	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	27	-26817	Not Applicable	0	2298	Not Available	Not Available	TCGA-A2-A0CS-D7280;TCGA-A2-A0CS-D7277	0b827c0b-3829-40ed-8e56-86f2a957472b;c1d5ddf5-8870-4ff6-a547-018f3e5d0bc4	Not Available;Not Available	28;28	597;Not Available	217;190	Zometa;Anastrozole	Not Available;Not Available	1;1	3;Not Available	4;1	mg;mg	OTHER, SPECIFY IN NOTES;ADJUVANT	Maintenance therapy;Not Applicable	2;1	IV;PO	NO;YES	Other, specify in notes;Hormone Therapy	Bisphosphonate;Not Available	12;Not Available	mg;Not Available	Not Available;Not Available	2011;2011	Not Available	80-89%	NOT HISPANIC OR LATINO	Other, specify	Ovary	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0CS-F14456;TCGA-A2-A0CS-F59316	F9BF7708-01D9-48C5-9E59-C6D9F33D0D89;B08C8976-E321-45FD-AC53-648FE294B2C1				13;8		Not Available;None	Not Applicable;2348	2298;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	TUMOR FREE;Unknown			Not Available;None			YES;YES		YES;YES	Alive;Dead	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Skin biopsy	Other method, specify:	Equivocal	Negative	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	1.09	Not Available	Not Available	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	1.09	Not Available	Not Available	Not Available	Not Available	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	0	No	A0CS	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0CS-R7285	a50ef65d-3b95-41e4-82e7-f0ab5f9ae804	1	28	161	106	Not Available	1	61	11080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M1	N3a	T4b	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2004
TCGA-D8-A1JS	FEMALE	371	Other, specify	Breast	Alive	T1c	N0	M0	Stage IA	0	371			TUMOR FREE				77	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JS	0d03055c-186b-418a-b614-e2035757bc3b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	28	-28178	Not Applicable	0	105	Not Available	Not Available	TCGA-D8-A1JS-D14052	8318EC65-2D4F-490D-9C42-264220D999DA	Not Available	18	Not Available	14	Tamoxifen	Not Available	7	Not Available	20	mg/day	ADJUVANT	Not Applicable	hormone therapy	PO	YES	Hormone Therapy	Not Available	Not Available	mg/day	Not Available	2011	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JS-F14051	07528AAE-783F-405C-92D4-AE19620D76CB				18		Not Available	Not Applicable	371		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	papillary	No	C50.9	8503/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JS	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A1KS	FEMALE	350	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	350			TUMOR FREE				69	Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A1KS	bb8d42d3-ad65-4d88-ae1d-f9aadfc7962d	Not Available	Positive	4 Point Scale	2+	4 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	1	-25230	Not Applicable	0	16	Not Available	NO	TCGA-AO-A1KS-D9873	5cf6039b-6a9e-45da-a518-f9ed69ee620f	Not Available	1	Not Available	155	Arimidex	Not Available	4	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	3.2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A1KS-F9872;TCGA-AO-A1KS-F21777	A2741227-EEE0-4B41-9C5E-22E3AE495BC9;507BCF20-7BA4-4C69-9D6F-41883512FAD1	Not Available;None	Not Available;None	Not Available;None	1;20	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	16;350	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;2	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	10-19%	Positive >2.2	2+	40	Not Available	3.2	1.0	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	0	No	A1KS	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A1KS-R9876	dc16cc6f-20a3-44d0-b0ff-794d86ead108	1	1	Not Available	Not Available	Not Available	4	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A07F	FEMALE	577	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	577			TUMOR FREE				65	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07F	5d688049-f271-40ef-813a-d37240ffe21c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-23742	Not Applicable	0	577	Not Available	Not Available	TCGA-A8-A07F-D37883;TCGA-A8-A07F-D37884;TCGA-A8-A07F-D37885;TCGA-A8-A07F-D37886	9376A2EE-E979-4870-8EE1-39BC963B3B53;1E1543B7-C41E-4E32-B36C-8B255B09B7C0;2EF8C377-0721-408E-BEFA-873ECE792E98;68745060-A6F4-4638-9ADB-D798AA9BF1F7	Not Available;Not Available;Not Available;Not Available	6;6;6;6	31;31;31;Not Available	Not Available;Not Available;Not Available;365	5-Fluorouracil;Epirubicin;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07F-F40826	820EEFC0-3A02-4112-A50A-CC0ABD447D83				2			Not Applicable	577																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07F-R38189	9B5CFAA3-D092-43B8-9105-C1EDC216D232	Not Available	11	212	181	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-B6-A0RP	FEMALE	3126	Mixed Histology (please specify)	Breast	Dead	T2	N1b	M0		1	2787.0	Bone	Distant Metastasis	Not Available				73	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RP	451e1a67-47e6-4738-99d7-fb7771ef61a3	Negative	Positive	Not Available	Not Available	Not Available	Modified radical mastectomy	Positive	Lumpectomy	Not Applicable	NO	2	-26941	3126	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	NO		TCGA-B6-A0RP-F13786	3A57F47C-7FC0-48B0-9F95-B5C63CEC73BE				12		Not Available	3126	Not Available		2787				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	7	Bone	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	ductal/lobular	No	C50.9	8522/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	2	Not Available	No	A0RP	Not Available	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1994
TCGA-A7-A26H	FEMALE	724	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1a	M0	Stage IIA	1	291.0	Liver	Distant Metastasis	Not Available				72	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A26H	dddd8e2f-e540-418a-b02e-698d18a12c14	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	4	-26423	Not Applicable	0	65	Not Available	NO	TCGA-A7-A26H-D29622;TCGA-A7-A26H-D29623	5ABD5AE2-14DC-45D0-8CD9-C1CE4EE9A336;B0A12ECD-CF75-4AE7-BE0D-05D694119222	Not Available;Not Available	26;26	296;486	44;311	Anastrozole;Taxol	Not Available;Not Available	3;3	Not Available;8	1;139-141	mg/day;mg	ADJUVANT;RECURRENCE	Not Applicable;Not Applicable	1;2	PO;IV	NO;NO	Hormone Therapy;Chemotherapy	Not Available;Not Available	253;1535	mg;mg	Not Available;Not Available	2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.2	YES;None	NO;None	NO;None		TCGA-A7-A26H-F29621;TCGA-A7-A26H-F39890	FD079079-3AC7-4D84-A3E4-04CDD759A2FF;5F40A4B3-5B64-42A8-BC00-6DCDCBE7883D				26;5		Not Available;None	Not Applicable;Not Applicable	400;724		291;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	10-19%;None	Positive;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Negative;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Negative;None	3;2	Liver;None	Distant Metastasis;None	Not Available;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;311	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;YES	WITH TUMOR;WITH TUMOR			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	PathVysion Her-2 DNA	2+	20	Not Available	5.8	2.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	1	Yes	A26H	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1	Bilateral Mastectomy	YES	NO	A7	Breast	Not Applicable	Alive	2011	2011
TCGA-A2-A0D4	FEMALE	767	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	767			TUMOR FREE				37	Left	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0D4	75113445-d2d6-44a0-866c-c9175e6d214b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	21	-13805	Not Applicable	0	496	Not Available	Not Available	TCGA-A2-A0D4-D1849;TCGA-A2-A0D4-D1846;TCGA-A2-A0D4-D1845;TCGA-A2-A0D4-D1848	04ba8237-4afb-4363-8a82-459dabc3dae3;dfa2e5c7-323c-4d7a-bd29-45874eb4249b;ccf14e19-fbff-4548-b109-e64aeb37f5b7;8883ac5c-2a78-4739-b762-eb643646c226	Not Available;Not Available;Not Available;Not Available	22;22;22;22	Not Available;99;99;155	279;57;57;113	Tamoxifen;Adriamycin;Cytoxan;Taxol	Not Available;Not Available;Not Available;Not Available	9;9;9;9	Not Available;4;4;4	20 mg daily;130;1304;380	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;2;1;3	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;520;5216;1520	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0D4-F13726	F768A36A-1B8C-45BE-9D50-F05E55C3BF24				10		Not Available	Not Applicable	767		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.14	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A0D4	TUMOR FREE	Not Available	Not Available	Not Available	Intensity=weak	Intensity=moderate	Not Available	Not Available	10-19%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field;Regional site;Primary Tumor Field	TCGA-A2-A0D4-R1844;TCGA-A2-A0D4-R70744;TCGA-A2-A0D4-R70745	57d650d1-6d75-46ef-8f36-bd6e5b1b1a09;181DB4A2-4173-4660-AEAF-01855F51CBFA;50296DE4-49F9-46B7-AEAA-C7505915F783	1;Not Available;Not Available	22;3;3	244;244;251	203;203;245	Not Available;Complete Response;Complete Response	9;3;3	Not Available;Not Available;Not Available	5040;5040;1000	NO;NO;NO	EXTERNAL BEAM;External;External	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2010;2015;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-BH-A18L	FEMALE	811	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N1mi	M0	Stage IIIA	0	811			Not Available				50	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A18L	9ddc3e7b-8b54-4a83-8335-8053940f56c1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	9	-18519	811	0	Not Available	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	1	No	A18L	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T3	total mastectomy and sentinel node biopsy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2003
TCGA-AO-A03R	FEMALE	2091	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2091			TUMOR FREE				57	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A03R	2e82e576-3095-4aee-9853-65f676647c34	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	19	-20930	Not Applicable	0	1707	Not Available	Not Available	TCGA-AO-A03R-D2953;TCGA-AO-A03R-D2956;TCGA-AO-A03R-D2955;TCGA-AO-A03R-D2952	ef4485c7-bf90-4b7a-a8db-28bc351ea4be;5ae7957b-39b0-45da-96ed-2c27dda3e59a;880fcfd1-ad27-4247-8df0-2518b514a93e;0484daf8-16e0-46d1-8655-ec65e9573fe0	Not Available;Not Available;Not Available;Not Available	19;19;19;19	109;Not Available;165;109	67;192;123;67	DOXORUBICIN;LETROZOLE (FEMARA);PACLITAXEL;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;Not Available;4;4	60;2.5;175;600	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	424;Not Available;1240;4248	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	70	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A03R-F2947;TCGA-AO-A03R-F15469	69B88C8B-A186-4D82-A8EB-6F8D0319FD93;BCD222CA-5847-43C0-8BEA-028A0E76FA81	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1707;2091	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	Not Available	<10%	Ratio >=2.0	0	28	Not Available	105	1.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	3	0	No	A03R	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A03R-R2949	cb083b63-0f8b-4518-86d5-8c2675da9503	1	19	245	200	Not Available	9	23	10540	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2005
TCGA-AO-A0JE	FEMALE	2335	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	2335			TUMOR FREE				53	Right Lower Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JE	36fe6152-f61e-4948-9ccc-23ac01a9d77d	Not Available	Negative	Not Available	Not Available	Not Available	Not Evaluated	Negative	Lumpectomy	Not Applicable	NO	20	-19516	Not Applicable	0	1966	Not Available	Not Available	TCGA-AO-A0JE-D3202;TCGA-AO-A0JE-D3203;TCGA-AO-A0JE-D3200;TCGA-AO-A0JE-D3199	33e32dbf-9c8e-4dff-b75b-c6342c56420a;2806bb73-968f-4ce0-a287-e75f00b76f6d;50d69645-1eb9-4fa7-83c0-f6614085a07f;d2701b3c-2642-422e-afff-33ea4ef76359	Not Available;Not Available;Not Available;Not Available	20;20;20;20	161;462;105;105	119;119;63;63	PACLITAXEL;TRASTUZUMAB;DOXORUBICIN;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;22;4;4	175;6;60;600	mg/m2;mg/kg;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1220;7869;428;4272	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	71	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JE-F3197;TCGA-AO-A0JE-F15488	5076E01B-BDF8-4116-84A5-E432D1D45E3A;975B8C53-2E18-4DBB-9A34-2DCCA4680406	Not Available;None	Not Available;None	Not Available;None	20;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1966;2335	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	50-59%	RATIO > = 2.0	3+	33	Not Available	269	3.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	29	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	8	0	No	A0JE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-AO-A0JE-R3198	a51218ad-d05c-4f75-9d0b-4a9a4bd51689	1	20	243	202	Not Available	9	30	16000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2005
TCGA-AN-A0FX	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE				52	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A0FX	13b860c3-8048-4dc9-9eb0-7480bc660837	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-19309	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FX-F68967	29111D0E-E852-4132-98D1-EFDEB235F4F6				24			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	0	No	A0FX	TUMOR FREE	Not Available	Not Available	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-EW-A1J6	FEMALE	875	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	875			TUMOR FREE				70	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1J6	87281a89-91d2-44f7-9f80-668567ad5c72	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	11	-25830	Not Applicable	0	595	Not Available	NO	TCGA-EW-A1J6-D21611	DE34FA0A-12BB-466B-9E7B-053B947EC696	Not Available	16	Not Available	111	Femara	Not Available	2	Not Available	2.5	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1J6-F21347	8D84D7F5-C455-4390-BCC6-C33048E6CC19				6		Not Available	Not Applicable	875		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1J6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A0B7	FEMALE	2559	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2559			TUMOR FREE				42	Right	Not Available	Not Available	TCGA-BH-A0B7	214a4507-d974-4b3e-8525-7408fccc6a0f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	4	-15593	Not Applicable	0	1733	Not Available	NO	TCGA-BH-A0B7-D58721;TCGA-BH-A0B7-D58722	341C74D1-788A-4312-A88D-96B3FAAB73CE;4F4B553E-E1BA-43B5-AA88-811D9E6FE6A1	Not Available;Not Available	22;22	168;378	105;196	Adriamycin;Taxol	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0B7-F58717	9C4412C3-9117-491D-9B4E-9579762E7EF3				22			Not Applicable	2559																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	Not Available	No	A0B7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-BH-A0B7-R58718;TCGA-BH-A0B7-R58720	50A9D3AB-1FDB-404E-94D5-6CEEA124DF29;F586906B-024C-452A-9A32-350AFD7F2932	Not Available;Not Available	22;22	356;356	305;305	Complete Response;Complete Response	4;4	28;27	5040;4860	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-B6-A400	FEMALE	215	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	215			TUMOR FREE				43	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-B6-A400	D9A1C06F-7B50-46B0-878E-89E8C31863AE	Not Available	Negative	4 Point Scale	1+	4 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	20	-16022	Not Applicable	0	215	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-B6-A400-F59655	59780D28-66A6-427C-9E17-691B40C10281				3			Not Applicable	215																				YES																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	Not Available	No	A400	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	2008
TCGA-AR-A1AQ	FEMALE	3021	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	3021			TUMOR FREE				49	Right Upper Inner Quadrant;Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AQ	98e0b4de-52fc-4945-9bf5-11e29368f939	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	14	-18109	Not Applicable	0	1310	Not Available	Not Available	TCGA-AR-A1AQ-D21806;TCGA-AR-A1AQ-D21811;TCGA-AR-A1AQ-D21808	E3335007-9F30-4A8C-8027-2E69648DCB76;FB4C564B-3B93-4B6F-98A5-FDCE6A415267;26C8ACC1-6306-4A4B-AE2E-178288FA6A52	Not Available;Not Available;Not Available	27;27;27	74;88;74	32;88;32	Doxorubicin;Paclitaxel;Cytoxan	Not Available;Not Available;Not Available	2;2;2	4;1;4	60;175;600	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	480;340;4780	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AQ-F21801;TCGA-AR-A1AQ-F69276	0E0D419B-0483-45CE-BD2D-C5F70BB17DDE;A25BE870-3A72-431A-A4A5-2B9C5FDAD5BA				27;31		Not Available;None	Not Applicable;Not Applicable	1310;3021		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AQ-R21804	3579DB65-F66D-41A4-B13A-E32DD54BEBDF	1	27	163	121	Not Available	2	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-D8-A1XL	FEMALE	606	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	606			TUMOR FREE				34	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XL	2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	9	-12668	Not Applicable	0	319	Not Available	NO	TCGA-D8-A1XL-D29992;TCGA-D8-A1XL-D29991	99E79238-A6D7-4960-8534-AC4370815F98;A6E0C004-801E-45BB-AC10-CCEC1557F108	Not Available;Not Available	31;31	Not Available;128	250;65	tamoxiphene+leuporeline+gosereline;doxorubicine+cyclophosphamide+tamoxifen	Not Available;Not Available	3;3	Not Available;4	20+11.25+10.8;100.8+1000.8	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	PO;IV	YES;NO	Hormone Therapy;Chemotherapy	Not Available;Not Available	Not Available;403.2+4032	mg;mg	Not Available;Not Available	2012;2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XL-F29990	A52FC449-F807-4D82-AB8E-CDCF9B2484D4				31		Not Available	Not Applicable	606		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	HercepTest TM Dako	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	Not Available	No	A1XL	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XL-R29993	0F71B55C-E625-4828-9275-B75E1E186FF7	Not Available	31	249	211	Not Available	3	55	11000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A1FG	FEMALE	577	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	NX	M0	Stage I	0	577			Not Available				88	Left	Not Available	Not Available	TCGA-BH-A1FG	d4e7426c-9739-4585-9114-e564b13c7c02	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	8	-32295	577	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Not Available	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	Not Available	Not Available	No	A1FG	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	NX	T1c	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-B6-A0I8	FEMALE	749	Infiltrating Ductal Carcinoma	Breast	Dead	T1	NX	M0	Stage X	1	746.0	Other, specify	Locoregional Disease	WITH TUMOR				46	Right Upper Inner Quadrant;Right	No axillary staging	Not Available	TCGA-B6-A0I8	6e6408d6-6c48-4dfc-9f1c-28b7386e87b4	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	NO	2	-17073	749	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	YES	YES		TCGA-B6-A0I8-F12607	939A3148-247E-4863-9E71-A8EB0B343009				1		746	749	Not Available		746				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	6	Other, specify	Locoregional Disease	Pectoral muscle	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	0	Not Available	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	Not Available	Not Available	Yes	A0I8	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	NX	T1	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1992
TCGA-EW-A6SA	MALE	510	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	MX	Stage II	0	510			TUMOR FREE				59	Left;Left Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A6SA	ABA5F46A-E67A-4CD2-9C52-C0686968FF04	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	27	-21623	Not Applicable	0	510	Not Available	Not Available																								Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									MALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	1	No	A6SA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i+)	T2	Not Available	YES	NO	EW	Breast	Not Applicable	Alive	2015	2013
TCGA-A2-A1FW	FEMALE	528	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	0	528			TUMOR FREE				62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A1FW	54883111-d475-4515-ba3f-fece8a71e79e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	11	-22779	Not Applicable	0	221	Not Available	NO	TCGA-A2-A1FW-D11831;TCGA-A2-A1FW-D11823;TCGA-A2-A1FW-D11830;TCGA-A2-A1FW-D20812	1c60eee0-e3cd-4edb-8287-bf56a9f4efa9;4ea58c35-fcc2-4136-9aa0-752ace9b87e0;86b10331-62e5-40e8-bdc7-80184a5896d4;4F2494FD-3934-42BA-8414-FE4FEFF62B75	Not Available;Not Available;Not Available;Not Available	17;17;17;12	154;154;245;Not Available	65;65;175;364	Cytoxan;Adriamycin;Taxotere;Femara	Not Available;Not Available;Not Available;Not Available	5;5;5;1	4;4;4;Not Available	Not Available;Not Available;Not Available;2.5	Not Available;Not Available;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;1;2;4	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A1FW-F20810	45FA1D4F-ECD9-4962-8D88-C93EFFAFBCD2				12		Not Available	Not Applicable	528		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	5	Not Available	No	A1FW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A1FW-R15272	9FDD44F3-884C-407E-B5B9-D1064D91CDA9	1	16	324	277	Not Available	8	52	18120	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A1AR	FEMALE	524	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N2	M0	Stage IIIA	1	268.0	Other, specify	New Primary Tumor	TUMOR FREE				50	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AR-A1AR	eda6d2d5-4199-4f76-a45b-1d0401b4e54c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	28	-18482	524	0	Not Available	Not Available	Not Available	TCGA-AR-A1AR-D21852;TCGA-AR-A1AR-D21854;TCGA-AR-A1AR-D21853	A68EA7A7-0E11-4956-8188-70EA2C45DECF;7B4BBD98-19AC-4156-B24A-AE9E584860AB;8E6652BF-209E-4F74-87AE-371F6CB1244D	Not Available;Not Available;Not Available	27;27;27	159;159;159	Not Available;Not Available;Not Available	Docetaxel;Not Available;Doxorubicin	Not Available;Not Available;Not Available	2;2;2	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available		TCGA-AR-A1AR-F21816;TCGA-AR-A1AR-F21825	A22FFD2C-82FF-4832-A3C3-258EE37920E3;9CEE3AB5-7F21-46B0-AB2D-B2102DC1113C				27;27		Not Available;Not Available	524;524	Not Available;Not Available		268;387				Scheduled Follow-up Submission;Additional New Tumor Event							Not Available;Not Available			Not Available;Not Available					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2;2	Other, specify;Other, specify	New Primary Tumor;New Primary Tumor	Breast;Breast	YES;YES																																		WITH TUMOR;WITH TUMOR			Not Available;Not Available			YES;YES		YES;YES	Dead;Dead	2012;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	5	Not Available	Yes	A1AR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-AR-A1AR-R21851	3B2FC16E-C838-43CC-A732-D6C5969A0532	1	26	251	Not Available	Not Available	2	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2011	2007
TCGA-D8-A3Z6	FEMALE	563	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3a	M0	Stage IIIC	0	563			TUMOR FREE				56	Left	Other (specify)	mastectomy with TLND	TCGA-D8-A3Z6	A6E5F869-1182-4F81-B4BB-CF55261C8F3F	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	3	-20629	Not Applicable	0	185	Not Available	NO	TCGA-D8-A3Z6-D51368;TCGA-D8-A3Z6-D51370;TCGA-D8-A3Z6-D51372;TCGA-D8-A3Z6-D59241	FA44D3C7-5509-4E8A-8B5F-C6C804AE85E3;FEEC29B8-84BD-4F1D-AF6E-93F1592B2E13;D00B426C-3576-4D63-AFD6-FBEFFDB9ADA7;25ADCD91-C55B-445C-8B2D-4008D97434AE	Not Available;Not Available;Not Available;Not Available	18;18;18;6	86;185;Not Available;86	22;108;260;22	cyclophosphamidum;taxol;tamoxifen;Doxorubicinum	Stable Disease;Stable Disease;Not Applicable;Stable Disease	11;11;11;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-D8-A3Z6-F51367	9DD39B06-7D2B-4656-9C5F-90AAA50D3A64				18			Not Applicable	563																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	19	Not Available	No	A3Z6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A3Z6-R51369	7BE92C39-4EED-4E33-85EB-996F80FEC082	Not Available	18	260	234	Stable Disease	11	22	45	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2012	2011
TCGA-BH-A1F8	FEMALE	1	Infiltrating Ductal Carcinoma	Breast	Dead	T4b	N2	M0	Stage IIIB	0	1			WITH TUMOR				90	Left	Not Available	Not Available	TCGA-BH-A1F8	ee554215-bea2-4268-aaf9-784e68cdb969	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	7	-32871	1	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	13	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	12	Not Available	No	A1F8	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N2	T4b	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-A2-A0SX	FEMALE	1534	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	1	1239.0			WITH TUMOR				48	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0SX	18d35983-ea6a-4b70-a209-9bef37595956	Negative	Negative	Not Available	Not Available	Not Available	Lumpectomy	Negative	Lumpectomy	Not Applicable	YES	9	-17774	Not Applicable	0	1288	Not Available	Not Available	TCGA-A2-A0SX-D4024;TCGA-A2-A0SX-D4019;TCGA-A2-A0SX-D4023;TCGA-A2-A0SX-D4025;TCGA-A2-A0SX-D14036	8f6e3477-88fd-4f1b-b06f-0e3510b0ac5d;76901188-6afa-4900-ae30-7d296985c5de;a0280f47-3ba8-42cf-ab14-ff4fd7db88b0;16e4fd14-6c2b-4c7e-964a-c240c2b36ceb;634383B8-9F0E-4A8B-84FE-B308540A6F38	Not Available;Not Available;Not Available;Not Available;Not Available	12;20;24;24;11	132;132;1359;1359;Not Available	62;62;1289;1289;1429	Adriamycin;Cytoxan;Carboplatin;Gemcitabine;Xeloda	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;5	6;6;4;4;Not Available	100;1000;610;1800;1500-2000	mg;mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;3;4;5	IV;IV;IV;IV;PO	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	600;6000;2203;7200;Not Available	mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;Not Available	NO;Not Available	YES;Not Available	Not Available;None	TCGA-A2-A0SX-F4018;TCGA-A2-A0SX-F14037	2FBA2DC6-991D-4F21-A885-0C9489F2546E;FD49FD62-003E-47C4-82ED-06FDB0E1CF23	Negative;None	Not Available;None	Negative;None	9;14	1239;None	Not Available;Not Available	Not Applicable;Not Applicable	1288;1534	Not Available;None	1239;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	0;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Negative;None	Not Evaluated;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	11;7	None;Not Available	None;Not Available	None;Not Available	None;NO																																		WITH TUMOR;WITH TUMOR	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	0	No	A0SX	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0SX-R4026	b73451cc-daa2-4f73-bf06-517ddecd777f	1	12	213	Not Available	Not Available	11	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2007
TCGA-AO-A0JM	FEMALE	2184	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	2184			TUMOR FREE				40	Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JM	44bec761-b603-49c0-8634-f6bfe0319bb1	Not Available	Positive	Not Available	1+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-14653	Not Applicable	0	1826	Not Available	Not Available	TCGA-AO-A0JM-D3235;TCGA-AO-A0JM-D3233;TCGA-AO-A0JM-D3231;TCGA-AO-A0JM-D3232;TCGA-AO-A0JM-D3230	140fbd02-a0c1-4e38-99e8-eaaac337f3b2;6106b296-02f3-4373-8d46-4d6c3906a6b4;ad12218d-1986-4f13-bab1-12b1315ad67f;425ca3d3-c246-49e1-9039-fa57865be48a;b2c38850-e368-40ba-afe1-d8faf3c2647d	Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20	Not Available;498;120;177;120	330;134;78;134;78	TAMOXIFEN;TRASTUZUMAB;DOXORUBICIN;PACLITAXEL;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	Not Available;23;4;4;4	20;6;60;175;600	mg/day;mg/kg;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;2;1;1;1	PO;IV;IV;IV;IV	YES;NO;NO;NO;NO	Hormone Therapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;9095;452;1360;4520	Not Available;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	74	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JM-F3228;TCGA-AO-A0JM-F15496	049E6CA9-0F3F-4DE6-854E-CB6C131ECBF1;3A5AB256-1C98-41B7-A84A-3BFB46668518	Not Available;None	Not Available;None	Not Available;None	20;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1826;2184	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	70-79%	Not Available	3+	30	Not Available	366	5.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Positive	Positive	23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A0JM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Not Available	Not Available	Regional site	TCGA-AO-A0JM-R3229	7e8ccc49-defa-4a33-bd6a-edb852153291	1	20	294	260	Not Available	9	25	10000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2005
TCGA-BH-A0BG	FEMALE	1871	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	1871			TUMOR FREE				73	Left Lower Outer Quadrant	Not Available	Not Available	TCGA-BH-A0BG	4f608829-ffc4-4527-886e-6bc764ab29f5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	8	-26988	Not Applicable	0	756	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BG-F58615	C970540D-F1A7-425C-BEF1-2AD70CD6AD13				16			Not Applicable	1871																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BG-R58616	FBA2D677-DEA7-483C-AA88-82D4D14CB644	Not Available	16	131	84	Complete Response	4	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Segmental mastectomy with sentinel axillary lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-OL-A97C	FEMALE	271	Other, specify	Breast	Alive	T3	N0	M0	Stage IIB	1	275.0	Lung	Distant Metastasis	TUMOR FREE				67	Left	Not Available	Not Available	TCGA-OL-A97C	6FFD1B8C-6F0B-456A-9160-E0C8021E5897	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	18	-24735	Not Applicable	0	195	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A97C-F66330	A92B2964-F02C-4129-A664-4BBB320621E7				31			Not Applicable	271																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						Unknown		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	malignant phyllodes	No	C50.9	9020/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Negative	6	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Unknown	Unknown	Not Available	275	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Lung	Distant Metastasis	Not Available	Unknown	Not Available	YES	0	Not Available	No	A97C	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2014	2013
TCGA-BH-A1FL	FEMALE	1673	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	1673			WITH TUMOR				69	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FL	14d1d84e-99e1-41ad-8892-3b4da3d4f948	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	8	-25558	1673	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	22	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	4	Not Available	No	A1FL	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-A2-A0YF	FEMALE	1535	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0 (i+)	M0	Stage I	0	1535			TUMOR FREE				67	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A0YF	ae8c77fe-e6c8-44d5-8265-4a38c637bbef	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	2	-24660	Not Applicable	0	289	Not Available	Not Available	TCGA-A2-A0YF-D5507	481c8460-6527-43a9-a403-f39ee68057e2	Not Available	2	Not Available	Not Available	Arimidex	Not Available	12	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0YF-F16755;TCGA-A2-A0YF-F59385	5F7B4D0A-13E7-4308-A1C2-670BB17D88C7;AEE7A858-E746-4B8D-85F5-75D4F0F185F9				16;12		Not Available;None	Not Applicable;Not Applicable	469;1535		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	9;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	1	No	A0YF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1b	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-LQ-A4E4	FEMALE	849	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1a	MX	Stage IIIA	1	681.0	Bone	Distant Metastasis	TUMOR FREE				73	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-LQ-A4E4	4F321D41-3255-46A4-AE0D-1CF39699E624	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	5	-26883	Not Applicable	0	484	Not Available	Not Available	TCGA-LQ-A4E4-D37612	A6AB6FB7-5552-45E1-9CE2-F1DB3B0752D9	Not Available	5	Not Available	111	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.1					TCGA-LQ-A4E4-F52290	10069AFF-4C83-4D78-8926-50B590E2C1B3				2			Not Applicable	849																				NO																						12					YES	YES	Not Available	681	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Bone	Distant Metastasis	Not Available	NO	Not Available	YES	WITH TUMOR						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	1.1	1.05	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	26	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	0	No	A4E4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field	TCGA-LQ-A4E4-R37611	8DA26ACA-40A2-4C08-90E0-BDECEEDE3964	Not Available	5	111	63	Complete Response	12	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	NO	YES	LQ	Breast	Not Applicable	Alive	2012	2011
TCGA-E9-A1QZ	FEMALE	755	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	755			TUMOR FREE				61	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1QZ	b6b932ce-6856-4d94-9e6c-16dfbe51906f	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	28	-22397	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1QZ-F29720;TCGA-E9-A1QZ-F66270	67F347E5-E803-4F86-81E4-70D6BBA65A9D;E97CFB3D-31E0-4AED-82C6-C775CF5282FE				28;7		Not Available;None	Not Applicable;Not Applicable	362;755		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;NO		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1QZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-C8-A1HG	FEMALE	345	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	345			TUMOR FREE				50	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HG	0c23c380-363c-474d-b64c-b47f612a8225	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	24	Not Available	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A1HG-F19096	E5B2D364-8B39-452F-9930-E30DA170B55F				2		Not Available	Not Applicable	345		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A1HG	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 7	Allred Score 8	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0DD	MALE	2486	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2486			TUMOR FREE				58	Right	Not Available	Not Available	TCGA-BH-A0DD	dba9beec-5e51-48c0-9229-0ee286a02a1a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	18	-21386	Not Applicable	0	1394	Not Available	NO	TCGA-BH-A0DD-D60387;TCGA-BH-A0DD-D60388	5889C498-95E3-4F7F-AFCD-CC096717CD6C;7421BB29-2783-495B-8C92-73DC7451EEB8	Not Available;Not Available	9;9	217;217	105;105	Docetaxel;Carboplatin	Complete Response;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-BH-A0DD-F60386	125C6661-A8F1-4D50-8E0B-28DD4EC98880				9			Not Applicable	2486																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	MALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	22	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0DD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-B6-A0WV	FEMALE	2417	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	2417			TUMOR FREE				67	Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0WV	7588a286-6935-424a-bc5f-92e24c83eb37	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	14	-24803	2417	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0WV-F15732	19EA87A8-6263-4AB4-99A7-F46F9369F416				29		Not Available	2417	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Not Evaluated	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	4	Not Available	No	A0WV	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1995
TCGA-AN-A0FN	FEMALE	218	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	218			TUMOR FREE				61	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FN	c2a742fe-3e8b-4210-85a6-7191a1123609	Not Available	Positive	Not Available	1+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-22629	Not Applicable	0	218	Not Available	Not Available																								dextran coated charcoal	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FN-F68953	16502F77-C804-49D7-99F6-20F92037D659				23			Not Applicable	218																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	20-29%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FN	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	250	Not Available	Not Available	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-A2-A0CP	FEMALE	2813	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	2813			TUMOR FREE				60	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CP	fe15c48b-116d-461e-9b40-68514730fd18	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	8	-22133	Not Applicable	0	2495	Not Available	Not Available	TCGA-A2-A0CP-D2004;TCGA-A2-A0CP-D2002;TCGA-A2-A0CP-D2003	6a6c88d1-1963-4a43-b81a-b46a280df51f;f2a18707-8081-432a-ba13-4789e14d46c9;e1068c5e-35cf-4b45-9e78-0d8b415602e8	Not Available;Not Available;Not Available	13;13;13	2043;134;134	206;70;70	Anastrozole;Cytoxan;Adriamycin	Not Available;Not Available;Not Available	8;8;8	Not Available;4;4	1 mg daily;1056-1062;106	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;1;2	PO;IV;IV	NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;4236;424	Not Available;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0CP-F13741	7BF10142-06B6-4D5A-BF38-AE1D5E2468DF				10		Not Available	Not Applicable	2813		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0CP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0CP-R2001	2bd9726c-9c8e-4177-a060-ea91da683282	1	13	210	163	Not Available	8	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2003
TCGA-D8-A1XO	FEMALE	1682	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1682			TUMOR FREE				56	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XO	6a186809-3422-41d0-83d2-867145830936	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-20606	Not Applicable	0	242	Not Available	NO	TCGA-D8-A1XO-D72207	C1C52C47-5334-40A2-8898-0E1B7949D3A0	Not Available	29	Not Available	93	Tamoxifen	Discrepancy	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-D8-A1XO-F29447;TCGA-D8-A1XO-F72206	4C872E64-EB75-4271-B57E-023595983986;A139305D-B569-4F6F-B37F-3134FD222946				19;29		Not Available;None	Not Applicable;Not Applicable	473;1682		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	0	No	A1XO	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XO-R29448	3E9D9BA8-2F52-4028-9284-AD01E58BF05E	Not Available	19	119	93	Not Available	3	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0CZ	FEMALE	1616	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1616			TUMOR FREE				46	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CZ	9f93ea0a-1687-44e0-9e8a-eeb4097d471c	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	YES	14	-17026	Not Applicable	0	1339	Not Available	Not Available	TCGA-A2-A0CZ-D2007;TCGA-A2-A0CZ-D2006;TCGA-A2-A0CZ-D2008	8d024ed9-cab0-4645-9ef7-d2443495432a;b80c8dcd-95cb-43e8-baaf-50704eb883f9;df7c95fe-5410-4be7-b482-c0d6c6973671	Not Available;Not Available;Not Available	16;16;16	148;148;Not Available	106;106;236	Cytoxan;Adriamycin;Tamoxifen	Not Available;Not Available;Not Available	9;9;9	4;4;Not Available	1045;104-105;20	mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;3	IV;IV;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	4180;418;Not Available	mg;mg;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0CZ-F13728	A104937A-EABD-4777-8D6C-1EC71D882F19				10		Not Available	Not Applicable	1616		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	2	Positive	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0CZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	20-29%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2007
TCGA-E9-A244	FEMALE	21	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	21			TUMOR FREE				54	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A244	a4c59287-1ad5-46a5-8040-e591e6ce064f	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	15	-19778	Not Applicable	0	21	Not Available	NO	TCGA-E9-A244-D31166;TCGA-E9-A244-D31168	B71D5E8E-B7EF-4786-8FB2-E7ACF5FE2C75;E07A4B20-C911-4AB0-81F9-1D66E0F74A44	Not Available;Not Available	24;24	16;16	16;16	Cyclophosphamide;Doxorubicin	Not Available;Not Available	4;4	1;1	1000;100	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1000;100	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E9-A244-F31164	39F4E7E2-641B-4D72-8E4C-8066AAD6A679				24		Not Available	Not Applicable	21		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A244	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0H3	FEMALE	1928	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1928			TUMOR FREE				46	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0H3	6cdc0d53-f813-4101-81e5-9bee68270536	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	11	-17152	Not Applicable	0	1149	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0H3-F58599	22CC69F7-3445-4524-A216-80F457933E1A				15			Not Applicable	1928																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Negative	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0H3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site;Primary Tumor Field	TCGA-BH-A0H3-R58600;TCGA-BH-A0H3-R58601	C0B72A02-DD39-4927-8682-60DBA02D6279;091A7641-7710-4553-8542-90FDEBEFA4AF	Not Available;Not Available	15;15	115;126	77;118	Complete Response;Complete Response	4;4	28;7	5040;14	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Gy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Left segmental mastectomy with axillary lymph node dissection	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A18Q	FEMALE	1692	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	1692			Not Available				56	Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A18Q	db4bc6aa-2e7d-4bcb-8519-a455f624d33b	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	24	-20675	1692	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.8	8500/3	C50.8	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Negative	25	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	2	No	A18Q	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2001
TCGA-BH-A0DQ	FEMALE	98	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	98			TUMOR FREE				42	Right Upper Inner Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0DQ	a851ca14-7bbf-455b-a054-ec03979a4247	Not Available	Positive	Not Available	1+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	9	-15533	Not Applicable	0	98	Not Available	Not Available	TCGA-BH-A0DQ-D4554;TCGA-BH-A0DQ-D4541;TCGA-BH-A0DQ-D4556	B62A0DC1-F5F2-4A14-B4F0-D5F688D2387C;A7564051-9FF3-4CF9-8103-E8F1EA030475;9B9ED158-839A-41DD-A7B0-844FA3D347A2	Not Available;Not Available;Not Available	17;17;30	204;204;309	141;141;225	DOXORUBICIN;CYCLOPHOSPHAMIDE;TAXOL	Not Available;Not Available;Not Available	11;11;11	4;4;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	H-SCORE 136	60-69%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0DQ-F4560	CDBA9234-AC86-44D5-A25D-CDFA2E27F36D	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	98	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A0DQ	TUMOR FREE	H-SCORE 140	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DQ-R4559	54780F16-C78A-4736-AE8D-0FDF2D5C1D37	1	17	377	329	Not Available	11	Not Available	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-A7-A6VW	FEMALE	285	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	285			TUMOR FREE				48	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A6VW	98E709E7-E195-4B37-9537-F6081AFFB609	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	29	-17539	Not Applicable	0	176	Not Available	Not Available	TCGA-A7-A6VW-D57225;TCGA-A7-A6VW-D57226;TCGA-A7-A6VW-D57254	037B0D49-1CCC-47FB-9442-F8841E1663C5;DD497F99-3155-4D4E-904E-FD5904316A52;02D81B38-5418-4F7D-B18B-0AE11DBE806B	Not Available;Not Available;Not Available	6;6;6	257;134;134	148;84;84	Taxol;Doxorubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A6VW-F57227	4E6B8FB6-BAFC-4287-BC6A-AB3BA00294C9				6			Not Applicable	285																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-A7-A6VW-R57253	75FCD986-D2B7-4F5B-B37A-FE0AF6FC2AC8	Not Available	31	331	285	Complete Response	3	28	50.40	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2013
TCGA-E9-A1NF	FEMALE	1072	Mixed Histology (please specify)	Breast	Dead	T2	N0	M0	Stage IIA	1	90.0	Lung	Distant Metastasis	TUMOR FREE				60	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1NF	a8b1f6e7-2bcf-460d-b1c6-1792a9801119	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	23	-21981	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1NF-D32919;TCGA-E9-A1NF-D32920;TCGA-E9-A1NF-D32921;TCGA-E9-A1NF-D32922;TCGA-E9-A1NF-D32923;TCGA-E9-A1NF-D32924	9A0E9054-76D2-4DFA-B120-DA25523FEC81;3F6B874E-A4B8-460B-A135-C9AAF2975A26;12ABC791-CDA4-46C3-9913-518EEDEF203A;8B6A8702-47E0-4CFA-A700-8618FE4CA0B0;8AE1CA3A-950C-45F8-A327-AD92398769BE;A11CB0B1-B0B0-4E89-8C87-63A0F6638B32	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15	63;63;63;178;178;Not Available	21;21;21;91;91;280	Doxorubicin;Cyclophosphamide;5-Fluorouracil;Vinorelbine;Mitomycin;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;None	Not Available;None	NO;None		TCGA-E9-A1NF-F29168;TCGA-E9-A1NF-F39778	7942FB91-56B2-43E4-AC0A-D312AB589118;BF1ADCE9-14BB-4F7D-9B8D-DC8A5E3D824F				21;1		Not Available;None	Not Applicable;1072	610;Not Available		90;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;2	Lung;None	Distant Metastasis;None	Not Available;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	WITH TUMOR;WITH TUMOR			Not Available;None			YES;YES		NO;NO	Alive;Dead	2014;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1NF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0DS	FEMALE	78	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	78			TUMOR FREE				71	Right Upper Inner Quadrant;Right Lower Inner Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0DS	fb57c598-b45b-478a-9d34-ca1f050d5b7c	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Other	Not Applicable	NO	9	-25944	Not Applicable	0	78	Not Available	Not Available	TCGA-BH-A0DS-D4565;TCGA-BH-A0DS-D4567	BD1D875E-B540-4026-831D-F6E299CD76BE;65485195-3F60-4437-BB26-7445C4269376	Not Available;Not Available	17;17	Not Available;Not Available	47;78	CYCLOPHOSPHAMIDE;TAXOTERE	Not Available;Not Available	11;11	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	H-SCORE 190	70-79%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0DS-F4573	2A2365B3-1F58-4BEF-B339-62EC3E2DF7E0	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	78	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	No	A0DS	TUMOR FREE	H-SCORE 162	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DS-R4570	9D8636BF-0DD9-40C4-830F-ACEF70BE5B34	1	22	Not Available	245	Not Available	11	Not Available	Not Available	YES	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2010
TCGA-E2-A15S	FEMALE	428	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	428			TUMOR FREE				34	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A15S	0f7ab21b-1fd0-45e0-9a47-17c4691eb84f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	14	-12671	Not Applicable	0	274	Not Available	NO	TCGA-E2-A15S-D19140;TCGA-E2-A15S-D19137;TCGA-E2-A15S-D19136;TCGA-E2-A15S-D19139	CEBFFF93-6688-400B-AA11-6CD3B44EFE31;E2A0AE1A-0AFD-48FC-A05A-64B284BBC153;8460E5C6-9209-4D1B-889B-72D74DE61493;F323125C-76E3-4E3E-AFB8-2355B2C63C47	Not Available;Not Available;Not Available;Not Available	16;16;16;16	Not Available;78;78;Not Available	314;50;50;Not Available	Arimidex;Doxorubicin;Cyclophosphamide;Taxol	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;3;3;Not Available	1;92;918;Not Available	mg/day;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;1;1;2	PO;IV;IV;Not Available	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1;276;2754;Not Available	mg/day;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15S-F19135	E148F43C-C230-4941-9B16-BF0B9D4C9AF4				16		Not Available	Not Applicable	428		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A15S	TUMOR FREE	Not Available	Not Available	Not Available	Allred score = 2	Allred score = 7	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A15S-R19141	404E4F73-F254-4DB0-A932-852FCB819377	1	16	247	191	Not Available	11	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A0J3	FEMALE	651	Other, specify	Breast	Alive	T2	N1b	M0	Stage IIB	0	651			TUMOR FREE				67	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-AO-A0J3	39cde586-df95-435f-b9a6-73b0c0ee5e92	Not Available	Positive	Not Available	4+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	19	-24519	Not Applicable	0	302	Not Available	Not Available	TCGA-AO-A0J3-D3051;TCGA-AO-A0J3-D3044;TCGA-AO-A0J3-D3050;TCGA-AO-A0J3-D3042;TCGA-AO-A0J3-D3054;TCGA-AO-A0J3-D3055;TCGA-AO-A0J3-D3047	2cba97f0-e44a-41cf-a5e6-96b637c1e453;b66cb509-ac95-4cae-8fde-5fecc8d6d9a6;d78ab251-4543-49f7-b7a5-3dd2cbe6ff27;04eb8d7b-e0fe-48f0-903f-0b0a03343d79;4d690b3c-0e7e-4e46-91c4-a1405ba74fa1;514f9a1d-4c93-4657-9f68-4a5a83d64589;d0506624-2dd1-4f05-995e-fe7527c6ccaa	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;19;19;19	191;107;191;107;191;Not Available;121	149;66;149;66;149;245;121	METHOTREXATE;CYCLOPHOSPHAMIDE;FLOUROURACIL;DOXORUBICIN;CYCLOPHOSPHAMIDE;ANASTROZOLE (ARIMIDEX);PACLITAXEL	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9	3;4;3;4;3;Not Available;1	40;600;600;60;600;1;175	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1;2;1	IV;IV;IV;IV;IV;PO;IV	NO;NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	240;4700;3600;470;3600;Not Available;340	mg;mg;mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J3-F2957;TCGA-AO-A0J3-F15477	26278313-311F-4604-93D1-B6D087933874;9F50DC63-8F33-4824-9078-B96B2188703D	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	302;651	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	10-19%	Ratio >=2.2	2+	40	Not Available	2.4	0.9	Not Available	Other, specify	neuroendocrine and ductal	No	C50.9	8523/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	36	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A0J3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A0J3-R3040	e7906fe2-660d-4ad4-ae6b-4b90b2eff3fa	1	19	263	223	Not Available	9	28	10080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009
TCGA-BH-A18S	FEMALE	2009	Mucinous Carcinoma	Breast	Dead	T1c	N0	M0	Stage I	0	2009			TUMOR FREE				79	Right Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A18S	433427a1-bacf-4381-91ba-5fec8a0953f9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	2	-28974	2009	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.3	8523/3	C50.3	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A18S	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	total mastectomy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2003
TCGA-D8-A1XG	FEMALE	448	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N1a	M0	Stage IIIB	0	448			TUMOR FREE				86	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XG	de531604-bd1a-49df-96c2-6de3ae703f1d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	16	-31748	Not Applicable	0	75	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XG-F29444	F26CFC15-575E-4E12-B7A9-B4319F986FF9				26		Not Available	Not Applicable	448		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	0	No	A1XG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	10-75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T4b	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A0J5	FEMALE	792	Other, specify	Breast	Dead	T4	N1a	M1	Stage IV	1				WITH TUMOR				48	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-AO-A0J5	c1442467-d618-435f-8792-b1a18f696f1a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	7	-17815	Not Applicable	0	735	Not Available	Not Available	TCGA-AO-A0J5-D6005;TCGA-AO-A0J5-D6007;TCGA-AO-A0J5-D6006;TCGA-AO-A0J5-D6008	3daac793-eb29-42ea-8866-27b14eca5820;effd840a-7e52-4422-a5e1-ad5c2f84aa8a;2819fde9-35d0-4e7e-a9eb-da8263789223;272824b5-160a-4d48-8b48-bcaa074214bb	Not Available;Not Available;Not Available;Not Available	10;10;10;10	Not Available;Not Available;422;Not Available	-1;422;9;618	Zoledronic Acid;Xeloda (Capecitabine);Femara (Letrozole);Fulvestrant (Faslodex)	Not Available;Not Available;Not Available;Not Available	1;1;1;1	Not Available;Not Available;Not Available;Not Available	4;1500;2.5;250	mg;mg/day;mg/day;mg	OTHER, SPECIFY IN NOTES;PROGRESSION;OTHER, SPECIFY IN NOTES;PROGRESSION	Neo-adjuvant;Not Applicable;Neo-Adjuvant;Not Applicable	1;2;1;3	IV;PO;PO;IM	YES;YES;NO;YES	Other, specify in notes;Chemotherapy;Hormone Therapy;Hormone Therapy	Bisphosphonate;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Lung;Bone;Liver	Not Available	64	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J5-F5869;TCGA-AO-A0J5-F19407	DDACC35F-1160-48BC-B755-EC8F6E8C2537;9C35625C-89D6-48BA-AE91-2B8411B85217	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;792	705;Not Available	735;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		WITH TUMOR;WITH TUMOR	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Dead	2010;2011	FEMALE	>2.2 Positive	3+ Positive	10-19%	Not Available	2+	25	Not Available	71	1.1	Not Available	Other, specify	Ductal/micropapillary	Yes	C50.9	8523/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0J5	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A0J5-R5870	f3025f80-8525-4819-b6cc-e2b2cd2207ed	1	7	371	336	Not Available	12	25	10625	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M1	N1a	T4	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2008
TCGA-BH-A1EU	FEMALE	1286	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N0	M0	Stage I	0	1286			TUMOR FREE				83	Right	Not Available	Not Available	TCGA-BH-A1EU	a1093598-d3a8-4ffe-83fc-bc7d1faff7e5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	7	-30339	1286	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	Not Available	Not Available	No	A1EU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Right segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-AR-A0TR	FEMALE	160	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1	M0	Stage IIB	0	160			Not Available				68	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TR	d1703dbd-5c93-4cf2-a4d1-0d90640882bd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	8	-25190	160	0	Not Available	Not Available	Not Available	TCGA-AR-A0TR-D19370	1D3E42DF-081F-4DA4-927E-03701EF9B270	Not Available	12	160	25	Tamoxifen	Not Available	12	Not Available	20	mg/dL	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A0TR-F18771	C7428C57-68C1-4574-81BA-167AAA258024				12		Not Available	160	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy not specified	Other method, specify:	Equivocal	Negative	27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A0TR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2011	2006
TCGA-AR-A24L	FEMALE	2866	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1	M0	Stage IIB	1	1414.0		Locoregional Disease	Not Available				26	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24L	de646f6a-6d50-4be2-b3cd-f17554b234df	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	12	-9706	Not Applicable	0	2221	Not Available	Not Available	TCGA-AR-A24L-D31271;TCGA-AR-A24L-D31269;TCGA-AR-A24L-D31270;TCGA-AR-A24L-D31272	5B4FA9C9-DE69-4615-BE89-619E2F835DEA;F4B58638-1544-44FA-9E05-9CA0F74B8232;F6EC056E-4FA3-4E3B-890D-E3B8307E19B1;D11B2960-E58A-4BCC-B247-CD1E491660A2	Not Available;Not Available;Not Available;Not Available	26;26;26;26	Not Available;Not Available;Not Available;1414	Not Available;Not Available;Not Available;145	Paclitaxel;Doxorubicin;Cytoxan;Tamoxifen	Not Available;Not Available;Not Available;Not Available	4;4;4;4	4;4;4;Not Available	Not Available;Not Available;Not Available;20	Not Available;Not Available;Not Available;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2	Not Available;Not Available;Not Available;PO	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A24L-F31266;TCGA-AR-A24L-F49488	35D4250F-9553-4152-BC03-40C5E38F5A33;98A5DD07-6036-40E1-AE50-9958B67DE1EF				26;2		Not Available;None	Not Applicable;2866	2221;Not Available		1414;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;10	Not Available;None	Locoregional Disease;None	Not Available;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;1414	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;YES	Not Available;WITH TUMOR			Not Available;None			YES;YES		YES;YES	Alive;Dead	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	2	Not Available	No	A24L	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24L-R31268	FA585658-1B63-499E-B19C-2E464838C89F	1	26	275	243	Not Available	4	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-D8-A1JM	FEMALE	590	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	590			TUMOR FREE				59	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JM	3e775c99-ceda-4246-8d6f-0f58ca5097c8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	29	-21602	Not Applicable	0	238	Not Available	Not Available	TCGA-D8-A1JM-D20743	D067FC8D-6FF0-4230-B498-599F566005F6	Not Available	15	144	39	doxorubicine cyclophosphamide tamoxifen	Not Available	1	6	1200+120+20	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy;Hormone Therapy	Not Available	7200+720+20	mg/m2	Not Available	2012	manual counting	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JM-F20742	F44EA1FB-71B0-4586-9DA1-F4C78A24F0E4				15		Not Available	Not Applicable	590		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	DAKOHercepTest TM	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	No	A1JM	TUMOR FREE	manual counting	Not Available	Not Available	0%	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1JM-R20744	DC5F01FD-AD1B-448F-8D51-F62F280E4F7D	Not Available	15	196	171	Not Available	1	45	9000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A076	FEMALE	1642	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1642			TUMOR FREE				66	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A076	23dabeef-8e3c-44bc-9a12-a9522d17be5c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24230	Not Applicable	0	1642	Not Available	Not Available	TCGA-A8-A076-D37845	D9725F84-E2BD-4A29-8D96-2689DDF06EB0	n/a	6	Not Available	59	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A076-F40821	AF505FDD-767F-4C9C-8BB2-2C2EB76FC975				2			Not Applicable	1642																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A076	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2006
TCGA-A8-A09G	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N3a	M0	Stage IIIC	0	0			TUMOR FREE				79	Right Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A09G	3927f736-3b5c-48c8-9d9e-83669ec44770	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-29006	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-A7-A2KD	FEMALE	679	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	679			Not Available				53	Right	No axillary staging	Not Available	TCGA-A7-A2KD	92654F8D-5137-4FFD-AAA3-5AE38EB88226	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	11	-19563	Not Applicable	0	182	Not Available	Not Available	TCGA-A7-A2KD-D31129;TCGA-A7-A2KD-D31143;TCGA-A7-A2KD-D31144;TCGA-A7-A2KD-D32490	D27EB374-1499-4A17-9A6F-D6EF17DF32D0;A86965D9-33B4-40A5-B803-EBD8F3205AA3;037E9933-2221-4B0E-B8CA-1397B14B6523;A17F619D-81A6-4A7B-BEB1-20FA1C828843	Not Available;Not Available;Not Available;Not Available	24;24;24;30	97;161;161;435	57;57;118;57	Cytoxan;Taxotere;Carboplatin;Herceptin	Not Available;Not Available;Not Available;Complete Response	4;4;4;5	3;6;3;Not Available	1370;170;810;Not Available	mg;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;Not Available	IV;IV;IV;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	4110;1020;2430;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;NO	2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A2KD-F31123;TCGA-A7-A2KD-F39783	03DDE331-432A-47B9-9D76-DF24C97ECD3B;0D8A8821-9994-454A-BB39-BADC6341A20E				24;1		Not Available;None	Not Applicable;Not Applicable	391;679		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	8	0	Yes	A2KD	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	BLACK OR AFRICAN AMERICAN	Not Available	Regional site	TCGA-A7-A2KD-R31158	89DD7D0D-FD33-4ABE-AEBB-2355F247846D	1	24	235	196	Not Available	4	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2011
TCGA-A2-A1FZ	FEMALE	683	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	683			TUMOR FREE				63	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A1FZ	805bfe39-3695-43c2-93e4-d66d0559b89f	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	21	-23055	Not Applicable	0	410	Not Available	NO	TCGA-A2-A1FZ-D12285	453a2e9f-7e83-478a-a0f5-0aa01232d4fb	Not Available	27	Not Available	Not Available	Arimidex	Not Available	4	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A1FZ-F20803	6FB6D566-9B81-4637-9760-6071E917078B				9		Not Available	Not Applicable	683		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	0	No	A1FZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-S3-AA15	FEMALE	525	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a		Stage IIB	0	525			TUMOR FREE				51	Right;Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-S3-AA15	E783E518-C1E5-4EAC-8EAF-E2D65CCD9692	Not Available	Negative	Not Available	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	18	-18659	Not Applicable	0	209	Not Available	Not Available	TCGA-S3-AA15-D58380;TCGA-S3-AA15-D58381;TCGA-S3-AA15-D58382;TCGA-S3-AA15-D58383	0B7D016E-CC28-4274-BF66-92AC08BD4CCD;CD0DBE0D-1FF4-4A8C-A3EF-5397C30A382A;4ACE7463-6DB8-42D6-93B0-327859CD747E;B4C53B22-0A11-4216-A8A3-EE51B419C715	Not Available;Not Available;Not Available;Not Available	18;18;18;18	125;125;125;236	82;82;82;138	ADRIAMYCIN;CYTOXAN;NEULASTA;TAXOL	Complete Response;Complete Response;Complete Response;Complete Response	4;4;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Ancillary;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	CAP SCORING GUIDELINE 2010	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-S3-AA15-F67625;TCGA-S3-AA15-F70445;TCGA-S3-AA15-F72098	516DF8F3-0887-44F0-B851-A01356DE4536;0C3A9677-3AAE-427C-836E-B83B55F9497A;90913D52-D037-495E-ADB9-41512D877984				7;26;10			Not Applicable;Not Applicable;Not Applicable	421;509;525																				NO;NO;NO																						11;2;4					Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE						YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2014;2015;2015	FEMALE	Not Available	CAP SCORING GUIDELINE 2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	No	AA15	TUMOR FREE	CAP SCORING GUIDELINE 2010	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-S3-AA15-R67624	FE3E452E-46DC-46B1-9014-9F6A43D28C78	Not Available	7	359	286	Complete Response	11	57	114	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	cM0 (i+)	N1a	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013
TCGA-AR-A2LQ	FEMALE	1233	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	1233			Not Available				59	Right Upper Inner Quadrant;Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LQ	4229E432-6AC5-49D2-B58A-E8713DDB79BD	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	12	-21865	Not Applicable	0	516	Not Available	NO	TCGA-AR-A2LQ-D37597;TCGA-AR-A2LQ-D37598;TCGA-AR-A2LQ-D37599	D4763C71-C17E-46DB-A137-2B5B9908DEAE;28848860-0F93-4CE5-A7CA-7C85A90EBBC7;409752F6-5669-4168-8F31-54550EB34917	Not Available;Not Available;Not Available	6;6;6	152;152;Not Available	89;89;176	Docetaxel;Cytoxan;Anastrozole	Not Available;Not Available;Not Available	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LQ-F37558;TCGA-AR-A2LQ-F49500	4A4F9815-80A4-4954-A2E6-416F0316C65A;1ED84A46-2DBF-4319-A235-9D33D7DCE14F				6;2			Not Applicable;Not Applicable	895;1233																				NO;Not Available																						12;10					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	Not Available;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	Not Available	No	A2LQ	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LQ-R37595	BC8640F7-F340-4B7A-8B3E-7FD66D6DA282	Not Available	6	240	201	Not Available	12	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2012	2010
TCGA-C8-A135	FEMALE	393	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	393			TUMOR FREE				64	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A135	33cea538-4c3f-470a-972d-257c43241ab4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	15	-23667	Not Applicable	0	13	Not Available	NO	TCGA-C8-A135-D70818;TCGA-C8-A135-D70819;TCGA-C8-A135-D70820;TCGA-C8-A135-D70821	E75ED433-A561-43B5-B3E0-5F8E12B99B40;2930DEE3-D647-42B8-9950-5BB8905B9DA2;C5031114-238E-45D7-9918-30514B75F06A;CD8B26E1-2982-4CDF-ACD5-FE6293F7B193	Not Available;Not Available;Not Available;Not Available	9;9;9;9	51;51;51;51	40;40;40;40	5-Flourouracil;Doxorubicin;Cyclophosphamide;Taxol	Complete Response;Complete Response;Complete Response;Complete Response	3;3;3;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2015;2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A135-F19081;TCGA-C8-A135-F70817	2EB99E29-CFEC-47C3-AE81-9035B00BA8BA;2713E11E-2440-4519-9A50-B0E7F2C3B23E				2;9		Not Available;None	Not Applicable;Not Applicable	32;393		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A135	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A54Y	FEMALE	725	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	725			TUMOR FREE				63	Right	Axillary lymph node dissection alone	Not Available	TCGA-E9-A54Y	182C4BDF-2C58-4303-B034-459DA86B9D90	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-23057	Not Applicable	0	7	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A54Y-F51391;TCGA-E9-A54Y-F66450	AAE29C65-F5ED-4CC0-BF9C-810CADD3AC3E;70266A12-6442-418F-BE85-E9C3979F2CAB				23;15			Not Applicable;Not Applicable	384;725																				NO;NO																						1;10					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						NO;NO		NO;NO	Alive;Alive	2014;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	8	Not Available	No	A54Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	50-59%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012
TCGA-LL-A5YO	FEMALE	440	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	MX	Stage IA	0	440			TUMOR FREE				50	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A5YO	B8AEFC48-4A6E-4254-A57F-5F688399B582	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	8	-18354	Not Applicable	0	97	Not Available	Not Available	TCGA-LL-A5YO-D43017;TCGA-LL-A5YO-D43018	2796DB97-696B-4A10-94A8-0596D8A2F43E;9E63512F-49BD-4691-8C4D-920BA81A33D7	Not Available;Not Available	8;8	160;160	56;56	TAXOTERE;CYTOXAN	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A5YO-F58638	8D9AF5E1-0A39-49CE-9F74-CB0D3A1E192E				17			Not Applicable	440																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A5YO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-LL-A5YO-R58642	4B671EF3-EA8C-45F5-9CCC-C2189FB3DF30	Not Available	17	210	192	Complete Response	4	15	40/48	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1b	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-BH-A1ES	FEMALE	3462	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1a	M0	Stage IIB	0	3462			WITH TUMOR				35	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A1ES	51ccbf1b-7cae-44ba-991a-11eda8b8c404	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	6	-13138	3462	0	Not Available	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Available	4	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1ES	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-C8-A1HM	FEMALE	375	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	375			TUMOR FREE				74	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HM	8b525ec6-d24b-49d4-bfcb-b354de4dae7c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	2	-27063	Not Applicable	0	6	Not Available	NO	TCGA-C8-A1HM-D70807;TCGA-C8-A1HM-D70808;TCGA-C8-A1HM-D70809	276724DA-C121-44EA-8584-13AB426F8DDD;B2D0CDD7-747C-49EC-B329-F2427BA79DDB;F67F216B-625D-4CDE-B551-FEBD1B76FE0F	Not Available;Not Available;Not Available	9;9;9	49;49;49	26;26;26	Doxorubicin;Cyclophosphamide;Taxol	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A1HM-F19078;TCGA-C8-A1HM-F70806	C8F7334F-6542-49D1-95F5-9C41AB38E44D;6F012BB5-7730-453F-96B2-C41EEF03F8BC				2;9		Not Available;None	Not Applicable;Not Applicable	70;375		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	Not Available	Not Available	No	A1HM	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 5	Allred Score 8	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-LD-A7W5	FEMALE	216	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	1				WITH TUMOR				52	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-LD-A7W5	A06FF6AE-B0DD-4516-A75C-0DB71694B46B	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Evaluated	Positive	Lumpectomy	Not Applicable	NO	3	-19169	Not Applicable	0	124	Not Available	Not Available	TCGA-LD-A7W5-D56345;TCGA-LD-A7W5-D56346	71C98143-F9F6-4C6F-A7DD-168C6BC9E034;C0C80864-B5AF-43CC-9232-BC05B4141491	Not Available;Not Available	3;3	145;Not Available	82;82	Taxotere;Cytoxan	Stable Disease;Not Applicable	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LD-A7W5-F69184	32C744CB-6C00-4920-9077-111C970D52BA				30			Not Applicable	216																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	23	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	23	Not Available	No	A7W5	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	YES	NO	LD	Breast	Not Applicable	Alive	2014	2013
TCGA-D8-A1JC	FEMALE	480	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	480			TUMOR FREE				59	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JC	02e6f999-24f2-4ad2-9b92-df3ee2b082e5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	29	-21898	Not Applicable	0	178	Not Available	Not Available	TCGA-D8-A1JC-D20848;TCGA-D8-A1JC-D65319	04150296-7BAD-4DD4-8B28-C14FCB79BD22;FECB156F-3FF8-4A4B-B968-896FD0893868	Not Available;Not Available	19;22	87;87	24;24	adriamycin;cyclophosphamide	Not Available;Not Available	1;9	4;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	240;Not Available	mg;Not Available	Not Available;NO	2012;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JC-F20847	6E9DB5EF-A97B-4101-B6FB-344C19F675D5				19		Not Available	Not Applicable	480		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	No	A1JC	TUMOR FREE	Not Available	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1JC-R20849	A9A5EA39-2CEF-4A69-A4C6-E072C872237D	Not Available	19	147	122	Not Available	1	Not Available	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-5L-AAT0	FEMALE	1477	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1477			TUMOR FREE				42	Right;Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-5L-AAT0	86C6F993-327F-4525-9983-29C55625593A	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	15	-15393	Not Applicable	0	1477	Not Available	Not Available	TCGA-5L-AAT0-D63723	BCA5B47A-BE3A-4258-8A17-692D7DFDDF87	Not Available	15	Not Available	322	Tamoxifen	Not Applicable	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	70-79%	HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Negative	Not Evaluated	8	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	AAT0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	50-59%	WHITE	YES	Primary Tumor Field	TCGA-5L-AAT0-R63722	F11A131E-E0C5-4BCE-A06B-BFEB0058AEDD	Not Available	15	411	371	Unknown	8	25	5000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	5L	Breast	Not Applicable	Alive	2014	2010
TCGA-AR-A2LL	FEMALE	2012	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	2012			Not Available				70	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LL	70FC011C-0F22-4026-9D72-87351126203A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	14	-25747	Not Applicable	0	224	Not Available	NO	TCGA-AR-A2LL-D37272	8B4531C7-8D35-45BE-B28C-0497928B42F3	Not Available	6	224	54	Tamoxifen	Unknown	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LL-F35205;TCGA-AR-A2LL-F49493	7E870DEF-F459-4137-9815-ABFC98FF18DF;A680A628-61D7-4619-A459-87CA6BAEE1D1				6;2			Not Applicable;Not Applicable	1719;2012																				NO;Not Available																						12;10					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	Not Available;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	Yes	A2LL	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2012	2007
TCGA-D8-A1JH	FEMALE	426	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	426			TUMOR FREE				56	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JH	4d1bf9e6-5837-4aed-b568-92f014ed5a4b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	28	-20497	Not Applicable	0	284	Not Available	Not Available	TCGA-D8-A1JH-D14056	59F08533-A2E2-4306-8DF3-F18CCAA18F58	Not Available	18	Not Available	66	nolvadex	Not Available	7	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg/day	Not Available	2011	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JH-F14055	27D2C49E-FEBC-47D6-8410-8912F0CE7977				18		Not Available	Not Applicable	426		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A1JH	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1JH-R14057	DF81712D-81A3-4CE4-B1EB-FEA240FD3B8C	Not Available	18	105	81	Not Available	7	20	45	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A27W	FEMALE	373	Mucinous Carcinoma	Breast	Alive	T4b	N0	M0	Stage IIIB	0	373			TUMOR FREE				55	Right	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27W	bfa3dbc0-361c-400e-8c10-0aca7049fce9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-20173	Not Applicable	0	15	Not Available	NO	TCGA-D8-A27W-D30108;TCGA-D8-A27W-D30110	638ECF5D-30BB-4107-95B4-9347666BF398;7E602CDB-4F73-4338-B776-1E33AC8151D9	Not Available;Not Available	2;2	162;Not Available	56;226	doxorubicine+cyclophosphamide;Tamoxifen	Not Available;Not Available	4;4	6;Not Available	Not Available;20	mg;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;PO	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	mg;mg	Not Available;Not Available	2012;2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27W-F30107	12E2DB12-F8A5-49D9-A51C-012731462DE5				2		Not Available	Not Applicable	373		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Venten	Not Available	Path Vysion HER2 DNA Probe Kit	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Positive	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A27W	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A27W-R30109	4F59F468-DD4A-40AE-B63B-3DDEA2721CA1	Not Available	2	221	189	Not Available	4	25	5500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T4b	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-AO-A125	FEMALE	3456	Other, specify	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3456			TUMOR FREE				72	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A125	8577ffcb-242e-40e2-98d4-2831d952be34	Not Available	Positive	Not Available	4+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	7	-26466	Not Applicable	0	3019	Not Available	Not Available	TCGA-AO-A125-D5936;TCGA-AO-A125-D5935	aa4b5228-8d3d-41fc-8036-e1dd449ea175;3c07a95a-8689-4e1c-8302-8af9978b4c0d	Not Available;Not Available	10;10	2535;799	799;129	Aromasin (Exemestane);Tamoxifen	Not Available;Not Available	1;1	Not Available;Not Available	25;20	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	PO;PO	NO;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2011;2011	Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A125-F5874;TCGA-AO-A125-F19398	3C85C98F-2012-40C5-A235-01C28ED1A954;EB7A61A5-3724-4055-9588-907D177D46E0	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	3019;3456	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	>=2.0 Positive	0	Not Available	Not Available	Not Available	1.0	Not Available	Other, specify	Papillary Carcinoma	No	C50.9	8050/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Negative	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A125	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2002
TCGA-C8-A1HF	FEMALE	332	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	332			TUMOR FREE				48	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HF	a2453bcb-90f2-4505-949d-a89cf4bfc9b8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	24	Not Available	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A1HF-F19092	437A6D3E-663B-42B1-840D-510BF0CA88B9				2		Not Available	Not Applicable	332		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Positive	Not Evaluated	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A1HF	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 3	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AN-A0XW	FEMALE	170	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	170			Not Available				36	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AN-A0XW	39de7761-e762-4811-b95c-8216b79ae06b	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Not Available	Not Applicable	NO	29	-13208	Not Applicable	0	170	Not Available	NO																								dextran coated charcoal	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XW-F68963	038DA5D7-B5DC-4B04-9B85-82C2912AE73A				23			Not Applicable	170																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	60-69%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Negative	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A0XW	Not Available	dextran coated charcoal	Not Available	Not Available	240 H	240 H	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A2IU	FEMALE	5176	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	4224.0	Other, specify	New Primary Tumor	Not Available				62	Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A2IU	9857BE0C-AECA-4A43-90B1-0535BD08E086	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	11	-22905	Not Applicable	0	4840	Not Available	Not Available																								image cytometry	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-B6-A2IU-F38907	63102408-1829-4144-8CE6-018FA7240B97				3			Not Applicable	5176																				NO																						1					YES	YES	Not Available	4224	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Other, specify	New Primary Tumor	Lung	NO	Not Available	YES	WITH TUMOR						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	28	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	Not Available	No	A2IU	Not Available	image cytometry	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	1998
TCGA-AR-A5QN	FEMALE	1013	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	0	1013			TUMOR FREE				68	Left	Axillary lymph node dissection alone	Not Available	TCGA-AR-A5QN	077506EA-8F11-405D-BB8E-3C9924FE54D0	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	15	-25089	Not Applicable	0	396	Not Available	Not Available	TCGA-AR-A5QN-D43902;TCGA-AR-A5QN-D43903;TCGA-AR-A5QN-D43911;TCGA-AR-A5QN-D43912	1656A4E7-6208-4559-9005-FBD70C8A7375;DC1B5976-040D-4E03-A09E-78DA087AAD55;5153CC9B-8AD7-4DAA-8A6A-47C5B422CBBE;9033B921-AB35-4CBF-9362-256C58629822	Not Available;Not Available;Not Available;Not Available	10;10;10;10	102;102;388;Not Available	39;39;128;388	Taxotere;Cytoxan;Anastrozole;Exemestane	Not Available;Not Available;Not Available;Not Available	6;6;6;6	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A5QN-F43862;TCGA-AR-A5QN-F69265	45449D22-C8F2-4781-B1E8-8413EBCC5A80;1B86CEE2-9C01-4E9F-8083-A7E49604B86C				10;31			Not Applicable;Not Applicable	488;1013																				NO;NO																						6;12					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	19	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	10	Not Available	No	A5QN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-AR-A5QN-R43901	12842F15-A078-4D68-BFED-ED9D6FA40DD3	Not Available	10	173	136	Not Available	6	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2013	2012
TCGA-E2-A15T	FEMALE	1563	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1563			TUMOR FREE				65	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15T	e68ebfd4-3688-4caa-9e38-7764f9258c30	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	14	-24054	Not Applicable	0	267	Not Available	NO	TCGA-E2-A15T-D19143	A71ADC96-7255-4D33-ABC9-4883E48C7DB3	Not Available	17	Not Available	34	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A15T-F19142;TCGA-E2-A15T-F70019	5FADD77F-D2D8-4A50-86D0-50425E3A96C6;686DF890-B124-45EE-95DB-3848AB3F3B73				16;9		Not Available;None	Not Applicable;Not Applicable	456;1563		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15T	TUMOR FREE	Allred score 2+3 = 5	Not Available	Not Available	Allred score = 5	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A1AO	FEMALE	2618	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	2618			TUMOR FREE				47	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AO	623befd6-0ca4-4a6c-9cf5-d9385c3b718f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	13	-17332	Not Applicable	0	1325	Not Available	Not Available	TCGA-AR-A1AO-D21783;TCGA-AR-A1AO-D21776;TCGA-AR-A1AO-D21781;TCGA-AR-A1AO-D21782	FC942EEA-FF1B-4138-9AF0-ACAEB4587C88;3FAD143B-6FA0-4A68-BD62-F68CF5C5E212;6AEEDC5D-E064-4E5B-A0BD-E4026DE10F96;486A390E-63A5-40C5-871A-82F3EB768849	Not Available;Not Available;Not Available;Not Available	27;27;27;27	Not Available;118;118;139	160;76;76;139	Tamoxifen;Doxorubicin;Cytoxan;Paclitaxel	Not Available;Not Available;Not Available;Not Available	2;2;2;2	Not Available;4;4;1	20;60;600;175	mg/day;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;425;4250;310	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AO-F21756;TCGA-AR-A1AO-F69274	1C4B1995-A5EE-466D-99ED-A906B6376D1C;C5985991-91B3-4B10-BFF1-93DACCAD48F5				27;31		Not Available;None	Not Applicable;Not Applicable	1325;2618		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	39	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	Not Available	No	A1AO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AO-R21773	E8DA70B1-BB41-4DD0-B17B-EFDEC13F33EE	1	27	210	168	Not Available	2	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-A2-A0YD	FEMALE	769	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i+)	M0	Stage IIB	0	769			TUMOR FREE				63	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0YD	2c6adb12-380d-4710-a7e6-93d5a0e53289	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	8	-23021	Not Applicable	0	550	Not Available	Not Available	TCGA-A2-A0YD-D5674;TCGA-A2-A0YD-D5673;TCGA-A2-A0YD-D5675	678cae6d-29ae-4c7c-b9f8-72d3270dc402;39d13e05-d042-4915-a89b-eb9460b38f36;94197033-7886-421d-a619-88769cecaade	Not Available;Not Available;Not Available	8;8;8	136;136;Not Available	63;63;143	Cytoxan;Adriamycin;Arimidex	Not Available;Not Available;Not Available	12;12;12	4;4;Not Available	1100;110;1	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;3	IV;IV;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	4400;440;Not Available	mg;mg;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YD-F15770	D23505E4-45DA-42D1-808A-CA517E53553F				30		Not Available	Not Applicable	769		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified	Not Available	60	Not Available	Not Available	1.04	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	1	No	A0YD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80-89%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-A2-A0D3	FEMALE	1873	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1873			TUMOR FREE				42	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0D3	4a16429b-884f-4c95-8683-feeedf0d6a55	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	28	-15524	Not Applicable	0	736	Not Available	Not Available	TCGA-A2-A0D3-D7248;TCGA-A2-A0D3-D7252;TCGA-A2-A0D3-D7246;TCGA-A2-A0D3-D7254	4676c63b-5c36-433a-a19d-b77bd02a9747;490b634f-290f-4617-ab36-d0b91a1def75;8f0c0628-9dff-4a13-bd14-246b3416cee2;b8248a0e-7dbf-47a8-a4d5-83d530250db9	Not Available;Not Available;Not Available;Not Available	31;31;31;31	173;Not Available;173;196	69;195;69;69	Carboplatin;Tamoxifen;Docetaxel;Herceptin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	6;Not Available;6;19	768;10;142;2-460	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;3;1;4	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	4608;Not Available;852;2917	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0D3-F13715;TCGA-A2-A0D3-F59451	C5EF3C66-6096-4F1F-BF13-223A064C292D;A98415CB-B3AF-4EF9-A0C2-EE010FC9D9E6				9;13		Not Available;None	Not Applicable;Not Applicable	875;1873		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.41	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	0	No	A0D3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A28Q	FEMALE	1119	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1119			TUMOR FREE				46	Right	Not Available	Not Available	TCGA-BH-A28Q	32861b48-83f5-43a3-bb54-45215ad2c5d6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	29	-16882	Not Applicable	0	196	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A28Q-F64272	5B9A0C32-1B0D-45AA-BD92-C67CD68D5DD6				28			Not Applicable	1119																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Indeterminate	18	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A28Q	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A138	FEMALE	380	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	380			TUMOR FREE				54	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A138	b6c286c6-2755-419b-87d3-59c7feda9653	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	15	-20053	Not Applicable	0	7	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A138-F19085;TCGA-C8-A138-F71893	796DB5B0-AE4E-4BF6-BDBC-21E5E0EAD6B7;CA8159BD-20C6-4347-8D27-78773527103D				2;31		Not Available;None	Not Applicable;Not Applicable	124;380		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A138	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Allred Score 5	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A03V	FEMALE	1351	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	1351			TUMOR FREE				41	Left Upper Inner Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A03V	a6cb373a-1604-4e25-bd81-da6c3e4f06ee	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	9	-15284	Not Applicable	0	886	Not Available	Not Available	TCGA-AO-A03V-D6001;TCGA-AO-A03V-D5998;TCGA-AO-A03V-D6002;TCGA-AO-A03V-D6004;TCGA-AO-A03V-D5999	7a86ed9d-040d-497b-b401-e175e0ad5024;6b741be6-03f1-4acd-b9c2-4b38fa485a52;a7b71a1a-29a2-4ced-9a77-1b29bf37f48a;3d49c566-fdcb-4849-9312-d27620f772f4;54c7a76e-7409-4470-9021-6b209c2c9b7b	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	200;200;735;Not Available;200	102;102;200;753;102	Fluorouracil;Cyclophosphamide;Tamoxifen;Arimidex;Methotrexate	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	8;8;Not Available;Not Available;8	600;600;20;1;40	mg/m2;mg/m2;mg/day;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;2;1	IV;IV;PO;PO;IV	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	8800;8800;Not Available;Not Available;600	mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A03V-F5865;TCGA-AO-A03V-F20912	0B379E3A-D581-4E7E-87DB-950BA57BA1BE;DB9D76BF-ADFA-4518-ADEC-B8FE3E187699	Not Available;None	Not Available;None	Not Available;None	9;24	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	886;1351	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	1;1	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	3+ Positive	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	0	No	A03V	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80-89%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2008
TCGA-GM-A2DH	FEMALE	2193	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i+)	M0	Stage I	0	2193			TUMOR FREE				58	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DH	5700C1B3-922A-4401-8AB8-89028908D696	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	29	-21344	Not Applicable	0	1286	Not Available	NO	TCGA-GM-A2DH-D47082;TCGA-GM-A2DH-D47083;TCGA-GM-A2DH-D47084;TCGA-GM-A2DH-D47085	556C375B-CFAB-497E-AE7A-22BC00FC3826;BA77ECF0-0A86-4F8A-9268-57921470CEC6;5D627B00-9BA1-4D32-971B-CCE6AF02327A;4B6748E0-604F-422B-9752-189DFFF16BD8	Not Available;Not Available;Not Available;Not Available	22;22;22;22	163;233;233;233	86;170;170;170	Taxol;Fluorouracil;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.80					TCGA-GM-A2DH-F47081	42FCC169-41BB-48F3-BB58-86689559BD62				22			Not Applicable	2193																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	2.80	1.00	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	1	No	A2DH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2007
TCGA-GM-A3NW	FEMALE	3361	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3361			TUMOR FREE				63	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A3NW	6DDAEE34-46EB-490C-BD13-F0AB963C4322	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	3	-23041	Not Applicable	0	2982	Not Available	NO	TCGA-GM-A3NW-D40402;TCGA-GM-A3NW-D40399;TCGA-GM-A3NW-D40401;TCGA-GM-A3NW-D40400	94E98AC3-6333-4A5B-A854-BE225AD37D6F;5A6BEDB9-C5EB-404D-B70B-EA0253B4FC05;0C26CDE2-DE29-4331-B678-BF68B7E1F9F8;F06F057C-E684-4B61-92FE-F22B0EF9A3F4	Not Available;Not Available;Not Available;Not Available	18;18;19;19	2055;181;181;181	205;65;65;65	Arimidex;Fluorouracil;Cytoxan;Epirubicin	Stable Disease;Stable Disease;Stable Disease;Stable Disease	2;2;2;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	1.57					TCGA-GM-A3NW-F40398	8B23B0F0-7990-4F02-878A-3D61DF21DB52				18			Not Applicable	3361																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	30-39%	Not Available	1+	60	Not Available	1.80	1.15	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	0	No	A3NW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	20-29%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2012	2003
TCGA-D8-A27R	FEMALE	307	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	307			TUMOR FREE				41	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27R	0b23b5fe-6c7e-4297-bc55-f93fcb830ac4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-15122	Not Applicable	0	29	Not Available	NO	TCGA-D8-A27R-D29702	8D2A839B-9923-4EDA-9E50-5BDA071574E2	Not Available	28	218	57	adriamycin+cyclophosphamide	Not Available	3	4	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	240+2400	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	polisomy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available		TCGA-D8-A27R-F29700;TCGA-D8-A27R-F29701	6A541EC5-15E4-48FD-B3AA-B0EFBE8FDFDB;129D0E3E-3420-4E29-8434-91ECC7A3E6C3				28;28		Not Available;Not Available	Not Applicable;Not Applicable	307;Not Available		Not Applicable;Not Available				Scheduled Follow-up Submission;Scheduled Follow-up Submission							Not Available;Not Available			Not Available;Not Available					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	3;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Not Available																																		TUMOR FREE;Not Available			Not Available;Not Available			YES;Not Available		YES;Not Available	Alive;Not Available	2012;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	not amplified	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	11	Not Available	No	A27R	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A27R-R29703	9A1612A4-80AF-4413-B95B-768251E6704D	Not Available	28	262	237	Not Available	3	25	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A09N	FEMALE	31	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	31			TUMOR FREE				57	Right Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A09N	33919e92-4ea9-47e5-a6f4-36e51845d50f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-21002	Not Applicable	0	31	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09N	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2006
TCGA-AO-A12H	FEMALE	1234	Other, specify	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1234			TUMOR FREE				69	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A12H	b5b99291-507e-4b68-a039-9a0f571f55df	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	8	-25515	Not Applicable	0	863	Not Available	Not Available	TCGA-AO-A12H-D5983	6712f22e-0667-4a78-baed-2051f7f4f05a	Not Available	10	Not Available	73	Arimidex (Anastrozole)	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A12H-F5910;TCGA-AO-A12H-F19451	FCD6D02C-1D96-4158-B169-A5AAECD39B21;1F5D7F28-3872-40B5-BD20-1E1E6418630D	Not Available;None	Not Available;None	Not Available;None	8;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	863;1234	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	MUCINOUS & PAPILLARY	No	C50.9	8523/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A12H	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2008
TCGA-AC-A2QH	FEMALE	1005	Metaplastic Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	1005			TUMOR FREE				58	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A2QH	67C5F371-3FA9-47C5-8B15-C2DD9ACC8519	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	18	-21488	Not Applicable	0	31	Not Available	NO	TCGA-AC-A2QH-D64102;TCGA-AC-A2QH-D64103;TCGA-AC-A2QH-D64104	35EB8EC6-E1A8-4C43-9FF1-8743A658A8F9;5555AA7B-5597-4D92-BC2B-20E6EC3BB630;CFAD5F9E-8CC3-430E-A4BC-F6079D09BC84	Not Available;Not Available;Not Available	26;26;26	208;208;208	94;94;94	Cytoxan;Adriamycin;Aloxi	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2QH-F64100	91E76EF9-3B27-4249-8F36-04C648DEAA31				26			Not Applicable	1005																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A2QH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A2QH-R64101	731DA497-5254-41D5-A65B-F5F0222CE5A1	Not Available	26	305	246	Complete Response	8	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2011	2011
TCGA-D8-A27F	FEMALE	488	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	488			TUMOR FREE				40	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27F	1549dc64-3dab-43fc-96e9-b07d520957e1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	18	-14731	Not Applicable	0	106	Not Available	NO	TCGA-D8-A27F-D29516	623BDB83-F7A0-4C0E-8D45-D2C8A45913FF	Not Available	21	488	379	adriamycin+cyclophosphamide	Not Available	3	6	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	360+3600	mg	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27F-F29515	57370D31-378D-4228-9DAA-39A366A418B6				21		Not Available	Not Applicable	488		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	0	No	A27F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A27F-R29517	971EDB07-58FF-45DD-9E58-5B6F0310BF2A	Not Available	21	182	158	Not Available	3	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A4SF	FEMALE	545	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	545			TUMOR FREE				54	Right	Sentinel node biopsy alone	Not Available	TCGA-A7-A4SF	D81594D9-DD6A-45C3-8BAD-61960611D78D	Positive	Positive	3 Point Scale	Not Available	Not Available	Other	Negative	Lumpectomy	Right Breast Reexcision	YES	25	-19985	Not Applicable	0	369	Not Available	Not Available	TCGA-A7-A4SF-D40583;TCGA-A7-A4SF-D40584;TCGA-A7-A4SF-D40585;TCGA-A7-A4SF-D40586	308EA6ED-2B83-4B5B-95E0-CBDEF48D7909;68535884-BA16-4956-99F0-FB17F5DE630D;1A67FA24-FD67-47D8-A0B6-75D33DABFB3A;0F0BE62E-9086-4B0B-9D8A-0D6DE8B921E5	Not Available;Not Available;Not Available;Not Available	25;25;25;25	202;202;453;Not Available	89;89;89;306	Carboplatin;Docetaxel;Trastuzumab;Anastrozole	Complete Response;Complete Response;Complete Response;Not Applicable	2;2;2;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A4SF-F49721	FBC837B9-2100-498A-9BB9-BAEFE1F2EEB5				9			Not Applicable	545																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4SF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-A7-A4SF-R40587	305434B5-E683-4AEB-AA5E-B6BF6E111BA7	Not Available	25	279	232	Complete Response	2	33	6100	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-E2-A14S	FEMALE	1009	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1009			TUMOR FREE				65	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A14S	c2b104ee-f914-4e79-9e1b-56bf88157472	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	6	-23878	Not Applicable	0	834	Not Available	NO	TCGA-E2-A14S-D18836;TCGA-E2-A14S-D18832;TCGA-E2-A14S-D18834	37A94E43-59E6-49FE-BC0D-AB11CA6B3130;DFE33AFA-BE0A-47EB-AA3E-07745099111C;3CD785FB-FFD4-4BC9-8B61-5CDF4C3205F4	Not Available;Not Available;Not Available	3;3;3	Not Available;119;119	147;50;50	Aromasin;Cytoxan;Taxotere	Not Available;Not Available;Not Available	11;11;11	Not Available;4;4	25;1182;148	mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	25;4728;592	mg/day;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14S-F18831	BA1A9FEA-BC27-4CF3-95A9-65E53B46B582				3		Not Available	Not Applicable	1009		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.04	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14S	TUMOR FREE	Allred score 4+3 = 7	Not Available	Not Available	Allred score = 7	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A14S-R18837	4A373E26-3FEB-48D8-B451-FAD04381BE4F	1	3	212	160	Not Available	11	34	6280	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-D8-A27G	FEMALE	409	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	409			TUMOR FREE				75	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27G	6f6e7356-3521-4674-8eec-ad01340d4b8e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-27521	Not Applicable	0	210	Not Available	NO																								manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27G-F29519	370A2AC1-5396-4903-BD8B-07F1F32B4725				21		Not Available	Not Applicable	409		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	not amplified	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	31	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	0	No	A27G	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-LL-A441	FEMALE	996	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	996			TUMOR FREE				62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-LL-A441	69FC24FC-CFE2-487A-935F-1A954B30B709	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	5	-22772	Not Applicable	0	91	Not Available	Not Available	TCGA-LL-A441-D36591;TCGA-LL-A441-D36592	26759221-D07C-4BDA-BBB6-36A76DE3EDA6;EAC2A2A2-E81E-4A91-A483-5055C21238F3	Not Available;Not Available	5;5	133;133	61;61	Taxotere;Cytoxan	Complete Response;Complete Response	11;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A441-F46386	942378CA-13DA-43CB-9FE1-A95010C3B668				7			Not Applicable	996																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A441	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-LL-A441-R46385	62DCBDEC-4D8A-446D-B28A-643F6BB679F7	Not Available	7	216	153	Complete Response	8	33	6600	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2012	2012
TCGA-E2-A1LG	FEMALE	1523	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1523			TUMOR FREE				50	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A1LG	ef4cbd38-bc79-4d60-a715-647edd2ebe9e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	3	-18492	Not Applicable	0	350	Not Available	NO	TCGA-E2-A1LG-D20670;TCGA-E2-A1LG-D20672;TCGA-E2-A1LG-D20669;TCGA-E2-A1LG-D20676	DF10E7FA-8490-438B-9DCA-DD142DC33D12;166CD47F-16CF-45F5-8581-239149E00AD1;488371CC-2C95-4257-B1B6-36AB27305123;9B0E366A-08A8-40E8-A5C4-5C424DAE717E	Not Available;Not Available;Not Available;Not Available	17;17;17;17	112;203;112;179	70;126;70;70	Doxorubicin;Paclitaxel;Cyclophosphamide;Bevacizumab or Placebo	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;10;4;4	121;162;1212;880	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Phase III clinical trial	484;1554;4848;8860	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1LG-F20667;TCGA-E2-A1LG-F70390	0CC64B15-C83B-4BF7-A4C0-A7F03654D49E;F8B62F0A-6F64-498B-826E-51156ED65F81				17;16		Not Available;None	Not Applicable;Not Applicable	574;1523		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	60-69%	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	19	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	Yes	A1LG	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0DT	FEMALE	2403	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	2403			TUMOR FREE				41	Right	Not Available	Not Available	TCGA-BH-A0DT	74f31744-0aed-4633-beec-4e203315f0b7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	11	-15078	Not Applicable	0	1170	Not Available	NO	TCGA-BH-A0DT-D59150;TCGA-BH-A0DT-D59151;TCGA-BH-A0DT-D59152	3624978D-3FC4-4B29-A10C-B30306A0483B;C4190558-6F95-4A8A-9E8D-218E6E89D189;0F068054-E971-4558-AD6A-D6CD1FB72167	Not Available;Not Available;Not Available	1;1;1	287;287;287	118;118;118	Taxotere;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-BH-A0DT-F59149	547CCD51-6C97-4C0B-9A88-08154FBB4C87				1			Not Applicable	2403																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	Not Available	No	A0DT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Total mastectomy with sentinel lymoh node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-AN-A0FF	FEMALE	172	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	M0	Stage IA	0	172			TUMOR FREE				32	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FF	d5cab7f5-e4f1-40ee-a0c8-4c8004c1c9a0	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	27	-11929	Not Applicable	0	172	Not Available	Not Available																								dextran coated charcoal	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FF-F68943	9B3D0EEE-F464-4E46-B81D-A11ED9A05517				23			Not Applicable	172																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FF	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T1b	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-A2-A4S3	FEMALE	666	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	666			TUMOR FREE				59	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A4S3	418C11E8-2670-48D5-BBF5-95B46BFF1201	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-21762	Not Applicable	0	104	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A4S3-F59128	06C49930-B182-44EA-8B71-8FCF2306DD46				1			Not Applicable	666																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	No	A4S3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	90-99%	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2013	2012
TCGA-A2-A1G1	FEMALE	584	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	584			TUMOR FREE				85	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A1G1	75b5529b-565a-4eba-918a-910b2f441d32	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	12	-31223	Not Applicable	0	371	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	51	Not Available	Not Available	Not Available		TCGA-A2-A1G1-F20808	BF8ABE0A-8961-4EC0-9687-21F465824BF8				12		Not Available	Not Applicable	584		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	30	Not Available	816	16.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A1G1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A1G1-R11798	b0a03ce9-a77f-43d8-8c34-8f37099e4531	1	12	143	92	Not Available	5	28	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A1BD	FEMALE	1133	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1133			TUMOR FREE				53	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1BD	0e1d0d46-7a7b-4538-95dd-b9fc20a15aec	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	25	-19627	Not Applicable	0	317	Not Available	NO	TCGA-E2-A1BD-D19445	2534A6C5-8DD5-454D-8887-6098E2B7CBB1	Not Available	9	Not Available	170	Arimidex	Not Available	12	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1BD-F19439;TCGA-E2-A1BD-F70021	BC31751C-7DEF-4DDF-A6D3-FD1E906BAB71;C93AB29A-00FC-49AC-89DC-AC44ED0A1F59				9;9		Not Available;None	Not Applicable;Not Applicable	520;1133		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1BD	TUMOR FREE	Allred score 5+3 = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1BD-R19442	9FC62023-6140-4514-B9DE-74BCC48157A0	1	9	108	55	Not Available	12	Not Available	6600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A12O	FEMALE	385	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	385			TUMOR FREE				50	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12O	83f26720-007c-42c9-a7de-7484bf8afa89	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	13	-18506	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12O-F20261	0FF852B6-07CA-4E22-8B58-A6EC5D9BC503				9		Not Available	Not Applicable	385		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12O	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 7	Allred Score 7	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A083	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	0			TUMOR FREE				67	Left	Not Available	Not Available	TCGA-A8-A083	afb9418e-91eb-4db1-aacf-12bd946c9ba0	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24746	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A083	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A1IG	FEMALE	2140	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	M0	Stage IIB	0	2140			TUMOR FREE				45	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IG	bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	28	-16757	Not Applicable	0	755	Not Available	NO	TCGA-E2-A1IG-D19935;TCGA-E2-A1IG-D19936;TCGA-E2-A1IG-D19933;TCGA-E2-A1IG-D19934;TCGA-E2-A1IG-D70393	35DF36F9-799F-4E34-98BB-453D807A55AF;83E712C3-ABC5-4875-A5A1-4AEBEA1D27BA;521E6E77-C1C4-4361-8566-1E7AE45D7CC4;3DAFFE53-CA87-4B06-A70E-1F55782E3964;86F3FAA8-97CD-4A7E-B217-21DCAB6419BA	Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;16	150;Not Available;94;94;Not Available	108;234;52;52;1991	Paclitaxel;Tamoxifen;Cyclophosphamide;Doxorubicin;Letrozole	Not Available;Not Available;Not Available;Not Available;Not Applicable	12;12;12;12;3	4;Not Available;4;4;Not Available	290;20;990;99;Not Available	mg;mg/day;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;3;1;1;Not Available	IV;PO;IV;IV;Not Available	NO;YES;NO;NO;YES	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	1160;20;3960;396;Not Available	mg;mg/day;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;NO	2011;2011;2011;2011;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1IG-F19932;TCGA-E2-A1IG-F70394	47ADEC2D-3377-4579-9805-CD96D949C94D;F362DE95-E046-4400-8D1C-27C92BCA588A				21;16		Not Available;None	Not Applicable;Not Applicable	997;2140		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A1IG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A1IG-R19937	4215BF0B-2E69-49EA-8801-5539FE4BC44D	1	21	222	178	Not Available	12	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-LL-A73Y	FEMALE	477	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	477			TUMOR FREE				67	Right;Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A73Y	EA645243-DF49-4466-A255-9F3D4321E357	Not Available	Negative	3 Point Scale	3+	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	12	-24647	Not Applicable	0	126	Not Available	Not Available	TCGA-LL-A73Y-D51201;TCGA-LL-A73Y-D51202	F696F179-D694-412F-9044-A859E9371783;E1AF783B-A8A8-4502-92CE-C221FF5DE1BD	Not Available;Not Available	12;12	126;126	42;42	taxotere;cytoxan	Unknown;Unknown	11;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A73Y-F67099	E9959843-2F90-4BF2-B36D-9C4F8836A0E1				30			Not Applicable	477																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A73Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-AC-A5XU	FEMALE	455	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0 (i-)	MX	Stage IIB	0	455			TUMOR FREE				74	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A5XU	97677FD7-8523-48C5-A8CE-614FD4010551	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Unknown	15	-27191	Not Applicable	0	9	Not Available	Not Available	TCGA-AC-A5XU-D60183	C044891E-2E52-4DC9-BA16-4CA6D345F0D6	Not Available	31	Not Available	235	Letrozole	Not Applicable	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A5XU-F60181	8F4EF134-A173-4B96-BCBC-EE7249039A4E				31			Not Applicable	455																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5XU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	60-69%	BLACK OR AFRICAN AMERICAN	Unknown	Primary Tumor Field	TCGA-AC-A5XU-R60182	1C1F9080-ED1B-4E9E-8B1F-3B8BA8E5F3FC	Not Available	31	199	156	Complete Response	5	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2013
TCGA-AR-A0U1	FEMALE	4052	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	4052			Not Available				36	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0U1	17d9e646-6ab3-40b3-a0bc-2c834d3c3213	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Other	Not Applicable	NO	28	-13467	Not Applicable	0	2134	Not Available	Not Available	TCGA-AR-A0U1-D19569;TCGA-AR-A0U1-D19568;TCGA-AR-A0U1-D19567	257BEE3C-93D1-422F-8D83-C9A0D7BF86AD;449863BE-C8F7-4FFC-BF24-F45FC0017C16;128732AA-7BD1-4411-94E4-8EE57ED82476	Not Available;Not Available;Not Available	15;15;15	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Paclitaxel;Cytoxan;Doxorubicin	Not Available;Not Available;Not Available	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0U1-F18522;TCGA-AR-A0U1-F49477;TCGA-AR-A0U1-F71729	93833C57-FF00-4C8F-A42B-E8955E57E2DF;E66A8970-F7F3-4E60-BDA5-3E9DC9624B3A;055E3024-866F-4E2A-BA13-31E14C4DEC7F				15;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	2134;3101;4052		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Available	31	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	Not Available	No	A0U1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A0U1-R18523	2FB31685-A717-4F66-94C3-D496AC6DD159	1	15	200	152	Not Available	12	33	6080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2004
TCGA-A8-A08C	FEMALE	881	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	881			TUMOR FREE				65	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A08C	78e1da41-127c-4e9c-aaaa-77a0d94c31d0	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24017	Not Applicable	0	608	Not Available	Not Available	TCGA-A8-A08C-D37815;TCGA-A8-A08C-D37816;TCGA-A8-A08C-D37817;TCGA-A8-A08C-D37818	316BC7DA-9F45-49F7-92C4-16831B2B6BE7;DE7131F0-268C-4FA4-B008-01D742EDF242;FE9DA209-FD04-42A5-B165-8596370AC78C;12320A9F-0C0D-402C-92BD-95A4C989BA15	n/a;n/a;n/a;n/a	6;6;6;6	151;151;151;Not Available	31;31;31;243	5-Fluorouracil;Epirubicin;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08C-F40842	EE8A8BCF-C75E-4E24-9DA3-1CD8DFA9B713				2			Not Applicable	881																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08C	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08C-R38170	0D8A37D3-AE94-4C70-8872-27E4BDAFA181	Not Available	11	243	182	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A0TY	FEMALE	1699	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	1	544.0	Bone	Distant Metastasis	Not Available				54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TY	da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	10	-19836	1699	0	Not Available	Not Available	Not Available	TCGA-AR-A0TY-D19589;TCGA-AR-A0TY-D19590;TCGA-AR-A0TY-D19587;TCGA-AR-A0TY-D19588	8AF1AE1C-AC88-42CF-85CB-59C890EFBCA7;67BBC709-F34C-473D-AFB4-E8E35852ED65;035DEB95-23A9-4215-B3F4-9D2A08D941C9;B06C690B-5D84-4092-8606-77F7AC010E76	Not Available;Not Available;Not Available;Not Available	15;15;15;15	Not Available;557;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Paclitaxel;Anastrozole;Doxorubicin;Cytoxan	Not Available;Not Available;Not Available;Not Available	12;12;12;12	4;Not Available;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A0TY-F18561	78C812FE-1E96-434A-AA4B-15BF524153A4				15		Not Available	1699	Not Available		544				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Bone	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1+	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0TY	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2011	2004
TCGA-AR-A1AJ	FEMALE	2383	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	2383			TUMOR FREE				83	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AJ	23e7a78a-1d56-4ad1-9bb4-72ec0178aff2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	13	-30489	Not Applicable	0	1605	Not Available	Not Available																								Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AJ-F21724;TCGA-AR-A1AJ-F69269	3F140F1F-D69C-4523-BA2A-97FEBAC37EAC;E2C23026-41E4-4841-8697-7CCCD8C1E45B				27;31		Not Available;None	Not Applicable;Not Applicable	1605;2383		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;NO		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AJ-R21731	77F74A3C-E216-4E1F-B44D-0012EB147360	1	27	79	47	Not Available	2	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-OL-A66J	FEMALE	1996	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	MX	Stage I	0	1996			TUMOR FREE				80	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A66J	96E1FC6D-693F-4F4F-B5F7-8D6E1C6C43F8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Unknown	11	-29345	Not Applicable	0	1658	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A66J-F58495	D190CA5D-31E1-4E9F-A6DF-042F0D7D982E				11			Not Applicable	1996																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.50	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A66J	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	50-59%	WHITE	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2008
TCGA-D8-A27T	FEMALE	398	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	398			TUMOR FREE				53	Right Upper Outer Quadrant;Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-D8-A27T	27c1c094-690b-4973-8900-a797ad88f98c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	21	-19591	Not Applicable	0	136	Not Available	NO	TCGA-D8-A27T-D30097;TCGA-D8-A27T-D30098	2BC3A132-221D-403F-9E82-697C8B87ADFD;8592A3D1-BE31-4706-AC39-9C5D149F0914	Not Available;Not Available	2;2	Not Available;220	227;115	Tamoxifen;doxorubicine+cyclophosphamide	Not Available;Not Available	4;4	Not Available;6	20;101.4+1014	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	PO;IV	YES;NO	Hormone Therapy;Chemotherapy	Not Available;Not Available	Not Available;405.6+4056	mg;mg	Not Available;Not Available	2012;2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27T-F30096	2B56379D-571E-4B7B-B40D-9720573C8983				2		Not Available	Not Applicable	398		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Venten	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	12	Not Available	No	A27T	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A27T-R30099	FA4577E5-E322-4AEF-9C38-1D265D740A86	Not Available	2	301	272	Not Available	4	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-AR-A1AH	FEMALE	3807	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	1	1136.0	Other, specify	New Primary Tumor	TUMOR FREE				51	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AR-A1AH	a6e11b30-3ae8-4dd1-b04c-a730c6a79746	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	13	-18991	Not Applicable	0	2298	Not Available	Not Available	TCGA-AR-A1AH-D21706;TCGA-AR-A1AH-D21712	E17CEAC2-757D-453F-824F-D3835792B356;37BF063D-A8DE-410C-991D-B2FD6B00EA10	Not Available;Not Available	27;27	Not Available;2241	Not Available;Not Available	Not Available;Tamoxifen	Not Available;Not Available	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;PO	NO;NO	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AH-F21695;TCGA-AR-A1AH-F69267	4CD580BF-CBB7-45CB-A465-E287DDD6E4AA;39F31D97-DBEF-45B5-BF5A-73B8859724B9				27;31		Not Available;None	Not Applicable;Not Applicable	2298;3807		1136;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;12	Other, specify;None	New Primary Tumor;None	Renal;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1AH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Total Mastectomy	NO	YES	AR	Breast	Not Applicable	Alive	2011	2004
TCGA-C8-A12X	FEMALE	385	Mucinous Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	385			TUMOR FREE				62	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12X	65cde5d5-1efc-4e30-b1bd-a93598794f2c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	13	-22889	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12X-F19102	72134208-F31F-470B-845A-66954265B46D				2		Not Available	Not Applicable	385		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12X	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 7	Allred Score 8	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A18J	FEMALE	612	Infiltrating Ductal Carcinoma	Breast	Dead	T4b	N2	M1	Stage IV	0	612			WITH TUMOR				56	Right	Not Available	Not Available	TCGA-BH-A18J	cc074b7f-d3b2-4880-902e-bf10e667b665	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	8	-20678	612	0	Not Available	Not Available	YES																								Not Available	40-49%	NOT HISPANIC OR LATINO	Bone	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A18J	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30-39%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M1	N2	T4b	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2000
TCGA-AC-A2BK	FEMALE	2222	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	2222			TUMOR FREE				78	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A2BK	6FA2A667-9C36-4526-8A58-1975E863A806	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	16	-28625	Not Applicable	0	1172	Not Available	NO	TCGA-AC-A2BK-D43988;TCGA-AC-A2BK-D43990;TCGA-AC-A2BK-D43991;TCGA-AC-A2BK-D43992	9DE66FB7-BCEC-4B84-B97E-1A9F68D8E87A;1502DE28-84D8-4351-BCEE-9661DACD2B21;4869DCB0-723E-46A0-AB90-3D5FF038203A;8283B14A-D235-4D20-B272-9B4A8A095886	Not Available;Not Available;Not Available;Not Available	10;10;10;10	136;136;164;164	73;73;149;149	Cytoxan;Adriamycin;Taxol;Avastin	Complete Response;Complete Response;Complete Response;Complete Response	6;6;6;6	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-AC-A2BK-F43987	256CE2CD-BE4C-49CD-8395-1A4991708D69				10			Not Applicable	2222																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	6	Not Available	No	A2BK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-AC-A2BK-R43989	5F23873B-7D5F-43C9-86F1-820C26351615	Not Available	10	254	203	Complete Response	6	25	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2006
TCGA-E9-A1R3	FEMALE	78	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	0	78			TUMOR FREE				70	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1R3	4922cddc-575c-4b8a-8245-ce5f6876760c	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	28	-25693	Not Applicable	0	64	Not Available	NO	TCGA-E9-A1R3-D30823;TCGA-E9-A1R3-D30824;TCGA-E9-A1R3-D30826;TCGA-E9-A1R3-D30822	42526DF7-F5F2-4212-80D8-73443892CEB6;57C90782-1DBC-41F4-8674-D1FB85B98542;63FBD160-E49D-4A37-ADC7-7BF300319F6A;8AAB711A-821D-49F2-97B5-DB26D061A35B	Not Available;Not Available;Not Available;Not Available	17;17;17;17	50;50;Not Available;50	41;41;45;41	Methotrexate;Cyclophosphamide;Tamoxifen;5-Fluorouracil	Not Available;Not Available;Not Available;Not Available	4;4;4;4	1;1;Not Available;1	100;2000;20;2000	mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	100;2000;Not Available;2000	mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1R3-F30820;TCGA-E9-A1R3-F48697	441B7AE0-63A1-4A1B-9FF4-89DB394CF0DE;CC3C4599-3B2A-41F5-B233-DDCD72DFC819				17;19		Not Available;None	Not Applicable;Not Applicable	78;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;9	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		YES;Not Available	Alive;Not Available	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	10	Not Available	No	A1R3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1R3-R30827	BF0CBEB8-1696-468C-B183-5EE4D72E45AC	1	17	78	55	Not Available	4	Not Available	37400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2010
TCGA-GM-A2DA	FEMALE	6593	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	1	3014.0	Bone	Distant Metastasis	WITH TUMOR				46	Right Upper Inner Quadrant;Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-GM-A2DA	C07B122E-AC50-4DB2-ADD2-5617A5D0E976	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-16854	Not Applicable	0	5909	Not Available	YES	TCGA-GM-A2DA-D47211;TCGA-GM-A2DA-D47213;TCGA-GM-A2DA-D47214;TCGA-GM-A2DA-D47215;TCGA-GM-A2DA-D47217;TCGA-GM-A2DA-D47219;TCGA-GM-A2DA-D47220;TCGA-GM-A2DA-D47221;TCGA-GM-A2DA-D47222;TCGA-GM-A2DA-D47223;TCGA-GM-A2DA-D47224;TCGA-GM-A2DA-D47225;TCGA-GM-A2DA-D47228;TCGA-GM-A2DA-D47229;TCGA-GM-A2DA-D47230;TCGA-GM-A2DA-D47231;TCGA-GM-A2DA-D47232;TCGA-GM-A2DA-D47234;TCGA-GM-A2DA-D47236;TCGA-GM-A2DA-D47237;TCGA-GM-A2DA-D47238;TCGA-GM-A2DA-D47240;TCGA-GM-A2DA-D47241	1CE4C77C-03D8-4A3E-9B4E-17A37FEBF574;9DBAC4E4-29D1-4620-BB0E-E85862C78A16;FBF6B10E-F9FA-412E-8317-7BC12FDECECD;A308134D-A87B-4D38-A1B5-AD5A5BACFF22;F1691109-2DFB-4D93-B667-029E43AFA481;FDBDD508-2625-4646-B410-82178F238FB5;A9D3732A-4B83-435F-AFE7-98604C52FEAF;E6B44B72-350F-4D39-ACA6-4751D537EC29;34A11D07-D395-44A8-B0FA-B6785948D3FE;B90F3A89-5CDC-406E-B9B8-C850C6C5DD76;66BF0675-E5AC-453D-B319-3E0DCE3C4C2A;D8B2FED7-8269-47D8-90DC-E1A16E08E05F;A7B8633B-19CD-4008-887D-77BE720AF867;E41E7973-FE0F-4D97-A8DB-69BFE8B0D08C;F503B87E-A4F9-4FA8-9508-93B7658C1FDA;B9F6747C-A8E8-4DFF-B2FF-6378094F03E1;3411631A-3C34-4A06-A5E7-DB6F0E49CA25;BAE1A1F1-6EDC-4E7E-BA5E-632C9F3E6AA9;28B70E98-675A-4649-A171-1CCC398CFB9F;D2F15985-953A-4B07-B205-27967C46571D;89719FBA-E180-4F48-AE3B-75CBFB127146;4CDD3F8E-EFF0-49C7-972E-40AE2CAB2B7A;EEBDC3B3-BCF1-4629-9C08-8129305599B7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23;23	147;147;147;276;276;3131;3131;3415;4307;4435;4494;4494;4720;5015;5455;5678;5797;6028;6029;6213;6536;6422;6536	74;74;74;203;203;3061;3061;3141;3434;4347;4470;4470;4515;4721;5021;5455;5684;5797;5909;6051;6051;6372;6372	fluorouracil;Adriamycin;Cytoxan;Methotrexate;Vinblastine;Tamoxifen;Aromasin;Taxotere;Letrozole;Megace;Xeloda;Yondelis;Xeloda;Aromasin;Xeloda;Abraxane;Ixabepilone;Herceptin;Tamoxifen;Xeloda;Lapatinib;Navelbine;Herceptin	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Stable Disease;Stable Disease;Stable Disease;Stable Disease;Clinical Progressive Disease;Stable Disease;Clinical Progressive Disease;Stable Disease;Stable Disease;Clinical Progressive Disease;Stable Disease	8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;YES;YES;NO;NO;NO;YES;YES;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	3.70					TCGA-GM-A2DA-F47040	1FE24E96-5D31-480A-9AA9-C2702EE3ABAF				21			6593	Not Available																				NO																						8					YES;YES;NO;NO	YES;NO;NO;YES	Not Available;6359;Not Available;Not Available	3014;4343;6535;6536	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Bone;Liver;Other, specify;Brain	Distant Metastasis;Distant Metastasis;Distant Metastasis;Distant Metastasis	Not Available;Not Available;Intrathoracic Lymph Node;Not Available	NO;YES;NO;NO	Not Available;Not Available;Not Available;Not Available	YES	WITH TUMOR						YES		YES	Dead	2013	FEMALE	Not Available	Not Available	90-99%	Not Available	2+	60	Not Available	15	4.05	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Positive	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	0	No	A2DA	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	50-59%	WHITE	Not Available	Primary Tumor Field;Distant Recurrence;Distant Recurrence;Distant Recurrence	TCGA-GM-A2DA-R47042;TCGA-GM-A2DA-R47203;TCGA-GM-A2DA-R47204;TCGA-GM-A2DA-R47205	E29E83F2-FD9A-4339-A928-6DACBFBF05BD;1F70E01D-1936-4BA1-A6E6-C6BFB3BECB50;B67CB273-F63A-44AD-B63E-1CCFBAD5DD10;0E0EB0C4-1A13-47AF-BBA6-45B73E378A4E	Not Available;Not Available;Not Available;Not Available	21;23;23;23	326;5111;6052;6552	284;5098;6048;6538	Complete Response;Stable Disease;Stable Disease;Stable Disease	8;8;8;8	Not Available;10;5;10	Not Available;30;20;30	NO;NO;NO;NO	External;External;External;External	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Gy;Gy;Gy	2013;2013;2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	1993
TCGA-OK-A5Q2	FEMALE	64	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage II	0	64			Unknown				59	Right	Axillary lymph node dissection alone	Not Available	TCGA-OK-A5Q2	CD7FB75E-1C2E-4201-86D3-B3BA21F476BF	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	22	-21555	Not Applicable	0	64	Not Available	Not Available																								Not Available	90-99%	Not Evaluated	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Not Available	Negative	Not Evaluated	13	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	2	No	A5Q2	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	20-29%	Not Evaluated	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	OK	Breast	Not Applicable	Alive	2013	2012
TCGA-AR-A0U0	FEMALE	1988	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1988			Not Available				73	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0U0	e3c336f5-c32f-4c5d-81fb-e2408ae145b2	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	7	-26993	Not Applicable	0	8	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A0U0-F18526;TCGA-AR-A0U0-F65068	6EC1894A-DB87-4B55-844F-3FE18EC1F09D;795958AD-2E03-4480-B9E3-2EDF04451128				16;18		Not Available;None	Not Applicable;Not Applicable	1988;1988		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;9	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			Not Available;Unknown		YES;YES	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	2	No	A0U0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-AR-A0U0-R19618	DBAB51CF-D502-4C13-9478-26E924967804	1	16	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2004
TCGA-OL-A5RX	FEMALE	878	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	878			TUMOR FREE				51	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A5RX	43C0BEC6-6FAC-47B1-83CB-200A15A932BE	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Unknown	16	-18942	Not Applicable	0	513	Not Available	Not Available																								Not Available	90-99%	Unknown	Not Available	Not Available	Not Available					TCGA-OL-A5RX-F56570	135BBA94-947F-4E8D-88E1-06FFE7C587EC				14			Not Applicable	878																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A5RX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	90-99%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2011
TCGA-E2-A15M	FEMALE	336	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	336			TUMOR FREE				66	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15M	59be60a3-e0f6-4d63-b98c-574ef92428c4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	14	-24266	Not Applicable	0	235	Not Available	NO	TCGA-E2-A15M-D18853	6085AD44-E291-473A-9D84-846B9D83A6A7	Not Available	15	Not Available	202	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15M-F18852	65D32D89-B105-414F-A57D-98CFB36F9863				15		Not Available	336	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15M	TUMOR FREE	Not Available	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A15M-R18855	85069D51-475A-4210-8DA5-3C2AF8E51324	1	15	211	140	Not Available	11	Not Available	6600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A0JJ	FEMALE	1887	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1887			TUMOR FREE				54	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JJ	bef7b135-a727-45e8-850a-cc4cd56c49aa	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-19758	Not Applicable	0	1512	Not Available	Not Available	TCGA-AO-A0JJ-D2972;TCGA-AO-A0JJ-D2968;TCGA-AO-A0JJ-D2974;TCGA-AO-A0JJ-D2969;TCGA-AO-A0JJ-D2971	d0f2f580-2076-4fcd-9849-8a81d7f2032c;099545fb-d2c8-42e3-8f4a-7757316b4d86;9b8965e1-1b43-431d-9e0a-34e799297fae;d4c6bfa5-ed26-40c9-b7df-6e754510d790;c14cd41b-9bac-4238-b267-0ccf43eae566	Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20	154;98;Not Available;98;112	126;56;154;56;112	Abraxane;Cyclophospamide;Letrozole (Femara);Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	3;4;Not Available;4;1	200;600;2.5;60;175	mg/m2;mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;1;1	IV;IV;PO;IV;IV	NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1280;4800;Not Available;480;350	mg;mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JJ-F2962;TCGA-AO-A0JJ-F15493	C94CDE29-C7A4-459A-872E-6704D8598DB0;0466F12C-73BA-4B3A-9794-698974812CF6	Not Available;None	Not Available;None	Not Available;None	20;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1512;1887	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A0JJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available	Regional site	TCGA-AO-A0JJ-R2967	dbd25158-9d0f-4bfc-aa40-b2b6ac9685ea	1	20	256	217	Not Available	9	25	10000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2006
TCGA-A8-A09E	FEMALE	1492	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N1a	M0	Stage IIIB	1				WITH TUMOR				73	Left Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A09E	dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-26724	Not Applicable	0	943	Not Available	Not Available	TCGA-A8-A09E-D37745	312D7C87-4134-4840-A47E-CA2E186B1CEA	n/a	6	Not Available	335	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09E-F40334	F6B0C0F3-A72D-419B-8361-645F56B72C5A				17			Not Applicable	1492																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A09E	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09E-R38152	1C5F574D-5456-4528-8CC3-DC465F84FBB9	Not Available	11	91	60	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T4b	Surgical resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-GM-A2DC	FEMALE	2535	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	2535			TUMOR FREE				57	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-GM-A2DC	DD43FFD9-DA18-4AD3-ABE7-6F443C76A717	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	29	-21122	Not Applicable	0	1628	Not Available	NO	TCGA-GM-A2DC-D47063;TCGA-GM-A2DC-D47064;TCGA-GM-A2DC-D47065;TCGA-GM-A2DC-D47066;TCGA-GM-A2DC-D47067;TCGA-GM-A2DC-D47068;TCGA-GM-A2DC-D47069	679FB4FD-B762-4872-806F-4EE16E16D89D;5E67582A-3CD1-4483-9C0E-C98EF42102E3;F653FE5D-76FD-4DD7-A553-952CA706E60F;4D71435A-BF64-420E-BAAA-4892EADB051F;DD73F85B-7DFB-4F68-ACDB-DA28D8449C86;9A846B76-30FF-41CC-854D-8BFDBE8D172E;01F8744B-71EA-4966-BDDF-8D9D5CFD632C	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	22;22;22;22;22;22;22	119;119;208;208;208;341;383	57;57;140;140;140;294;355	Xeloda;Taxotere;Not Available;Epirubicin;Cytoxan;Letrozole;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;NO;NO	2013;2013;2013;2013;2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	4.43					TCGA-GM-A2DC-F47061	6AC27496-A61A-402E-BF63-5AF1D989727E				22			Not Applicable	2535																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	4.70	1.06	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A2DC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-GM-A2DC-R47062	62127898-C5DE-49F3-853B-892863D6FAD6	Not Available	22	278	236	Complete Response	8	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2006
TCGA-A2-A0T7	FEMALE	631	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	631			TUMOR FREE				51	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0T7	43d5632e-7272-4aad-9496-7f5a99671223	Negative	Positive	Not Available	2+	Not Available	Other	Positive	Modified Radical Mastectomy	Skin excision	YES	17	-18756	Not Applicable	0	397	Not Available	Not Available	TCGA-A2-A0T7-D3999;TCGA-A2-A0T7-D4001;TCGA-A2-A0T7-D4002;TCGA-A2-A0T7-D4000	55597860-77c6-472c-8515-75406e8ee3b4;3a7507c1-490c-40f0-b3fb-dc14638ea9b7;c5d05f28-9eff-492b-9d3d-086b3d55ffdd;045f1736-1059-4fa3-bfeb-d36fc7a6c693	Not Available;Not Available;Not Available;Not Available	17;17;17;17	145;243;Not Available;145	117;159;365;117	Adriamycin;Taxol;Tamoxifen;Cytoxan	Not Available;Not Available;Not Available;Not Available	11;11;11;11	3;12;Not Available;3	110;145;20;1100	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;4;2	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0T7-F13953	ADD4998E-EC7F-4B93-8D24-3920CCC4FE34				12		Not Available	Not Applicable	631		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	1	No	A0T7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-D8-A27E	FEMALE	530	Other, specify	Breast	Alive	T1c	N0	M0	Stage IA	0	530			TUMOR FREE				66	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A27E	680f23a9-fcce-493e-b908-27c1ad202e4c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	21	-24315	Not Applicable	0	182	Not Available	NO	TCGA-D8-A27E-D30113	3D420476-7EB9-4632-B3F8-3BB85B979A0D	Not Available	2	Not Available	125	tamoxiphen+anastrazolum	Not Available	4	Not Available	20+1	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27E-F30112	AB1218C8-CF64-40A3-80A9-654B1A5A0BD3				2		Not Available	Not Applicable	530		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Hercep Test  TM Dako	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	infiltrating ductal and mucinous	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A27E	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	>75%	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A27E-R30114	8DF3C173-15EF-461F-BF7E-D5D973330EF5	Not Available	2	95	90	Not Available	4	10	3400	NO	RADIOISOTOPE	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	quadrantectomy	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AC-A7VB	FEMALE	250	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	MX	Stage IIA	0	250			TUMOR FREE				51	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A7VB	56230E4A-29CA-4F37-A0F9-730DBDFB6FA2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	26	-18806	Not Applicable	0	74	Not Available	Not Available																								Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A7VB-F66026	1B155B86-984D-4C0B-995C-F687FDA6901E				1			Not Applicable	250																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	15	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	Not Available	No	A7VB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T1c	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2013
TCGA-E9-A2JS	FEMALE	904	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N1	M0	Stage IIB	1	524.0	Bone	Distant Metastasis	TUMOR FREE				72	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A2JS	4A831893-F4CA-4357-A756-B5E954E35DD7	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	20	-26407	Not Applicable	0	13	Not Available	Not Available	TCGA-E9-A2JS-D34102;TCGA-E9-A2JS-D34103;TCGA-E9-A2JS-D34104;TCGA-E9-A2JS-D34106;TCGA-E9-A2JS-D40294;TCGA-E9-A2JS-D55896	09E54119-585C-4096-A9D8-136656471893;786F4DB8-BC47-4FEF-9D2E-624B59F1E9A2;11E5178D-A5E2-4AC3-BAD0-0664514A1B41;8049BD0B-2078-4946-AFA8-BF2EEB3FD34E;98CD1B77-8557-4EBF-9914-8FF674101890;43929A44-3CE4-467E-85DC-FCF130402CFB	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	30;30;30;30;15;17	Not Available;191;191;191;846;713	21;17;17;17;524;677	Tamoxifen;Cyclophosphamide;Methotrexate;5-Fluorouracil;Pamidronic acid;Zoladex	Not Applicable;Complete Response;Complete Response;Complete Response;Unknown;Clinical Progressive Disease	7;7;7;7;2;1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Ancillary;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2013;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;None	NO;None	NO;None		TCGA-E9-A2JS-F34100;TCGA-E9-A2JS-F40293	70D902D4-238E-44C9-AC2F-9DADFFD7D327;2F028700-8717-47EE-B60E-F0D73A04C1B2				17;15		Not Available;None	Not Applicable;904	540;Not Available		524;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;2	Bone;None	Distant Metastasis;None	Liver;None	YES;None	None;YES;YES	None;NO;NO	None;Not Available;Not Available	None;524;524	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Bone;Liver	None;Distant Metastasis;Distant Metastasis	None;Not Available;Not Available	None;NO;NO	None;Not Available;Not Available	None;YES	WITH TUMOR;WITH TUMOR			Not Available;None			YES;YES		YES;YES	Alive;Dead	2014;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	Not Available	No	A2JS	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site;Regional site	TCGA-E9-A2JS-R34107;TCGA-E9-A2JS-R55891;TCGA-E9-A2JS-R55892	74963151-D7B0-4C4B-8806-0961A312E981;E02F523B-959F-4754-B3BF-54778A1970F7;4030FD77-DBC6-4EA9-8695-C17F48881165	Not Available;Not Available;Not Available	30;17;17	133;133;133	105;105;105	Complete Response;Complete Response;Complete Response	7;1;1	Not Available;Not Available;Not Available	45;41;38	NO;NO;NO	External;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Gy;Gy;Gy	2012;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AQ-A04J	FEMALE	819	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	819			TUMOR FREE				45	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AQ-A04J	9938ce5c-e74e-446e-a932-f096f85cc3b1	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	15	-16615	Not Applicable	0	160	Not Available	Not Available	TCGA-AQ-A04J-D10110;TCGA-AQ-A04J-D10098;TCGA-AQ-A04J-D10111	D8796E39-CFDE-459F-9BCD-D002AFF025CF;C6A8B218-BCD7-4F96-B5AB-9B20A7A0B735;9826B415-20EE-4140-A2D8-EA39857695D9	Not Available;Not Available;Not Available	7;7;7	104;104;160	61;61;118	Cytoxan;Adriamycin;Taxol	Not Available;Not Available;Not Available	4;4;4	4;4;4	600;60;175	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2400;240;700	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AQ-A04J-F10104;TCGA-AQ-A04J-F21740	B746D98E-FBB4-4B00-9F7B-15D7187ED53D;09FC391F-4113-4C17-8BDA-25158626688E	Not Available;None	Not Available;None	Not Available;None	7;20	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	500;819	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;2	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A04J	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	AQ	Breast	Not Applicable	Alive	2010	2009
TCGA-AC-A2FO	FEMALE	2255	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	MX	Stage IIB	0	2255			TUMOR FREE				65	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node plus Level I and Level II lymph nodes	TCGA-AC-A2FO	F5D4C2D3-CC69-4B38-8551-0917E3622A68	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	21	-23928	Not Applicable	0	1542	Not Available	NO	TCGA-AC-A2FO-D43224;TCGA-AC-A2FO-D43227	E2156068-0D07-42BF-877C-C70B71322A3E;74E898D7-9552-4550-9764-4F924FC55872	Not Available;Not Available	15;15	Not Available;Not Available	105;225	Chemo, NOS;Hormone, NOS	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2FO-F43223	EF71A0D0-16AB-45A4-A42D-625AFEF971B8				15			Not Applicable	2255																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Indeterminate	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A2FO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2005
TCGA-A7-A26I	FEMALE	661	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	661			Not Available				65	Left	Axillary lymph node dissection alone	Not Available	TCGA-A7-A26I	b2ecbc0f-2c30-4200-8d5e-7b95424bcadb	Negative	Negative	Not Available	Not Available	Not Available	Other	Negative	Lumpectomy	Re-Excision of Superior Margin	NO	29	-23948	Not Applicable	0	122	Not Available	NO	TCGA-A7-A26I-D31070;TCGA-A7-A26I-D31057	8D9064E7-67A8-4172-A033-3A6E46CA915D;B0D2110C-8FC3-414F-ABF8-61FEC6144D1D	Not Available;Not Available	23;23	164;164	60;60	Cytoxan;Taxotere	Not Available;Not Available	4;4	6;6	1130;140	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6780;840	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	2.0	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A26I-F30876;TCGA-A7-A26I-F39791	E39CC129-3D21-4C50-A94A-6EA7E24F25CD;66A09C74-D0D8-438E-8C18-EC119CB56D3A				18;1		Not Available;None	Not Applicable;Not Applicable	369;661		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Path Vysion HER-2 DNA probe kit	2+	229	Not Available	2.2	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	Yes	A26I	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A26I-R30889	72D346BE-A998-4B4F-919F-D0ACF1E8D7F2	1	18	258	213	Not Available	4	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A1EV	FEMALE	365	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N1b	M0	Stage IIIA	1				WITH TUMOR				45	Left	Not Available	Not Available	TCGA-BH-A1EV	417dea5f-f68e-4dab-940e-43ae8c67e5e6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	7	-16504	365	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A1EV-F59154	6934F0BA-FA6D-4451-9935-E84F316DC61A				1			365	Not Available																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						NO		YES	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Evaluated	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	3	Not Available	No	A1EV	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-BH-A1EV-R59155;TCGA-BH-A1EV-R59156	14C932E3-F25E-44E0-B94B-C633091990EC;70674749-BAAD-4C56-AA1E-92C3F0FB568C	Not Available;Not Available	1;1	139;139	48;48	Radiographic Progressive Disease;Radiographic Progressive Disease	5;5	Not Available;Not Available	6000;5000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-BH-A0HA	FEMALE	1611	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	1611			TUMOR FREE				31	Right	Not Available	Not Available	TCGA-BH-A0HA	e666081b-caaf-4e8b-9446-807be71201a5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	2	-11379	Not Applicable	0	856	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-BH-A0HA-F19337;TCGA-BH-A0HA-F43320	A2A6ED0E-CEB2-4245-A4A4-A8C2181645F4;3BFD818A-CF1F-4459-9B36-7CAD9D475D5B				8;17		Not Available;None	Not Applicable;Not Applicable	856;1611		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;NO		NO;NO	Alive;Alive	2011;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0HA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	bilateral total mastectomies with right sentinel node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-AC-A5EH	FEMALE	511	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	511			TUMOR FREE				76	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A5EH	D13FB44B-291B-4EA4-920C-142DAA8D1989	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	12	-27964	Not Applicable	0	63	Not Available	Not Available																								Not Available	20-29%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A5EH-F60185	0BF107A0-50A7-481B-957D-E8F1C0A4D8F2				31			Not Applicable	511																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5EH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	BLACK OR AFRICAN AMERICAN	Unknown	Primary Tumor Field	TCGA-AC-A5EH-R60186	982113B3-EE91-4E1A-8D9E-FBE98CA4B6B6	Not Available	31	216	163	Complete Response	5	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2012
TCGA-MS-A51U	FEMALE	681	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	681			WITH TUMOR				44	Left Upper Outer Quadrant;Left Lower Outer Quadrant;Left	Not Available	Not Available	TCGA-MS-A51U	910655DA-2C12-4572-96B7-DED616E69B4B	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	12	-16213	Not Applicable	0	85	Not Available	NO	TCGA-MS-A51U-D64920;TCGA-MS-A51U-D64916;TCGA-MS-A51U-D64919	011802B1-AEBD-4C2D-8258-19D929C01583;E6091FDA-563B-4A0F-A091-666380676D1E;4E4467F8-D750-4B3D-9A07-CED8733E6813	Not Available;Not Available;Not Available	17;17;17	178;116;116	130;57;57	Paclitaxel;Adriamycin;Cytoxan	Stable Disease;Stable Disease;Stable Disease	10;10;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-MS-A51U-F59818	5CC7E973-2B41-4164-B766-828CA02625F3				4			Not Applicable	681																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	18	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A51U	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	20-29%	WHITE	Not Available	Primary Tumor Field	TCGA-MS-A51U-R66068	A8E94E4E-431A-46FA-84EF-9001BDAD527D	Not Available	2	266	218	Radiographic Progressive Disease	10	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	MS	Breast	Not Applicable	Alive	2012	2012
TCGA-E9-A1N6	FEMALE	678	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1	M0	Stage IIB	1	443.0	Bone	Distant Metastasis	TUMOR FREE				52	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1N6	955d4263-61f7-42e8-8a6e-772a0d6c209d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	NO	23	-19327	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1N6-D32896;TCGA-E9-A1N6-D63545;TCGA-E9-A1N6-D63546;TCGA-E9-A1N6-D63562	1602F6B3-37E4-4305-9B0F-60739FCAE4A1;9C2EBE7E-9BD0-4B27-A254-6B5EF6E962A3;5A20287E-F225-416A-9A83-86038A1BE690;E69B2ABD-369B-40EF-BC6B-8FE52DC62E45	Not Available;Not Available;Not Available;Not Available	15;12;12;13	Not Available;574;574;678	128;447;447;575	Tamoxifen;Doxorubicin;Cyclophosphane;Letrozole	Not Applicable;Stable Disease;Stable Disease;Clinical Progressive Disease	6;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1N6-F29152;TCGA-E9-A1N6-F63536	61B7B175-64BF-4960-B4A5-D2AEFE1B9A17;D6C11D26-4FA8-426C-B4FC-9A280F1ED8D3				9;12		Not Available;None	Not Applicable;678	410;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;8	Not Available;None	Not Available;None	Not Available;None	NO;None	None;YES;NO;NO	None;NO;NO;NO	None;Not Available;Not Available;Not Available	None;443;648;672	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Bone;Not Available;Liver	None;Distant Metastasis;Locoregional Recurrence;Distant Metastasis	None;Not Available;Not Available;Not Available	None;NO;NO;NO	None;Not Available;Not Available;Not Available	None;YES	TUMOR FREE;WITH TUMOR			Not Available;None			YES;YES		YES;YES	Alive;Dead	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	0	No	A1N6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1N6-R29155	A2417E8F-0B84-4931-A517-4609148E7278	Not Available	9	117	82	Not Available	3	19	3800	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A1L9	FEMALE	598	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IIA	0	598			TUMOR FREE				40	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A1L9	5ea18514-51ad-4844-abea-15e82f0b10c9	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	7	-14868	Not Applicable	0	388	Not Available	NO	TCGA-E2-A1L9-D20601;TCGA-E2-A1L9-D20600;TCGA-E2-A1L9-D20598	EA86D6FC-965B-4DD5-BAA8-D08128E3B0F1;ACCE2AC2-3256-4F8C-B862-CA109FC03BA3;4A43A807-30FB-4969-B77C-A3BC9D040351	Not Available;Not Available;Not Available	11;11;11	Not Available;122;122	187;56;55	Tamoxifen;Taxotere;Cytoxan	Not Available;Not Available;Not Available	1;1;1	Not Available;4;4	20;Not Available;Not Available	mg/day;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	PO;Not Available;Not Available	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	20;Not Available;Not Available	mg/day;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1L9-F20597	1D1EB5B9-2C8B-47F3-BBD6-E02A269BE683				11		Not Available	Not Applicable	598		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1L9	TUMOR FREE	Not Available	Not Available	Not Available	allred score = 7	allred score = 7	Not Available	YES	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1L9-R20602	FB33C7DC-7439-4DE4-B8CE-2F122C0D2BB8	1	11	177	140	Not Available	1	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-E2-A1LH	FEMALE	3247	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	3247			TUMOR FREE				59	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A1LH	d8ecba6a-9fff-4993-a799-9a8d2aea524e	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	3	-21628	Not Applicable	0	2876	Not Available	NO	TCGA-E2-A1LH-D20652;TCGA-E2-A1LH-D20659	908E780C-09EB-4CBC-AD5A-75B352A71460;2D696153-39F9-4F7D-8E35-5B056E1F654F	Not Available;Not Available	12;12	104;104	41;41	Adriamycin;Cytoxan	Not Available;Not Available	1;1	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1LH-F20649	29497476-76A6-4D7C-9478-FBA0801FDFDF				12		Not Available	Not Applicable	3247		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1LH	TUMOR FREE	Not Available	ACIS	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A1LH-R20662	08EE86D2-364F-4AA5-9959-6D8413398AD2	1	12	189	147	Not Available	1	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2002
TCGA-AC-A3W5	FEMALE	504	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	504			TUMOR FREE				65	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A3W5	4C313E5B-4DC3-408E-8E92-22427F74743E	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	24	-24029	Not Applicable	0	55	Not Available	Not Available	TCGA-AC-A3W5-D56178;TCGA-AC-A3W5-D56179;TCGA-AC-A3W5-D56180;TCGA-AC-A3W5-D56181	3299B6BC-BE87-4C84-91EA-AEF9CE77EACE;44D7F9EC-9D9E-48D2-A04D-33F37CEC738A;8ABC79CD-6BDB-44B7-8F89-4E5762E620F8;402336C9-639C-49F2-BFA8-F0BA1A3636F2	Not Available;Not Available;Not Available;Not Available	29;29;29;29	139;139;392;Not Available	56;56;56;170	Docetaxel;Cyclophosphamide;Herceptin;Letrozole	Complete Response;Complete Response;Complete Response;Not Applicable	1;1;1;1	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3W5-F56177	CAD3F986-FD23-42DF-A0E3-B22ADAE9F1A8				29			Not Applicable	504																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Positive	3	Close	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	A3W5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	30-39%	BLACK OR AFRICAN AMERICAN	Unknown	Primary Tumor Field	TCGA-AC-A3W5-R56182	D989D457-B8CB-4B67-871E-49FD6F55A4CB	Not Available	29	182	154	Complete Response	1	21	5256	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-A8-A0A2	FEMALE	579	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	579			TUMOR FREE				66	Right Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A0A2	34d5a193-85e5-4399-8a9b-e92858eafdfe	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24380	Not Applicable	0	579	Not Available	Not Available	TCGA-A8-A0A2-D37901	3C849DD1-A3D9-4F0A-A1B2-332514713CC6	Not Available	6	Not Available	92	Tamoxifen	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0A2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A0A2-R38192	1E9265EA-89C2-4B29-A848-0DA6F4AD95B9	Not Available	11	92	31	Unknown	12	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-C8-A274	FEMALE	508	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	508			TUMOR FREE				63	Right	Not Available	Not Available	TCGA-C8-A274	dbcad60f-86c7-41e3-b0ae-baa39c9f83dd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	21	-23337	Not Applicable	0	1	Not Available	Not Available	TCGA-C8-A274-D70832	4593E9A7-6ECF-4C21-BADB-4309FC423900	Not Available	9	Not Available	8	Tamoxifen	Discrepancy	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A274-F20275;TCGA-C8-A274-F70831	EE62C6FF-017B-4C06-873D-47D00D8EB4AF;52DC036E-216B-4745-ACB0-5EA2953BCF96				9;9		Not Available;None	Not Applicable;Not Applicable	290;508		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A274	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 7	Allred Score 8	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0BA	FEMALE	1132	Mixed Histology (please specify)	Breast	Alive	T3	N3a	M0	Stage IIIC	0	1132			TUMOR FREE				51	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0BA	49dc3e68-6206-4f16-969f-a758cc7be8ed	Not Available	Positive	Not Available	1+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	4	-18839	Not Applicable	0	1132	Not Available	Not Available	TCGA-BH-A0BA-D15464;TCGA-BH-A0BA-D15465;TCGA-BH-A0BA-D15462	DF60161D-106E-4FB8-8D03-71A048D7C3AA;DACDCDBB-0BA5-4572-A515-6E4831F17245;22BBDDCD-4D31-43CF-BA69-28A677A615E4	Not Available;Not Available;Not Available	4;4;4	94;171;94	63;119;63	Cytoxan;Paclitaxel;Adriamycin	Not Available;Not Available;Not Available	11;11;11	04;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	80-89%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0BA-F15461	A7C13A2B-D403-4A9E-AA4C-8206CDD41509				4		Not Available	Not Applicable	1132		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal & lobular	No	C50.9	8522/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	27	Not Available	No	A0BA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BA-R15467	074F0CFD-17CA-47A8-88C5-A36FF8978CF4	1	4	262	187	Not Available	11	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2006
TCGA-AO-A03L	FEMALE	2442	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2	M0	Stage IIIA	0	2442			TUMOR FREE				34	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A03L	1174f6e4-ffbe-4e59-a000-8d861c968369	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	7	-12443	Not Applicable	0	2442	Not Available	Not Available	TCGA-AO-A03L-D5921;TCGA-AO-A03L-D5920;TCGA-AO-A03L-D5925;TCGA-AO-A03L-D5926;TCGA-AO-A03L-D5923	f4461ec4-9a69-4f0c-a38c-2fb57692c388;bdf77be9-8a97-410e-9290-fe7f90761885;57884874-30e3-4850-a42c-bf89ec191ccd;1def3807-a1e2-4d1c-a417-9b8d8302d065;70c52b36-df70-4dd1-b109-5d7c12ef900e	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	140;140;2057;2057;140	36;36;227;363;36	Cyclophosphamide;Doxorubicin;Tamoxifen;Lupron;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	4;4;Not Available;Not Available;4	600;60;20;Not Available;175	mg/m2;mg/m2;mg/day;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;2;1	IV;IV;PO;IM;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	63	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A03L-F5858;TCGA-AO-A03L-F19390	46CF8472-9AC2-4CA9-AE52-1D40A3A5AA0A;CC654247-3426-49B3-B47E-C503B40F898C	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	2442;2442	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	Not Available	10-19%	>= 2.0 Positive	2+	30	Not Available	47	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Positive	Negative	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	4	Not Available	No	A03L	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	ASIAN	Not Available	Regional site	TCGA-AO-A03L-R5859	5fb3a572-ca52-4caf-8a15-9bf2aa8e7bba	1	7	208	167	Not Available	12	28	10080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2003
TCGA-BH-A208	FEMALE	1759	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	1759			TUMOR FREE				48	Left	Not Available	Not Available	TCGA-BH-A208	ddcbdac6-9e43-4146-a611-d033125eba14	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	Not Available	8	-17715	1759	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	15	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	3	Not Available	No	A208	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1995
TCGA-AO-A1KQ	MALE	1882	Infiltrating Ductal Carcinoma	Breast	Alive	T4	N1	M0	Stage IIIB	0	1882			TUMOR FREE				84	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A1KQ	d2219a3f-4c55-4dee-9b08-c6f330dd1acf	Not Available	Positive	4 Point Scale	3+	4 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	1	-30859	Not Applicable	0	1519	Not Available	NO	TCGA-AO-A1KQ-D9884	0dd32c09-be32-467e-9a5b-83a6e7f6f713	Not Available	1	Not Available	49	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A1KQ-F9883;TCGA-AO-A1KQ-F21775	8350EB70-2195-46FD-81B0-248546115C74;DB04403E-1473-4BBC-B665-0103F9DB2608	Not Available;None	Not Available;None	Not Available;None	1;20	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1519;1882	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;2	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	MALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	9	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	2	0	No	A1KQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	80-89%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T4	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2006
TCGA-BH-A0EI	FEMALE	1926	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	1926			TUMOR FREE				51	Right	Not Available	Not Available	TCGA-BH-A0EI	22b35927-1c3f-4f98-ba42-deafc56b677a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	11	-18741	Not Applicable	0	743	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0EI-F59115	E894DC0C-AE6E-4101-A406-2A464420B984				1			Not Applicable	1926																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	2	Not Available	No	A0EI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-BH-A0EI-R59119;TCGA-BH-A0EI-R59121	669FAA2A-602A-4BED-A5DD-084DAE9E91F7;AAB0EEA5-BADE-4CBB-BBD8-3F0FBC725701	Not Available;Not Available	1;1	321;350	274;350	Complete Response;Complete Response	5;5	33;Not Available	5040;900	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	segmental mastectomy with right sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A3XT	FEMALE	2770	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2770			TUMOR FREE				45	Left	Other (specify)	FNA plus axillary lymph node dissection	TCGA-A2-A3XT	C72CB184-462D-4009-9CDB-848782FF8A76	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	17	-16649	Not Applicable	0	2238	Not Available	Not Available	TCGA-A2-A3XT-D34495;TCGA-A2-A3XT-D34496;TCGA-A2-A3XT-D34497	C93B9D6C-DE38-4B66-AA69-C788731E6DA2;314F8E23-81C1-41B5-BB1D-78A78525EE50;3E9B81CF-BFAD-4C78-AC24-32461C485692	Not Available;Not Available;Not Available	17;17;17	83;83;161	35;35;97	Cyclophosphamide;Doxorubicin;Docetaxel	Partial Response;Partial Response;Partial Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3XT-F43309;TCGA-A2-A3XT-F55841	32EAD95B-751B-4BFD-BE2E-908EA3CE2617;60EA646B-4B74-49E4-8493-AE2DA1AF4BFA				16;16			Not Applicable;Not Applicable	2525;2770																				NO;NO																						5;1					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.13	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Negative	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A3XT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field;Regional site;Regional site;Primary Tumor Field	TCGA-A2-A3XT-R34498;TCGA-A2-A3XT-R34499;TCGA-A2-A3XT-R34500;TCGA-A2-A3XT-R34501	3FC8B1C4-9668-4CC8-B355-AF3B27746C49;8749065D-442D-4F58-98EA-5CFEAC7F5AB3;44C63D6A-9809-45D0-A622-FC1FFD502681;D6509E2C-F849-48E2-9026-A7B97686D7D7	Not Available;Not Available;Not Available;Not Available	17;17;17;17	275;275;275;282	233;233;233;278	Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8	28;28;28;5	5040;5040;868;1000	NO;NO;NO;NO	External;External;External;External	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	cGy;cGy;cGy;cGy	2012;2012;2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2006
TCGA-AR-A2LM	FEMALE	1935	Infiltrating Lobular Carcinoma	Breast	Alive	T1	N1	M0	Stage II	0	1935			Not Available				49	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LM	0BF6E772-1AA1-4F54-9A50-C1414E2F22F3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	12	-18053	Not Applicable	0	1218	Not Available	NO	TCGA-AR-A2LM-D37338;TCGA-AR-A2LM-D37339;TCGA-AR-A2LM-D37345;TCGA-AR-A2LM-D37346	AFF8E2B0-7981-4EDB-811C-11EBF3B60ED0;57372622-06C2-481D-8D49-98803E959075;955A2DF7-0D64-49CF-9A73-05F722680C2B;F4D3BD0B-BC50-4E1A-A781-07B6C2A53B31	Not Available;Not Available;Not Available;Not Available	6;6;6;6	99;141;141;967	78;78;120;170	Docetaxel;Cytoxan;Abraxane;Tamoxifen	Not Available;Not Available;Not Available;Not Available	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LM-F37336;TCGA-AR-A2LM-F71746	D6D5F194-B9A7-44DB-B31C-AB8AF2E8F81B;7E511158-49BC-41A4-B9B7-0A7639BED9D7				6;30			Not Applicable;Not Applicable	1585;1935																				NO;NO																						12;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	1	Not Available	No	A2LM	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2012	2007
TCGA-AR-A24H	FEMALE	4894	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	4894			Not Available				65	Right Lower Inner Quadrant;Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24H	6f89509c-f802-482e-b4da-94553aa76fe9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	29	-24046	Not Applicable	0	3333	Not Available	Not Available	TCGA-AR-A24H-D31252;TCGA-AR-A24H-D31253	D5707F24-629C-4F1F-9D73-89CD2F7CA8A3;FB37D0A3-9242-440E-A64A-2859934FB1A9	Not Available;Not Available	25;25	1042;3094	23;1042	Tamoxifen;Anastrozole	Not Available;Not Available	4;4	Not Available;Not Available	20;1	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	PO;PO	NO;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24H-F31212;TCGA-AR-A24H-F49484;TCGA-AR-A24H-F65797	8A8D77E4-29CE-4FC2-B271-FBF2BBA3FD77;BDA1D14F-8B56-49F4-B1DE-D36E3C2E506B;7BBA9594-4A67-4A39-9664-D97928D1413F				25;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	3333;4776;4894		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	4;10;9	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24H	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24H-R31217	7926DA2C-4D80-45A5-8E14-24F769E48DF1	1	25	111	37	Not Available	4	Not Available	6300	NO	Not Available	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2001
TCGA-AR-A24K	FEMALE	1548	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1548			Not Available				46	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24K	599c3701-df7a-4a75-a347-fa9b510dd242	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	12	-16961	Not Applicable	0	1548	Not Available	Not Available	TCGA-AR-A24K-D31262;TCGA-AR-A24K-D31261;TCGA-AR-A24K-D31260	CDC672D1-9D6E-4784-B377-5AE2546F2EDB;CF20F7DD-121A-44A7-B932-B417039C45D5;3AFC8797-628E-464D-A40B-5D0B624E3B20	Not Available;Not Available;Not Available	25;25;25	170;Not Available;Not Available	Not Available;Not Available;Not Available	Paclitaxel;Cytoxan;Doxorubicin	Not Available;Not Available;Not Available	4;4;4	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	No value Given	10-19%	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A24K-F31255;TCGA-AR-A24K-F49485	29310A70-EB33-495F-93E9-9687F4A26EBF;4D12DA3E-BE3E-4324-A4D9-7006E014CA9E				25;2		Not Available;None	Not Applicable;Not Applicable	1548;1548		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24K	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24K-R31259	7EBD9D8A-5AA6-452F-979A-3A3CDDA5B87F	1	25	241	195	Not Available	4	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2004
TCGA-BH-A18K	FEMALE	2763	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N0	M0	Stage I	0	2763			WITH TUMOR				46	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A18K	50619f8c-10aa-464a-a227-90a7aa6ffd43	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	9	-16824	2763	0	Not Available	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	11	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A18K	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	segmental mastectomy with axillary dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-BH-A1FR	FEMALE	1642	Other, specify	Breast	Dead	T4b	N1a	M0	Stage IIIB	0	1642			WITH TUMOR				73	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A1FR	bf3b1481-ae31-4406-b084-b6cc1d7163e3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	8	-26684	1642	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	mixed idc and mucinous	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	4	Not Available	No	A1FR	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1a	T4b	segmental mastectomy with excision of mass on chest wall and axillary node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1997
TCGA-OL-A66H	FEMALE	812	Mucinous Carcinoma	Breast	Alive	T1c	N1mi	MX	Stage IB	0	812			TUMOR FREE				74	Right	Not Available	Not Available	TCGA-OL-A66H	76BD9BB9-9A8B-4A90-BB7C-EAFE76472EE4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	11	-27280	Not Applicable	0	413	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.7					TCGA-OL-A66H-F58492	9696265B-08D0-4DF9-922E-7EF1C0281AD6				11			Not Applicable	812																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.8	1.03	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A66H	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	80-89%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A66H-R64840	0C6BC7D3-CF64-40E8-AAB3-B75DA3F377A3	Not Available	12	105	68	Complete Response	9	Not Available	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2012
TCGA-GM-A5PV	FEMALE	412	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	412			TUMOR FREE				63	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-GM-A5PV	67C8DC41-EDCB-4563-96B3-3F93F9EDCBE9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	12	-23215	Not Applicable	0	412	Not Available	Not Available	TCGA-GM-A5PV-D42156;TCGA-GM-A5PV-D42166	1316596D-D637-490A-BC7F-1E1C61EB3AE0;F72DFCCB-CAB4-4F6D-8B1B-FC0364E48134	Not Available;Not Available	12;12	174;174	107;107	Taxotere;Cytoxan	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.70																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	40	Not Available	3.65	1.35	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5PV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	30-39%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2013	2011
TCGA-A2-A0EU	FEMALE	1043	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1043			TUMOR FREE				79	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0EU	c0427237-b476-4af4-b664-7bd479922ea5	Negative	Positive	Not Available	Not Available	Not Available	Lumpectomy	Positive	Lumpectomy	Not Applicable	YES	11	-29144	Not Applicable	0	733	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0EU-F13717	FC478CCD-9561-4F06-81A2-F8BA25C5AF85				10		Not Available	Not Applicable	1043		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	0.97	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A0EU	TUMOR FREE	Not Available	Not Available	Not Available	Intensity=Strong	Intensity=Strong	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0EU-R1714	bc456128-c77d-444f-a359-a200d25bf391	1	12	193	116	Not Available	8	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-D8-A143	FEMALE	431	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	431			TUMOR FREE				51	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A143	1c40b84e-a0e3-429f-a48c-21566cf881c0	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	25	-18984	Not Applicable	0	172	Not Available	Not Available	TCGA-D8-A143-D13818;TCGA-D8-A143-D64910	786A632D-1981-4D67-B28C-DFEA95E74CCA;655A6770-6A40-4D7C-9453-094F18309168	Not Available;Not Available	4;15	172;172	67;67	doxorubicin;cyclophosphamide	Not Available;Not Available	7;9	6;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	AC;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg/m2;Not Available	Not Available;NO	2011;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A143-F13817	A3F360DB-0BEF-4CC5-8175-D859A234AF9E				4		Not Available	Not Applicable	431		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A143	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A3Z5	FEMALE	1015	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	1015			TUMOR FREE				54	Right	Other (specify)	mastectomy with TLND	TCGA-D8-A3Z5	77E25AE8-82EC-4DEA-8E62-1176F27E47BA	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	3	-19846	Not Applicable	0	441	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-D8-A3Z5-F57869	FBAE89FD-F5B0-4393-928B-00C4DAD6776E				28			Not Applicable	1015																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	19	Not Available	No	A3Z5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2012	2011
TCGA-AC-A2FF	FEMALE	2759	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	MX	Stage IIB	0	2759			TUMOR FREE				40	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A2FF	3CA67CD0-81DA-4F68-A9FA-F1A8C013C28D	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	23	Not Available	Not Applicable	0	1686	Not Available	NO	TCGA-AC-A2FF-D56170;TCGA-AC-A2FF-D56171;TCGA-AC-A2FF-D56172;TCGA-AC-A2FF-D56173	2F38E250-56D9-415C-8694-16634DED723D;DF17DE1B-3B13-469B-B9AF-F461F5B9791D;C4A61CA0-51A5-4811-8017-090A5DE9AA62;CA6E2206-6437-4F20-B4CE-07925A8A8D79	Not Available;Not Available;Not Available;Not Available	29;29;29;29	153;153;245;Not Available	70;70;153;382	Cytoxan;Adriamycin;Taxol;Tamoxifen	Complete Response;Complete Response;Complete Response;Complete Response	1;1;1;1	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Available	30-39%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2FF-F56166;TCGA-AC-A2FF-F58655	68379DFA-59F3-4129-9B2D-D8107CD335C5;44BE030F-E207-4D98-80C9-F9F658C96AE7				29;17			Not Applicable;Not Applicable	2420;2759																				NO;NO																						1;4					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.7	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	7	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	3	0	No	A2FF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	ASIAN	Not Available	Primary Tumor Field	TCGA-AC-A2FF-R56168	1F8155CE-49F0-4917-AA85-4DF9FBE799B1	Not Available	29	377	336	Complete Response	1	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2006
TCGA-D8-A1XV	FEMALE	461	Mucinous Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	461			TUMOR FREE				84	Right Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1XV	87b85935-a058-44ad-8fb6-8511130eaffe	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-30830	Not Applicable	0	147	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XV-F29457	A788378C-1EF4-49A8-B595-22C22A19823D				19		Not Available	Not Applicable	461		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	not amplified	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XV	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A251	FEMALE	3030	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	3030			Not Available				51	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A251	8c51bbcb-7c8d-47ad-9193-70ca157c6900	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Negative	Other	Not Applicable	Not Available	30	-18771	Not Applicable	0	1374	Not Available	Not Available	TCGA-AR-A251-D31823;TCGA-AR-A251-D31825;TCGA-AR-A251-D31827;TCGA-AR-A251-D31828	B8F1A566-55CF-4FF1-A3EE-9C35DD719C78;999250A8-21B7-48BC-8677-4FC3B42AA617;2B479B1F-F3B2-41EF-B929-49E70C892BB5;96941235-258D-4BEE-85A3-8CFDAAAA042F	Not Available;Not Available;Not Available;Not Available	22;22;22;22	87;87;141;1969	44;44;100;175	Doxorubicin;Cytoxan;Paclitaxel;Tamoxifen	Not Available;Not Available;Not Available;Not Available	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A251-F31818;TCGA-AR-A251-F49509;TCGA-AR-A251-F71716	AA1DA6BC-6231-42AC-B67A-A97549A902BD;796BE9A5-BB26-4986-8913-3657208A0538;093C1D48-92BC-4598-A3EE-B841A4259944				9;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1374;2387;3030		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	7	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	4	Not Available	No	A251	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A251-R31821	8995BFD6-45E6-4008-9BEE-8F0AA9E64948	1	9	195	160	Not Available	5	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-A8-A095	FEMALE	1277	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1277			TUMOR FREE				45	Left	Not Available	Not Available	TCGA-A8-A095	29df128d-ace2-40cf-88ee-3f6f2170f159	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-16742	Not Applicable	0	1277	Not Available	Not Available	TCGA-A8-A095-D37811;TCGA-A8-A095-D37812;TCGA-A8-A095-D37813;TCGA-A8-A095-D37814	57584D49-5DD8-4991-A154-50BB92C2FB5A;4968DB45-29C7-41D8-BC0A-204367F2EB4E;023B7F41-CB22-43B7-81EE-6DC8B72DD4F3;DD6C452A-B9DD-48FF-B9C3-2D1DCC1F1143	n/a;n/a;n/a;n/a	6;6;6;6	120;120;120;Not Available	0;0;0;181	5-Fluorouracil;Doxorubicin;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A095-F40554	6CCE328F-29A6-4589-B6C4-32FBE8EBA27E				23			Not Applicable	1277																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A095	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A095-R38169	424F7885-0277-4F10-91D2-8BB221F37C57	Not Available	11	181	120	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-LL-A6FP	FEMALE	0	Infiltrating Lobular Carcinoma	Breast	Alive	T2	NX	MX	Stage IIA	0	0			TUMOR FREE				90	Right Upper Outer Quadrant	No axillary staging	Not Available	TCGA-LL-A6FP	5C9D8163-A68E-43CE-9CBA-EFFB7405761E	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	3	-32873	Not Applicable	0	0	Not Available	Not Available	TCGA-LL-A6FP-D47969;TCGA-LL-A6FP-D47970	3D373A52-0D38-443C-AAC5-0376FC840F09;1ED178CF-05EE-41AD-B1AC-37FA1DAE065A	Not Available;Not Available	3;3	Not Available;0	0;0	Arimidex;Tamoxifen	Not Applicable;Unknown	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	3.1					TCGA-LL-A6FP-F64050	31BBE6D1-6AF1-4980-985B-A696679676AA				25			Not Applicable	0																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	549	Not Available	2.6	0.9	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	Yes	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A6FP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	NO	20-29%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	NX	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2012
TCGA-BH-A0BS	FEMALE	2612	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1c	M0	Stage IIIA	0	2612			TUMOR FREE				55	Left	Not Available	Not Available	TCGA-BH-A0BS	2b22db1d-54a1-4b9e-a86e-a174cf51d95c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	18	-20374	Not Applicable	0	1641	Not Available	NO	TCGA-BH-A0BS-D63392;TCGA-BH-A0BS-D63400	FCDA8776-2D25-4001-B9CC-956E0043F6A8;993049EF-D3F7-4F12-B97F-3D6AE4023498	Not Available;Not Available	7;7	207;207	44;44	Adriamycin;Cytoxan	Complete Response;Complete Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BS-F61955	7D2BC44D-7ED6-4B0D-84B9-31E38397201F				7			Not Applicable	2612																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Negative	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BS	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-BH-A0BS-R63397;TCGA-BH-A0BS-R63398	8727D0E4-840A-4524-962B-7AD1986FB858;FB9FF030-2089-4C98-BB5C-D04016148325	Not Available;Not Available	7;7	302;302	245;245	Complete Response;Complete Response	8;8	25;26	6040;46.8	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Gy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1c	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-A8-A07O	FEMALE	304	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	304			TUMOR FREE				51	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07O	cf9db1af-17f0-490e-8139-142bd704763a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-18870	Not Applicable	0	304	Not Available	Not Available	TCGA-A8-A07O-D37865	FE74A740-3180-4A13-A733-54DDF7212A91	Not Available	6	151	61	Not Available	Complete Response	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07O-F40831	A8FC8B58-BD10-40C0-BEE5-E0DA7F4431C4				2			Not Applicable	304																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07O	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07O-R38184	B6552840-8AC7-4FA4-8CE2-7EAB6774004A	Not Available	11	212	182	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-E2-A15F	FEMALE	658	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	658			TUMOR FREE				64	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15F	ec77a23d-84f5-47e4-bf2a-fa1c03baf3db	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-23660	Not Applicable	0	469	Not Available	NO	TCGA-E2-A15F-D18907	1EAC6D1E-0E8F-4AD2-8571-21809FF6F41C	Not Available	10	Not Available	87	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15F-F18906	B97A662C-1E3B-4E86-A42A-E23819047D85				10		Not Available	Not Applicable	658		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A15F-R18908	D9E37765-4428-4C8E-A7D0-6C851A7C95FF	1	10	86	42	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-A8-A08L	FEMALE	30	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N2a	M0	Stage IIIA	0	30			TUMOR FREE				89	Left	Not Available	Not Available	TCGA-A8-A08L	8bd68696-5eeb-46d7-9dc6-c39c849029a4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-32842	30	0	Not Available	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08L-F40847	621DB5E5-F1F5-43B1-8D8C-45A3E8C58EEC				2			30	Not Available																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		YES	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08L	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08L-R38161	D73DFE9C-A7EF-4DD0-8879-04052984D07D	Not Available	11	30	30	Unknown	12	Not Available	45	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Dead	2011	2008
TCGA-BH-A0W4	FEMALE	759	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	759			TUMOR FREE				46	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0W4	0772cdbe-8b0d-452b-8df1-bd70d1306363	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	15	-16911	Not Applicable	0	175	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0W4-F34069	A10FFD93-E9C3-4083-A4E6-F61D9E83E9C9				29		Not Available	Not Applicable	759		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	Not Available	Not Available	No	A0W4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Total mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010
TCGA-AN-A03Y	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE				66	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A03Y	a991644b-3ee6-4cda-acf0-e37de48a49fc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	29	-24232	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A03Y-F68977	53FFC456-27B7-427B-9E7B-E89905DC80E9				24			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A03Y	TUMOR FREE	Not Available	Not Available	Not Available	210	210	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-BH-A204	FEMALE	2534	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	2534			Not Available				80	Left	Not Available	Not Available	TCGA-BH-A204	05135396-df5c-49db-b34e-f4add5b65a2b	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	Not Available	8	-29529	2534	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	16	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A204	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1996
TCGA-A8-A09K	FEMALE	912	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	M0	Stage IIA	0	912			TUMOR FREE				68	Left Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A09K	6f959c92-b79f-4f84-9ee5-d07d3212d52d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24960	Not Applicable	0	912	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09K-F40332	094D8DCB-8317-4A5C-8A40-A134ADD8DBDE				17			Not Applicable	912																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A09K	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Surgical resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A24N	FEMALE	3035	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	3035			Not Available				54	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24N	30047d32-0833-4aca-98d1-3b9ab7122863	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	16	-19989	Not Applicable	0	2074	Not Available	Not Available																								Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24N-F31355;TCGA-AR-A24N-F49491;TCGA-AR-A24N-F71723	BEF9D8BE-4363-4948-A6E3-37095E1903CC;7FF92C18-C896-42D4-938C-B0891048B2AE;5A3C20C7-DC2F-4027-8996-DA5A07981E0E				1;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	2074;2388;3035		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			NO;NO;NO		NO;NO;NO	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24N	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-C8-A12L	FEMALE	363	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	363			TUMOR FREE				67	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12L	441919eb-8c9f-478c-bda3-8de4f8295e8a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	12	-24710	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12L-F20258	9A790E77-B373-41E6-98DD-4520857BB46F				9		Not Available	Not Applicable	363		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Suregery	Other method, specify:	Equivocal	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A12L	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AN-A0XU	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			Not Available				54	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A0XU	a1da9db1-db11-4f4d-a249-c738db81b87e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	Not Available	28	-20052	Not Applicable	0	10	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XU-F68961	4194E7B2-A2E1-4D92-80F0-394939FBCD04				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0XU	Not Available	Not Available	Not Available	Not Available	0	0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A26W	FEMALE	381	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	381			TUMOR FREE				58	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-C8-A26W	ff0f875f-113a-4c0f-8c0a-4259cd496e6d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	21	-21391	Not Applicable	0	7	Not Available	Not Available	TCGA-C8-A26W-D70797;TCGA-C8-A26W-D70798	6FA5FD97-F91B-4EA5-8434-AD7296AE38C1;C80FD468-DF82-483E-8999-EF2110391C96	Not Available;Not Available	9;9	193;193	23;23	Doxorubicin;Cyclophosphamide	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A26W-F70796	0471D048-FE29-4B0C-AC3B-79C58867B410				9			Not Applicable	381																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A26W	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 8	Allred Score 8	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A6VX	FEMALE	317	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	317			TUMOR FREE				68	Left;Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A7-A6VX	7EEA2B6E-771F-44C0-9350-38F45C8DBE87	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	29	-25066	Not Applicable	0	169	Not Available	Not Available	TCGA-A7-A6VX-D50834;TCGA-A7-A6VX-D50836;TCGA-A7-A6VX-D57517	660703C0-DE54-4AB9-A7E1-9AC73C6D7D75;7F01C477-E69D-4E9E-81AB-2DB85686C1D2;699D81B9-5EC8-4E6A-AE3A-3C9AD9B40B98	Not Available;Not Available;Not Available	31;31;13	142;142;Not Available	79;79;230	Docetaxel;Cyclophosphamide;Anastrazole	Complete Response;Complete Response;Not Applicable	10;10;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2014	Immune Stain by GenPath	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A6VX-F57518	447123BC-55E4-401F-9F3E-452E63FAED88				13			Not Applicable	317																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VX	TUMOR FREE	Immune stain by GenPath	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field;Primary Tumor Field	TCGA-A7-A6VX-R57519;TCGA-A7-A6VX-R57531	717DF965-D0A9-459A-8C2F-BDB9C73B25D6;77DBF440-49CC-420D-B998-91FAAED0B34A	Not Available;Not Available	14;14	204;220	170;206	Complete Response;Complete Response	3;3	25;10	4500;2000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2013
TCGA-AC-A8OQ	FEMALE	34	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	34			TUMOR FREE				72	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A8OQ	DFAABD03-2D40-4422-B210-CAF112FF4229	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	26	-26535	Not Applicable	0	34	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Indeterminate	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A8OQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2011
TCGA-A2-A0YE	FEMALE	554	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	554			TUMOR FREE				48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0YE	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	10	-17727	Not Applicable	0	253	Not Available	Not Available	TCGA-A2-A0YE-D5668;TCGA-A2-A0YE-D5669;TCGA-A2-A0YE-D5670	8aff8385-be06-4dc8-900a-bd3755cdd8e5;635760ed-24dd-4491-bd61-c6793eb02a35;a2d7f767-e939-4557-b767-387f1623d5ba	Not Available;Not Available;Not Available	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Taxotere;Adriamycin;Cytoxan	Not Available;Not Available;Not Available	12;12;12	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YE-F15771	7D263191-4081-4DD8-9E46-6D37D7714745				30		Not Available	Not Applicable	554		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	No membrane staining or incomplete membrane staining in <10% of tumor cells is negative	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	Not Available	No	A0YE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YE-R5671	2fe7a331-456c-44f1-913e-6bb5abdea657	1	8	267	225	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2010
TCGA-E2-A1B4	FEMALE	1004	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N2a	M0	Stage IIIA	0	1004			TUMOR FREE				74	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1B4	dbb2da92-99dd-400c-bc05-e87d7273656c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	25	-27241	Not Applicable	0	911	Not Available	NO	TCGA-E2-A1B4-D19444	A6C154F3-9CE0-4FC3-943B-640A43ADC915	Not Available	8	1004	176	arimidex	Not Available	12	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	828	mg	Not Available	2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1B4-F19443	C0578C7E-FCF4-4943-8D39-E0350CDF44D3				8		Not Available	1004	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	10-19%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	3	Not Available	No	A1B4	TUMOR FREE	Allred score 5+3 = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1B4-R19446	BD169F79-61EA-4201-866C-A99BFEB0CFC4	1	8	187	83	Not Available	12	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A24O	FEMALE	3607	Mixed Histology (please specify)	Breast	Alive	T3	N2	M0	Stage IIIA	1	2561.0			TUMOR FREE				43	Left	Not Available	Not Available	TCGA-AR-A24O	125b0a9a-6cbe-4207-9178-e7ff03487e87	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	16	-15977	Not Applicable	0	1998	Not Available	Not Available	TCGA-AR-A24O-D31366;TCGA-AR-A24O-D31363;TCGA-AR-A24O-D31360;TCGA-AR-A24O-D31367;TCGA-AR-A24O-D31368	473BCA10-A4E7-4AEE-AA89-5A8A66DABFEF;8B674BE2-3DB0-4A12-942B-F5E9B424F4A1;38BF2C09-8748-454C-A56E-36FDD41E6268;342B68A1-E8FE-4380-A4A7-669B934A259E;70462AEF-4D61-423E-9388-4DAA2DFDDAE5	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	149;93;93;1994;2283	107;44;44;153;1998	Paclitaxel;Cytoxan;Doxorubicin;Tamoxifen;Letrozole	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	4;4;4;Not Available;Not Available	175;600;60;20;2.5	mg/m2;mg/m2;mg/m2;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2;3	IV;IV;IV;PO;PO	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	1200;3820;390;Not Available;Not Available	mg;mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24O-F31356;TCGA-AR-A24O-F49492;TCGA-AR-A24O-F71713	6C6CAD9C-079E-4CB1-BA22-BFB702D52A2E;93ABDAE4-8A54-4D8A-BA69-C7706A59F8D4;E72F8FEE-ED75-4BD3-9257-CC47C1D1BD62				1;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1998;2561;3607		2561;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	YES;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;2561;2561	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;YES;YES	WITH TUMOR;WITH TUMOR;WITH TUMOR			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Lobular carcinoma with ductal features	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Negative	Not Evaluated	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	7	Not Available	No	A24O	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24O-R31357	7319E2CD-94B7-467E-A60A-FF7EBEA36F2C	1	1	218	174	Not Available	5	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-A7-A0CG	FEMALE	1043	Mixed Histology (please specify)	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1043			TUMOR FREE				78	Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A0CG	67eef990-5ff4-45d1-843d-d22d7848f130	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	7	-28596	Not Applicable	0	167	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0CG-F3066;TCGA-A7-A0CG-F39202	390BC631-A036-45D1-B4F2-9E55C4B00237;1A0EDC84-2E6A-4F64-80E3-F86E7F597E1A	Not Available;None	Not Available;None	Not Available;None	8;15	Not Available;None	Not Available;None	Not Applicable;Not Applicable	231;1043	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;1					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;Unknown	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	NO;NO	Not Available;None	YES;YES	Alive;Alive	2010;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Mixed infiltrating lobular and grade 1 ductal carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A0CG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0CG-R3053	8a3d7282-2622-42f4-a841-7621c3e442c7	1	8	176	146	Not Available	11	42	10480	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2010
TCGA-A2-A04V	FEMALE	1920	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	0	1920			WITH TUMOR				39	Right Lower Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A04V	64f67506-f2df-4f0a-b7be-29b4949e986a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	10	-14250	1920	0	Not Available	Not Available	Not Available	TCGA-A2-A04V-D2667;TCGA-A2-A04V-D2673;TCGA-A2-A04V-D2672;TCGA-A2-A04V-D2768;TCGA-A2-A04V-D2674;TCGA-A2-A04V-D2668	e691b7e7-6b22-430c-9b18-b7f08912f85a;41160c56-81c5-42b7-83b8-cc0018073cac;c1e949b8-77cf-4bbb-b6f2-a74ede20457a;4de0e435-5d29-44a0-a877-986681b96a3b;a2308b51-8301-425e-b065-0be458fe1672;8e869f6b-ed8a-4174-ad9e-fff54d6496cc	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	92;Not Available;1258;1439;Not Available;92	50;1452;107;1269;1577;50	CYTOXAN;EXEMESTANE;TAMOXIFEN;LETROZOLE;XELODA;ADRIAMYCIN	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8	4;Not Available;Not Available;Not Available;Not Available;4	1146;25;20;2.5;Not Available;115	mg;mg;mg;mg;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;4;3;6;5;2	IV;PO;PO;PO;PO;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4584;Not Available;Not Available;Not Available;Not Available;460	mg;Not Available;Not Available;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	NO	NO	TCGA-A2-A04V-F10273	8A12F731-0D21-451D-AED9-2677F2356DE2	Not Available	Not Available	Not Available	18	Not Available	Not Available	1920	Not Available	Not Available	1470	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																						WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	0	No	A04V	WITH TUMOR	Not Available	Not Available	Not Available	MODERATE	STRONG	Not Available	Not Available	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2005
TCGA-PE-A5DE	FEMALE	2645	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2645			TUMOR FREE				41	Left	Not Available	Not Available	TCGA-PE-A5DE	89C128B9-1C6B-4C04-A4AF-7066772E783C	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	24	-15216	Not Applicable	0	1855	Not Available	Not Available	TCGA-PE-A5DE-D42973;TCGA-PE-A5DE-D66369;TCGA-PE-A5DE-D66370	F709235A-EEE6-4F2B-BCB5-C273A7BC66D0;1E2B873D-3AE8-418A-8727-97077CF103B5;444F6B72-2D26-488F-AE79-26A7C0CEA076	Not Available;Not Available;Not Available	6;13;13	105;105;Not Available	42;42;182	Taxotere;Cytoxan;Tamoxifen	Complete Response;Complete Response;Not Applicable	5;10;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2014;2014	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available					TCGA-PE-A5DE-F66373	18DA1661-A5A3-419D-B7FA-A5B9C32431B1				13			Not Applicable	2645																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5DE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-PE-A5DE-R66372	8C0689B9-FFAA-4060-86D2-7CEFD920316E	Not Available	13	167	124	Complete Response	10	32	4600	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Partial Mastectomy	NO	YES	PE	Breast	Not Applicable	Alive	2013	2007
TCGA-OL-A6VR	FEMALE	1220	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	MX	Stage IA	0	1220			TUMOR FREE				48	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-OL-A6VR	DB3E1CE8-4A05-4BFC-B5AE-13CF789369E1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	5	-17702	Not Applicable	0	848	Not Available	Not Available																								Not Available	30-39%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A6VR-F59367	FEC2BC26-90CA-4ACF-87BF-4F743CBDB5D4				10			Not Applicable	1220																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.23	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	2	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	90-99%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1b	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2011
TCGA-A7-A4SD	FEMALE	441	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	441			TUMOR FREE				52	Right	Sentinel node biopsy alone	Not Available	TCGA-A7-A4SD	8C09F413-E938-4F2E-A414-84F0E7FCFE41	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	19	-19131	Not Applicable	0	168	Not Available	Not Available	TCGA-A7-A4SD-D40418;TCGA-A7-A4SD-D40420	AC6661B8-5744-4B0F-99D8-1C6C82FF86D4;642ABB42-0832-4A3A-9FB0-AE825D90EEC6	Not Available;Not Available	19;19	134;134	64;64	Taxotere;Cytoxan	Complete Response;Complete Response	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	5					TCGA-A7-A4SD-F52732	DDAD5580-4821-46F0-9F96-9C8F4615A7DF				5			Not Applicable	441																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA Probe Kit	2+	20	Not Available	6.4	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4SD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-OL-A6VQ	FEMALE	600	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	600			TUMOR FREE				49	Right	Not Available	Not Available	TCGA-OL-A6VQ	34126CD5-CC38-4198-8582-C14FB5DB7ACB	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Positive	Lumpectomy	Not Applicable	Not Available	20	-18151	Not Applicable	0	229	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A6VQ-F59366	7EB828D6-D22B-42FC-B51A-FE00B3181056				10			Not Applicable	600																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.05	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Not Evaluated	Negative	1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	10-19%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2014	2012
TCGA-OL-A5RU	FEMALE	1219	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	MX	Stage IIA	0	1219			TUMOR FREE				63	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A5RU	B8A44FDF-9CB9-4123-9AB0-4BC198921FEE	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Unknown	16	-23108	Not Applicable	0	841	Not Available	Not Available	TCGA-OL-A5RU-D65252;TCGA-OL-A5RU-D65253	69BA6DFE-4BE6-4D86-BA5B-77352DEA913A;6A5D8B38-7542-47E7-BC90-14735FEA1214	Not Available;Not Available	24;24	134;134	71;71	cyclophosphamide;docetaxel	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	90-99%	Unknown	Not Available	Not Available	Not Available					TCGA-OL-A5RU-F56569	117AF3FA-5687-4518-936E-40CD09BB40E5				14			Not Applicable	1219																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.02	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5RU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	80-89%	BLACK OR AFRICAN AMERICAN	YES	Regional site	TCGA-OL-A5RU-R65251	22B829AF-B769-4C42-B835-9B5461DCF6FC	Not Available	24	197	160	Complete Response	9	Not Available	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2010
TCGA-E2-A155	FEMALE	640	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	640			TUMOR FREE				58	Left Upper Inner Quadrant;Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A155	01f50abf-fc15-446e-9d07-edeecc545a32	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	7	-21348	Not Applicable	0	553	Not Available	NO	TCGA-E2-A155-D18962;TCGA-E2-A155-D19107;TCGA-E2-A155-D19105;TCGA-E2-A155-D18944;TCGA-E2-A155-D19111	E7F98449-1AD2-4788-98A9-C1B731F13D28;FF8866DF-0183-4B72-8285-E71C4F120359;39BFC0D7-45BC-4640-BA13-4397A0A9CE06;C399DF54-62D4-49E4-AB11-5B0008E16218;DFA20391-05F7-4053-9EC5-1BD5F5261968	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	Not Available;249;Not Available;Not Available;Not Available	30;Not Available;Not Available;30;249	Cytoxan;Tamoxifen;Taxol;Adriamycin;Arimidex	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	4;Not Available;12;4;Not Available	Not Available;20;Not Available;Not Available;1	Not Available;mg/day;Not Available;Not Available;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;1;4	Not Available;PO;Not Available;Not Available;PO	NO;NO;NO;NO;YES	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;20;Not Available;Not Available;1	Not Available;mg/day;Not Available;Not Available;mg/day	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A155-F18942	35A9196F-3E2C-44FE-822F-32FB066756A0				8		Not Available	Not Applicable	640		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	2	Not Available	No	A155	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-LL-A7T0	FEMALE	376	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	376			Unknown				70	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-LL-A7T0	D8F8064F-02EF-4FED-942B-714CBE5E8455	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	3	-25867	Not Applicable	0	98	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A7T0-F64970	5E8482F3-AA4B-4156-A3DD-F383B7FF97D8				16			Not Applicable	376																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	1	Not Available	No	A7T0	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	<10%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2014	2013
TCGA-BH-A0AY	FEMALE	777	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	777			TUMOR FREE				62	Left Lower Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0AY	93ed6066-b567-4e1c-ab81-23370f9d3452	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	3	-22703	Not Applicable	0	777	Not Available	Not Available	TCGA-BH-A0AY-D15457;TCGA-BH-A0AY-D15459	3FA11B70-C4E4-4DA1-954E-E885461FFC9D;CEBF2E3D-12FA-496F-96BE-C677BBC8A801	Not Available;Not Available	3;3	192;Not Available	131;209	Unknown;Aromasin	Not Available;Not Available	11;11	4;Not Available	Not Available;50	Not Available;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;PO	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0AY-F15456	A54FAA28-CE61-4E7A-A5C4-2CC9FFE880CA				3		Not Available	Not Applicable	777		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0AY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-AO-A0JD	FEMALE	2190	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	2190			TUMOR FREE				59	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JD	0a229f95-0ea1-4d63-953e-74f5ec2f3028	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-21831	Not Applicable	0	1813	Not Available	Not Available	TCGA-AO-A0JD-D3196;TCGA-AO-A0JD-D3190;TCGA-AO-A0JD-D3195;TCGA-AO-A0JD-D3188	2d8f1a8d-5cbd-4852-b7e3-145eec155402;447d92b5-bace-4477-9abc-3687a1fab237;4c003fb7-7ce0-45bf-bec5-8af6fb62d6b3;bf1780f4-0ad9-4861-ab51-bf0698571363	Not Available;Not Available;Not Available;Not Available	20;20;20;20	Not Available;104;160;104	261;62;118;62	ANASTROZOLE (ARIMIDEX);CYCLOPHOSPHAMIDE;PACLITAXEL;DOXORUBICIN	Not Available;Not Available;Not Available;Not Available	9;9;9;9	Not Available;4;4;4	1;600;175;60	mg/day;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;4536;1296;452	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	49	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JD-F3185;TCGA-AO-A0JD-F15487	54A693AC-26E1-4E40-9878-D73CBC2BE8EA;A1246D11-43BB-492B-AE6E-FDB6790A8599	Not Available;None	Not Available;None	Not Available;None	20;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1813;2190	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	RATIO > = 2.0	1+	20	Not Available	68	1.4	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	3	0	No	A0JD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	WHITE	Not Available	Regional site	TCGA-AO-A0JD-R3186	aaf5b702-d5e8-428b-bab0-d0534119f010	1	20	244	195	Not Available	9	33	10620	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2005
TCGA-D8-A1JB	FEMALE	1688	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1688			TUMOR FREE				54	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JB	dd96a9c7-899c-47cd-a0f9-b149ed07a5d6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	29	-19822	Not Applicable	0	365	Not Available	Not Available	TCGA-D8-A1JB-D20850;TCGA-D8-A1JB-D65318	169E2D43-D1E5-42FF-AA6C-DB036D823477;31DE8E14-409E-43CB-96CD-369FD9AF142F	Not Available;Not Available	19;22	111;111	51;51	adriamycin;cyclophosphamide	Not Available;Not Available	1;9	4;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	240;Not Available	mg;Not Available	Not Available;NO	2012;2014	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-D8-A1JB-F20852;TCGA-D8-A1JB-F72209	B676086B-3785-49BA-BD79-4DE804A29EA2;8A90816F-786C-42BC-A9D7-81292956CE90				19;29		Not Available;None	Not Applicable;Not Applicable	569;1688		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Path Vysion HER2 DNA Probe Kit	2+	Not Available	Not Available	not amplified	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Positive	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A1JB	TUMOR FREE	manual counting	Not Available	Not Available	10-75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1JB-R20851	8B735435-06BF-4F0A-880B-532D5CA6D853	Not Available	19	554	532	Not Available	1	Not Available	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A1F6	FEMALE	2965	Infiltrating Ductal Carcinoma	Breast	Dead	T4d	N2a	MX		0	2965			Not Available				51	Left	Not Available	Not Available	TCGA-BH-A1F6	ad18820b-a804-49c0-ba8a-86c09fa6bce2	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	7	-18691	2965	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	6	Not Available	No	A1F6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	MX	N2a	T4d	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1996
TCGA-E2-A1LS	FEMALE	1604	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	1604			TUMOR FREE				46	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1LS	91a2f2af-e4b1-4a0b-ab20-6a36ce63c533	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	3	-16887	Not Applicable	0	239	Not Available	NO	TCGA-E2-A1LS-D20604;TCGA-E2-A1LS-D20606	225992D9-0568-4DD6-BF26-D1C6E065C3DE;ECEACF6D-18C4-4309-8AA5-54E2B721DAFE	Not Available;Not Available	17;17	112;112	Not Available;Not Available	Cyclophosphamide;Taxotere	Not Available;Not Available	1;1	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Allred score 0+0 = 0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1LS-F20603;TCGA-E2-A1LS-F70016	512AFC08-F4A9-4570-91A2-F8F491877292;D73A246D-93CE-4E3C-8364-A243EFA91C86				17;9		Not Available;None	Not Applicable;Not Applicable	470;1604		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1LS	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A145	FEMALE	410	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	410			TUMOR FREE				80	Right Upper Inner Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-D8-A145	4958c36f-1dc7-4f14-9dec-36e14107dbe3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	25	-29280	Not Applicable	0	49	Not Available	Not Available	TCGA-D8-A145-D13812	9C0F81FC-804B-4F15-901B-D5256B63E8AF	Not Available	4	Not Available	42	Tamoxifen	Not Available	7	Not Available	20	mg/day	ADJUVANT	Not Applicable	tamoxifen daily	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A145-F13811	B69A91EE-1BA2-4163-A64D-36753ABD9880				4		Not Available	Not Applicable	410		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	Not Available	No	A145	TUMOR FREE	manual counting	Not Available	Not Available	Not Available	>75%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A14T	FEMALE	2311	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2311			TUMOR FREE				52	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A14T	e0929c47-cff3-4518-a188-8764af01073a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	6	-19237	Not Applicable	0	890	Not Available	NO	TCGA-E2-A14T-D18829;TCGA-E2-A14T-D18826;TCGA-E2-A14T-D18818;TCGA-E2-A14T-D18823	A411020C-8212-4584-90F9-D797C7120B81;88256CB4-C3CF-4406-866A-27621E1D1013;491C04CD-29DC-4BA7-AC0E-EB33E9119638;0EA62B2B-479A-481F-8E0A-271DDF8A2202	Not Available;Not Available;Not Available;Not Available	7;7;7;7	Not Available;145;89;89	159;103;47;47	Arimidex;Paclitaxel;Doxorubicin;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;4;4;4	1;357;124;1242	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;2;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1;1428;496;4968	mg/day;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A14T-F18814;TCGA-E2-A14T-F70396	57A9496F-A47A-430A-A574-AA4A953432BA;A5C92857-ABED-45D2-8326-E7A5DFA71B1F				3;17		Not Available;None	Not Applicable;Not Applicable	1013;2311		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.29	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Negative	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14T	TUMOR FREE	Allred score 2+2 = 4	Not Available	Not Available	Allred score = 4	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A0E9	FEMALE	2489	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2489			TUMOR FREE				53	Right	Not Available	Not Available	TCGA-BH-A0E9	76ace6aa-0505-442c-978a-f889cf2d44bb	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	11	-19415	Not Applicable	0	1405	Not Available	NO	TCGA-BH-A0E9-D59110;TCGA-BH-A0E9-D59111;TCGA-BH-A0E9-D59113	ED0808E6-A224-44C7-8353-2A9DF81486C5;303A080F-9FE8-4C7A-B424-44DF8F97B57C;D3529E84-7664-4493-AF4D-F8B121B6983B	Not Available;Not Available;Not Available	1;1;1	503;503;503	96;96;96	Taxotere;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-BH-A0E9-F59107	265B9809-54D2-4DF5-8DB0-4D44667B3A1E				1			Not Applicable	2489																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	3	Not Available	No	A0E9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-BH-A0E9-R59108;TCGA-BH-A0E9-R59109	D79458CD-6078-486D-8B25-624CA0AF0452;F5797B5C-F9B3-4797-9DE9-0A5DEACCBF3C	Not Available;Not Available	1;1	189;201	150;192	Complete Response;Complete Response	5;5	28;7	5040;1400	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-BH-A0HU	FEMALE	392	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	392			TUMOR FREE				52	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0HU	dc657ca8-98e8-4ec4-a513-1b848be0e85d	Not Available	Positive	Not Available	2+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	11	-19216	Not Applicable	0	392	Not Available	Not Available	TCGA-BH-A0HU-D4801;TCGA-BH-A0HU-D4803;TCGA-BH-A0HU-D4802	6D4CA4CC-7926-4E56-B25B-F27500BD827C;26626424-B305-42C3-A6BD-086F573FE20B;5F867E23-30D8-48D8-B2D0-B005C681645F	Not Available;Not Available;Not Available	17;18;18	Not Available;110;110	110;47;47	Tamoxifen;Docetaxel;Cyclophosphamide	Not Available;Not Available;Not Available	11;11;11	Not Available;4;4	20;170;1362	mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;684;5472	Not Available;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	H-Score 140	40-49%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HU-F4813	40F5F2C3-261E-4B28-ACD9-B4999AFB0205	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	392	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0HU	TUMOR FREE	H-Score 140	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0HU-R4804	3BA2AF28-AFDF-46E2-A50D-AB7322DF428C	1	17	196	155	Not Available	11	30	5750	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-BH-A201	FEMALE	856	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage IA	0	856			TUMOR FREE				64	Left	Not Available	Not Available	TCGA-BH-A201	3bf81a9f-abb4-4495-a514-fd3865e13a03	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	8	-23423	Not Applicable	0	210	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A201-F64222	D0597150-E8C6-47DC-A8B9-BD013573E573				27			Not Applicable	856																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A201	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A201-R64223	94B7945B-92D9-4D1A-868B-84D66F2C3F4D	Not Available	27	108	56	Complete Response	8	28	6640	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	segmental mastectomy with sentinel lymph node biopsy and wire localization	NO	YES	BH	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A06X	FEMALE	943	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N0	M0	Stage IIB	0	943			TUMOR FREE				77	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A06X	70931617-b3df-4a12-8e3f-2b2307602f48	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-28338	943	0	Not Available	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A06X-F40818	1791687B-A509-4CA3-B10E-4EDB80B779B6				2			943	Not Available																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		YES	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06X	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A06X-R38179	0E1337C9-4541-4CCF-B78A-A3CF4F763A06	Not Available	11	92	61	Unknown	12	Not Available	52	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Dead	2011	2006
TCGA-BH-A42V	FEMALE	635	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IB	0	635			TUMOR FREE				41	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A42V	57CF380D-AB52-467F-B9AE-740B2F84C820	Negative	Positive	Not Available	Not Available	Not Available	Other	Positive	Modified Radical Mastectomy	Reexcision of segmental mastectomy	Not Available	17	-15158	Not Applicable	0	272	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A42V-F61941	2027C9E7-9C37-444B-A786-938EFDD802E6				10			Not Applicable	635																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A42V	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-BH-A42V-R61942	623AE02D-1141-4C6D-A4E3-FB0DA24B9110	Not Available	10	141	92	Complete Response	7	36	66.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2013	2012
TCGA-BH-A0HO	FEMALE	76	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	76			TUMOR FREE				48	Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0HO	8332806e-f547-4aae-89af-6d5bec831fd2	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Other	Not Applicable	YES	11	-17710	Not Applicable	0	76	Not Available	Not Available	TCGA-BH-A0HO-D4766;TCGA-BH-A0HO-D4767;TCGA-BH-A0HO-D4765;TCGA-BH-A0HO-D4763	DA5665DF-7CBC-43C3-8336-3A83A34713D9;DADE4DB6-CB27-4D06-88B6-8C4F1526C992;A3D353FB-8B2F-42C9-BD6E-D38D90A0568E;55BAEF2A-C3A1-470D-92D7-80BF180C4054	Not Available;Not Available;Not Available;Not Available	22;22;22;30	182;287;182;Not Available	119;210;119;378	Cyclophosphamide;Paclitaxel;Doxorubicin;Tamoxifen	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;12;4;Not Available	860;115;86;20	mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	3440;1380;344;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-Score 200	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HO-F4771	58E9756A-3F14-478E-8CF9-BFFB29089102	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	76	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	1	No	A0HO	TUMOR FREE	H-Score 290	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0HO-R4769	95039DE4-9BE0-4A86-A302-3D44887F8231	1	30	369	312	Not Available	11	33	6060	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-E2-A15I	FEMALE	1692	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1692			TUMOR FREE				44	Left Upper Outer Quadrant;Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15I	64089c20-939f-48b4-ae8b-904ad0597145	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	13	-16163	Not Applicable	0	411	Not Available	NO	TCGA-E2-A15I-D18890	F282FF05-35FC-48D3-B9BD-E0006F0F255D	Not Available	14	Not Available	41	Tamoxifen	Not Available	11	Not Available	20	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	20	mg/day	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A15I-F18888;TCGA-E2-A15I-F70023	FC992314-E382-422C-8DCB-0F5EA947DCD4;6FDF2BA1-9D26-4621-A9B4-D4CD25811DB6				14;9		Not Available;None	Not Applicable;Not Applicable	530;1692		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.04	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15I	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A0HX	FEMALE	829	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	829			TUMOR FREE				54	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0HX	3b01d064-8c00-4972-9f07-407eac8e7534	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	YES	11	-19900	Not Applicable	0	829	Not Available	Not Available	TCGA-BH-A0HX-D4837;TCGA-BH-A0HX-D4833;TCGA-BH-A0HX-D4836;TCGA-BH-A0HX-D4834	D1EDD48C-D395-40FC-AADC-7222D4037419;B906D9FD-E934-49A6-B493-F9E15460BEDE;E0A73F7B-3621-4C44-B73F-4C6B1CEC05B8;80535D9D-13BA-4040-A6CB-E650C6AC3E4D	Not Available;Not Available;Not Available;Not Available	17;18;18;18	Not Available;Not Available;Not Available;Not Available	278;117;Not Available;117	Arimidex;Adrimycin;Taxotere;Cytoxan	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;Not Available;Not Available;Not Available	1;Not Available;Not Available;Not Available	mg/day;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-Score 270	80-89%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HX-F4838	477758CF-349A-441F-B63C-93C9677D3415	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	829	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	2	No	A0HX	TUMOR FREE	H-Score 190	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	50-59%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-BH-A0E0	FEMALE	134	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N3a	M0	Stage IIIC	0	134			TUMOR FREE				38	Left Upper Outer Quadrant;Left Lower Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0E0	20e8106b-1290-4735-abe4-7621e08e3dc8	Not Available	Negative	Not Available	0	Not Available	Not Evaluated	Negative	Modified Radical Mastectomy	Not Applicable	NO	9	-14175	Not Applicable	0	134	Not Available	Not Available	TCGA-BH-A0E0-D4599;TCGA-BH-A0E0-D4596;TCGA-BH-A0E0-D4593	8EB7D1DE-E03C-401A-A845-0B5329E85271;DF2372AA-F01A-4FB6-9656-6FE9E01FE4E1;B2E22558-CF61-46B8-90DA-D2B204CF8D7A	Not Available;Not Available;Not Available	18;18;18	143;143;143	38;38;38	DOCETAXEL;DOXORUBICIN;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available	11;11;11	6;6;6	130;87;820	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	763;503;5034	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	H-SCORE 0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0E0-F4603	8EA495C0-4ADC-49A9-9235-6D360CB615E2	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	134	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	No	A0E0	TUMOR FREE	H-SCORE 0	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0E0-R4601	7729AB44-C0F8-40F3-A012-E97C7F94CAC7	1	22	255	198	Not Available	11	Not Available	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-BH-A0E1	FEMALE	477	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	477			TUMOR FREE				52	Left Upper Inner Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0E1	606fbc6a-b41b-441d-9401-51e54912bf5e	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	NO	9	-19192	Not Applicable	0	477	Not Available	Not Available	TCGA-BH-A0E1-D4606;TCGA-BH-A0E1-D4605;TCGA-BH-A0E1-D4630;TCGA-BH-A0E1-D4604	F8C26458-97F0-4CF8-A153-FBA11A222937;80A0A78F-619A-4E22-AFF1-7C0E3E08A26B;040CDDFF-2EDD-437D-AB7D-3C4C995301A3;87AC4755-E995-47CF-90E0-FDD408456387	Not Available;Not Available;Not Available;Not Available	30;30;30;30	203;203;596;Not Available	140;140;308;349	CYTOXAN;ADRIAMYCIN;TAXOTERE;ARIMIDEX	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;4;12;Not Available	Not Available;Not Available;Not Available;1	Not Available;Not Available;Not Available;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-SCORE 180	70-79%	Not Available	Not Available	Not Available	1.67	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0E1-F4631	CFD1B195-8DD2-421F-B5EC-E88E05B12781	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	477	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	2.81	1.69	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	17	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0E1	TUMOR FREE	H-SCORE 245	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	50-59%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-A2-A0T5	FEMALE	531	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	531			TUMOR FREE				39	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0T5	36d77496-99f8-4911-ba7c-89fae32662aa	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	9	-14503	Not Applicable	0	321	Not Available	Not Available	TCGA-A2-A0T5-D4004;TCGA-A2-A0T5-D4005;TCGA-A2-A0T5-D4007	da0a191b-d070-4b24-a363-86c0b3ba4582;651802d7-8efb-4de1-acac-0cde103d8b74;ad72c4e8-6494-47a3-b46a-180feb91e7ce	Not Available;Not Available;Not Available	9;9;9	166;166;Not Available	Not Available;Not Available;Not Available	Taxotere;Cytoxan;Tamoxifen	Not Available;Not Available;Not Available	11;11;11	4;4;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	IV;IV;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0T5-F13949	FF9E318B-6811-4218-A62F-2D57AA48A597				12		Not Available	Not Applicable	531		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	0	No	A0T5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-E2-A14Q	FEMALE	1163	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	M0	Stage IIB	0	1163			TUMOR FREE				50	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14Q	303a1d77-a37a-4966-a4a4-9981d99ba1b4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	31	-18507	Not Applicable	0	974	Not Available	NO	TCGA-E2-A14Q-D18801	38EC0589-8337-4CE8-B1F2-D4F29BB091A1	Not Available	20	Not Available	53	Tamoxifen	Not Available	10	Not Available	20	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	20	mg/day	Not Available	2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14Q-F18800	D5D37217-A5A0-4F1E-A521-F1E6125491B4				20		Not Available	Not Applicable	1163		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A14Q	TUMOR FREE	Allred score 5+3 = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A1AS	FEMALE	1150	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1150			Not Available				54	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AR-A1AS	7d681cc6-689d-41c8-9e84-e13733089ec9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	14	-20028	Not Applicable	0	1150	Not Available	Not Available	TCGA-AR-A1AS-D22098;TCGA-AR-A1AS-D22092;TCGA-AR-A1AS-D22094	A43B3752-2843-4BA5-A3BA-DB1229CD3C62;31EE0BA4-5B45-4A29-BE1E-D544D6290707;FE2D8B3C-0216-4CAE-B606-2C2BF40EBB87	Not Available;Not Available;Not Available	27;28;28	Not Available;43;43	57;29;29	Anastrozole;Doxorubicin;Cytoxan	Not Available;Not Available;Not Available	2;2;2	Not Available;2;2	1;60;600	mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;200;1970	Not Available;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	70-79%	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AS-F22088;TCGA-AR-A1AS-F49470	6568AC84-702A-4E37-9A5D-F8A2C0B5CEBE;86521E70-553E-442A-BB81-F0E66AEFAE1B				28;2		Not Available;None	Not Applicable;Not Applicable	1150;1150		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			NO;NO		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1AS	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	ASIAN	Not Available	Primary Tumor Field	TCGA-AR-A1AS-R22090	82211072-5912-45D8-9836-6D27865EF389	1	28	118	77	Not Available	2	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-BH-A0BQ	FEMALE	2255	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	1	1709.0	Other, specify	Locoregional Recurrence	TUMOR FREE				39	Left	Not Available	Not Available	TCGA-BH-A0BQ	b3bb8fd6-ee54-4813-b042-2bbe70115382	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	10	-14494	Not Applicable	0	827	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BQ-F58695	25CF786D-560F-4C04-A050-A7C323A6D649				22			Not Applicable	2255																				NO																						4					Not Available	Not Available	1750	1709	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Locoregional Recurrence	Dermis and epidermis	YES	Not Available	YES	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Total mastectomy with retromammary lymph node excision	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-AR-A2LO	FEMALE	1198	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1198			Not Available				46	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LO	AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	12	-17080	Not Applicable	0	633	Not Available	NO	TCGA-AR-A2LO-D37194;TCGA-AR-A2LO-D37258;TCGA-AR-A2LO-D37259;TCGA-AR-A2LO-D37607;TCGA-AR-A2LO-D37608;TCGA-AR-A2LO-D37609	FAE98AD4-647B-4B8A-877A-9A3E35C85515;B5922B72-CFFD-4EE0-9F3E-35C6AE2A69D9;0751053B-FD4A-4022-A9A0-46243CD85D32;97212CFD-8883-4CC9-BED8-3F45E9AB5E76;03E05488-13C5-4F00-BB7D-AA459862D124;6F0A0541-DE11-49E8-914A-2AE90BA4BB39	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7	84;84;175;161;903;Not Available	44;44;98;44;199;903	Adriamycin;Cytoxan;Paclitaxel;Bevacizumab;Tamoxifen;Anastrozole	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;YES	2012;2012;2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LO-F37193;TCGA-AR-A2LO-F49498	CDD91705-9314-4F46-A3AA-39BD618E4623;7D5DE440-FD86-4C8D-B599-F4AEB2820AA4				7;2			Not Applicable;Not Applicable	935;1198																				NO;Not Available																						12;10					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	Not Available;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	1	Not Available	No	A2LO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LO-R37257	ADDD5CDF-B239-4A98-AA02-A5DF64C626FF	Not Available	7	228	196	Not Available	12	25	5000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2012	2010
TCGA-AC-A2FB	FEMALE	1234	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	1234			TUMOR FREE				65	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A2FB	02BBB632-0F7F-439D-B8F0-C86A06237424	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	20	-23851	Not Applicable	0	44	Not Available	NO	TCGA-AC-A2FB-D45600;TCGA-AC-A2FB-D45601;TCGA-AC-A2FB-D45602	874799CE-92C6-4A14-9087-50637D5A0BFB;83D4DEF8-DDC1-4477-B951-DA1E2EE02B89;E9BB9D9C-C752-4FC4-AA16-B531C23C1BEF	Not Available;Not Available;Not Available	17;17;17	205;443;895	101;212;225	Taxotere;Herceptin;Arimidex	Complete Response;Complete Response;Complete Response	7;7;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2FB-F45574	64865AFC-B952-4D29-AEA3-BF902B430461				17			Not Applicable	1234																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	10-19%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	1	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A2FB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2009
TCGA-E2-A105	FEMALE	1308	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1308			TUMOR FREE				79	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A105	b0bcb829-cee0-4247-bb75-093a5bea89ee	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	11	-28855	Not Applicable	0	1163	Not Available	Not Available	TCGA-E2-A105-D7696	e88c01a6-d3d9-48bf-8e5e-929c0c0c7d9a	Not Available	14	Not Available	65	Arimidex	Not Available	2	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Allred score 3 + 2 = 5	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A105-F17431	98CF51C1-3D09-49B5-A0F2-BD06DB419082				9		Not Available	Not Applicable	1308		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	70-79%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A105	TUMOR FREE	Allred score 3 + 2 = 5	Not Available	Not Available	Allred score 5	Allred score 5	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A105-R7695	686c1c4e-ee34-4e9d-adfb-82306b6becf2	1	14	122	61	Not Available	2	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-D8-A4Z1	FEMALE	659	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	659			TUMOR FREE				68	Right;Right Upper Inner Quadrant	No axillary staging	Not Available	TCGA-D8-A4Z1	80419545-4E5D-4BAF-8948-F84589B5EF3E	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	1	-25097	Not Applicable	0	223	Not Available	Not Available	TCGA-D8-A4Z1-D39760	3EDA844D-C123-4BB2-8172-06DB3BAD4DD4	Not Available	1	Not Available	104	Tamoxifen	Not Applicable	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-D8-A4Z1-F58485	00555AC3-B1C1-4712-A6CD-9FDF98F9D2B3				11			Not Applicable	659																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A4Z1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	10-19%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2013	2012
TCGA-A8-A0A6	FEMALE	640	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	640			TUMOR FREE				64	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A0A6	4b0d295c-e185-4b52-9752-178e5bc1d47d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-23404	Not Applicable	0	640	Not Available	Not Available	TCGA-A8-A0A6-D37740;TCGA-A8-A0A6-D37741;TCGA-A8-A0A6-D37742;TCGA-A8-A0A6-D37743;TCGA-A8-A0A6-D37744	2FD51391-D472-472E-9309-A80A518724D1;B93873B4-2604-43FB-8AF4-C7BF99021F9A;0C70B64D-A56E-43D4-BC98-F0E21C22E396;524B50B7-2D72-437D-B997-68ACAEE9481B;81F60DB0-ED0A-47FB-8CCE-8848A03AB8F4	n/a;n/a;n/a;n/a;n/a	6;6;6;6;6	184;184;245;Not Available;Not Available	61;61;214;245;306	Epirubicin;Cyclophosphamide;Exemestane;Anastrozole;Zoledronic acid	Complete Response;Complete Response;Complete Response;Not Applicable;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A0A6-F40325	63860C23-6640-45E1-B9C8-1E420148833D				16			Not Applicable	640																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0A6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A0A6-R38120	B5A342AD-F331-44AF-8190-79467FA299ED	Not Available	11	275	214	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	surgical resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A1FH	FEMALE	1034	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M1	Stage IV	0	1034			WITH TUMOR				47	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FH	1783cac1-253a-40af-a9ac-48dfb20e1ab8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	8	-17172	1034	0	Not Available	Not Available	YES																								Not Available	Not Available	NOT HISPANIC OR LATINO	Bone	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	13	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	No	A1FH	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M1	N1b	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-AQ-A0Y5	FEMALE	172	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2a	MX	Stage IIIA	0	172			TUMOR FREE				70	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AQ-A0Y5	d0b78f3f-a198-437a-ab8c-204345d3b75d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	7	-25793	172	0	Not Available	Not Available	NO	TCGA-AQ-A0Y5-D10117;TCGA-AQ-A0Y5-D10118;TCGA-AQ-A0Y5-D10116	5fbb7fe9-4b27-43af-8832-ae64ee3e4acc;5c09333c-d15e-4c62-ad09-c1984b22cbda;1aef9741-6d96-4b9c-abcf-994ed14f4ce4	Not Available;Not Available;Not Available	7;7;7	146;146;146	83;83;83	Cytoxan;Herceptin;Taxotere	Not Available;Not Available;Not Available	4;4;4	4;4;4	600;8;75	mg/m2;mg/kg;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2400;32;300	mg/m2;mg/kg;mg/m2	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-AQ-A0Y5-F10119	7CB4C161-65D3-44E6-82F7-CDAA2C40D530	Not Available	Not Available	Not Available	7	Not Available	Not Available	172	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	3.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	5	Not Available	Yes	A0Y5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	40-49%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	YES	NO	AQ	Breast	Not Applicable	Dead	2011	2010
TCGA-BH-A42T	FEMALE	320	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N0 (i+)	M0	Stage IIA	0	320			TUMOR FREE				75	Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A42T	10C829EC-FD66-49C4-8AFE-AD3AE567372C	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	28	-27731	Not Applicable	0	30	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A42T-F61922	94A68C9F-6AE9-4265-8FB9-C05BC75D0B91				10			320	Not Available																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Equivocal	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	1	No	A42T	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2012	2012
TCGA-E9-A1N3	FEMALE	1059	Mixed Histology (please specify)	Breast	Alive	T1c	N2	M0	Stage IIIA	0	1059			TUMOR FREE				70	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1N3	03c143e0-d8a1-4d60-a4a3-df0501fc6b6e	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	26	-25714	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1N3-D39762;TCGA-E9-A1N3-D39763;TCGA-E9-A1N3-D39764;TCGA-E9-A1N3-D29142	21C8B531-6DB2-4EDA-91D6-9A71B698CFFA;896CF3A1-1C37-4ECE-8AAD-2408414FF8D7;B6DFF894-6069-4D41-8556-D15BC03DD3BF;3B2AB151-9032-4CCD-9351-CD95CFE9FBFD	Not Available;Not Available;Not Available;Not Available	1;1;1;27	68;68;68;Not Available	15;15;15;130	5-Fluorouracil;Doxorubicin;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Available	2;2;2;11	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;20	Not Available;Not Available;Not Available;mg/day	Not Available;Not Available;Not Available;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;2	Not Available;Not Available;Not Available;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;mg	NO;NO;NO;Not Available	2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1N3-F29141;TCGA-E9-A1N3-F62627	E73FFC2F-744D-472F-8A61-29D66DA1494C;51209566-A8D1-4EC8-8974-323532A10AAB				27;22		Not Available;None	Not Applicable;Not Applicable	541;1059		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;7	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	7	Not Available	No	A1N3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2010
TCGA-UL-AAZ6	FEMALE	518	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	518			TUMOR FREE				73	Right	Not Available	Not Available	TCGA-UL-AAZ6	4B54E06E-A280-4981-A4E1-9AEA154341B4	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	28	-26999	Not Applicable	0	426	Not Available	Not Available	TCGA-UL-AAZ6-D64302	764AAD53-3A9B-4942-82BD-DE5F2932C2B1	Not Available	28	Not Available	122	Herceptin	Not Applicable	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-UL-AAZ6-F69329	6E7AC488-7920-46A8-8009-C92426F9D8CC				5			Not Applicable	518																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3+	Not Available	90-99%	Positive	Not Available	Not Available	50-59%	Not Available	Not Available	3+	3 Point Scale	1+	3 Point Scale	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Not Available	Positive	Not Evaluated	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	AAZ6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	<10%	BLACK OR AFRICAN AMERICAN	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	UL	Breast	Not Applicable	Alive	2014	2013
TCGA-A2-A0CV	FEMALE	3011	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	3011			TUMOR FREE				41	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0CV	ad7fcc89-82a3-48aa-8461-581c1a857677	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-15289	Not Applicable	0	1870	Not Available	Not Available	TCGA-A2-A0CV-D7432;TCGA-A2-A0CV-D7431;TCGA-A2-A0CV-D7430;TCGA-A2-A0CV-D7428	546eb18e-fefa-41d3-a86b-bef28743095c;c7ce28fd-8d85-4a62-949f-f36325333465;f6b8fbb1-9792-48f4-ad8f-0f6490d403ae;0fecbde9-3113-43c9-9873-5c3dc1c9158c	Not Available;Not Available;Not Available;Not Available	1;1;1;1	Not Available;176;106;106	274;120;64;64	Tamoxifen;Taxol;Cytoxan;Adriamycin	Not Available;Not Available;Not Available;Not Available	2;2;2;2	Not Available;4;4;4	10;276;950;95	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;3;2;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;1104;3800;380	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0CV-F13722;TCGA-A2-A0CV-F59321	1CE47479-972B-4A3C-8A13-0093B066DBFA;70EFBD77-D291-4618-84F9-617087564F77				13;8		Not Available;None	Not Applicable;Not Applicable	1930;3011		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	4	0	No	A0CV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	ASIAN	Not Available	Primary Tumor Field	TCGA-A2-A0CV-R7434	ae409847-2014-463b-b89a-9b5c9ed32bb7	1	9	263	229	Not Available	2	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2005
TCGA-AN-A041	FEMALE	7	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	7			Not Available				29	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A041	316e021c-5175-4ab3-bdb6-2bf9683f657a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	Not Available	1	-10812	Not Applicable	0	7	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A041-F68971	D69B074B-6C93-4843-B205-6D3254728C90				24			Not Applicable	7																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A041	Not Available	Not Available	Not Available	Not Available	0	170	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A1KP	FEMALE	2953	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	2953			TUMOR FREE				77	Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A1KP	3aaabc62-f5a4-4025-9b29-5adf82c86c84	Not Available	Positive	4 Point Scale	4+	4 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	1	-28247	Not Applicable	0	2513	Not Available	NO	TCGA-AO-A1KP-D9888;TCGA-AO-A1KP-D9891;TCGA-AO-A1KP-D9889;TCGA-AO-A1KP-D9893	6dbc8d44-d5cc-47ee-884f-abfb08b15c5c;c40a1ef3-ee24-431c-bc24-3d0560dcebef;756b07bd-7b7d-499b-a092-be8e6c7eab77;263a6dfb-0cbe-43e4-84ce-66714eb4fe98	Not Available;Not Available;Not Available;Not Available	1;1;1;1	237;237;237;2161	86;86;86;335	Fluorouracil;Cyclophosphamide;Methotrexate;Arimidex	Not Available;Not Available;Not Available;Not Available	4;4;4;4	8;8;8;Not Available	600;600;40;1	mg/m2;mg/m2;mg/m2;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;PO	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	8064;8064;320;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A1KP-F9887;TCGA-AO-A1KP-F21774	AC4C4A60-0A25-4A0D-A0C2-8CA86319498B;57BE50C2-0DB3-4688-8591-106B44818CA6	Not Available;None	Not Available;None	Not Available;None	1;20	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	2513;2953	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;2	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	<10%	>=2.0 Positive	1+	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Negative	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	1	No	A1KP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	40-49%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2003
TCGA-A1-A0SH	FEMALE	1437	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1437			TUMOR FREE				39	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A1-A0SH	a6a863d9-b39d-4965-b47f-79a1bcf3c976	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	6	-14595	Not Applicable	0	1437	Not Available	Not Available	TCGA-A1-A0SH-D4488	13E24868-A281-4960-AF6C-21F950AF311B	Not Available	7	179	102	TC	Not Available	12	4	Not Available	Not Available	ADJUVANT	Not Applicable	1	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	1.8																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	2.5	1.4	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	No	A0SH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2010	2006
TCGA-A2-A0ST	FEMALE	3017	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	1				Not Available				62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0ST	12d31787-e54d-4729-ace8-9141043c92b8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	9	-22922	Not Applicable	0	2619	Not Available	Not Available	TCGA-A2-A0ST-D3716;TCGA-A2-A0ST-D3718;TCGA-A2-A0ST-D3719;TCGA-A2-A0ST-D3717;TCGA-A2-A0ST-D3720;TCGA-A2-A0ST-D3721	4c03e578-c8ca-49dd-abbd-aa6f1f676b33;0ad8fde3-e018-471c-a012-d97a9ad7a75e;8c26b6ae-71a7-47c8-86ce-4f99b68272d0;47ecba15-fb35-479e-beaa-92b787d0d2c6;b18f2d63-850a-44b6-b52d-f59f6187d11a;f6b4a321-022e-475b-8d7d-a813f500b336	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10	85;155;286;85;Not Available;Not Available	44;85;251;44;287;495	Adriamycin;Taxol;Letrozole;Cytoxan;Anastrozole;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	4;4;Not Available;4;Not Available;Not Available	98;287;2.5;984;1;20	mg;mg;mg/day;mg;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;4;2;5;6	IV;IV;PO;IV;PO;PO	NO;NO;NO;NO;Not Available;Not Available	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	392;1148;Not Available;3936;Not Available;Not Available	mg;mg;Not Available;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0ST-F14035	6E01D82D-BA83-4093-9E7A-387715D2F3A5				14		Not Available	Not Applicable	3017		Not Available				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	YES																																		WITH TUMOR			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Negative	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	3	0	No	A0ST	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site;Primary Tumor Field	TCGA-A2-A0ST-R3715;TCGA-A2-A0ST-R70357;TCGA-A2-A0ST-R70359	47e3cb28-a8ec-4f8b-8219-929a312408ae;CE471AA1-298A-487F-B6A3-445126A2578E;793704FD-D7A0-4911-AC99-9ACD0E500467	1;Not Available;Not Available	10;9;9	233;233;240	190;190;236	Not Available;Complete Response;Complete Response	11;2;2	Not Available;Not Available;Not Available	5040;5040;1000	NO;NO;NO	EXTERNAL BEAM;External;External	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2010;2015;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2003
TCGA-AO-A12C	FEMALE	2372	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2372			TUMOR FREE				42	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A12C	71626753-cc34-4731-abc0-ae188b0964e7	Negative	Positive	Not Available	2+	Not Available	Modified radical mastectomy	Positive	Lumpectomy	Not Applicable	NO	8	-15469	Not Applicable	0	1994	Not Available	Not Available	TCGA-AO-A12C-D5966;TCGA-AO-A12C-D5967;TCGA-AO-A12C-D5969;TCGA-AO-A12C-D5968;TCGA-AO-A12C-D5965	6147d681-b15d-4868-86c9-8f70bb709894;ab88616c-baf7-417e-b9d8-511b3458b868;8310a990-257e-49ec-96a6-4addbb579f36;acf716d9-c5e8-4e07-b741-6844bb0c2df9;9558d4f9-c6cd-495d-acea-01d22843ae19	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	158;221;2149;524;158	116;179;335;179;116	Doxorubicin;Paclitaxel;Tamoxifen;Trastuzumab;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	4;4;Not Available;22;4	60;175;20;6;600	mg/m2;mg/m2;mg/day;mg/kg;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;3;2;1	IV;IV;PO;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	444;1296;Not Available;Not Available;4440	mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	78	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A12C-F5889;TCGA-AO-A12C-F19425	FFD79690-4C63-448F-AD9B-07699806F943;C6079795-077B-4961-8C09-C9FAF4B8C1A2	Not Available;None	Not Available;None	Not Available;None	8;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1994;2372	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	90-99%	>=2.0 Positive	3+	30	Not Available	125	1.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Positive	Negative	31	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	2	Not Available	No	A12C	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	WHITE	Not Available	Regional site	TCGA-AO-A12C-R5890	6902c82f-5fd7-4dcd-95bf-c393615f7531	1	8	321	277	Not Available	12	28	9540	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2005
TCGA-EW-A1OY	FEMALE	908	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	908			TUMOR FREE				63	Left	Sentinel node biopsy alone	Not Available	TCGA-EW-A1OY	53ff5893-7d5e-4bcb-be9c-665fa34b7824	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	10	-23266	Not Applicable	0	593	Not Available	NO	TCGA-EW-A1OY-D32264;TCGA-EW-A1OY-D32265;TCGA-EW-A1OY-D32267;TCGA-EW-A1OY-D32268	03D8BE5B-C488-4B80-B892-D6A4C2EE03B5;E5516788-6C73-4B51-B902-5B5FE65F9658;EBCAFCA5-6D9C-465B-B053-FE7F6CA8EADA;B36F48F2-F93A-4964-B8B9-7CF74F5CB0B1	Not Available;Not Available;Not Available;Not Available	22;30;30;30	Not Available;161;161;308	478;109;109;180	Femara;Doxorubicin;Cyclophosphamide;Paclitaxel	Not Applicable;Unknown;Unknown;Stable Disease	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1OY-F30950	26FD0127-AD2F-4FAB-B570-B297E9CC4EFD				23		Not Available	Not Applicable	908		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1OY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1OY-R32269	8C92A96B-0D36-494B-A441-16C4148B266C	1	15	376	341	Not Available	5	29	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-OL-A5S0	FEMALE	620	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	620			TUMOR FREE				66	Right	Axillary lymph node dissection alone	Not Available	TCGA-OL-A5S0	43B3BF47-7313-4DFB-952A-EC0B9D48E16C	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	16	-24139	Not Applicable	0	298	Not Available	Not Available	TCGA-OL-A5S0-D65265;TCGA-OL-A5S0-D65266	8498E674-7702-4F90-9214-66B02D73543D;BFE8B8D7-C0CE-4D2E-A587-DDC39BE732B1	Not Available;Not Available	24;24	228;228	67;67	TAXOL;HERCEPTIN	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	30-39%	Unknown	Not Available	Not Available	Not Available					TCGA-OL-A5S0-F56567	5E87825C-A737-4301-8FAD-C577C69C56AF				14			Not Applicable	620																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Positive	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	No	A5S0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Regional site	TCGA-OL-A5S0-R65264	BDA0BB3D-2C0A-4827-898B-070CC5BFA0E9	Not Available	24	202	153	Complete Response	9	Not Available	60.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2012
TCGA-D8-A1XC	FEMALE	377	Mucinous Carcinoma	Breast	Dead	T4b	N1a	M0	Stage IIIB	1		Bone	Distant Metastasis	TUMOR FREE				85	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XC	ee14e049-b891-4dda-a730-8ce99bd93baf	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-31220	Not Applicable	0	81	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	NO		TCGA-D8-A1XC-F29439	27296384-E750-4A9E-9214-F7D9E9040B5B				26		Not Available	377	Not Available		Discrepancy				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Bone	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			NO		NO	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	0	No	A1XC	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T4b	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A1AY	FEMALE	1026	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	1026			Not Available				65	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AY	5fd9552a-c742-4388-940d-295d1107ae00	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	14	-23927	Not Applicable	0	615	Not Available	Not Available	TCGA-AR-A1AY-D21981;TCGA-AR-A1AY-D21982	4898241A-D0FD-474A-AB71-1B9BC5FBE3F1;4BBF53A3-33EC-452E-ABEB-55BC506B0EBD	Not Available;Not Available	28;28	117;117	Not Available;Not Available	Doxorubicin;Cytoxan	Not Available;Not Available	2;2	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AY-F21977;TCGA-AR-A1AY-F49482	B606F4FD-7228-4416-8B81-02C8861CF309;E5648A84-5439-451B-A1FB-234DA91B8F76				28;2		Not Available;None	Not Applicable;Not Applicable	1026;1026		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AY	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Not Available	TCGA-AR-A1AY-R21978	D74AC1F9-01CC-47D6-8F12-D8FBADBC40A9	1	28	208	Not Available	Not Available	2	33	6040	NO	Not Available	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide Local Excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2008
TCGA-A8-A093	FEMALE	546	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	546			TUMOR FREE				61	Right	Not Available	Not Available	TCGA-A8-A093	02f5ae33-a563-4ecb-9e33-dfa500a44931	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-22373	Not Applicable	0	546	Not Available	Not Available	TCGA-A8-A093-D37755	53987C58-785E-4E57-B53F-0CBD9C1C3579	n/a	6	Not Available	28	Tamoxifen	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A093-F40555	376223F3-2A05-4951-B83B-C798FF047DFD				23			Not Applicable	546																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A093	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A093-R38155	A04E3037-0795-4C6C-8BD3-D7C3FB72AF9B	Not Available	11	59	28	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A6R9	FEMALE	160	Metaplastic Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	160			TUMOR FREE				61	Left	Not Available	Not Available	TCGA-BH-A6R9	43CC074D-B85A-4B0B-8FEB-833094FFC565	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	13	-22325	Not Applicable	0	160	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A6R9-F63678	D2AF96B0-8735-4AE4-9821-E64B25949D6E				15			Not Applicable	160																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A6R9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2014	2012
TCGA-AO-A0J2	FEMALE	997	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	997			TUMOR FREE				41	Left Lower Inner Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A0J2	d2f2560c-ec80-4fea-9474-c47a2e85ea95	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	19	-15324	Not Applicable	0	585	Not Available	Not Available	TCGA-AO-A0J2-D3125;TCGA-AO-A0J2-D3122;TCGA-AO-A0J2-D3124	56624a3a-1602-438a-b089-4782c8fcbed6;e2ba693c-5978-4227-b81a-4a4823d3ee84;ed9afd15-7930-40b7-808e-705182137410	Not Available;Not Available;Not Available	19;19;19	162;106;106	120;64;64	PACLITAXEL;CYCLOPHOSPHAMIDE;DOXORUBICIN	Not Available;Not Available;Not Available	9;9;9	4;4;4	175;600;60	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1040;3600;360	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J2-F3120;TCGA-AO-A0J2-F15481	E53098E7-BE78-4106-8496-E08E4D23D102;04B90C44-B6F4-4F85-A233-052B0C12C62B	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	585;997	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	30-39%	RATIO > 2.2	2+	40	Not Available	3.5	1.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0J2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2008
TCGA-AC-A6IX	FEMALE	373	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	MX	Stage IIIC	0	373			TUMOR FREE				49	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A6IX	7486A2B3-B09F-4E9C-9864-8B51B58D9FB3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-17969	Not Applicable	0	13	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A6IX-F66025	23A43B78-CE3E-4306-96BB-F26BDC52FB61				1			Not Applicable	373																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	21	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	19	Not Available	No	A6IX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2013
TCGA-B6-A0I2	FEMALE	4361	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	4361			TUMOR FREE				45	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0I2	328dfcb0-b5ae-43f2-bc87-dad0ab3df9e7	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	NO	2	-16702	Not Applicable	0	3827	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0I2-F12630	57FE226B-27F7-407B-81E0-EB90A79DC9DB				2		Not Available	Not Applicable	4361		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Evaluated	8	Not Available	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0I2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1995
TCGA-EW-A1P1	FEMALE	1210	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3b	MX	Stage IIIC	1	1014.0	Lung	Distant Metastasis	WITH TUMOR				68	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1P1	f2e28af9-c40e-41c4-9e82-205cca38f26a	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	27	-24923	Not Applicable	0	920	Not Available	YES	TCGA-EW-A1P1-D29234;TCGA-EW-A1P1-D29233;TCGA-EW-A1P1-D29235;TCGA-EW-A1P1-D29275;TCGA-EW-A1P1-D29274;TCGA-EW-A1P1-D29276	48C077A1-8D4D-4F04-9651-C690CC977963;4741983E-274B-433C-B89D-5BEAE68D4803;F27A496D-E750-4C38-8AB0-8E9458182736;1C58018D-9EDE-4229-BE75-BAF2AE767EB5;409B60F9-D4ED-4733-A1F0-318ED27B2FA3;8A876DD1-A78D-4A4E-ABE0-48E9D87B5018	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;13;13;13	147;119;178;119;119;178	140;77;157;77;77;157	Taxol;Taxotere;Adriamycin;Cyclophosphamide;Adriamycin;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	2;3;2;3;3;2	144;131;108;875;88;1080	mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;TAC;AC;TAC;TAC;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	288;377;217;2515;252;2172	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012	Not Available	<10%	HISPANIC OR LATINO	Lung	Not Available	Not Available	NO	NO	YES		TCGA-EW-A1P1-F29115	1B13E198-7074-4211-9F1F-EDBD860D6F76				8		1200	Not Applicable	1210		1014				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	3	Lung	Distant Metastasis	Not Available	YES																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	2+	Not Available	Not Available	Not Available	1.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	1+	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Equivocal	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Negative	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1+	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	3 Point Scale	Not Available	3 Point Scale	Equivocal	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	No	A1P1	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1P1-R29236	A05C32BB-CE32-45B3-88F1-10EE839FC231	1	12	322	281	Not Available	3	Not Available	11,000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N3b	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A254	FEMALE	2605	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	2605			Not Available				50	Left Upper Inner Quadrant;Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A254	6014a582-d22e-46e1-9000-c8e2fbad7acf	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	31	-18270	Not Applicable	0	1212	Not Available	Not Available	TCGA-AR-A254-D31890;TCGA-AR-A254-D31891;TCGA-AR-A254-D31892;TCGA-AR-A254-D31893;TCGA-AR-A254-D31895;TCGA-AR-A254-D31896;TCGA-AR-A254-D31897;TCGA-AR-A254-D31898;TCGA-AR-A254-D31899	276D5F77-4A5C-4323-9158-72968222455E;3895A0CD-D7A0-4299-AA1D-0CDB26606542;33D981C7-C2D3-4B84-B64B-267D0B560FC1;8811257C-6F1A-45B1-93CF-66DB671186E7;A0A91D98-9C6D-4F84-8E0F-B7124F907FAB;ADB0D2AC-132B-4083-91AF-52B43CA173F3;0197F934-6D0A-489C-BB0C-B8BB754191DE;7B1B7CB1-6836-4211-916E-AFF61B5EC621;82C6D00C-ABFC-4885-88F3-5A4E67579462	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;23;23;23;23;23	43;99;173;170;170;22;184;344;Not Available	22;50;106;106;106;22;29;232;262	Paclitaxel;Abraxane;Fluorouracil;Epirubicin;Cytoxan;Trastuzumab;Trastuzumab;Trastuzumab;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Immunotherapy;Immunotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A254-F31889;TCGA-AR-A254-F49511;TCGA-AR-A254-F71726	28E4B542-285D-4875-AB72-9BBA6EB599D1;D6FF63CD-5109-4256-84D7-02F8243C8553;5CAA4B0A-9F82-4A99-AD51-4DF0011ECD25				10;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1212;2213;2605		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Wide local incision	Other method, specify:	Positive	Not Evaluated	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	9	Not Available	No	A254	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A254-R31900	967465A7-0A86-4FBD-A554-CA1E36E827D2	1	10	291	252	Not Available	5	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-GM-A3XN	FEMALE	2019	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	2019			TUMOR FREE				44	Left;Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-GM-A3XN	0930E97A-72EA-4BD5-B2F0-50C76AF695F3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	1	-16109	Not Applicable	0	1641	Not Available	Not Available	TCGA-GM-A3XN-D35531;TCGA-GM-A3XN-D35532;TCGA-GM-A3XN-D35534;TCGA-GM-A3XN-D35535;TCGA-GM-A3XN-D41968;TCGA-GM-A3XN-D41969	FC4B09BC-E04D-4AAD-8ADC-943214589F12;7594E8FE-166B-40DC-82BA-FAB360C98DB2;D27177DE-0207-41D5-AA50-1BF7FAE5FBDC;8AD2952D-C463-426C-BCFF-674C4A1821B8;5A81151E-DC13-4510-B131-29DB3185B815;F9D001E6-39C1-43A9-B5B7-5A833D67EBE7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;8;8	211;282;282;282;1591;Not Available	134;218;218;218;416;1592	Paclitaxel;Fluorouracil;Adriamycin;Cytoxan;Tamoxifen;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	10;10;10;10;4;4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2013;2013	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.73					TCGA-GM-A3XN-F46967	D2D39B9A-798A-44E3-8BDB-5D3DA01F9BDD				20			Not Applicable	2019																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	1.85	1.07	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Negative	Negative	34	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	0	No	A3XN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field	TCGA-GM-A3XN-R35530	BEB66920-DAD1-453E-A0F4-9C99FAAFDF03	Not Available	1	394	359	Complete Response	10	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2012	2007
TCGA-AN-A0XV	FEMALE	162	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	162			Not Available				67	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0XV	ac18b3a3-8d52-4e35-8625-673171a7fd92	Not Available	Positive	Not Available	1+	3 Point Scale	Not Available	Positive	Not Available	Not Applicable	NO	29	-24779	Not Applicable	0	162	Not Available	NO																								dextran coated charcoal	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XV-F68962	0DB9CDF6-70F8-4923-AF76-D187338FB3AE				23			Not Applicable	162																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	60-69%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Negative	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	7	Not Available	No	A0XV	Not Available	dextran coated charcoal	Not Available	Not Available	90 H	270 H	Not Available	YES	30-39%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A574	FEMALE	1179	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1179			TUMOR FREE				44	Left	Sentinel node biopsy alone	Not Available	TCGA-E2-A574	029CE650-5E5A-4100-8596-CD94300E7EF5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	20	-16195	Not Applicable	0	605	Not Available	Not Available	TCGA-E2-A574-D44493;TCGA-E2-A574-D44495;TCGA-E2-A574-D44497	02DB6D61-50D4-4B55-B5BF-A0FA7D3B5B13;CC66FB23-52DD-432E-87B3-4C10E78479AA;DCC1FD78-D8B4-4CFE-8322-0E57C1F1D14B	Not Available;Not Available;Not Available	20;20;20	106;106;162	64;64;120	Adriamycin;Cytoxan;Abraxane	Unknown;Unknown;Unknown	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Allred 0 = 0+0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	2.8					TCGA-E2-A574-F67581;TCGA-E2-A574-F70296	4F60D388-7BCF-4844-A47B-E143279BEA01;F674155C-12D0-46EA-BD0C-3A5AC675C845				6;9			Not Applicable;Not Applicable	808;1179																				NO;NO																						11;2					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	200	Not Available	2.8	1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A574	TUMOR FREE	Allred 0 = 0+0	Not Available	Not Available	Allred Score	Allred Score	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-E2-A574-R44492	4F7A8469-49C3-4615-884A-A4068C9C9597	Not Available	20	246	195	Complete Response	6	36	6640	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2013	2011
TCGA-B6-A401	FEMALE	2596	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	2596			TUMOR FREE				47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-B6-A401	48FF0420-0F19-4E9D-A75D-6C54949A461A	Not Available	Positive	4 Point Scale	3+	4 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	20	-17438	Not Applicable	0	1989	Not Available	Not Available	TCGA-B6-A401-D41100;TCGA-B6-A401-D41102;TCGA-B6-A401-D41103;TCGA-B6-A401-D41105	9AC61F74-CB87-4FC6-B069-6DA7425DABAB;AA65ED83-981C-42BA-9EDE-AA4991F5374C;583BFE0F-4663-46A0-81BE-C7282F6EBDE8;218EF3A9-4E64-430C-8C51-B6EE6EA27054	Not Available;Not Available;Not Available;Not Available	12;12;12;12	155;155;155;Not Available	50;50;50;375	Cyclophosphamide;Doxetaxel;Doxorubicin;Femara	Unknown;Unknown;Unknown;Unknown	3;3;3;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-B6-A401-F59658	598C5FF1-2D6F-4041-98A3-D52614BAC4F3				3			Not Applicable	2596																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A401	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-B6-A401-R41097	47DF79D5-C4F9-437F-9C6B-79FD20A4F17D	Not Available	12	284	205	Unknown	3	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	2007
TCGA-E2-A1LE	FEMALE	879	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N3a	M0	Stage IIIC	1	361.0	Lung	Distant Metastasis	WITH TUMOR				71	Right Upper Inner Quadrant;Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A1LE	7317E605-93BA-49A9-8743-20613B02767A	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	7	-26239	879	0	Not Available	Not Available	NO	TCGA-E2-A1LE-D20660;TCGA-E2-A1LE-D20658;TCGA-E2-A1LE-D20661;TCGA-E2-A1LE-D20664	19196460-368E-41C9-B27F-4DB7C615B079;E1057F1C-5208-4158-B2EA-5017FB560FF6;522A5688-06F7-4DE2-AAB5-1A7CFA4286A1;7BC50522-B439-499F-88CC-E549DC5D26A6	Not Available;Not Available;Not Available;Not Available	18;18;18;18	54;54;54;530	54;54;54;468	herceptin;docetaxel;cyclophosphamide;gemcitabine	Not Available;Not Available;Not Available;Not Available	1;1;1;1	1;1;1;3	635;134;1074;Not Available	mg;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	635;134;1074;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	NO		TCGA-E2-A1LE-F20657	4AB0B560-C397-4945-A69B-2DC2A6437160				18		Not Available	879	Not Available		361				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Lung	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		YES	Dead	2012	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	27	Not Available	No	A1LE	WITH TUMOR	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1LE-R20665	73C4148D-EEC1-42AD-A3D6-67DE98AE432B	01	18	146	101	Not Available	1	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Dead	2011	2008
TCGA-D8-A1XU	FEMALE	395	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	395			TUMOR FREE				56	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1XU	332148f5-f070-4c20-8eb1-4d8c0673aa52	Negative	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-20715	Not Applicable	0	150	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XU-F29456	6F200E00-AAAB-4ED7-A6A8-C21C9B30CF9E				26		Not Available	Not Applicable	395		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XU	TUMOR FREE	%IHC	Not Available	Not Available	10-75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A1IK	FEMALE	1800	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IIA	0	1800			TUMOR FREE				71	Left	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IK	becedbfd-b2aa-4dde-b7f4-29e6f59ec32c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	17	-26052	Not Applicable	0	519	Not Available	NO	TCGA-E2-A1IK-D19977	11888A89-B610-43B7-9103-C695EDAB9332	Not Available	3	Not Available	92	Arimidex	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1IK-F19976;TCGA-E2-A1IK-F70395	0E98A0A0-78D3-4D4F-AA64-BA761C736E42;C706AB33-CD90-495B-AD28-271551DB85A8				3;17		Not Available;None	Not Applicable;Not Applicable	689;1800		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A1IK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-E2-A2P6	FEMALE	1051	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1051			TUMOR FREE				77	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A2P6	F83B866B-0B2E-4BBA-9367-BE6DCCF56232	Negative	Positive	Not Available	Not Available	Not Available	Modified radical mastectomy	Positive	Lumpectomy	Not Applicable	NO	19	-28411	Not Applicable	0	168	Not Available	NO	TCGA-E2-A2P6-D33515	06510269-80AF-46F3-B6EA-7AE5484CBCC2	Not Available	5	Not Available	106	Anastrozole	Not Applicable	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Allread score 5+3 = 8	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A2P6-F33514;TCGA-E2-A2P6-F68574	0B4810CA-DB4D-49CD-BFB4-DAACBEE0DE41;51E462D5-D07F-4E42-A9E8-4171DEEE1AE1				29;26		Not Available;None	Not Applicable;Not Applicable	168;1051		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;11	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	5	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	Not Available	No	A2P6	TUMOR FREE	Allred score 2+2 = 4	Not Available	Not Available	Allred score = 4	Allred score = 8	Not Available	YES	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2011
TCGA-A7-A26G	FEMALE	722	Other, specify	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	722			Not Available				50	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A26G	5ed024e8-d05e-4c65-9441-eda9930ccc82	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	10	-18362	Not Applicable	0	210	Not Available	NO	TCGA-A7-A26G-D14906;TCGA-A7-A26G-D14908	90ABBBFF-599A-4245-A3A3-FAFC37EEC924;7D7AE68F-EC3A-4BA6-A19A-4A4D2590CA7E	Not Available;Not Available	10;10	152;152	89;89	Taxotere;Cytoxan	Not Available;Not Available	8;8	4;4	160-168;1308-1344	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	648;5292	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A26G-F29419;TCGA-A7-A26G-F39047	91E3B3A1-3446-4119-8A7F-2419BAEC4831;1C41020E-8C83-4C5D-8CB2-6926012E4ED9				16;9		Not Available;None	Not Applicable;Not Applicable	334;722		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;1	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Invasive ductal carcinoma with Metaplastic features (Area of sarcomatoid carcinoma)	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A26G	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Total Mastectomy	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010
TCGA-LL-A6FR	FEMALE	489	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	489			TUMOR FREE				50	Right;Right Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A6FR	1347C23D-8D6E-4C15-9461-640249838C96	Not Available	Negative	Not Available	1+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	30	-18520	Not Applicable	0	118	Not Available	Not Available	TCGA-LL-A6FR-D47889;TCGA-LL-A6FR-D47891;TCGA-LL-A6FR-D47893;TCGA-LL-A6FR-D47895	D0FB9FA8-EBF9-40CA-A6A9-33C218691797;6D5775A7-8E46-4707-97FE-6C70DDAFE0B8;A66D9CC5-476E-4593-A53E-FA86BC54E216;CEC73C96-5595-4A8D-8D57-498C116A7957	Not Available;Not Available;Not Available;Not Available	30;30;30;30	104;104;489;195	62;62;118;118	Adriamycin;CYTOXAN;HERCEPTIN;TAXOL	Unknown;Unknown;Unknown;Unknown	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A6FR-F64045	37B5965A-69C8-46A2-92CE-4A03623AF4AC				25			Not Applicable	489																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	20	Not Available	Not Available	2.7	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A6FR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-LL-A6FR-R64048	3D5B50EB-00E9-4CCE-9CCA-F0862B1AEC5E	Not Available	25	262	230	Unknown	8	22	54.72	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-E2-A1IL	FEMALE	118	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	118			Not Available				78	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IL	b63391a0-73f8-4544-9e94-f6529245ca2a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	29	-28495	Not Applicable	0	14	Not Available	NO	TCGA-E2-A1IL-D20281	383F11A4-7593-479A-95EA-EBB7ED807F66	Not Available	3	Not Available	64	Arimidex	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2012	allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1IL-F20276	7E6EDBFE-0E8F-4123-97EA-7557145A44C4				3		Not Available	Not Applicable	118		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A1IL	Not Available	allred score 4 + 3 = 7	Not Available	Not Available	allred score = 7	allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Not Available	TCGA-E2-A1IL-R20283	3634D556-4A85-4BAC-ABA1-862FFE83DB91	1	3	112	84	Not Available	1	24	5840	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-E9-A22E	FEMALE	1269	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	1269			TUMOR FREE				56	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A22E	64d4dfae-8d91-464b-adc3-80ba7caf54ae	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	2	-20574	Not Applicable	0	0	Not Available	NO	TCGA-E9-A22E-D29933;TCGA-E9-A22E-D29937;TCGA-E9-A22E-D29932	65C41709-5F20-4641-81E0-A088A34E3FBF;5E6E3BA5-6698-470A-AEF8-FD14C5823576;A08D578D-BE6C-4B00-A7A9-3F364189E4C6	Not Available;Not Available;Not Available	9;9;9	226;226;226	13;13;13	Cyclophosphane;5-Fluorouracil;Doxorubicin	Not Available;Not Available;Not Available	1;1;1	6;6;6	900;900;90	mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	3600;3600;360	mg;mg;mg	Not Available;Not Available;Not Available	2013;2014;2014	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A22E-F29931;TCGA-E9-A22E-F55571;TCGA-E9-A22E-F63565	521A96A8-8FE3-459F-A70A-1AC826A0EA55;71C2365F-67A1-447E-87BF-BFFF492E00E9;0D065B9C-234C-4A64-8BDB-604298451D32				30;9;13		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	392;912;1269		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	3;1;8	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2014;2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	4	0	No	A22E	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A22E-R29938	96410A12-7396-491A-B9A2-EC4CD9C55310	Not Available	9	128	105	Not Available	1	23	4600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-D8-A1X9	FEMALE	727	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	727			TUMOR FREE				66	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1X9	34a74805-300c-4773-ab59-2085fcc2e6cc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-24417	Not Applicable	0	380	Not Available	NO	TCGA-D8-A1X9-D29432	24E1ACCD-BB3A-4B2A-8E81-18F3452912AA	Not Available	19	320	197	adriamycin+cyclophosphamide	Not Available	3	Not Available	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1X9-F29431	7DFB15F7-F9D2-4987-8254-9C11C8EAD28E				19		Not Available	Not Applicable	727		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	not amplified	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Indeterminate	Negative	23	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	0	No	A1X9	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1X9-R29433	104383D3-283E-4D53-AAA0-4A610BB320E7	Not Available	19	350	320	Not Available	3	20	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A26X	FEMALE	376	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	376			TUMOR FREE				58	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-C8-A26X	70ab4f23-23c4-409f-a5cc-18a010c3a24e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	21	-21463	Not Applicable	0	11	Not Available	Not Available	TCGA-C8-A26X-D70793;TCGA-C8-A26X-D70794;TCGA-C8-A26X-D70795	C99DA711-C86E-4BA8-8AD6-9274208C28D7;CFD4307C-F098-4A9C-A34B-E337C15B7BDC;69033C6A-572E-4B72-BB72-027C7F663381	Not Available;Not Available;Not Available	9;9;9	207;207;207	200;200;200	5-Flourouracil;Cyclophosphamide;Doxorubicin	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A26X-F70792	521990DD-93CE-4A11-ABED-112046F3A659				9			Not Applicable	376																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A26X	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A133	FEMALE	0	Other, specify	Breast	Alive	T3	N1	M0	Stage IIIA	0	0			TUMOR FREE				65	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A133	b8b6cebc-26dc-43ae-a94a-20da6018f7ae	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	15	-23922	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	ductal/mucinous	No	C50.9	8523/3	C50.9	Not Available	YES	Modified Radical Masectomy	Other method, specify:	Not Evaluated	Not Evaluated	26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A133	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 8	Allred Score 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0B3	FEMALE	1203	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1203			TUMOR FREE				53	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0B3	18eb4dfc-556f-4bf3-a411-4780209ed1e0	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Other	Not Applicable	NO	3	-19479	Not Applicable	0	1203	Not Available	Not Available	TCGA-BH-A0B3-D15420;TCGA-BH-A0B3-D15419;TCGA-BH-A0B3-D15421	13E5B5DC-2CA1-474B-A21D-B7AD5884839B;49AB6F59-1B1E-4B04-914E-82339768A10C;E89062E2-7543-4BBA-9DA0-D4F6C81279C6	Not Available;Not Available;Not Available	3;3;3	115;115;213	52;52;136	CYCLOPHOSPHAMIDE;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available	11;11;11	4;4;12	1128;113;154	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	4540;454;1873	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0B3-F15418	493B0584-FAA6-475F-97F9-CFE0524DF460				3		Not Available	Not Applicable	1203		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0B3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0B3-R15422	F9F1D8C1-B2FA-4516-B98F-D50ACCB6C8C6	1	3	72	24	Not Available	11	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-C8-A12Z	FEMALE	382	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	382			TUMOR FREE				45	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12Z	42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	13	-16508	Not Applicable	0	12	Not Available	NO	TCGA-C8-A12Z-D70811;TCGA-C8-A12Z-D70812;TCGA-C8-A12Z-D70813	DC8851E6-AC37-4E31-80EE-4C4CB77EAFE6;01F0FCA1-431B-40BF-9290-D82BCD61BA7C;302C0CC5-6BC8-4CEF-8936-0BE869DB8E4C	Not Available;Not Available;Not Available	9;9;9	107;107;107	102;102;102	5-Flourouracil;Doxorubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A12Z-F70810	CFB88891-DA2A-4058-B2A7-44A8A2E2AFDE				9			Not Applicable	382																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	2	Not Available	No	A12Z	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AC-A3TM	FEMALE	762	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1mi	M0	Stage IIIA	0	762			TUMOR FREE				50	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A3TM	67C73260-A242-4BBA-87C5-D2302556DFF7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	1	-18535	Not Applicable	0	93	Not Available	NO	TCGA-AC-A3TM-D60195;TCGA-AC-A3TM-D60196;TCGA-AC-A3TM-D60197;TCGA-AC-A3TM-D60198	B113D625-D78D-45A4-ADD0-80AB8685389D;B550D10F-C488-4B1D-9461-2F40087F552D;EDF4E71D-99B4-4E19-AB96-9999AC773627;B38B327E-F854-4338-B383-77104EC6F403	Not Available;Not Available;Biological Therapy/Monoclonal Antibody;Not Available	31;31;31;31	213;213;213;Not Available	132;132;132;272	Cytoxan;Taxotere;Not Available;Arimidex	Complete Response;Complete Response;Complete Response;Not Applicable	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Immunotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;YES;NO	2014;2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.9					TCGA-AC-A3TM-F60193	56C9B648-1452-4AC4-BD75-E1EF3F85A933				31			Not Applicable	762																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	60	Not Available	3.3	1.9	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Equivocal	4	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	2	No	A3TM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A3TM-R60194	CF6D6ED8-625C-463C-9639-3609DC5BB383	Not Available	31	266	219	Complete Response	5	33	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-BH-A1EN	FEMALE	2127	Infiltrating Ductal Carcinoma	Breast	Dead	T2	NX	M0	Stage IIA	0	2127			TUMOR FREE				78	Right	Not Available	Not Available	TCGA-BH-A1EN	858652b8-c4c2-41d8-be32-fdc88e1a7bb0	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	3	-28724	2127	0	Not Available	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Positive	Not Available	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	Not Available	Not Available	No	A1EN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	NX	T2	right segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-AO-A1KR	FEMALE	2513	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2513			TUMOR FREE				51	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AO-A1KR	b7f74ae1-6f58-447c-be50-a7666eb19d9a	Not Available	Negative	4 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-18900	Not Applicable	0	2141	Not Available	NO	TCGA-AO-A1KR-D21772;TCGA-AO-A1KR-D21771;TCGA-AO-A1KR-D21770	3870F7E2-7A57-4F72-B49B-6234D97C5792;BC8E60BC-1325-4D58-8CFC-5647A26B6628;9814E3A1-23C9-4193-94E2-B1E096A02EA1	Not Available;Not Available;Not Available	20;20;20	174;118;118	132;76;76	paclitaxel;cyclophosphamide;doxorubicin	Not Available;Not Available;Not Available	2;2;2	4;4;4	175;600;60	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	658;4512;452	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AO-A1KR-F21768	72013907-4371-4723-AF90-55C5BC120D64				21		Not Available	Not Applicable	2513		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	1	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A1KR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2005
TCGA-AN-A0XS	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	10			Not Available				63	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A0XS	95e949d3-b1f3-46c6-9451-8fe92c99e4cf	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	28	-23358	Not Applicable	0	10	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XS-F68959	81BF97A6-7C9E-480B-A317-746E9A86CDB8				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A0XS	Not Available	Not Available	Not Available	Not Available	160	0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-W8-A86G	FEMALE	347	Infiltrating Lobular Carcinoma	Breast	Alive	T2a	N0 (i-)	MX	Stage IIA	0	347			TUMOR FREE				66	Left;Left Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-W8-A86G	90FF48C3-B14B-4A8B-94A1-98C0BAB0D27B	Negative	Positive	3 Point Scale	1+	3 Point Scale	Other	Positive	Lumpectomy	Mastectomy	YES	29	-24125	Not Applicable	0	161	Not Available	Not Available	TCGA-W8-A86G-D56169	6C2E0E3B-091B-4623-A0A4-027B8D824788	Not Available	29	Not Available	161	Arimidex	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-W8-A86G-F65574	A38C6D67-17D8-4B82-804F-1EA3A8D16D03				25			Not Applicable	347																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	A86G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	70-79%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2a	Not Available	YES	NO	W8	Breast	Not Applicable	Alive	2014	2013
TCGA-E2-A1LA	FEMALE	748	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	748			TUMOR FREE				59	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A1LA	ce9e0309-9756-42d2-ae94-d91264a79498	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	1	-21773	Not Applicable	0	463	Not Available	NO	TCGA-E2-A1LA-D20587	2BE8D472-4522-4803-AA13-CA72D38B9A45	Not Available	12	Not Available	48	Arimidex	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2012	allred score 5 + 3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1LA-F20586	1E00479E-F37F-4BC0-8819-1EE4A5496823				12		Not Available	Not Applicable	748		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.15	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1LA	TUMOR FREE	allred score 5 +3 = 8	Not Available	Not Available	allred score = 8	allred score = 8	Not Available	YES	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-AC-A2FK	FEMALE	2650	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	2650			TUMOR FREE				45	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AC-A2FK	79126E88-9CF8-45FF-BF91-A98DA3B304D7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	13	-16627	Not Applicable	0	1180	Not Available	NO	TCGA-AC-A2FK-D66198;TCGA-AC-A2FK-D66199;TCGA-AC-A2FK-D66200;TCGA-AC-A2FK-D66201	A85E31F8-6790-4964-AC1A-C6253F9E413D;118A7D45-089C-4980-B978-FD970C000905;96CBB13E-8C96-4CE4-B4FE-2FC707EC8044;67C16321-C0D6-4EE5-AA5C-25C290914D9E	Not Available;Not Available;Not Available;Not Available	3;3;3;3	174;174;Not Available;174	51;51;294;51	Cytoxan;Adriamycin;Femara;Taxotere	Complete Response;Complete Response;Complete Response;Complete Response	10;10;10;10	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2FK-F66196	DD3AB466-3C36-42BB-8F4A-E288ED7C6078				3			Not Applicable	2650																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	3	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	3	Not Available	No	A2FK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A2FK-R66197	C93A72D1-3D52-4D17-A14F-82E4B3670AE8	Not Available	3	280	243	Complete Response	10	28	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2006
TCGA-A2-A0YL	FEMALE	1474	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	0	1474			TUMOR FREE				48	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0YL	b205c89f-af62-4186-acad-ed23d243fa98	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	27	-17702	Not Applicable	0	268	Not Available	Not Available	TCGA-A2-A0YL-D5814;TCGA-A2-A0YL-D5816;TCGA-A2-A0YL-D5815;TCGA-A2-A0YL-D5817	15d20bc4-14c3-4ec8-8005-389f518e1ac0;e0eb6325-2068-4cbc-83a8-228079ff9e5f;9f659c06-6017-43f8-b229-7164566871f4;57d63ce1-4d7f-430f-930c-e6605a768c00	Not Available;Not Available;Not Available;Not Available	28;28;28;28	154;154;154;Not Available	50;50;50;177	Cytoxan;Taxotere;Adriamycin;Arimidex	Not Available;Not Available;Not Available;Not Available	12;12;12;12	6;6;6;Not Available	940;140;94;1	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;4	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	5640;840;564;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0YL-F16749;TCGA-A2-A0YL-F59387	A6C1DE45-CB75-45AE-9712-C35C9D111F3B;1DAD0270-FD03-455C-9A03-28C55A7DC2B7				16;12		Not Available;None	Not Applicable;Not Applicable	445;1474		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	9;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	4	0	No	A0YL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YL-R5813	45b399c8-8af8-4a9a-9507-682af704063e	1	28	224	177	Not Available	12	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2010
TCGA-BH-A0EE	FEMALE	943	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	0	943			TUMOR FREE				68	Right Upper Inner Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0EE	ca76c6fc-ff30-4833-884d-3a94fe53ff17	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	9	-24850	Not Applicable	0	943	Not Available	Not Available	TCGA-BH-A0EE-D4671;TCGA-BH-A0EE-D4670;TCGA-BH-A0EE-D4672;TCGA-BH-A0EE-D4673	578D5C85-931D-4D7F-A308-7699D8870212;8B266B9C-45E7-4072-A13E-0146D0834946;5C2E885D-E1C2-409E-BBF0-05B55F3AF8B7;03244A97-6A7C-44C9-86DC-65110C599437	Not Available;Not Available;Not Available;Not Available	18;18;18;18	173;173;173;411	47;47;47;47	Docetaxel;Docetaxel;Carboplatin;Trastuzumab	Not Available;Not Available;Not Available;Not Available	11;11;11;11	6;6;6;17	130;130;540;549	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	839;839;2632;6800	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	NO	TCGA-BH-A0EE-F4674	6F1C8397-CC8C-47DA-8266-62801060B148	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	943	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	30-39%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0EE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-D8-A1Y1	FEMALE	302	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N1a	MX	Stage IIIA	1				TUMOR FREE				80	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1Y1	38a631a1-6875-4216-a335-ee93c90a86d6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	9	-29474	Not Applicable	0	116	Not Available	NO	TCGA-D8-A1Y1-D30085	5389E215-9B46-4ED9-A3F2-0392ACD376A5	Not Available	2	302	58	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	NO	Hormone Therapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1Y1-F30084	B147E8C4-F15B-4D80-98D2-281316F91CE1				2		Not Available	302	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		WITH TUMOR			Not Available			YES		NO	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	22	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1Y1	TUMOR FREE	manual counting	Not Available	Not Available	>75%	10-75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A18G	FEMALE	149	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	149			Not Available				81	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A18G	747083ff-0703-431b-aad4-f2adff739516	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	1	-29820	Not Applicable	0	61	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A18G-F64216	112BA8BF-77D2-4E83-AAFE-9FABF7EC76CA				27			Not Applicable	149																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.5	8500/3	C50.5	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A18G	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A18G-R64217	911630F0-5BE2-4E57-8DB4-987BF400F086	Not Available	27	149	103	Complete Response	8	25	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	right segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010
TCGA-AN-A0AR	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE				55	Right Upper Inner Quadrant	No axillary staging	Not Available	TCGA-AN-A0AR	ebc460c2-df88-4dc0-a2c0-aca8072b75ad	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-20152	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AR-F68946	07FE1A95-D842-4DF8-9EAA-36D34C7989DD				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-AR-A24T	FEMALE	3202	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3	M0	Stage IIIC	0	3202			Not Available				46	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24T	9e3de467-fb0d-4021-89f8-b34968a7c7bc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	30	-17135	Not Applicable	0	1620	Not Available	Not Available	TCGA-AR-A24T-D31512;TCGA-AR-A24T-D31507;TCGA-AR-A24T-D31505;TCGA-AR-A24T-D31508;TCGA-AR-A24T-D31510	1CAF26F7-14B5-441D-B185-4B37F4059B93;00300D73-B562-4EE9-A8D4-27E5B97AE501;E38D1685-E03E-45B3-B2E3-14C26D6034CB;6582CFB0-38DB-40AA-B9DB-3E4241EE51EF;4564981E-0469-40CD-A0F1-7EA3750491FF	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	Not Available;80;80;157;1864	1995;38;38;94;189	Letrozole;Cytoxan;Doxorubicin;Paclitaxel;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	Not Available;4;4;4;Not Available	2.5;600;60;175;20	mg/day;mg/m2;mg/m2;mg/m2;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;1;1;1;2	PO;IV;IV;IV;PO	YES;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;4270;420;1260;Not Available	Not Available;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24T-F31503;TCGA-AR-A24T-F49463;TCGA-AR-A24T-F71728	5DD029D1-BE31-4AA9-AA4E-CA2D73E449D0;71B7C342-2D87-4E59-B1DA-18539B19FA10;37FE3D8F-859F-4A8D-9AA3-443C80674854				4;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1620;2312;3202		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	15	Not Available	No	A24T	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24T-R31504	6E123228-9066-4185-98D4-BF4F80D1BE4A	1	4	225	189	Not Available	5	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-A2-A0YI	FEMALE	1505	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i+)	M0	Stage I	0	1505			TUMOR FREE				62	Right Upper Outer Quadrant	Other (specify)	Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy	TCGA-A2-A0YI	72cd1b17-d349-4551-83f7-3062ce9db865	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	14	-22961	Not Applicable	0	358	Not Available	Not Available	TCGA-A2-A0YI-D5446	9b1f4d69-c1f1-49a2-b010-51bdc29628fa	Not Available	14	Not Available	Not Available	Femara	Not Available	12	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0YI-F16751;TCGA-A2-A0YI-F59386	C6B5D502-E855-42FF-A1A1-54CED61329FF;C56BF853-8F73-44A9-8701-42CCAFA4D028				16;12		Not Available;None	Not Applicable;Not Applicable	441;1505		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	9;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8522/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	1	No	A0YI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YI-R5445	ed6b0c3f-eef8-4151-8920-2293436afc0c	1	14	116	77	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-BH-A0BJ	FEMALE	660	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	660			TUMOR FREE				41	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0BJ	d6f911b5-e895-43f8-8f86-0ac2f1bc6fae	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Other	Not Applicable	NO	8	-15027	Not Applicable	0	660	Not Available	Not Available	TCGA-BH-A0BJ-D4477;TCGA-BH-A0BJ-D4478;TCGA-BH-A0BJ-D4476;TCGA-BH-A0BJ-D4475	F1AE1E33-905A-4F33-AE9B-5EF9CDF0169A;EE8AE120-A73B-4822-ADBB-CF076779A064;50C21FE3-942E-4B85-BB19-70A6C75B85BE;77930396-9746-4296-9C9F-1829EDBF76DB	Not Available;Not Available;Not Available;Not Available	15;15;15;15	198;296;198;Not Available	126;219;126;343	DOXORUBICIN;PACLITAXEL;CYCLOPHOSPHAMIDE;ARIMIDEX	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;10;4;Not Available	123;164;1230;1	mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	492;1640;4920;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-Score 300	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0BJ-F4480	75A342F3-7D6D-42F8-961D-523D0100ABE8	Not Available	Not Available	Not Available	15	Not Available	Not Available	Not Applicable	660	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0BJ	TUMOR FREE	H-Score 260	Not Available	Not Available	H-Score	H Score	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BJ-R4479	5F4133B4-BA40-404B-8F1E-98D266078E77	1	15	443	398	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-E2-A1B0	FEMALE	1631	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	1631			TUMOR FREE				50	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A1B0	996bd3f0-d767-4eff-9c82-99fcb5a3006a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	25	-18346	Not Applicable	0	1271	Not Available	NO	TCGA-E2-A1B0-D19464;TCGA-E2-A1B0-D19480;TCGA-E2-A1B0-D19466;TCGA-E2-A1B0-D19463	A0811C15-BA7F-4042-8E8C-0C3BA33C8A89;B08E096E-EE65-42AA-B000-0198892EB17B;F6516BAA-1825-4C57-824A-D8EE3A2497D8;5806DC75-529D-450D-952E-3AEA4294E6CB	Not Available;Not Available;Not Available;Not Available	7;7;7;7	119;557;217;119	35;231;140;35	cytoxan;herceptin;taxol;adriamycin	Not Available;Not Available;Not Available;Not Available	12;12;12;12	6;16;6;6	1260;545;160;126	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	7560;8720;1920;756	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1B0-F19460	14D44CAA-26DC-4B41-B2A0-DC4A8A58BED3				7		Not Available	Not Applicable	1631		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	6	Not Available	No	A1B0	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1B0-R19461	07FCCE4F-84AC-4AC3-A6BE-A677BDAD8EF3	1	7	300	257	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-E9-A1N4	FEMALE	1000	Mixed Histology (please specify)	Breast	Alive	T2	N2	M0	Stage IIIA	0	1000			TUMOR FREE				41	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1N4	69a68fbc-e43d-4652-85ee-693211bded47	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	NO	26	-15055	Not Applicable	0	5	Not Available	NO	TCGA-E9-A1N4-D29812;TCGA-E9-A1N4-D29814;TCGA-E9-A1N4-D29813;TCGA-E9-A1N4-D39768	FC7FE4AB-6ABA-44ED-847B-11390559C9F6;4237DC30-5933-4DD7-95C8-33FFC7D78A05;03BC90EC-3B30-4864-B67F-CD5A00D65BFC;80B1429D-E3E0-4E41-B47E-344887D4864D	Not Available;Not Available;Not Available;Not Available	29;29;29;1	194;194;194;Not Available	118;118;118;230	Doxorubicin;5-Fluorouracil;Cyclophosphane;Tamoxifen	Not Available;Not Available;Not Available;Not Applicable	3;3;3;2	6;6;6;Not Available	80;800;800;Not Available	mg/day;mg/day;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;Not Available	IV;IV;IV;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	480;4800;4800;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;NO	2012;2012;2012;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1N4-F29811;TCGA-E9-A1N4-F39767	F2EEEE1E-A44E-4B8B-B9BC-AED21CA10D22;7A3C4560-6D33-44A1-BC57-E835DFEC288C				29;1		Not Available;None	Not Applicable;Not Applicable	341;1000		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	4	0	No	A1N4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1N4-R29815	B5ADCED0-177B-4804-9589-C6F334CE467D	Not Available	29	96	69	Not Available	3	20	400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A18M	FEMALE	2207	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N1	M0	Stage IIIA	0	2207			Not Available				39	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A18M	f63722c1-a0bb-4bf9-8a10-1d76a8e1a0ba	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	15	-14532	2207	0	Not Available	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.3	8500/3	C50.3	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	6	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	4	4	No	A18M	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2001
TCGA-EW-A1OW	FEMALE	694	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	694			TUMOR FREE				58	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1OW	f55dd73d-8c36-440b-84e5-9aae53107775	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	18	-21465	Not Applicable	0	464	Not Available	NO	TCGA-EW-A1OW-D29123;TCGA-EW-A1OW-D29280;TCGA-EW-A1OW-D29278;TCGA-EW-A1OW-D29279	F1A2F243-E72C-4F14-9F60-6942754A3638;2AC7C8DB-4D01-4FE0-9CA5-E7C406356CBE;444E5133-0315-4949-8801-8905B7A49C1F;1684EE5E-6B0E-4898-964A-9055C7ABE13B	Not Available;Not Available;Not Available;Not Available	8;13;13;13	213;213;213;213	108;108;108;108	Fluorouracil;Taxotere;Epirubicin;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	3;3;3;3	3;3;3;3	965;163;193;965	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	FEC then T;FEC then T;FEC then T;FEC then T	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	2895;489;579;2895	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1OW-F29117	7C5B80F1-BF04-41CB-8B91-725221A42BF0				8		Not Available	Not Applicable	694		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8090/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1OW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-EW-A1OW-R29230	80666302-3A99-4636-86B0-790EB34C1D21	1	12	338	294	Not Available	3	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-E9-A1RF	FEMALE	200	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	200			TUMOR FREE				68	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RF	c694615c-b1c6-499c-8058-995633ebf948	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	2	-25119	Not Applicable	0	38	Not Available	NO	TCGA-E9-A1RF-D30635;TCGA-E9-A1RF-D30636;TCGA-E9-A1RF-D30637;TCGA-E9-A1RF-D30634	BB320C8C-AD02-463F-904A-B4301628BB5B;E24DA2B4-5273-4C8A-A468-E3BCF7FCD214;90F42AFB-EFAC-4C90-999B-DA0E246EF300;59D29C9B-773E-49D8-B79E-18BCF84061DC	Not Available;Not Available;Not Available;Not Available	13;13;13;16	194;194;Not Available;194	54;54;30;54	Doxorubicin;5-Fluorouracil;Tamoxifen;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	4;4;4;4	5;5;Not Available;5	100;1000;20;1000	mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	500;5000;Not Available;5000	mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1RF-F30633;TCGA-E9-A1RF-F48703	8239B7BC-A659-4F20-BD86-9185AA136FA4;35166AFC-AAC8-4F95-931D-11660E40DDCF				13;19		Not Available;None	Not Applicable;Not Applicable	200;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;9	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		YES;Not Available	Alive;Not Available	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	5	Not Available	No	A1RF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1RF-R30638	10729565-ADC4-4C6F-891E-1606E11ABA81	1	13	144	118	Not Available	4	Not Available	3740	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A1-A0SO	FEMALE	852	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	852			TUMOR FREE				67	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SO	6644fd4e-d2fe-4785-a73c-0f36fcc740e2	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	6	-24826	Not Applicable	0	852	Not Available	Not Available	TCGA-A1-A0SO-D4449	26D19DA7-541E-4272-8678-F08424C58A63	Not Available	6	180	61	Not Available	Not Available	12	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	3.2																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	1.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	Not Available	No	A0SO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-A1-A0SO-R4448	8E839EE0-AABF-432E-B55A-BEAD9FC6A0FC	1	6	266	205	Not Available	12	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2010	2007
TCGA-A8-A090	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE				74	Right	Not Available	Not Available	TCGA-A8-A090	f4b69043-4a67-48e3-a4d1-72a21ae2d175	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-27121	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A090	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-A8-A079	FEMALE	274	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N3	M0	Stage IIIB	0	274			TUMOR FREE				69	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A079	31c31cce-1b4d-4f12-922f-84f389403170	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-25294	Not Applicable	0	274	Not Available	Not Available	TCGA-A8-A079-D37842;TCGA-A8-A079-D37843;TCGA-A8-A079-D37844	D30A1FC1-2462-464E-B8B4-6EC389A33928;83CBDD5D-F540-4E22-BFF6-1977215312E5;D39B1438-ADE8-40F1-A772-470F7B3FE40D	n/a;n/a;n/a	6;6;6	183;183;183	30;30;30	5-Fluorouracil;Epirubicin;Cyclophosphamide	Unknown;Unknown;Unknown	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A079-F40822	5AFF0910-3B7D-408F-A464-C3E105392A8C				2			Not Applicable	274																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A079	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A079-R38176	BFA37E0C-E6C7-4667-84A9-FAD16411E814	Not Available	11	274	214	Unknown	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N3	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-A7-A0CJ	FEMALE	931	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	931			TUMOR FREE				57	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A0CJ	d69e59a8-b10b-46f5-b859-b6c178d90506	Not Available	Positive	Not Available	Not Available	Not Available	Other	Positive	Lumpectomy	Re-excision of the inferior margin	YES	7	-21014	Not Applicable	0	189	Not Available	Not Available	TCGA-A7-A0CJ-D2940;TCGA-A7-A0CJ-D2941;TCGA-A7-A0CJ-D13150	12be856f-cc3d-4090-844e-bddee5eda9d4;cde6bb96-e9e1-4308-9aed-0d9eadef467f;03D86C19-07DE-41C5-8A27-A742EA3E7D3D	Not Available;Not Available;Not Available	5;5;20	124;124;Not Available	61;61;203	Cytoxan;Taxotere;Arimidex	Not Available;Not Available;Not Available	11;11;6	4;4;208	1080;140;1	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	4320;560;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0CJ-F2958;TCGA-A7-A0CJ-F39740	3ABA56D3-D1C1-468E-B5D7-33748980F487;50209FC0-82C7-48DE-8CD9-0F33E8125B0E	Not Available;None	Not Available;None	Not Available;None	20;31	Not Available;None	Not Available;None	Not Applicable;Not Applicable	410;931	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;1					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2011;2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A0CJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0CJ-R2937	06bbdff4-295e-481d-90e9-5038ee936ce3	1	5	202	152	Not Available	11	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2010
TCGA-BH-A0HW	FEMALE	1561	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1561			TUMOR FREE				62	Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0HW	29fdc464-f216-4828-b456-829f71436e27	Not Available	Positive	Not Available	0	Not Available	Not Evaluated	Negative	Other	Not Applicable	NO	11	-22962	Not Applicable	0	1561	Not Available	Not Available	TCGA-BH-A0HW-D4819;TCGA-BH-A0HW-D4824;TCGA-BH-A0HW-D4822	2F384DC7-D076-4C3E-AD10-C21C91BE07A4;3AA2DD0F-A104-4DAD-91CC-8DCC9A958CAD;DA8527E8-79FA-4F17-8B5C-FA1FA0A3E377	Not Available;Not Available;Not Available	17;18;18	Not Available;135;135	223;72;72	Arimidex;Doxorubicin;Cyclophosphamide	Not Available;Not Available;Not Available	11;11;11	Not Available;4;4	1;90;900	mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;356;3564	Not Available;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HW-F4827	D8AD2E6A-F00C-40B6-A939-5FD2230FABA9	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	1561	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0HW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	ASIAN	Not Available	Primary Tumor Field	TCGA-BH-A0HW-R4826	4853EDD3-68CE-4693-B548-7B20BF2B0E2F	1	17	212	166	Not Available	11	34	6240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2006
TCGA-B6-A0I9	FEMALE	362	Infiltrating Ductal Carcinoma	Breast	Dead	T3	NX	M1	Stage IV	1				WITH TUMOR				62	Left Lower Outer Quadrant;Left	No axillary staging	Not Available	TCGA-B6-A0I9	44954053-0b93-4577-a436-42777e442300	Not Available	Indeterminate	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	NO	2	-22798	362	0	Not Available	Not Available	Not Available																								IHC	Not Available	NOT HISPANIC OR LATINO	Bone	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0I9-F12609	A410ADEE-B8AA-4E7F-BD5E-134E99D6BFEE				1		Not Available	362	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		WITH TUMOR			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	Not Available	Not Available	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A0I9	WITH TUMOR	IHC	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	M1	NX	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1992
TCGA-E9-A1RA	FEMALE	1369	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	1369			TUMOR FREE				48	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RA	4b4e4ea8-6eb9-49ad-b880-c5065fe6517f	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	NO	28	-17699	Not Applicable	0	29	Not Available	NO	TCGA-E9-A1RA-D30547;TCGA-E9-A1RA-D30552;TCGA-E9-A1RA-D30550	0CAD78B5-EA56-4810-802C-C8376A508B74;1A3D7515-4506-4F8C-AA69-7638A7FE0EAD;AFDB7AB8-943C-45D1-8584-CD15359E6AA5	Not Available;Not Available;Not Available	12;12;12	80;Not Available;80	10;9;10	Doxorubicin;Tamoxifen;Cyclophosphamide	Not Available;Not Available;Not Available	4;4;4	4;Not Available;4	100;20;1000	mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	380;Not Available;4000	mg;Not Available;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A1RA-F30544;TCGA-E9-A1RA-F39519;TCGA-E9-A1RA-F68493	6249CDE0-2155-4C90-964B-81E4418161AF;46EE054F-0DB7-413D-9436-92212E47D209;B963B3A4-E4B3-449D-A222-A537A95F05E9				12;24;20		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	608;976;1369		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	4;1;11	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Lumpectomy	Other method, specify:	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1RA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A1RA-R30553	2918CA71-A1A5-4A84-A168-C8FF9C942B11	1	12	134	93	Not Available	4	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-B6-A0RI	FEMALE	7126	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N1b	M0	Stage IIIB	1	1100.0	Other, specify	Locoregional Disease	WITH TUMOR				44	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RI	bfd55808-dddd-44c3-97d7-41600497b992	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-16138	Not Applicable	0	6796	Not Available	Not Available																								IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	YES	YES		TCGA-B6-A0RI-F13795	654D049A-8513-4069-B954-CF23980C432E				12		1100	Not Applicable	7126		1100				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	image cytometry	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other Reporting Scale	Not Available	Other Reporting Scale	Not Evaluated	Not Evaluated	Not Available	Not Available	105 fmol/mg	image cytometry	Not Available	Positive	7	Other, specify	Locoregional Disease	Chest Wall	YES																																		WITH TUMOR			133 fmol/mg			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	15	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	6	Not Available	No	A0RI	WITH TUMOR	IHC	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	M0	N1b	T4b	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1992
TCGA-AN-A0AJ	FEMALE	303	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	303			TUMOR FREE				79	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0AJ	9646160a-f1f9-437b-8c7d-efb0b57bfb97	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-29131	Not Applicable	0	244	Not Available	Not Available																								dextran coated charcoal	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AJ-F68941	F68BDA17-ACE3-4591-B611-EC8C99FDBD17				23			Not Applicable	303																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8522/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AJ	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	120	230	Not Available	Not Available	40-49%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-B6-A0WS	FEMALE	2965	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	NX	MX	Stage X	0	2965			TUMOR FREE				58	Left Upper Outer Quadrant;Left	No axillary staging	Not Available	TCGA-B6-A0WS	197741de-a098-4f04-bb37-8ea8b3bb39bc	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Lumpectomy	Not Applicable	NO	15	-21230	2965	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0WS-F15707	2E7292CB-C5A8-4E31-B7BC-7029B5951134				29		Not Available	2965	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	Not Available	Positive	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	Not Available	Not Available	No	A0WS	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	MX	NX	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2011	1996
TCGA-B6-A0IE	FEMALE	1993	Mixed Histology (please specify)	Breast	Dead	T3	N1b	M0	Stage IIIA	1	834.0	Bone	Distant Metastasis	WITH TUMOR				38	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IE	3f834fa7-6d7b-4b85-98c0-5c55d55b6c95	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	2	-13982	1993	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	YES	NO		TCGA-B6-A0IE-F12614	9B0D40DC-3C41-4873-8C8E-9B8D06A6EC6E				1		Not Available	1993	Not Available		834				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	6	Bone	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Lobular/Ductal	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Not Evaluated	Not Available	24	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	6	Not Available	No	A0IE	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T3	Wide re-excisional biopsy	NO	YES	B6	Breast	Not Applicable	Dead	2010	1995
TCGA-XX-A899	FEMALE	467	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N2a	MX	Stage IIIA	0	467			TUMOR FREE				46	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-XX-A899	F89588E9-CA73-4465-A7FB-7246EDB45E3A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-17022	Not Applicable	0	292	Not Available	Not Available	TCGA-XX-A899-D67388;TCGA-XX-A899-D67518;TCGA-XX-A899-D67634	E8DE13D8-49EB-4C42-AE4A-FCBA49BD0CC1;A746793A-ADCD-4ED7-A7C7-A3BD3B1403C8;5A2357E0-00ED-439F-B396-71ABA650DB5E	Not Available;Not Available;Not Available	11;11;11	201;201;Not Available	96;96;103	Cytoxan;Taxotere;Zoladex	Complete Response;Complete Response;Not Applicable	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-XX-A899-F67626	5FF6740C-F490-4530-9C62-7816D19C4948				11			Not Applicable	467																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	0	No	A899	TUMOR FREE	Not Available	Not Available	Not Available	strong	strong	YES	YES	70-79%	WHITE	YES	Primary Tumor Field;Regional site;Regional site	TCGA-XX-A899-R67395;TCGA-XX-A899-R67510;TCGA-XX-A899-R67512	F5A60110-7C0E-413D-9CAA-ACDDA286E5EC;3BDE2380-DD79-4356-8EB6-AD64AD3BDB5F;0A440F8C-5815-4F48-9C49-A71D26B1881A	Not Available;Not Available;Not Available	11;11;11	278;278;278	230;230;230	Complete Response;Complete Response;Complete Response	11;11;11	28;28;5	5040;5040;1000	NO;NO;NO	External;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T1c	Not Available	NO	YES	XX	Breast	Not Applicable	Alive	2014	2013
TCGA-A2-A0T1	FEMALE	521	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N3	M0	Stage IIIC	0	521			TUMOR FREE				55	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0T1	02bed00f-bef7-4fb7-b243-540354990e45	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	12	-20227	Not Applicable	0	323	Not Available	Not Available	TCGA-A2-A0T1-D3712;TCGA-A2-A0T1-D3711;TCGA-A2-A0T1-D3710	3674b5d0-54ba-4c56-b4d1-096bcdddbe9d;f7aadf3f-5dcd-4cf4-b04d-5b9f6907fc68;8ecf4ba5-9b63-4f13-90be-e4249f4d024b	Not Available;Not Available;Not Available	12;12;12	Not Available;187;187	46;46;46	Herceptin;Carboplatin;Taxotere	Not Available;Not Available;Not Available	11;11;11	Not Available;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	IV;IV;IV	YES;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0T1-F13946	C7405E45-2C5E-4447-884E-3AF0DDDF3479				18		Not Available	Not Applicable	521		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	10	Not Available	No	A0T1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	AMERICAN INDIAN OR ALASKA NATIVE	Not Available	Primary Tumor Field	TCGA-A2-A0T1-R3713	06674eb1-647c-45ef-8d3f-63cb7fd97891	1	12	252	189	Not Available	11	30	11840	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-A2-A25B	FEMALE	1291	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	1	1290.0	Bone	Distant Metastasis	TUMOR FREE				39	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A25B	eadf8482-e60e-4307-adb7-d5c3b9fa6cae	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	NO	15	-14454	Not Applicable	0	258	Not Available	NO	TCGA-A2-A25B-D14502;TCGA-A2-A25B-D14505;TCGA-A2-A25B-D14504;TCGA-A2-A25B-D31264	5CA1AA16-D037-4F6E-8F7B-46F0BFB54F17;4DB7724B-1C49-4082-A477-83CAA3AD9A6D;E1774708-5D16-4022-9B47-09313FA0BF3F;05A1B7D2-5DCF-454F-9FE4-33CA8289D1B2	Not Available;Not Available;Not Available;Not Available	20;20;20;17	148;148;148;Not Available	64;64;64;293	Taxotere;Cytoxan;Adriamycin;Tamoxifen	Not Available;Not Available;Not Available;Not Available	6;6;6;4	5;5;5;Not Available	148-150;985-1000;99-100;20	mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;4	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	745;4965;498;Not Available	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A25B-F31267;TCGA-A2-A25B-F70679	46B9BB2E-82B1-4C6A-B19F-E791DEBBF004;81C18AFE-BEA7-4D08-875B-339FFEA2E95D				16;2		Not Available;None	Not Applicable;Not Applicable	496;1291		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Unknown	None;Unknown	None;Not Available	None;1290	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Positive	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Bone	None;Distant Metastasis	None;Not Available	None;NO	None;Not Available	None;YES	TUMOR FREE;WITH TUMOR			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	0.93	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	8	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	2	Not Available	No	A25B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	BLACK OR AFRICAN AMERICAN	Not Available	Not Available	TCGA-A2-A25B-R14506	45D50414-CE7E-456B-BB0F-D49E70BB491D	1	15	Not Available	188	Not Available	7	Not Available	Not Available	YES	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A12Y	FEMALE	1476	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1476			TUMOR FREE				44	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12Y	298a1710-deb4-4064-a0f2-da32d43aa217	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Other	Not Applicable	Not Available	13	Not Available	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A12Y-F70839	BEEE8436-461C-4F8E-B7FC-6960B548AF37				9			Not Applicable	1476																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Not Evaluated	Not Evaluated	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0EP	FEMALE	3603	Infiltrating Lobular Carcinoma	Breast	Alive	T1	N0 (i+)	M0	Stage I	0	3603			TUMOR FREE				56	Right Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0EP	670F5022-5066-48F1-8472-5670129A1E0F	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	16	-20585	Not Applicable	0	3021	Not Available	Not Available	TCGA-A2-A0EP-D34476;TCGA-A2-A0EP-D34477;TCGA-A2-A0EP-D34479;TCGA-A2-A0EP-D34480;TCGA-A2-A0EP-D34482	2B8CBF67-155E-4E57-A98D-DE14635EFF9B;173BF0C9-24F6-4410-AFF4-7061C0A143DB;C6483A02-70E1-4780-BC05-4AE04CAF32CB;FFB9FA64-1267-4A11-8416-9F07A311CF55;0E2A204E-622E-437C-ADF2-E2DEA2F32B38	Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16	141;141;195;1781;2461	92;92;169;222;1959	Cyclophosphamide;Adriamycin;Paclitaxel;Arimidex;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A0EP-F42402;TCGA-A2-A0EP-F58499	DE19DCC9-C5D2-4C47-812D-3EA19E28A675;4D539EB8-A316-4209-AA4C-F82A823F47BC				18;11			Not Applicable;Not Applicable	3273;3603																				NO;NO																						4;4					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	1	No	A0EP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2004
TCGA-BH-A1EX	FEMALE	1508	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	1508			WITH TUMOR				67	Right Lower Inner Quadrant	Not Available	Not Available	TCGA-BH-A1EX	7b892055-c59d-4550-8688-ad039790af3d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	7	-24544	1508	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Negative	24	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	Not Available	No	A1EX	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2000
TCGA-EW-A1OX	FEMALE	911	Mucinous Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	911			TUMOR FREE				43	Right Upper Inner Quadrant	Other (specify)	sentinel + non sentinel	TCGA-EW-A1OX	5fc7ff35-d3f7-4687-8759-3542bd58e988	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	18	-15837	Not Applicable	0	562	Not Available	NO	TCGA-EW-A1OX-D29101;TCGA-EW-A1OX-D29664;TCGA-EW-A1OX-D29666;TCGA-EW-A1OX-D29102	E433F9E6-5D54-429A-8513-1C86731F4B06;0FAF19FA-F141-42D6-AC08-F2F51560A279;45F438EC-544B-4FB0-8940-FB5A0C51D244;BB04DDAB-CEB8-48BC-8439-5FE0794AB1C3	Not Available;Not Available;Not Available;Not Available	8;8;8;8	198;198;Not Available;Not Available	120;120;227;227	Taxotere;Cytoxan;Zoladex;Tamoxifen	Not Available;Not Available;Not Available;Not Available	3;3;3;3	4;4;Not Available;Not Available	164;1314;3.6;20	mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	TailorRX protocol;TailorRx Protocol;Not Available;Not Available	IV;IV;SC;PO	NO;NO;YES;YES	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	656;5256;Not Available;Not Available	mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1OX-F29099	2D559E4D-6B08-44DF-AB6D-FC122319CE7E				8		Not Available	Not Applicable	911		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8523/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1OX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1OX-R29100	9B7F9DE6-C196-489B-8DBA-6BA51CA85C62	1	8	253	211	Not Available	3	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-OL-A66N	FEMALE	792	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3	MX	Stage IIIC	0	792			TUMOR FREE				59	Left	Sentinel node biopsy alone	Not Available	TCGA-OL-A66N	E9002F4E-BA0B-4738-9368-DD9614A5DA8A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Unknown	11	-21608	Not Applicable	0	413	Not Available	Not Available																								Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A66N-F58500	50D68837-611C-4482-A388-7FDD9BE57607				11			Not Applicable	792																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	13	Not Available	No	A66N	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-OL-A66N-R64494	329248C5-412D-40AF-BC3D-5C54F1C54EB9	Not Available	12	412	374	Complete Response	9	Not Available	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3	T3	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2011
TCGA-BH-A1FD	FEMALE	1009	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N0	M0	Stage I	0	1009			WITH TUMOR				68	Left	Not Available	Not Available	TCGA-BH-A1FD	3c8b5af9-c34d-43c2-b8c9-39ea11e44fa6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	8	-24940	1009	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	19	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A1FD	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-AC-A2FM	FEMALE	792	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N1mi	M0	Stage IIB	1	780.0	Other, specify	Distant Metastasis	WITH TUMOR				87	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A2FM	B6B1DC9A-91F4-4B0A-AFD5-62C9A90C0D5E	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	YES	22	-31805	792	0	Not Available	Not Available	YES																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2FM-F43237	B54C9682-B927-4790-A081-623844557F09				15			792	Not Available																				NO																						5					NO	NO	Not Available	780	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Distant Metastasis	Bone Marrow	NO	Not Available	YES	WITH TUMOR						NO		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	0	No	A2FM	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Dead	2012	2004
TCGA-BH-A0HN	FEMALE	516	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	516			TUMOR FREE				67	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0HN	a68a3361-48b4-4bd0-999d-b4cc3d43eb4a	Negative	Positive	Not Available	3+	Not Available	Mastectomy NOS	Positive	Other	Not Applicable	NO	11	-24731	Not Applicable	0	516	Not Available	Not Available	TCGA-BH-A0HN-D4810	606F5F31-0DDC-48DB-954F-474604A3B7ED	Not Available	17	Not Available	82	ARIMIDEX	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-SCORE 300	90-99%	Not Available	Not Available	Not Available	1.78	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HN-F4811	979C6837-237A-4101-B902-FBDC71C7C474	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	516	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	2.0	1.13	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0HN	TUMOR FREE	H-SCORE 290	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-A8-A08I	FEMALE	365	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	365			TUMOR FREE				53	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A08I	7acf33e7-c386-45fd-8c9a-469600378687	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-19389	Not Applicable	0	365	Not Available	Not Available	TCGA-A8-A08I-D37829;TCGA-A8-A08I-D37830;TCGA-A8-A08I-D37831;TCGA-A8-A08I-D37832	9BEA877F-F02D-449C-96A0-557D85624425;F5F19298-9376-430D-9F41-C332F2ABAB4F;C33E9B1F-F94C-41BC-B949-028D039B668A;8817E13F-ED74-42EB-9E2A-B873D79488B6	n/a;n/a;n/a;n/a	6;6;6;6	153;153;153;Not Available	31;31;31;212	5-Fluorouracil;Epirubicin;Cyclophosphamide;Letrozole	Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08I-F40845	98D30323-480E-40B0-825C-3EA0C137401C				2			Not Applicable	365																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08I	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08I-R38173	0322ED7F-C303-4755-B8C3-4FED19B89D49	Not Available	11	212	184	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A202	FEMALE	795	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage II	0	795			Not Available				60	Left	Not Available	Not Available	TCGA-BH-A202	e7a00d67-2c26-4d1f-bd17-35f659e88bc1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	8	-22052	Not Applicable	0	22	Not Available	Not Available	TCGA-BH-A202-D64230;TCGA-BH-A202-D64231	0D4881E9-AE20-4588-920D-75E5D8AB81ED;C3C5CF2E-3889-4D44-A699-9F66D21CE0E1	Not Available;Not Available	27;27	169;169	47;47	Carboplatin;Taxotere	Complete Response;Complete Response	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A202-F64226	32ACC3F7-B74B-4080-8297-329EDC6A00D5				27			Not Applicable	795																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	4	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A202	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A202-R64232	2384CC18-9597-4204-8AD1-330A44034AC4	Not Available	27	231	182	Complete Response	8	25	6100	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2011
TCGA-E9-A1NH	FEMALE	576	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	576			TUMOR FREE				71	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1NH	b2aac45b-2073-4c7a-adb9-769a4fdcc111	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	23	-26221	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1NH-D35054	23703F4A-C80E-4EF7-BB6D-673805FC8899	Not Available	14	Not Available	33	Tamoxifen	Not Applicable	9	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A1NH-F35049	6610DD91-CA89-400B-83F5-1B08AEADAF1A				14			Not Applicable	576																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	3	0	No	A1NH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A2-A25A	FEMALE	3276	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3276			TUMOR FREE				44	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A25A	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	21	-16084	Not Applicable	0	2968	Not Available	NO	TCGA-A2-A25A-D14583;TCGA-A2-A25A-D14585;TCGA-A2-A25A-D14581;TCGA-A2-A25A-D14584	37B653A5-16F9-4CFA-91C8-7AAE12B3D81D;CD0F0B87-4BE9-4070-BC27-F4217BB6F250;DAE723E3-48C2-47C6-932F-B670C43AAEF1;CDAB626B-3EFA-48B1-A671-C525E974334C	Not Available;Not Available;Not Available;Not Available	22;22;22;22	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Cytoxan;Femara;Adriamycin;Taxol	Not Available;Not Available;Not Available;Not Available	7;7;7;7	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;4;1;3	IV;PO;IV;IV	Not Available;Not Available;Not Available;Not Available	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A25A-F30927	23DA0430-B849-4D44-91A7-3099F6931B76				19		Not Available	Not Applicable	3276		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	Yes	A25A	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Not Available	TCGA-A2-A25A-R14586	E691C50B-1796-4283-817C-0F5231B1908D	1	22	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2003
TCGA-A2-A04N	FEMALE	4354	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	4354			TUMOR FREE				66	Right	Other (specify)	Sentinel lymph node biopsy plus non-sentinel lymph node biopsy	TCGA-A2-A04N	197428f7-bd77-4c5f-8119-87157b5c35b9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	27	-24155	Not Applicable	0	3153	Not Available	Not Available	TCGA-A2-A04N-D7482;TCGA-A2-A04N-D7481;TCGA-A2-A04N-D7480	87e62dc0-ef4f-4a7c-9870-8919bc877226;6e45013f-a69c-43a0-8972-435c99dafbd9;9eaef08e-aeb6-4f55-b9dd-61803a467369	Not Available;Not Available;Not Available	28;28;28	2121;107;107	308;42;42	Arimidex;Cytoxan;Adriamycin	Not Available;Not Available;Not Available	1;1;1	Not Available;4;4	1;1130;113	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	PO;IV;IV	NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;4520;452	Not Available;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A2-A04N-F9336;TCGA-A2-A04N-F59311	B8DC7DC2-B3A7-4D0A-BFD6-936C98652439;0BCE4BB0-63D3-4F46-91B3-622ACD436F79	Not Available;None	Not Available;None	Not Available;None	18;8	Not Available;None	Not Available;None	Not Applicable;Not Applicable	3188;4354	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;5					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Negative	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	0	No	A04N	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A04N-R7483	bcef384b-a85a-4552-b96a-7c0b94f8b4c2	1	28	191	143	Not Available	1	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2002
TCGA-A2-A0SU	FEMALE	1662	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	1662			TUMOR FREE				66	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0SU	c632675e-e8af-43cd-8744-5be3754c1c14	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	17	-24219	Not Applicable	0	1352	Not Available	Not Available	TCGA-A2-A0SU-D3989	94ab7027-4e66-4e27-be4f-266bfe28933f	Not Available	17	Not Available	93	Arimidex	Not Available	11	Not Available	Not Available	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0SU-F13954	95DB2CB9-9078-478C-8496-948B59DEABE3				12		Not Available	Not Applicable	1662		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	1	No	A0SU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2006
TCGA-A8-A08A	FEMALE	30	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	30			TUMOR FREE				89	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A08A	7fe4670d-4626-459d-869b-ab15f478c6a7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-32750	Not Applicable	0	30	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08A	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-A8-A09Z	FEMALE	0	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	0			WITH TUMOR				83	Right	Not Available	Not Available	TCGA-A8-A09Z	81e7a3d3-be70-4834-8018-4d2cc077a4e6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-30590	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09Z	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-PL-A8LY	FEMALE	8	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	1				WITH TUMOR				30	Right;Right Upper Outer Quadrant	Not Available	Not Available	TCGA-PL-A8LY	9BA11EA8-97D3-464A-90A4-EC1151BE9088	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	26	-11199	Not Applicable	0	8	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-PL-A8LY-F64851	D22A3C5D-4EAD-4A4B-ACAF-158F43785286				17			Not Applicable	8																				YES																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Evaluated	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A8LY	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	YES	NO	PL	Breast	Not Applicable	Alive	2014	2013
TCGA-B6-A0RG	FEMALE	2082	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	0	2082			TUMOR FREE				26	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RG	9b13927c-7357-44fd-8385-92ae6a656b7d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	2	-9840	Not Applicable	0	2082	Not Available	Not Available																								IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0RG-F13793	81C89D48-283C-43B0-97AE-F30BB640272D				12		Not Available	Not Applicable	2082		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	19	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0RG	TUMOR FREE	IHC	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1991
TCGA-D8-A142	FEMALE	425	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	425			TUMOR FREE				74	Left Lower Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-D8-A142	ccb22ecc-6e18-44b8-ad48-6ab51314b16e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	25	-27313	Not Applicable	0	61	Not Available	Not Available	TCGA-D8-A142-D13815;TCGA-D8-A142-D64906;TCGA-D8-A142-D64908	20BD3B94-30E2-4571-B116-A786A8D72633;C9AD9634-5799-4DB1-B41C-28D2AB117AF2;3AB62920-B064-4CD7-9D3B-F002D10D66E5	Not Available;Not Available;Not Available	20;15;15	271;271;271	61;61;61	cyclophosphamid;metotreksat;fluorouracil	Not Available;Not Available;Not Available	6;9;9	6;Not Available;Not Available	100;Not Available;Not Available	mg/m2;Not Available;Not Available	ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	CMF;Not Available;Not Available	IV;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg/m2;Not Available;Not Available	Not Available;NO;NO	2011;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A142-F13813	955192A4-D534-42D7-8A51-67D7446F1AE1				20		Not Available	Not Applicable	425		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A142	TUMOR FREE	Not Available	FISH	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A6HE	FEMALE	847	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3	MX	Stage IIIC	0	847			Unknown				45	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E9-A6HE	7E9C8D3C-790C-46AD-8F31-B557B7C26F69	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	16	-16697	Not Applicable	0	92	Not Available	Not Available	TCGA-E9-A6HE-D56814;TCGA-E9-A6HE-D56815;TCGA-E9-A6HE-D56816;TCGA-E9-A6HE-D70948	75161762-89C2-45DD-B3F6-2C5CE67185BB;A670D2BD-0DD4-415F-91E3-B74DFC267B86;33B0A4BB-DC7E-43C0-86E2-93A6B112CAC5;841B570D-BF43-46C2-BA09-48D7F7A17424	Not Available;Not Available;Not Available;Not Available	24;24;24;10	174;174;307;Not Available	104;104;104;547	Adriamycin;Cyclophosphamide;Paclitaxel;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	2;2;2;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2015	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.7					TCGA-E9-A6HE-F56813;TCGA-E9-A6HE-F70947	04C878A3-833B-4620-BFE5-089365972076;E4603D87-4400-4911-84C6-3A4D5F0371DC				24;10			Not Applicable;Not Applicable	468;847																				NO;NO																						2;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	<10%	Not Available	1+	30	Not Available	1.8	1.08	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	12	Not Available	No	A6HE	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	90-99%	WHITE	Unknown	Primary Tumor Field	TCGA-E9-A6HE-R56817	35448ACB-8809-472B-873C-7B257ECB579D	Not Available	24	299	259	Complete Response	2	28	50.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3	T3	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012
TCGA-E9-A54X	FEMALE	727	Mucinous Carcinoma	Breast	Alive	T1b	N0 (i-)	M0	Stage IA	0	727			TUMOR FREE				85	Left;Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A54X	3DBC8D60-3A97-47B2-91D0-C18FB46B4365	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	21	-31173	Not Applicable	0	0	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A54X-F51390;TCGA-E9-A54X-F66449	53D71BE3-FC14-4DA9-968B-918D9FC1117D;AF2FFFFE-FAF6-48EC-893A-15C569E3387A				18;15			Not Applicable;Not Applicable	375;727																				NO;NO																						11;10					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						NO;NO		NO;NO	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	Not Available	No	A54X	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	90-99%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1b	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012
TCGA-A2-A04Y	FEMALE	1099	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	M0	Stage IIB	0	1099			TUMOR FREE				53	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A04Y	9ce7ce09-4409-4fa3-9f78-b2b24716f860	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	9	-19533	Not Applicable	0	764	Not Available	Not Available	TCGA-A2-A04Y-D2729;TCGA-A2-A04Y-D2733;TCGA-A2-A04Y-D2731;TCGA-A2-A04Y-D2754;TCGA-A2-A04Y-D2732;TCGA-A2-A04Y-D2741;TCGA-A2-A04Y-D2746	bb88b686-73af-4f28-b19b-97bdb837eddb;ea8b13ac-f088-4440-a155-06c71299a37e;351c5069-eb0c-468e-ba16-bf6ab636303f;e34536c3-f6b1-4a30-8208-da6658e0d4bd;e7199f09-af18-4584-8015-6eebc968cd8c;d6d00a85-5494-4f08-8711-63169285c197;227dd2b0-0b22-46bd-95d4-20775978c5dd	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;12	135;659;135;Not Available;226;371;Not Available	93;149;93;503;149;273;372	Cytoxan;Herceptin;Adriamycin;Zometa;Taxol;Tamoxifen;Arimidex	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8	4;22;4;Not Available;12;Not Available;Not Available	1200;170-600;120;4;160-165;10;1	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Patient has oesteoporosis (Prevention of further bone loss;Not Applicable;Not Applicable;Not Applicable	1;4;2;7;3;5;6	IV;IV;IV;IV;IV;PO;PO	NO;NO;NO;YES;NO;NO;YES	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Other, specify in notes;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Bisphosphonate therapy;Not Available;Not Available;Not Available	4800;10037;480;Not Available;3900;Not Available;Not Available	mg;mg;mg;Not Available;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-A2-A04Y-F9330	0CE61CBA-C744-4182-820C-81C33344DFCD	Not Available	Not Available	Not Available	18	Not Available	Not Available	Not Applicable	1099	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.13	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	0	No	A04Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Strong	Not Available	Not Available	10-19%	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-A2-A04Y-R2727;TCGA-A2-A04Y-R70740	e64c8ab7-4c64-47d5-b50e-188fb963eed4;8D05878C-2457-487F-8DF3-A4F0B1688D9E	1;Not Available	12;3	297;290	293;251	Not Available;Complete Response	8;3	Not Available;Not Available	1000;5040	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;cGy	2010;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-E9-A5UP	FEMALE	803	Other, specify	Breast	Alive	T2	N0	M0	Stage IIA	0	803			TUMOR FREE				63	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A5UP	A412B374-4D25-491F-B76F-DDAA989ACF59	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	NO	23	-23371	Not Applicable	0	0	Not Available	Not Available	TCGA-E9-A5UP-D57717	DCB3552D-9065-47A4-A78C-6C66D46F8D06	Not Available	21	Not Available	8	Tamoxifen	Not Applicable	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A5UP-F57716;TCGA-E9-A5UP-F71525	E0F63996-79B7-4B36-AAE5-2D10D7A17457;95FB53E8-8B32-4656-9B5C-1384676E9BFF				21;26			Not Applicable;Not Applicable	438;803																				NO;NO																						3;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Infiltrating papillary adenocarcinoma	No	C50.9	8503/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5UP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown	Primary Tumor Field;Regional site;Regional site;Regional site;Regional site	TCGA-E9-A5UP-R57718;TCGA-E9-A5UP-R57719;TCGA-E9-A5UP-R57720;TCGA-E9-A5UP-R57722;TCGA-E9-A5UP-R57723	B7F0EB25-DAD8-4E55-AFD1-5B1A12F009CD;3FAF99BF-83F4-49DE-AE9F-99A2D468D3E9;24449F45-1D96-49E5-9300-B5A5F8E06330;36D0D37C-2664-4204-9CA1-A61CD78FF6B9;5578F153-CCB2-4B38-9BD2-2DF088DD9BC2	Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21	78;78;78;101;101	44;44;44;80;80	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response	3;3;3;3;3	Not Available;Not Available;Not Available;Not Available;Not Available	46;44;40;33;30	NO;NO;NO;NO;NO	External;External;External;External;External	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Gy;Gy;Gy;Gy;Gy	2014;2014;2014;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012
TCGA-A8-A07R	FEMALE	273	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	273			Not Available				80	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07R	72e486b8-a866-4916-b2e4-8b4bb5dcd92d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-29251	Not Applicable	0	273	Not Available	Not Available	TCGA-A8-A07R-D37859	405A82A8-7239-4AA4-9C46-4C081D26D8E4	n/a	6	Not Available	181	Zoledronic acid	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Ancillary	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07R	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07R-R38182	79E24A2B-F8AD-4310-8924-83117D9C4CC3	Not Available	11	151	120	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-A8-A09M	FEMALE	1006	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	1006			TUMOR FREE				75	Right Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A09M	626b4ff0-2188-4a14-aac8-6703c624917f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-27455	Not Applicable	0	457	Not Available	Not Available	TCGA-A8-A09M-D37785;TCGA-A8-A09M-D37786	C1C79A95-B5D8-45E8-8FE0-B54E7E435634;09FBDD53-0E66-4D9E-AACA-888BC15FA3CF	n/a;n/a	6;6	184;Not Available	31;276	Paclitaxel;Exemestane	Complete Response;Not Applicable	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09M-F40331	6B25050A-F752-4FED-A111-E3D271B3BD15				17			Not Applicable	1006																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09M	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09M-R38162	5ACACE6F-008C-433C-9F3C-EED2853291D8	Not Available	11	276	214	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-B6-A0IQ	FEMALE	4285	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1b	M0	Stage IIIA	0	4285			TUMOR FREE				40	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IQ	01eef340-598c-4205-a990-cec190ac2ca5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	2	-14669	Not Applicable	0	3872	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0IQ-F12629	8D04EFD2-BFDA-4F6B-ACA2-E86C4B2B9B74				2		Not Available	Not Applicable	4285		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	26	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	1	Not Available	No	A0IQ	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1996
TCGA-AO-A0JL	FEMALE	1683	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	1683			TUMOR FREE				59	Left Upper Outer Quadrant;Left Lower Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-AO-A0JL	d5d8e76e-2f2a-49bc-ba0a-d51283611b16	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	20	-21895	Not Applicable	0	1319	Not Available	Not Available	TCGA-AO-A0JL-D3224;TCGA-AO-A0JL-D3226;TCGA-AO-A0JL-D3223;TCGA-AO-A0JL-D3225	8dcbe4a5-051a-4efa-8075-bd9b1286cb99;159bd986-fd08-4ac4-bca0-67dfa5bdf56f;b9f318a5-5322-4ead-a810-926101586b5e;e91e3c59-4d69-4fa4-8fdb-3221b74de9a2	Not Available;Not Available;Not Available;Not Available	20;20;20;20	122;493;122;178	80;136;80;136	DOXORUBICIN;TRASTUZUMAB;CYCLOPHOSPHAMIDE;PACLITAXEL	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;22;4;4	60;6;600;175	mg/m2;mg/kg;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	488;9476;4872;1372	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	50	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JL-F3220;TCGA-AO-A0JL-F15495	DD0750D5-100B-40A1-9393-C49DA44B5F66;2DA970A3-1C67-4AE5-BAC4-13FDE30BD4D0	Not Available;None	Not Available;None	Not Available;None	20;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1319;1683	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	RATIO > = 2.0	1+	21	Not Available	131	2.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Positive	26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	7	Not Available	No	A0JL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A0JL-R3221	d709ea17-69fa-422f-ad04-a50953144eb1	1	20	240	192	Not Available	9	45	10776	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2006
TCGA-D8-A27L	FEMALE	499	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	499			TUMOR FREE				49	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-D8-A27L	6020d1b4-ee20-4cc9-82a3-340b5e3122f1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-18025	Not Applicable	0	126	Not Available	NO	TCGA-D8-A27L-D29591	53DEB285-A9E3-4877-A72F-64441D85E4F9	Not Available	26	238	100	adriamycin+cuclophosphamide	Not Available	3	4	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	240+2400	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27L-F29590	F7C1DB5B-81CE-49D1-89AE-3C672EAE8635				26		Not Available	Not Applicable	499		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	2	Not Available	No	A27L	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A18U	FEMALE	1563	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2a	M0	Stage IIIA	0	1563			TUMOR FREE				72	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A18U	233b02f3-c4f0-4a67-9db5-e68d5cdaccb6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	2	-26426	1563	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.4	8500/3	C50.4	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	9	Not Available	No	A18U	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	total mastectomy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2003
TCGA-GM-A2D9	FEMALE	1812	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N0 (i-)	M0	Stage I	1	536.0	Bone	Distant Metastasis	WITH TUMOR				69	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2D9	1133B8A9-6B11-4511-B70A-F200E3B8B5DB	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	28	-25490	1812	0	Not Available	Not Available	YES	TCGA-GM-A2D9-D47254;TCGA-GM-A2D9-D47255;TCGA-GM-A2D9-D47256;TCGA-GM-A2D9-D47257	64CF04C2-4790-4726-A0F7-9B4EF1148E1D;3BAECB5B-8DFC-452B-93BF-ED08CA82E4EC;1BAEBAA5-762C-4559-8CFF-34C352DD5B0A;F83B835B-003A-4E5D-AA90-9504C8171A8D	Not Available;Not Available;Not Available;Not Available	23;23;23;23	1265;1354;1455;1567	559;1266;1362;1470	Arimidex;Tamoxifen;Xeloda;Gemcitabine	Stable Disease;Stable Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Bone	Not Available	1.93					TCGA-GM-A2D9-F47033	6B63FE41-80F5-49EC-9AD0-40B71FED880D				21			1812	Not Available																				NO																						8					YES;YES;YES	YES;NO;NO	536;Not Available;Not Available	536;1351;1351	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Positive;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Bone;Other, specify;Lung	Distant Metastasis;Distant Metastasis;Distant Metastasis	Not Available;Intrathoracic lymph node;Not Available	YES;NO;NO	Not Available;Not Available;Not Available	YES	WITH TUMOR						YES		YES	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	2.23	1.16	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	90-99%	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	0	No	A2D9	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	40-49%	WHITE	Not Available	Primary Tumor Field;Distant Recurrence	TCGA-GM-A2D9-R47037;TCGA-GM-A2D9-R47253	BE3ADDFC-5406-471C-984B-8229F0EEA8D7;21CA09CB-DF2B-458F-813B-66DA60B6C923	Not Available;Not Available	21;23	96;1434	68;1413	Not Available;Stable Disease	8;8	30;10	60;30	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Dead	2011	2006
TCGA-A8-A09V	FEMALE	457	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	457			TUMOR FREE				51	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A09V	cc348a26-ee11-47a4-8b51-de922967e175	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-18628	Not Applicable	0	457	Not Available	Not Available	TCGA-A8-A09V-D37903	4BD8862A-EC1F-43A3-8343-7616B73F5DB5	Not Available	6	Not Available	123	Tamoxifen	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09V-F40328	0021AB34-8C5F-451E-8B64-DF949CB50034				17			Not Applicable	457																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09V	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09V-R38193	19729E19-9B06-4822-85A2-5D7A86976764	Not Available	11	92	31	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-E2-A1LK	FEMALE	266	Infiltrating Ductal Carcinoma	Breast	Dead	T4b	N3a	M0	Stage IIIC	1	155.0	Other, specify	Locoregional Disease	WITH TUMOR				84	Left Upper Outer Quadrant;Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A1LK	1d27253f-b036-44e7-a04d-8da5bbf57419	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	3	-30757	266	0	Not Available	Not Available	NO																								Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	YES		TCGA-E2-A1LK-F20620	84091637-DEEE-4309-9AAE-75A596E9218D				12		200	266	Not Available		155				Scheduled Follow-up Submission							Not Available			Not Available					2+	Allred score 0+0 = 0	Not Available	Negative	Not Available	Not Available	30-39%	Not Available	0.95	Not Available	Not Available	Not Available	Not Available	Equivocal	Negative	Not Available	Not Available	Allred Score = 0	Allred score 0+0 = 0	Not Available	Negative	1	Other, specify	Locoregional Disease	Left axilla	YES																																		WITH TUMOR			Allred score = 0			NO		NO	Dead	2012	FEMALE	Not Available	Not Available	80-89%	Not Available	2+	Not Available	Not Available	Not Available	1.41	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	11	Not Available	No	A1LK	WITH TUMOR	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T4b	Not Available	NO	YES	E2	Breast	Not Applicable	Dead	2011	2008
TCGA-A2-A4S1	FEMALE	820	Metaplastic Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	820			TUMOR FREE				66	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A4S1	843C8F16-5E59-40D4-9ECC-8A75375156F6	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	26	-24353	Not Applicable	0	365	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A4S1-F58925	67A3F1E4-5375-4437-89BD-6EF2EB2BCDCC				28			Not Applicable	820																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4S1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	YES	Primary Tumor Field;Primary Tumor Field	TCGA-A2-A4S1-R40670;TCGA-A2-A4S1-R40671	3B3276B7-1916-4C7C-9209-216BCC694612;8236A730-E0C4-4C4B-8DD0-EFD9FA7D81AC	Not Available;Not Available	26;26	123;130	91;126	Complete Response;Complete Response	2;2	25;5	5000;1000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2013	2012
TCGA-D8-A73U	FEMALE	492	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1				WITH TUMOR				88	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-D8-A73U	96F02BE7-F2DF-483C-8968-A5BD2D887206	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	28	-32208	Not Applicable	0	492	Not Available	Not Available	TCGA-D8-A73U-D57872	96016F6D-6A93-4CA4-8261-A995B5304A9D	Not Available	28	Not Available	75	tamoxifen	Not Applicable	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-D8-A73U-F57871	66FB6CC5-35C7-47CF-9FB4-63E3DB488520				28			Not Applicable	492																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A73U	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	NO	70-79%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2014	2012
TCGA-PE-A5DC	FEMALE	1430	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N2a	M0	Stage IIIA	0	1430			TUMOR FREE				72	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-PE-A5DC	76099BEB-0ABE-4B56-8B4E-E4485E0402E6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	30	-26514	1430	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Not Evaluated	31	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	Not Available	No	A5DC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	PE	Breast	Not Applicable	Dead	2013	2005
TCGA-PL-A8LZ	FEMALE	302	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N2	M0	Stage IIIB	0	302			TUMOR FREE				29	Left;Left Upper Outer Quadrant	Unknown	Not Available	TCGA-PL-A8LZ	9087585F-E792-4F33-BAAA-56FFE0F745BE	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	5	-10869	Not Applicable	0	120	Not Available	Not Available	TCGA-PL-A8LZ-D60805	B7CC5531-DE12-4FCF-A668-AD54FDDCB143	Not Available	26	48	4	paclitaxel	Unknown	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-PL-A8LZ-F64850	7245952D-7C0E-4FF3-BAD0-8A21D5524A97				15			Not Applicable	302																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Evaluated	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A8LZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Unknown	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T4b	Not Available	YES	NO	PL	Breast	Not Applicable	Alive	2014	2013
TCGA-E9-A247	FEMALE	1186	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1186			TUMOR FREE				59	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A247	636b0a90-c8c2-4ad6-a77d-6cd428a826d1	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	18	-21562	Not Applicable	0	13	Not Available	NO	TCGA-E9-A247-D31208	5A067FB7-4E61-4DD8-9DCF-061185296A15	Not Available	25	Not Available	10	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A247-F31204;TCGA-E9-A247-F40240;TCGA-E9-A247-F61874	8BAC0FD9-1E30-4203-B0C7-0382C7E97B77;1B31A774-A7D0-41F4-A4E0-B650129E3C2D;8455B922-8FE0-4FB7-9DFB-3798FA5B1CB0				20;14;23		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	463;828;1186		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	9;2;7	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2013;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Lumpectomy	Other method, specify:	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A247	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A247-R31207	26249F86-F8CF-4233-A328-0F7884EEB5A0	1	25	64	33	Not Available	4	23	4600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-E9-A295	FEMALE	375	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	375			TUMOR FREE				71	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A295	fec0da58-1047-44d2-b6d1-c18cceed43dc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	12	-25957	Not Applicable	0	22	Not Available	Not Available	TCGA-E9-A295-D35357	C6FF0A55-DD00-4370-882C-4CDA4D7F524D	Not Available	5	Not Available	152	Tamoxifen	Not Applicable	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A295-F35355	3DDA0B38-4114-4BCD-8EB4-4D82877CC1FC				25			Not Applicable	375																				YES																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A295	TUMOR FREE	Not Available	Not Available	Not Available	7	7	Not Available	YES	80-89%	WHITE	Not Available	Regional site	TCGA-E9-A295-R35358	20725E45-0E63-4739-8B3F-414F2BBAAC47	Not Available	25	74	46	Complete Response	9	65	130	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-D8-A1JK	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			Not Available				90	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JK	56203436-8634-4fd0-96b5-ba6be9d87857	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	29	-32872	Not Applicable	0	0	Not Available	Not Available																								manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JK-F20751	E9360A7B-562C-479B-8705-03D745CA6930				19		Not Available	Not Applicable	0		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	DAKOHercepTest TM	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JK	Not Available	manual counting	Not Available	Not Available	Not Available	0%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A1-A0SJ	FEMALE	416	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	416			TUMOR FREE				39	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SJ	a2db9dd1-44d5-48b5-817c-a21a85fadb21	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	6	-14383	Not Applicable	0	416	Not Available	Not Available																								Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	4																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	5	1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	19	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	3	Not Available	No	A0SJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2010	2006
TCGA-A8-A08F	FEMALE	1004	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	1004			TUMOR FREE				59	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A08F	0a017f15-1c6b-45e7-8d55-e0a71df1b2e8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-21641	Not Applicable	0	549	Not Available	Not Available	TCGA-A8-A08F-D37756;TCGA-A8-A08F-D37757;TCGA-A8-A08F-D37758;TCGA-A8-A08F-D37759;TCGA-A8-A08F-D37760	A407F51A-F51F-4CCD-B64B-41D298C30F9C;BD575045-6AED-4137-9E4C-2BB9C02A1E89;D0945071-31AC-4310-AF0A-4AC89DC8D74D;4213A223-3502-4936-813C-875A28B2F161;4B4B76FD-2BE6-4E59-9D03-D67BFF3D823F	n/a;n/a;n/a;n/a;n/a	6;6;6;6;6	92;92;92;123;Not Available	31;31;31;92;243	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Letrozole	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08F-F40843	6303FB2D-9618-4364-8331-667962F57160				2			Not Applicable	1004																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A08F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08F-R38156	669B30AD-2747-4953-BAC9-E5E3AFAE9216	Not Available	11	215	184	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-AC-A2FG	FEMALE	1853	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	1853			TUMOR FREE				79	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A2FG	39CDA4C9-E1C8-44C2-BAB7-F5849C12F879	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	21	-29211	Not Applicable	0	1125	Not Available	NO	TCGA-AC-A2FG-D43222	1263ADA3-9E75-48E3-AC3C-891A3C9AF9AB	Not Available	15	Not Available	39	Arimidex	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available					TCGA-AC-A2FG-F43221	06360A31-72BE-4B48-BC93-870CEB0E9BED				15			Not Applicable	1853																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	1	No	A2FG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2007
TCGA-A8-A07I	FEMALE	426	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	426			TUMOR FREE				69	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07I	566792ae-f853-4a47-856d-f02cdcfcb18a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-25263	Not Applicable	0	426	Not Available	Not Available	TCGA-A8-A07I-D37873;TCGA-A8-A07I-D37874;TCGA-A8-A07I-D37875;TCGA-A8-A07I-D37876;TCGA-A8-A07I-D37877;TCGA-A8-A07I-D37878	2E3715CB-3802-4392-A7FD-4A36AE0E3D43;DEE16E8F-6322-49BB-8B56-D708F62283F3;D9C7F7BE-AA3C-45E5-B2B3-272DA8642C88;AF49DCB1-E14E-4848-9903-7D13E60573C7;4626641D-270B-4338-980A-D4A594F94997;5488CE4C-EA04-476A-AA6B-6FE37646BC75	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6;6	122;122;122;183;Not Available;334	61;61;61;122;183;183	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Exemestane;Trastuzumab	Complete Response;Complete Response;Complete Response;Complete Response;Clinical Progressive Disease;Complete Response	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07I-F40828	339036C6-8D30-466F-9CDD-9F7F28402C81				2			Not Applicable	426																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07I	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07I-R38187	1BF7CBC3-B465-4421-911B-D37309EF031F	Not Available	11	304	245	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-A8-A07C	FEMALE	1034	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1034			TUMOR FREE				57	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07C	b6633c36-7ce4-4b69-9bf6-30b64d46c66f	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-20820	Not Applicable	0	580	Not Available	Not Available	TCGA-A8-A07C-D37838;TCGA-A8-A07C-D37839;TCGA-A8-A07C-D37840;TCGA-A8-A07C-D37841	80A825CD-F344-4738-AB3F-163220CF126F;44BA63A5-D965-4A75-BB06-9C2DD6F50AD6;1A826A54-48E2-429B-A130-9112B0552A47;4749D00E-48DA-45FB-BDBF-BAD8C06F1036	n/a;n/a;n/a;n/a	6;6;6;6	62;62;62;123	0;0;0;92	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel	Complete Response;Complete Response;Complete Response;Complete Response	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07C-F40824	8090BEDB-F551-48C4-81E1-F2BC695F9981				2			Not Applicable	1034																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07C	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07C-R38175	BFF5B463-20EA-48A9-8E45-19AE74E3112A	Not Available	11	184	153	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-B6-A0IB	FEMALE	3941	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N3	M1	Stage IV	1	2717.0	Other, specify	Distant Metastasis	WITH TUMOR				64	Right Upper Inner Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IB	157ec9e0-ca6e-4da1-9233-f976cf0db433	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-23646	3941	0	Not Available	Not Available	Not Available																								IHC	Not Available	NOT HISPANIC OR LATINO	Other, specify	Skin	Not Available	Not Available	Not Available	NO		TCGA-B6-A0IB-F12612	B3CE5BB9-A83F-46D9-B1B3-71711115FFF4				1		Not Available	3941	Not Available		2717				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	image cytometry	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	fmol/mg	image cytometry	Not Available	Positive	6	Other, specify	Distant Metastasis	lung, bone, liver	YES																																		WITH TUMOR			fmol/mg			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	15	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	8	Not Available	No	A0IB	WITH TUMOR	IHC	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	M1	N3	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1992
TCGA-C8-A1HL	FEMALE	317	Other, specify	Breast	Alive	T3	N1	M0	Stage IIIA	0	317			TUMOR FREE				38	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HL	a8a199c9-d781-4e6c-af8c-c85d60c7cd40	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	2	Not Available	Not Applicable	0	2	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A1HL-F20266	FC4E3C55-61FA-44EF-83CE-5A7BEEC6B79D				9		Not Available	Not Applicable	317		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Infiltrating Mucinous-papillary ductal carcinoma	No	C50.9	8480/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Equivocal	Not Evaluated	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	Not Available	Not Available	Yes	A1HL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Allred Score 8	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A03P	FEMALE	2911	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1	M0	Stage IIB	1	1922.0	Liver	Distant Metastasis	WITH TUMOR				54	Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A03P	2d4c778c-7f77-4f0a-8261-2086accf15fd	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	19	-19724	Not Applicable	0	2576	Not Available	Not Available	TCGA-AO-A03P-D3084;TCGA-AO-A03P-D3083;TCGA-AO-A03P-D3082;TCGA-AO-A03P-D3079;TCGA-AO-A03P-D15460	a2e0b197-c210-47bf-94ae-a6c24311cc17;9d61ae92-631d-4965-be2d-59cb2d7b83eb;726efafa-90dd-4a5e-b0fd-4e283d1caebb;fd50d042-4a2a-43d3-9cd4-d7f90dd15f4e;0431F2EF-29FF-4AD2-A3CC-BF47622615EA	Not Available;Not Available;Not Available;Not Available;Not Available	6;19;19;19;22	2822;2839;2422;2331;2881	2451;2422;2332;1918;2853	BEVACIZUMAB;CAPECITABINE;EXEMESTANE (AROMASIN);LETROZOLE (FEMARA);FULVESTRANT	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;8	27;Not Available;Not Available;Not Available;3	10;1500;25;2.5;500	mg/kg;mg/day;mg/day;mg/day;mg	RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Estrogen receptor antagonist in metastatic breast cancer	3;3;2;1;5	IV;PO;PO;PO;IM	NO;NO;NO;NO;NO	Immunotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	20050;Not Available;Not Available;Not Available;1500	mg;Not Available;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;Not Available	NO;Not Available	YES;NO	Not Available;None	TCGA-AO-A03P-F3073;TCGA-AO-A03P-F15452	E3386E19-D171-4D36-A0E4-E8278E44C2FA;46278B90-E76B-4B39-B3C0-42D6AC1CF690	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	1922;Not Available	Not Applicable;2911	Not Available;Not Available	2576;None	1922;1922	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	40;40	Not Available;None	Not Available;None	4.0;4.0	Not Available;None	Not Available;None	Not Available;None		2+;2+	Not Available;Not Available	90-99%;90-99%	Positive;Positive	2.4;2.4	3+ POSITIVE;3 Point Scale	20-29%;20-29%	RATIO > 2.2;RATIO >2.2	1.7;1.7	4+;4+	None;4 Point Scale	2+;2+	None;4 Point Scale	Equivocal;Equivocal	Negative;Negative	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	80-89%;80-89%	Positive;Positive	9;8	None;Liver	None;Distant Metastasis	None;Not Available	None;YES																																		WITH TUMOR;WITH TUMOR	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	NO;NO	Not Available;None	YES;YES	Alive;Dead	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	26	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	2	No	A03P	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-AO-A03P-R3077	880c6fc2-c85f-4ab2-a92c-9cbb2dfd34ab	1	19	141	98	Not Available	9	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2003
TCGA-A7-A3IZ	FEMALE	322	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	322			TUMOR FREE				62	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A3IZ	15FF4B02-BB69-4D24-8A07-B82F428E428D	Negative	Positive	Not Available	Not Available	Not Available	Other	Negative	Lumpectomy	Reexcision	YES	12	-22997	Not Applicable	0	148	Not Available	NO	TCGA-A7-A3IZ-D29226;TCGA-A7-A3IZ-D29225;TCGA-A7-A3IZ-D34493	D6D7C497-BCC6-4864-94CB-FCD2B53EC7B6;A1B93297-6E83-4565-943F-92213D0BA738;D4791F16-F661-488F-9546-AE3B6AC25372	Not Available;Not Available;Not Available	12;12;16	134;134;Not Available	73;73;124	Cytoxan;Taxotere;Anastrozole	Not Available;Not Available;Not Applicable	3;3;8	4;4;Not Available	1000;129-131;Not Available	mg;mg;Not Available	ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable	1;1;Not Available	IV;IV;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	4000;522;Not Available	mg;mg;Not Available	Not Available;Not Available;NO	2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	3.0					TCGA-A7-A3IZ-F34491	69577EC0-0532-4A9C-BCBA-5A79E096D13B				16			Not Applicable	322																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA probe kit.	2+	569	Not Available	3.0	1.0	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	Not Available	1	No	A3IZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A3IZ-R34492	B45436BD-3C65-4EC5-9C41-1D009B1E0435	Not Available	16	226	181	Complete Response	8	33	6100	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2011
TCGA-A7-A425	FEMALE	447	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3a	MX	Stage IIIC	1	419.0	Other, specify	Locoregional Recurrence	Unknown				70	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A425	A8F5C479-8685-4E2D-BB60-63F1CC651083	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	5	-25678	Not Applicable	0	293	Not Available	Not Available	TCGA-A7-A425-D36587;TCGA-A7-A425-D36588;TCGA-A7-A425-D36589;TCGA-A7-A425-D41690	7AA4AFE0-6678-4A17-96DE-062AB5E85D67;65234BE9-7E88-41BF-9163-37261DF76FED;D8A19C0E-E2E4-410F-B480-D1FC1EAEA6CD;3E02A5A3-AF45-42DE-BF76-E56FAE2440DA	Not Available;Not Available;Not Available;Not Available	5;5;5;26	197;197;288;Not Available	127;127;211;378	Adriamycin;Cytoxan;Taxol;Arimidex	Unknown;Unknown;Unknown;Not Applicable	11;11;11;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.5					TCGA-A7-A425-F41648	8EE1DAAF-2EFE-4CA4-B494-4674A8AC9C79				25			Not Applicable	447																				NO																						3					Unknown;Unknown	Unknown;Unknown	419;Not Available	419;443	Not Available;Not Available	Not Available;Not Available	1+;Not Available	Not Available;Not Available	90-99%;Not Available	Positive;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	3 Point Scale;Not Available	Not Available;Not Available	3 Point Scale;Not Available	Negative;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	<10%;Not Available	Negative;Not Available	Other, specify;Bone	Locoregional Recurrence;Distant Metastasis	Left Breast;Not Available	YES;NO	Not Available;Not Available	YES	WITH TUMOR						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	30-39%	Pathvysion HER-2 DNA Probe Kit	3+	228	Not Available	2.8	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Indeterminate	Negative	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	12	Not Available	No	A425	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	70-79%	WHITE	YES	Primary Tumor Field;Regional site	TCGA-A7-A425-R41699;TCGA-A7-A425-R41726	3E540589-038B-4233-A130-F771D76578D6;F05F3412-8D0F-4DA4-9950-3B625351074E	Not Available;Not Available	26;26	359;352	317;317	Radiographic Progressive Disease;Radiographic Progressive Disease	3;3	28;25	5040;4500	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T3	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2012
TCGA-AC-A3BB	FEMALE	987	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N2a	MX	Stage IIIA	0	987			TUMOR FREE				46	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A3BB	048549CF-D0A5-4743-A0A1-2004F7CC2B08	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	3	-16983	Not Applicable	0	30	Not Available	NO	TCGA-AC-A3BB-D58955;TCGA-AC-A3BB-D58956;TCGA-AC-A3BB-D58957	29980E13-140D-4302-8067-9256665BC673;CAB74A66-0CCF-4E51-8F5A-FF613B5A43C7;260FF621-0F12-4118-8D3F-AA44CC70F345	Not Available;Not Available;Not Available	29;29;29	197;197;197	92;92;92	Cytoxan;Adriamycin;Taxotere	Complete Response;Complete Response;Complete Response	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3BB-F58953	4140D0AE-C992-47B8-BB8C-23A0F298C461				29			Not Applicable	987																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	5	Not Available	No	A3BB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-AC-A3BB-R58954	DE55AD06-AA01-4B82-90E5-16F511E133AD	Not Available	29	261	217	Complete Response	4	28	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-E2-A15G	FEMALE	554	Mixed Histology (please specify)	Breast	Alive	T2	N0	M0	Stage IIA	0	554			TUMOR FREE				76	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15G	271e8024-a008-4bf0-9f6e-177f60096b1b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-28013	Not Applicable	0	316	Not Available	NO	TCGA-E2-A15G-D18903	BFCCD553-AC21-473B-BF95-489271D20DF1	Not Available	14	Not Available	125	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15G-F18901	119A323C-CF89-4041-ADD3-34AF96D44CEE				14		Not Available	Not Applicable	554		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Invasive ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15G	TUMOR FREE	Not Available	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A15G-R18904	B33EE5B5-9277-45F1-8B30-E68D495EB0A8	1	14	103	49	Not Available	11	Not Available	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-WT-AB41	FEMALE	1611	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	1611			TUMOR FREE				55	Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant	No axillary staging	Not Available	TCGA-WT-AB41	E7DB08A7-B439-4230-8DC4-1B54AF4736C4	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	16	Not Available	Not Applicable	0	1550	Not Available	Not Available	TCGA-WT-AB41-D62422;TCGA-WT-AB41-D62423;TCGA-WT-AB41-D62424;TCGA-WT-AB41-D62425	F3CB280B-1BAF-4C0D-AC67-5A602FB8F3BF;A0282F4E-3251-4690-9FC0-FC12FED22320;D3833BF8-80A4-48E5-B86D-8F75692C7472;1D21BF3A-67F1-4026-A0E6-739FCA50B55A	Not Available;Not Available;Not Available;Not Available	16;16;16;16	273;Not Available;150;150	181;273;89;89	Arimidex;Tamoxifen;Taxotere;Cytoxan	Complete Response;Not Applicable;Complete Response;Complete Response	7;7;7;7	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;YES;NO;NO	Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-WT-AB41-F66639	BF795D81-B99B-4A0E-9A01-42FDB7F837BD				21			Not Applicable	1611																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	Yes	AB41	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	NO	YES	WT	Breast	Not Applicable	Alive	2014	2010
TCGA-A8-A09T	FEMALE	579	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	MX		0	579			TUMOR FREE				68	Left	Not Available	Not Available	TCGA-A8-A09T	0adf59c6-581a-475d-a2f4-40aa40060b5b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-25110	Not Applicable	0	579	Not Available	Not Available	TCGA-A8-A09T-D37898	BDD31916-FC21-4D48-B1B5-442465133D4B	Not Available	6	Not Available	122	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09T-F40329	C0DB6775-BC42-4631-9AAD-006977242B0E				17			Not Applicable	579																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09T	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09T-R38191	3B9677B4-105D-478C-BB4A-25C46395FB94	Not Available	11	92	61	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-E2-A15D	FEMALE	526	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	526			TUMOR FREE				47	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A15D	c85f080a-1075-41df-959f-1b514a11b3c4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-17224	Not Applicable	0	316	Not Available	NO	TCGA-E2-A15D-D18784	39818837-2CB1-402D-AEE7-456C52833C47	Not Available	9	316	111	Tamoxifen	Not Available	11	Not Available	20	mg	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	4100	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15D-F18783	3C9904FC-1B91-4FBD-B16D-F2FBBAE64A14				9		Not Available	Not Applicable	526		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15D	TUMOR FREE	Not Available	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A15D-R18785	36563FC0-3E99-4312-B812-D3595CDCFEE4	1	9	106	61	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-EW-A2FW	FEMALE	672	Other, specify	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	672			TUMOR FREE				52	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A2FW	E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	5	-19085	Not Applicable	0	191	Not Available	NO	TCGA-EW-A2FW-D32339;TCGA-EW-A2FW-D32340;TCGA-EW-A2FW-D32341;TCGA-EW-A2FW-D32343;TCGA-EW-A2FW-D32344	42AD7850-0CAF-41A6-89C4-F5AB746C8401;650B3C64-48F3-4FF7-B6F8-C1542FA0D9D1;F099D2F0-2747-4610-9467-F7261F1C4137;88241187-2654-4E09-872E-16C9376DC51F;C01E02E6-1EE4-42C5-A55A-2C49B956BE8F	Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;23	154;154;154;217;Not Available	112;112;112;175;0	Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Exemestane	Unknown;Unknown;Unknown;Unknown;Not Applicable	5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-EW-A2FW-F32335;TCGA-EW-A2FW-F42062	E245BE5D-7CB8-4AF7-B953-7D2ED89114AE;15C65211-A67D-4438-BA46-7DE122DB17FB				23;10		Not Available;None	Not Applicable;Not Applicable	412;672		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	5;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	invasive papillary carcinoma	Discrepancy	C50.9	8503/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A2FW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A2FW-R32337	8048DA7B-76F8-45CF-8B2D-46D6509CF44F	1	23	329	279	Not Available	5	30	6400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2011
TCGA-3C-AALK	FEMALE	1448	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i+)	M0	Stage IA	0	1448			TUMOR FREE				52	Right	Sentinel node biopsy alone	Not Available	TCGA-3C-AALK	C31900A4-5DCD-4022-97AC-638E86E889E4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	28	-19074	Not Applicable	0	1217	Not Available	Not Available	TCGA-3C-AALK-D62908;TCGA-3C-AALK-D65510;TCGA-3C-AALK-D65525;TCGA-3C-AALK-D65526	571B5F2E-D8FE-48A4-8649-10F230CC8BB9;6E4745D5-0034-4021-9CF7-C578C4793766;0E79A684-C8F1-4AEB-9831-77AA9B72957E;404CEE87-D8B8-4CEE-92A7-3A7FAD80183C	Not Available;Not Available;Not Available;Not Available	28;24;24;24	528;829;528;528	371;507;371;371	Docetaxel;Herceptin;Carboplatin;Trastuzumab	Unknown;Unknown;Unknown;Unknown	7;9;9;9	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-3C-AALK-F68063;TCGA-3C-AALK-F71676	508BF78A-4516-408C-90B2-CA6EC2BA9F5E;9A947236-6EF3-47DF-9F4B-E9AC47728F13				13;27			Not Applicable;Not Applicable	1221;1448																				NO;NO																						11;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;Discrepancy		NO;NO	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	2	Close	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	1	No	AALK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	80-89%	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1c	Not Available	NO	YES	3C	Breast	Not Applicable	Alive	2014	2011
TCGA-GM-A2DD	FEMALE	2282	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	2282			TUMOR FREE				53	Right	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DD	B343BFE0-7C23-4C6A-8C84-9EE39DB2ECDA	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	29	-19415	Not Applicable	0	1309	Not Available	NO	TCGA-GM-A2DD-D47071;TCGA-GM-A2DD-D47072;TCGA-GM-A2DD-D47073	2664E496-34C1-4DFB-893B-7102CD0171B3;A4DAE917-9FC6-409F-9FDD-1E8F876394CA;30DC9EB0-B305-4BC7-B006-221E80F1AE25	Not Available;Not Available;Not Available	22;22;22	202;202;202	90;90;90	Fluorouracil;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.45					TCGA-GM-A2DD-F47070	1AC34321-8651-4F6E-B962-E0E9FC7860EC				22			Not Applicable	2282																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	<10%	Not Available	2+	60	Not Available	1.62	1.11	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	Yes	A2DD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2007
TCGA-AO-A12B	FEMALE	2989	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2989			TUMOR FREE				63	Right Upper Inner Quadrant;Right Lower Inner Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A12B	f6ed684f-ee7a-496c-80d5-6eacd494d16a	Not Available	Positive	Not Available	4+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	8	-23150	Not Applicable	0	2359	Not Available	Not Available	TCGA-AO-A12B-D5959;TCGA-AO-A12B-D5958;TCGA-AO-A12B-D5961;TCGA-AO-A12B-D5960	2470c06b-34d1-4a59-9d6c-ee4578b7caac;adc6778f-388f-403a-af06-ced81e3e0d53;4455833b-0272-453e-8f0b-2ad2e971c751;36ded530-1c08-428f-a97e-7c11db1a953c	Not Available;Not Available;Not Available;Not Available	10;10;10;10	118;118;1980;118	45;45;140;45	Methotrexate;Cyclophosphamide;Arimidex;Fluorouracil	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;4;Not Available;4	40;600;1;600	mg/m2;mg/m2;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;1	IV;IV;PO;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	261.6;3924;Not Available;3924	mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;None;None	TCGA-AO-A12B-F5887;TCGA-AO-A12B-F19422;TCGA-AO-A12B-F43473	C8F9252B-73CB-4886-B7CF-A7628F26138A;F103C9C8-1341-45A9-92A0-ECFC79605ACA;3FA3F48A-1DC7-49B7-BA5C-07AB14D891F2	Not Available;None;None	Not Available;None;None	Not Available;None;None	8;12;22	Not Available;None;None	Not Available;Not Available;None	Not Applicable;Not Applicable;Not Applicable	2359;2622;2989	Not Available;None;None	Not Available;Not Applicable;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;Scheduled Follow-up Submission;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;None;NO	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	12;12;5	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;NO;None	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;NO	TUMOR FREE;Not Available;TUMOR FREE	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	YES;YES;YES	Not Available;None;None	NO;NO;NO	Alive;Alive;Alive	2010;2011;2013	FEMALE	Not Available	3+ Positive	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A12B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2004
TCGA-A2-A0EM	FEMALE	3094	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0 (i-)	M0	Stage IA	0	3094			TUMOR FREE				73	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0EM	2fdfd287-d13c-4910-9788-73987d45908a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	6	-26845	Not Applicable	0	2758	Not Available	Not Available	TCGA-A2-A0EM-D1856	74da4aa7-764e-4340-8062-1e2f5b8e5479	Not Available	23	Not Available	75	Tamoxifen	Not Available	8	Not Available	10 mg BID	mg	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0EM-F13714	B2013AC6-E2F9-4125-9F5F-459BAE754700				9		Not Available	Not Applicable	3094		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0EM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0EM-R1857	dc50a49e-3060-45e5-b116-412aadc8f497	1	23	119	72	Not Available	8	33	6060	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2002
TCGA-A8-A081	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE				80	Right	Not Available	Not Available	TCGA-A8-A081	9d876f05-5080-4c4e-9bf5-45f631d381e5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-29555	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A081	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-D8-A1XJ	FEMALE	664	Other, specify	Breast	Alive	T3	N1a	MX	Stage IIIA	0	664			TUMOR FREE				76	Left Upper Outer Quadrant;Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XJ	cc510968-fe52-4109-a79f-74f216b48c78	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	9	-27967	Not Applicable	0	352	Not Available	NO	TCGA-D8-A1XJ-D29988	B04923EA-FC7E-4EFA-B2B2-65D43ABA760D	Not Available	31	Not Available	85	tamoxifen	Not Available	3	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg/day	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available		TCGA-D8-A1XJ-F29989;TCGA-D8-A1XJ-F30111	D3BBE7A7-94B5-469E-8789-88FFAE42853C;113C903F-41E1-4D93-B084-A99AAED7A32D				31;2		Not Available;Not Available	Not Applicable;Not Applicable	664;663		Not Applicable;Not Applicable				Scheduled Follow-up Submission;Scheduled Follow-up Submission							Not Available;Not Available			Not Available;Not Available					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	3;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO																																		TUMOR FREE;TUMOR FREE			Not Available;Not Available			YES;YES		NO;NO	Alive;Alive	2012;2012	FEMALE	Not Available	Hercep Test  TM Dako	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal/Mucinous	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Evaluated	43	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	Not Available	No	A1XJ	TUMOR FREE	manual counting	Not Available	Not Available	10-75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A0A7	FEMALE	30	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	30			TUMOR FREE				57	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A0A7	995fdab7-7284-4d33-befa-ec22aa7c6479	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-20940	Not Applicable	0	30	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0A7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A0HL	FEMALE	72	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	72			TUMOR FREE				56	Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0HL	602083f0-18d9-48b6-a529-31e165c54b37	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	10	-20804	Not Applicable	0	72	Not Available	Not Available	TCGA-BH-A0HL-D4785;TCGA-BH-A0HL-D4783;TCGA-BH-A0HL-D4775;TCGA-BH-A0HL-D4787	2320DBDB-D9E1-4E90-B4E3-9D754C69377B;86629B94-BA88-49F7-8D40-3226D6F4AE4B;FE6D45BC-6826-4206-A202-F4B08A55B85B;6C6B9022-14ED-4E07-9EF6-71CDD596E65F	Not Available;Not Available;Not Available;Not Available	18;18;22;22	135;135;Not Available;237	72;72;492;156	CYCLOPHOSPHAMIDE;DOXORUBICIN;ARIMIDEX;TAXOTERE	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;4;Not Available;4	1200;120;1;Not Available	mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	4800;480;Not Available;Not Available	mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-SCORE 295	90-99%	Not Available	Not Available	Not Available	2.25	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HL-F4792	AE1F5D23-CBC5-4BC8-9B75-9EC9624A5E34	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	72	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	2.23	0.99	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8503/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0HL	TUMOR FREE	H-SCORE 200	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	40-49%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-EW-A1PA	FEMALE	575	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	575			TUMOR FREE				59	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A1PA	4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	11	-21837	Not Applicable	0	267	Not Available	NO	TCGA-EW-A1PA-D30944;TCGA-EW-A1PA-D30938;TCGA-EW-A1PA-D30941;TCGA-EW-A1PA-D30945;TCGA-EW-A1PA-D30948	576A0855-EEB0-4E10-A8B5-6D5961A63A9E;CDEC6B0A-4685-44B6-89A0-A9459569D2CF;5D03E3B4-4612-47BD-8BD5-9BCC599F8B5C;87CC0E37-421A-47F8-8637-29FB7DC684C3;3518E805-38B9-4A27-8C05-6997651B6FA8	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	206;206;206;206;Not Available	143;143;143;143;262	Cyclophosphamide;Fluorouracil;Epirubicin;Docetaxel;Nolvadex	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	3;3;3;2;Not Available	1040;1040;52.5;160;20	mg;mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	FEC then T;FEC;FEC;FEC then T;TAM	IV;IV;IV;IV;PO	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	3120;3120;157.5;320;Not Available	mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PA-F30937	E558B7BC-59D7-435C-8ADA-7B2B8B280FBE				8		Not Available	Not Applicable	575		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A1PA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1PA-R30947	7EF75334-1718-4EDB-A178-B2E9D80D8952	1	8	262	225	Not Available	3	56	11,032	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A27K	FEMALE	1461	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1461			TUMOR FREE				47	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27K	7f97971b-2818-4e4b-9c9e-7c0246f9484c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-17426	Not Applicable	0	119	Not Available	NO	TCGA-D8-A27K-D29589;TCGA-D8-A27K-D72202	08CE6CE2-B1EE-4E48-AFCD-DF600C649E6E;B5F1746D-61A5-4826-81D4-303798C56880	Not Available;Not Available	26;29	117;Not Available	49;49	adriamycin+cyclophosphamid;Tamoxifen	Not Available;Not Applicable	3;4	4;Not Available	60+600;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	IV;Not Available	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	240+2400;Not Available	mg;Not Available	Not Available;NO	2012;2015	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-D8-A27K-F29588;TCGA-D8-A27K-F72201	060ACA7E-17C2-4C0F-893F-068B65ED5256;A434782B-9E68-4CAB-9DC0-41AF7599933F				26;29		Not Available;None	Not Applicable;Not Applicable	287;1461		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	2	Not Available	No	A27K	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-E9-A2JT	FEMALE	288	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	288			TUMOR FREE				63	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A2JT	B35FBE19-0E6D-427E-B9BE-EE3527B5FCA6	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	20	-23318	Not Applicable	0	23	Not Available	Not Available	TCGA-E9-A2JT-D34098	9899A8BD-E368-4788-944F-E1685DA002C6	Not Available	30	Not Available	27	Tamoxifen	Not Applicable	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A2JT-F34097;TCGA-E9-A2JT-F40292	BD6E3218-FD63-434B-8453-99FC7DC05314;1B8BFE3C-EFD6-44EC-83E7-D91CA4678C10				30;15		Not Available;None	Not Applicable;Not Applicable	261;288		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	No	A2JT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A2JT-R34099	0BD58064-0B71-450B-9DF6-ECD92445BE83	Not Available	30	87	58	Complete Response	7	23	46	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-S3-AA0Z	FEMALE	629	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	629			TUMOR FREE				63	Left;Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-S3-AA0Z	CFFE832C-8A81-4CDB-8B25-DF7F35AFAFDC	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	18	-23314	Not Applicable	0	322	Not Available	Not Available	TCGA-S3-AA0Z-D58353;TCGA-S3-AA0Z-D58342;TCGA-S3-AA0Z-D58343;TCGA-S3-AA0Z-D58551	3637BA55-6C9D-4F13-A47E-32FD9792653B;52E9F222-05FA-42AB-A37A-8494A24CC569;B9B5E318-2BBB-4B47-82CC-96C736833EFC;2E454798-EBBB-4BE9-BC9A-A8A1E4A9C043	Not Available;Not Available;Not Available;Not Available	18;18;18;18	84;84;84;Not Available	84;84;84;113	NEULASTA;DOXORUBICIN;CYTOXAN;ANASTROZOLE	Complete Response;Complete Response;Complete Response;Not Applicable	4;4;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Ancillary;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	CAP scoring guideline 2010	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	33					TCGA-S3-AA0Z-F67525;TCGA-S3-AA0Z-F70168	397466CB-7104-4751-8B52-A50887F445FD;CD0FD114-2C9E-415B-A350-A4738DA7CB7C				6;26			Not Applicable;Not Applicable	511;629																				NO;NO																						11;2					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2014;2015	FEMALE	Not Available	CAP scoring guideline 2010	10-19%	CAP scoring guideline 2010	1+	20	Not Available	42	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	0	No	AA0Z	TUMOR FREE	CAP scoring guideline 2010	Not Available	Not Available	Not Available	moderate	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013
TCGA-PL-A8LX	FEMALE	5	Infiltrating Ductal Carcinoma	Breast	Alive	T4	N1a	M1	Stage IV	1				WITH TUMOR				35	Left;Left Upper Outer Quadrant	Unknown	Not Available	TCGA-PL-A8LX	FE2CD610-AA52-4789-AC62-7683281BB22F	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Unknown	25	-12840	Not Applicable	0	5	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Bone;Liver	Not Available	Not Available					TCGA-PL-A8LX-F64852	0E44B46C-87DA-4980-8CD3-F0E13C3681B0				17			Not Applicable	5																				YES																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Evaluated	Not Available	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	No	A8LX	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M1	N1a	T4	Not Available	YES	NO	PL	Breast	Not Applicable	Alive	2014	2013
TCGA-A1-A0SE	FEMALE	1321	Mixed Histology (please specify)	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	1321			TUMOR FREE				56	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SE	c397e6c2-ba3a-4f5e-a258-c140611192fe	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	6	-20717	Not Applicable	0	1321	Not Available	Not Available																								Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	2																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	2	1	Not Available	Mixed Histology (please specify)	invasive ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Negative	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	No	A0SE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2010	2005
TCGA-AN-A0XP	FEMALE	9	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	9			Not Available				69	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-AN-A0XP	cf0e7e4e-b857-4db5-9ae2-551a899f77be	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	25	-25305	Not Applicable	0	9	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XP-F68958	158CE98D-2791-4E1C-AC57-0A24BD75BEB7				23			Not Applicable	9																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A0XP	Not Available	Not Available	Not Available	Not Available	140	260	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A1LL	FEMALE	1309	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2a	MX	Stage IIIA	1	1303.0	Liver	Distant Metastasis	TUMOR FREE				73	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A1LL	2a84997d-ccee-4f46-bea2-752534f26416	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	3	-27028	Not Applicable	0	1014	Not Available	NO	TCGA-E2-A1LL-D20617;TCGA-E2-A1LL-D20618	9EECED51-430D-48E6-9828-E3E8CF095C2A;8FE9F6AA-8F33-41C4-8D94-56C3DA00BD0B	Not Available;Not Available	17;17	49;49	49;49	Docetaxel;Cyclophosphamide	Not Available;Not Available	1;1	1;1	158;1260	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	158;1260	mg;mg	Not Available;Not Available	2012;2012	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	NO		TCGA-E2-A1LL-F20616	A4E4C69D-7D3F-41E4-AF0A-681E4603326E				17		Not Available	Not Applicable	1309		1303				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Liver	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	5	Not Available	No	A1LL	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Regional site	TCGA-E2-A1LL-R20619	544DB6E4-9E02-45A2-ACCB-0254D6BB05D9	1	17	147	105	Not Available	1	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N2a	T3	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-D8-A1XR	FEMALE	482	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	482			TUMOR FREE				56	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XR	70f34c5c-3671-44c8-9469-99f9786efec1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-20488	Not Applicable	0	168	Not Available	NO	TCGA-D8-A1XR-D29450	5484F965-9C70-444A-8C52-BE87ECFA4EE5	Not Available	19	168	105	adriamycin+cyclophosphamide	Not Available	3	Not Available	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XR-F29451	1B14AB2D-AA4F-4BF6-9AE3-88DD7EF231A1				6		Not Available	Not Applicable	482		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	0	No	A1XR	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0CU	FEMALE	158	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i+)	M0	Stage IIA	0	158			TUMOR FREE				73	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CU	332423a7-8866-4ee3-b08f-3c8d7c16af80	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	9	-26823	158	0	Not Available	Not Available	Not Available	TCGA-A2-A0CU-D1971	a4307c98-baf1-4f65-b40b-87bb611d8a4a	Not Available	10	Not Available	98	Tamoxifen	Not Available	10	Not Available	10	mg	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0CU-F13735	99B03F76-5B6B-4C3C-899F-D63D8FC39C5D				10		Not Available	158	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	1	No	A0CU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2005
TCGA-D8-A73W	FEMALE	385	Mucinous Carcinoma	Breast	Dead	T3	N1a	MX	Stage IIIA	1	21.0	Lung	Distant Metastasis	Unknown				79	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A73W	EA8DBC7A-54C6-469C-865E-F49D00B0223D	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	28	-29125	Not Applicable	0	244	Not Available	Not Available	TCGA-D8-A73W-D72199	A09294E3-9DBD-4A35-B806-8C3B050532A1	Not Available	29	-620	-709	Tamoxifen	Clinical Progressive Disease	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	70-79%	NOT HISPANIC OR LATINO	Lung;Bone	Not Available	Not Available					TCGA-D8-A73W-F57875;TCGA-D8-A73W-F72197	139213E3-53E1-401C-ADFB-412395451F9A;8CD03DE3-D51F-4514-B1A4-CC559A84B5C3				28;29			Not Applicable;385	244;Not Available																				NO;NO																						3;4					Not Available;NO	Not Available;YES	Not Available;Not Available	Not Available;21	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Evaluated	Not Available;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Evaluated	Not Available;Lung	Not Available;Distant Metastasis	Not Available;Not Available	Not Available;NO	Not Available;Not Available	NO;YES	Unknown;WITH TUMOR						YES;YES		YES;YES	Alive;Dead	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	NO	1	Not Available	No	A73W	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Distant site	TCGA-D8-A73W-R72198	09B56850-CF72-433D-B179-43E43E8213F8	Not Available	29	-652	-652	Stable Disease	4	1	800	NO	External	Not Applicable	Not Available	Not Available	cGy	2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2014	2013
TCGA-AN-A0AK	FEMALE	224	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	224			TUMOR FREE				76	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0AK	9e894662-b718-40f8-8899-b5e036cfbd76	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	21	-27977	Not Applicable	0	224	Not Available	Not Available																								dextran coated charcoal	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AK-F68942	62A33B4D-8305-4A17-85E8-832C43A07ED5				23			Not Applicable	224																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	70-79%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AK	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	230	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-B6-A0WZ	FEMALE	6292	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1b	M0	Stage II	1	5117.0	Bone	New Primary Tumor	TUMOR FREE				50	Right Upper Inner Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0WZ	08740d7f-5a5e-4dfa-bd48-7fbf228a7a28	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	14	-18584	Not Applicable	0	3941	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0WZ-F15735;TCGA-B6-A0WZ-F71575	E49207CE-142F-4C8D-8EC5-94BD6AE7B23D;B36349B9-27D9-4343-9447-A347465484A3				29;30		Not Available;None	Not Applicable;Not Applicable	3941;6292		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	8;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;5117	None;5117	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Bone	None;New Primary Tumor	None;Not Available	None;YES	None;Not Available	None;YES	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	21	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	No	A0WZ	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage II	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Fine Needle aspiration biopsy	NO	YES	B6	Breast	Not Applicable	Alive	2010	1996
TCGA-AN-A049	FEMALE	19	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	19			TUMOR FREE				62	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A049	2e1e3bf0-1708-4b65-936c-48b89eb8966a	Not Available	Positive	Not Available	2+	Not Available	Modified radical mastectomy	Positive	Simple Mastectomy	Not Applicable	NO	29	-22710	Not Applicable	0	19	Not Available	Not Available																								Allred (Biocare)	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A049-F68978	FE2AC366-DA1D-44C8-ACF7-B1703E8DAFC4				24			Not Applicable	19																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Dako Hercept test	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A049	TUMOR FREE	Allred (Biocare)	Not Available	Not Available	100	80	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2008
TCGA-D8-A1XF	FEMALE	463	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	463			TUMOR FREE				45	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XF	6f6afd31-b5dd-48ab-b18f-6390ba18a5f0	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-16787	Not Applicable	0	97	Not Available	NO	TCGA-D8-A1XF-D29443	0C6384BF-1F92-4793-B12E-4B62D23851CC	Not Available	26	356	311	adriamycin+cyclophosphamide	Not Available	3	4	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XF-F29442	F9DFA106-1DBD-4EB8-9586-DF8D2300FB35				19		Not Available	Not Applicable	463		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	8	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XF	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-S3-AA14	FEMALE	529	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0 (i+)		Stage I	0	529			TUMOR FREE				47	Right	Sentinel node biopsy alone	Not Available	TCGA-S3-AA14	929ACC67-B8BF-4F65-9110-380E44AB66B7	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	18	-17352	Not Applicable	0	218	Not Available	Not Available	TCGA-S3-AA14-D58559;TCGA-S3-AA14-D58561;TCGA-S3-AA14-D58562;TCGA-S3-AA14-D58563;TCGA-S3-AA14-D58564	83B53265-EDFD-4A74-ACCA-B6D079983317;19C8BDA0-73FA-4112-A3E0-04738D2582BE;6E4C1CA4-4878-438D-BA03-D9E0A56288F4;3EE34E77-CAF8-4915-9C7F-49F74F3C750D;B5D44FCB-607E-4DB0-9F91-FC2787B93697	Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18	104;104;104;Not Available;Not Available	62;62;62;118;118	ADRIAMYCIN;CYTOXAN;NEULASTA;TRASTUZUMAB;TAXOL	Complete Response;Complete Response;Complete Response;Not Applicable;Not Applicable	4;4;4;4;4	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Ancillary;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2014;2014;2014;2014;2014	CAP SCORING GUIDELINE 2010	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-S3-AA14-F67622;TCGA-S3-AA14-F70444	49A0491B-CE59-4BDF-98C3-5394E5691C3E;436AD5C3-8095-4D66-BA22-A9384C74D951				7;26			Not Applicable;Not Applicable	455;529																				NO;NO																						11;2					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	CAP SCORING GUIDELINE 2010	70-79%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	3	No	AA14	TUMOR FREE	CAP SCORING GUIDELINE 2010	Not Available	Not Available	Not Available	Not Available	YES	YES	70-79%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-S3-AA14-R58557	FF05CFAD-F5C8-4C9F-9FA9-E785F6EFDDA9	Not Available	18	267	221	Complete Response	4	35	6440	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	cM0 (i+)	N0 (i+)	T1	EXCISION WITH NEEDLE WIRE LOCALIZATION	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013
TCGA-D8-A1JU	FEMALE	447	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	447			TUMOR FREE				51	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1JU	af2a8e2f-2ae1-48bc-bba5-0e2c077c4e48	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	28	-18733	Not Applicable	0	106	Not Available	Not Available	TCGA-D8-A1JU-D14044	E80A862C-2FA5-4802-9986-D1635BD35BD7	Not Available	18	Not Available	87	Tamoxifen	Not Available	7	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	20	mg/day	Not Available	2011	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JU-F14045	B6D244EC-4151-4FF5-BDCF-0C2E6D22101A				18		Not Available	Not Applicable	447		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JU	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0CM	FEMALE	754	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	0	754			WITH TUMOR				40	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CM	eb2dbb4f-66b6-4525-8323-431970f7a64e	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	6	-14969	754	0	Not Available	Not Available	Not Available	TCGA-A2-A0CM-D2018;TCGA-A2-A0CM-D2026;TCGA-A2-A0CM-D2020;TCGA-A2-A0CM-D2022;TCGA-A2-A0CM-D2024;TCGA-A2-A0CM-D2027	51cca21e-fd29-4d59-9de1-916fc77056e0;80df2add-560a-429f-9f42-6469a5e88bba;88adeb77-bcc1-48cb-a270-92cdc1fe8f24;afae9c46-2307-4844-b80b-cb436fc1e8bb;2a0f9e7d-47a8-4977-9845-f9255d292e92;e8027663-89df-4c62-9c8c-b7709606de60	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;24;24;24;24	147;615;147;Not Available;601;433	98;391;98;234;391;391	Adriamycin;Capecetabine;Cytoxan;Tamoxifen;Docetaxel;Zometa	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8	4;8;4;Not Available;8;2	106;2000-3500;1062;20;100-131;4	mg;mg;mg;mg/day;mg;mg	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;5;2;3;4;6	IV;PO;IV;PO;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Not Available;Not Available;Bisphosphonate therapy	424;24400;4248;Not Available;890;8	mg;mg;mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	NO	Not Available	TCGA-A2-A0CM-F2013	5609C4A1-D006-4EAF-B197-174CAF31D43E	Not Available	Not Available	Not Available	6	Not Available	Not Available	754	Not Available	Not Available	382	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	9																																						WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	0	No	A0CM	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2003
TCGA-AO-A0JG	FEMALE	798	Other, specify	Breast	Alive	T2	N2a	M0	Stage IIIA	0	798			TUMOR FREE				49	Right Lower Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-AO-A0JG	58959e88-54e2-4558-9664-2effda7403dc	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-18021	Not Applicable	0	449	Not Available	Not Available	TCGA-AO-A0JG-D3217;TCGA-AO-A0JG-D3216;TCGA-AO-A0JG-D3218;TCGA-AO-A0JG-D3215	0da9c957-0267-41cc-9517-ac96284494e9;a33b3892-3e6b-4da6-9f8e-d172913aa440;6c1bae55-7974-4d4d-b031-2e8c522b0a5d;b263b426-435b-4224-a98e-8fb254f0a03a	Not Available;Not Available;Not Available;Not Available	20;20;20;20	185;122;Not Available;122	136;80;197;80	PACLITAXEL;DOXORUBICIN;ARIMIDEX;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;4;Not Available;4	175;60;1;600	mg/m2;mg/m2;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;1	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1280;440;Not Available;4400	mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JG-F3212;TCGA-AO-A0JG-F15492	70C0FC3F-1AC8-4DF6-A1A2-1DAC1F7A195A;B37C0A82-E26C-40E9-AC60-492996CD6E5E	Not Available;None	Not Available;None	Not Available;None	20;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	449;798	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal & Mucinous	No	C50.9	8523/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	19	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	4	0	No	A0JG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	WHITE	Not Available	Regional site	TCGA-AO-A0JG-R3214	6e8b98b1-8cb9-4b43-b0cd-fcac615f65a2	1	20	273	238	Not Available	9	25	11400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009
TCGA-B6-A0RU	FEMALE	8605	Other, specify	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	1	3076.0	Other, specify	New Primary Tumor	TUMOR FREE				40	Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RU	6956473b-92e5-4069-a26b-b48e280e76f2	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	2	-14920	Not Applicable	0	7067	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	YES;None		TCGA-B6-A0RU-F13790;TCGA-B6-A0RU-F71565	6251D894-D6C0-46A4-A938-1E5FA5D5E280;C76B35D5-C269-4642-994F-7458C733F814				12;26		3076;None	Not Applicable;Not Applicable	7067;8605		3076;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;3	Other, specify;None	New Primary Tumor;None	Right Breast;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal/Metaplastic	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Available	15	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0RU	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Excisional biopsy	NO	YES	B6	Breast	Not Applicable	Alive	2010	1990
TCGA-OL-A5RV	FEMALE	1062	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3	MX	Stage IIIC	0	1062			TUMOR FREE				43	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-OL-A5RV	1D38D356-D126-4476-94D0-26616B9375B1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-15820	Not Applicable	0	733	Not Available	Not Available	TCGA-OL-A5RV-D65254;TCGA-OL-A5RV-D65255;TCGA-OL-A5RV-D65256	F0F4E472-BC9E-4970-A306-4702DE384D0F;55A6BAAD-D9D1-432E-944D-57781807E2BD;D588C324-FD32-4951-B780-BE01F71AA7DD	Not Available;Not Available;Not Available	24;24;24	161;161;161	63;63;63	Doxorubicin;CYTOXAN;Paclitaxel	Complete Response;Complete Response;Complete Response	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	Unknown	Not Available	Not Available	Not Available					TCGA-OL-A5RV-F56564	AA52F64A-01A5-47BB-A85F-26B25B7BAED7				14			Not Applicable	1062																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.00	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	20	Not Available	No	A5RV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	BLACK OR AFRICAN AMERICAN	YES	Regional site	TCGA-OL-A5RV-R65257	09E25775-2A38-48D7-8505-A90B508ACD39	Not Available	24	249	202	Complete Response	9	Not Available	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2011
TCGA-BH-A0EB	FEMALE	745	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	745			TUMOR FREE				69	Right Lower Inner Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0EB	ec6930e5-2d83-435a-9a57-a2c5c22caf02	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	9	-25259	Not Applicable	0	745	Not Available	Not Available	TCGA-BH-A0EB-D4659	187080D3-F3AD-4B6D-BEE2-FB2DCA27EA0C	Not Available	17	Not Available	55	ARIMIDEX	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-SCORE 300	90-99%	Not Available	Not Available	Not Available	2.13	NO	NO	NO	NO	TCGA-BH-A0EB-F4662	9563674B-70FE-4A30-9DB9-85CCA3D7BCB6	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	745	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	2.65	1.25	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0EB	TUMOR FREE	H-SCORE 210	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0EB-R4660	2612BEAD-4FDA-41EC-99DD-EAF33C89F685	1	17	118	73	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-C8-A12W	FEMALE	385	Infiltrating Ductal Carcinoma	Breast	Alive	T4	N1	M0	Stage IIIB	0	385			TUMOR FREE				49	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12W	6adca853-1b09-47ff-814c-47b732a76d96	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	13	-18140	Not Applicable	0	7	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12W-F20244	8D4153E6-1D54-4375-9DDB-E9811157BA3E				9		Not Available	Not Applicable	385		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12W	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 6	Allred Score 7	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T4	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A24M	FEMALE	3660	Mixed Histology (please specify)	Breast	Alive	T2	N2	M0	Stage IIIA	0	3660			Not Available				38	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24M	aa30ac3d-4216-45dd-a314-1ae192fafcb2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	12	-14119	Not Applicable	0	1991	Not Available	Not Available	TCGA-AR-A24M-D31349;TCGA-AR-A24M-D31351;TCGA-AR-A24M-D31350;TCGA-AR-A24M-D31347;TCGA-AR-A24M-D31353	0CE63344-9846-491C-BB79-071A252824D6;A56BF7ED-38FA-4172-BA59-B2E1B0FED601;3AAE3639-A0AE-48F7-81A2-C05BA2ED7782;6CF36578-40F0-4B65-B7A9-2E017552BF04;7600BF7D-7046-47BB-B302-45F9C1AD0002	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	Not Available;597;Not Available;Not Available;Not Available	Not Available;171;Not Available;Not Available;597	Cytoxan;Tamoxifen;Paclitaxel;Doxorubicin;Letrozole	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	4;Not Available;4;4;Not Available	Not Available;20;Not Available;Not Available;2.5	Not Available;mg/day;Not Available;Not Available;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1;3	Not Available;PO;Not Available;Not Available;PO	NO;NO;NO;NO;YES	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24M-F31275;TCGA-AR-A24M-F49489;TCGA-AR-A24M-F71732	177526AB-A3B2-4310-854F-D6AD40F55BA5;F4C44AB5-CE2E-484C-8430-7CE5DC5486F4;D6CB81E1-AE9D-4A1C-8E40-6E68F4B6936B				26;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1991;2947;3660		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	4;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	4	Not Available	No	A24M	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24M-R31289	993D8611-83E6-452A-8153-DD07E97149A3	1	27	221	172	Not Available	4	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-A2-A0D1	FEMALE	1051	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1051			TUMOR FREE				76	Left Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0D1	084c6aec-94f7-4090-8f3f-59fa9e89721a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	21	-28084	Not Applicable	0	786	Not Available	Not Available	TCGA-A2-A0D1-D1836;TCGA-A2-A0D1-D1840;TCGA-A2-A0D1-D1837;TCGA-A2-A0D1-D1838	051e5eee-d34e-496f-bd8f-bdb8f99368a0;cb590dde-3e1f-4b38-a4fb-a6a1fc7eb4cc;883b03cb-e338-4344-822c-fd144c3d5280;6ef785f5-54a6-46b8-a1bd-09fe99c2ed9a	Not Available;Not Available;Not Available;Not Available	21;21;21;21	79;201;79;428	79;131;79;79	Taxotere;Abraxane;Carboplatin;Herceptin	Not Available;Not Available;Not Available;Not Available	9;9;9;9	1;3 cycles (9 doses);1;23 doses	140;176-180;366;135-600	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;4;2;3	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	140;1600;366;6575	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0D1-F13733	00808159-4015-4B79-B29A-1BBE85BF2CF2				9		Not Available	Not Applicable	1051		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	5.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0D1	TUMOR FREE	Not Available	Not Available	Not Available	Intensity=Weak	Intensity=Weak	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0D1-R1835	699a1213-cb1d-4281-8197-7c2e6d3ed2d3	1	21	296	252	Not Available	9	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-B6-A0IO	FEMALE	5042	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	5042			TUMOR FREE				66	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IO	04af44fc-c487-4005-b3cb-cb64815824a2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Indeterminate	Modified Radical Mastectomy	Not Applicable	NO	2	-24322	Not Applicable	0	3350	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0IO-F12626;TCGA-B6-A0IO-F71503	2E99B735-8834-4DF8-B3D5-512337319C15;E3BA117D-59D6-449B-9AC8-88BECDB2682A				2;26		Not Available;None	Not Applicable;Not Applicable	3350;5042		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Available	17	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0IO	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	2001
TCGA-S3-AA11	FEMALE	421	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	421			TUMOR FREE				67	Right	Sentinel node biopsy alone	Not Available	TCGA-S3-AA11	0DD8DBC1-C48B-4E7C-B401-57101F724967	Not Available	Positive	4 Point Scale	2+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	18	-24813	Not Applicable	0	169	Not Available	Not Available	TCGA-S3-AA11-D58358;TCGA-S3-AA11-D58359;TCGA-S3-AA11-D67566	0469F246-0A00-46F4-ACA0-0B25A14C6D08;88D345D0-A5BB-4598-983F-ABA5E9ADE52E;FF58F7AA-3F5B-42A3-B786-9CD8F5B3998B	Not Available;Not Available;Not Available	18;18;7	169;309;Not Available	53;169;309	LETROZOLE;EXEMESTANE;ANASTROZOLE	Complete Response;Complete Response;Complete Response	4;4;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	CAP scoring guideline 2010	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	40					TCGA-S3-AA11-F67563	9543CB0E-D4A5-447F-A0A4-AC2D3E56FC37				7			Not Applicable	421																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	CAP scoring guideline 2010	<10%	CAP scoring guideline 2010	2+	20	Not Available	59	1.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	AA11	TUMOR FREE	CAP scoring guideline 2010	Not Available	Not Available	Not Available	Not Available	YES	YES	60-69%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-S3-AA11-R58357	DC89E056-7189-4F52-A31E-1EB00BF6D61C	Not Available	18	123	77	Complete Response	4	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013
TCGA-E2-A158	FEMALE	450	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IIA	0	450			TUMOR FREE				43	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A158	a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	7	-15903	Not Applicable	0	450	Not Available	NO	TCGA-E2-A158-D18963;TCGA-E2-A158-D18958;TCGA-E2-A158-D18960;TCGA-E2-A158-D18961	B94489C2-71D2-40FE-86DD-A3E999BF3373;A3051694-896A-4A9D-9178-CA248163F114;8C16F7B2-EFBC-4B7E-AA40-8A152D0E4F0F;67C4C12D-8CB3-4ED8-8913-666D05A6057D	Not Available;Not Available;Not Available;Not Available	8;8;8;8	Not Available;228;228;228	450;Not Available;Not Available;Not Available	arimidex;doxorubicin;cytoxan;Taxane	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;Not Available;Not Available;Not Available	1;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;1;1;2	PO;Not Available;Not Available;Not Available	YES;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A158-F18956	24E85CD5-EEC3-42FE-A66B-6A8DEE474B14				8		Not Available	Not Applicable	450		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	Yes	A158	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-D8-A1JD	FEMALE	552	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	552			TUMOR FREE				41	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JD	530ad151-703d-4638-851f-0b5111ff318b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	29	-15166	Not Applicable	0	273	Not Available	Not Available	TCGA-D8-A1JD-D20845;TCGA-D8-A1JD-D65321	39C2C11A-3C77-464E-98F4-A7A7C922535A;32787263-6D4A-4283-B7C7-50D3650A330D	Not Available;Not Available	19;22	113;113	50;50	Adriamycin;cyclophosphamide	Not Available;Not Available	1;9	4;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	240;Not Available	mg;Not Available	Not Available;NO	2012;2014	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JD-F20844	D3EFEE22-D62C-42F4-B23C-E08897B69A53				19		Not Available	Not Applicable	552		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	0	No	A1JD	TUMOR FREE	manual counting	Not Available	Not Available	10-75%	>75%	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1JD-R20846	1EE12D22-7FFD-4B4B-AB50-8F43C4E58C30	Not Available	19	183	151	Not Available	1	20	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-LL-A5YM	FEMALE	394	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	NX	M0	Stage IIIB	1	258.0	Other, specify	Locoregional Recurrence	WITH TUMOR				88	Left;Left Upper Inner Quadrant	No axillary staging	Not Available	TCGA-LL-A5YM	E9A12DF9-024E-4CBC-B6BF-E4E87485FA90	Negative	Positive	3 Point Scale	3+	3 Point Scale	Mastectomy NOS	Positive	Other	Not Applicable	Not Available	3	-32478	Not Applicable	0	143	Not Available	Not Available	TCGA-LL-A5YM-D57542	EBAB50E8-81A5-49D8-92FB-7A44273418AB	Not Available	14	Not Available	Not Available	letrozole	Not Applicable	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	54					TCGA-LL-A5YM-F57541	D396D059-CF4A-4F46-86D7-079FA3777796				14			Not Applicable	394																				NO																						3					YES	YES	258	258	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Other, specify	Locoregional Recurrence	Skin left chest wall	YES	Not Available	YES	WITH TUMOR						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	20	Not Available	172	3.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8541/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A5YM	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	90-99%	BLACK OR AFRICAN AMERICAN	NO	Local Recurrence	TCGA-LL-A5YM-R57543	90327544-390D-4E11-88EB-FCDB0ABD67FA	Not Available	14	339	307	Partial Response	3	20	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	NX	T4b	partial mastectomy	YES	NO	LL	Breast	Not Applicable	Alive	2013	2012
TCGA-V7-A7HQ	FEMALE	2033	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	2033			TUMOR FREE				75	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-V7-A7HQ	1285EB55-415C-494A-AA58-936F0427CDD0	Negative	Positive	3 Point Scale	3+	3 Point Scale	Other	Positive	Modified Radical Mastectomy	Additional resection/ margins (taken after first margin positive)	NO	31	-27684	Not Applicable	0	1590	Not Available	Not Available	TCGA-V7-A7HQ-D71971	AAF9A475-0FCA-4018-A727-0BCEFFE5281D	Not Available	31	1869	129	letrozole	Complete Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.0					TCGA-V7-A7HQ-F71970	5C6DF2E3-461B-4B41-B40C-9C1ED089EE74				31			Not Applicable	2033																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	20	Not Available	1.1	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Negative	18	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	Not Available	No	A7HQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Moderate to strong	NO	YES	80-89%	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-V7-A7HQ-R71972	FFFCCFB6-6613-401F-9E04-8B3517F882FE	Not Available	31	133	90	Complete Response	3	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	NO	YES	V7	Breast	Not Applicable	Alive	2015	2009
TCGA-E2-A10F	FEMALE	878	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	878			TUMOR FREE				47	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A10F	8e159b50-8136-42d4-b9c7-d579a74e4931	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	11	-17257	Not Applicable	0	360	Not Available	Not Available	TCGA-E2-A10F-D7750;TCGA-E2-A10F-D17872;TCGA-E2-A10F-D17186	1bd78b9a-fdb8-45a6-9848-9e03ad1b28fd;3DE26760-A09A-4CD8-9EB1-5D20924A929A;A5A45F4A-EB30-4F25-8A01-B2CC187C6EF8	Not Available;Not Available;Not Available	14;27;27	337;132;132	223;69;69	Tamoxifen;Docetaxel;Cyclophosphamide	Not Available;Not Available;Not Available	2;9;9	Not Available;4;4	20;160;1284	mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;1	PO;IV;IV	NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	20;640;5136	mg/day;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A10F-F17187	30AF5AC3-356D-445F-AB37-B36BE75AE6EB				27		Not Available	Not Applicable	878		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	20-29%	Not Available	2+	Not Available	Not Available	Not Available	1.05	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A10F	TUMOR FREE	Allred score 5+3=8	Not Available	Not Available	Allred score 8	Allred score 8	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A10F-R7744	ddf6fed7-242c-4544-bb29-f2d335f2dcb7	1	14	216	170	Not Available	2	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-AN-A0FL	FEMALE	231	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	231			TUMOR FREE				62	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FL	baf1207d-7d1a-4cad-ba58-62c26be2415e	Not Available	Negative	Not Available	1+	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-22805	Not Applicable	0	231	Not Available	Not Available																								dextran coated charcoal	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FL-F68952	240E4926-540A-4B61-A6CE-1A9793228A2B				23			Not Applicable	231																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	20-29%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FL	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-E9-A245	FEMALE	26	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	26			TUMOR FREE				47	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A245	8218119a-f68b-4ea7-9ee4-5e2edc2ae342	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	16	-17363	Not Applicable	0	26	Not Available	NO	TCGA-E9-A245-D31172	015CA647-3EBD-4950-A3AA-A0672ED5011F	Not Available	24	Not Available	20	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E9-A245-F31169	74AC779B-F5F6-466E-8318-6C6459C1609D				24		Not Available	Not Available	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	3	Not Available	No	A245	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A1-A0SI	FEMALE	635	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	635			TUMOR FREE				52	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SI	16368c32-2118-4fcf-8693-6c89995e49d8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	30	-19250	Not Applicable	0	635	Not Available	NO																								Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	23	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A0SI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2011	2007
TCGA-A2-A3KC	FEMALE	1102	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1102			TUMOR FREE				55	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A3KC	2D29A4AC-98E7-4663-9DD6-5681BC32AC2E	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	14	-20401	Not Applicable	0	363	Not Available	NO	TCGA-A2-A3KC-D30126;TCGA-A2-A3KC-D30125;TCGA-A2-A3KC-D30128;TCGA-A2-A3KC-D30127;TCGA-A2-A3KC-D59209	89F4A022-4646-4C62-92B2-D98CBA444FB0;ABA4D3E6-1A06-465B-83A0-EF2E9F3BAA4A;16218EC6-7B12-489E-8AB0-BD5C8278E00F;332AAD9D-0369-443A-B563-28B1E2B02E65;7D787BBB-1268-4E08-9C9E-BFA413D22B04	Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;5	182;182;1101;182;Not Available	77;77;203;77;1102	Adriamycin;Cytoxan;Tamoxifen;Taxotere;Arimidex	Not Available;Not Available;Not Available;Not Available;Not Applicable	3;3;3;3;5	6;6;Not Available;6;Not Available	106;1060;20;159;Not Available	mg;mg;mg/day;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;4;3;Not Available	IV;IV;PO;IV;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	636;6360;Not Available;954;Not Available	mg;mg;Not Available;mg;Not Available	Not Available;Not Available;Not Available;Not Available;NO	2012;2012;2012;2012;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.9					TCGA-A2-A3KC-F37340;TCGA-A2-A3KC-F59210	6468BE4A-4E05-4B7F-93C7-642E6C1FD9E5;471ED8F4-04BC-465A-A8E7-C1D948B5CBAA				3;5			Not Applicable;Not Applicable	635;1102																				NO;NO																						12;5					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	20	Not Available	1.8	1.0	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	2	0	No	A3KC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	BLACK OR AFRICAN AMERICAN	Not Available	Not Available	TCGA-A2-A3KC-R30129	D4342F05-5278-45FA-BC38-987E587E740C	1	12	Not Available	Not Available	Not Available	3	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2012	2011
TCGA-S3-A6ZF	FEMALE	572	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	572			TUMOR FREE				64	Right;Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-S3-A6ZF	FBEE40F1-D6D8-4156-8D42-36E09BB9F095	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	12	-23650	Not Applicable	0	212	Not Available	Not Available	TCGA-S3-A6ZF-D51061;TCGA-S3-A6ZF-D51062;TCGA-S3-A6ZF-D51087;TCGA-S3-A6ZF-D51086;TCGA-S3-A6ZF-D63998;TCGA-S3-A6ZF-D64005	4503FC44-1AA6-4A16-BE16-63146AF1ECEB;2B4A620C-E5B7-45D0-823B-A7D09CD7F72D;DA38E0A7-A07F-4D6E-85AD-465748551C97;E2F5E7F8-10E2-4432-A00A-7087B5955C9E;CEDA468F-784C-42EC-B0C6-8B42B8C5BEE1;1F99661D-577D-4D3C-BFF3-6436D7DA50A3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;27;27	170;429;170;170;278;Not Available	65;65;78;65;191;278	taxotere;Trastuzumab;Neulasta;Cytoxan;LETROZOLE;ANASTROZOLE	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable;Not Applicable	11;11;11;11;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Immunotherapy;Ancillary;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;YES	2013;2013;2013;2013;2014;2014	CAP scoring guideline 2010	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	39					TCGA-S3-A6ZF-F59305;TCGA-S3-A6ZF-F67764	B9F9D3D7-E836-4C18-A8AA-1F7DA4D37DDA;376B6C8B-37BD-46AA-8323-631C9C20E5C8				27;11			Not Applicable;Not Applicable	502;572																				NO;NO																						8;11					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2014;2014	FEMALE	Not Available	CAP scoring guideline 2010	50-59%	Not Available	2+	20	Not Available	60	1.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A6ZF	TUMOR FREE	CAP scoring guideline 2010	Not Available	Not Available	moderate	Moderate	YES	YES	40-49%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2013	2013
TCGA-BH-A0BO	FEMALE	2197	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	M0	Stage I	0	2197			TUMOR FREE				54	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A0BO	26573441-eedb-4364-966c-e7f803deef19	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	9	-19767	Not Applicable	0	1085	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BO-F61949	9BC4BD65-416A-4031-AA01-5C1BAA89DD04				10			Not Applicable	2197																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BO-R61950	ABF66B91-2FC8-47CE-9799-E6CE80FF0818	Not Available	10	119	72	Complete Response	7	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1b	Segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-PE-A5DD	FEMALE	1953	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1953			TUMOR FREE				64	Right Lower Inner Quadrant	Not Available	Not Available	TCGA-PE-A5DD	B0700958-5F90-4546-B35F-635CD506889B	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	6	-23686	Not Applicable	0	1953	Not Available	Not Available	TCGA-PE-A5DD-D66362;TCGA-PE-A5DD-D42974	56C0330D-81DB-48E3-B677-CA6765713AB6;07D66B09-526B-4452-AD8F-860E0674487B	Not Available;Not Available	13;13	Not Available;Not Available	191;38	Femara;Not Available	Not Applicable;Complete Response	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;NO	Hormone Therapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-PE-A5DD-F66361	0E7AB498-2BA4-460B-896C-866D724D7640				13			Not Applicable	1953																				YES																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Positive	Positive	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5DD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	ASIAN	NO	Primary Tumor Field	TCGA-PE-A5DD-R66363	7414F39D-4F10-4955-B284-72E857327754	Not Available	13	160	130	Complete Response	10	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Reexc of biopsy site for gross/micro residual disease	NO	YES	PE	Breast	Not Applicable	Alive	2013	2006
TCGA-EW-A3U0	FEMALE	532	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	532			TUMOR FREE				61	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A3U0	D9DC3B59-613D-469E-8B4F-6C5A557EB26A	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	24	-22520	Not Applicable	0	229	Not Available	NO	TCGA-EW-A3U0-D42035;TCGA-EW-A3U0-D42036;TCGA-EW-A3U0-D42037;TCGA-EW-A3U0-D42038	FD889A7B-41D1-42B5-A58A-BE562B865525;7D3EE7E9-9692-488D-866E-054AF4EC0EAD;39091340-4E3F-492C-9FA3-3FC1468ADDDD;2ACE8F03-CCD2-49E1-BB73-5DC383D76E8C	Not Available;Not Available;Not Available;Not Available	9;9;9;9	127;127;197;197	85;85;148;148	Cisplatin;Taxotere;Doxorubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response;Complete Response	4;4;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-EW-A3U0-F42032	5FBF8A7F-C830-4250-B7C4-A372BC4DB5A7				9			Not Applicable	532																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A3U0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Regional site	TCGA-EW-A3U0-R42033	6E6A19AF-0B87-410E-AFCA-59AC61E7336D	Not Available	9	281	229	Complete Response	4	Not Available	109	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	partial left mastectomy	YES	NO	EW	Breast	Not Applicable	Alive	2012	2011
TCGA-EW-A1P5	FEMALE	703	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	703			TUMOR FREE				77	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1P5	53d0af48-d7ea-42c9-8695-c614b89b415b	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	11	-28177	Not Applicable	0	365	Not Available	NO	TCGA-EW-A1P5-D32250	ADFE3F98-9CCF-4A9C-99A0-279B5FBE82B5	Not Available	22	Not Available	199	Anastrozole	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1P5-F32249	8E77875E-E696-4AE3-86E6-544E806A0DD8				15		Not Available	Not Applicable	703		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	1.12	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Negative	40	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	3	0	No	A1P5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1P5-R32257	ABC06C94-9A7F-4CD6-B371-E40477EF4EBC	1	15	185	124	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A24R	FEMALE	3430	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N2	M0	Stage IIIA	0	3430			Not Available				45	Right Upper Inner Quadrant;Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24R	db62d9c7-8343-4771-84fc-146d2e307bb8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	26	-16642	Not Applicable	0	1746	Not Available	Not Available	TCGA-AR-A24R-D32053;TCGA-AR-A24R-D31466;TCGA-AR-A24R-D31468;TCGA-AR-A24R-D31464;TCGA-AR-A24R-D31495	2D99DA1B-9B2A-4ECA-AE32-B72EA98D544B;2C100981-948D-403E-AD66-4E1C0D27C498;A5F6149E-F23B-460C-976E-013FB96B1C92;CCA3DC0B-E23D-40B1-9E84-27AA4E047FF8;8ABD8AA5-234C-4EE7-8757-5E4639897AF3	Not Available;Not Available;Not Available;Not Available;Not Available	15;3;3;3;4	Not Available;157;214;151;1904	1969;53;172;53;228	Letrozole;Cytoxan;Paclitaxel;Doxorubicin;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	Not Available;5;4;5;Not Available	Not Available;60;175;24;20	Not Available;mg/m2/day;mg/m2;mg/m2;mg/day	Not Available;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;1;1;1;2	Not Available;PO;IV;IV;PO	YES;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;10500;1200;600;Not Available	Not Available;mg;mg;mg;Not Available	NO;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24R-F31462;TCGA-AR-A24R-F49499;TCGA-AR-A24R-F71731	B874C101-A757-4D0F-9AB6-D5BC0F444BB6;7FD6DCC3-94BA-40B7-8949-A360B92F61D9;20CD927D-EA75-4B4E-9695-06932A02A418				3;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1746;2653;3430		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	6	Not Available	No	A24R	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24R-R31463	95453BBE-20F4-4F6E-9C53-6FC33C65D529	1	3	295	249	Not Available	5	34	6240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-A2-A04T	FEMALE	2246	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2246			TUMOR FREE				62	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A04T	b58ad350-5140-4fa8-bc2c-24bca8395f3a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	9	-22707	Not Applicable	0	1950	Not Available	Not Available	TCGA-A2-A04T-D2759;TCGA-A2-A04T-D2761;TCGA-A2-A04T-D2760	cd18d339-0df7-42da-a74d-266504627111;6ad79761-aee6-43f7-83c2-d7f5f8ac6189;dc41b9d2-298f-4934-b566-dfdda2dea217	Not Available;Not Available;Not Available	9;9;9	117;173;117	75;131;75	Cyclophosphamide;Taxol;Adriamycin	Not Available;Not Available;Not Available	8;8;8	4;3;4	1150;250-338;58	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	4600;838;232	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-A2-A04T-F9343	94203642-8318-4406-9B37-865EB9288015	Not Available	Not Available	Not Available	17	Not Available	Not Available	Not Applicable	2246	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A04T	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A04T-R9342	eac92060-57fb-4a09-8498-7c5e1e4b9924	1	21	249	206	Not Available	3	Not Available	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2004
TCGA-AO-A03U	FEMALE	1793	Other, specify	Breast	Dead	T1c	N0 (i-)	M0	Stage I	1	1614.0	Lung	New Primary Tumor	TUMOR FREE				31	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A03U	0685edd2-ce1c-4e0e-8dda-393139af4223	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	9	-11354	1793	0	Not Available	Not Available	Not Available	TCGA-AO-A03U-D5987;TCGA-AO-A03U-D5990;TCGA-AO-A03U-D5989	12f8a04a-2cf9-4e12-9417-eb6e8ca1ef3d;cd54a4e8-2031-4653-a3af-4a21b63888d7;c1bd6420-c945-476c-afdc-c107a55824c4	Not Available;Not Available;Not Available	10;10;10	216;216;216	70;70;70	Cyclophosphamide;Fluorouracil;Methotrexate	Not Available;Not Available;Not Available	1;1;1	8;8;8	600;600;40	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	8640;8640;576	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;NO	Not Available;None	TCGA-AO-A03U-F5863;TCGA-AO-A03U-F20907	46826A53-3583-4996-BC0C-037B1A0AFCE5;2CBBFF6D-770D-4735-95B5-35ACF9B4A070	Not Available;None	Not Available;None	Not Available;None	9;24	Not Available;None	Not Available;Not Available	1793;1793	Not Available;Not Available	Not Available;None	Not Available;1614	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Negative	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Negative	Not Available;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Negative	1;1	None;Lung	None;New Primary Tumor	None;Not Available	None;YES																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Dead;Dead	2011;2012	FEMALE	Not Available	3+ Positive	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	secretory	No	C50.9	8502/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	0	No	A03U	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Dead	2011	2001
TCGA-A2-A0CT	FEMALE	2289	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2289			TUMOR FREE				71	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CT	378778d2-b331-4867-a93b-c64028c8b4c7	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	9	-25959	Not Applicable	0	1918	Not Available	Not Available	TCGA-A2-A0CT-D1976;TCGA-A2-A0CT-D1974;TCGA-A2-A0CT-D1975;TCGA-A2-A0CT-D1973	fe69a660-e936-4a3f-8e5d-8cbfbb6dfeb4;76a54d5e-e978-4768-b8d6-d25277ef9803;b6f4f507-e6ee-45bc-b50b-d9a2bb53bcaa;46d7f184-146c-4978-a041-32b27f642b48	Not Available;Not Available;Not Available;Not Available	9;9;9;9	1537;138;433;138	559;75;160;75	Tamoxifen;Cytoxan;Arimidex;Adriamycin	Not Available;Not Available;Not Available;Not Available	9;9;9;9	Not Available;4;Not Available;4	20;900;1;90	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;2;3;1	PO;IV;PO;IV	NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;3600;Not Available;360	Not Available;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0CT-F13730	E5069DEC-D655-42B1-81A6-4F008FC9EF78				9		Not Available	Not Applicable	2289		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0CT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2005
TCGA-BH-A1F5	FEMALE	2712	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N1a	M0	Stage IIA	0	2712			TUMOR FREE				62	Right	Not Available	Not Available	TCGA-BH-A1F5	e663954c-05a8-479a-a623-400c1eb5efc6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	7	-22842	2712	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	Yes	A1F5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2002
TCGA-B6-A3ZX	FEMALE	1152	Mixed Histology (please specify)	Breast	Dead	T3	N1	M1	Stage IV	1	994.0	Bone	Distant Metastasis	WITH TUMOR				50	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-B6-A3ZX	9434687A-197C-4959-B6B8-9C05F1DD7F53	Negative	Negative	4 Point Scale	1+	4 Point Scale	Lumpectomy	Negative	Lumpectomy	Not Applicable	NO	20	-18434	Not Applicable	0	1132	Not Available	Not Available	TCGA-B6-A3ZX-D40951;TCGA-B6-A3ZX-D40952;TCGA-B6-A3ZX-D40954	1F002506-250B-498B-99E6-54FF46B5FB23;BB2609B3-27AB-446D-85F7-5351CD9EC3A2;F6C3B0B8-B9E0-4962-BCCD-705214844D6F	Not Available;Not Available;Not Available	7;7;7	147;147;225	91;91;148	Cyclophosphamide;Doxorubicin;Paclitaxel	Unknown;Unknown;Unknown	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Bone	Not Available	Not Available					TCGA-B6-A3ZX-F59573	2242BB2F-C23E-4005-94CA-3E9F32043C1C				3			1152	Not Available																				NO																						6					YES	YES	1096	994	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Bone	Distant Metastasis	Not Available	YES	Not Available	YES	WITH TUMOR						YES		YES	Dead	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	ductal and lobular	No	C50.9	8522/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	7	Close	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES	YES	Not Available	994	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Bone	Distant Metastasis	Not Available	NO	Not Available	YES	1	Not Available	No	A3ZX	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-B6-A3ZX-R40955	5B8D0E18-6490-40BE-80EC-6AD12BC416FA	Not Available	7	386	354	Unknown	3	25	200	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M1	N1	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	2007
TCGA-A2-A0CY	FEMALE	1673	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1673			TUMOR FREE				63	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0CY	757df7b0-4774-4493-98bf-999ded9ac86e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	10	-23229	Not Applicable	0	1288	Not Available	Not Available	TCGA-A2-A0CY-D2037;TCGA-A2-A0CY-D2042;TCGA-A2-A0CY-D2035;TCGA-A2-A0CY-D2036;TCGA-A2-A0CY-D2041;TCGA-A2-A0CY-D2038;TCGA-A2-A0CY-D2039;TCGA-A2-A0CY-D2034;TCGA-A2-A0CY-D2040	18ee660a-937e-4b2e-8965-26eac0c8eeca;f939ece6-83f5-47de-903f-49a909ca253c;9b6cfae2-3c2c-4c37-9713-fe0ab090e606;f14a412b-1425-4f47-ae9a-36a4915d9a26;d5d250f1-15c3-4766-94ed-40ac4f8f7cc0;3dd69ff8-546a-4ac3-bc5b-256b74c682b9;447a07c8-be8d-45d3-8404-b6d76b16b0bc;bb794a4d-53f8-4917-bb80-d7fc4646766c;bad877aa-b726-4dc3-ab46-c4c508f5b58c	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;14;14	147;Not Available;119;177;1162;357;507;119;665	133;1261;77;133;1071;197;455;77;634	Gemzar;Letrozole;Cytoxan;Taxol;Exemestane;Tamoxifen;Anastrozole;Adriamycin;Anastrozole	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9;9;9	2;Not Available;4;4;Not Available;Not Available;Not Available;4;Not Available	4320;2.5;1300-1308;216-378;25;20;1;130;1	mg;mg;mg;mg;mg;mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;9;2;3;8;5;6;1;7	IV;PO;IV;IV;PO;PO;PO;IV;PO	NO;YES;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8640;Not Available;5216;1121;Not Available;Not Available;Not Available;520;Not Available	mg;Not Available;mg;mg;Not Available;Not Available;Not Available;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0CY-F13731	AE7B55F3-F2F1-4FA6-9921-07C9E99F7EEB				9		Not Available	Not Applicable	1673		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	0.89	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A0CY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2006
TCGA-3C-AALJ	FEMALE	1474	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1474			TUMOR FREE				62	Right	Not Available	Not Available	TCGA-3C-AALJ	427D0648-3F77-4FFC-B52C-89855426D647	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	28	-22848	Not Applicable	0	1228	Not Available	Not Available	TCGA-3C-AALJ-D62904;TCGA-3C-AALJ-D65377;TCGA-3C-AALJ-D65375;TCGA-3C-AALJ-D65527;TCGA-3C-AALJ-D65378	D9762142-667A-4123-846B-B3B965CE9A90;EA7483F7-D53B-4A10-9E28-68A29E1F04A9;F0F4D7C5-9237-480F-876C-60663BBBE325;4EFE0CA1-39BA-4A36-9BDD-55F322DA8C11;B5D318C4-A505-475B-8ABC-DFEAA6B55593	Not Available;Not Available;Not Available;Not Available;Not Available	28;24;24;24;18	511;490;126;126;511	368;154;63;63;151	Metformin;Trastuzumab;Doxorubicin;Cyclophosphamide;Herceptin	Unknown;Not Available;Unknown;Unknown;Not Available	7;9;9;9;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Not Available;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO;NO	2014;2014;2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-3C-AALJ-F68060;TCGA-3C-AALJ-F71675	DF650B2E-12C2-468A-9F26-9A43CA378AF2;AB533AC3-9333-4176-A6E3-E0E03E8A0FFC				13;27			Not Applicable;Not Applicable	1302;1474																				NO;NO																						11;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						Discrepancy;NO		NO;NO	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Indeterminate	Not Evaluated	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	AALJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	30-39%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	3C	Breast	Not Applicable	Alive	2014	2011
TCGA-A8-A06Y	FEMALE	791	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	791.0			TUMOR FREE				66	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A06Y	515b1400-e896-4f2a-81bd-70895441a0bd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24442	Not Applicable	0	791	Not Available	Not Available	TCGA-A8-A06Y-D37851	E625C1D0-D92D-46AE-8C5E-BD0D9436E191	Not Available	6	Not Available	92	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A06Y-F40819	CAEFEE71-9247-4AAD-80DA-82865D83AC02				2			Not Applicable	791																				NO																						3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	791;791	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A06Y-R38178	08A51480-CA83-4DDC-853D-0644DC663604	Not Available	11	122	61	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-AN-A04A	FEMALE	90	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	90			TUMOR FREE				36	Left Lower Inner Quadrant;Left Lower Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A04A	e5aae05a-478e-4a55-a27c-12b2b4be302a	Not Available	Positive	Not Available	1+	Not Available	Modified radical mastectomy	Positive	Simple Mastectomy	Not Applicable	NO	29	-13445	Not Applicable	0	90	Not Available	Not Available																								Allred (Biocare)	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A04A-F68973	7C41E6F7-07DD-4DFA-8EBB-82C1546E7788				24			Not Applicable	90																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Dako Hercept test	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	7	Positive	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	4	0	No	A04A	TUMOR FREE	Allred (Biocare)	0	Not Available	87	112	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2008
TCGA-A8-A08T	FEMALE	3409	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1a	M1	Stage IV	1	2557.0			WITH TUMOR				64	Right	Not Available	Not Available	TCGA-A8-A08T	32bc7cc4-d185-4594-bbee-4b96410be512	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-23560	Not Applicable	0	2830	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08T-F40559	643ED7A2-6EA2-4E09-A96E-6C6D54CFBEF0				24			3409	Not Available																				NO																						2					Not Available	Not Available	Not Available	2557	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	WITH TUMOR						Unknown		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08T	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M1	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2002
TCGA-AR-A1AW	FEMALE	2632	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2632			Not Available				65	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AW	a12fd22a-7f84-4b6e-b6d8-012e38eb73d7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	14	-23855	Not Applicable	0	1072	Not Available	Not Available	TCGA-AR-A1AW-D21880;TCGA-AR-A1AW-D21882;TCGA-AR-A1AW-D21884	B118CFF2-8566-464E-BC22-044DA44E6715;CFE3594C-AFCE-4DC0-9A24-2F3F93988BBE;E157CFB4-4E3C-419E-B051-B1574E3EFECB	Not Available;Not Available;Not Available	28;28;28	50;50;Not Available	50;50;157	Docetaxel;Cytoxan;Anastrozole	Not Available;Not Available;Not Available	2;2;2	1;1;Not Available	75;600;1	mg/m2;mg/m2;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;2	IV;IV;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	150;1210;Not Available	mg;mg;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A1AW-F21874;TCGA-AR-A1AW-F49478;TCGA-AR-A1AW-F71714	E44B1D03-A203-409D-8BF8-0296FC2192B7;56185A8A-B29D-4B04-982B-0D3ABEE0D37E;96D8CA37-5732-42D2-9984-18CAD787048F				28;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1072;1935;2632		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	2;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AW	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AW-R21878	414051C6-7D5D-4256-86B8-C8F330A26C1B	1	28	115	76	Not Available	2	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-E2-A156	FEMALE	726	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	726			TUMOR FREE				61	Left	Sentinel node biopsy alone	Not Available	TCGA-E2-A156	f05d314c-5ec5-4e2a-b785-9a702716f111	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	7	-22422	Not Applicable	0	481	Not Available	NO	TCGA-E2-A156-D18787	9FA71240-8DEF-42FE-9235-91CC3980DDF7	Not Available	8	Not Available	119	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A156-F18786	9E28761C-EBC4-40AB-9207-41291C7D40E8				8		Not Available	Not Applicable	726		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A156	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A156-R18788	0AF5A75E-1E2C-4321-9544-A1774FEBC9B0	1	8	123	74	Not Available	10	33	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-D8-A1J8	FEMALE	431	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	431			TUMOR FREE				77	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1J8	62d70067-ff77-4f95-8b69-f537abaf74ce	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	23	-28444	Not Applicable	0	256	Not Available	Not Available	TCGA-D8-A1J8-D14041	3DDE2EBA-A85F-48E1-AAC2-D34371DCC95D	Not Available	18	Not Available	32	nolvadex	Not Available	7	Not Available	20	mg/day	ADJUVANT	Not Applicable	hormone therapy	PO	YES	Hormone Therapy	Not Available	Not Available	mg/day	Not Available	2011	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1J8-F14040	EE01E96E-58A8-4B56-AE04-E66483766188				18		Not Available	Not Applicable	431		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	No	A1J8	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-EW-A1P7	FEMALE	915	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	1	729.0	Other, specify	Distant Metastasis	TUMOR FREE				59	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1P7	01674b2c-5cf2-478f-84a1-f69c39f47bd4	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	18	-21750	Not Applicable	0	635	Not Available	NO	TCGA-EW-A1P7-D29238;TCGA-EW-A1P7-D29273	02AB6152-BB5D-4E54-9189-8B1A5D581075;97468A51-638F-48FB-B604-59FE79E75919	Not Available;Not Available	12;13	Not Available;Not Available	93;93	Carboplatin;Taxol	Not Available;Not Available	3;3	12;12	550;234	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Carboplatin/Taxol;Carboplatin/Taxol	IV;IV	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	<10%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	YES		TCGA-EW-A1P7-F29118	19E7F481-84A1-4837-B990-B4172DE0DBD5				8		793	Not Applicable	915		729				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Other, specify	Distant Metastasis	mediastinal lymph nodes	YES																																		WITH TUMOR			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	1.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1P7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-EW-A1P6	FEMALE	562	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	562			TUMOR FREE				64	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1P6	ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	19	-23485	Not Applicable	0	312	Not Available	NO	TCGA-EW-A1P6-D30269;TCGA-EW-A1P6-D30271;TCGA-EW-A1P6-D30270;TCGA-EW-A1P6-D30268;TCGA-EW-A1P6-D30267;TCGA-EW-A1P6-D30273	D3941135-B841-428D-B697-006C00F9A233;0F16DDBE-E7EC-4A73-AD9D-C03723C57A19;AFDF574F-0437-489B-AD18-43196C2A548A;3A0A588D-DF4B-450F-A1BD-06F255D551B7;635E9C0E-99F9-4277-A604-E090DC019E30;B13DE4DD-820A-49D2-AD88-0F26B649546B	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7	205;303;233;205;205;Not Available	162;254;233;162;162;444	Cyclophosphamide;Paclitaxel;Docetaxel;Fluorouracil;Epirubicin;Arimidex	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	3;8;1;3;3;Not Available	870;131;164;870;172;1	mg;mg;mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;1;1;4	IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2590;1080;164;2590;518;Not Available	mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1P6-F29114	7A4439F1-4C6D-474E-B2DD-55E519D70AEA				8		Not Available	Not Applicable	562		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	25	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	0	No	A1P6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1P6-R30274	0BDDDA09-CD55-4750-91BC-0F28F73E5244	1	7	386	321	Not Available	3	Not Available	10,500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A278	FEMALE	297	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	297			TUMOR FREE				61	Left	Not Available	Not Available	TCGA-C8-A278	65077db7-dd59-4362-9d28-d5a9154e9be0	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	21	-22598	Not Applicable	0	9	Not Available	Not Available	TCGA-C8-A278-D70993	C2C73BBA-5B7A-4D5E-9026-7C416C68754A	Not Available	12	Not Available	23	Tamoxifen	Discrepancy	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A278-F20278	C06E117F-44A5-4CD4-8B4B-0149099DECE2				9		Not Available	Not Applicable	297		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Positive	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A278	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A0IG	FEMALE	4456	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	4456			WITH TUMOR				50	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IG	34ab0cb8-bf19-4cbb-b4eb-3c45ee5aa60b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-18433	4456	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0IG-F12616	8FD670AC-8E65-4365-8F5F-B23F906ED929				2		Not Available	4456	Not Available		Not Available				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available																																		Not Available			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	16	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	4	Not Available	No	A0IG	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1994
TCGA-AR-A1AL	FEMALE	2971	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1	M0	Stage IIIA	0	2971			TUMOR FREE				60	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AL	1f99e4d4-4e8b-4cc1-a129-227a2a82780e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	15	-22023	Not Applicable	0	1485	Not Available	Not Available	TCGA-AR-A1AL-D22160;TCGA-AR-A1AL-D22159;TCGA-AR-A1AL-D22162;TCGA-AR-A1AL-D22158;TCGA-AR-A1AL-D22163;TCGA-AR-A1AL-D22161	434BD03D-F052-4518-BA27-5FFA55676AB0;2856DA7C-FB15-45B1-97F6-4D562D8F705F;49AE2F00-CB5D-4C4E-8134-0E856F245217;377B613B-C56A-444F-9267-A2E5EDFEA3AF;D49EE915-818B-484E-BE1B-15C7D3685DF8;CD0DAAB8-2A50-4F39-ABB3-A57C7DB0E95A	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1	Not Available;Not Available;366;Not Available;Not Available;Not Available	Not Available;Not Available;192;Not Available;387;Not Available	Paclitaxel;Cytoxan;Anastrozole;Doxorubicin;Letrozole;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	1;4;Not Available;4;Not Available;3	Not Available;Not Available;1;Not Available;2.5;Not Available	Not Available;Not Available;mg/day;Not Available;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;1;2;1	Not Available;Not Available;PO;Not Available;PO;Not Available	NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AL-F22156;TCGA-AR-A1AL-F69272	8DFEDF7F-9E87-4602-9619-424358C6560B;578E2FC1-A2D0-4E95-9683-5CA06AD1313D				1;31		Not Available;None	Not Applicable;Not Applicable	1485;2971		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	3	Not Available	No	A1AL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AL-R22157	9613B599-7554-4DD1-BFA1-DD813EC257DB	1	1	192	153	Not Available	3	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-E2-A15P	FEMALE	595	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	595			TUMOR FREE				61	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15P	a1674d7b-787a-45c4-bf16-1b7d0efce207	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	14	-22524	Not Applicable	0	315	Not Available	NO	TCGA-E2-A15P-D19145;TCGA-E2-A15P-D19146	F89D7938-6B30-4AF5-84F0-30B5D1B87F69;CEE4C48F-410A-452E-9C36-DF6142898E8D	Not Available;Not Available	16;16	220;Not Available	105;223	Arimidex;Aromasin	Not Available;Not Available	11;11	Not Available;Not Available	1;25	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	PO;PO	NO;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	115;25	mg;mg/day	Not Available;Not Available	2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15P-F19144	FF988B0B-A019-44FD-8CB3-0DEF979A82D9				16		Not Available	Not Applicable	595		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15P	TUMOR FREE	Allred score 2+2 = 4	Not Available	Not Available	Allred score = 4	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A15P-R19147	747DC091-0514-4945-B09E-1CAD551849C8	1	16	98	51	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A1FE	FEMALE	2273	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1	M0	Stage IIB	0	2273			WITH TUMOR				31	Left	Not Available	Not Available	TCGA-BH-A1FE	4aa68586-6331-4795-b40c-859386640df6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	8	-11650	2273	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1FE	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-BH-A0E6	FEMALE	293	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	293			TUMOR FREE				69	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0E6	6c0066e3-96df-4870-bcd3-98cda64082e9	Not Available	Negative	Not Available	0	Not Available	Not Evaluated	Negative	Other	Not Applicable	NO	9	-25408	Not Applicable	0	293	Not Available	Not Available	TCGA-BH-A0E6-D4647;TCGA-BH-A0E6-D4646	066B8D3A-D2FB-4BC0-B6C5-9D06F6529B73;85D6AB5B-4057-4C31-B9B0-CF2D73E1CE93	Not Available;Not Available	18;18	121;121	58;58	CYTOXAN;TAXOTERE	Not Available;Not Available	11;11	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	H-SCORE 0	Not Available	Not Available	Not Available	Not Available	2.38	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0E6-F4650	57382918-996B-4452-A6EC-6520C9719E12	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	293	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	2.83	1.19	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0E6	TUMOR FREE	H-SCORE 0	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0E6-R4649	6D6BDE4C-3E32-4C6A-9BBA-B937678BBDE3	1	17	191	145	Not Available	11	32	5860	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-E9-A1RE	FEMALE	1419	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	1419			TUMOR FREE				74	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RE	24046547-d038-4616-b190-52ac93f4965f	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	28	-27392	Not Applicable	0	47	Not Available	NO	TCGA-E9-A1RE-D30629;TCGA-E9-A1RE-D30625;TCGA-E9-A1RE-D30626;TCGA-E9-A1RE-D30628;TCGA-E9-A1RE-D30627;TCGA-E9-A1RE-D30630;TCGA-E9-A1RE-D30631	88021F1F-6F05-49C2-974E-C81F92FBF7E1;7DC35BFA-9C80-4F0C-91E8-F45010BFF3A1;BC07A0C3-99D7-49FA-8CDA-8BDC0A5B3CFE;1955E286-AE41-4016-95CE-453A407709C0;E75E0ABA-5130-4FBE-B9D7-44081F1FF713;AB669FF9-A215-4611-851F-9CF3F1DB948C;7E328C05-236F-4222-82CC-33615BDF9124	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13	145;145;145;145;145;145;Not Available	50;50;50;50;50;50;39	Doxorubicin;5-Fluorouracil;5-Fluorouracil;Doxorubicin;Doxorubicin;Cyclophosphamide;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4	1;3;1;1;2;4;Not Available	100;2000;1500;80;60;1600;20	mg;mg;mg;mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	100;6000;1500;80;120;6400;Not Available	mg;mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A1RE-F30615;TCGA-E9-A1RE-F39532;TCGA-E9-A1RE-F68732	3B025302-2864-4320-8F48-62483817A045;3097477B-AE0C-423F-8D1B-82856ADEA544;4C8D48A2-1C70-473F-8AED-C5D3C3385E26				24;24;12		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	659;1054;1419		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	1;1;12	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2014;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	9	Not Available	No	A1RE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1RE-R30632	3C41D803-3D12-4E01-B2D6-2940A6BE6E4C	1	13	209	183	Not Available	4	20	4000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A10E	FEMALE	865	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	865			TUMOR FREE				64	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A10E	dc15a8ae-991e-421c-bc70-70e94f79dd17	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	11	-23684	Not Applicable	0	418	Not Available	Not Available	TCGA-E2-A10E-D7737;TCGA-E2-A10E-D7739;TCGA-E2-A10E-D17354;TCGA-E2-A10E-D17356	bd0584f4-ee79-49a0-9ade-0ad380645278;7ec81080-5df3-4dc4-8ec6-5e0ea241af2e;00E33CEE-3545-4F64-BF71-25DC3724D422;299A38EF-5935-4D67-8EF7-C7BCE9FF5DCC	Not Available;Not Available;Not Available;Not Available	14;14;26;26	123;Not Available;123;123	60;217;60;60	Cytoxan and Taxotere;Arimidex;Docetaxel;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	2;2;9;9	4;Not Available;4;4	Not Available;1;115;918	Not Available;mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;1;460;3672	Not Available;mg/day;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A10E-F17248	B250E415-A582-4263-A230-F81B31F7F5F5				26		Not Available	Not Applicable	865		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	40-49%	Not Available	2+	Not Available	Not Available	Not Available	1.07	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	2	Not Available	No	A10E	TUMOR FREE	Allred score 3+2=5	Not Available	Not Available	Allred score 5	Allred score 8	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A10E-R7734	5ff50f19-2a03-46b9-bc52-f3a402b02e14	1	14	218	173	Not Available	2	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A0BR	FEMALE	2330	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	2330			TUMOR FREE				59	Left Lower Inner Quadrant	Not Available	Not Available	TCGA-BH-A0BR	3ecb0147-276d-486c-9af0-ce437c24ba83	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	10	-21622	Not Applicable	0	1633	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BR-F61951	9BA76E22-268F-4181-8B35-A67DC8D99EFC				10			Not Applicable	2330																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BR-R61952	630A649B-3586-470C-A97A-7698334CFDA5	Not Available	10	108	58	Complete Response	7	36	64.8	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-JL-A3YX	FEMALE	352	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	352			Unknown				46	Left	Axillary lymph node dissection alone	Not Available	TCGA-JL-A3YX	75F6E476-233A-409C-A3EF-0240BE569813	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Unknown	8	Not Available	Not Applicable	0	352	Not Available	Not Available																								Not Available	30-39%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	30-39%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A3YX	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	30-39%	ASIAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	JL	Breast	Not Applicable	Alive	2012	2011
TCGA-OL-A66K	FEMALE	1275	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N0	MX	Stage IIA	0	1275			TUMOR FREE				72	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A66K	2AB1B35B-9E56-475C-AC9B-15ED0A422683	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Unknown	11	-26299	Not Applicable	0	1021	Not Available	Not Available																								Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A66K-F58498	A7D35DF2-9B47-41B2-B62E-898F9B98D659				11			1275	Not Available																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.23	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A66K	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	90-99%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2010
TCGA-BH-A18N	FEMALE	468	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIA	0	468			Not Available				88	Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A18N	665dd3d3-779c-4abd-b5d7-13342340451d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	15	-32404	468	0	Not Available	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A18N-F59153	2F3D622E-63F7-4090-9D6F-974AA4A2CCAB				1			468	Not Available																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown						NO		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Available	26	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	2	No	A18N	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2001
TCGA-AN-A0XO	FEMALE	375	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	375			TUMOR FREE				59	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A0XO	195b6731-6ae6-416e-a345-0eb8874a0ca2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	Not Available	1	-21640	Not Applicable	0	375	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XO-F68957	24DEF0F1-801A-49B6-B800-68003374231A				23			Not Applicable	375																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	Not Available	No	A0XO	TUMOR FREE	Not Available	Not Available	Not Available	0	180	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A572	FEMALE	1208	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	1208			TUMOR FREE				72	Left	Axillary lymph node dissection alone	Not Available	TCGA-E2-A572	06EF6E83-5583-45B9-A0BD-EDEA68943083	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	10	-26399	Not Applicable	0	831	Not Available	Not Available	TCGA-E2-A572-D48249;TCGA-E2-A572-D48250;TCGA-E2-A572-D48251	E2D5FD02-12D8-4B62-B9C9-CF7275EFA17A;D7049B0E-CA68-4603-B147-7FE56C43BF18;50D48DA4-E3E7-49B4-9DCA-3BDA540825A4	Not Available;Not Available;Not Available	10;10;10	133;200;Not Available	91;147;263	Doxorubicin;Taxol;Arimidex	Unknown;Complete Response;Not Applicable	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E2-A572-F65007	1E6255EF-F076-40C9-8A5B-35FC4FF7CA8B				17			Not Applicable	1208																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	8	Yes	A572	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-E2-A572-R48248	6AF2B719-A8B2-4E95-BAF5-C4FAFA2FF01A	Not Available	10	263	196	Complete Response	9	28	60.4	NO	Unknown	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2013	2011
TCGA-BH-A18T	FEMALE	224	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	224			WITH TUMOR				70	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A18T	30ec8b1f-28c4-4f46-8a1b-a8d51e558c7d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	2	-25674	224	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A18T	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Dead	2011	2003
TCGA-AN-A0AT	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE				62	Right Upper Inner Quadrant	No axillary staging	Not Available	TCGA-AN-A0AT	05506f4c-e701-4a9d-ae06-97f066aade43	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-22798	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AT-F68948	6E5C0241-D8BE-4DB8-8893-0E939CCED8F6				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AT	TUMOR FREE	Not Available	0	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-OL-A66I	FEMALE	714	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	MX	Stage IIA	0	714			TUMOR FREE				36	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A66I	35BD694D-1DD2-466F-AB27-03320614B40E	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Unknown	11	-13458	Not Applicable	0	714	Not Available	Not Available	TCGA-OL-A66I-D64844;TCGA-OL-A66I-D65246;TCGA-OL-A66I-D65247	F22168A0-48F2-4929-8D24-FC96F98FBDD8;43174F1C-A7E8-41DB-91CD-79BF16DDA0CC;BFFBBF56-08F9-40CB-99D1-13CE9A5FB330	Not Available;Not Available;Not Available	12;24;24	312;312;312	43;43;43	ADRIAMYCIN;CYTOXAN;TAXOL	Complete Response;Complete Response;Complete Response	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A66I-F58496	43440205-5036-4417-B0CB-BF085DC77CFC				11			Not Applicable	714																				YES																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.04	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	13	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A66I	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A66I-R64843	BD0C1305-129A-41D6-94AD-5D5CACC08ABB	Not Available	12	285	239	Complete Response	9	Not Available	5041	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2008
TCGA-E9-A1NI	FEMALE	300	Mixed Histology (please specify)	Breast	Alive	T2	N0	M0	Stage IIA	0	300			TUMOR FREE				51	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1NI	c65b835a-2d38-4250-a173-0780d2c2cf58	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	23	-18985	Not Applicable	0	-7	Not Available	NO	TCGA-E9-A1NI-D35022;TCGA-E9-A1NI-D35023;TCGA-E9-A1NI-D35027;TCGA-E9-A1NI-D35028	9DFDBBC7-631F-4C94-A923-948195F59A36;FD81C1FD-32D3-41C2-91E3-B62B8B916AE7;216067BB-58F6-4991-9A18-2FCE36C80910;D4990B88-4B53-4E5A-A245-788D6F0CB831	Not Available;Not Available;Not Available;Not Available	13;13;13;13	80;80;80;Not Available	0;0;0;86	Doxorubicin;Cyclophosphane;5-Fluorouracil;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	9;9;9;9	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1NI-F29213;TCGA-E9-A1NI-F52056	25652B21-898C-410A-A0C0-2CD806632066;4876BC0D-F943-41B2-8EE0-FAF3D05A3FCE				12;27		Not Available;None	Not Applicable;Not Applicable	300;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;11	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		NO;Not Available	Alive;Not Available	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1NI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AN-A04C	FEMALE	54	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	54			TUMOR FREE				51	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A04C	66072c06-f251-4f0b-b6ae-12b407c52cc6	Not Available	Negative	Not Available	0	Not Available	Modified radical mastectomy	Negative	Simple Mastectomy	Not Applicable	NO	29	-18851	Not Applicable	0	54	Not Available	Not Available																								Allred (Biocare)	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A04C-F68974	6E0AB9FC-6CD3-4762-AD22-CCA478E6C580				24			Not Applicable	54																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Dako Hecept Test	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	2	0	No	A04C	TUMOR FREE	Allred (Biocare)	Not Available	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2008
TCGA-A7-A0CH	FEMALE	1079	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1079			TUMOR FREE				79	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A0CH	9de678e5-67ed-4453-a98b-7ac351d5d0f1	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Simple Mastectomy	Not Applicable	YES	4	-29104	Not Applicable	0	162	Not Available	Not Available	TCGA-A7-A0CH-D2934	2daa89c3-a79e-4a11-9bd4-c2472930362c	Not Available	5	Not Available	107	Arimidex	Not Available	11	Not Available	1	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	247	mg	Not Available	2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0CH-F2935;TCGA-A7-A0CH-F39148	54F1C21B-1D60-4A2F-A2AF-52A73EE8DCFC;70682038-C827-4F58-A9DC-8433BFCE1CF6	Not Available;None	Not Available;None	Not Available;None	5;14	Not Available;None	Not Available;None	Not Applicable;Not Applicable	233;1079	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;1					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A0CH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2009
TCGA-C8-A8HQ	FEMALE	380	Mucinous Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	380			TUMOR FREE				53	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A8HQ	6951FE6A-D7D1-4F41-85AF-76655B5D1F62	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	29	-19432	Not Applicable	0	9	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A8HQ-F69879	4243CE27-CD57-4D7A-B76B-03869D2A4945				22			Not Applicable	380																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	4	No	A8HQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	ASIAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2014	2013
TCGA-C8-A12V	FEMALE	385	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	385			TUMOR FREE				55	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12V	7e1673f8-5758-4963-8804-d5e39f06205b	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	22	-20346	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12V-F19095	12E9D7F7-A7A6-4E0F-B152-CE708D83BA6C				2		Not Available	Not Applicable	385		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	5	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A12V	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A1R2	FEMALE	1063	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3	MX	Stage IIIC	0	1063			TUMOR FREE				51	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1R2	8631969d-4ac6-4fe1-9db3-d47db604494a	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Negative	Lumpectomy	Not Applicable	NO	28	-18936	Not Applicable	0	19	Not Available	NO	TCGA-E9-A1R2-D55472;TCGA-E9-A1R2-D55473;TCGA-E9-A1R2-D55474	659FE77A-7EC8-4976-A86E-8D54BB201D8E;102D03D1-BC76-4688-BFA9-5EFD862C35D7;57A9F155-B541-4EFD-8BFE-CBD7447C24D1	Not Available;Not Available;Not Available	7;7;7	144;144;144	36;36;36	Taxotere;Adriamycin;Cytoxan	Complete Response;Complete Response;Complete Response	1;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	74	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1R2-F33184;TCGA-E9-A1R2-F57941	CD0E60BD-4C4D-4205-B1BD-644352B5816E;62EFCDC5-4570-4B6F-A920-8FE3F82173CF				8;31		Not Available;None	Not Applicable;Not Applicable	1063;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		YES;Not Available	Alive;Not Available	2013;2014	FEMALE	Not Available	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	114	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	17	Not Available	No	A1R2	TUMOR FREE	Not Available	Not Available	Not Available	Two-tier	Two-tier	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-E9-A1R2-R56895;TCGA-E9-A1R2-R56896	D7CA210D-C2B0-4BF4-8D15-3C719E3FD2D8;850B4523-573A-4F66-A0BA-85E00855505E	Not Available;Not Available	25;25	223;223	174;174	Complete Response;Complete Response	2;2	Not Available;Not Available	6240;5040	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A2-A1G4	FEMALE	595	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	595			TUMOR FREE				71	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A1G4	e3b555aa-7f0a-49c6-9b13-182c61a144c1	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	22	-25966	Not Applicable	0	372	Not Available	NO	TCGA-A2-A1G4-D12345;TCGA-A2-A1G4-D12347;TCGA-A2-A1G4-D12344;TCGA-A2-A1G4-D12346	6491326b-97e4-4bc3-bc1b-3420c081b2bf;f7d16c97-46c7-4712-83cb-f31c52b38ea4;5971ea22-14b8-49be-8ee4-c621e8529ea7;59b0a147-3154-47c9-907a-765fdba4002d	Not Available;Not Available;Not Available;Not Available	27;27;27;27	185;Not Available;185;185	80;207;80;80	Adriamycin;Femara;Cytoxan;Taxotere	Not Available;Not Available;Not Available;Not Available	4;4;4;4	6;Not Available;6;6	80;2.5;795;120	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;4;1;3	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	480;Not Available;4770;720	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A1G4-F20805	05CF4C23-40FE-4F52-B9E0-3BE877BC4F3F				9		Not Available	Not Applicable	595		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	2	Not Available	Yes	A1G4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-JL-A3YW	FEMALE	360	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	360			Unknown				49	Left	Axillary lymph node dissection alone	Not Available	TCGA-JL-A3YW	A2434F47-2168-47D0-9BBB-981071597843	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Unknown	8	Not Available	Not Applicable	0	360	Not Available	Not Available																								Not Available	30-39%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	30-39%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	0	No	A3YW	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	30-39%	ASIAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	JL	Breast	Not Applicable	Alive	2012	2011
TCGA-AR-A252	FEMALE	2838	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	2838			Not Available				50	Left Upper Outer Quadrant;Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A252	4d0fec97-e024-4608-a0cc-426a3decc7b1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	30	-18611	Not Applicable	0	1236	Not Available	Not Available	TCGA-AR-A252-D31834;TCGA-AR-A252-D31835;TCGA-AR-A252-D31836	2B107267-0243-41AB-A8D4-E3A877850BFF;15E7A4D2-8203-45A9-B8A1-DAB0C819E8AA;A51DB83F-929F-44F2-B30E-2A608BEFBB50	Not Available;Not Available;Not Available	22;22;22	97;97;Not Available	55;55;116	Doxorubicin;Cytoxan;Tamoxifen	Not Available;Not Available;Not Available	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A252-F31829;TCGA-AR-A252-F49510;TCGA-AR-A252-F71727	8922C8E4-9215-4E25-A1EE-4F5A07FA1AE0;976FA976-190E-4CEA-AFE1-D220E1EF1524;52A82191-71D1-4E9A-AB5F-7F3869722CD1				9;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1236;2226;2838		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A252	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A252-R31832	DA3119FA-2C7A-401D-A8D4-5E9BC5396C15	1	9	159	118	Not Available	5	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-E2-A2P5	FEMALE	821	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N3	M0	Stage IIIC	1	597.0	Bone	Distant Metastasis	TUMOR FREE				78	Left	Axillary lymph node dissection alone	Not Available	TCGA-E2-A2P5	F0DE67FF-8967-4FCE-9C12-0E07193285CD	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	19	-28621	Not Applicable	0	326	Not Available	NO	TCGA-E2-A2P5-D33517	BB98F3FD-3E77-42DE-B60F-4556F6BBDBEF	Not Available	5	Not Available	163	Arimidex	Not Applicable	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Allred score = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A2P5-F33516;TCGA-E2-A2P5-F68575	DC06A07E-55FC-4C89-B724-15DA57A30FF9;76F6E0C5-BD3F-4008-AA91-1E51F54AF7DF				29;26		Not Available;None	Not Applicable;821	515;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;11	Not Available;None	Not Available;None	Not Available;None	NO;None	None;YES	None;NO	None;Not Available	None;597	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Evaluated	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Evaluated	None;Not Evaluated	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Evaluated	None;Bone	None;Distant Metastasis	None;Not Available	None;NO	None;Not Available	None;YES	TUMOR FREE;WITH TUMOR			Not Available;None			YES;YES		YES;YES	Alive;Dead	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.0	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	21	Not Available	Yes	A2P5	TUMOR FREE	Allred score = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Regional site	TCGA-E2-A2P5-R33529	9D9DEECE-7130-4B3B-890A-CCBD6A3A989F	Not Available	5	143	98	Complete Response	7	28	60.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2011
TCGA-A7-A26J	FEMALE	627	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	627			WITH TUMOR		FPPP	TCGA	49	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A26J	6cb6f179-defd-4661-af0a-c353b74c0c49	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	28	-17930	Not Applicable	0	68	Not Available	NO	TCGA-A7-A26J-D30819	486CE20D-4F3C-40CA-B3BB-95A9F2BC54F7	Not Available	17	Not Available	92	Tamoxifen	Not Available	4	Not Available	20	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	5540	mg	Not Available	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A26J-F30814;TCGA-A7-A26J-F39793	880E5F65-E490-4289-BFF2-CA57F3107CDC;33485A24-DB2A-469D-BF9A-D0B33DF4A20E				17;1		Not Available;None	Not Applicable;Not Applicable	369;627		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A26J	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A10A	FEMALE	1229	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	1	75.0	Bone	Distant Metastasis	WITH TUMOR				41	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A10A	4da7abaf-ac7a-41c0-8033-5780a398545c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	11	-15085	Not Applicable	0	352	Not Available	Not Available	TCGA-E2-A10A-D7700;TCGA-E2-A10A-D7699;TCGA-E2-A10A-D17430	932948c9-faaa-4f8d-a773-780433c65a7a;de773115-886c-445c-874a-99ed871ca85d;4729CED9-4A3B-43B6-AB21-95DC86CFA9FE	Not Available;Not Available;Not Available	14;14;27	Not Available;Not Available;Not Available	91;88;148	Tamoxifen;Zoladex;Zometa	Not Available;Not Available;Not Available	2;2;9	Not Available;Not Available;Not Available	20;3.6;4	mg/day;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	2;1;2	PO;SC;IV	YES;YES;YES	Hormone Therapy;Hormone Therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;3.6;Not Available	Not Available;mg;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 4+3=7	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;YES	YES;YES	NO;NO		TCGA-E2-A10A-F17422;TCGA-E2-A10A-F17522	9389E64B-E562-45E1-8E41-869781EEF1FC;80443D13-7053-4DEE-AB14-7199DF35B8FD				13;12		Not Available;Not Available	Not Applicable;Not Applicable	1229;1229		75;92				Scheduled Follow-up Submission;Scheduled Follow-up Submission							Not Available;Not Available			Not Available;Not Available					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;10	Bone;Brain	Distant Metastasis;Distant Metastasis	Not Available;Not Available	YES;YES																																		Not Available;Not Available			Not Available;Not Available			YES;YES		YES;YES	Alive;Alive	2011;2011	FEMALE	Not Available	Not Available	40-49%	Not Available	2+	Not Available	Not Available	Not Available	1.21	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Negative	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	0	No	A10A	WITH TUMOR	Allred score 5+3=8	Not Available	Not Available	Allred score 8	Allred score 7	Not Available	Not Available	Not Available	WHITE	Not Available	Distant Recurrence;Distant Recurrence	TCGA-E2-A10A-R7701;TCGA-E2-A10A-R7698	eceeff60-cf37-412c-958b-cf5faaf96030;7ef33888-270b-489f-900d-6d0b83e76ddf	2;1	14;14	102;130	102;119	Not Available;Not Available	2;2	1;5	2200;3000	NO;NO	OTHER;OTHER	gamma knife radiasurgery;stereostatic radiotherapy	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-B6-A0RN	FEMALE	8008	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	8008			TUMOR FREE				60	Right Upper Inner Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RN	2199b7a1-bd47-4bb5-b36a-a3e291e3e259	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	2	-22077	Not Applicable	0	5261	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0RN-F13798;TCGA-B6-A0RN-F71514	FF2B6C81-2139-42A0-AFCB-87293273EFA1;268E69D6-E783-4413-9FC9-6D584E476CF4				12;26		Not Available;None	Not Applicable;Not Applicable	5261;8008		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0RN	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1993
TCGA-A8-A06Q	FEMALE	31	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2	M0	Stage IIIA	0	31			TUMOR FREE				63	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A06Q	281f70c5-876f-44b3-84fb-f2302f85e74c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-23164	Not Applicable	0	31	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06Q	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-AO-A12F	FEMALE	1842	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1842			TUMOR FREE				36	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A12F	495f9eda-b9be-4eef-bae1-766a4bfbd68e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	8	-13409	Not Applicable	0	1471	Not Available	Not Available	TCGA-AO-A12F-D5981;TCGA-AO-A12F-D5979;TCGA-AO-A12F-D5980	272961f9-9281-4a6c-81c0-f2052b56f0e1;c34652a1-fcbd-42e8-9bfb-991088feb8bd;694d184f-3285-46a6-904c-6c2136c0e92d	Not Available;Not Available;Not Available	10;10;10	189;189;189	63;63;63	Paclitaxel;Cyclophosphamide;Doxorubicin	Not Available;Not Available;Not Available	1;1;1	4;4;4	175;600;60	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A12F-F5899;TCGA-AO-A12F-F19434	D78677C1-3F45-44EB-B8B7-0DCE0D11019D;20F415F8-AAC1-42CF-B61F-F8035EAD23B8	Not Available;None	Not Available;None	Not Available;None	8;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1471;1842	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A12F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A12F-R5904	d6634ff1-45f7-48bb-9b16-7b9d2f69a6db	1	8	254	220	Not Available	12	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2006
TCGA-LD-A7W6	FEMALE	404	Other, specify	Breast	Alive	T2	N1a	M0	Stage IIB	0	404			TUMOR FREE				54	Right;Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-LD-A7W6	0B0F9938-CE1E-4814-8821-0132D137EB9E	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	3	-20077	Not Applicable	0	140	Not Available	Not Available	TCGA-LD-A7W6-D56359	98AA201E-F562-487E-A7DC-EB64623A1085	Not Available	3	Not Available	146	Letrozole	Not Applicable	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Chemotherapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LD-A7W6-F69193	51CDD6F7-8467-42F0-8B9F-4C3BD0C4AFD9				30			Not Applicable	404																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Invasive lobular carcinoma, mixed classical (70%) and pleomorphic/solid (30%) types	No	C50.2	8524/3	C50.2	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	No	A7W6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	LD	Breast	Not Applicable	Alive	2014	2013
TCGA-AC-A4ZE	FEMALE	890	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	890			TUMOR FREE				63	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A4ZE	0CF0D67C-2F7F-42A6-94F3-407D0EC46C88	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	9	-23284	Not Applicable	0	152	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A4ZE-F72379	93BEFC77-D0BC-4528-A5D1-3774D3341331				9			Not Applicable	890																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A4ZE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2015	2012
TCGA-A8-A07P	FEMALE	334	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	334			TUMOR FREE				68	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07P	8cccf160-93e9-48a5-9b8b-54aa50153142	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24929	Not Applicable	0	334	Not Available	Not Available	TCGA-A8-A07P-D37860;TCGA-A8-A07P-D37861;TCGA-A8-A07P-D37862;TCGA-A8-A07P-D37863;TCGA-A8-A07P-D37864	51A06630-6788-4AF6-B0A3-C4B649D4966B;8927D85C-E657-4253-9085-7F56495EEBCE;9AA7C3E5-F877-4767-99B4-5D448798AE79;75AA33AD-D619-4CF8-BA27-5431C367A9B3;6E70AFEF-B5DD-4CDE-89B1-50C8857BA3CF	n/a;n/a;n/a;n/a;n/a	6;6;6;6;6	181;181;181;181;Not Available	61;61;61;61;273	5-Fluorouracil;Doxorubicin;Cyclophosphamide;Docetaxel;Anastrozole	Unknown;Unknown;Unknown;Unknown;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07P-F40832	B5B63F7A-129B-4BDA-9D97-8F173A9A02DA				2			Not Applicable	334																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07P	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07P-R38183	0890E30B-F3E9-4908-8B48-F0D3D612D57D	Not Available	11	212	181	Unknown	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AR-A0TV	FEMALE	2288	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2288			TUMOR FREE				66	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TV	6439621e-da61-4723-91cc-c5d87d0a4abc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	10	-24279	Not Applicable	0	905	Not Available	Not Available																								Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A0TV-F18574;TCGA-AR-A0TV-F71734	B795EB26-8475-47E2-9011-44D1A2624880;7EDE43D9-4F69-47CC-86A2-583C68ECC646				12;30		Not Available;None	Not Applicable;Not Applicable	1288;2288		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;NO		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0TV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-AO-A0JC	FEMALE	1547	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1547			TUMOR FREE				64	Right Upper Outer Quadrant;Right Lower Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JC	03565036-b6d3-432f-8d9a-7099818e0788	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	20	-23404	Not Applicable	0	1547	Not Available	Not Available	TCGA-AO-A0JC-D3184;TCGA-AO-A0JC-D3183;TCGA-AO-A0JC-D3182;TCGA-AO-A0JC-D3181	7ca89abd-c5d1-4bb2-a0d8-80b329119bdd;8599b409-0662-4eea-a61a-c27500d39b91;ae622289-bf49-4818-8ada-6629cddbb999;04fadaa5-10b7-4b05-be8a-2f5ad9ea89b6	Not Available;Not Available;Not Available;Not Available	20;20;20;20	Not Available;221;221;221	292;70;70;70	LETROZOLE (FEMARA);FLUOROURACIL;CYCLOPHOSPHAMIDE;METHOTREXATE	Not Available;Not Available;Not Available;Not Available	9;9;9;9	Not Available;8;8;8	2.5;600;600;40	mg/day;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;8700;8700;560	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JC-F3179;TCGA-AO-A0JC-F15486	05FE3C54-5669-446E-867D-3327FB427967;A1E5BE94-918A-4E6B-97DC-9C8BE85726A8	Not Available;None	Not Available;None	Not Available;None	20;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1547;1547	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0JC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50-59%	WHITE	Not Available	Regional site	TCGA-AO-A0JC-R3180	541d6c3c-3efe-4473-9818-68bb9f9a9693	1	20	298	252	Not Available	9	33	21160	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2006
TCGA-C8-A26V	FEMALE	616	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2	M0	Stage IIIA	0	616			TUMOR FREE				47	Right	Not Available	Not Available	TCGA-C8-A26V	89414e79-7f89-42d9-8228-101b5bf2f31f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	21	-17468	Not Applicable	0	9	Not Available	Not Available	TCGA-C8-A26V-D70800	10D4E1C4-0036-44D9-8206-D14CECDEA307	Not Available	9	613	247	Tamoxifen	Complete Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A26V-F70799	505ACEFD-F363-4529-B80D-839879624DF1				9			Not Applicable	616																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Modified Radical Masectomy	Other method, specify:	Negative	Not Evaluated	Not Available	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A26V	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 8	Allred Score 8	Not Available	NO	Not Available	ASIAN	Not Available	Regional site	TCGA-C8-A26V-R70801	8A854D11-9805-4A1B-BC0A-6018147BD138	Not Available	9	247	212	Complete Response	3	25	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A26Z	FEMALE	470	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	470			TUMOR FREE				59	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-C8-A26Z	dc11b1c7-1f00-4813-b4b5-ecf776b2eb37	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	21	Not Available	Not Applicable	0	4	Not Available	NO	TCGA-C8-A26Z-D70836	D3391CBA-5CB0-47AE-9813-D21384BF7466	Not Available	9	Not Available	11	Tamoxifen	Complete Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A26Z-F20279;TCGA-C8-A26Z-F70835	3D40203B-FE09-43E0-BDCC-643110359D34;EA721DF8-5AD0-46F3-A433-3CEF5C43AF19				9;9		Not Available;None	Not Applicable;Not Applicable	252;470		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A26Z	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 4	Allred Score 8	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A128	FEMALE	3248	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3248			TUMOR FREE				61	Right Lower Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A128	016caf42-4e19-4444-ab5d-6cf1e76c4afa	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	7	-22340	Not Applicable	0	2877	Not Available	Not Available	TCGA-AO-A128-D5943;TCGA-AO-A128-D5945;TCGA-AO-A128-D5942	e2154fbe-e02b-44f3-a61a-e08146c61db2;39C00F42-C756-42EC-98DC-BB6F6434718B;554dcbf2-b7a5-4237-9b68-7484e41a52ab	Not Available;Not Available;Not Available	10;10;10	124;222;124	82;160;82	Doxorubicin;Paclitaxel;Cyclophosphamide	Not Available;Not Available;Not Available	1;1;1	4;4;4	62;175;619	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	480;1360;4800	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	49	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A128-F5879;TCGA-AO-A128-F19405	2A6DEEAE-C739-4E88-8095-431BF42899E3;CAAF9EFF-2A56-4182-A1F0-115AA2CDDAED	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	2877;3248	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	>=2.0 Positive	0	30	Not Available	52	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A128	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A128-R5880	a8fd3954-09d3-4dd2-8fa4-4e734dc2918b	1	7	308	263	Not Available	12	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2002
TCGA-E2-A154	FEMALE	591	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	591			TUMOR FREE				68	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A154	24e39609-9645-43e5-960b-db5446eaea65	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	7	-24999	Not Applicable	0	325	Not Available	NO	TCGA-E2-A154-D18941	A19AD7AA-E6A9-40A8-A357-65677967265C	Not Available	8	Not Available	325	arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A154-F18940	640B6B5F-8868-48C5-BB54-8BCAD1124002				8		Not Available	Not Applicable	591		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A154	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A154-R18943	0161D7CC-AED1-4B99-B6DC-36967E820C26	1	8	77	32	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-E9-A22G	FEMALE	1239	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1239			TUMOR FREE				47	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A22G	56033839-35d5-4d72-8b8c-400cb345263d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	YES	2	-17300	Not Applicable	0	0	Not Available	NO	TCGA-E9-A22G-D29941;TCGA-E9-A22G-D29940	ABA87C32-53D8-46A3-913D-B4D47AD62165;7E19BC38-8238-4EC8-ABE3-5F5165B0FEBD	Not Available;Not Available	30;30	170;136	31;14	Cyclophosphane;Doxorubicin	Not Available;Not Available	3;3	6;6	800;80	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3200;320	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A22G-F29939;TCGA-E9-A22G-F62594	EB1E348F-175B-4412-8994-A50BF74DCD2A;B265DE44-B99C-489D-BD86-D6AE6272402E				30;21		Not Available;None	Not Applicable;Not Applicable	715;1239		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;7	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2014;2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A22G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AC-A23G	FEMALE	2248	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N1	MX	Stage IIA	0	2248			TUMOR FREE				76	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-AC-A23G	A721DAC6-0126-476C-B2D4-2DBF7406454B	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	14	-27934	Not Applicable	0	330	Not Available	NO	TCGA-AC-A23G-D43243;TCGA-AC-A23G-D43244;TCGA-AC-A23G-D43245;TCGA-AC-A23G-D43246	10502588-843C-4F06-BCB5-FC3640306A2F;AD503E66-08BD-4F4E-877D-4D9D499AB832;24D15948-49E0-4B96-870D-492C786C0937;8C1BBA20-CDAA-4C57-BAE6-BF46E12CFDE0	Not Available;Not Available;Not Available;Not Available	15;15;15;15	190;190;220;Not Available	109;109;190;237	Cytoxan;Adriamycin;Taxol;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available					TCGA-AC-A23G-F43241	CBABBD3D-7093-4CB3-9F87-A561F537C731				15			Not Applicable	2248																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	2	Not Available	No	A23G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	80-89%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1	T1c	Right Total Mastectomy and Sentinel Node Biopsy	NO	YES	AC	Breast	Not Applicable	Alive	2011	2006
TCGA-AC-A62Y	FEMALE	530	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	MX	Stage IIB	0	530			TUMOR FREE				79	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A62Y	05AF737D-89AA-49B6-97B2-28B8AC8BD2CF	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	19	-28876	Not Applicable	0	55	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A62Y-F65833	566B4F48-EA89-45EB-B57F-28D307B98C2C				30			Not Applicable	530																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A62Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	80-89%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2012
TCGA-A7-A3IY	FEMALE	345	Mucinous Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	345			TUMOR FREE				71	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A7-A3IY	6B4E0262-F589-4532-B578-9F2D76C19D90	Negative	Positive	Not Available	Not Available	Not Available	Lumpectomy	Positive	Lumpectomy	Not Applicable	NO	19	-26042	Not Applicable	0	151	Not Available	NO	TCGA-A7-A3IY-D33857	C48F9151-4B8D-4590-AE3F-C0FD5C568755	Not Available	20	Not Available	151	Anastrozole	Not Applicable	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A7-A3IY-F33856	BC3680DF-06D0-4445-9DB2-63B4EC299C1C				20		Not Available	Not Applicable	345		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A3IY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A3IY-R29468	E359F454-990F-4308-983F-6F88ECAB2FF3	1	19	116	70	Not Available	3	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2011
TCGA-EW-A2FV	FEMALE	788	Other, specify	Breast	Alive	T3	N3a	MX	Stage IIIC	0	788			TUMOR FREE				39	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A2FV	F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A	Negative	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	5	-14316	Not Applicable	0	239	Not Available	NO	TCGA-EW-A2FV-D32327;TCGA-EW-A2FV-D32328;TCGA-EW-A2FV-D32329;TCGA-EW-A2FV-D32330;TCGA-EW-A2FV-D32331	A38929AB-8A68-468D-ADE5-A9CA41F35D39;1E9A1A88-0C4F-4990-8144-7C1499F9CFE3;B03E11F1-B000-4AF8-867B-BBAA82017EFD;A6AB155D-A721-4195-B5D4-0D2C98677EBE;A0359D0A-8675-430D-B394-9D12D035767C	Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;23	246;246;246;Not Available;Not Available	141;141;141;268;268	Docetaxel;Doxorubicin;Cyclophosphamide;Tamoxifen;Goserelin	Unknown;Unknown;Unknown;Not Applicable;Not Applicable	5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-EW-A2FV-F32324;TCGA-EW-A2FV-F42065	A772DDD5-FD35-4692-BB42-38E76B8D5016;54F63442-7AE5-4512-B4D8-853D2F27707A				23;10		Not Available;None	Not Applicable;Not Applicable	428;788		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	5;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	invasive micropapillary ductal carcinoma	No	C50.9	8507/3	C50.9	3+	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	32	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	29	Not Available	No	A2FV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A2FV-R32325	F344EF8E-08CC-4FBD-B10F-ED74909B2EDD	1	23	391	329	Not Available	5	30	9700	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T3	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2011
TCGA-A2-A0T4	FEMALE	624	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	624			TUMOR FREE				62	Right Upper Inner Quadrant	Other (specify)	SLN and non-SLN biopsy	TCGA-A2-A0T4	b0f8d698-a30e-4d8d-b0a2-a5a01fac8406	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	17	-22849	Not Applicable	0	395	Not Available	Not Available	TCGA-A2-A0T4-D3991	c3b20047-64e2-4f31-b600-d2eb3c74c467	Not Available	17	Not Available	85	Femara	Not Available	11	Not Available	2.5	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0T4-F13948	43B17021-D7A9-468C-8D2B-2554DDEBFC47				12		Not Available	Not Applicable	624		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	0	No	A0T4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-D8-A147	FEMALE	584	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0		0	584			Not Available				45	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A147	fc18d029-9be2-4fa0-9aef-6d647dc55f0b	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	27	-16736	Not Applicable	0	2	Not Available	Not Available	TCGA-D8-A147-D20738;TCGA-D8-A147-D64911;TCGA-D8-A147-D64912;TCGA-D8-A147-D64913	A5E59A9B-F5F1-45A0-B6D1-DB44F0A7168B;CEB8DA00-D300-4AFB-BE1C-2BD15BF0E020;C92110BF-B562-4AFE-A419-2217BD718E8F;063BD28B-E3D7-44D7-BEA3-38407B9852F0	Not Available;Not Available;Not Available;Not Available	14;15;15;15	135;135;135;135	21;21;21;21	doxorubicine;cyclophosphamide;paclitaxel;docetaxel	Not Available;Not Available;Not Available;Not Available	1;9;9;9	5;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	Not Available;NO;NO;NO	2012;2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A147-F20737	6B778912-AC2E-4C50-A3F5-4D28049BE764				14		Not Available	Not Applicable	584		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Hercep Test  TM Dako	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	1	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A147	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A147-R20739	C093FF02-9F16-4B3D-89AA-4760FC8CA1DC	Not Available	14	223	188	Not Available	1	1 brachy+25	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A0RS	FEMALE	3063	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	1	2041.0	Other, specify	New Primary Tumor	WITH TUMOR				38	Left Lower Inner Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RS	9416ff9b-6f29-4554-b04d-b537a3ae3969	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	2	-14134	3063	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	YES		TCGA-B6-A0RS-F13788	3B180A84-15DE-49BC-8E60-E6E97CD0EE18				12		2041	3063	Not Available		2041				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	7	Other, specify	New Primary Tumor	Breast	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	15	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0RS	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1988
TCGA-BH-A1F0	FEMALE	785	Infiltrating Ductal Carcinoma	Breast	Dead	T1a	N1c	M0	Stage IIA	0	785			WITH TUMOR				80	Left	Not Available	Not Available	TCGA-BH-A1F0	21ef1730-e5a7-47ce-b419-d000bb59ae15	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Indeterminate	Modified Radical Mastectomy	Not Applicable	Not Available	7	-29335	785	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	9	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1F0	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1c	T1a	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2000
TCGA-D8-A1X6	FEMALE	541	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2a	MX	Stage IIIA	0	541			TUMOR FREE				80	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1X6	42e47f3a-dff7-41e4-8f84-146d97e8ab72	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	9	-29256	Not Applicable	0	236	Not Available	NO	TCGA-D8-A1X6-D29982	4AC37B69-6DC4-4880-9775-F6A571022CB5	Not Available	31	Not Available	65	tamoxifen	Not Available	3	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1X6-F29980	98F6BFFF-5DE5-4EBE-A1E8-B4C971C5155C				31		Not Available	Not Applicable	541		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	5	Not Available	No	A1X6	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T3	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A1F2	FEMALE	959	Infiltrating Ductal Carcinoma	Breast	Dead	T4b	N1b	M0	Stage IIIB	0	959			TUMOR FREE				53	Left	Not Available	Not Available	TCGA-BH-A1F2	6a2972e3-cca9-47e5-aac0-b770f2399eeb	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	7	-19701	959	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8541/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	19	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	6	Not Available	No	A1F2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T4b	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-E2-A106	FEMALE	2541	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IB	0	2541			TUMOR FREE				34	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A106	87e09544-eddb-473b-8617-212407ce644e	Negative	Positive	Not Available	Not Available	Not Available	Other	Positive	Simple Mastectomy	inner-upper margin re-excision	NO	11	-12528	Not Applicable	0	1555	Not Available	Not Available	TCGA-E2-A106-D7753;TCGA-E2-A106-D7751	d99bb0ba-6f4a-424f-ad5f-6ec86deec9b5;da3db900-ed98-41e6-9c1e-6cdde2b53b91	Not Available;Not Available	14;14	Not Available;Not Available	883;883	Zoladex;Tamoxifen	Not Available;Not Available	2;2	Not Available;Not Available	3.6;20	mg;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	SC;PO	YES;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	3.6;Not Available	mg;Not Available	Not Available;Not Available	2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A106-F17181;TCGA-E2-A106-F70397	453994A4-28A8-43A0-B4F2-4D4F5A37984A;86E020FA-8617-4BFB-855C-06DA3C5ECFD9				28;17		Not Available;None	Not Applicable;Not Applicable	1807;2541		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	9;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;Unknown			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	1.05	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	16	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	Not Available	No	A106	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80-89%	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2006
TCGA-D8-A1JI	FEMALE	577	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	MX	Stage IIA	0	577			TUMOR FREE				54	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JI	baf2afc8-f16c-488f-947c-efc9083c6bef	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	30	-20072	Not Applicable	0	21	Not Available	Not Available	TCGA-D8-A1JI-D20756;TCGA-D8-A1JI-D65326;TCGA-D8-A1JI-D65327	47A735BC-1929-456F-A0AB-F5026052E183;48F56CD7-78CE-4306-8B6C-236C717C7B5B;48CDB206-6F2C-4B85-AD7B-E40F9B481D47	Not Available;Not Available;Not Available	19;22;22	162;162;162	41;41;41	doxorubicine;cyclophosphamide;letrozolum	Not Available;Not Available;Not Available	1;9;9	6;Not Available;Not Available	2.5;Not Available;Not Available	mg/m2/day;Not Available;Not Available	ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;Not Available;Not Available	Not Available;NO;NO	2012;2014;2014	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JI-F20757	64833FD0-E1B5-4773-8638-1E41D0B9B4F0				19		Not Available	Not Applicable	577		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	DAKOHercepTest TM	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A1JI	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-D8-A1JI-R20755	A5565D0D-C16A-4574-BE2A-7D4C24927E76	Not Available	19	231	204	Not Available	1	20	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A0I5	FEMALE	8556	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1b	M0	Stage IIB	0	8556			TUMOR FREE				49	Right Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0I5	1a18974d-967c-4727-b42e-12ae7be66589	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	2	-18038	Not Applicable	0	4550	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0I5-F12603;TCGA-B6-A0I5-F71505	8632E268-43BE-49FF-8314-3522D6CAF767;D037DF28-A91C-4F37-9DAE-68F9CB4A367E				1;26		Not Available;None	Not Applicable;Not Applicable	4550;8556		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	13	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	5	Not Available	No	A0I5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	biopsy	NO	YES	B6	Breast	Not Applicable	Alive	2010	1988
TCGA-A2-A0ES	FEMALE	2190	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2190			TUMOR FREE				52	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0ES	a2934508-3daf-49e2-b14f-ed9b7693f96f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	25	-19160	Not Applicable	0	1001	Not Available	Not Available	TCGA-A2-A0ES-D6684;TCGA-A2-A0ES-D6683;TCGA-A2-A0ES-D6682;TCGA-A2-A0ES-D6685	08fef96e-bb08-4bf3-ad02-6018935a8f47;6ea08fed-b015-4b7a-9ab3-d4beda0a721e;6c50633b-c480-4794-b943-a834c0c12463;410e1f53-15e7-4ae7-9d01-2fee31ecd2f6	Not Available;Not Available;Not Available;Not Available	7;7;7;7	458;141;141;Not Available	203;77;77;459	Anastrozole;Docetaxel;Cytoxan;Exemestane	Not Available;Not Available;Not Available;Not Available	1;1;1;1	Not Available;4;4;Not Available	1;160;1180-1280;25	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;2;1;4	PO;IV;IV;PO	NO;NO;NO;YES	Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;640;5018;Not Available	Not Available;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0ES-F13718;TCGA-A2-A0ES-F59395	C9932931-F12D-40AD-BF47-AB513F33CA9B;478BA8B4-7059-4636-9A1A-07F93335C426				10;12		Not Available;None	Not Applicable;Not Applicable	1127;2190		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.32	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	0	No	A0ES	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2008
TCGA-E9-A1N8	FEMALE	1039	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1039			TUMOR FREE				48	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1N8	ac075bc0-1b59-4557-beea-541694faee03	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	NO	23	-17652	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1N8-D29135;TCGA-E9-A1N8-D29137;TCGA-E9-A1N8-D29138	3D42D744-34FF-4E25-862B-1766D65AE0A2;D95B794D-470B-454C-AD92-C20080A5BB02;6D5C845C-F385-41B2-ABCB-2CC309BAA5DF	Not Available;Not Available;Not Available	9;9;9	107;107;107	22;22;22	Doxorubicin;5-Fluorouracil;Cyclophosphane	Not Available;Not Available;Not Available	3;3;3	4;4;4	80;800;800	mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	320;3200;3200	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1N8-F29134;TCGA-E9-A1N8-F53518	F1F2BA48-146B-4F38-B7BF-DBB528AC689B;F4D07D12-E2E7-45AA-A24F-D15D9A955DF7				9;12		Not Available;None	Not Applicable;Not Applicable	365;1039		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1N8	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A4SA	FEMALE	454	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	454			TUMOR FREE				40	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A4SA	A2EFE7E1-ACA3-440F-825F-ED621EDCA69F	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	19	-14906	Not Applicable	0	241	Not Available	Not Available	TCGA-A7-A4SA-D40422;TCGA-A7-A4SA-D40423;TCGA-A7-A4SA-D40424;TCGA-A7-A4SA-D40425	D1394A9B-E263-4C3E-9B21-9C7C7A27F4DD;90ABC9E4-87E8-4C1B-A001-A9A02F4B7AAB;6BB3CF2B-3286-4031-A91D-48803A014612;625C328C-CA7E-445E-A8AB-B77D5CC49C4A	Not Available;Not Available;Not Available;Not Available	19;19;19;19	115;115;213;Not Available	73;73;136;217	Doxorubicin;Cyclophosphamide;Paclitaxel;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	2;2;2;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES	2013;2013;2013;2013	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A4SA-F49560	8EE2B4A8-14AD-4A21-9746-83D9A7F27F14				3			Not Applicable	454																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	0	No	A4SA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-E2-A570	FEMALE	931	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IB	0	931			TUMOR FREE				47	Right Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A570	CDD8C046-FD97-482A-A11F-2217B321C4D1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	21	-17456	Not Applicable	0	549	Not Available	Not Available	TCGA-E2-A570-D44535	569DEEF9-63F5-49E8-8D2F-AC6BA220410F	Not Available	21	Not Available	252	Anastrozole	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Allred 7 = 5+2	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	2.0					TCGA-E2-A570-F61335	D033E907-A771-48E7-AC23-E1DC385C5CD1				27			Not Applicable	931																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	200	Not Available	2.2	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A570	TUMOR FREE	Allred 8 = 5+3	Not Available	Not Available	Allred Score	Allred Score	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2013	2011
TCGA-BH-A0C3	FEMALE	2709	Mixed Histology (please specify)	Breast	Alive	T1c	N0	M0	Stage I	1	2674.0	Bone	Distant Metastasis	TUMOR FREE				47	Left	Not Available	Not Available	TCGA-BH-A0C3	7bcf6d42-eb8f-4aa2-825b-38671d4f9e3a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	11	-17221	Not Applicable	0	1464	Not Available	NO	TCGA-BH-A0C3-D63540;TCGA-BH-A0C3-D63541	4DF39809-E3F7-4075-A18D-2883605F6B37;0540668E-ECBB-43B1-AEE3-51C9F20C42B1	Not Available;Not Available	12;12	209;209	109;109	Adriamycin;Cytoxan	Clinical Progressive Disease;Clinical Progressive Disease	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-BH-A0C3-F63533	823D487F-FD80-4797-A129-C63FDF8002BC				12			Not Applicable	2709																				NO																						8					Not Available	Not Available	Not Available	2674	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Bone	Distant Metastasis	Not Available	Not Available	Not Available	YES	WITH TUMOR						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	with ductal and lobular phenotypes	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0C3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0C3-R63542	22C40DCA-0F16-42B4-A28F-29FEAC78B565	Not Available	12	262	209	Radiographic Progressive Disease	8	34	6640	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Segmental mastectomy with sentinel node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-D8-A1XW	FEMALE	1309	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1309			TUMOR FREE				53	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-D8-A1XW	887b9e5b-99db-44ac-9c30-c0dc6877b41c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-19478	Not Applicable	0	118	Not Available	NO	TCGA-D8-A1XW-D29460	DBD8AFC3-3C19-4ED7-A10C-F38A65FC6B47	Not Available	19	181	76	adriamycin+cyclophosphamide	Not Available	3	6	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	360+3600	mg	Not Available	2012	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-D8-A1XW-F29459;TCGA-D8-A1XW-F72205	372FDE60-88B9-4D07-8F10-9929A463945A;46CA0608-FFCA-4EEC-AA1E-7739ADCAD4C2				19;29		Not Available;None	Not Applicable;Not Applicable	385;1309		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1XW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	0%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A09C	FEMALE	31	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage X	0	31			Not Available				69	Right	Not Available	Not Available	TCGA-A8-A09C	80f3f48a-cc21-415c-b181-c77e7ba1c563	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-25355	Not Applicable	0	31	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A09C	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Surgical resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A1EW	FEMALE	1694	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIA	0	1694			WITH TUMOR				38	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1EW	9d166970-07c8-4ca3-9cfa-ed0049df9ecc	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	7	-14090	1694	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	16	Not Available	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1EW	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Left segmental mastectomy with level 1 and level 2 axillary dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-A2-A0T0	FEMALE	533	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	533			TUMOR FREE				59	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0T0	95c53f69-0f05-4348-822a-571f3d757001	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	12	-21575	Not Applicable	0	337	Not Available	Not Available	TCGA-A2-A0T0-D3430;TCGA-A2-A0T0-D3434;TCGA-A2-A0T0-D3432	7b30d8b7-1a91-4f14-93d1-1d690c083a3a;d86d4e6c-4305-493c-b8bf-968971f358c9;e011bb8b-77b8-4daa-9bea-75f9c039e676	Not Available;Not Available;Not Available	12;12;12	234;234;234	50;50;50	Taxotere;Cytoxan;Adriamycin	Not Available;Not Available;Not Available	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;3;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0T0-F13944	B0DC7631-8558-431C-B56D-B8C9C74C29F5				18		Not Available	Not Applicable	533		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	2	Not Available	No	A0T0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0T0-R3435	216a63e4-215a-4fc7-a5ea-e50076307b40	1	12	323	262	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-A2-A3XV	FEMALE	996	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	996			TUMOR FREE				46	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A3XV	189E1F27-7738-413A-A4D4-97D41D592A13	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	24	-16971	Not Applicable	0	428	Not Available	Not Available	TCGA-A2-A3XV-D34630;TCGA-A2-A3XV-D34631;TCGA-A2-A3XV-D34632;TCGA-A2-A3XV-D34633	71D050BF-7E93-4BA7-B969-F1887FC94B89;7CF49A37-54D6-47C1-B0FA-F3732990E8A2;212FE1BA-E2B8-435A-91E6-5BC6F1B03C9B;660D3D61-D8EE-44B2-8CE3-F93CB2202075	Not Available;Not Available;Not Available;Not Available	24;24;24;24	175;175;428;Not Available	62;62;62;429	Carboplatin;Docetaxel;Trastuzumab;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.7					TCGA-A2-A3XV-F43306;TCGA-A2-A3XV-F59117	F58B3842-7B71-4CD6-B9D5-605951079187;057E80F7-F449-4E70-8571-4D0D06A94C23				16;1			Not Applicable;Not Applicable	699;996																				NO;NO																						5;5					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	60	Not Available	4.5	2.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A3XV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field;Primary Tumor Field	TCGA-A2-A3XV-R34634;TCGA-A2-A3XV-R34635	F2E7F201-0A1D-4AD5-B148-EA69A1294BA6;EFC36FA5-0568-4B56-8EFF-E56B96239F74	Not Available;Not Available	24;24	246;258	211;247	Complete Response;Complete Response	8;8	25;5	50;10	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2012	2011
TCGA-EW-A1PE	FEMALE	320	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	320			TUMOR FREE				56	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A1PE	f3b86c02-09a5-4e97-aa7a-86f13f7cda4b	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	27	-20694	Not Applicable	0	107	Not Available	NO	TCGA-EW-A1PE-D30264;TCGA-EW-A1PE-D30263;TCGA-EW-A1PE-D30262;TCGA-EW-A1PE-D30702;TCGA-EW-A1PE-D30261	9419C58F-6F5C-443B-A471-E46D727005DE;DD378684-5C18-47DC-902E-D3280283DAAB;9592447F-C6E8-43AF-8E6D-A30F6ED75544;9A2FDA20-E99F-42D4-B233-C6EBD504545D;12C9B1C5-FC49-432B-BDD4-5492291120CA	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	174;111;111;Not Available;111	132;71;71;269;71	Taxotere;Fluorouracil;Cyclophosphamide;Exemestane;Epirubicin	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	3;3;3;Not Available;3	200;200;1000;25;1000	mg;mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	FEC then T;FEC then T;FEC then T;2;FEC then T	IV;IV;IV;PO;IV	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	603;598;2990;Not Available;2990	mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PE-F29108	24F4F0FF-7280-401C-AA8D-816162986D9B				8		Not Available	Not Applicable	320		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8507/3	C50.9	3+	YES	Not Available	Discrepancy	Negative	Not Evaluated	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A1PE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1PE-R30266	E51F4CA1-EFA3-4660-BE2F-4A2E464A2496	1	8	269	208	Not Available	3	25	10,500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2011
TCGA-AN-A0FY	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	10			TUMOR FREE				55	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A0FY	de75d0b9-0f47-4732-8df5-05c350cfcd32	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	29	-20347	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FY-F68968	B6587F06-C3D0-4336-8B60-9DFAC3C4898A				24			Not Applicable	10																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FY	TUMOR FREE	Not Available	Not Available	Not Available	110	80	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-AC-A3TN	FEMALE	456	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	456			TUMOR FREE				75	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A3TN	81B70C58-4A12-448C-A594-2ADE44F6A0AE	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	1	-27421	Not Applicable	0	34	Not Available	NO	TCGA-AC-A3TN-D60192	66521E70-01FD-49E2-B58C-E2A9B05E4F2C	Not Available	31	Not Available	55	Arimidex	Not Applicable	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3TN-F60190	DF2E666E-E3D8-430F-8006-49177FDA1884				31			Not Applicable	456																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Unknown	Other method, specify:	Positive	Indeterminate	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A3TN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A3TN-R60191	F59786E2-ADDA-4D6F-AD25-572BB54CEA1E	Not Available	31	144	96	Complete Response	5	Not Available	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2012
TCGA-BH-A0C7	FEMALE	2767	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	M0	Stage IIB	0	2767			TUMOR FREE				48	Left	Not Available	Not Available	TCGA-BH-A0C7	e1119732-3e97-4259-bc69-dc4269d9496d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	11	-17871	Not Applicable	0	1305	Not Available	NO	TCGA-BH-A0C7-D59179;TCGA-BH-A0C7-D59180;TCGA-BH-A0C7-D59181	716C77CF-18B0-4B77-BE11-C5B4B61DFCED;34A1744E-AFE4-4ECB-A86D-0AA9F44D0ABF;04AB53D8-4D37-4845-B139-414A9D08CFC3	Not Available;Not Available;Not Available	2;2;2	113;113;113	50;50;50	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0C7-F59178	DE59E19C-C2B2-44A8-A313-696DFCDB91EE				2			Not Applicable	2767																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Positive	18	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	Not Available	No	A0C7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-B6-A0IC	FEMALE	0	Other, specify	Breast	Dead	T2	NX	MX	Stage X	0	0			Not Available				90	Right	No axillary staging	Not Available	TCGA-B6-A0IC	b804f7ae-da8f-4414-be11-f880f1859160	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	2	-32872	0	0	Not Available	Not Available	Not Available																								IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0IC-F12613	CF95FD2E-C76A-41EB-9F33-EBE7067B8203				1		Not Available	0	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Invasive Papillary	No	C50.9	8503/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Available	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	Not Available	Not Available	No	A0IC	Not Available	IHC	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	3rd	Not Applicable	Not Applicable	Not Available	MX	NX	T2	Excisional biopsy	NO	YES	B6	Breast	Not Applicable	Dead	2010	1992
TCGA-EW-A6S9	FEMALE	463	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	M0	Stage IIA	0	463			TUMOR FREE				34	Right;Right Upper Outer Quadrant	Not Available	Not Available	TCGA-EW-A6S9	9676E46B-8F29-43CD-AB65-EB6A535CCED4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	13	-12755	Not Applicable	0	463	Not Available	Not Available																								Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-EW-A6S9-F71706	873F23EE-D1B9-48B8-B112-C6CE519DD5AF				30			Not Applicable	463																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2015	FEMALE	Not Available	Not Available	50-59%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	1	No	A6S9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Not Available	Not Available	Not Available	EW	Breast	Not Applicable	Alive	2015	2013
TCGA-AR-A1AT	FEMALE	1272	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	1272			Not Available				62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AT	4d26dada-5eb7-4d4e-8eb8-f5465c5c3428	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	14	-22942	1272	0	Not Available	Not Available	Not Available	TCGA-AR-A1AT-D22153;TCGA-AR-A1AT-D22152;TCGA-AR-A1AT-D22150	46749B9C-613A-40A5-B0CB-44978EEF1A91;022F99BE-9A3B-44EF-94DE-B304CF259B65;63B8C39E-9EA4-4B8E-9431-A97DAA709EB4	Not Available;Not Available;Not Available	1;1;1	1272;Not Available;Not Available	174;Not Available;Not Available	Anastrozole;Trastuzumab;Not otherwise specified	Not Available;Not Available;Not Available	3;3;3	Not Available;Not Available;Not Available	1;Not Available;Not Available	mg/day;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;2;1	PO;Not Available;Not Available	NO;NO;NO	Hormone Therapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A1AT-F22148	D7B56DE8-A5E4-4524-80B2-C2260F0A0054				1		Not Available	1272	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		YES	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1AT	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Not Available	TCGA-AR-A1AT-R22149	53C226CF-2609-447A-8D85-B49B4E12C7ED	Not Available	1	Not Available	Not Available	Not Available	3	Not Available	Not Available	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Dead	2011	2007
TCGA-BH-A0B6	FEMALE	2483	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	2483			TUMOR FREE				47	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0B6	FA4E082A-D213-412E-8D91-842A6F4BEF12	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	4	-17346	Not Applicable	0	1732	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0B6-F61943	DBFF7E03-09CD-4687-B14C-277D6E8073C5				10			Not Applicable	2483																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Available	4	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	Yes	A0B6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0B6-R61948	8CC21685-71B7-44DA-8672-63853A6F8706	Not Available	10	143	94	Complete Response	7	36	6640	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-BH-A0BT	FEMALE	2365	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IIA	0	2365			TUMOR FREE				56	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A0BT	a32cb96a-78bf-456e-a6ab-2d47b2c67ad4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	2	-20625	Not Applicable	0	1386	Not Available	NO	TCGA-BH-A0BT-D59146;TCGA-BH-A0BT-D59148	162F9144-80E7-4C0F-BF74-1D23DDE80EF5;857A1D7C-790E-4A2E-9420-9E23B1F2B32F	Not Available;Not Available	1;1	139;139	97;97	Adriamycin;Cytoxan	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BT-F59143	539EDB85-18FF-4D9F-B1C5-F1C962551945				1			Not Applicable	2365																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	Not Available	Not Available	No	A0BT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BT-R59144	9C01B233-7499-4880-BDBF-74AE44ED26D6	Not Available	1	227	167	Complete Response	5	36	66.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	segmental mastectomy with sentinel lymph node excision and biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-BH-A1ET	FEMALE	2520	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N0	M0	Stage I	0	2520			TUMOR FREE				55	Left	Not Available	Not Available	TCGA-BH-A1ET	8986a141-eae7-4157-b695-02cc6fc3b071	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	7	-20425	2520	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	19	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1ET	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Left segmental mastectomy with left axillary lymph node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-E9-A1RG	FEMALE	647	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2	M0	Stage IIIA	0	647			TUMOR FREE				62	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RG	8744733a-7b46-43aa-bdef-64876816adbb	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	2	-22788	Not Applicable	0	35	Not Available	NO	TCGA-E9-A1RG-D30645;TCGA-E9-A1RG-D30651;TCGA-E9-A1RG-D30644;TCGA-E9-A1RG-D30646;TCGA-E9-A1RG-D30649;TCGA-E9-A1RG-D30647;TCGA-E9-A1RG-D30652;TCGA-E9-A1RG-D30643;TCGA-E9-A1RG-D30650	F5810F71-8A39-45E8-B825-FFD43A8B53F6;17A6D8A3-3C52-47CE-9472-6B5586F2A692;7AAD1A06-8D8C-4EF1-8A1A-EF566C06B16B;9DC27C00-1D63-4E9D-A801-199B11EBABFF;6E4EA79B-DDD5-42BE-A154-8BD0E469C04B;5BFAE4C4-9F95-4703-828F-E55740F9BD7A;679A17F2-BFCD-4260-AE16-9D5E95B41D3A;AD8B41A3-608E-459B-8F60-B4B600921860;E1E678C3-0EE1-4950-BB4A-001B9FD2F4B9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13;13	200;200;200;200;200;200;Not Available;200;200	32;32;32;32;32;32;31;32;32	Methotrexate;Cyclophosphamide;5-Fluorouracil;Methotrexate;Cyclophosphamide;Methotrexate;Tamoxifen;5-Fluorouracil;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4;4	2;4;4;2;1;2;Not Available;2;1	100;1000;1000;70;2000;50;20;2000;1600	mg;mg;mg;mg;mg;mg;mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;PO;IV;IV	NO;NO;NO;NO;NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	200;4000;4000;140;2000;100;Not Available;4000;1600	mg;mg;mg;mg;mg;mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1RG-F30642;TCGA-E9-A1RG-F39534	89106DE0-F716-4415-8769-8B80305655DA;8AF68D77-E97C-4EA0-9609-FE1BC59C0186				24;24		Not Available;None	Not Applicable;Not Applicable	647;647		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;1	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2014;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	4	Not Available	No	A1RG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1RG-R30653	E189A27D-B536-4D3F-A1D3-7E38373AB1A7	1	13	177	149	Not Available	4	45	9000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-XX-A89A	FEMALE	488	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	488			TUMOR FREE				68	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-XX-A89A	CA20249F-B7EA-4FD9-9ECB-34F74755AE35	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	21	-25000	Not Applicable	0	278	Not Available	Not Available																								Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-XX-A89A-F67425	1807302C-1D1D-4F80-82EE-65C4D14723B7				11			Not Applicable	488																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A89A	TUMOR FREE	Not Available	Not Available	Not Available	moderately to strongly	moderately to strongly	NO	YES	70-79%	WHITE	YES	Primary Tumor Field;Regional site	TCGA-XX-A89A-R67377;TCGA-XX-A89A-R67428	D5D20F81-441E-41AB-AA19-72DF8214A047;2D465698-646A-4347-BBC1-1C97FF34D940	Not Available;Not Available	11;11	112;112	59;59	Complete Response;Complete Response	11;11	10;18	1800;3240	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	NO	YES	XX	Breast	Not Applicable	Alive	2014	2013
TCGA-GM-A2DN	FEMALE	3091	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3091			TUMOR FREE				58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-GM-A2DN	56BBD282-B88D-4730-9242-AB97D08DC83A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	30	-21288	Not Applicable	0	2352	Not Available	NO	TCGA-GM-A2DN-D47126;TCGA-GM-A2DN-D47127;TCGA-GM-A2DN-D47128;TCGA-GM-A2DN-D47129;TCGA-GM-A2DN-D47130	2F3C7A0D-A528-4393-8A8C-E4BA2A55F39A;23F229E0-8687-49C9-A84B-FF6D954A025E;F64D6F34-B6B3-4B1A-88DE-96B8C8A07835;9CB21DFD-9BDD-4A32-A8A7-1E5F2519AC34;F102C2E8-AC64-42D3-8420-DD1DF9F856C0	Not Available;Not Available;Not Available;Not Available;Not Available	22;22;22;22;22	244;314;314;314;1063	167;251;251;251;335	Taxol;Fluorouracil;Epirubicin;Cytoxan;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response	8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;NO	2013;2013;2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A2DN-F47124	8C417396-011E-4C2E-B08C-42A8A47EA1D7				22			Not Applicable	3091																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2DN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2004
TCGA-A8-A06P	FEMALE	396	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	396			TUMOR FREE				63	Right	Not Available	Not Available	TCGA-A8-A06P	5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-23011	Not Applicable	0	396	Not Available	Not Available	TCGA-A8-A06P-D37894;TCGA-A8-A06P-D37895	5069E310-A864-427D-819F-D2601933A155;31453368-BCF6-42B5-AAC7-78DADCD6A50B	Not Available;Not Available	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Tamoxifen	Unknown;Unknown	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A06P-F40814	F2C11286-6956-4C14-9C00-EE235CF900A8				2			Not Applicable	396																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06P	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A06P-R38190	32B9AD47-AE11-4A7B-B3A9-67D64A1A732F	Not Available	11	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A6R8	FEMALE	293	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	293			TUMOR FREE				46	Left	Not Available	Not Available	TCGA-BH-A6R8	91B09291-5944-4691-A0D8-7D1CCC649B9B	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	13	-16829	Not Applicable	0	293	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A6R8-F63677	DF7231E8-9032-4F1E-88AE-B322DE8EDCFD				15			Not Applicable	293																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	4	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6R8	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-BH-A6R8-R56589	03ACA3BC-B3FB-419B-91CF-87F71BB7189B	Not Available	13	253	194	Complete Response	2	Not Available	61	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2014	2012
TCGA-5T-A9QA	FEMALE	303	Other, specify	Breast	Alive	T2	NX	MX	Stage IIA	0	303			Unknown				52	Left	No axillary staging	Not Available	TCGA-5T-A9QA	2FD36838-5A83-433E-AC80-B1F77448E5AA	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Negative	Unknown	Not Applicable	NO	23	-19031	Not Applicable	0	12	Not Available	Not Available	TCGA-5T-A9QA-D66890;TCGA-5T-A9QA-D66891;TCGA-5T-A9QA-D66892;TCGA-5T-A9QA-D66893	41E877E4-A74A-4E15-A061-03DAFF7922A1;906BC4D2-3C18-42A8-ABE2-BF47933ABA1F;70C5FF1B-00BC-47E3-BD00-A0923F47645F;DCD07D88-6185-4E6B-B95A-FCBE7B9ECDDB	Not Available;Not Available;Not Available;Not Available	25;25;25;25	94;Not Available;198;94	23;304;115;Discrepancy	Adriamycin;Letrozole;Taxol;Cytoxan	Complete Response;Not Available;Not Available;Complete Response	10;10;10;10	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;YES;NO;NO	Not Available;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-5T-A9QA-F66889	5041DB15-D0C3-4364-8D32-850CD958C0BB				25			Not Applicable	303																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	infiltrating ductal and mucinous	No	C50.9	8523/3	C50.9	2+	YES	Not Applicable	Excisional Biopsy	Equivocal	Negative	Not Available	Unknown	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A9QA	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	NO	Not Available	BLACK OR AFRICAN AMERICAN	Unknown	Primary Tumor Field	TCGA-5T-A9QA-R66894	C8E7F188-6E0A-469B-9BF2-4432E605A7EE	Not Available	31	277	227	Unknown	10	35	6440	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	NX	T2	Not Available	YES	NO	5T	Breast	Not Applicable	Alive	2013	2013
TCGA-A2-A0YT	FEMALE	723	Infiltrating Ductal Carcinoma	Breast	Dead	T4b	N2a	M0	Stage IIIB	0	723			TUMOR FREE				56	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0YT	14b95463-2108-4921-afc2-e29eef52b18f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	10	-20482	723	0	Not Available	Not Available	Not Available	TCGA-A2-A0YT-D5687	5b1e9a0c-a2c4-41f0-a952-c9b39c961f76	Not Available	10	723	286	Arimidex	Not Available	12	Not Available	1	mg	ADJUVANT	Not Applicable	4	PO	NO	Hormone Therapy	Not Available	Not Available	mg	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YT-F15768	11090CD1-89D2-476B-BC1F-AA586743C2A8				30		Not Available	723	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified	Not Available	60	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	5	Not Available	No	A0YT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YT-R5683	2af6a586-e409-4367-a05b-da5e9fd37b28	1	10	280	231	Not Available	12	61	11080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T4b	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2008
TCGA-E9-A22H	FEMALE	1232	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1232			TUMOR FREE				42	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A22H	161917b8-88ad-407b-ade6-d6b98478b359	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	2	-15504	Not Applicable	0	0	Not Available	NO	TCGA-E9-A22H-D29944;TCGA-E9-A22H-D29947;TCGA-E9-A22H-D29946;TCGA-E9-A22H-D29945	F67CF379-4420-4D5D-8FEC-0FD435A79B19;FA024AFC-6558-412D-81F5-3D0FD0A1566B;499F5082-99DF-470D-84D6-9FBBFC024994;88E1A537-55BC-4B26-9B5E-576C51D8AA0A	Not Available;Not Available;Not Available;Not Available	30;30;27;27	226;Not Available;226;226	15;330;15;15	Doxorubicin;Tamoxifen;5-Fluorouracil;Cyclophosphane	Not Available;Not Available;Not Available;Not Available	3;3;11;11	6;Not Available;6;6	90;20;900;900	mg/day;mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3600;130;3600;3600	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A22H-F29943;TCGA-E9-A22H-F40642;TCGA-E9-A22H-F63224	A7CD3C92-FA95-4FCF-8BDE-2480F7E8E4C0;96EF7CF3-8F22-4C87-873C-B9949AF32410;7BF83619-D8BE-48D5-A1F5-A812D36024B4				22;26;4		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	330;630;1232		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	7;2;8	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2014;2013;2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	0	No	A22H	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available	Regional site	TCGA-E9-A22H-R29948	F3897CAB-461B-410A-97F0-4EF8AEBC50BF	Not Available	27	78	78	Not Available	11	20	4000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A8G0	FEMALE	662	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	662			TUMOR FREE				54	Left	Not Available	Not Available	TCGA-BH-A8G0	59D60247-E549-4326-A672-50B05C13A291	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	26	-19975	Not Applicable	0	199	Not Available	Not Available	TCGA-BH-A8G0-D57780;TCGA-BH-A8G0-D57781	D9246CEE-989C-4F55-8C8E-F44C20C26427;1554145F-6AD9-4A57-92CC-2C65179DF840	Not Available;Not Available	26;26	267;267	155;155	Taxotere;Cytoxan	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A8G0-F64200	10DA390E-2291-419B-8B1D-56CD9274E316				27			Not Applicable	662																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	Not Available	No	A8G0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2014	2012
TCGA-A8-A09Q	FEMALE	761	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N2a	M0	Stage IIIB	1				WITH TUMOR				83	Left Lower Inner Quadrant	Not Available	Not Available	TCGA-A8-A09Q	09c2bc35-c21f-4aa4-ac30-0d8db02ad811	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-30528	Not Applicable	0	761	Not Available	Not Available	TCGA-A8-A09Q-D37769	F3220351-3FF6-4231-8B5E-3A27001C00EB	n/a	6	Not Available	31	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09Q-F41022	4B42D5B1-911A-4C69-9E7E-C9578A82AB6B				10			Not Applicable	761																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09Q	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A15J	FEMALE	1640	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1640			TUMOR FREE				51	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15J	1fef9454-b3e8-4d9d-a9aa-aa1f1a32b80c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	13	-18771	Not Applicable	0	464	Not Available	NO	TCGA-E2-A15J-D18893;TCGA-E2-A15J-D18896;TCGA-E2-A15J-D18895	A6C43C80-32E8-4A0D-A6C0-6332C91C8B32;E6213072-8B49-4836-BAAF-DE4685016685;D882E0A2-E3B4-4D0A-ADB8-9D48507E0D7B	Not Available;Not Available;Not Available	15;15;15	128;Not Available;128	65;151;65	Docetaxel;Tamoxifen;Cyclophosphamide	Not Available;Not Available;Not Available	11;11;11	4;Not Available;4	126;20;1008	mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	504;20;4032	mg;mg/day;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A15J-F18892;TCGA-E2-A15J-F70020	AA79264E-5F95-4C32-80C4-910248E78E0D;EA54E7E2-D8FF-48C4-8B88-F15C664136DF				15;9		Not Available;None	Not Applicable;Not Applicable	590;1640		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15J	TUMOR FREE	Not Available	Not Available	Not Available	Allred score = 8	Allred score = 7	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-B6-A1KF	FEMALE	3088	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	3088			TUMOR FREE				68	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-B6-A1KF	f30eb65f-fb44-4062-ac39-a38d072f655f	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	19	-24891	Not Applicable	0	3088	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A1KF-F15739	61E927F2-F19E-4BA3-8DF6-318C8BB8E3A5				29		Not Available	Not Applicable	3088		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	60-69%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	2	Not Available	No	A1KF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Excisional biopsy	NO	YES	B6	Breast	Not Applicable	Alive	2011	1998
TCGA-EW-A1J2	FEMALE	403	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N1mi	MX		0	403			TUMOR FREE				50	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1J2	a381275f-8858-4793-a8a2-0ca9db7274c8	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	27	-18558	Not Applicable	0	140	Not Available	NO	TCGA-EW-A1J2-D21614;TCGA-EW-A1J2-D21615;TCGA-EW-A1J2-D29266	0BA44965-31D8-40C3-B712-C60B3D7BA6E7;D15551D0-9A3A-448E-9FAF-EEB581FFD077;7CC33BB1-6AF2-42C9-9E77-17C799E6CB7E	Not Available;Not Available;Not Available	16;16;13	140;Not Available;140	76;150;76	Taxotere;Arimidex;Cytoxan	Not Available;Not Available;Not Available	2;2;3	4;Not Available;4	135;1;1080	mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	TC;Not Available;TC	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1J2-F21544	D0492C5F-C48F-4FF0-92F1-074003210DFE				6		Not Available	Not Applicable	403		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	1	No	A1J2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T1c	total mastectomy	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A09X	FEMALE	426	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N3a	M0	Stage IIIC	0	426			Not Available				62	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A09X	27b05b15-a44b-45ed-a6e3-e7d1ca488ea9	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-22858	426	0	Not Available	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09X	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Dead	2011	2009
TCGA-E2-A1L6	FEMALE	1648	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IIA	0	1648			TUMOR FREE				44	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A1L6	2e32f31f-9817-4935-b259-96c59936ee33	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	7	-16403	Not Applicable	0	1312	Not Available	NO	TCGA-E2-A1L6-D20571;TCGA-E2-A1L6-D20576;TCGA-E2-A1L6-D20574;TCGA-E2-A1L6-D20572;TCGA-E2-A1L6-D20577;TCGA-E2-A1L6-D20573	2A551287-56B0-41BD-BFD3-1F24A796AAC3;D638F4F1-F401-40B5-B9C4-16792E4F1718;C2F3080E-04F4-408F-945A-184A8E8F53AD;5BDBE33A-381E-477B-B28D-073FCBA0DB9F;ED98E166-5C11-4AE6-82DC-463DE3C00BEE;C239325B-6739-43DD-A6FB-832310B2644B	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10	91;Not Available;1120;91;Not Available;147	49;49;49;49;148;105	Cyclophosphamide;Triptorelin;Clodronate;Doxorubicin;Tamoxifen;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1	4;Not Available;Not Available;4;Not Available;4	935;3.75;1600;95;20;270	mg;mg;mg/day;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;3;1;4;2	IV;IM;PO;IV;PO;IV	NO;YES;NO;NO;YES;NO	Chemotherapy;Other, specify in notes;Other, specify in notes;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Phase III Clinical Trial;Phase III Clinical Trial;Not Available;Not Available;Not Available	3740;Not Available;1600;380;20;1080	mg;Not Available;mg/day;mg;mg/day;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012	allred score 5 + 3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1L6-F20570	78110A92-E50F-46A7-A227-ABEDC2F39EDC				10		Not Available	Not Applicable	1648		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	40-49%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1L6	TUMOR FREE	allred score 5 + 3 = 8	Not Available	Not Available	allred score =  8	allred score = 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-A8-A08R	FEMALE	30	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	30			TUMOR FREE				52	Left	Not Available	Not Available	TCGA-A8-A08R	6412854a-f874-469e-9d1f-8bd3ae5bd41d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-19298	Not Applicable	0	30	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08R	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-A7-A0CD	FEMALE	1165	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	1165			TUMOR FREE				66	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A0CD	09765b0a-94f6-47d2-af56-93368084ac3a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	5	-24242	Not Applicable	0	171	Not Available	Not Available	TCGA-A7-A0CD-D4373	94451533-8be6-41aa-a175-9eaa6aae7381	Not Available	2	Not Available	112	Arimidex	Not Available	12	Not Available	1 mg Daily	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	4.0	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0CD-F3310;TCGA-A7-A0CD-F39827	67DED7B1-E8A4-4E39-A848-1D9113D6382F;131C07DA-8E6A-44E7-898D-DEB2E3D91277	Not Available;None	Not Available;None	Not Available;None	8;4	Not Available;None	Not Available;None	Not Applicable;Not Applicable	372;1165	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;2					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2013	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA Probe Kit	2+	279	Not Available	4.6	1.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	Not Available	Yes	A0CD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0CD-R4383	5258db1e-4a32-4ee1-9be3-24a249424127	1	8	74	70	Not Available	12	10	3400	NO	OTHER	High-dose rate brachytherapy of intracavitary type Mammosite	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2009
TCGA-A8-A07Z	FEMALE	1371	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1371			TUMOR FREE				85	Left	Not Available	Not Available	TCGA-A8-A07Z	a272171b-44f5-47a5-89be-7520413c01ad	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-31351	Not Applicable	0	853	Not Available	Not Available	TCGA-A8-A07Z-D37893	7451614E-5AF0-44F4-8C54-978B7E546B5D	Not Available	6	Not Available	Not Available	Exemestane	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07Z-F40836	517EFC98-3027-495D-88B5-D50994A0F178				2			Not Applicable	1371																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07Z	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-C8-A12K	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	0			TUMOR FREE				80	Right Upper Inner Quadrant	Other (specify)	Pateys surgery	TCGA-C8-A12K	6b923e30-2ddc-407f-91b1-c202f1373fbb	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Other	Not Applicable	NO	12	-29463	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Not Evaluated	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A12K	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Pateys surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A15C	FEMALE	694	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	694			TUMOR FREE				61	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15C	da840a22-8d30-4682-bbd0-8fa87bd40528	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-22583	Not Applicable	0	497	Not Available	NO	TCGA-E2-A15C-D18936	057D51BB-CBBC-401E-BB09-3E7A10ADCA74	Not Available	9	Not Available	65	arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15C-F18935	C22968BC-CE2C-417D-B613-7801B0F89A52				9		Not Available	Not Applicable	694		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	20-29%	Not Available	2+	Not Available	Not Available	Not Available	1.02	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A15C	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A15C-R18937	B2859F7D-EF4C-413B-BDF2-D76014910FBF	1	9	102	55	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-A7-A6VV	FEMALE	313	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	313			TUMOR FREE				51	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A6VV	57AF5C72-0D60-4A6B-B1B4-EC6DAB90F80F	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	22	-18695	Not Applicable	0	181	Not Available	Not Available	TCGA-A7-A6VV-D57247;TCGA-A7-A6VV-D57248	8A804A22-B193-4C71-8EBB-6FD22D9F605E;52B5F633-7FB7-42E1-A8EC-60B50825FBCF	Not Available;Not Available	6;6	266;266	160;160	Cyclophosphamide;Taxotere	Complete Response;Complete Response	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A6VV-F57249	2A10E9C7-16B5-4CDC-8548-D21B927922EE				6			Not Applicable	313																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2013
TCGA-BH-A0GY	FEMALE	923	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIA	0	923			TUMOR FREE				67	Left Lower Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0GY	7d9d3522-ec3b-4efe-8c8e-c0e675276ef5	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	10	-24493	Not Applicable	0	917	Not Available	Not Available	TCGA-BH-A0GY-D4688;TCGA-BH-A0GY-D4692;TCGA-BH-A0GY-D4690	4D4A179C-D0BD-42DC-AD93-EAC585385ACD;6C08A79A-E8ED-4073-B385-8D190A48E158;F37A755D-57BF-47B5-BB9B-4656199BC057	Not Available;Not Available;Not Available	17;18;18	Not Available;Not Available;Not Available	351;202;202	Arimidex;Cyotxan;Adriamycin	Not Available;Not Available;Not Available	11;11;11	Not Available;Not Available;Not Available	1;Not Available;Not Available	mg/day;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	H-Score 150	40-49%	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	NO	TCGA-BH-A0GY-F4695	426FCA35-2C66-49F8-8A54-D246D2D79D53	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	923	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	No	A0GY	TUMOR FREE	H-Score 290	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0GY-R4694	78B3B214-FA94-42A3-A70B-7FD74250E365	1	17	365	317	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-A2-A04U	FEMALE	2654	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	2654			TUMOR FREE				47	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A04U	1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	5	-17474	Not Applicable	0	671	Not Available	Not Available	TCGA-A2-A04U-D6673;TCGA-A2-A04U-D6680;TCGA-A2-A04U-D6675;TCGA-A2-A04U-D6679	7c4f7833-834c-4045-b558-4a53c47aec04;14adba24-28a7-4eac-bcdf-6542a26395b8;15e8f3ac-8410-402b-85c4-76caeb242226;0a1f5288-fb98-4a32-ab56-4dca69f8d629	Not Available;Not Available;Not Available;Not Available	7;7;7;7	120;671;120;197	78;481;78;134	Adriamycin;Zometa;Cytoxan;Taxotere	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;3;4;4	116;4;1160;140-192	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;4;2;3	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy	Not Available;Bisphosphonate;Not Available;Not Available	464;12;4640;612	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A2-A04U-F9334;TCGA-A2-A04U-F59317	99826B0C-9A4E-43B0-9EF8-F52CF27DD53E;022819FE-3C6C-4DDD-90FD-EBF7BD427042	Not Available;None	Not Available;None	Not Available;None	17;8	Not Available;None	Not Available;None	Not Applicable;Not Applicable	1486;2654	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;5					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	TUMOR FREE;Unknown	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	2.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Positive	3	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	1	No	A04U	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2004
TCGA-E2-A1IH	FEMALE	1026	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1026			TUMOR FREE				80	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IH	ec0155ab-1b14-498d-8fa9-9f63e3ccb990	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	28	-29444	Not Applicable	0	658	Not Available	NO	TCGA-E2-A1IH-D19961	ADCF42F6-D220-4FED-B497-03BA85C4304D	Not Available	21	Not Available	32	Aromasin	Not Available	12	Not Available	25	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	25	mg/day	Not Available	2011	allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1IH-F19960	65E9B5ED-CC0C-41F6-8985-1A9D0EF1712D				21		Not Available	Not Applicable	1026		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	20-29%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1IH	TUMOR FREE	allred score 5+3+8	Not Available	Not Available	allred score = 8	allred score = 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-A7-A13D	FEMALE	965	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	965			TUMOR FREE		FPPP	TCGA	46	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A7-A13D	8785012f-f73e-4d68-87cf-1d804af32782	Negative	Negative	Not Available	Not Available	Not Available	Lumpectomy	Positive	Lumpectomy	Not Applicable	NO	23	-17070	Not Applicable	0	267	Not Available	Not Available	TCGA-A7-A13D-D8216;TCGA-A7-A13D-D8215	c345ebac-a9ee-49bc-b310-9629cee33830;559c6d67-c4d2-4b4d-bf0b-b13454988426	Not Available;Not Available	23;23	155;155	71;71	Cytoxan;Taxotere	Not Available;Not Available	2;2	5;5	1410-1428;176-179	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	7104;889	mg;mg	Not Available;Not Available	2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.8	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A13D-F8217;TCGA-A7-A13D-F39794	3D820843-BF50-4A74-8708-4B00899AF6D3;6E464627-70AF-44BE-8CCD-1AA8D584B152	Not Available;None	Not Available;None	Not Available;None	24;1	Not Available;None	Not Available;None	Not Applicable;Not Applicable	267;965	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;2					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2011;2013	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA Probe Kit	2+	197	Not Available	1.9	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A13D	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-A7-A13D-R8218	558c4f55-6729-4f9a-817b-ae35c1c3b2e2	1	23	237	188	Not Available	2	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A3XZ	FEMALE	1532	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1532			TUMOR FREE				46	Left Upper Inner Quadrant;Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A3XZ	FE7F74B8-20F4-4471-91DC-4CCA8C68E5C0	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	21	-16978	Not Applicable	0	973	Not Available	Not Available	TCGA-A2-A3XZ-D34516;TCGA-A2-A3XZ-D34517;TCGA-A2-A3XZ-D34518	EC157BD8-01E2-4587-87D0-ED9A7863A136;9E6E1263-16AB-4E0E-8C59-14347BB6F50C;3F688A9E-5E71-4676-BA57-190015FED400	Not Available;Not Available;Not Available	21;21;21	202;202;423	97;97;97	Carboplatin;Docetaxel;Trastuzumab	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3XZ-F43307;TCGA-A2-A3XZ-F58924	24F38B79-CE2B-497E-A800-AAD515C7A2B1;16A1FC59-6B05-472B-A7F8-427B5324C1A5				17;28			Not Applicable;Not Applicable	1165;1532																				NO;NO																						5;4					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A3XZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2009
TCGA-A7-A4SB	FEMALE	418	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1mi	M0	Stage IIIA	0	418			TUMOR FREE				56	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A7-A4SB	A947A945-4721-45CC-BC45-13B8EA41C10E	Negative	Positive	3 Point Scale	Not Available	3 Point Scale	Other	Positive	Lumpectomy	Right Breast reexcision	YES	20	-20539	Not Applicable	0	200	Not Available	Not Available	TCGA-A7-A4SB-D40444;TCGA-A7-A4SB-D40445;TCGA-A7-A4SB-D49626	50FAB4F7-9961-47ED-A399-7EA0F55FF5EC;9F679293-FBF6-4C18-8842-A0A4A2E10805;8051EB4D-DE3F-4F20-B2D4-F5559D2AE0AD	Not Available;Not Available;Not Available	20;20;4	124;124;Not Available	61;61;218	Docetaxel;Cyclophosphamide;Anastrozole	Complete Response;Complete Response;Not Applicable	2;2;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A4SB-F49625	DF6EE235-5417-41D0-A77B-0237FC3EC31B				4			Not Applicable	418																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	1	No	A4SB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	50-59%	WHITE	YES	Primary Tumor Field;Regional site	TCGA-A7-A4SB-R41881;TCGA-A7-A4SB-R41883	04E0A0FD-1492-4ADA-97BD-0DC43F53D491;6AC058D6-3E65-4193-AF2C-58D23B788B99	Not Available;Not Available	2;2	217;206	167;167	Complete Response;Complete Response	4;4	31;Not Available	6100;4500	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T3	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-A1-A0SB	FEMALE	259	Other, specify	Breast	Alive	T1c	N0	M0	Stage I	0	259			TUMOR FREE				70	Left	Sentinel node biopsy alone	Not Available	TCGA-A1-A0SB	0045349c-69d9-4306-a403-c9c1fa836644	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	30	-25833	Not Applicable	0	259	Not Available	NO																								Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Adenoid Cystic Carcinoma	No	C50.9	8200/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A0SB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A1B6	FEMALE	867	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	867			TUMOR FREE				44	Left	Sentinel node biopsy alone	Not Available	TCGA-E2-A1B6	e0b1bcd2-1139-44b9-98b3-67bcf92bcc39	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	25	-16370	Not Applicable	0	338	Not Available	NO	TCGA-E2-A1B6-D19412;TCGA-E2-A1B6-D19420;TCGA-E2-A1B6-D19399	41211D2C-2E5E-4A2E-B31D-B8B5FD4053B0;5B691CC0-6DE5-419D-96FB-0C8A7DEB398B;3110E408-194F-4231-98AC-379E031BB58E	Not Available;Not Available;Not Available	9;9;9	163;163;163	Not Available;Not Available;Not Available	Adriamycin;Taxol;Cytoxan	Not Available;Not Available;Not Available	12;12;12	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1B6-F19389	52C7E9E7-E0FB-4221-B4AF-7EDF9586E0D6				8		Not Available	Not Applicable	867		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	1.03	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1B6	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-A1-A0SK	FEMALE	967	Other, specify	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	1				Not Available				54	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SK	a5b44d66-c162-46b5-9df2-86305f0385c5	Negative	Negative	Not Available	Not Available	Not Available	Other	Negative	Lumpectomy	surgical resection	Not Available	6	-20048	967	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A1-A0SK-F15926	5F98C53B-5EE8-444C-9089-1E7EF433117D				7		Not Available	967	Not Available		Not Available				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available																																		WITH TUMOR			Not Available			Not Available		Not Available	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Neuroendocrine carcinoma, large-cell type, high-grade	No	C50.9	8013/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	4	Positive	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	No	A0SK	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Dead	2010	2007
TCGA-D8-A27H	FEMALE	397	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	397			TUMOR FREE				72	Right Upper Outer Quadrant	No axillary staging	Not Available	TCGA-D8-A27H	0dca98b0-f43e-45b6-9a02-00092c78678c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	18	-26588	Not Applicable	0	19	Not Available	NO	TCGA-D8-A27H-D29537	4AB576A6-1236-4F08-9245-2BA70A7A8F57	Not Available	22	141	36	doxorubicin+ cyclophosphamide	Not Available	3	6	60+600	mg	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	360+3600	mg	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27H-F29536	24D385C9-D517-47C8-90B6-128C9B86C4AB				22		Not Available	Not Applicable	397		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A27H	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-D8-A1JG	FEMALE	1612	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1612			TUMOR FREE				62	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1JG	7f2a63e6-64d5-4be1-9814-e8416fc9e688	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	28	-22878	Not Applicable	0	187	Not Available	Not Available	TCGA-D8-A1JG-D14061;TCGA-D8-A1JG-D65325	8AC1E40A-2939-4FD6-93E8-DE97A4C64960;79FA201D-29D2-4F82-BD32-02AAC1E0DE5E	Not Available;Not Available	18;22	Not Available;Not Available	269;269	doxorubicin;cyclophosphamide	Not Available;Not Applicable	7;9	Not Available;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	AC;Not Available	IV;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg/m2;Not Available	Not Available;NO	2011;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-D8-A1JG-F14060;TCGA-D8-A1JG-F72208	7C44E839-34A8-49E0-A07D-4465FD24CA33;43A0E4B3-430E-4554-9982-A15A1C5DF509				18;29		Not Available;None	Not Applicable;Not Applicable	366;1612		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	not amplified	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1JG-R14062	C24109D8-C044-41DF-BAF0-A3B8FC106D1B	1	18	156	131	Not Available	7	21	42.5+10	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A0IJ	FEMALE	7106	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	0	7106			TUMOR FREE				42	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IJ	2c86c3ea-d926-4d39-a5ae-39ece4774287	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-15625	Not Applicable	0	5383	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0IJ-F12619;TCGA-B6-A0IJ-F71500	40AA9979-4BAB-40CA-BE6C-1787ABDDE22A;118F133D-5C79-473C-B86B-7CF50EEBCFB2				2;26		Not Available;None	Not Applicable;Not Applicable	5383;7106		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Available	27	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0IJ	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1995
TCGA-D8-A146	FEMALE	643	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	643			Not Available				57	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-D8-A146	03da7a65-fa2f-42cb-a709-5fe8736f21d3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	30	-20861	Not Applicable	0	344	Not Available	NO																								manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A146-F20750	33ECAE33-7777-48D5-BE7F-83396199B0FC				15		Not Available	Not Applicable	643		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	DAKO Hercep Test TM	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	Yes	A146	Not Available	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A07J	FEMALE	365	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	365			TUMOR FREE				35	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07J	316625b8-a217-4829-90d1-dfd9cb7e4bc3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-12965	Not Applicable	0	365	Not Available	Not Available	TCGA-A8-A07J-D37868;TCGA-A8-A07J-D37869;TCGA-A8-A07J-D37870;TCGA-A8-A07J-D37871;TCGA-A8-A07J-D37872	30FC02A5-ACD9-4CE4-A312-69CCBD6291A6;67EB5A96-AE11-405C-854F-6ABAE77D78A2;042C8BB6-D133-47F7-86D9-C19D091DC859;4D185435-8F11-4933-9616-FE908DBDF03F;3048378F-307F-4B1C-8A8E-286754868C32	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	92;92;92;153;Not Available	31;31;31;92;184	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Tamoxifen	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07J-F40829	17B903FF-A6D0-49CC-A697-C524DE70E422				2			Not Applicable	365																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07J	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07J-R38186	D420AEC4-2B57-4231-822E-611BDD49C141	Not Available	11	184	153	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AO-A03M	FEMALE	1866	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	1866			TUMOR FREE				29	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A03M	095c7985-3842-494f-b591-706ad1cd2133	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	9	-10616	Not Applicable	0	1455	Not Available	Not Available	TCGA-AO-A03M-D5995;TCGA-AO-A03M-D5996;TCGA-AO-A03M-D5994;TCGA-AO-A03M-D5992	20c31de8-d96e-4867-8335-719ccb5806a3;c13d0b89-a948-4f3f-ac88-4e9387d555db;9bdbaaed-6f6d-4d45-a7c0-dd1366b813db;e5a69005-a19c-4fc9-a8f2-9a2c939cb391	Not Available;Not Available;Not Available;Not Available	10;10;10;10	161;Not Available;105;105	119;161;63;63	Paclitaxel;Tamoxifen;Cyclophosphamide;Doxorubicin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;Not Available;4;4	175;20;600;60	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1100;Not Available;3768;376	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A03M-F5861;TCGA-AO-A03M-F30186	1F587B26-56C6-43CE-B5E9-1666DA4EAB4D;62767797-1CEB-468B-A320-FB552F1B6627	Not Available;None	Not Available;None	Not Available;None	9;4	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1455;1866	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	1;4	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	3+ Positive	30-39%	>= 2.0 Positive	2+	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	0	No	A03M	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2006
TCGA-AR-A2LK	FEMALE	1649	Infiltrating Lobular Carcinoma	Breast	Dead	T3	N2	M0	Stage III	1	1304.0	Bone	Distant Metastasis	Not Available				62	Right Upper Outer Quadrant;Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LK	1B703058-E596-45BC-80FE-8B98D545C2E2	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Positive	Other	Not Applicable	Not Available	25	-22800	Not Applicable	0	1304	Not Available	NO	TCGA-AR-A2LK-D37268;TCGA-AR-A2LK-D37269;TCGA-AR-A2LK-D37270;TCGA-AR-A2LK-D37735	80FE69D1-54B5-44CA-8D96-AFF0EC366BB2;C8B24AF7-897D-4A58-9CF0-393DEB02542C;873DD1AD-E816-474B-AE05-EB495268C779;F52A9E2B-71AB-4E83-826D-E7307A8EE004	Not Available;Not Available;Not Available;Not Available	6;6;6;6	Not Available;Not Available;Not Available;1310	Not Available;Not Available;Not Available;263	Adriamycin;Cytoxan;Paclitaxel;Anastrozole	Not Available;Not Available;Not Available;Not Available	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LK-F35203	01404DEF-ED7D-4186-9DC8-5FE8C812821B				6			1649	Not Available																				NO																						12					Not Available	Not Available	Not Available	1304	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Bone	Distant Metastasis	Not Available	Not Available	Not Available	YES	Not Available						YES		YES	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	18	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	No	A2LK	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LK-R37267	B628417D-C4BC-45CE-968F-80AAE78899EB	Not Available	6	262	218	Not Available	12	33	6100	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2012	2007
TCGA-A2-A1G0	FEMALE	616	Other, specify	Breast	Alive	T2	N1a	M0	Stage IIB	0	616			Not Available				49	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A1G0	2e538802-2a31-4774-89a8-c6e4381a887d	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	21	-18002	Not Applicable	0	380	Not Available	NO	TCGA-A2-A1G0-D12277;TCGA-A2-A1G0-D12278;TCGA-A2-A1G0-D12279;TCGA-A2-A1G0-D12281	3f7e4bbf-f665-40a2-b4ac-ec01e86be371;98afbca9-9725-421f-98a6-9f7f299a0e0b;684a3831-0dbd-4c77-bcad-abc00bca6fcf;ef4fe873-a6fc-46bb-a3f7-225d1f22dbc3	Not Available;Not Available;Not Available;Not Available	27;27;27;27	177;177;177;Not Available	72;52;72;Not Available	Adriamycin;Taxotere;Cytoxan;Tamoxifen	Not Available;Not Available;Not Available;Not Available	4;4;4;4	6;6;6;Not Available	94-96;141-148;940-960;20	mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;3;4	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	574;872;5720;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A1G0-F20802	99FAEFEA-9BBB-42E0-B43E-9020702DB5F9				9		Not Available	Not Applicable	616		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.2	Not Available	Other, specify	Infiltrating Tubulolobular Carcinoma	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	2	Not Available	No	A1G0	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Regional site	TCGA-A2-A1G0-R12283	d076e89d-1cdd-4918-a564-6081ad5fcb64	1	27	244	201	Not Available	4	31	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A03O	FEMALE	2483	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	0	2483			TUMOR FREE				69	Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A03O	1111fb30-46ce-4722-98da-ec9ba2323d90	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	19	-25362	2483	0	Not Available	Not Available	Not Available	TCGA-AO-A03O-D3149;TCGA-AO-A03O-D3144;TCGA-AO-A03O-D3145;TCGA-AO-A03O-D3147	61963f8b-da23-40f1-9f6b-787d38f7651a;fe3f418d-b735-4bd3-8ed0-0b7ad64da47d;dc3d1205-5393-48bd-bdeb-9f9a8ac66e73;46526dc6-105c-4615-981d-3ce9f318d5ab	Not Available;Not Available;Not Available;Not Available	19;19;19;19	993;98;98;158	182;54;54;112	ANASTROZOLE (ARIMIDEX);DOXORUBICIN;CYCLOPHOSPHAMIDE;PACLITAXEL	Not Available;Not Available;Not Available;Not Available	9;9;9;9	Not Available;4;4;4	1;300;300;300	mg/day;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;1;1	PO;IV;IV;IV	NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;436;4380;1276	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	>10% STAINING = POSITIVE	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	68	Not Available	Not Available	Not Available	Not Available	TCGA-AO-A03O-F3141	740A6308-84E3-4231-995D-82D7D5A34C86	Not Available	Not Available	Not Available	19	Not Available	Not Available	2483	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2010	FEMALE	Not Available	3+ POSITIVE	<10%	> = 2.0	1+	29	Not Available	73	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A03O	TUMOR FREE	Not Available	Not Available	Not Available	>10% STAINING = POSITIVE	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Dead	2010	2002
TCGA-D8-A1JF	FEMALE	366	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	366			TUMOR FREE				79	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JF	dcd5e079-813a-4c1a-b320-0931468d2bbc	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-29199	Not Applicable	0	96	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JF-F14058	B68084F0-7E58-4822-841C-EEF1C187A504				18		Not Available	Not Applicable	366		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	No	A1JF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A0DA	FEMALE	1085	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1085			TUMOR FREE				62	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A0DA	3afa1e93-1df8-4e4c-aaa4-557463f4bb77	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	10	-22708	Not Applicable	0	373	Not Available	Not Available	TCGA-A7-A0DA-D6123;TCGA-A7-A0DA-D6125;TCGA-A7-A0DA-D6126	848337bd-29ff-4b6c-8710-4bb3ac828398;84e6d642-6da6-4216-a376-2077ac969442;1b1e115e-9a35-4b44-a883-94573341a893	Not Available;Not Available;Not Available	13;13;13	107;107;199	65;65;122	Adriamycin;Cytoxan;Taxol	Not Available;Not Available;Not Available	1;1;1	4;4;12	100;990-1000;90-130	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	400;3990;1435	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0DA-F6131;TCGA-A7-A0DA-F38487	528F3E9A-532F-464C-944C-2B0B7952D753;492F04DA-FBF7-48D8-99A9-9F4490E79F21	Not Available;None	Not Available;None	Not Available;None	13;14	Not Available;None	Not Available;None	Not Applicable;Not Applicable	373;1085	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;12					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	0	Not Available	No	A0DA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0DA-R5953	43ddf4b7-e2e9-4629-9fbc-01598b2cb8aa	1	10	274	226	Not Available	1	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2009
TCGA-D8-A1JN	FEMALE	620	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3a	MX	Stage IIIC	0	620			TUMOR FREE				80	Left	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JN	28911b97-42bf-4189-9961-522fc0aeebc6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	29	-29331	Not Applicable	0	217	Not Available	Not Available	TCGA-D8-A1JN-D20746	2A418FF9-581C-4A9B-A4AB-B7B2C072C0EA	Not Available	15	Not Available	63	anastrozolum	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JN-F20745	8392D4C7-1892-4B0D-873C-049A73A24FF4				15		Not Available	Not Applicable	620		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	HER2 amplification - negative	DAKOHercepTest TM	Not Available	PathVision HER2 DNA Probe Kit	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Indeterminate	Negative	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	No	A1JN	TUMOR FREE	manual counting	Not Available	Not Available	Not Available	>75%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T3	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A1JE	FEMALE	575	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	575			TUMOR FREE				62	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JE	115bc72c-116f-40c1-be9b-e3dd7650efae	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-22683	Not Applicable	0	57	Not Available	Not Available	TCGA-D8-A1JE-D20761;TCGA-D8-A1JE-D65322	A21FF951-1D85-43F8-B890-E68699047B3E;B2854BDF-784F-41A1-AB7D-354A86C7F89E	Not Available;Not Available	8;22	162;162	103;103	adriamicin;cyclophosphamid	Not Available;Not Available	1;9	9;Not Available	600;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	540;Not Available	mg;Not Available	Not Available;NO	2012;2014	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JE-F20759	5A7761FF-5F3F-43F6-93D6-DE3358891478				8		Not Available	Not Applicable	575		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	No	A1JE	TUMOR FREE	manual counting	Not Available	Not Available	10-75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AN-A03X	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE				74	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A03X	88cd6ccc-70f7-436e-a99c-039b9d31e335	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-27163	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A03X-F68976	469F1ACF-B8FD-4F11-9FE1-D2DBA8D25947				24			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A03X	TUMOR FREE	Not Available	Not Available	Not Available	200	200	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-AR-A1AK	FEMALE	3159	Infiltrating Lobular Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	3159			TUMOR FREE				70	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AK	94b03e1d-50ec-4680-bffd-7086d1536ff2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	15	-25825	Not Applicable	0	1559	Not Available	Not Available	TCGA-AR-A1AK-D22155	37D99581-850D-476B-8328-D3E0BD6DC049	Not Available	1	1843	33	Anastrozole	Not Available	3	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	NO	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AK-F22154;TCGA-AR-A1AK-F69271	DF7EF2E1-3F76-4517-A7B5-8A638431A253;4D10493E-351E-498F-A607-D7E32C755D8A				1;31		Not Available;None	Not Applicable;Not Applicable	1559;3159		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-E2-A107	FEMALE	1047	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	0	1047			WITH TUMOR				54	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A107	eff2360e-399a-4167-ab2b-798e27bef739	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	11	-20065	Not Applicable	0	763	Not Available	Not Available	TCGA-E2-A107-D7757;TCGA-E2-A107-D7756;TCGA-E2-A107-D7759;TCGA-E2-A107-D7758;TCGA-E2-A107-D7755;TCGA-E2-A107-D17174;TCGA-E2-A107-D17818;TCGA-E2-A107-D17179;TCGA-E2-A107-D17823;TCGA-E2-A107-D17180;TCGA-E2-A107-D17821	94caf20f-89a4-438f-919c-b340c5ce2469;c58484ad-b8a7-4f27-9386-eecae3edc98a;defcd3cc-c0c4-4a02-9921-4c97f1ab4e62;32e23773-9014-438f-887b-f921486a2877;a7e00902-e7a5-4186-af3b-ad72c543f90a;46E34570-DA26-49E6-9564-CD69C9A9ECE6;01B8342F-2262-4BEE-8828-DD3CC79BA416;F8A4A3FF-59B7-45D2-93E6-AB8090FD077D;B6BDB863-8723-4E39-981C-050BD35D2153;B2F276EF-9F6D-4748-B73C-14E98959428A;154B47FC-B1D3-491D-9EA5-29AF63F4E160	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14;28;28;28;28;28;28	333;242;Not Available;355;151;151;151;417;333;Not Available;242	165;165;459;305;109;109;109;397;249;459;165	Avastin;Taxol;Tamoxifen;Arimidex;Adriamycin, cytoxan, avastin;Cyclophosphamide;Doxorubicin;Aromasin;Bevacizumab;Tamoxifen;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;9;9;9;9;9;9	13;12;Not Available;Not Available;4;4;4;Not Available;4;Not Available;12	1065;80;Not Available;Not Available;Not Available;1050;105;Not Available;1049;20;140	mg;mg/m2/wk;Not Available;Not Available;Not Available;mg;mg;Not Available;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;2;4;3;1;1;1;5;3;6;2	IV;IV;PO;PO;IV;IV;IV;PO;IV;PO;IV	NO;NO;YES;NO;NO;NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13845;140;Not Available;Not Available;Not Available;4200;420;Not Available;4196;Not Available;1680	mg;mg/wk;Not Available;Not Available;Not Available;mg;mg;Not Available;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011;2011;2011	Allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A107-F17173	C7D2518B-F2DE-4B90-93B3-EA2F681E4044				28		Not Available	Not Applicable	1047		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.2	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	4	Not Available	No	A107	WITH TUMOR	Allred score 0+0=0	Not Available	Not Available	Allred score 0	Allred score 8	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A107-R7754	1241840c-6acc-43d3-8ca1-58be8ecb2824	1	14	326	279	Not Available	2	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-AC-A7VC	FEMALE	1	Metaplastic Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	1			TUMOR FREE				56	Left	Sentinel node biopsy alone	Not Available	TCGA-AC-A7VC	2B36853F-34D3-47C5-BA6A-E5A93233D2B1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	29	-20479	Not Applicable	0	1	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A7VC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2013
TCGA-BH-A0W3	FEMALE	728	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	728			TUMOR FREE				58	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A0W3	3c612e12-6de8-44fa-a095-805c45474821	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	14	-21369	Not Applicable	0	180	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0W3-F34065	0C4DAF8C-F0CA-4E03-9F35-21E17062ECEB				29		Not Available	Not Applicable	728		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Not Available	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	1	No	A0W3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-BH-A0W3-R34066;TCGA-BH-A0W3-R34067	2559A85D-0AA2-4EAE-937A-6BF2C5B27942;A6B969D8-4A1C-4537-94C9-B06187812BFA	Not Available;Not Available	29;29	98;96	63;63	Complete Response;Complete Response	7;7	Not Available;Not Available	46;46	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A56Z	FEMALE	252	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	252			TUMOR FREE				69	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A56Z	45C3975C-D333-4237-93F7-E12DC2451C38	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	20	-25282	Not Applicable	0	219	Not Available	Not Available	TCGA-E2-A56Z-D44509	B6730BD0-5AB2-4AC6-A8F5-F2DFB0DDBAD9	Not Available	20	Not Available	130	Arimidex	Not Applicable	6	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Allred 8 = 5+3	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.2					TCGA-E2-A56Z-F67584	8EFC436C-C4BE-4ADF-8B69-B4055EE66553				6			Not Applicable	252																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	200	Not Available	3.2	1.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A56Z	TUMOR FREE	Allred 5 = 2+3	Not Available	Not Available	Allred Score	Allred Score	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	YES	Regional site	TCGA-E2-A56Z-R44510	ED43F584-56B4-41B9-B645-3A751C3355FA	Not Available	20	129	84	Complete Response	6	33	60.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2013	2012
TCGA-E9-A1N5	FEMALE	1120	Mixed Histology (please specify)	Breast	Alive	T2	N1	M0	Stage IIB	0	1120			TUMOR FREE				45	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1N5	f954de05-1b44-4087-8933-6cc72d81028d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	NO	23	-16736	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1N5-D29151;TCGA-E9-A1N5-D30708;TCGA-E9-A1N5-D30709;TCGA-E9-A1N5-D30707	37B2E899-6C5E-4AC5-993C-7D0CC5659174;C1DD8D4B-44DC-4476-9E5A-BCCA90CA080E;4635036F-43AC-41A4-91E0-672BE9D92DA7;D9225842-4B81-41D8-A299-BC1B204AEDD6	Not Available;Not Available;Not Available;Not Available	9;16;16;16	133;133;Not Available;133	22;22;173;22	Doxorubicin;5-Fluorouracil;Tamoxifen;Cyclophosphane	Not Available;Not Available;Not Available;Not Available	3;4;4;4	6;6;Not Available;6	80;800;20;800	mg/day;mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;1	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	480;4800;Not Available;4800	mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1N5-F29150;TCGA-E9-A1N5-F39765	BFF144B5-6704-4A2E-990B-275BD153D6F4;B4847252-8EFC-42E5-A862-992780803AD3				9;1		Not Available;None	Not Applicable;Not Applicable	508;1120		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	0	No	A1N5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A08J	FEMALE	1127	Infiltrating Ductal Carcinoma	Breast	Dead	T4b	N3	M1	Stage IV	1				WITH TUMOR				52	Right	Not Available	Not Available	TCGA-A8-A08J	68177e92-4784-45d9-af14-4ce0c00eae74	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-19266	1127	0	Not Available	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08J-F40846	511A5351-B4EC-4B3F-8F4E-00AFD1613ED1				2			1127	Not Available																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR						Unknown		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8541/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08J	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M1	N3	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Dead	2011	2005
TCGA-BH-A0DK	FEMALE	423	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	423			TUMOR FREE				49	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-BH-A0DK	f2bbfa9d-9a9d-4f46-9fde-378e4c44e2ad	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	8	-18237	Not Applicable	0	423	Not Available	Not Available	TCGA-BH-A0DK-D4531	F66FFF44-E13B-490E-B862-8317DB185752	Not Available	17	Not Available	112	TAMOXIFEN	Not Available	11	Not Available	20	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-SCORE 260	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0DK-F4532	00ADA7FD-4CEC-4D7C-A86A-BAFE4B35FEE2	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	423	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0DK	TUMOR FREE	H-SCORE 120	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-BH-A2L8	FEMALE	612	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	612			TUMOR FREE				45	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A2L8	BAC4B268-C781-4408-96D8-43A48FEC7418	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	27	-16658	Not Applicable	0	168	Not Available	NO	TCGA-BH-A2L8-D43167	D1B01084-E040-4E41-ACAC-3A7D4A79E959	Not Available	14	197	136	Cytoxan	Complete Response	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A2L8-F39616	C86ACD7B-AFEA-462D-BDA8-0A6980460D1E				28			Not Applicable	612																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	0	No	A2L8	TUMOR FREE	Not Available	Not Available	Not Available	Oncotype Dx test	Oncotype Dx test	Not Available	YES	80-89%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	TOTAL MASTECTOMY	YES	NO	BH	Breast	Not Applicable	Alive	2012	2011
TCGA-A2-A0YK	FEMALE	588	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	588			TUMOR FREE				61	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0YK	8f34cb4c-5798-47a0-89a1-f0ee26a8ae93	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	28	-22625	Not Applicable	0	334	Not Available	Not Available	TCGA-A2-A0YK-D5847;TCGA-A2-A0YK-D5845;TCGA-A2-A0YK-D5846	2805802e-eb3a-4f17-90b5-9fa824b24022;c5a7f0c7-a217-4ad7-a621-78da30961ddc;c494a6d6-0fcb-4709-b505-fef203efcd1b	Not Available;Not Available;Not Available	28;28;28	Not Available;141;141	Not Available;78;78	Arimidex;Cytoxan;Taxotere	Not Available;Not Available;Not Available	12;12;12	Not Available;4;4	1;1115;140	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;1;2	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;4460;560	Not Available;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YK-F16750	5352B4DE-D0F2-4460-A22F-4D82A51444FE				16		Not Available	Not Applicable	588		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0YK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-D8-A73X	FEMALE	767	Other, specify	Breast	Alive	T2	N0	M0	Stage IIA	0	767			TUMOR FREE				53	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A73X	1BE375FE-5AE5-4E75-A729-69F86A661D9A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	28	-19607	Not Applicable	0	368	Not Available	Not Available	TCGA-D8-A73X-D57880	43C74671-DCEB-4C5F-B13C-C3F184FEFDBD	Not Available	28	Not Available	12	tamoxifen	Not Applicable	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-D8-A73X-F57879;TCGA-D8-A73X-F72193	47682239-B701-418A-AC8C-C0AB10D3F37D;A7B1B400-8E75-4DE4-AC2C-60D227A635E6				28;29			Not Applicable;Not Applicable	368;767																				NO;NO																						3;4					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	tubular carcinoma	No	C50.9	8211/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A73X	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	NO	70-79%	WHITE	YES	Primary Tumor Field;Primary Tumor Field	TCGA-D8-A73X-R57881;TCGA-D8-A73X-R72196	A963F922-06B5-4D26-9E75-C79BF2E2B6E0;481C16C4-941C-4E6D-8C08-66A6108AB13F	Not Available;Not Available	28;29	75;53	75;41	Complete Response;Stable Disease	3;4	25;Not Available	50;50	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2014	2013
TCGA-A2-A4RW	FEMALE	222	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	222			TUMOR FREE				49	Right;Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A4RW	0D146997-CFDC-4587-888C-E876FC455C80	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	27	-18060	Not Applicable	0	222	Not Available	Not Available																								Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A4RW-F59123	33B06046-3374-42DE-8585-2C4E3130E18B				1			Not Applicable	222																				YES																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	27	0	No	A4RW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	90-99%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2013	2011
TCGA-AR-A2LH	FEMALE	616	Infiltrating Lobular Carcinoma	Breast	Dead	T3	N3	M0	Stage III	1	434.0	Bone	Distant Metastasis	Not Available				55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LH	376FFE63-EFD7-42AF-90E1-261255B28BB7	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	12	-20288	616	0	Not Available	Not Available	YES	TCGA-AR-A2LH-D37175;TCGA-AR-A2LH-D37260;TCGA-AR-A2LH-D37261	0674353C-7BE2-4FF0-952E-236E7F1BCB93;02991FAB-6700-40A7-86F6-5C1C3507F336;40102DFF-32EF-4C9C-B97B-78B3CC02F990	Not Available;Not Available;Not Available	6;6;6	84;84;140	42;42;98	Adriamycin;Cytoxan;Paclitaxel	Not Available;Not Available;Not Available	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Bone;Liver	Not Available	Not Available					TCGA-AR-A2LH-F35165	0F86B9CC-D89A-47B8-A9D1-60EA8626DB04				6			616	Not Available																				NO																						12					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	434;434	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Evaluated;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Evaluated;Not Evaluated	Not Evaluated;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Evaluated;Not Evaluated	Bone;Liver	Distant Metastasis;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES	Not Available						YES		YES	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	39	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	29	Not Available	No	A2LH	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LH-R37176	C1A492A6-382A-4863-9A54-E60996E31148	Not Available	6	214	Not Available	Not Available	12	25	5000	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage III	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2012	2007
TCGA-AN-A0FZ	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	10			TUMOR FREE				45	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A0FZ	8240c4ae-f878-4882-aa07-7857c7ac52cf	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	29	-16533	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FZ-F68969	5E7AC543-2D63-4F9A-95A9-9F1AA3C5B8A0				24			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	0	No	A0FZ	TUMOR FREE	Not Available	Not Available	Not Available	0	120	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-AC-A5XS	FEMALE	588	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	588			TUMOR FREE				74	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A5XS	D9627184-B972-4E00-8C11-B0B946AC357A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	15	-27160	Not Applicable	0	47	Not Available	Not Available	TCGA-AC-A5XS-D64109	3EECF063-E00F-473F-AC9F-C848E33C6EA6	Not Available	26	Not Available	97	Femara	Not Applicable	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A5XS-F64108	BA010C17-664A-44B7-ACC2-32E13D6552EB				26			Not Applicable	588																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	Yes	A5XS	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2012
TCGA-E9-A229	FEMALE	1148	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	1148			TUMOR FREE				37	Right Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A229	cea9d8f9-e18c-4947-a461-5f712e3c1e6d	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	2	-13817	Not Applicable	0	0	Not Available	NO	TCGA-E9-A229-D29803;TCGA-E9-A229-D29802;TCGA-E9-A229-D29800	7E071032-AA10-4F23-BDD1-ADB151254339;5D1A648D-B766-45C5-A426-F17BEA87EFD8;B1E9251D-B543-4832-9798-633B74C588FB	Not Available;Not Available;Not Available	29;29;29	182;182;182	24;24;24	5-Fluorouracil;Doxorubicin;Cyclophosphamide	Not Available;Not Available;Not Available	3;3;3	6;6;6	700;90;900	mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	4200;360;3600	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A229-F29798;TCGA-E9-A229-F65803	155219BA-2CDA-407F-B8C7-00AADE3DB297;F2689D1C-F153-4432-93F5-54D768688BB2				29;30		Not Available;None	Not Applicable;Not Applicable	405;1148		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;9	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A229	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A229-R29804	96F0A1DE-9AD4-4E84-B783-31C0475F7C9A	Not Available	29	235	207	Not Available	3	19	3800	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0B9	FEMALE	1572	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1572			TUMOR FREE				44	Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0B9	5a57dc25-d252-4b22-b192-4de630d7002f	Not Available	Negative	Not Available	0	Not Available	Not Evaluated	Negative	Other	Not Applicable	NO	4	-16310	Not Applicable	0	1572	Not Available	Not Available	TCGA-BH-A0B9-D15440;TCGA-BH-A0B9-D15439	13B25C27-6D31-4812-9A44-FC50A5A1DFA8;D648DF65-E9A7-46B4-8758-F6D2241D7892	Not Available;Not Available	4;4	111;111	48;48	CYCLOPHOSPHAMIDE;Doxorubicin	Not Available;Not Available	11;11	4;4	950;95	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3800;380	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0B9-F15438	2C430BC9-3919-471B-B6F0-EE5346626686				4		Not Available	Not Applicable	1572		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0B9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0B9-R15441	BB3B3DEB-1D17-48BB-B0BF-5491D69AAC51	1	4	180	132	Not Available	11	34	6240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2006
TCGA-LL-A8F5	FEMALE	596	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	596			Unknown				61	Right;Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A8F5	E1786E78-AC46-46FD-8CE0-8F7456E46082	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	19	-22544	Not Applicable	0	189	Not Available	Not Available	TCGA-LL-A8F5-D56702;TCGA-LL-A8F5-D56703;TCGA-LL-A8F5-D56704;TCGA-LL-A8F5-D56705;TCGA-LL-A8F5-D66963	F5AE22A2-3E4F-4944-B374-7697B1786986;299217BC-C179-466A-80AB-9CCE9BF914EF;0B7E86ED-9DCF-476C-A42C-FB9E98B7D14C;9B54A11A-0EAE-44E2-BBBF-A52A4FF67166;7E14293E-E235-410C-AD67-13482C7AEBB9	Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;29	154;154;175;259;Not Available	112;112;175;189;315	cyclophosphamide;doxorubicin HCL;paclitaxel;abraxane;ARIMIDEX	Unknown;Unknown;Unknown;Complete Response;Not Applicable	2;2;2;2;10	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2014;2014;2014;2014;2014	Not Available	20-29%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LL-A8F5-F66965	F431BC83-8B10-4B98-8517-31411BC2CC4A				29			Not Applicable	596																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A8F5	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-LL-A8F5-R66964	492E3E55-5D5B-4E10-AB3F-6B271471D319	Not Available	29	316	282	Complete Response	10	22	54.72	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2014	2013
TCGA-E2-A1L7	FEMALE	1836	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	1	1619.0	Other, specify	New Primary Tumor	TUMOR FREE				40	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A1L7	791c5768-f0f5-4ab6-86eb-998e5c4b49e3	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	1	-14854	Not Applicable	0	633	Not Available	NO	TCGA-E2-A1L7-D20590;TCGA-E2-A1L7-D20589;TCGA-E2-A1L7-D20592;TCGA-E2-A1L7-D20594;TCGA-E2-A1L7-D20591	36955FD4-89C2-4248-AAA1-8D8CE8F1DA04;B07261AA-1C81-4C97-9D43-2C0E1543ABFF;0C4583A4-E88D-4BDE-9CB3-9938094B71F8;EAECF0E4-3985-48CF-AB0D-2AC40D9B4036;42D99A31-F6C7-4E6D-9F04-7D6E1901B392	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	83;83;Not Available;Not Available;153	41;41;170;240;97	Cyclophosphamide;Doxorubicin;Clodronate;Arimidex;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	4;4;Not Available;Not Available;4	1200;120;1600;1;359	mg;mg;mg/day;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;3;4;2	IV;IV;PO;PO;IV	NO;NO;YES;YES;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Hormone Therapy;Chemotherapy	Not Available;Not Available;Phase III Clinical Trial;Not Available;Not Available	4800;480;1600;1;1436	mg;mg;mg/day;mg/day;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Allred score 1+1 = 2	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1L7-F20588;TCGA-E2-A1L7-F70298	3F50F013-BAFD-4D4C-915F-4D9CF0494F7A;0E0A1363-5109-4CB5-B655-FCBCEF191361				12;16		Not Available;None	Not Applicable;Not Applicable	834;1836		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;NO	None;YES	None;1662	None;1619	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Negative	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Negative	None;Other, specify	None;New Primary Tumor	None;left breast	None;YES	None;Not Available	None;YES	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	7	Not Available	No	A1L7	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 2	Not Available	YES	Not Available	WHITE	Not Available	Regional site;Primary Tumor Field	TCGA-E2-A1L7-R20596;TCGA-E2-A1L7-R70387	DB702F0D-3D33-490B-8DBE-AB55654B03A8;D9FCDCF6-AA31-494F-918B-042E492EEDF2	1;Not Available	12;16	237;1735	191;1694	Not Available;Complete Response	1;3	33;30	6040;60	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;Gy	2012;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-HN-A2NL	FEMALE	79	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	79			TUMOR FREE				56	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-HN-A2NL	124B693C-77DC-4FA8-B703-54E8B5054A92	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	30	-20483	Not Applicable	0	79	Not Available	Not Available	TCGA-HN-A2NL-D60150;TCGA-HN-A2NL-D60151	FC632444-8B7E-4F7E-94DD-B12171B1E0D6;D9161F5E-D3C5-4B6F-8267-C280BAEBD2D4	Not Available;Not Available	30;30	Not Available;Not Available	59;59	Cyclophosphamide;Doxorubicin	Unknown;Unknown	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2014;2014	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available					TCGA-HN-A2NL-F60149	0CBA7FE6-A784-4125-BBE8-43108D8E03E2				30			Not Applicable	79																				YES																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	0	No	A2NL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	Not Evaluated	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	HN	Breast	Not Applicable	Alive	2014	Not Available
TCGA-A8-A096	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE				73	Right	Not Available	Not Available	TCGA-A8-A096	d7cac141-9269-4733-83ce-e1bc0b503254	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-26723	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A096	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AR-A2LR	FEMALE	1742	Metaplastic Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	1742			TUMOR FREE				49	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A2LR	D093173F-08AB-4138-BF3C-399C45A6E163	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	14	-18214	Not Applicable	0	620	Not Available	NO	TCGA-AR-A2LR-D37602;TCGA-AR-A2LR-D37603	03400FAC-D55D-4626-A257-9C1AE7178017;CDD3764F-94E6-493E-8E99-6A9A7370E1B2	Not Available;Not Available	6;6	-1386;-1386	-1428;-1428	Adriamycin;Cytoxan	Not Available;Not Available	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AR-A2LR-F37600;TCGA-AR-A2LR-F71747	22969DEA-7B38-42A9-95BD-4710D4BBFA96;E250D902-9F8D-4000-8C72-4DBD74E19452				6;30			Not Applicable;Not Applicable	846;1742																				NO;NO																						12;3					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						NO;NO		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	Yes	A2LR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A2LR-R37601	892A1FE4-D10E-4BD7-B38E-303B77033602	Not Available	6	-1306	-1347	Not Available	12	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2012	2010
TCGA-A8-A08G	FEMALE	607	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	607			TUMOR FREE				41	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A08G	719082cc-1ebe-4a51-a659-85a59db1d77d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-14976	Not Applicable	0	607	Not Available	Not Available	TCGA-A8-A08G-D37833;TCGA-A8-A08G-D37834;TCGA-A8-A08G-D37835;TCGA-A8-A08G-D37836;TCGA-A8-A08G-D37837	E6829D65-9323-4DFA-86D6-AB3D485C1105;4C83B99B-AD52-428E-B14F-0623E65A872F;AD33A302-4E92-4716-B438-F7605A26337D;0B6BC52D-FF9B-4B29-9078-94FD2D4A935F;A2F25EB4-625A-4E4F-A809-B67F837EB7AE	n/a;n/a;n/a;n/a;n/a	6;6;6;6;6	89;89;89;150;Not Available	28;28;28;89;181	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Exemestane	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08G-F40844	2E2652A5-951A-4B3B-AF47-55EC819C68F2				2			Not Applicable	607																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08G-R38174	565C6FF1-BC4D-4E70-8DAC-BEC6DFF29A9F	Not Available	11	212	150	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AO-A1KO	FEMALE	622	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i+)	M0	Stage IIB	0	622			TUMOR FREE				46	Left Upper Outer Quadrant;Left Lower Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A1KO	c25898b4-eb33-42f4-bf3f-bf532a929e7d	Not Available	Positive	4 Point Scale	4+	4 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	1	-16817	Not Applicable	0	448	Not Available	NO	TCGA-AO-A1KO-D9902;TCGA-AO-A1KO-D9900;TCGA-AO-A1KO-D9903;TCGA-AO-A1KO-D9901	6524d129-d2a8-47ca-8d86-a659d0f1289b;20a6f8cb-e82a-4275-99dd-c1dec8bbf00b;994fc070-2c81-4aec-ad37-86de8d038e4a;fdaf8481-4ae7-4917-a33f-7f4624338ea8	Not Available;Not Available;Not Available;Not Available	1;1;1;1	160;160;Not Available;160	70;70;231;70	Paclitaxel;Cyclophosphamide;Tamoxifen;Doxorubicin	Not Available;Not Available;Not Available;Not Available	4;4;4;4	4;4;Not Available;4	175;600;20;60	mg/m2;mg/m2;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A1KO-F9898;TCGA-AO-A1KO-F20630	DA36CD69-A4AD-4365-8E14-29AAC2D9783B;345F758B-4506-48DC-87A7-25B67862B7DC	Not Available;None	Not Available;None	Not Available;None	1;20	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	448;622	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	4;2	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	4+	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	1	No	A1KO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T3	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A0CK	FEMALE	4159	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	1	1364.0	Other, specify	New Primary Tumor	TUMOR FREE				60	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0CK	5ACA16CA-4516-4E27-8249-6914029A7EBF	Negative	Positive	3 Point Scale	3+	3 Point Scale	Modified radical mastectomy	Positive	Lumpectomy	Not Applicable	NO	21	-22094	Not Applicable	0	3820	Not Available	NO	TCGA-A2-A0CK-D32654;TCGA-A2-A0CK-D32655;TCGA-A2-A0CK-D32656;TCGA-A2-A0CK-D42397;TCGA-A2-A0CK-D42398;TCGA-A2-A0CK-D42399	9B39167B-12F1-4113-A4B9-6D87C0D579F0;66EDDC61-9F6C-4BBA-A99E-BCD484A1A162;9C6B9B44-4C5B-42CD-8AA6-38038395E117;F5986AFE-856D-4225-B5CE-EA9C5922B674;DACB6594-4AB8-425A-8BF3-E16A2296F99E;DB784ADC-6137-423C-8F1C-5832E32592E5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;18;18;18	Not Available;Not Available;Not Available;1518;Not Available;Not Available	Not Available;Not Available;Not Available;1451;1569;Not Available	Adriamycin;Cytoxan;Taxol;Taxotere;Anastrozole;E-75	Complete Response;Complete Response;Complete Response;Complete Response;Not Available;Unknown	6;6;6;4;4;4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Vaccine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	2012;2012;2012;2013;2013;2013	Not Available	40-49%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A0CK-F42396	4AC2C5F2-CF56-492A-B095-C6D9640612E1				18			Not Applicable	4159																				NO																						4					YES	NO	1409	1364	Not Available	Not Available	Not Available	Not Available	50-59%	Positive	Not Available	Not Available	Not Available	Not Available	1.2	2+	3 Point Scale	1+	3 Point Scale	Negative	Negative	Not Available	Not Available	Not Available	Not Available	10-19%	Positive	Other, specify	New Primary Tumor	LEFT BREAST	YES	Not Available	YES	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Excisional Biopsy	Negative	Negative	20	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	4	Not Available	No	A0CK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	80-89%	WHITE	Not Available	Regional site;Regional site	TCGA-A2-A0CK-R32647;TCGA-A2-A0CK-R32653	4B8B651E-F54C-4EB0-AC3F-BFEFB8E3BF05;57C35411-3766-4C37-B699-47F58743FD98	Not Available;Not Available	5;6	280;280	243;243	Complete Response;Complete Response	6;6	Not Available;Not Available	5040;5040	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2001
TCGA-A2-A04W	FEMALE	3102	Other, specify	Breast	Alive	T2	N1mi	M0	Stage IIB	0	3102			TUMOR FREE				50	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A04W	00807dae-9f4a-4fd1-aac2-82eb11bf2afb	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	5	-18345	Not Applicable	0	1918	Not Available	Not Available	TCGA-A2-A04W-D6687;TCGA-A2-A04W-D6689;TCGA-A2-A04W-D6690;TCGA-A2-A04W-D6691;TCGA-A2-A04W-D6692	236eedf5-1416-4267-9403-20ce7d6acbf7;65ec14e5-944c-4f65-bd7f-af3f9f1de109;ce20855f-bc0d-4156-97a3-58368e52b5fa;ed0088f6-01ce-4f8a-99e1-998641ad9eac;a9c9c08e-0668-48ba-a67a-68928076d805	Not Available;Not Available;Not Available;Not Available;Not Available	7;7;10;10;10	100;100;191;352;Not Available	58;58;114;198;1023	Cytoxan;Adriamycin;Taxol;Herceptin;Zometa	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	4;4;12;18;Not Available	1100;110;147-148;146-463;4	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;3;4;5	IV;IV;IV;IV;IV	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Other, specify in notes	Not Available;Not Available;Not Available;Not Available;Bisphosphonate	4400;440;1768;4187;Not Available	mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A2-A04W-F9331;TCGA-A2-A04W-F59320	1A023862-902F-44D7-A002-1D289E1946EB;B47778FE-E5A6-4E67-86BC-1A39A7C39BFE	Not Available;None	Not Available;None	Not Available;None	18;8	Not Available;None	Not Available;None	Not Applicable;Not Applicable	1948;3102	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;5					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3.2	Not Available	Other, specify	Apocrine	No	C50.9	8401/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	1	Not Available	No	A04W	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2005
TCGA-A2-A1G6	FEMALE	501	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	501			TUMOR FREE				50	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A1G6	295cf595-4a29-46a3-a0c5-e5f08f947031	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	22	-18514	Not Applicable	0	132	Not Available	NO	TCGA-A2-A1G6-D12537;TCGA-A2-A1G6-D12532;TCGA-A2-A1G6-D12535	03170c14-0cc8-47b8-8211-e7feae86ed65;b86d0b45-cd36-46d7-9964-b170549420ac;57fef464-1259-484f-8b66-7473fa062401	Not Available;Not Available;Not Available	28;28;28	172;119;119	132;69;69	Docetaxel;Adriamycin;Cytoxan	Not Available;Not Available;Not Available	4;4;4	3;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	3;1;2	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A1G6-F20947	3427FD70-83B5-4A78-A617-838013915E15				9		Not Available	Not Applicable	501		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	4	Not Available	No	A1G6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site;Regional site;Regional site	TCGA-A2-A1G6-R20946;TCGA-A2-A1G6-R31779;TCGA-A2-A1G6-R31780	AF32408D-BB2D-4910-8E8A-B62DC6DDE68E;8A5DBB7F-2FCD-45AF-807E-57F4DE9EA749;0C5AA321-F0DC-4B91-9633-0CABB1EDE7C7	1;2;3	25;9;9	283;283;293	249;249;284	Not Available;Not Available;Not Available	1;5;5	25;25;8	4500;4500;1600	NO;NO;NO	EXTERNAL BEAM;EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;ADJUVANT;ADJUVANT	Not Available;Not Available;Not Available	cGy;cGy;cGy	2012;2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-EW-A1PF	FEMALE	439	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	439			TUMOR FREE				50	Right Upper Outer Quadrant	Other (specify)	sentinel + 2 non-sentinel LN	TCGA-EW-A1PF	848773a3-2f4a-4186-ab3f-de667129accf	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	27	-18384	Not Applicable	0	140	Not Available	NO	TCGA-EW-A1PF-D30298;TCGA-EW-A1PF-D30301;TCGA-EW-A1PF-D30302	7E4FD718-8A92-44C0-995A-555BC0DA3615;04D4281E-70C8-4C99-9286-AE02449AB775;513C4EA7-1EE9-4A4C-ACC1-535D859B1EC5	Not Available;Not Available;Not Available	8;8;8	188;188;Not Available	125;125;217	Docetaxel;Cyclophosphamide;Arimidex	Not Available;Not Available;Not Available	3;3;3	4;4;Not Available	130;1038;1	mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;2	IV;IV;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	524;4176;Not Available	mg;mg;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PF-F29109	9341ABC2-15C0-4C5D-B764-BB4F2E925C0F				8		Not Available	Not Applicable	439		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1PF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	total mastectomy	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A12E	FEMALE	2142	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i+)	M0	Stage IIB	0	2142			TUMOR FREE				51	Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-AO-A12E	2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	8	-18721	Not Applicable	0	1743	Not Available	Not Available	TCGA-AO-A12E-D5976;TCGA-AO-A12E-D5977;TCGA-AO-A12E-D5975;TCGA-AO-A12E-D5978	6aaca2a6-421f-4cc8-a564-961b2eeef1e4;e02b1a51-def1-423d-ae62-08bfedaa5d90;d57c2221-a1f2-48a8-9c17-4f74b834b465;8a8189d2-30da-4c99-b5d7-462cd2a6794e	Not Available;Not Available;Not Available;Not Available	10;10;10;10	127;184;127;Not Available	85;141;85;222	Doxorubicin;Paclitaxel;Cyclophosphamide;Tamoxifen	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;4;4;Not Available	60;175;600;20	mg/m2;mg/m2;mg/m2;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	408;1192;4080;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A12E-F5895;TCGA-AO-A12E-F19431	FD98FD53-49BB-464D-9AA5-3167BBC632BF;1CA8FF89-A5C5-4D7A-B043-F371A82CEA7C	Not Available;None	Not Available;None	Not Available;None	8;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1743;2142	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	1	No	A12E	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	WHITE	Not Available	Regional site	TCGA-AO-A12E-R5896	2f7dc558-30d7-46dc-8dfa-b8f59d9588bf	1	8	288	251	Not Available	12	28	10080	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T3	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2005
TCGA-C8-A12T	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE				43	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12T	71229981-97c2-4ae1-a130-fe5de336b37d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	11	Not Available	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Positive	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A12T	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 8	Allred Score 6	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A0X0	FEMALE	3945	Other, specify	Breast	Dead	T1c	N0 (i-)	M0	Stage I	0	3945			Not Available				54	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0X0	1e68e760-a4cf-4100-bf9c-e50fa8d126f6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	15	-19802	3945	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0X0-F15710	B50DBB7C-6050-4E27-9FE2-3D444CD297A0				29		Not Available	3945	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Cribiform	No	C50.919	8201/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	31	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0X0	Not Available	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2011	1996
TCGA-E2-A10C	FEMALE	1220	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1220			TUMOR FREE				54	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A10C	9ac44381-5d43-4f63-aa3f-7703bfc923c9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	11	-19849	Not Applicable	0	854	Not Available	Not Available	TCGA-E2-A10C-D7705;TCGA-E2-A10C-D7703;TCGA-E2-A10C-D7707;TCGA-E2-A10C-D7710;TCGA-E2-A10C-D17854	4cbad17f-9385-400c-bb9d-3a2291f3b143;5c41cc1b-b8b3-448c-93a2-c30024ccf123;d7774b1e-92e1-4644-a255-ea3a5ce1ad57;06a90674-8f6e-4a9b-97e0-2d52d0cf21dc;A35F5E09-22C4-4854-B838-0F4399668114	Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;26	252;139;343;Not Available;139	160;95;282;343;95	Taxol;Cytoxan;Arimidex;Femara;Adriamycin	Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;9	12;4;Not Available;Not Available;4	80;Not Available;1;2.5;Not Available	mg/m2/wk;Not Available;mg/day;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;3;4;1	IV;IV;PO;PO;IV	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	160;Not Available;1;Not Available;Not Available	mg/wk;Not Available;mg/day;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A10C-F17357	19E548DF-F99C-484B-84C4-C93E7FA746C6				26		Not Available	Not Applicable	1220		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	Not Available	No	A10C	TUMOR FREE	Allred score 3+3=6	Not Available	Not Available	Allred score 6	Allred score 8	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A10C-R7702	68221d80-766f-4c8b-b59b-029f87ad94d2	1	14	328	279	Not Available	2	29	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-OL-A5RY	FEMALE	752	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	MX	Stage IIA	0	752			WITH TUMOR				52	Right	Sentinel node biopsy alone	Not Available	TCGA-OL-A5RY	8360CEC6-DAF6-41C9-9A4F-7FC03C958DCC	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Negative	Lumpectomy	Not Applicable	Unknown	16	-19216	Not Applicable	0	429	Not Available	Not Available																								Not Available	10-19%	Unknown	Not Available	Not Available	Not Available					TCGA-OL-A5RY-F56565	EC19B71A-1285-42EF-836D-0AEA3910712B				14			Not Applicable	752																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Ultrasound-guided biopsy	Other method, specify:	Not Evaluated	Positive	25	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5RY	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2011
TCGA-BH-A18H	FEMALE	652	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	M0	Stage IA	0	652			Not Available				63	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A18H	878f975b-94fd-4d69-b7e7-1ed3ac2ee438	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	6	-23065	Not Applicable	0	0	Not Available	Not Available	TCGA-BH-A18H-D59201;TCGA-BH-A18H-D59202;TCGA-BH-A18H-D59203	79B05235-CBBB-4B01-819B-84C9483B56B7;0E5715EA-719D-42AE-8516-6AD9DA3F885F;8719BC2E-D714-4B56-8035-F3E2D07DD9CF	Not Available;Not Available;Not Available	2;2;2	118;118;219	34;34;118	Adriamycin;Cytoxan;Taxotere	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A18H-F59198	975B9460-CA44-4CE3-A700-C1FC9E8C97DE				2			Not Applicable	652																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Equivocal	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	Yes	A18H	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-BH-A18H-R59199;TCGA-BH-A18H-R59200	48AE0EED-8630-4FB3-B325-284F85E0652E;874B4EE2-C5FA-4C67-B91A-FB143D18AE49	Not Available;Not Available	2;2	259;266	219;260	Complete Response;Complete Response	5;5	28;5	50.4;10	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1b	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A130	FEMALE	370	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2	M0	Stage IIIA	0	370			TUMOR FREE				52	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A130	8cf54607-01ce-42b0-9bd9-8627edd9f3b7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	13	-19117	Not Applicable	0	4	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A130-F19091;TCGA-C8-A130-F70814	D72089AC-6F2C-4D82-BAF8-B9BC85F4C19E;ACA661FA-1BC0-459D-89D8-025D8D39E976				2;9		Not Available;None	Not Applicable;Not Applicable	96;370		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;Discrepancy		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	8	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A130	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 7	Allred Score 7	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A4S2	FEMALE	643	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N2	M0	Stage IIIA	0	643			TUMOR FREE				62	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A4S2	9DDC014D-9A8B-407B-845F-452A73F08E5E	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-22936	Not Applicable	0	205	Not Available	Not Available	TCGA-A2-A4S2-D40762;TCGA-A2-A4S2-D40763;TCGA-A2-A4S2-D40764;TCGA-A2-A4S2-D59084	72B353D4-7256-4161-B9C8-EA9FDC872D78;30184077-58DE-45BD-94A3-1F57F5419536;B81A498A-A3FC-4E99-A912-6B5CBC9E288D;8B0F87F5-E925-40EB-9A72-E44475BF4CB3	Not Available;Not Available;Not Available;Not Available	28;28;28;30	96;96;173;Not Available	47;47;110;261	Adriamycin;Cytoxan;Paclitaxel;Arimidex	Complete Response;Complete Response;Complete Response;Not Available	2;2;2;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A4S2-F59085	89751129-F1B3-48E2-9375-C334B436639B				30			Not Applicable	643																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8524/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	0	No	A4S2	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	NO	Regional site;Regional site;Regional site	TCGA-A2-A4S2-R59112;TCGA-A2-A4S2-R59114;TCGA-A2-A4S2-R59116	DEAE1C6E-08EF-4645-92DA-D80F6A0E5147;7B603231-EF4A-4100-AB4A-ACEAF43C323D;5330A79E-4763-4522-A54F-B042170DDBAC	Not Available;Not Available;Not Available	1;1;1	260;260;271	224;224;261	Complete Response;Complete Response;Complete Response	5;5;5	25;25;7	4500;4500;1400	NO;NO;NO	External;External;External	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2014;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2013	2012
TCGA-AR-A0TX	FEMALE	1972	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	1972			Not Available				64	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AR-A0TX	c364e81c-eb1e-4870-ab37-9c661f5f2e3d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	10	-23653	Not Applicable	0	15	Not Available	Not Available																								Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0TX-F18770;TCGA-AR-A0TX-F49468;TCGA-AR-A0TX-F63939	2209AE18-3C7D-4B37-B4E6-7AF69F83F2DE;430C16CF-997B-4D57-9615-B27A264E0BEA;25A1DB00-F68E-4BAB-BFFD-B8FF97587207				16;2;21		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1972;1972;1972		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;8	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;Unknown	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			Not Available;Not Available;Unknown		YES;YES;YES	Alive;Alive;Alive	2011;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	3	Not Available	No	A0TX	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-AR-A0TX-R19619	BA27F3B1-95DB-46EC-A3DC-2BC907DF01CD	Not Available	16	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-A7-A6VY	FEMALE	266	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	266			TUMOR FREE				48	Right;Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A6VY	E8EA576B-EB16-44F7-B241-DAEFC1375388	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	25	-17640	Not Applicable	0	125	Not Available	Not Available	TCGA-A7-A6VY-D57229;TCGA-A7-A6VY-D57230;TCGA-A7-A6VY-D57231	5D3D1784-E381-460E-B773-DE56BABA6BCF;2DB83098-CA32-424E-ACFA-3207D2899E95;5D349A3C-E310-48A5-A0E1-248ABE65246D	Not Available;Not Available;Not Available	6;6;6	111;111;167	68;68;126	Cyclophosphamide;Doxorubicin;Paclitaxel	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A6VY-F57257	11D83905-3096-497D-A947-096697D1CD40				6			Not Applicable	266																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	2	Not Available	No	A6VY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field;Primary Tumor Field	TCGA-A7-A6VY-R57255;TCGA-A7-A6VY-R57256	395D4E07-8431-402C-932F-61689DB69B9E;E45FC357-F0D6-4CAF-A745-480BB0BD7C42	Not Available;Not Available	6;6	247;266	211;251	Complete Response;Complete Response	3;3	25;10	4500;2000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2013
TCGA-E2-A1B5	FEMALE	984	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	984			TUMOR FREE				46	Left	Sentinel node biopsy alone	Not Available	TCGA-E2-A1B5	7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	25	-17039	Not Applicable	0	774	Not Available	NO	TCGA-E2-A1B5-D19397;TCGA-E2-A1B5-D19408;TCGA-E2-A1B5-D19400	CB3816CF-67CB-4392-B82C-D7FC2F387357;EE248DCA-EF7B-4120-BC49-86460A2BD750;D6F378A8-CE13-4C40-A22C-63B7D803BC36	Not Available;Not Available;Not Available	8;8;8	190;Not Available;190	Not Available;190;Not Available	taxol;tamoxifen;cytoxan	Not Available;Not Available;Not Available	12;12;12	Not Available;Not Available;Not Available	Not Available;20;Not Available	Not Available;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;mg;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1B5-F19393	C39FB1AF-80F5-4372-B7A6-02C6E902D4DB				8		Not Available	Not Applicable	984		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1B5	TUMOR FREE	Allred score 2+3 = 5	Not Available	Not Available	Allred score = 5	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1B5-R19413	AA902F8D-0E4A-40C2-BE07-BED2DD67E7DC	1	8	174	130	Not Available	12	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-B6-A0IA	FEMALE	8391	Other, specify	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	8391			TUMOR FREE				51	Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IA	0807435a-e75e-4e04-8e45-ed0cd49a841a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	2	-18748	Not Applicable	0	6719	Not Available	Not Available																								IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0IA-F12610;TCGA-B6-A0IA-F71513	4D334E64-3DE2-4A7D-BEAC-5E9B8813CA01;0F55E065-C77C-4851-8F2E-1E223AF5CE7C				1;26		Not Available;None	Not Applicable;Not Applicable	6719;8391		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal/Cribiform	No	C50.9	8523/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	15	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0IA	TUMOR FREE	IHC	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Excisional biopsy	NO	YES	B6	Breast	Not Applicable	Alive	2010	1992
TCGA-C8-A27A	FEMALE	747	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	747			TUMOR FREE				48	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-C8-A27A	3b1f7e48-216d-47de-ba79-db350f52bff0	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	21	-17779	Not Applicable	0	371	Not Available	Not Available	TCGA-C8-A27A-D70787;TCGA-C8-A27A-D70788;TCGA-C8-A27A-D70789;TCGA-C8-A27A-D70790	839564A6-2E39-4BCE-9DCC-20EF59A3ABBB;1E7B539F-54D5-456B-B74C-EBEB8406CD24;9E9A47A2-2C29-46A6-8CB5-842A186DA178;C72AD225-877E-4C85-904D-850850DAD36A	Not Available;Not Available;Not Available;Not Available	9;9;9;9	434;434;434;434	411;411;411;411	5-Flourouracil;Doxorubicin;Cyclophosphamide;Taxol	Complete Response;Complete Response;Complete Response;Complete Response	3;3;3;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2015;2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A27A-F70786	ED1A7238-3D18-4031-891C-4DB84E6DCB36				9			Not Applicable	747																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A27A	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Allred Score 7	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A1L8	FEMALE	2240	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2240			TUMOR FREE				52	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A1L8	eebad74f-5961-4e91-b0eb-157a2f6f952b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	7	-19187	Not Applicable	0	1015	Not Available	NO	TCGA-E2-A1L8-D20579;TCGA-E2-A1L8-D20582;TCGA-E2-A1L8-D20584;TCGA-E2-A1L8-D20580;TCGA-E2-A1L8-D20581	93A3B706-6851-4D5B-94A6-715C910C6825;5D31DD41-67CF-4788-B56F-452F014B7821;04419A9C-960A-495A-B91F-48F2C8876597;D86361A9-8F77-4C1D-AF65-1E775A676B4E;00FD3E45-CD1B-4F71-915F-C2CF8C467F22	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	99;Not Available;Not Available;99;155	57;211;246;57;113	Cyclophosphamide;Clodronate;Arimidex;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	3;Not Available;Not Available;3;4	1320;1600;1;132;428	mg;mg/day;mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;4;1;2	IV;PO;PO;IV;IV	NO;YES;YES;NO;NO	Chemotherapy;Other, specify in notes;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Phase III Clinical Trial;Not Available;Not Available;Not Available	3960;1600;1;396;1712	mg;mg/day;mg/day;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	allred score 5 + 3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1L8-F20578;TCGA-E2-A1L8-F70018	0B9DBEFA-1DF5-45D1-89E1-30BB4C92D599;8F1CA815-127E-49BE-AB1C-538DC9D42ACA				11;9		Not Available;None	Not Applicable;Not Applicable	1205;2240		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	40-49%	Not Available	2+	Not Available	Not Available	Not Available	1.10	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	Not Available	Yes	A1L8	TUMOR FREE	allred score 4 + 3 = 7	Not Available	Not Available	allred score = 7	allred score = 8	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Regional site	TCGA-E2-A1L8-R20585	FD3CF554-DCE8-4A47-B16B-CFC4D70AF7DA	1	11	245	198	Not Available	1	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A0BW	FEMALE	2371	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	2371			TUMOR FREE				71	Left Lower Outer Quadrant	Not Available	Not Available	TCGA-BH-A0BW	5d1d00c6-fcae-479e-ae1e-de76efd41d98	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	10	-25974	Not Applicable	0	355	Not Available	NO	TCGA-BH-A0BW-D59133;TCGA-BH-A0BW-D59134	AFDD7926-10D2-458F-9188-C9634F0A81A6;E47D5A3A-3F23-45FE-AFF6-035D2D0D84BA	Not Available;Not Available	1;1	114;114	51;51	Adriamycin;Cytoxan	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BW-F59127	B292C3C3-6CCE-4DB3-B3E2-B262836D0F7D				1			Not Applicable	2371																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Negative	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-BH-A0BW-R59129;TCGA-BH-A0BW-R59130	5D553E5C-3989-41EC-84FD-DB87F4560DE7;E65FC14F-8CC3-4FC3-8C54-D99CF8CB0D50	Not Available;Not Available	1;1	184;196	146;187	Complete Response;Complete Response	5;5	28;Not Available	50.4;16	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Gy;Gy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-AC-A2FE	FEMALE	2636	Infiltrating Lobular Carcinoma	Breast	Dead	T3	N3a	MX	Stage IIIC	1	766.0	Bone	Distant Metastasis	WITH TUMOR				62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A2FE	F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	3	-22746	Not Applicable	0	791	Not Available	Not Available	TCGA-AC-A2FE-D37368;TCGA-AC-A2FE-D37369;TCGA-AC-A2FE-D37370;TCGA-AC-A2FE-D47779;TCGA-AC-A2FE-D47781;TCGA-AC-A2FE-D47782	B60BCD38-9FFA-43B5-B2C0-C855C05883BB;516F7FB6-37E9-4E44-AD00-37D688CD51FA;4DF74C32-567B-4238-B008-44BA2231AC3A;A99BF733-8B3D-4B21-921E-79FDE40A04AF;8AC64C61-1BA6-4891-B438-AFF91FC30F54;E2A083D8-3A0B-465B-9603-BE32342ACC48	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;28;28;28	173;173;Not Available;173;Not Available;Not Available	67;67;273;67;2516;2516	Adriamycin;Taxol;Arimidex;Cytoxan;Xeloda;Abraxane	Partial Response;Partial Response;Not Available;Complete Response;Clinical Progressive Disease;Clinical Progressive Disease	12;12;12;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;Not Available;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2013;2013;2013	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2FE-F47723;TCGA-AC-A2FE-F47725	D5ADEC6C-7EEA-4059-A611-D95C59BE08DD;19EC4E99-4AD7-41C8-A15C-7B826C486A39				28;28			Not Applicable;2636	2240;Not Available																				NO;NO																						8;8					NO;YES	YES;NO	Not Available;Not Available	766;2496	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Evaluated;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Evaluated;Not Evaluated	Not Evaluated;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Evaluated;Not Evaluated	Bone;Liver	Distant Metastasis;Distant Metastasis	Not Available;Not Available	NO;NO	Not Available;Not Available	YES;YES	WITH TUMOR;WITH TUMOR						YES;Not Available		YES;Not Available	Alive;Dead	2013;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	NO	YES	Not Available	766	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Bone	Distant Metastasis	Not Available	NO	Not Available	YES	18	Not Available	No	A2FE	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	WHITE	YES	Primary Tumor Field;Distant site	TCGA-AC-A2FE-R37361;TCGA-AC-A2FE-R37371	C5673D17-EA8E-4D12-A7A5-B160F1177F64;FA6DFCE6-F2F8-4D52-B805-C1B07A828C99	Not Available;Not Available	3;3	219;813	178;791	Partial Response;Partial Response	12;12	28;Not Available	5040;Not Available	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;Not Available	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N3a	T3	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2012	2005
TCGA-BH-A0B1	FEMALE	1148	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1148			TUMOR FREE				66	Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0B1	b4e4fea2-b802-4a86-923e-3fcbd3c708fe	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	3	-24315	Not Applicable	0	1148	Not Available	Not Available	TCGA-BH-A0B1-D15430;TCGA-BH-A0B1-D15432;TCGA-BH-A0B1-D15431;TCGA-BH-A0B1-D15433	1B65710D-8E59-4084-9524-988DEC29A8B3;03678C40-36FA-410E-8D6E-C971338392FB;7DBDAF3F-FD88-4F6B-8AD8-B6E6830A8D92;79FCFCBC-5F07-4265-95FB-659E6537BF46	Not Available;Not Available;Not Available;Not Available	3;3;3;3	232;311;232;Not Available	53;251;53;269	Adriamycin;Paclitaxel;Cytoxan;Arimidex	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;4;4;Not Available	Not Available;Not Available;Not Available;1	Not Available;Not Available;Not Available;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0B1-F15429	555CC286-5677-4A66-8FD4-E7B131D2E99B				3		Not Available	Not Applicable	1148		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	0	No	A0B1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0B1-R15434	6CBDF1E7-E2BB-4EEC-9C61-547430A54E0A	1	3	343	287	Not Available	11	28	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-BH-A1EO	FEMALE	2798	Mixed Histology (please specify)	Breast	Dead	T1c	N1	M0	Stage IIA	0	2798			TUMOR FREE				68	Right	Not Available	Not Available	TCGA-BH-A1EO	4510295e-8aa7-4ef1-b2b7-91cc902f8200	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	6	-25136	2798	0	Not Available	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	ductal and lobular features	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Not Available	15	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	Not Available	No	A1EO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	right segmental mastectomy witrh axillary node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1999
TCGA-A8-A099	FEMALE	304	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N3a	MX	Stage X	0	304			Not Available				76	Right	Not Available	Not Available	TCGA-A8-A099	e98b69bc-766a-485f-b5e8-9166b8d457b3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-28063	Not Applicable	0	304	Not Available	Not Available	TCGA-A8-A099-D37807	0287D246-1FC1-4967-B545-E9D3A91C35A9	n/a	6	Not Available	61	Exemestane	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A099-F40552	B6F0CCAB-A857-4381-8721-9D235581ADA6				23			Not Applicable	304																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Unknown						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A099	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A099-R38167	E30C6BD0-6060-41EC-8F04-8DA25A39056F	Not Available	11	123	92	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N3a	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AC-A62V	MALE	348	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1a	M1	Stage IV	1				WITH TUMOR				58	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A62V	D5F2B85A-94A9-4168-BBE8-149EC71342B0	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-21389	Not Applicable	0	2	Not Available	Not Available	TCGA-AC-A62V-D60179;TCGA-AC-A62V-D60180	1206FBA9-884A-4E22-8D01-5CFD61F171AD;356FD6D4-61DF-485A-AB87-3A4A43CFC9B7	Not Available;Not Available	31;31	266;245	21;114	Denosumab;Paclitaxel	Partial Response;Partial Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Ancillary;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Bone	Not Available	Not Available					TCGA-AC-A62V-F60177	CB4E105E-D21E-4F43-A860-F45AEEAD0E9A				31			348	Not Available																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						YES		YES	Dead	2014	MALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	17	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	Not Available	No	A62V	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	BLACK OR AFRICAN AMERICAN	Unknown	Distant site	TCGA-AC-A62V-R60178	6A2AE9B0-D973-40FF-9BC8-C68CA9049408	Not Available	31	46	21	Partial Response	5	13	3250	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M1	N1a	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2013
TCGA-A8-A06O	FEMALE	396	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	396			TUMOR FREE				60	Left	Not Available	Not Available	TCGA-A8-A06O	69054195-9e93-49e5-b820-69b0091cc2d4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-22157	Not Applicable	0	396	Not Available	Not Available	TCGA-A8-A06O-D37896	C45C3AB5-2102-4DC9-AABA-2E722C048077	Not Available	6	Not Available	62	Letrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A06O-F40806	9AAAC44E-7751-40C8-84B7-D95B4899BABF				1			Not Applicable	396																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06O	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AC-A3OD	FEMALE	451	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	451			TUMOR FREE				68	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A3OD	F2622CDB-AC92-42B3-A1CA-67E133C3DD4A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	19	-25186	Not Applicable	0	35	Not Available	NO																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3OD-F45582	1C298E20-D286-4A08-9193-1AB7F91CC8BD				17			Not Applicable	451																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A3OD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A3OD-R45583	976C8875-AC78-48C4-AD55-5DFCB541E560	Not Available	17	120	76	Complete Response	7	25	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-E2-A109	FEMALE	1417	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1417			Not Available				64	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A109	f0787165-6f58-4d67-b510-928eea2c4882	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	11	-23521	Not Applicable	0	1172	Not Available	Not Available	TCGA-E2-A109-D7772;TCGA-E2-A109-D7765;TCGA-E2-A109-D7760;TCGA-E2-A109-D7769;TCGA-E2-A109-D7762;TCGA-E2-A109-D7764;TCGA-E2-A109-D7763;TCGA-E2-A109-D7767	c3820a88-cd09-4aa5-bfb5-d4812af05d33;c11ab503-55a1-4706-8e19-4306df0021b6;87fba7ad-05d6-4c59-a6de-0c0c59379e51;c186939c-e896-47d0-8370-b151b3b79e00;596420b7-1032-4b1e-bac4-031b00ef07c2;c755119e-684b-49ba-9d65-985dcde6d41b;8df90aa0-372a-4649-9663-282c2d48b544;db4b5ad5-5f00-43e8-8a2c-e32766f985ff	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14;14;14;14	Not Available;685;215;807;209;608;300;734	857;643;111;734;111;318;230;699	Femara;Aromasin;Cytoxan;Tamoxifen;Adriamycin;Arimidex;Taxol;Femara	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2	Not Available;Not Available;15;Not Available;15;Not Available;6;Not Available	2.5;25;60;20;24;1;367;2.5	mg/day;mg/day;mg/m2/day;mg/day;mg/m2/day;mg/day;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	6;3;1;5;1;2;1;4	PO;PO;PO;PO;IV;PO;IV;PO	YES;NO;NO;NO;NO;NO;NO;NO	Hormone Therapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2.5;25;125;20;52;1;2202;2.5	mg/day;mg/day;mg/day;mg/day;mg/wk;mg/day;mg;mg/day	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011	Allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A109-F17418	52DADCDC-5F66-4C71-8D5F-3BCE69F19291				9		Not Available	Not Applicable	1417		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	50-59%	Not Available	2+	Not Available	Not Available	Not Available	1.46	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A109	Not Available	Allred score 0+0=0	Not Available	Not Available	Allred score 0	Allred score 8	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-AC-A8OR	FEMALE	40	Mucinous Carcinoma	Breast	Alive	T1c	N0 (i-)	MX	Stage IA	0	40			TUMOR FREE				75	Left	Sentinel node biopsy alone	Not Available	TCGA-AC-A8OR	8CD1BA0B-EAD9-4661-A796-6C9DBF1C42CD	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-27605	Not Applicable	0	40	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A8OR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	90-99%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T1c	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2013
TCGA-BH-A0W5	FEMALE	1288	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	1288			TUMOR FREE				77	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0W5	da9c10ea-c13f-4d88-8b94-a0cbc106d036	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	15	-28304	Not Applicable	0	543	Not Available	Not Available	TCGA-BH-A0W5-D34071	985E78AA-4536-424D-A1B5-8510D98A84D5	Not Available	29	144	22	Arimidex	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0W5-F34070	82D27FD8-ED77-4388-9C3F-711EDCEF3A4D				29		Not Available	Not Applicable	1288		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Equivocal	11	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	1	No	A0W5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0W5-R34072	38458462-2593-488B-927B-D274D9182D8F	Not Available	29	144	113	Complete Response	7	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A15K	FEMALE	275	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	275			TUMOR FREE				58	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A15K	17c1d42c-cb84-4655-a4cd-b54bae17ecaf	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-21514	Not Applicable	0	34	Not Available	NO	TCGA-E2-A15K-D18871;TCGA-E2-A15K-D18877;TCGA-E2-A15K-D18874	9C486924-7EF1-47D8-B98A-2676AE270FE8;DFF4C694-40E2-4F27-BDD5-0AF99106E3C5;06D39A90-4056-428C-A6A2-7AEF31C3FE5C	Not Available;Not Available;Not Available	15;15;15	131;208;131	61;146;61	Adriamycin;Taxol;Cytoxan	Not Available;Not Available;Not Available	11;11;11	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15K-F18869	0C192618-60F0-4ED8-B0BA-0873916821EE				15		Not Available	Not Applicable	275		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	0.9	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	2	Not Available	No	A15K	TUMOR FREE	Allred score 2+2 = 4	Not Available	Not Available	Allred score = 4	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A15K-R18879	597CFDF4-47EE-4CFD-8D2B-66BD1D75DE2B	1	15	273	232	Not Available	11	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-EW-A1J3	FEMALE	504	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	504			TUMOR FREE				61	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A1J3	bb1de798-0c02-437e-b539-33cb556d3993	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	18	-22332	Not Applicable	0	252	Not Available	NO	TCGA-EW-A1J3-D21352;TCGA-EW-A1J3-D21617;TCGA-EW-A1J3-D29268;TCGA-EW-A1J3-D29269	FB07AE31-7F2E-4B1D-887E-770458A579BB;1A6110CD-1997-41AA-8625-90D2731C06FF;5C005F17-6282-4637-A5C3-3E033262CDBD;683A449C-7376-4BF2-BF3D-29B8A6B2B6A7	Not Available;Not Available;Not Available;Not Available	10;16;13;13	294;Not Available;294;294	189;336;189;189	Carboplatin;Arimidex;Docetaxel;Trastuzumab	Not Available;Not Available;Not Available;Not Available	2;2;3;3	6;Not Available;6;6	6;1;100;6	AUC;mg/day;mg;mg/kg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	TCH;Not Available;TCH;TCH	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1J3-F21351	54FFFA80-83D5-486F-9A9C-5D2F9B13221F				6		Not Available	Not Applicable	504		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1J3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	TOTAL MASTECTOMY	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A27M	FEMALE	410	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	410			TUMOR FREE				59	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A27M	ae65baeb-6b78-492a-8c63-bb7e93e83dc2	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	17	-21910	Not Applicable	0	145	Not Available	NO	TCGA-D8-A27M-D29593	0BE1EFFF-4959-45B6-A90D-D5954D024746	Not Available	26	238	84	methotrexate+5 fluorouracil+cyclophosphamide	Not Available	3	6	40+600+100	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	240+3600+600	mg	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27M-F29592	F7028889-8575-484F-8C51-2F75DA0740BC				26		Not Available	Not Applicable	410		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A27M	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A0A1	FEMALE	365	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	365			TUMOR FREE				84	Right	Not Available	Not Available	TCGA-A8-A0A1	3efa245d-177d-4ef9-94f7-f554c54e345e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-30742	Not Applicable	0	365	Not Available	Not Available	TCGA-A8-A0A1-D37902	A7EE46AB-50EC-4F0E-9E46-F0C31EC14204	Not Available	6	Not Available	31	Tamoxifen	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0A1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A8FY	FEMALE	295	Infiltrating Lobular Carcinoma	Breast	Dead	T1c	N0 (i+)	M0	Stage IA	0	295			TUMOR FREE				87	Left;Left Upper Outer Quadrant;Left Lower Outer Quadrant	Not Available	Not Available	TCGA-BH-A8FY	5F4D16AA-9CC4-4EDB-B714-394E2661439A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	25	-31932	295	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	Yes	A8FY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T1c	Not Available	YES	NO	BH	Breast	Not Applicable	Dead	2014	2012
TCGA-AO-A12G	FEMALE	1639	Other, specify	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	1639			TUMOR FREE				75	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A12G	58c56d4b-3f85-4aad-a779-5f9e1791677d	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	8	-27705	Not Applicable	0	1266	Not Available	Not Available	TCGA-AO-A12G-D5982	b5ce13aa-ba6c-49c3-aa75-d881b89317cb	Not Available	10	Not Available	177	Arimidex (Anastrozole)	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	67	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A12G-F5907;TCGA-AO-A12G-F19448	0CCA8F63-EBA9-483E-8780-5F9E43AFE3B5;7E5B69F5-8504-4C78-8405-AC9D2989C122	Not Available;None	Not Available;None	Not Available;None	8;16	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1266;1639	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;6	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	Not Available	Not Available	>=2.0 Positive	2+	23	Not Available	66	1.0	Not Available	Other, specify	pleomorphic infiltrating lobular carcinoma	No	C50.9	8022/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Positive	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	1	No	A12G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30-39%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2006
TCGA-A7-A26E	FEMALE	954	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1a	MX	Stage IIIA	0	954			TUMOR FREE		FPPP	TCGA	71	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A26E	011b9b2d-ebe5-42bf-9662-d922faccc7a1	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	28	-26274	Not Applicable	0	421	Not Available	NO	TCGA-A7-A26E-D14334;TCGA-A7-A26E-D14322;TCGA-A7-A26E-D14323	0C2B9A8F-545C-48C7-A411-6086687670A8;C7645868-53FA-4051-9EEE-5F7F6FD7DEB5;BFCADEC4-0E84-4052-BA0C-C5F91DCDE496	Not Available;Not Available;Not Available	28;28;28	Not Available;164;164	247;101;101	Arimidex;Cytoxan;Taxotere	Not Available;Not Available;Not Available	7;7;7	174;4;4	1;1000;130	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;4000;520	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A26E-F14328;TCGA-A7-A26E-F39792	F9E29A3B-E71E-4720-B9B3-C9E1DA264FDA;3EB59670-FB49-4558-A017-3800A97063FB				28;1		Not Available;None	Not Applicable;Not Applicable	421;954		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	Yes	A26E	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	20-29%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A26E-R14325	1308CF80-262B-4503-AA14-B83907126CA2	1	28	246	205	Not Available	7	54	9720	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T3	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A15R	FEMALE	1732	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	1732			TUMOR FREE				64	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A15R	33b7bf50-53f4-4839-aa83-9665f85671d8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	14	-23570	Not Applicable	0	330	Not Available	NO	TCGA-E2-A15R-D19171;TCGA-E2-A15R-D19172;TCGA-E2-A15R-D19174;TCGA-E2-A15R-D19173	28619333-01BE-42CB-9524-04AFE22A9D84;14E71F28-E7FC-4F5A-AAB3-781734D03604;1A8B3B00-0153-4DD2-8AC8-804B467C84CF;1B56D8BF-E538-4CCC-B9F5-1F7CC5EA6366	Not Available;Not Available;Not Available;Not Available	16;16;16;16	134;134;Not Available;197	92;92;266;148	cyclophosphamide;doxorubicin;arimidex;paclitaxel	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;4;Not Available;4	900;90;1;268	mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	01;01;03;02	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3600;360;Not Available;1072	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	1.9	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A15R-F19170;TCGA-E2-A15R-F70011	2324E485-E1D1-4060-BC35-34CC59F89FD8;942E79FF-F95B-4D03-A700-778F79C4083A				16;9		Not Available;None	Not Applicable;Not Applicable	519;1732		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	2.4	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	3	Not Available	No	A15R	TUMOR FREE	Allred score 2+2 = 4	Not Available	Not Available	Allred score = 4	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A15R-R19175	DD5ECAD9-B60E-43D2-A390-69CCC0C71FD3	01	16	267	218	Not Available	11	33	5900	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A1X7	FEMALE	509	Other, specify	Breast	Alive	T2	N0	MX	Stage IIA	0	509			Not Available				40	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1X7	cdab777e-62de-4d51-92af-b6eb089c111f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	9	-14858	Not Applicable	0	85	Not Available	NO	TCGA-D8-A1X7-D29986	F5CBC7F0-42CF-407F-8F28-441B89B91D06	Not Available	31	134	64	doxorubicine+cyclophosphamide+tamoxifen	Not Available	3	Not Available	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV;PO	NO	Chemotherapy;Hormone Therapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1X7-F29985	DBB236CA-AAC6-48BD-B702-95BA93EBE283				31		Not Available	Not Applicable	509		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal partially papillary	No	C50.9	8503/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1X7	Not Available	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0BC	FEMALE	974	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	0	974			TUMOR FREE				60	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0BC	327a2395-85c8-42e1-9638-8e037a1723ed	Not Available	Positive	Not Available	1+	Not Available	Not Available	Positive	Other	Not Applicable	NO	4	-21949	Not Applicable	0	974	Not Available	Not Available	TCGA-BH-A0BC-D15409;TCGA-BH-A0BC-D15413;TCGA-BH-A0BC-D15411;TCGA-BH-A0BC-D15408;TCGA-BH-A0BC-D15412	25DE46D5-5A3F-4DAC-A98E-5BFE3430C05F;EA6A86CD-D2D8-4A14-BF9C-4D1918CABE51;4D2FEA19-8DBD-4372-B1A8-4A983BB9D901;748DA09C-F045-4030-9629-73419051E23E;599CEF77-9455-48E3-9C50-7119D3A37F58	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	169;900;169;Not Available;239	106;795;106;106;190	Doxorubicin;Docetaxel;CYCLOPHOSPHAMIDE;Arimidex;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	4;6;4;Not Available;12	124;130;1236;1;164	mg;mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1	IV;IV;IV;PO;IV	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	495;785;4944;Not Available;1264	mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0BC-F4487	4825C6EA-F0A2-4F0C-9BF7-ABE3F09863B9	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Applicable	974	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	No	A0BC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30-39%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BC-R15414	3B79C753-1212-4F23-BC19-498992CDF995	1	4	361	312	Not Available	11	32	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-AN-A0FD	FEMALE	196	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	196			TUMOR FREE				71	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AN-A0FD	c6086936-7544-4da0-8c0c-114166848483	Not Available	Positive	Not Available	1+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	20	-26007	Not Applicable	0	196	Not Available	Not Available																								dextran coated charcoal	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FD-F68949	9FB2953C-EB8B-42E6-AF03-F9EF349ADA40				23			Not Applicable	196																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	dextran coated charcoal	60-69%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Tumor resection	Positive	Positive	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FD	TUMOR FREE	dextran coated charcoal	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-E9-A22D	FEMALE	1248	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1248			TUMOR FREE				38	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A22D	cf0a3f38-5850-44e1-8574-808bd37d84a3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	2	-14115	Not Applicable	0	0	Not Available	Not Available	TCGA-E9-A22D-D29929;TCGA-E9-A22D-D29928;TCGA-E9-A22D-D29927;TCGA-E9-A22D-D29913	CC819813-FFDB-48CC-BE92-4A82FEC5E8FA;291C8DBC-432A-4B49-BDD4-FEDCC82245C1;19D3B016-37B3-4CD9-8EAD-68E4AE3A15C4;B2DEB206-A8C5-4371-9443-BC4CE3883311	Not Available;Not Available;Not Available;Not Available	30;30;30;30	Not Available;189;189;189	193;16;16;16	Tamoxifen;5-Fluorouracil;Cyclophosphane;Doxorubicin	Not Available;Not Available;Not Available;Not Available	3;3;3;3	Not Available;6;6;6	20;900;900;90	mg/day;mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3160;3600;3600;360	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A22D-F29912;TCGA-E9-A22D-F39787	E2BBDAB7-AC72-4F40-B2CF-8892D5B09CD1;708BFBE6-3708-4A7E-A6BA-1AFC6260F3EC				27;1		Not Available;None	Not Applicable;Not Applicable	402;1248		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2013;2013	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A22D	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AN-A0AS	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	10			TUMOR FREE				70	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A0AS	7c2a8440-0206-4039-8474-8d62f6c7de0c	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-25658	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AS-F68947	6DA8757D-7D76-4A0B-B31F-24A36D38E1F8				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	4	0	No	A0AS	TUMOR FREE	Not Available	Not Available	Not Available	0	190	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-BH-A0GZ	FEMALE	328	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	328			TUMOR FREE				62	Left Upper Inner Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0GZ	27dfb9d4-3a2c-44bc-9acf-8f638d3f3004	Negative	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	10	-22714	Not Applicable	0	328	Not Available	Not Available	TCGA-BH-A0GZ-D4691	DF515EB3-0AC1-4BBE-B0F5-D74BBA8B245C	Not Available	17	Not Available	157	ARIMIDEX	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-SCORE 300	90-99%	Not Available	Not Available	Not Available	2.08	NO	NO	NO	NO	TCGA-BH-A0GZ-F4697	6B3FE8B6-3E78-48C6-8CE0-77EFFD2F5DF5	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	328	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	2.2	1.05	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A0GZ	TUMOR FREE	H-SCORE 280	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0GZ-R4693	2C0E7F31-3FAC-443E-BBDB-9DDEF10114BA	1	17	Not Available	Not Available	Not Available	11	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-D8-A1Y0	FEMALE	472	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N2a	MX	Stage IIIA	0	472			TUMOR FREE				65	Left	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1Y0	ced2c048-b047-43ff-b0e7-cd7ad480850c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	9	-24083	Not Applicable	0	167	Not Available	NO	TCGA-D8-A1Y0-D30083;TCGA-D8-A1Y0-D30082	E9799A77-D625-4619-8775-110F09A13235;2E4B995D-B134-417F-8651-39114BCED462	Not Available;Not Available	2;2	Not Available;167	540;62	tamoxiphene;cyclophosphamide+methotrexatum+fluorouracillum	Not Available;Not Available	4;4	Not Available;6	20;970+58.2+970	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	PO;IV	YES;NO	Hormone Therapy;Chemotherapy	Not Available;Not Available	Not Available;5820+349.2+5820	mg;mg	Not Available;Not Available	2012;2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1Y0-F30080	A1CF1328-C069-4C74-80C9-4C569F082DC1				2		Not Available	Not Applicable	472		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Negative	Not Evaluated	15	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	9	Not Available	No	A1Y0	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1Y0-R30081	432151C6-E47F-4973-B1B2-57622A49678E	Not Available	2	232	201	Not Available	4	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A259	FEMALE	1596	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	1596			TUMOR FREE				70	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A259	3fc3755d-a3f8-4e2c-813f-ff124f2a75c1	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	20	-25666	Not Applicable	0	1286	Not Available	NO	TCGA-A2-A259-D14577	F4C128EF-E7C2-407A-833B-C1EC52088D3D	Not Available	20	Not Available	96	Arimidex	Not Available	7	Not Available	1	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	125	Not Available	Not Available	Not Available		TCGA-A2-A259-F31034	91F2A594-2323-476B-9FE1-3BE4B7A05EFB				23		Not Available	Not Applicable	1596		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	132	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A259	TUMOR FREE	Not Available	Not Available	Not Available	Strong using Weak, Moderate and Strong	Strong using Weak, Moderate and Strong	Not Available	YES	80-89%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2007
TCGA-PL-A8LV	FEMALE		Medullary Carcinoma	Breast		T4	N0	M0	Stage IIIB	0				WITH TUMOR				54	Right;Right Upper Outer Quadrant	No axillary staging	Not Available	TCGA-PL-A8LV	389E5B18-8F89-41A9-9FA5-EFD4172836E2	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	25	-19746	Not Applicable	0	-7	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-PL-A8LV-F64849	4E70ED42-A1AA-48DD-81F7-E7153F19F679				17			Not Applicable	-7																				YES																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Unknown						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Not Evaluated	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	Not Available	Not Available	No	A8LV	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	NO	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T4	Not Available	YES	NO	PL	Breast	Not Applicable	Alive	2014	2013
TCGA-GM-A4E0	FEMALE	2191	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3a	M0	Stage IIIC	0	2191			TUMOR FREE				67	Left;Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-GM-A4E0	6397D7BC-9CB1-4A84-81AD-76954E0A8CEE	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	26	-24788	Not Applicable	0	1753	Not Available	Not Available	TCGA-GM-A4E0-D37113;TCGA-GM-A4E0-D37115;TCGA-GM-A4E0-D37116;TCGA-GM-A4E0-D37117;TCGA-GM-A4E0-D37118;TCGA-GM-A4E0-D37119	76CCB5FF-A056-43DA-8555-AEDB5683ADAE;4C24BBBE-85D7-4F91-867A-F3565F4E8AFB;503948AA-4087-417D-8768-32F533FEBEBE;D672E4DB-472F-4FCA-A031-1EAA79128C90;84DD5400-4F97-4F5B-BD39-228348DC7862;E59D3AC8-259B-48CF-A95F-9328FB248A09	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26;26	184;184;289;289;289;Not Available	121;121;226;226;226;320	Xeloda;Taxotere;5-FU;Epirubicin;Cytoxan;Arimidex	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	11;11;11;11;11;11	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES;NO	2012;2012;2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A4E0-F47030	50501D80-A3CE-4BD5-AA63-FBFB3EB907A3				21			Not Applicable	2191																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	10	1	No	A4E0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field	TCGA-GM-A4E0-R37111	72264053-A738-4D71-9A92-C677B67CB408	Not Available	26	357	315	Complete Response	11	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2012	2007
TCGA-D8-A1X8	FEMALE	783	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	783			TUMOR FREE				62	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1X8	8624354c-af25-423c-9c71-48a5dd821097	Not Available	Positive	Not Available	2+	4 Point Scale	Not Available	Indeterminate	Modified Radical Mastectomy	Not Applicable	NO	16	-22995	Not Applicable	0	272	Not Available	NO	TCGA-D8-A1X8-D29429	2392ED50-8D05-4D26-A5D9-F2EA353735BC	Not Available	19	182	23	adrimicin+cyclophosphamide	Not Available	3	Not Available	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1X8-F29428	516F8A4D-F178-4835-BF60-28271EF03221				19		Not Available	Not Applicable	783		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	0	No	A1X8	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1X8-R29430	46DDC44D-57CB-439D-BB1D-66ECCB9B9718	Not Available	19	239	209	Not Available	3	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A3RF	FEMALE	408	Mucinous Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	174.0	Bone	Distant Metastasis	TUMOR FREE				79	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A7-A3RF	7451AF3C-ACC0-4D79-8429-6B8BE96911D8	Negative	Positive	Not Available	Not Available	Not Available	Other	Positive	Lumpectomy	Left breast reexcision	NO	3	-29184	Not Applicable	0	54	Not Available	Not Available	TCGA-A7-A3RF-D40414	C60A018E-A8EC-4C00-AB28-40901C23F33E	Not Available	19	Not Available	137	Anastrozole	Clinical Progressive Disease	2	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A3RF-F40413	AC15B3B7-EBCC-4CCB-9491-7D2BA72CF137				19			Not Applicable	408																				NO																						2					NO;NO	NO;NO	Not Available;Not Available	174;192	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Bone;Liver	Distant Metastasis;Distant Metastasis	Not Available;Not Available	NO;NO	Not Available;Not Available	YES	WITH TUMOR						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	Not Available	No	A3RF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	30-39%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A3RF-R40415	D04B5775-2ABC-484C-A0AC-0B1AE645EFAE	Not Available	19	136	88	Radiographic Progressive Disease	2	34	6280	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2012
TCGA-UU-A93S	FEMALE	116	Infiltrating Ductal Carcinoma	Breast	Dead	T4d	N3b	M1	Stage IV	0	116			WITH TUMOR				63	Right;Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right Lower Inner Quadrant;Right Lower Outer Quadrant	No axillary staging	Not Available	TCGA-UU-A93S	45013972-2DFD-4F82-A076-E3E4AF1B43B8	Not Available	Negative	Not Available	Not Available	Not Available	Not Evaluated	Negative	Modified Radical Mastectomy	Not Applicable	YES	11	-23278	116	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Bone;Liver	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A93S	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	NO	NO	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M1	N3b	T4d	Not Available	YES	NO	UU	Breast	Not Applicable	Dead	2014	2013
TCGA-OL-A66O	FEMALE	528	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	528			TUMOR FREE				39	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A66O	A45833E1-7CC9-4273-B408-620F74679A12	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Unknown	11	-14272	Not Applicable	0	220	Not Available	Not Available	TCGA-OL-A66O-D64491;TCGA-OL-A66O-D65244	B0AF5BB3-D16F-4702-A5DA-AAA9B59EDEDE;A6C0E34D-00F1-42B6-883B-AE2C88CD9296	Not Available;Not Available	24;24	192;192	129;129	Cytoxan;Taxotere	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A66O-F58497	F6A56281-31A1-4289-A7C1-D2F3125484E4				11			Not Applicable	528																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	Not Available	No	A66O	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A66O-R64492	2489265C-022C-47F6-BFDF-9A678B41BC79	Not Available	12	121	77	Complete Response	9	Not Available	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2012
TCGA-BH-A0BV	FEMALE	1519	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1519			TUMOR FREE				78	Right Upper Inner Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0BV	87f03d04-e651-4a6e-aea6-1c946aa46202	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	9	-28699	Not Applicable	0	1519	Not Available	Not Available	TCGA-BH-A0BV-D4511;TCGA-BH-A0BV-D4506;TCGA-BH-A0BV-D4510;TCGA-BH-A0BV-D4512	BAB8E980-A3BB-4674-AA19-F13ED3CD6E8B;3000F32E-2841-466F-83FF-0A0F01E27285;11E80478-AE62-404C-9A63-6BC3B6785FA8;92F20E69-6E22-4D49-9016-E0127DA28068	Not Available;Not Available;Not Available;Not Available	15;15;15;16	153;Not Available;153;262	88;262;88;174	DOXORUBICIN;ARIMIDEX;CYCLOPHOSPHAMIDE;PACLITAXEL	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;Not Available;4;12	Not Available;1;Not Available;Not Available	Not Available;mg/day;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0BV-F4513	3AB769BD-C3C1-422B-A9FD-F72E00FB2D37	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	1519	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0BV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	50-59%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2006
TCGA-AR-A0TZ	FEMALE	3262	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2	M1		1	1313.0	Bone	Distant Metastasis	Not Available				43	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AR-A0TZ	c7c34fd9-3021-45b7-b6ff-30b4196585a8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	7	-15720	Not Applicable	0	2316	Not Available	Not Available	TCGA-AR-A0TZ-D19580;TCGA-AR-A0TZ-D19585;TCGA-AR-A0TZ-D19584;TCGA-AR-A0TZ-D19586;TCGA-AR-A0TZ-D19582	6D665117-F247-42AF-BCEE-58D9E5A8C4AA;DDAECFBE-9A39-40E2-9949-5BA7F0E59972;12E885E0-147E-493C-80A3-3FC7FA47B11A;7476015B-5A4D-4FC4-8716-34E766F01ACC;0D4D40A8-8486-46B8-9F85-FD8B559B4437	Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Doxorubicin;Tamoxifen;Paclitaxel;Not Available;Cytoxan	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Bone	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A0TZ-F18727;TCGA-AR-A0TZ-F49471	D5A8B1ED-5266-4FA7-B07A-15DF222EEFB6;07A8C3D6-9B1A-42F7-8AD6-B5FD24A8CF52				15;2		Not Available;None	Not Applicable;3262	2316;Not Available		1313;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;10	Bone;None	Distant Metastasis;None	Not Available;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;1313	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;YES	Not Available;Unknown			Not Available;None			YES;YES		YES;YES	Alive;Dead	2011;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	1+	Not Available	70-79%	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Positive	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1+	Not Available	70-79%	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	No	A0TZ	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-AR-A0TZ-R19575	C47F0686-D68D-4811-8F46-437865D65DD7	1	15	Not Available	Not Available	Not Available	12	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M1	N2	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2004
TCGA-C8-A1HN	FEMALE	394	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	394			TUMOR FREE				56	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HN	86a18ae0-dfb1-49c3-b5c4-67ec331d6e40	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	2	-20712	Not Applicable	0	2	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A1HN-F19089;TCGA-C8-A1HN-F71885	1DC4D8DA-D0F5-4B8E-A72E-38531C64E95A;60E148CB-FB45-4819-918F-BD620D94710E				2;31		Not Available;None	Not Applicable;Not Applicable	99;394		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	Not Available	Not Available	No	A1HN	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 3	Allred Score 8	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A0YJ	FEMALE	566	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	1	559.0	Other, specify	Distant Metastasis	TUMOR FREE				39	Left	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0YJ	796b593f-5886-4a27-bf94-7ea8df325e1a	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-14448	Not Applicable	0	326	Not Available	Not Available	TCGA-A2-A0YJ-D5821;TCGA-A2-A0YJ-D5820	54cf26b3-3b56-440e-9d2e-6c4df631992b;3d201259-de17-489f-89f8-f605fa43fe37	Not Available;Not Available	28;28	150;150	46;46	Cytoxan;Taxotere	Not Available;Not Available	12;12	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	YES		TCGA-A2-A0YJ-F16756	717318E8-D1B6-4D8D-8FFC-BBA23E110C17				16		559	Not Applicable	566		559				Scheduled Follow-up Submission							Not Available			Not Available					1+	Not Available	Not Available	Negative	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	9	Other, specify	Distant Metastasis	Left Cervical Lymph Node	YES																																		WITH TUMOR			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	5	Not Available	No	A0YJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YJ-R5819	99d00471-4902-455d-8eaf-2b4ee63fb7dc	1	28	223	180	Not Available	12	Not Available	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2010
TCGA-A8-A07W	FEMALE	304	Infiltrating Ductal Carcinoma	Breast	Alive	T2	NX	M1	Stage IV	1				WITH TUMOR				76	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07W	01263518-5f7c-49dc-8d7e-84b0c03a6a63	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	25	-27942	Not Applicable	0	304	Not Available	Not Available	TCGA-A8-A07W-D37852;TCGA-A8-A07W-D37853	F73231E4-FFC8-4EE0-8B3C-49503701A0E1;65DF696C-50FD-4538-824D-29D00F8BAB9A	n/a;Not Available	6;6	Not Available;Not Available	212;Not Available	Exemestane;Not Available	Not Applicable;Unknown	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;Not Available	Hormone Therapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;Not Available	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07W-F40835	4E5B10A4-29A2-4AB4-A3D4-1654295E7FDB				2			Not Applicable	304																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07W	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M1	NX	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-A1-A0SG	FEMALE	434	Other, specify	Breast	Alive	T2	N1a	M0	Stage IIB	0	434			Not Available				61	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SG	0ed9ad26-7fdc-4d75-93f9-d029eee94993	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	31	-22380	Not Applicable	0	434	Not Available	Not Available	TCGA-A1-A0SG-D12390	8D77AB37-9AB4-43CE-86A0-AFB9DF77E6FA	Not Available	31	Not Available	111	Not Available	Not Available	5	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	micropapillary carcinoma invasive	No	C50.9	8507/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A0SG	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2011	2006
TCGA-AN-A0FW	FEMALE	11	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	11			TUMOR FREE				67	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A0FW	e112b452-8850-4353-bfed-0dbdc243290b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Indeterminate	Modified Radical Mastectomy	Not Applicable	NO	28	-24692	Not Applicable	0	11	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FW-F68966	09AE2056-27E8-4B1D-B3BA-67034B18CFEC				24			Not Applicable	11																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	2	0	No	A0FW	TUMOR FREE	Not Available	Not Available	Not Available	10	180	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-A8-A091	FEMALE	1004	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	243.0			TUMOR FREE				61	Right	Not Available	Not Available	TCGA-A8-A091	f39edd06-1016-4e8e-a42e-12f7e699ddc5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-22554	Not Applicable	0	580	Not Available	Not Available	TCGA-A8-A091-D37748;TCGA-A8-A091-D37749;TCGA-A8-A091-D37750;TCGA-A8-A091-D37751;TCGA-A8-A091-D37752;TCGA-A8-A091-D37753;TCGA-A8-A091-D37754	BB7A58AA-67C4-4906-8662-C5ADC58A70E7;8FDB6109-FEFD-4D8A-BD04-D88DE1852A87;CAB281AD-1C82-4832-9982-1EC937E75187;A318C975-5C70-465F-B50F-29E1A23C842A;F9769A43-9D9A-4A64-8ACF-0B51D8CDD614;B4B5A2CC-1753-4C12-8472-45D92D2CF095;72915C6D-EEBE-4670-ABF0-E15D34050969	n/a;n/a;n/a;n/a;n/a;n/a;n/a	6;6;6;6;6;6;6	123;123;123;639;Not Available;Not Available;669	0;0;0;184;639;700;580	5-Fluorouracil;Epirubicin;Cyclophosphamide;Tamoxifen;Letrozole;Zoledronic acid;Pamidronate	Unknown;Unknown;Unknown;Stable Disease;Not Applicable;Not Applicable;Stable Disease	12;12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Ancillary;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A091-F40557	5C002AE2-4733-487B-8827-5B108727F910				23			Not Applicable	1004																				NO																						2					Not Available	Not Available	Not Available	243	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A091	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A091-R38154	B6AFE9FC-6769-4F5A-B728-625645B39410	Not Available	11	184	123	Unknown	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A25C	FEMALE	523	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	523			TUMOR FREE				50	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A25C	7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	15	-18508	Not Applicable	0	285	Not Available	NO	TCGA-A2-A25C-D14513;TCGA-A2-A25C-D14512;TCGA-A2-A25C-D14511;TCGA-A2-A25C-D14514;TCGA-A2-A25C-D31284;TCGA-A2-A25C-D31283	789E3F3F-057D-41A2-BC01-3C6103E3A603;B0EDF6A8-BC7C-44F3-B9A2-4306EC1EDE95;9A192F59-CCEE-4DCF-97FD-152DA7203A62;164E441C-E2D3-4CDA-B591-397424B65942;ED492381-E4FE-41BA-8ECB-CEC9010547CB;77D6AC50-7A0B-4BB5-9FA8-BFECB11CDC34	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;28;17;17	193;193;193;325;Not Available;475	108;108;108;292;476;325	Taxotere;Adriamycin;Cytoxan;Tamoxifen;Aromasin;Femara	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;7;4;4	5;5;5;Not Available;Not Available;Not Available	130;87;870;20;25;2.5	mg;mg;mg;mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;2;1;4;6;5	IV;IV;IV;PO;PO;PO	NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	650;435;4350;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A25C-F31282	423BE0BB-3129-452B-8F97-BCEEB2820AB4				17		Not Available	Not Applicable	523		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	3	Not Available	No	A25C	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	20-29%	WHITE	Not Available	Primary Tumor Field;Regional site;Regional site	TCGA-A2-A25C-R14515;TCGA-A2-A25C-R70680;TCGA-A2-A25C-R70681	223E00A3-9E87-41BF-98F5-2EF812DCFBF3;73455A7F-CA95-41DF-9E57-1EDB33FD89E1;0880198C-ED2F-4373-A920-AB4DDA7254AB	1;Not Available;Not Available	15;2;2	285;287;271	276;234;234	Not Available;Complete Response;Complete Response	7;3;3	33;28;25	6000;5040;4500	NO;NO;NO	EXTERNAL BEAM;External;External	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2011;2015;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A256	FEMALE	2854	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	1	1640.0		Locoregional Disease	Not Available				45	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A256	d3d545b3-457f-4389-821f-704cb24aff7f	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	31	-16642	2854	0	Not Available	Not Available	Not Available	TCGA-AR-A256-D31926;TCGA-AR-A256-D31927	B6C966AC-D18C-4B33-BFE1-11776EA2F338;B4890692-5CC2-43F9-B3F9-89528DD2F720	Not Available;Not Available	22;22	101;101	38;38	Doxorubicin;Cytoxan	Not Available;Not Available	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A256-F31923	ABDB80D8-BC00-469D-9827-36679803F8EF				11		Not Available	2854	Not Available		1640				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Locoregional Disease	Not Available	YES																																		Not Available			Not Available			YES		NO	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A256	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Mastectomy	NO	YES	AR	Breast	Not Applicable	Dead	2011	2001
TCGA-AC-A23E	FEMALE	698	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	MX	Stage IIB	0	698			TUMOR FREE				50	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A23E	e7bae6e7-f779-449d-92b9-66996041e00d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	18	-18500	Not Applicable	0	72	Not Available	NO	TCGA-AC-A23E-D43238	D789C42F-8DB9-4956-B101-E5635D52C40D	Not Available	15	Not Available	111	Tamoxifen	Not Applicable	5	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	30-39%	Not Available	Not Available	Not Available	Not Available					TCGA-AC-A23E-F43240	6B8CD25F-D9F0-46C3-AA28-66D68A889F91				15			Not Applicable	698																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	1	Not Available	No	A23E	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A23E-R43239	5D4AA189-74A9-4527-95E0-9CD8C7441796	Not Available	15	158	127	Complete Response	5	Not Available	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	Not Available	Not Available	AC	Breast	Not Applicable	Alive	2011	2010
TCGA-OL-A5RW	FEMALE	1106	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	MX	Stage IIA	0	1106			TUMOR FREE				40	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-OL-A5RW	A82D0A57-4383-473D-B334-D13B278404B1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Unknown	16	-14638	Not Applicable	0	797	Not Available	Not Available	TCGA-OL-A5RW-D65259;TCGA-OL-A5RW-D65260;TCGA-OL-A5RW-D65261	B981AF2A-14CD-4F9E-B7F0-E4097AC4A18C;47037AD5-7A17-40F3-B7B7-8FA8F3BF1294;9A883C83-C334-4ADE-9EC6-DEA81CFB7220	Not Available;Not Available;Not Available	24;24;24	234;234;234	69;69;69	ADRIAMYCIN;Cytoxan;TAXOL	Complete Response;Complete Response;Complete Response	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	Unknown	Not Available	Not Available	Not Available					TCGA-OL-A5RW-F56568	51FA5005-5700-4BB5-8303-4369C6D86E8D				14			Not Applicable	1106																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.91	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Not Evaluated	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5RW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A5RW-R65258	FE53ABA6-9490-4966-8236-991863C30A5D	Not Available	24	234	184	Complete Response	9	Not Available	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2010
TCGA-B6-A0RV	FEMALE	5156	Mixed Histology (please specify)	Breast	Alive	T3	N2	M0	Stage IIIA	0	5156			TUMOR FREE				42	Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RV	cd3faa15-743c-476f-ab0d-f205b14126b6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-15507	Not Applicable	0	4788	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0RV-F13791	2950EE46-B267-4898-9ADF-B5B140CAD0A8				12		Not Available	Not Applicable	5156		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Lobular/Ductal	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Not Evaluated	Not Available	10	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	5	Not Available	No	A0RV	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1996
TCGA-B6-A0IN	FEMALE	2573	Other, specify	Breast	Dead	T1c	NX	MX	Stage X	1	1412.0	Other, specify	Distant Metastasis	WITH TUMOR				45	Right Upper Outer Quadrant;Right	No axillary staging	Not Available	TCGA-B6-A0IN	16a8d916-ad46-4690-b1a5-3b2b323f4336	Negative	Positive	Not Available	Not Available	Not Available	Modified radical mastectomy	Negative	Other	Not Applicable	NO	2	-16705	2573	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	Not Available	NO		TCGA-B6-A0IN-F12625	B47C325B-7239-402E-8708-8C6DE45E6459				2		Not Available	2573	Not Available		1412				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	6	Other, specify	Distant Metastasis	bone, brain	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal with mucinous features	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Available	Not Available	Positive	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	Not Available	Not Available	No	A0IN	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	MX	NX	T1c	Excisional biopsy	NO	YES	B6	Breast	Not Applicable	Dead	2010	1996
TCGA-AN-A0G0	FEMALE	16	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	16			TUMOR FREE				56	Right Upper Inner Quadrant	No axillary staging	Not Available	TCGA-AN-A0G0	96312510-c126-485d-8109-ed81844a1dc3	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	29	-20504	Not Applicable	0	16	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0G0-F68970	15A83D83-B3D3-45E7-8262-3E6CDC4B1C5D				24			Not Applicable	16																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0G0	TUMOR FREE	Not Available	Not Available	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-C8-A273	FEMALE	513	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	513			TUMOR FREE				29	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-C8-A273	5a5f0f48-2b13-4e78-b130-901b85d9a7f3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	21	Not Available	Not Applicable	0	6	Not Available	Not Available	TCGA-C8-A273-D70834	34F9559E-95CB-4EBC-9B9D-042337C8811E	Not Available	9	Not Available	13	Tamoxifen	Discrepancy	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A273-F20280;TCGA-C8-A273-F70833	A517D06B-1DAC-4DD9-869F-98DBF8EFECF2;E0EA316B-AB47-4A36-8C89-6941291C208B				9;9		Not Available;None	Not Applicable;Not Applicable	294;513		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	2	Not Available	No	A273	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 5	Allred Score 8	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A0U2	FEMALE	2551	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2	M0	Stage IIIA	1	1609.0	Bone	Distant Metastasis	WITH TUMOR				47	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AR-A0U2	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d	Negative	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	24	-17390	2551	0	Not Available	Not Available	Not Available	TCGA-AR-A0U2-D19593;TCGA-AR-A0U2-D19594;TCGA-AR-A0U2-D19595;TCGA-AR-A0U2-D19592;TCGA-AR-A0U2-D19596	2E56AF80-2C77-4EA0-AD75-B645BC14CD63;DC973377-2597-4375-8377-9AB28D884777;59FD28B5-689E-4E96-AC37-80921DB220F9;CB681BE2-02B4-4823-BBE4-E34A66E10E57;320E795E-E0E7-4F90-9D11-014ABF0FF2BD	Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15	Not Available;Not Available;Not Available;Not Available;1603	Not Available;Not Available;142;Not Available;Not Available	Cytoxan;Paclitaxel;Tamoxifen;Doxorubicin;Exemestane	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	4;3;Not Available;4;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;1;3	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	10-19%	NOT HISPANIC OR LATINO	Bone;Liver	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A0U2-F18483	C7F93BF3-479C-4CE3-AC96-DEBDBE56649C				15		Not Available	2551	Not Available		1609				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Bone	Distant Metastasis	Liver	YES																																		Not Available			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Negative	Not Evaluated	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	2+	Not Available	70-79%	Positive	Not Available	Not Available	Not Available	Not Available	2.47	Not Available	Not Available	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2+	Not Available	70-79%	Positive	Not Available	Not Available	Not Available	Not Available	2.47	Not Available	Not Available	Not Available	Not Available	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	0	No	A0U2	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-AR-A0U2-R19591	572AD134-752F-4FAD-B70B-3FB15869115B	1	15	Not Available	Not Available	Not Available	12	28	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Dead	2011	2004
TCGA-EW-A1J5	FEMALE	477	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	0	477			TUMOR FREE				59	Left	Sentinel node biopsy alone	Not Available	TCGA-EW-A1J5	5d8ed961-a012-4b6b-bffb-9468d3953646	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	10	-21559	Not Applicable	0	227	Not Available	NO	TCGA-EW-A1J5-D21354;TCGA-EW-A1J5-D29270;TCGA-EW-A1J5-D29271;TCGA-EW-A1J5-D29272	1371E038-0A59-4F41-BE94-3306DDF2A13D;A98E7CEA-1E32-4CF2-B77F-F32B2B286E90;B9A4AECF-CCA5-44DA-A370-1F56723E07D1;6535FB84-2971-4559-BBB2-62715AD2E85F	Not Available;Not Available;Not Available;Not Available	6;13;13;13	247;247;247;247	94;94;94;94	Adriamycin;Cyclophosphamide;Paclitaxel;Herceptin	Not Available;Not Available;Not Available;Not Available	2;3;3;3	4;4;12;12	98;984;127;236	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	AC then TH;AC then TH;AC then TH;AC then TH	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	392;3936;1524;2832	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1J5-F21353	B3590EA5-E070-473D-8CCB-BE97155CED82				6		Not Available	Not Applicable	477		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A1J5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	total mastectomy	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-AC-A3EH	FEMALE	197	Infiltrating Lobular Carcinoma	Breast	Dead	T3	N3	M0	Stage IIIC	0	197			TUMOR FREE				79	Right	Axillary lymph node dissection alone	Not Available	TCGA-AC-A3EH	FAC173A8-1613-4BD4-87BA-83A2CFE8A37D	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	24	-29014	Not Applicable	0	17	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3EH-F65834	040824B3-8139-4984-8578-00C653C57223				30			197	Not Available																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8022/3	C50.9	Not Available	YES	Not Applicable	Excisional Biopsy	Negative	Negative	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	12	Not Available	No	A3EH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-OL-A66L	FEMALE	1301	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	1301			TUMOR FREE				71	Right Lower Inner Quadrant	Not Available	Not Available	TCGA-OL-A66L	AF0ACAA9-A61C-4E57-BC0D-453AD5BF193A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	11	-26186	Not Applicable	0	945	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A66L-F58493	43834AEE-2446-4577-8539-711FEA80E30F				11			Not Applicable	1301																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.10	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A66L	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	90-99%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A66L-R46789	A689A4CE-EE17-4BFB-B69D-86DDFF35870F	Not Available	12	120	71	Complete Response	9	Not Available	6080	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2010
TCGA-E2-A1IF	FEMALE	1138	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1138			TUMOR FREE				74	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IF	718db047-9f32-48c4-98c9-515218441bca	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	28	-27341	Not Applicable	0	956	Not Available	NO	TCGA-E2-A1IF-D19963	B72C6A80-3E80-4683-A073-49251E7CF780	Not Available	21	Not Available	41	Arimidex	Not Available	12	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1IF-F19962	CE3CD2D3-5B39-4490-BD37-8EA5028464DB				21		Not Available	Not Applicable	1138		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1IF	TUMOR FREE	allred score 4+2=6	Not Available	Not Available	allred score = 6	allred scrore = 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A1B1	FEMALE	2653	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	2653			TUMOR FREE				45	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1B1	8a0ef221-8070-43fc-9d98-def90abe4871	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	25	-16603	Not Applicable	0	1361	Not Available	NO	TCGA-E2-A1B1-D19433;TCGA-E2-A1B1-D19428;TCGA-E2-A1B1-D19424;TCGA-E2-A1B1-D19438;TCGA-E2-A1B1-D19419;TCGA-E2-A1B1-D19421;TCGA-E2-A1B1-D19435	1C0E879C-D0B0-45F3-B530-C9E53A0BFC31;607FFFF8-3B83-4A56-8A6B-04F87ECAD6F5;AA17D85A-0FDD-47FB-9D84-B8E632A19374;F78B48EF-E33F-4DC4-8527-32A39CF392F3;2F50945A-770E-4BAE-A4BA-BF8337D74422;347D45D4-7A50-4C57-9CAF-B7BE348BDE4F;8C3CFC3B-88E5-4E90-AE7E-1F4CE327F036	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9	232;491;969;134;Not Available;Not Available;134	155;155;71;71;239;71;71	paclitaxel;herceptin;zoledronic acid;adriamycin;tamoxifen;triptorelin;cyclophosphamide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12	11;24;15;4;Not Available;Not Available;4	195;672;4;146;20;3.75;1464	mg;mg;mg;mg;mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	02;02;01;01;04;03;01	IV;IV;IV;IV;PO;IM;IV	NO;NO;NO;NO;YES;YES;NO	Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;biphosphonate;Not Available;Not Available;Not Available;Not Available	2145;16128;60;584;Not Available;Not Available;5856	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011	Allred score 3+2 = 5	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1B1-F19416;TCGA-E2-A1B1-F70009	58DADC0D-AD16-4876-BA6E-B0967CF577A0;87D15560-4AE5-45AD-B931-54DE2E14C301				9;9		Not Available;None	Not Applicable;Not Applicable	1613;2653		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	70-79%	Not Available	2+	Not Available	Not Available	Not Available	15.12	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Positive	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A1B1	TUMOR FREE	Allred score 2+2 = 4	Not Available	Not Available	Allred score = 4	Allred score = 5	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1B1-R19440	06E5C1F9-947C-4BA4-8F46-AE56691487B8	01	9	314	302	Not Available	12	31	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-BH-A0HI	FEMALE	620	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	620			TUMOR FREE				78	Right Upper Inner Quadrant;Right Lower Inner Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0HI	e0375a8b-a135-4103-a59d-39063fcf4a6f	Not Available	Positive	Not Available	1+	Not Available	Not Evaluated	Positive	Other	Not Applicable	YES	10	-28644	Not Applicable	0	620	Not Available	Not Available	TCGA-BH-A0HI-D4751	793A09D5-84AB-4A44-8D82-805D14E45573	Not Available	17	Not Available	88	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-Score 240	50-59%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HI-F4756	0729B5EE-C7F0-4F0A-9F04-4A7E417515FC	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	620	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	0	No	A0HI	TUMOR FREE	H-Score 160	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0HI-R4754	42D1C987-18FD-4ABB-A93D-5D836F4ED4C4	1	22	141	96	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-BH-A18P	FEMALE	921	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N0	M0	Stage I	0	921			WITH TUMOR				60	Left Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A18P	557cb0a3-6f1b-4faf-8296-0a15c24158f9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	22	-22222	921	0	Not Available	Not Available	Not Available																								Not Available	<10%	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.3	8500/3	C50.3	1+	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Positive	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A18P	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2003
TCGA-D8-A1Y2	FEMALE	433	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	433			TUMOR FREE				71	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1Y2	c7d7a770-23c0-4310-ab48-1f6152dc2849	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	9	-26021	Not Applicable	0	73	Not Available	NO	TCGA-D8-A1Y2-D30087	8706F572-AB8C-430F-9761-2AEFA63F375B	Not Available	2	Not Available	66	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1Y2-F30086	960BDA3C-DBB7-4271-AEBE-9C28BF0353A4				2		Not Available	Not Applicable	433		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Venten	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Indeterminate	Negative	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1Y2	TUMOR FREE	manual counting	Not Available	Not Available	Not Available	>75%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-E9-A1RC	FEMALE	1224	Mixed Histology (please specify)	Breast	Alive	T4b	N3	M0	Stage IIIC	0	1224			TUMOR FREE				56	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RC	5cdae21d-eee5-478f-932a-0f51fcf5f031	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	28	-20795	Not Applicable	0	1224	Not Available	NO	TCGA-E9-A1RC-D30607;TCGA-E9-A1RC-D30609;TCGA-E9-A1RC-D30610;TCGA-E9-A1RC-D30606	E58C5E86-0316-4F5B-99B0-A13F95BE2CA5;62673F57-7FC4-4ED0-9E85-73C713C381A2;8DEF7FCD-2D76-448A-B718-638B681918AD;3D595692-CF03-4987-8958-AC8D85D1C26F	Not Available;Not Available;Not Available;Not Available	13;13;13;13	1222;1222;Not Available;1222	1222;1222;1220;1222	Mitoxantrone;Methotrexate;Tamoxifen;Mitomycin	Not Available;Not Available;Not Available;Not Available	4;4;4;4	1;1;Not Available;1	20;70;20;20	mg;mg;mg/day;mg	PALLIATIVE;PALLIATIVE;PALLIATIVE;PALLIATIVE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV	NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	20;70;Not Available;20	mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1RC-F30605;TCGA-E9-A1RC-F48701	997C07ED-D89A-4AE4-B2F7-D1BD05D15E4E;0590580D-9303-4488-AA52-6C6FA55009EF				13;19		Not Available;None	Not Applicable;Not Applicable	1224;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;9	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		NO;Not Available	Alive;Not Available	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	10	0	No	A1RC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T4b	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2007
TCGA-D8-A1XT	FEMALE	506	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	506			TUMOR FREE				61	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XT	64975923-d032-4182-8565-59fc37127d8d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	16	-22448	Not Applicable	0	193	Not Available	NO	TCGA-D8-A1XT-D29455	BA9F76EC-158B-4252-8921-AF7A7755CEAB	Not Available	19	228	74	adriamycin+cyclophosphamide	Not Available	3	6	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	360+3600	mg	Not Available	2012	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XT-F29454	1DBB325B-97FD-4160-A1DB-1849297B9592				26		Not Available	Not Applicable	506		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	3	0	No	A1XT	TUMOR FREE	%IHC	Not Available	Not Available	0%	0%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A8HP	FEMALE	396	Metaplastic Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	396			TUMOR FREE				59	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-C8-A8HP	8DB69F1D-72E2-40BA-AD8A-CF228499840D	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	29	-21613	Not Applicable	0	8	Not Available	Not Available	TCGA-C8-A8HP-D69611;TCGA-C8-A8HP-D69612;TCGA-C8-A8HP-D69613	97270AB3-9E3D-45C5-9D19-C829F713523B;E21CE453-A911-46D4-8A86-10840F94F4FB;FDA16E46-3280-4A4A-914B-F4BC3F889323	Not Available;Not Available;Not Available	15;15;15	224;224;224	31;31;31	5-Flourouracil;Epirubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	1;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A8HP-F69610	91FF3ABD-E5CD-49E0-BDE9-3D9971E451A6				15			Not Applicable	396																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	6	Not Available	No	A8HP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	ASIAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2014	2013
TCGA-AR-A255	FEMALE	2161	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	2161			Not Available				62	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A255	e8f3cc64-5e15-4f4d-b73e-5c9b250a664c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	31	-22809	Not Applicable	0	1059	Not Available	Not Available	TCGA-AR-A255-D31920;TCGA-AR-A255-D31921;TCGA-AR-A255-D31922	BB558EF4-41E7-493C-A6D2-FC80FE121679;ECE7A0A4-959E-4CC4-8857-7193628243DC;5283FFF6-C4EA-4F3D-AD5E-CAB099B3DF37	Not Available;Not Available;Not Available	22;22;22	54;419;Not Available	54;75;96	Trastuzumab;Trastuzumab;Anastrozole	Not Available;Not Available;Not Available	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Immunotherapy;Immunotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A255-F31917;TCGA-AR-A255-F49512;TCGA-AR-A255-F71745	0ED6F967-D520-4A7B-83AA-C5501DAB6CCC;B39FC06A-9138-40FC-9163-EF2896BEC091;457F26CE-CD5A-44A1-9C9C-13AF3302B6BC				11;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1059;1792;2161		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A255	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A255-R31919	339C3612-78BA-4998-8944-2594F16E7315	1	11	89	47	Not Available	5	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-A2-A0T6	FEMALE	575	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	0	575			TUMOR FREE				50	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0T6	08306ede-e74b-4be9-b768-7fd98647b6ac	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	17	-18334	Not Applicable	0	344	Not Available	Not Available	TCGA-A2-A0T6-D3997;TCGA-A2-A0T6-D3995;TCGA-A2-A0T6-D3994;TCGA-A2-A0T6-D3996	9a7b6e0f-5e16-4bcf-a58f-a0ee35e617af;23fa8497-3a06-42ab-900c-69deab1936ed;3ea8097f-3255-4d00-85b9-5d1f6e426c5f;bd93c307-9d87-4a15-bb03-b8d02cc44b57	Not Available;Not Available;Not Available;Not Available	17;17;17;17	Not Available;204;204;204	232;95;95;95	Tamoxifen;Adriamycin;Taxotere;Cytoxan	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;6;6;6	20;90;135;900	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;2;1;3	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;540;810;5400	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0T6-F13950	2B2337EC-2A4F-453E-8EE6-AA03BC570460				12		Not Available	Not Applicable	575		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	0	No	A0T6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0T6-R3993	d4bf30e0-a82d-445a-b39e-effcb98e7e05	1	17	279	231	Not Available	11	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-A1-A0SP	FEMALE	584	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	584			TUMOR FREE				40	Right	Axillary lymph node dissection alone	Not Available	TCGA-A1-A0SP	a9bb8159-32f0-454c-a946-b3286a52b9d5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	6	-14954	Not Applicable	0	584	Not Available	Not Available	TCGA-A1-A0SP-D4489	D44AD8B4-4B21-4F10-A99A-EEB2C92222FD	Not Available	7	173	108	Not Available	Not Available	12	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Not Available	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	3	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	Not Available	Yes	A0SP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A1-A0SP-R4223	5E22E8A7-7CD2-4DED-A532-43CB2DEF4F91	Not Available	7	259	215	Not Available	12	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2010	2007
TCGA-A8-A09R	FEMALE	273	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	273			TUMOR FREE				82	Left Lower Inner Quadrant	Not Available	Not Available	TCGA-A8-A09R	cb0a2055-2168-4454-8755-47dd613db36f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-30196	Not Applicable	0	273	Not Available	Not Available	TCGA-A8-A09R-D37768	E2A85158-819F-473B-AD84-8F5B443F5CCC	n/a	6	Not Available	0	Letrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09R-F40330	D44CD2FC-8E35-4FE5-94B7-1CF7C6BC3741				17			Not Applicable	273																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09R	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09R-R38158	CF62E51D-F3FB-4825-A290-6BF63239AAD1	Not Available	11	120	61	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AO-A03N	FEMALE	2031	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	1	1645.0		Locoregional Disease	WITH TUMOR				59	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A03N	9435447e-d65f-408b-863b-6576b1d652dd	Not Available	Positive	Not Available	1+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	13	-21816	Not Applicable	0	1645	Not Available	Not Available	TCGA-AO-A03N-D6118;TCGA-AO-A03N-D6120;TCGA-AO-A03N-D6114;TCGA-AO-A03N-D6113;TCGA-AO-A03N-D6116;TCGA-AO-A03N-D6117;TCGA-AO-A03N-D6119;TCGA-AO-A03N-D20929;TCGA-AO-A03N-D20930;TCGA-AO-A03N-D20927;TCGA-AO-A03N-D20923;TCGA-AO-A03N-D20931;TCGA-AO-A03N-D20932	bb405d51-df85-4189-a4ab-9692bcadc16d;4dc6b6e5-f0c5-4dce-8cbc-a61ccc36b856;a849ee00-3092-4cca-a302-6ecb620fb617;bb14e284-9eb3-47cd-b0fa-660a24ff2c7b;e9d527b8-949b-464a-82d8-3c5b5812ce32;6324b024-c954-4a43-b14e-c5c1a4acb314;00512901-db10-4833-8adf-5b3734b5d64f;182B47E5-FF2D-4BD1-A5D1-EBD1C0CDD4C0;C4226DFD-8E7A-4898-ACD6-2E907F30DD99;DC919671-3B3F-4A46-B89C-1B4BB7F356D1;105C9E04-6F4F-4BC9-98D4-C5E70D9BC254;1B00197C-7F84-4429-80E9-471F087D8753;5CB72B1A-283E-4161-A53A-824BC9641E61	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;24;24;24;24;24;24	820;Not Available;153;153;153;449;1007;1828;1842;1762;1667;Not Available;Not Available	450;1007;55;55;55;207;821;1814;1835;1699;1639;1857;1989	Femara;Tamoxifen;Cyclophosphamide;Doxorubicin;Paclitaxel;Arimidex;Aromasin;Paclitaxel;Gemcitabine;Tesetaxel;Fulvestrant;Vinorelbine;Xgeva	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1;1;1;1;1;1;1	Not Available;Not Available;4;4;4;Not Available;Not Available;2;2;4;3;16;2	2.5;20;600;60;175;1;25;80;800;27;250/5;25;120	mg/day;mg/day;mg/m2;mg/m2;mg/m2;mg/day;mg/day;mg/m2;mg/m2;mg/m2;mg/mL;mg/m2;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;2;1;1;1;2;2;10;11;9;8;12;13	PO;PO;IV;IV;IV;PO;PO;IV;IV;PO;IM;IV;SC	NO;YES;NO;NO;NO;NO;NO;NO;NO;NO;NO;YES;YES	Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Bone metastases	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;280;2800;230;1500;704;240	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2012;2012;2012;2012;2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;YES	Not Available;NO	NO;NO	Not Available;None	TCGA-AO-A03N-F6112;TCGA-AO-A03N-F20915	1301663C-BE4E-421C-B0FD-765CA43B6D62;117BE088-A51C-4E7F-B00B-919FF76F2596	Not Available;None	Not Available;None	Not Available;None	13;24	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1645;2031	Not Available;None	1645;1645	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Negative	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;4 Point Scale	Not Available;Not Available	None;4 Point Scale	Not Available;Negative	Not Available;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Negative	1;1	None;Not Available	None;Locoregional Disease	None;Not Available	None;YES																																		WITH TUMOR;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	2	Not Available	No	A03N	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2011	2006
TCGA-D8-A27I	FEMALE	439	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N2a	M0	Stage IIIA	0	439			TUMOR FREE				58	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27I	9c55032f-4db7-4026-ae83-8d060dd8e3fe	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-21327	Not Applicable	0	186	Not Available	NO	TCGA-D8-A27I-D29523	94238A97-A6AB-4233-B4FD-23DF34B10383	Not Available	21	160	76	adrimycin+cyclophosphamide	Not Available	3	4	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	240+2400	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27I-F29521	174B98DC-4E11-40CA-A49E-0EA85C0029E0				21		Not Available	Not Applicable	439		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	4	0	No	A27I	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A27I-R29524	6D6FB14C-78A7-435A-B30A-9FEC2D491CEC	Not Available	21	212	188	Not Available	3	20	4500	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A426	FEMALE	364	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3a	MX	Stage IIIC	0	364			Unknown				50	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A426	D48E9F25-F083-4F88-A92D-C12D9F765BA6	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	5	-18296	Not Applicable	0	229	Not Available	Not Available	TCGA-A7-A426-D36577;TCGA-A7-A426-D36578;TCGA-A7-A426-D36579;TCGA-A7-A426-D41740	96AB3786-43CC-4EB7-B2CE-1A163FDA1647;942628C7-12A1-4EF8-8464-8813B3BE2536;BD940BFE-90EE-4928-8D31-2084078B12E6;E049A833-72A0-4C05-8F37-8DB9DDE9746D	Not Available;Not Available;Not Available;Not Available	3;3;3;26	97;97;202;Not Available	55;55;111;258	Adriamycin;Cytoxan;Taxol;Tamoxifen	Unknown;Unknown;Unknown;Not Applicable	11;11;11;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2013	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A426-F41743	7D3C9088-BC36-4448-A5A3-B00DD0B124F0				26			Not Applicable	364																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	13	Not Available	Yes	A426	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	70-79%	WHITE	YES	Primary Tumor Field;Regional site	TCGA-A7-A426-R41741;TCGA-A7-A426-R41742	1A137F59-0C07-44D6-829F-E4B539D4F496;34569FAF-40C8-41C8-8CD2-79E24B283462	Not Available;Not Available	26;26	257;257	220;220	Complete Response;Complete Response	3;3	28;28	5040;5040	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T3	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2012
TCGA-AN-A0AM	FEMALE	5	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	5			TUMOR FREE				56	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A0AM	00a2d166-78c9-4687-a195-3d6315c27574	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-20713	Not Applicable	0	5	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0AM-F68945	CCD98B71-7FC0-4FB5-9595-B9E2959A20F0				23			Not Applicable	5																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0AM	TUMOR FREE	Not Available	0	Not Available	0	205	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-D8-A1Y3	FEMALE	430	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	430			TUMOR FREE				61	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1Y3	632984bd-dc81-42b6-b024-476cfd0bb2ae	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	9	-22317	Not Applicable	0	125	Not Available	NO	TCGA-D8-A1Y3-D30089;TCGA-D8-A1Y3-D30090	CD27D9E9-957F-4103-9146-BD4B8D8CCDBB;804ACAFF-8BBF-4830-B5D7-67949CD57F82	Not Available;Not Available	2;2	Not Available;125	133;62	tamoxiphene;doxorubicine+cyclophosphamide	Not Available;Not Available	4;4	Not Available;4	20;106.8+1068	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	PO;IV	YES;NO	Hormone Therapy;Chemotherapy	Not Available;Not Available	Not Available;427.2+4272	mg;mg	Not Available;Not Available	2012;2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1Y3-F30088	796131A4-3877-4190-8790-8A92DB48E978				2		Not Available	Not Applicable	430		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Venten	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Indeterminate	Negative	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	5	Not Available	No	A1Y3	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1Y3-R30091	A12F5CAC-72A2-430B-893C-10338084842F	Not Available	2	169	145	Not Available	4	40	9000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A159	FEMALE	762	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	762			TUMOR FREE				50	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A159	d7308344-5bab-4073-bb4f-4d8cd8d7bd17	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	7	-18621	Not Applicable	0	515	Not Available	NO	TCGA-E2-A159-D19116;TCGA-E2-A159-D19119;TCGA-E2-A159-D19118	57830A90-A8C2-4396-977D-CC41223CD5E3;10D6AF3A-547A-4172-A1AA-9C9266122BEF;E04BF780-9220-4AB5-9C43-2472BB5FBFD6	Not Available;Not Available;Not Available	8;8;8	91;141;91	50;113;50	Cyclophosphamide;Paclitaxel (Protein-Bound);Doxorubicin	Not Available;Not Available;Not Available	11;11;11	4;3;4	1272;378;127	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5088;1134;508	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A159-F19115	0C4FDB82-9EF8-4D7E-9A24-4B151317F7F1				8		Not Available	Not Applicable	762		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Negative	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A159	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A159-R19120	ABEB4CB1-0F56-4D55-8796-EF6EF74DD791	1	8	215	165	Not Available	11	34	6240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-A8-A08P	FEMALE	943	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	943			TUMOR FREE				70	Right	Not Available	Not Available	TCGA-A8-A08P	f947d67f-4aa2-4eb9-977e-21a5ae563613	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-25598	Not Applicable	0	943	Not Available	Not Available	TCGA-A8-A08P-D37773;TCGA-A8-A08P-D37774;TCGA-A8-A08P-D37775;TCGA-A8-A08P-D37776;TCGA-A8-A08P-D37777;TCGA-A8-A08P-D37778	BB038A0C-0856-4FB6-B98B-8CC6ACAAB26B;234F1043-A0C4-49F6-A6ED-C6290863D7BF;1253B515-4F10-40BF-B18B-2AA5B260D821;12F7BB14-6DC6-4008-9BF1-55DA93552260;66F6BB3D-C124-464B-ADA7-88793D0C636F;05503837-81F2-4017-88A9-C22758556147	n/a;n/a;n/a;n/a;n/a;n/a	6;6;6;6;6;6	182;182;182;182;Not Available;578	60;60;60;60;244;213	5-Fluorouracil;Doxorubicin;Cyclophosphamide;Docetaxel;Exemestane;Trastuzumab	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable;Complete Response	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08P-F40561	5AC6BE92-4C93-419D-A6B8-65C8B218B5D4				24			Not Applicable	943																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08P	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08P-R38160	CF63E708-3ED7-4F91-9929-41FD1CF62191	Not Available	11	244	182	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A1FB	FEMALE	3669	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	3669			WITH TUMOR				60	Right	Not Available	Not Available	TCGA-BH-A1FB	ecab16bc-28d5-4c3a-8735-3c785bd047c4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	Not Available	7	-21933	3669	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	15	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A1FB	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	segmental mastectomy with sentinel lymph node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	2000
TCGA-AC-A3YI	FEMALE	707	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N3a	MX	Stage IIIC	0	707			Unknown				74	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A3YI	A45D296E-EFC0-479E-B2F6-BAD834668CDF	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	8	-27143	Not Applicable	0	47	Not Available	Not Available	TCGA-AC-A3YI-D61514;TCGA-AC-A3YI-D61515;TCGA-AC-A3YI-D61516	53B8EF0C-8F23-4867-B4D9-F4A71B62BED0;2509B84B-EC3A-457C-9E7B-7F7095910A28;710B0219-323F-4EF2-A310-54559049BEDB	Not Available;Not Available;Not Available	30;30;30	167;167;167	82;82;82	Cytoxan;Methotrexate;5-FU	Complete Response;Complete Response;Complete Response	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3YI-F61513	7CA1E88A-71BA-41EA-9D4F-88DAF4FDBF8D				30			Not Applicable	707																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	12	Not Available	No	A3YI	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	20-29%	WHITE	Unknown	Primary Tumor Field	TCGA-AC-A3YI-R61517	F847AE09-DB60-4729-9889-41EF61CD8482	Not Available	30	297	250	Complete Response	6	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T1c	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2012
TCGA-AC-A8OP	FEMALE	614	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	MX	Stage IA	0	614			TUMOR FREE				72	Right Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A8OP	B9C6C069-2A2B-4CC7-A398-DC45C132D979	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-26550	Not Applicable	0	53	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A8OP-F66027	051ED97E-B012-42EF-BD2D-25AF9EE444F3				1			Not Applicable	614																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Indeterminate	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A8OP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	10-19%	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T1c	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2014	2011
TCGA-A2-A25F	FEMALE	322	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	322			TUMOR FREE				66	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A25F	c836951b-3ffb-4e20-8504-0eccb7d50dd4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	26	-24319	Not Applicable	0	114	Not Available	NO	TCGA-A2-A25F-D31195;TCGA-A2-A25F-D31196	891B2981-580C-4A0A-9C41-BED150D2AEB8;D5EBB6A6-DE10-4033-AB1F-6ADA8072684A	Not Available;Not Available	19;19	212;212	64;64	Taxotere;Cytoxan	Not Available;Not Available	4;4	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A25F-F31197	83BFBA11-0DA8-4A8E-8851-25F1414D2F33				23		Not Available	Not Applicable	322		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	0	No	A25F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A25F-R14509	DAB357C0-A2D3-4540-9F13-FA24263D85AD	1	26	43	37	Not Available	7	10	3400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2011
TCGA-C8-A1HI	FEMALE	343	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	343			TUMOR FREE				40	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A1HI	444374f8-9282-439c-af00-0f828edcbff3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	1	Not Available	Not Applicable	0	0	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A1HI-F19099	41B909BA-C457-4643-9821-7881F6EA6087				2		Not Available	Not Applicable	343		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	Not Available	Not Available	No	A1HI	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 6	Allred Score 8	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AC-A3YJ	FEMALE	754	Other, specify	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	754			TUMOR FREE				66	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A3YJ	86CF879E-3B40-44DD-AAA7-6F49F54A15D9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	3	-24439	Not Applicable	0	40	Not Available	Not Available	TCGA-AC-A3YJ-D60188;TCGA-AC-A3YJ-D60189	C21296BA-1657-4E74-A813-2141490BA609;DF2F7479-281D-48B4-AB92-DB37A062A978	Not Available;Not Available	31;31	247;Not Available	62;256	Arimidex;Femara	Unknown;Not Applicable	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3YJ-F60187	F91129E1-94BA-4771-B7FA-4F07CA7CB24B				31			Not Applicable	754																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Invasive Papillary Carcinoma	No	C50.9	8050/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Not Available	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A3YJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2012
TCGA-E2-A1IN	FEMALE	675	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	675			TUMOR FREE				60	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IN	f43d622f-eed5-4933-adc6-ae9ad1e33028	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	29	-22199	Not Applicable	0	392	Not Available	NO	TCGA-E2-A1IN-D20324	F7685815-0BF1-443B-9F43-01B6887E6A92	Not Available	4	Not Available	103	Arimidex	Not Available	1	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2012	allred score 5+3=8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1IN-F20323	14834E52-B0E0-43D7-B13B-32A3D0D390E3				4		Not Available	Not Applicable	675		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1IN	TUMOR FREE	allred score 5+3+8	Not Available	Not Available	allred score = 8	allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1IN-R20326	EF81F606-FAFB-46F1-82DB-B3285D7A9803	1	4	101	57	Not Available	1	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A15A	FEMALE	710	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	710			TUMOR FREE				45	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A15A	73ccc949-01b7-48d3-a7c4-c4bcd261672a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	7	-16750	Not Applicable	0	502	Not Available	NO	TCGA-E2-A15A-D18932;TCGA-E2-A15A-D18929;TCGA-E2-A15A-D18931;TCGA-E2-A15A-D18933	EDEDBFBC-2FEA-4A60-929F-17C65470B874;03F02177-F519-4582-80D5-FB49841CED1B;D589DD76-9CC5-49F7-AB78-94321F8B1402;F855C3B6-E0E7-4A87-9CF5-5BB51DD2E354	Not Available;Not Available;Not Available;Not Available	10;10;10;10	145;89;89;Not Available	103;47;47;103	Paclitaxel;Cyclophosphamide;Doxorubicin;Zoledronic Acid	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;4;4;Not Available	280;948;95;4	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;1;3	IV;IV;IV;IV	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1120;3792;380;44	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15A-F18926	89F6BF10-DB74-4BB3-B5DC-B8C065538CDB				10		Not Available	Not Applicable	710		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	13	Not Available	No	A15A	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A15A-R18938	78528A96-4A5C-4ADD-8526-E921E5238F87	1	10	222	145	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-AR-A0TS	FEMALE	2558	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	2558			Not Available				46	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TS	972447aa-4332-47e7-bddd-2eb699dbb664	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	8	-17141	Not Applicable	0	1138	Not Available	Not Available	TCGA-AR-A0TS-D19189;TCGA-AR-A0TS-D19194;TCGA-AR-A0TS-D19193	6DDD0B18-B972-42FE-81B7-F4D84C27F23E;3B977891-44ED-474F-973E-0BB631AA37E4;674B9434-AFDB-4831-BF85-31EAEBAB94D1	Not Available;Not Available;Not Available	12;12;12	100;156;100	61;114;61	Doxorubicin;Paclitaxel;Cytoxan	Not Available;Not Available;Not Available	12;12;12	4;4;4	60;175;600	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	460;1320;4600	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0TS-F18644;TCGA-AR-A0TS-F49516;TCGA-AR-A0TS-F71730	DDE2E871-EE01-4B9E-B31D-D5BB5687213A;4ABA8613-33A6-4918-9B4F-8315C2EDA06A;94425F1E-C3C6-4EF7-B1CD-AA1FBAF14FBE				12;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1138;2275;2558		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	2	Not Available	No	A0TS	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A0TS-R18646	B5DA5037-58AA-4B53-B86A-0C254CBEECE0	1	12	228	185	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-BH-A0DE	FEMALE	2372	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2372			TUMOR FREE				62	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0DE	7f0bbba1-9bc3-45db-bdda-eb3319bb15d2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	11	-22656	Not Applicable	0	948	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0DE-F63543	BC05D1FA-6912-499B-8634-5B1EBA26C03A				12			Not Applicable	2372																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0DE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DE-R63544	53372D2F-D9F7-48BC-8E09-94CF40CC253F	Not Available	12	149	105	Complete Response	8	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-AQ-A54O	MALE	1001	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1001			TUMOR FREE				51	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AQ-A54O	35CA5E2A-861A-4DD2-A4CE-D294CF080DA3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-18694	Not Applicable	0	665	Not Available	Not Available	TCGA-AQ-A54O-D40684;TCGA-AQ-A54O-D40686;TCGA-AQ-A54O-D40687;TCGA-AQ-A54O-D40688	D051B585-6A82-4408-B25B-3CB75C56A0C8;69C618BF-24A2-46C0-BA45-AAD9D605E8E6;D56A18AB-9A5D-4B8F-B5FE-4CFDE2C87A45;02A79C21-928D-4FE9-BD1D-934CD3ABE809	Not Available;Not Available;Not Available;Not Available	26;26;26;26	118;118;176;Not Available	77;77;132;199	Adriamycin;Cytoxan;Taxol;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	2;2;2;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AQ-A54O-F55731	8B3E15A7-7C5B-4B61-869F-74A0E7751612				14			Not Applicable	1001																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	MALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	14	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	A54O	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	70-79%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	AQ	Breast	Not Applicable	Alive	2013	2011
TCGA-AQ-A04H	FEMALE	754	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	MX	Stage IIIA	0	754			TUMOR FREE				61	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AQ-A04H	83f943c7-3975-4b4f-985d-9c057741793b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	15	-22539	Not Applicable	0	439	Not Available	Not Available	TCGA-AQ-A04H-D4977;TCGA-AQ-A04H-D4976;TCGA-AQ-A04H-D40872;TCGA-AQ-A04H-D40873	178f263e-df57-4fc7-befd-4ea1a346680d;984f482a-0e8b-423e-a98f-af30f5c8a883;57AFEA30-9D59-45E4-A309-6717F0FBB64A;A6C7F4F8-93C6-435A-A59A-88ED37540B88	Not Available;Not Available;Not Available;Not Available	16;16;4;4	Not Available;133;133;133	175;29;29;29	Femara;Taxotere;Carboplatin;Herceptin	Not Available;Not Available;Complete Response;Complete Response	12;12;3;3	Not Available;6;Not Available;Not Available	2.5;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;Not Available;Not Available	PO;IV;Not Available;Not Available	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;NO;NO	2010;2010;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-AQ-A04H-F4906;TCGA-AQ-A04H-F35322	E074679E-8C42-46DC-A7E2-16B90D502AEE;E5147793-FAA6-44C5-BE7E-D11656CD8119	Not Available;None	Not Available;None	Not Available;None	15;24	Not Available;None	Not Available;None	Not Applicable;Not Applicable	439;754	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;9					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	30	Not Available	Not Available	3.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Indeterminate	Positive	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	4	Not Available	No	A04H	TUMOR FREE	Not Available	Not Available	Not Available	>10%	>10%	Not Available	Not Available	20-29%	WHITE	Not Available	Primary Tumor Field	TCGA-AQ-A04H-R4982	d113adb3-5e01-4acc-b1c5-f15e6762bb51	1	16	166	138	Not Available	12	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N2a	T2	Not Available	NO	YES	AQ	Breast	Not Applicable	Alive	2010	2009
TCGA-EW-A1PC	FEMALE	187	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0 (i-)	MX	Stage IIB	0	187			TUMOR FREE				66	Left	Sentinel node biopsy alone	Not Available	TCGA-EW-A1PC	F45210D3-9E66-4F5E-BEF1-5EE5547CC893	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	28	-24434	Not Applicable	0	187	Not Available	NO	TCGA-EW-A1PC-D29682	4784F718-8BC9-4960-AF35-7D27BE174EA2	Not Available	26	Not Available	98	Tamoxifen	Not Available	3	Not Available	20	mg/day	ADJUVANT	Not Applicable	TAM	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PC-F29681	A626E120-7532-413F-8810-E8EA00F76B76				26		Not Available	Not Applicable	187		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A1PC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	50-59%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T3	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A14W	MALE	974	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	974			TUMOR FREE				78	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A14W	eadb0562-2165-4adb-ad58-018e73f82780	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	25	-28664	Not Applicable	0	834	Not Available	NO	TCGA-E2-A14W-D18806;TCGA-E2-A14W-D18804;TCGA-E2-A14W-D18808;TCGA-E2-A14W-D18811	25E2567F-6AC2-4B0C-BB4C-6288D9260C8F;44D83D4E-70ED-4A03-8A24-AA0FAF79C3B9;9A006D8C-5728-4281-81D4-F33365AFA016;632F839F-82AA-43E0-BC1A-9CFCEB78B2CC	Not Available;Not Available;Not Available;Not Available	4;4;4;4	106;321;106;Not Available	43;43;43;169	Cytoxan;Herceptin;Docetaxel;Tamoxifen	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;16;4;Not Available	1122;585;140;20	mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	3786;5964;473;20	mg;mg;mg;mg/day	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14W-F18803	76297030-41ED-487B-B704-02C9E748CCC0				4		Not Available	Not Applicable	974		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	MALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Positive	5	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14W	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-3C-AALI	FEMALE	4005	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	4005			TUMOR FREE				50	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-3C-AALI	55262FCB-1B01-4480-B322-36570430C917	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	28	-18538	Not Applicable	0	3801	Not Available	Not Available	TCGA-3C-AALI-D62900	C09E3F7D-0FC8-4316-AF95-1D9CE3497071	Not Available	28	117	43	Poly E	Complete Response	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Not Available	Not Available	Not Available	Not Available	YES	2014	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-3C-AALI-F68057	4A52CBB9-665B-420E-8AC4-6A19058F550A				13			Not Applicable	4005																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	AALI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-3C-AALI-R62901	2FE462E5-9AEE-417B-BF7C-908AA69A55A9	Not Available	28	352	320	Not Available	7	25	5000	NO	Unknown	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	3C	Breast	Not Applicable	Alive	2014	2003
TCGA-LD-A74U	FEMALE	402	Other, specify	Breast	Alive	T3	N3a	M0	Stage IIIC	1				WITH TUMOR				79	Right	Axillary lymph node dissection alone	Not Available	TCGA-LD-A74U	38A4E9BD-93E9-432D-A756-3B1055B823BD	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	Unknown	30	-28981	Not Applicable	0	203	Not Available	Not Available	TCGA-LD-A74U-D55160	18D6C097-AA64-4C59-9CA9-C6737668C348	Not Available	30	301	52	Taxotere	Stable Disease	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	NO	2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LD-A74U-F69186	64202B52-3947-46FF-B25B-9AC52944E2F5				30			Not Applicable	402																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	WITH TUMOR						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Invasive lobular carcinoma, classical type, focal pleomorphic type	No	C50.9	8524/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	12	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	11	Not Available	Yes	A74U	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Not Available	YES	NO	LD	Breast	Not Applicable	Alive	2013	2013
TCGA-GM-A3XL	FEMALE	2108	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2108			TUMOR FREE				49	Right;Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A3XL	65CAC997-4D39-4501-85EC-4FCB328A8EB5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	1	-18171	Not Applicable	0	1717	Not Available	Not Available	TCGA-GM-A3XL-D35523;TCGA-GM-A3XL-D35524;TCGA-GM-A3XL-D35525;TCGA-GM-A3XL-D35526	E53B3221-61CB-48E0-A761-E99D86612033;3C18A200-60E1-402E-B214-AE55C2033154;AC30090D-D89E-4942-B93B-C44B8BBA2641;A7375485-9703-446C-A59F-3E2E7F2A3E83	Not Available;Not Available;Not Available;Not Available	1;1;1;1	163;163;163;248	100;100;100;191	Fluorouracil;Adriamycin;Cytoxan;Paclitaxel	Complete Response;Complete Response;Complete Response;Complete Response	10;10;10;10	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A3XL-F41970	FD97C14F-E6E6-45D7-9912-84402AECAD79				8			Not Applicable	2108																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0.99	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A3XL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-GM-A3XL-R35522	5579FB1C-390D-4919-A4B9-138CA5AF97BB	Not Available	1	315	274	Complete Response	10	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2012	2007
TCGA-BH-A0E2	FEMALE	435	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	435			TUMOR FREE				49	Right Upper Inner Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0E2	8ace3b8c-f23e-48a9-a137-9e046bd9549b	Not Available	Positive	Not Available	1+	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	9	-18152	Not Applicable	0	376	Not Available	Not Available	TCGA-BH-A0E2-D4633;TCGA-BH-A0E2-D4636;TCGA-BH-A0E2-D4635;TCGA-BH-A0E2-D4637	86CFCEA0-9EEF-48CD-BA6A-C91C80629601;2DA42AF6-78FA-4A56-B03C-9732F565896A;3DA5FC61-EF46-4724-959A-D97A1AC066DE;DBDA746D-4CC8-48BC-B2DA-84801984F92A	Not Available;Not Available;Not Available;Not Available	17;18;18;18	Not Available;151;151;221	256;81;81;172	TAMOXIFEN;DOXORUBICIN;CYCLOPHOSPHAMIDE;PACLITAXEL	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;4;4;11	20;110;1104;146	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;438;4392;1589	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-SCORE 300	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0E2-F4639	DD8C6D58-8E0A-47A6-BEB4-FA08BBC73CF3	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	435	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	No	A0E2	TUMOR FREE	H-SCORE 1	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-AN-A0XT	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	10			Not Available				54	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-AN-A0XT	3e25056d-d137-49f5-abaa-f68509426600	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Applicable	Not Available	28	-19794	Not Applicable	0	10	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0XT-F68960	837B572D-29D8-4983-8304-068372BD90DC				23			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	1	Not Available	No	A0XT	Not Available	Not Available	Not Available	Not Available	0	120	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A0X5	FEMALE	2097	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	1	1343.0	Other, specify	Distant Metastasis	WITH TUMOR				61	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0X5	4e6edfe6-adcb-4c12-8ff4-38a79f5887e8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	14	-22380	2097	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	NO	NO		TCGA-B6-A0X5-F15726	51D5C754-2AD5-4C88-9D30-FB526027E827				29		Not Available	2097	Not Available		1343				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Other, specify	Distant Metastasis	Liver and Pleura and Bone	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Not Evaluated	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	No	A0X5	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1995
TCGA-E9-A1R0	FEMALE	860	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	M0	Stage IIA	0	860			TUMOR FREE				58	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1R0	f2da1d3f-f226-4c99-a97e-9b26f67d7a5d	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	28	-21394	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1R0-D29797;TCGA-E9-A1R0-D29805	62BE4AFA-184B-4008-A0DA-3C7ED6C00EB4;B560F532-8633-49E9-A9C7-AE671251F874	Not Available;Not Available	29;29	103;103	36;36	Cyclophosphamide;Doxorubicin	Not Available;Not Available	3;3	4;4	800;80	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3200;320	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1R0-F29795;TCGA-E9-A1R0-F41214	6DD81350-F039-458B-A58D-50192EE6C328;AD367CF1-62C6-4796-AB47-569755FE6836				29;13		Not Available;None	Not Applicable;Not Applicable	435;860		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	12	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	1	Not Available	No	A1R0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0DZ	FEMALE	495	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	495			TUMOR FREE				43	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right Lower Inner Quadrant;Right Lower Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0DZ	478eb8aa-50b8-4ce5-98e4-d518ede4b174	Not Available	Positive	Not Available	2+	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	NO	9	-15980	Not Applicable	0	495	Not Available	Not Available	TCGA-BH-A0DZ-D4577;TCGA-BH-A0DZ-D4582;TCGA-BH-A0DZ-D4585;TCGA-BH-A0DZ-D4580	AC6C5D22-298B-4E01-A4BB-024810BF148A;C1100150-9A45-4A80-86C7-05997DFF9557;5C77B282-C471-4C6B-83CC-468EB487B8F5;DD38FE68-F847-493F-A1B3-73A5A98F41C1	Not Available;Not Available;Not Available;Not Available	17;18;18;18	Not Available;217;224;217	234;89;89;89	TAMOXIFEN;DOCETAXEL;HERCEPTIN;CARBOPLATIN	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;6;12;6	20;Not Available;Not Available;Not Available	mg/day;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-SCORE 140	50-59%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0DZ-F4588	F7218F8F-0D41-4B86-B276-C020CA69412E	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	495	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	30-39%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A0DZ	TUMOR FREE	H-SCORE 15	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-D8-A1JT	FEMALE	405	Other, specify	Breast	Alive	T2	N0	M0	Stage IIA	0	405			TUMOR FREE				70	Left Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1JT	cd781589-3820-45a2-906b-8d60cd02f3ef	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-25677	Not Applicable	0	123	Not Available	Not Available	TCGA-D8-A1JT-D14049	A1CE4BC2-90C8-4054-8F71-02F9119342A7	Not Available	18	Not Available	47	Arimidex	Not Available	7	Not Available	1	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	mg/day	Not Available	2011	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JT-F14048	61DFE752-C583-4674-9552-F736F4D0D0E5				18		Not Available	Not Applicable	405		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	not amplified	Not Available	Not Available	Other, specify	ductal and papillary	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1JT	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-EW-A1IY	FEMALE	258	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage I	0	258			TUMOR FREE				38	Right Upper Inner Quadrant	Other (specify)	sentinel LN and one non sentinel LN	TCGA-EW-A1IY	5ff12cbe-a3e0-4ce6-8452-12b984a1baaf	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	10	-14122	Not Applicable	0	258	Not Available	NO	TCGA-EW-A1IY-D29086	B9D6330E-568E-4DCD-8ED3-7D3138997A66	Not Available	5	119	57	Taxotere/Cytoxan	Not Available	3	4	T:136;C:1092	mg	ADJUVANT	Not Applicable	TC regimen	IV	NO	Chemotherapy	Not Available	T:544;C:4368	mg	Not Available	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1IY-F29084	147F2CD8-48E7-43BC-901D-A96966A4ABC2				5		Not Available	Not Applicable	258		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A1IY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2009
TCGA-AO-A129	FEMALE	3286	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	3286			TUMOR FREE				29	Left Lower Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-AO-A129	c70ee5e1-4703-4996-bb5c-f4cca0fb53ba	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	8	-10898	Not Applicable	0	2923	Not Available	Not Available	TCGA-AO-A129-D5950;TCGA-AO-A129-D5947;TCGA-AO-A129-D5949	2c562434-088f-444b-82ca-9ad77b8fdaa2;592cacd9-a024-4b2d-a780-d45766869b1a;7a4726f6-1df6-4d6c-af20-b21164882894	Not Available;Not Available;Not Available	10;10;10	162;162;162	67;67;67	Paclitaxel;Cyclophosphamide;Doxorubicin	Not Available;Not Available;Not Available	1;1;1	4;4;4	175;600;60	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	49	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A129-F5882;TCGA-AO-A129-F19415	63E8194B-C67D-4A8B-84CD-2773F597186A;C40939D7-1F54-4652-BEEF-94586A5F9051	Not Available;None	Not Available;None	Not Available;None	8;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	2923;3286	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	>=2.0 Positive	0	31	Not Available	52	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	2	Not Available	No	A129	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Regional site	TCGA-AO-A129-R5883	0417042c-5493-4b8d-b969-7077215b602d	1	8	246	216	Not Available	12	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2002
TCGA-B6-A0RQ	FEMALE	4267	Infiltrating Lobular Carcinoma	Breast	Dead	T3	N0 (i-)	M0	Stage IIB	0	4267			TUMOR FREE				68	Right Upper Outer Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RQ	caa9b533-24b4-4ecd-9159-c165de049f6a	Negative	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	15	-25010	4267	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0RQ-F13787	A826EFB1-9FF7-48D1-9C56-36E5A2747CA7				12		Not Available	4267	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	14	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0RQ	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	excisional biopsy	NO	YES	B6	Breast	Not Applicable	Dead	2011	1994
TCGA-C8-A137	FEMALE	379	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	1	136.0		Locoregional Recurrence	TUMOR FREE				34	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A137	03ab1e9f-4918-404d-b178-3a4fd929c5e8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	15	-12729	Not Applicable	0	34	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A137-F19076;TCGA-C8-A137-F70815	47D6F2FA-9859-4953-BE4F-C79803394070;3319B260-E0F5-4ABA-9676-DA21E0BDF2CB				2;9		Not Available;None	Not Applicable;Not Applicable	125;379		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;NO	None;YES	None;Not Available	None;136	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Locoregional Recurrence	None;Not Available	None;NO	None;Not Available	None;YES	TUMOR FREE;WITH TUMOR			Not Available;None			YES;Discrepancy		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A137	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	ASIAN	Not Available	Local Recurrence	TCGA-C8-A137-R70816	6A57E479-51F6-4266-BF13-7BF4F13D224C	Not Available	9	Not Available	137	Stable Disease	3	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A0DO	FEMALE	1644	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1644			TUMOR FREE				78	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A0DO	d3d4d709-ab34-4617-aa8c-51a3d0a3efe6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	11	-28529	Not Applicable	0	525	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0DO-F63671	609BA6DE-5B63-4ABA-A085-21880B110253				15			Not Applicable	1644																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	Yes	A0DO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2009
TCGA-A7-A3J1	FEMALE	343	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	343			TUMOR FREE				63	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A3J1	8F9AD301-6699-4078-A80D-886E40894AF7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	12	-23209	Not Applicable	0	75	Not Available	NO	TCGA-A7-A3J1-D36742;TCGA-A7-A3J1-D36752;TCGA-A7-A3J1-D36755	DD2D3EBE-A0AB-41A9-B7C7-D19BCEF1E844;637756E0-631E-439C-AE4F-8627197B8B18;14B7B938-1FD8-4DE7-8846-C4F32A49A5DE	Not Available;Not Available;Not Available	12;12;12	175;251;Not Available	137;189;300	Anastrazole;Tamoxifen;Aromasin	Unknown;Unknown;Not Applicable	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A3J1-F36693	B21A2460-AFDC-43FE-A22E-A2DDF374A03D				12			Not Applicable	343																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	Yes	A3J1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A3J1-R36695	2476582A-72E1-4F42-86D0-721640EC49D6	Not Available	12	134	89	Complete Response	11	33	6100	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2011
TCGA-EW-A1IX	FEMALE	1208	Other, specify	Breast	Alive	T1b	N1a	MX	Stage IIA	0	1208			TUMOR FREE				48	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1IX	e8614b7d-132e-4b4e-b1ae-df8bb4f2d4d4	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	10	-17597	Not Applicable	0	1082	Not Available	NO	TCGA-EW-A1IX-D21609	9F1CC0D6-E9B7-4875-9B34-DC146AFDC982	Not Available	16	Not Available	871	Femara	Not Available	2	Not Available	2.5	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1IX-F21542	0ACED877-3F0E-4050-A7E1-6CCFE9AEBEA3				6		Not Available	Not Applicable	1208		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Invasive tubulolobular carcinoma	No	C50.9	8524/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	27	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	1	No	A1IX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1a	T1b	total mastectomy	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-E9-A3HO	FEMALE	1158	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1158			TUMOR FREE				49	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A3HO	807B62ED-D3F7-4211-83BE-754386FF2C96	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	20	-18046	Not Applicable	0	19	Not Available	NO	TCGA-E9-A3HO-D34120;TCGA-E9-A3HO-D34121;TCGA-E9-A3HO-D34122;TCGA-E9-A3HO-D34123;TCGA-E9-A3HO-D40290;TCGA-E9-A3HO-D40291	D0C4B016-5BD8-4E67-A168-03CBC0840AD8;E5BBB372-92D7-41A2-8819-BFEBB1F526B3;B87D3CDD-0D31-4353-9E68-879DB3A804D4;6B7696A0-95DC-48FD-BC5E-F5D77A8E683E;B80F3DF7-5616-4DEB-B5B1-9AFD2E7A34EA;FC15DB60-9371-4C3A-8C2C-34D254C7B264	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	30;30;30;30;15;15	26;26;26;Not Available;337;64	26;26;26;28;313;61	Cyclophosphamide;5-Fluorouracil;Methotrexate;Tamoxifen;Leuprorelin;Zoladex	Complete Response;Complete Response;Complete Response;Not Applicable;Complete Response;Complete Response	7;7;7;7;2;2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A3HO-F34119;TCGA-E9-A3HO-F40289;TCGA-E9-A3HO-F61875	790B0540-C4A2-480F-BC85-F2021B89FE54;2F7EA195-DA67-4B9A-B5E2-F2E1E7723756;A4391DDE-1085-446A-9A5D-93492906AD7D				30;15;9		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	337;793;1158		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	7;2;7	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2012;2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A3HO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2012	2011
TCGA-BH-A0HF	FEMALE	727	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	727			TUMOR FREE				77	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0HF	17ca61a2-607a-45ff-88fa-ef72e80bf891	Not Available	Positive	Not Available	1+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	10	-28233	Not Applicable	0	727	Not Available	Not Available	TCGA-BH-A0HF-D4730	52CDAF4B-976B-48BE-B49F-DBC0DDD25B7A	Not Available	17	Not Available	34	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-Score 295	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HF-F4734	61BFA455-749F-42A0-9883-8ECFC203B71B	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	727	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0HF	TUMOR FREE	H-Score 15	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0HF-R4733	78BFE41B-F146-4BC6-9D8E-1A21BCB1599E	1	17	111	64	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-A2-A0SW	FEMALE	1365	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2	M1	Stage IV	0	1365			WITH TUMOR				82	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0SW	991e1427-3c01-423d-abfd-4584302ca72c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	8	-30085	1365	0	Not Available	Not Available	Not Available	TCGA-A2-A0SW-D3702;TCGA-A2-A0SW-D3703	5751c947-6519-4f54-b423-fda73bc2b43a;1e0659e4-5a29-4057-a83b-90e3e8f398ee	Not Available;Not Available	8;8	479;1365	85;479	Arimidex;Tamoxifen	Not Available;Not Available	11;11	Not Available;Not Available	1;20	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;2	PO;PO	NO;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	mg;mg	Not Available;Not Available	2010;2010	Not Available	40-49%	NOT HISPANIC OR LATINO	Liver	Not Available	Not Available	NO	NO	NO	Not Available	TCGA-A2-A0SW-F3701	11921C4C-DBDF-41E9-B605-4FF55BB12DDE	Not Available	Not Available	Not Available	8	Not Available	Not Available	1365	Not Available	Not Available	653	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11																																						WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Dead	2010	FEMALE	Not Available	Not Available	Not Available	Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified	Not Available	60	Not Available	Not Available	1.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	No	A0SW	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0SW-R3704	b82f6467-290c-4472-9248-1095701eaf20	1	8	Not Available	54	Not Available	11	Not Available	10680	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M1	N2	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2010	2006
TCGA-BH-A0HK	FEMALE	178	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	178			TUMOR FREE				81	Right Upper Inner Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0HK	24334ac1-28a3-4b61-b590-3f51e375b247	Not Available	Positive	Not Available	0	Not Available	Not Evaluated	Negative	Modified Radical Mastectomy	Not Applicable	NO	10	-29751	Not Applicable	0	178	Not Available	Not Available	TCGA-BH-A0HK-D4755	015FC627-C844-4744-8F86-34152041F127	Not Available	17	Not Available	38	ARIMIDEX	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-SCORE 260	70-79%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HK-F4758	F754A354-2AFA-4E66-8B81-540A812E244C	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	178	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0HK	TUMOR FREE	H-SCORE 0	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2010
TCGA-BH-A0BP	FEMALE	2296	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N0	M0	Stage I	0	2296			TUMOR FREE				76	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0BP	f251cb6c-d18e-4691-9c82-24ed1ac0abf9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	9	-27917	Not Applicable	0	1481	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BP-F59122	A6C7E31C-28D6-4762-AC61-52999F2DFB05				1			2296	Not Available																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-BH-A0BP-R59124;TCGA-BH-A0BP-R59125	F27E0482-22DF-4596-9362-2054248AF498;3F5C1BF6-607D-47CE-BCE8-FA3A3A183E79	Not Available;Not Available	1;1	153;162	124;162	Complete Response;Complete Response	5;5	33;Not Available	5000;1600	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-D8-A1J9	FEMALE	532	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	532			TUMOR FREE				48	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1J9	d5e9a403-88ce-40fc-bb85-80cf3f8ff6bc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	29	-17879	Not Applicable	0	248	Not Available	Not Available																								manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1J9-F20944	9648DFD3-BFF5-4CC5-BE38-C1D57FEFE0D7				19		Not Available	Not Applicable	532		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Positive	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A1J9	TUMOR FREE	manual counting	Not Available	Not Available	0%	10-75%	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-A8-A06N	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N0	M0	Stage IIIB	0	0			TUMOR FREE				66	Left	Not Available	Not Available	TCGA-A8-A06N	3a711140-1b89-4611-9992-3861e3d0e01a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-24288	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06N	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-A7-A0DB	FEMALE	1007	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1007			TUMOR FREE		FPPP	TCGA	56	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A0DB	f130f376-5801-40f9-975d-a7e2f7b5670d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	4	-20570	Not Applicable	0	141	Not Available	Not Available	TCGA-A7-A0DB-D2932	bcfb5d3f-efe5-4ea8-be83-bee5a5a802a4	Not Available	5	Not Available	141	Arimidex	Not Available	11	Not Available	1	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	216	mg	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0DB-F2931;TCGA-A7-A0DB-F38479	36D2F1C0-4545-438D-A3CD-F1E072A82DB2;675A6559-DE14-437A-A6D4-3F931CBCEDC7	Not Available;None	Not Available;None	Not Available;None	5;14	Not Available;None	Not Available;None	Not Applicable;Not Applicable	267;1007	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;12					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A0DB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0DB-R2933	20c16888-67e5-4b28-8f59-2b6d1f28d23a	1	5	138	92	Not Available	11	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2009
TCGA-A8-A08Z	FEMALE	1217	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N3a	M0		0	1217			TUMOR FREE				76	Left	Not Available	Not Available	TCGA-A8-A08Z	d7808cbc-4b8c-467b-b2c3-f48d05b9ecab	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-28003	Not Applicable	0	1217	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08Z	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2004
TCGA-BH-A0BZ	FEMALE	2255	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	2255			TUMOR FREE				59	Left	Not Available	Not Available	TCGA-BH-A0BZ	4a032bad-e726-48f2-8f39-e3acc109cc91	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	10	-21856	Not Applicable	0	1492	Not Available	NO	TCGA-BH-A0BZ-D58689;TCGA-BH-A0BZ-D58690;TCGA-BH-A0BZ-D58691	B11042C3-48A4-4427-AD8F-54AE2DE97D00;025FAF2B-F67F-42A2-86B3-DFC2BBB21487;27F92F87-436A-44BE-A7AE-0AE19498D67C	Not Available;Not Available;Not Available	22;22;22	167;167;197	76;76;167	Doxorubicin;Cyclophosphamide;Abraxane	Complete Response;Complete Response;Complete Response	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BZ-F58683	5A5736DB-EA1E-47C5-8CDB-335A2A0274AD				21			Not Applicable	2255																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Available	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	Not Available	No	A0BZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field;Regional site;Primary Tumor Field	TCGA-BH-A0BZ-R58684;TCGA-BH-A0BZ-R58685;TCGA-BH-A0BZ-R58687;TCGA-BH-A0BZ-R58688	72F11767-FAE3-406C-9239-648AC9322232;6883F907-24F3-4229-B29A-0DCE18F291CA;D0470E61-8557-41E7-BDD8-97D0B17E1D00;D22DAA71-0A92-4F4F-A8DC-864A0863B07A	Not Available;Not Available;Not Available;Not Available	21;21;22;22	293;293;293;300	257;257;257;294	Complete Response;Complete Response;Complete Response;Complete Response	4;4;4;4	25;25;25;Not Available	50;50;45;10	NO;NO;NO;NO	External;External;External;External	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Gy;Gy;Gy;Gy	2014;2014;2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-BH-A203	FEMALE	1174	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	M0	Stage IIB	0	1174			WITH TUMOR				78	Right	Not Available	Not Available	TCGA-BH-A203	b3264748-947a-43aa-b227-b294fbcc8447	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	Not Available	8	-28609	1174	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Not Evaluated	Not Evaluated	39	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	35	Not Available	No	A203	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1996
TCGA-A7-A13H	FEMALE	899	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	1	795.0	Other, specify	New Primary Tumor	TUMOR FREE				61	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A13H	2E243F0E-9D7D-4CB0-9678-70607F90430A	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	22	-22643	Not Applicable	0	551	Not Available	NO	TCGA-A7-A13H-D36144	5204919F-EBC8-4F13-A5D7-E1135D397732	Not Available	19	Not Available	78	Anastrozole	Not Applicable	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.7					TCGA-A7-A13H-F36143;TCGA-A7-A13H-F41651	7C078E97-824D-4A33-90D1-8E5589C7AFA3;C8F6BA58-704D-4F09-8511-4EA0A2C9B96A				19;25			Not Applicable;Not Applicable	740;899																				NO;NO																						10;3					Not Available;NO	Not Available;NO	Not Available;840	Not Available;795	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Evaluated	Not Available;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Other, specify	Not Available;New Primary Tumor	Not Available;Skin lesion-Basal Cell Left Lower Lateral Back	Not Available;YES	Not Available;Not Available	NO;YES	TUMOR FREE;TUMOR FREE						YES;NO		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Pathvysion HER2 DNA Probe Kit	2+	371	Not Available	3.2	2.2	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	2	No	A13H	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	30-39%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2010
TCGA-BH-A0AU	FEMALE	1914	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1914			TUMOR FREE				45	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A0AU	360d1d6d-cf3e-4c78-b36f-ef5e3160aa6b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-16688	Not Applicable	0	746	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0AU-F60769	A74198DE-7ECF-4CBE-A42F-C8BB8ACFD761				16			Not Applicable	1914																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Negative	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A0AU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Unknown	TCGA-BH-A0AU-R60783	1F29756B-02AC-49AA-BE44-BC4EDCEFBD8E	Not Available	16	Not Available	65	Complete Response	6	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	left segmental mastectomy with sentinel node dissection	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-AR-A0U4	FEMALE	3261	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	3261			Not Available				54	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0U4	71f97b63-c970-44ee-98c2-e02e663d5a40	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	10	-19729	Not Applicable	0	1684	Not Available	Not Available	TCGA-AR-A0U4-D19342;TCGA-AR-A0U4-D19341;TCGA-AR-A0U4-D19343	E0C6F2ED-E72F-409A-BB26-85708A763D79;324CC111-37BE-4840-A581-F1CED82AA6C5;34F346D8-CBF0-4AA7-8B08-1A238EAED715	Not Available;Not Available;Not Available	12;12;12	98;98;154	53;53;112	Cytoxan;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available	12;12;12	4;4;4	600;60;175	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5380;540;1560	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0U4-F18724;TCGA-AR-A0U4-F49483;TCGA-AR-A0U4-F71739	0A78AC62-8CD2-4BCF-9F75-0E07C79431C2;6FC7B699-27CB-43BD-96E2-BED36D990E97;2E6CB219-767B-4D70-8ED4-CA0032345759				12;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1684;2615;3261		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0U4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-AQ-A7U7	FEMALE	584	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N2a	M0	Stage IIIA	0	584			TUMOR FREE				55	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AQ-A7U7	19015644-9C17-4AE7-A656-0FE8623C04AE	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	18	-20239	Not Applicable	0	304	Not Available	Not Available	TCGA-AQ-A7U7-D54378;TCGA-AQ-A7U7-D54381;TCGA-AQ-A7U7-D54382;TCGA-AQ-A7U7-D54385;TCGA-AQ-A7U7-D54386;TCGA-AQ-A7U7-D54387	F857DE6F-EDB7-4A82-8BE1-58094AF4D53A;EBE759A2-2DF0-4B0B-B155-47E54A053E90;5AC8BA1D-DEBC-48E8-83C5-2866BCF86F9B;894571F0-1421-4634-8EF3-350800E2C13A;F2C99A5C-0BC4-4921-952F-76BF03F2B539;CCBE1A5B-B0E1-430F-9221-C2B446502EEC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18;18	193;193;193;165;193;Not Available	123;123;123;123;123;296	Rituximab;Cyclophosphamide;Doxorubicin;Vincristine;Prednisone;Letrozole	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AQ-A7U7-F68763	394E58E9-4FB5-4EAD-954C-DDB7179F6E8E				15			584	Not Available																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	0	Yes	A7U7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	80-89%	WHITE	YES	Primary Tumor Field	TCGA-AQ-A7U7-R54388	E8D0BC37-34EF-4639-B2AC-10DA059F3B08	Not Available	18	278	236	Complete Response	12	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	L Total Mastectomy	YES	NO	AQ	Breast	Not Applicable	Alive	2013	2013
TCGA-E2-A1AZ	FEMALE	2329	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	2329			TUMOR FREE				63	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1AZ	89128dba-403f-4a96-bb3b-23ed0d5e2147	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	25	-23230	Not Applicable	0	1965	Not Available	NO	TCGA-E2-A1AZ-D19468;TCGA-E2-A1AZ-D19476	A7A7027F-58E3-4B34-B912-C6A0C84BECC8;64F31114-ABD4-4E0D-BAAD-06531F01F8A0	Not Available;Not Available	6;6	121;121	61;61	Adriamycin;Cytoxan	Not Available;Not Available	12;12	4;4	115;1125	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	460;4500	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1AZ-F19462	63961B20-F6AE-45FA-B444-3430F85E6CBF				6		Not Available	Not Applicable	2329		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0.42	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Indeterminate	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A1AZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1AZ-R19479	2A546C14-A33E-4C74-BA07-B68C803BD4AA	1	6	211	167	Not Available	12	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2004
TCGA-A2-A1FX	FEMALE	1847	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	0	1847			TUMOR FREE				61	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A1FX	ac6d3ba9-f84f-4657-aa85-4d66fb7c09da	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Positive	Lumpectomy	Not Applicable	NO	12	-22344	Not Applicable	0	935	Not Available	NO	TCGA-A2-A1FX-D11802;TCGA-A2-A1FX-D11811;TCGA-A2-A1FX-D11806	b78310b5-e2f5-4a69-a170-d5d8b9f9ff96;d761afbc-f8fb-4593-8461-0b7bafa935e9;a39f5502-14a7-4c8d-8d51-34ef34e9bb26	Not Available;Not Available;Not Available	12;12;12	155;Not Available;155	74;198;74	Taxotere;Arimidex;Cytoxan	Not Available;Not Available;Not Available	5;5;5	4;Not Available;4	Not Available;1;Not Available	Not Available;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;3;2	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	160	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A1FX-F20806;TCGA-A2-A1FX-F59654	06617655-F9F7-4EA6-BFAA-875AE6032908;90A36B66-1105-46F9-AB5D-538C89E715E1				12;19		Not Available;None	Not Applicable;Not Applicable	1119;1847		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	185	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	6	Not Available	No	A1FX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	60-69%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A1FX-R11813	1afd58fc-db29-4e80-b23d-79c9ce04bff9	1	12	231	186	Not Available	5	31	10560	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2008
TCGA-E2-A15E	FEMALE	630	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	630			TUMOR FREE				40	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A15E	0a2a3529-f645-4967-9a58-89ee20b8bb62	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	25	-14894	Not Applicable	0	518	Not Available	NO	TCGA-E2-A15E-D18925;TCGA-E2-A15E-D18927;TCGA-E2-A15E-D18920;TCGA-E2-A15E-D18924;TCGA-E2-A15E-D18928;TCGA-E2-A15E-D18930;TCGA-E2-A15E-D18921	9E5B5BB6-2140-4A7E-A602-A78255F5E0C5;407C7081-6BAE-49FF-BA21-08E9B1FFC04D;46743446-EA3E-448F-B26B-48229B9F7E41;AD397BC8-6AFC-4D6E-8808-994CFFAB1FF1;B5431001-AC5A-44E5-A998-A5071332A876;B1551326-BA16-476F-9732-DB302B702454;41AF0E0A-6F0D-4BC6-97E8-6D887A944099	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9	489;Not Available;105;198;448;Not Available;105	119;77;63;119;203;451;63	trastuzumab;clodronate;doxorubicin;paclitaxel;tamoxifen;aromasin;cyclophosphamide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11	24;Not Available;4;12;Not Available;Not Available;4	232;1600;95;130;20;25;954	mg;mg/day;mg;mg;mg/day;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;3;1;2;4;5;1	IV;PO;IV;IV;PO;PO;IV	NO;YES;NO;NO;NO;YES;NO	Chemotherapy;Other, specify in notes;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;clinical trial - bisphosphonates as adjuvant therapy;Not Available;Not Available;Not Available;Not Available;Not Available	6098;Not Available;380;1560;4900;Not Available;3816	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A15E-F18919	D9946A73-A046-481D-A377-E617A25BB8FB				9		Not Available	Not Applicable	630		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Positive	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A15E	TUMOR FREE	Allred score 5+3 = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A15E-R18922	47F13F36-41AE-454A-B878-B9F1AE276011	1	9	275	218	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-LD-A9QF	FEMALE	323	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	323			TUMOR FREE				73	Left	Sentinel node biopsy alone	Not Available	TCGA-LD-A9QF	95C53ECF-D8F1-4BCB-9B1A-C9A0542939F0	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	7	-26869	Not Applicable	0	266	Not Available	Not Available	TCGA-LD-A9QF-D69217;TCGA-LD-A9QF-D69218	DD58AC64-B826-4A72-A389-94813C6C0B32;C272D5D2-87EC-40F4-AE07-C273B787A7AA	Not Available;Not Available	30;30	Not Available;Not Available	190;190	Taxol;Herceptin	Not Applicable;Not Applicable	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-LD-A9QF-F69216	3602B53B-6E99-4063-AC77-94842CA333C4				30			Not Applicable	323																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	0	Not Available	No	A9QF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	LD	Breast	Not Applicable	Alive	2014	2013
TCGA-AN-A04D	FEMALE	52	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	52			TUMOR FREE				58	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A04D	49717f75-0f2d-4e1c-9a12-f1cd7877b80a	Not Available	Negative	Not Available	0	Not Available	Modified radical mastectomy	Negative	Simple Mastectomy	Not Applicable	NO	20	-21426	Not Applicable	0	52	Not Available	Not Available																								Allred (Biocare)	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A04D-F68975	EE0071B8-0C20-431B-8150-16603C61D46F				24			Not Applicable	52																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Dako Hercept Test	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	2	0	No	A04D	TUMOR FREE	Allred (Biocare)	Not Available	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2008
TCGA-AR-A24Q	FEMALE	3172	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	3172			Not Available				49	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24Q	28e9048a-e540-42de-a1f4-4ef894fccc4c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Not Available	30	-18084	Not Applicable	0	2009	Not Available	Not Available	TCGA-AR-A24Q-D31414;TCGA-AR-A24Q-D31416;TCGA-AR-A24Q-D31408;TCGA-AR-A24Q-D31418;TCGA-AR-A24Q-D31409;TCGA-AR-A24Q-D31410;TCGA-AR-A24Q-D31413;TCGA-AR-A24Q-D31412	F76C3A55-BA43-4C18-A156-8B352AE00302;4476480D-D2D0-4265-8B55-C8622DC76046;41C3CA51-2FA0-4FB2-B09E-5A39902B85FC;C01824C6-29F9-492F-9DA8-E9A25BD34492;AA34E461-7470-4313-A778-7199FB3B12DF;ECA92825-C9DC-44DF-A73D-AA6635A1F2B3;BFC7D7CA-0605-47AB-8BD1-36E53660AD7F;04E1D133-F414-45DA-8B0A-F0508DAE0713	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2	155;511;50;1988;50;155;79;155	86;180;36;208;36;79;79;87	Trastuzumab;Trastuzumab;Doxorubicin;Anastrozole;Cytoxan;Paclitaxel;Trastuzumab;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5	4;14;2;Not Available;2;1;Not Available;3	2;6;60;1;600;90;4;60	mg/kg;mg/kg;mg/m2;mg/day;mg/m2;mg/m2;mg/kg;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;2;1;3;1;1;1;1	IV;IV;IV;PO;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Immunotherapy;Immunotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1400;7387;220;Not Available;2210;310;260;970	mg;mg;mg;Not Available;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012;2012;2012	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None		TCGA-AR-A24Q-F31405;TCGA-AR-A24Q-F49495;TCGA-AR-A24Q-F65067;TCGA-AR-A24Q-F65802	7D993A0B-8469-4F77-BA53-8C25B48FD3B4;8704C7B2-E9AF-4A4A-813B-1B4FB8257422;8F8E0B9B-7D99-4B11-A510-C4DEC6682EF2;4516B9C5-D979-4A2D-837C-5E9079FAAD42				2;2;18;30		Not Available;None;None;None	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3088;3088;3172;3172		Not Applicable;None;None;None				Scheduled Follow-up Submission;None;None;None							Not Available;None;None;None			Not Available;None;None;None				None;NO;NO;NO	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	5;10;9;9	Not Available;None;None;None	Not Available;None;None;None	Not Available;None;None;None	NO;None;None;None	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;Not Available;Not Available;Not Available	None;NO;NO;NO	Not Available;TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None;None			YES;YES;YES;YES		YES;YES;YES;YES	Alive;Alive;Alive;Alive	2012;2013;2014;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24Q	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24Q-R31406	94DB3EB1-1ED0-4F5D-AA78-0482FB31D9FF	1	2	230	196	Not Available	5	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-EW-A2FS	FEMALE	1604	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	MX	Stage IIB	0	1604			TUMOR FREE				41	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A2FS	D34471A1-B367-4F8A-B35A-C5901C4F5503	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	12	-15302	Not Applicable	0	1173	Not Available	NO	TCGA-EW-A2FS-D32290;TCGA-EW-A2FS-D32291;TCGA-EW-A2FS-D32292;TCGA-EW-A2FS-D32293;TCGA-EW-A2FS-D32294;TCGA-EW-A2FS-D32295	E4D5F98B-9912-459A-AC81-4DEAF3FBE3C1;9720934C-6807-40ED-95F9-E25B66C9BF52;5752A032-5B94-483E-B22A-0927779121F1;886177D2-3C39-40AC-B112-79B370B885AA;0CC44FB4-CCFA-4BF7-A1E7-281CA65EFE4A;E518AF83-5C33-4071-BCE1-1E37F303A078	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;23;23	Not Available;1166;227;227;318;332	343;140;164;164;164;248	Tamoxifen;Goserelin;Doxorubicin;Cyclophosphamide;Bevacizumab;Paclitaxel	Not Applicable;Stable Disease;Unknown;Unknown;Not Available;Unknown	5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;NO;NO;NO;NO;NO	Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;YES;YES;YES;YES	2012;2012;2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-EW-A2FS-F32287;TCGA-EW-A2FS-F42061	0057B553-0157-425E-9511-8FA81FBAC25A;07000F6B-F69E-4B6B-AB76-A744BB203540				23;10		Not Available;None	Not Applicable;Not Applicable	1422;1604		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	5;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	1	Not Available	No	A2FS	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-EW-A2FS-R32288	0AB7DA2D-C868-42CA-9C7C-A4C0DAD3EC9E	1	23	439	394	Not Available	5	Not Available	6400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A1FV	FEMALE	714	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i+)	M0	Stage IIB	0	714			TUMOR FREE				74	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A1FV	cd0c96a4-6414-4efb-879b-7408b62ed5b6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-27287	Not Applicable	0	461	Not Available	NO	TCGA-A2-A1FV-D12263;TCGA-A2-A1FV-D12266;TCGA-A2-A1FV-D12265	4a36ce19-e3bb-4484-a0c0-8c815afa84a7;09c584e4-9d41-455c-9e08-87c9f0f931b7;bad34945-e422-45a6-9c03-6f05d34514c8	Not Available;Not Available;Not Available	26;26;26	133;Not Available;133	70;141;70	Cyclophosphamide;Arimidex;Docetaxel	Not Available;Not Available;Not Available	5;5;5	4;Not Available;4	1032;1;129	mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;3;2	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	4128;Not Available;516	mg;Not Available;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A1FV-F20238	AC3FEC50-CC82-40E1-968F-65B1B6619C0D				9		Not Available	Not Applicable	714		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	0.92	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	1	No	A1FV	TUMOR FREE	Not Available	Not Available	Not Available	Strong	Strong	Not Available	YES	<10%	WHITE	Not Available	Regional site	TCGA-A2-A1FV-R12267	f0cdeb52-224b-47d4-8e49-4f3783f09429	1	26	216	169	Not Available	5	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T3	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-OL-A5DA	FEMALE	1783	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	1783			TUMOR FREE				61	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A5DA	4E509F73-99C7-48EB-A3A4-D34E3BFACE33	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Unknown	23	-22411	Not Applicable	0	1357	Not Available	Not Available																								Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A5DA-F55440	23A668B0-A47F-47D6-BCDF-8E2A5C754314				10			Not Applicable	1783																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	1	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Ultrasound-guided mammotome biopsy	Other method, specify:	Not Evaluated	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	0	No	A5DA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	60-69%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	partial mastectomy	NO	YES	OL	Breast	Not Applicable	Alive	2013	2009
TCGA-A8-A0AB	FEMALE	518	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	518			TUMOR FREE				54	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A0AB	22eaba28-be67-4730-9846-860bc1fca29a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-19814	Not Applicable	0	518	Not Available	Not Available	TCGA-A8-A0AB-D37905;TCGA-A8-A0AB-D37906;TCGA-A8-A0AB-D37907;TCGA-A8-A0AB-D37908	C764E219-0133-4595-A695-9FC0D32C02E6;24D0F28A-D91B-47A2-AE9C-BD963075AFE4;CB9E17C3-E42E-4B04-9ADC-59AB74070C25;E3113882-092E-4FBB-8664-055788237872	Not Available;Not Available;Not Available;Not Available	6;6;6;6	184;184;184;Not Available	61;61;61;214	5-Fluorouracil;Doxorubicin;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A0AB-F40322	8A60E4E1-747F-4974-9159-CA9BEAA7E445				16			Not Applicable	518																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0AB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-OL-A6VO	FEMALE	858	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	858			TUMOR FREE				43	Right;Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-OL-A6VO	398FB71B-CA83-44E7-BF0D-B1CA464B0283	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	5	-15780	Not Applicable	0	480	Not Available	Not Available	TCGA-OL-A6VO-D63192;TCGA-OL-A6VO-D65548	CE66AA70-6EA4-4FAA-84F8-24A41673E3CE;AB34EC19-3799-4671-962A-F4C7E3E37EA6	Not Available;Not Available	12;25	147;147	71;71	TAXOTERE;Cytoxan	Complete Response;Complete Response	8;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-OL-A6VO-F59365	E7A38310-96E2-4B1D-93D6-BF1D8DC187E4				10			Not Applicable	858																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.23	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	7	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A6VO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-OL-A6VO-R63547	C53F9699-EC12-450E-A717-917D11632C0A	Not Available	12	201	156	Complete Response	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2012
TCGA-A8-A075	FEMALE	518	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	518			TUMOR FREE				42	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A075	7861a5f2-8910-4bcb-9c34-f79c5acd6e21	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-15369	Not Applicable	0	518	Not Available	Not Available	TCGA-A8-A075-D37846;TCGA-A8-A075-D37847;TCGA-A8-A075-D37848;TCGA-A8-A075-D37849;TCGA-A8-A075-D37850	01EB4E82-BDB4-4A0D-AE50-BE001501E918;4F50CB8E-0F25-40D0-A2A9-E840A63A5158;3B670A10-80C3-4879-BC47-89AD2311D0CA;BEDE978F-31C6-4E5C-98AE-D4AE802920F2;02D06787-6B7F-42B2-BEB7-F10802F43C59	n/a;n/a;n/a;n/a;n/a	6;6;6;6;6	122;122;214;Not Available;Not Available	31;31;122;275;214	Epirubicoin;Cyclophosphamide;Docetaxel;Tamoxifen;Zoledronic acid	Complete Response;Complete Response;Complete Response;Not Applicable;Not Applicable	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A075-F40820	030338FD-A8B6-40FA-B40C-D31ECB4B3CD2				2			Not Applicable	518																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A075	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A075-R38177	7D9218C9-489E-4C64-9C92-7EE1AEB9C75E	Not Available	11	275	214	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-BH-A1FU	FEMALE	1688	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N0	M0	Stage IA	0	1688			WITH TUMOR				44	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FU	c348a9b3-c901-4384-a222-144387bac0c5	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	8	-16174	1688	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A1FU	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1997
TCGA-D8-A1JP	FEMALE	639	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	639			Not Available				73	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A1JP	752f4773-5a12-4485-a1f6-896e148ddf4d	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Positive	Lumpectomy	Not Applicable	Not Available	29	-26862	Not Applicable	0	167	Not Available	Not Available	TCGA-D8-A1JP-D20741	E016C444-DD80-48AC-83D9-42A76BE14860	Not Available	15	Not Available	68	TAMOXIFEN	Not Available	1	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1JP-F20740	F5A697E5-7254-4E78-99D2-2C0D8F8C5549				15		Not Available	Not Applicable	639		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	DAKOHercepTest TM	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A1JP	Not Available	manual counting	Not Available	Not Available	Not Available	>75%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-D8-A1JA	FEMALE	502	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	NX	M0		1	431.0		Locoregional Disease	TUMOR FREE				60	Left Upper Outer Quadrant	No axillary staging	Not Available	TCGA-D8-A1JA	9ced0c70-c46c-4f98-8f48-840defe4b8b1	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	29	-21918	Not Applicable	0	18	Not Available	Not Available	TCGA-D8-A1JA-D20942;TCGA-D8-A1JA-D65317	49D90CDE-D4EF-46EF-94D8-525D69BE2B09;954BBBEE-5DA3-43B7-986A-7AA80BA0744F	Not Available;Not Available	19;22	403;403	340;340	adriamycin;cyclophosphamide	Not Available;Not Available	1;9	4;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	240;Not Available	mg;Not Available	Not Available;NO	2012;2014	manual counting	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	YES	NO		TCGA-D8-A1JA-F20941	2C26170E-B4E3-428E-A2F1-D91B478E0568				19		Not Available	Not Applicable	502		431				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	1	Not Available	Locoregional Disease	Not Available	YES																																		WITH TUMOR			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Positive	Not Evaluated	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	No	A1JA	TUMOR FREE	manual counting	Not Available	Not Available	0%	Not Available	Not Available	NO	Not Available	WHITE	Not Available	Local Recurrence	TCGA-D8-A1JA-R20943	1A6BC6F2-1938-46E7-9B84-1C48C8AD6921	Not Available	19	472	431	Not Available	1	Not Available	5000	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	NX	T4b	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A24W	FEMALE	1550	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1550			Not Available				55	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24W	67526f5a-3a30-45b2-aeab-2b21a855063e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	10	-20123	Not Applicable	0	1550	Not Available	Not Available	TCGA-AR-A24W-D31635;TCGA-AR-A24W-D31637;TCGA-AR-A24W-D31640;TCGA-AR-A24W-D31641;TCGA-AR-A24W-D31642	1CD0389E-EE24-475D-B7C2-4004B7E66425;B02CD97F-591A-4C8A-ADBE-EDE8209C6296;567A9E78-2614-4140-A312-1D519B05A899;B0D36A62-52F5-4332-A90A-58BBBE026CE6;1C382941-469A-4FBC-BBFC-AECC59416F32	Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21	Not Available;Not Available;Not Available;345;Not Available	Not Available;Not Available;Not Available;164;345	Doxorubicin;Cytoxan;Paclitaxel;Letrozole;Anastrozole	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A24W-F31634;TCGA-AR-A24W-F49476	E65CA6F6-4AD9-411B-B4F6-A3F3C34F1DBA;7B6E8320-51FE-49BF-A68A-6AB693D91DD2				7;2		Not Available;None	Not Applicable;Not Applicable	1550;991		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	5;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	3	Not Available	No	A24W	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Total Mastectomy	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-E2-A14X	FEMALE	972	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	972			TUMOR FREE				55	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14X	60df7543-6da5-4c75-943b-5800c1e08234	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	6	-20105	Not Applicable	0	692	Not Available	NO	TCGA-E2-A14X-D18865;TCGA-E2-A14X-D18863;TCGA-E2-A14X-D18864;TCGA-E2-A14X-D18861;TCGA-E2-A14X-D18866	FE204945-F99F-464A-9E6F-D168A421C139;FCF5541F-112D-4384-BD87-6B4BCBAD598D;A9E35661-F258-4F47-B234-1EEDC19E838C;A713574D-B6F2-4C3E-A90D-81F33EAB041C;DB24F34E-51A3-4AF7-A17C-27D81176D60D	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	97;188;199;280;97	55;55;111;182;55	doxorubicin;avastin;paclitaxel;clodronic acid;cyclophosphamide	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	2;7;5;Not Available;2	128;1470;171;75200;1284	mg;mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2;1	IV;IV;IV;PO;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Other, specify in notes;Chemotherapy	Not Available;Not Available;Not Available;clinical trial - bisphosphonates as adjuvant therapy;Not Available	512;9310;1642;75200;5136	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14X-F18857	02DF16E7-CE1F-4746-952C-B32F958EF48B				4		Not Available	Not Applicable	972		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	5	Not Available	No	A14X	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-E2-A14X-R18859	F63A992C-A3FF-4949-86BE-6556F627B1A3	1	4	271	218	Not Available	11	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-A2-A0EX	FEMALE	752	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i+)	M0	Stage IIB	0	752			TUMOR FREE				46	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A0EX	9d8702e1-1a36-4bca-85ab-5f11d58d7953	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Positive	Lumpectomy	Not Applicable	YES	13	-16858	Not Applicable	0	550	Not Available	Not Available	TCGA-A2-A0EX-D2011;TCGA-A2-A0EX-D2010;TCGA-A2-A0EX-D2012	a18f54ee-33e5-4dc3-a61a-ba662d4e192d;e8a75fe6-b841-46ea-9bd8-51b5fe21c01e;2a817b25-0580-4742-b337-8cd0a8bfb143	Not Available;Not Available;Not Available	13;13;13	222;Not Available;Not Available	172;165;273	Lupron;Tamoxifen;Zoladex	Not Available;Not Available;Not Available	8;8;8	3;Not Available;Not Available	3.75;10 mg;3.6 mg monthly	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;3	IM;PO;SC	NO;YES;YES	Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available	11.25;Not Available;Not Available	mg;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO;Not Available	NO;Not Available	Not Available;Not Available	Not Available;None	TCGA-A2-A0EX-F2323;TCGA-A2-A0EX-F13742	C5A96D70-A9CE-4CDB-AAA2-5894EEA7A773;622294E1-0361-4A19-8410-DE5E8A4CB231	Not Available;None	Not Available;None	Not Available;None	14;10	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	550;752	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	10;6	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	NO;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.22	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	1	No	A0EX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-AC-A5EI	FEMALE	442	Other, specify	Breast	Alive	T1c	N1mi	MX	Stage IB	0	442			TUMOR FREE				88	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A5EI	01B9F68B-4DE4-4374-B4F2-8A0685E18153	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	12	-32375	Not Applicable	0	0	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A5EI-F60184	9AE528AA-45A7-458E-8361-B5B6123CE23D				31			Not Applicable	442																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Malignant Phyllodes Tumor	No	C50.9	9020/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	Yes	A5EI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	60-69%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1mi	T1c	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2012
TCGA-AC-A2QJ	FEMALE	446	Metaplastic Carcinoma	Breast	Dead	T4b	N0	M0	Stage IIIB	1	237.0	Bone	Distant Metastasis	TUMOR FREE				48	Left Upper Outer Quadrant;Left Lower Outer Quadrant	Other (specify)	Sentinel lymph node and axillary lymph node biopsy	TCGA-AC-A2QJ	D9FD2724-7DB0-4AF3-AC14-217BDFA5203F	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	18	-17569	Not Applicable	0	69	Not Available	NO	TCGA-AC-A2QJ-D44024;TCGA-AC-A2QJ-D44025;TCGA-AC-A2QJ-D44026;TCGA-AC-A2QJ-D44873;TCGA-AC-A2QJ-D44874;TCGA-AC-A2QJ-D44876	C5CB5329-7C61-47A9-A6C2-1BA45837EE19;ED128C91-BA77-4FBB-B670-962EA86F9365;900E4830-C0E0-4B02-8648-811C3D9C6780;D4B923DD-9936-4FD1-B31D-7EC1BD1E03EB;AE31D0D7-2D48-4096-8A15-44362B8615FB;A7788968-8449-4721-9548-BFB6C599C876	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;28;28;28	111;111;202;385;407;418	69;69;125;322;386;349	Cytoxan;Adriamycin;Abraxane;Gemzar;Carboplatin;Faslodex	Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	6;6;6;6;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2013;2013;2013;2013;2013;2013	Not Available	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2QJ-F44021	3A8D4436-79F0-4371-8E16-9ABB1EC95ECA				28			446	Not Available																				NO																						6					YES	YES	Not Available	237	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Bone	Distant Metastasis	Not Available	NO	Not Available	YES	WITH TUMOR						YES		YES	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	Not Available	No	A2QJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-AC-A2QJ-R44022;TCGA-AC-A2QJ-R44023	3B3D8F3B-C6C9-4D81-A6BB-E1EA9484B841;8AD664BA-6C40-4CAA-8CB1-F5CDAD9C7202	Not Available;Not Available	10;10	279;312	241;299	Radiographic Progressive Disease;Radiographic Progressive Disease	6;6	20;10	05000;01800	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T4b	Mastectomy	YES	NO	AC	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A152	FEMALE	2128	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	1	54.0	Liver	Distant Metastasis	WITH TUMOR				56	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A152	a8015490-9740-45c9-8bd2-eb6d1beefc2e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	6	-20705	Not Applicable	0	588	Not Available	NO	TCGA-E2-A152-D19134;TCGA-E2-A152-D19126;TCGA-E2-A152-D19125;TCGA-E2-A152-D19133;TCGA-E2-A152-D19127	BF017551-9DD2-4283-A0AD-FA9F13FC6972;CE4C026E-0255-4BF9-93C9-FBA8B76E0AA6;EA9D6B7D-D495-46D4-BF2D-BC35E0F65BFB;74FB0D62-6C47-4269-B25C-6A6340F18D06;4DDAC9D3-0FF6-47D1-8863-6BA83B231D43	Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17	Not Available;42;42;Not Available;217	42;42;42;231;63	Trastuzumab;Cyclophosphamide;Docetaxel;Arimidex;Paclitaxel (Protein-Bound)	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	Not Available;1;1;Not Available;6	460;942;118;1;156	mg;mg;mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;3;2	IV;IV;IV;PO;IV	YES;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	12678;942;118;1;2641	mg;mg;mg;mg/day;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;YES;None;None	NO;NO;None;None	NO;NO;None;None		TCGA-E2-A152-F19122;TCGA-E2-A152-F19123;TCGA-E2-A152-F71067;TCGA-E2-A152-F72471	E6A03A68-6E7C-49D0-8D66-D9C338FBC42A;8E3CDBC2-055A-4D81-A95C-70137ABE5F3D;F7360C7C-03AE-4B54-B8FB-ED6923473E88;F8357F98-0281-4FE8-9B0B-288221E20B2D				17;17;18;23		Not Available;Not Available;None;None	Not Applicable;Not Applicable;Not Applicable;Not Applicable	825;825;1994;2128		83;54;None;None				Scheduled Follow-up Submission;Scheduled Follow-up Submission;None;None							Not Available;Not Available;None;None			Not Available;Not Available;None;None				None;None;NO;NO	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	Not Available;Not Available;None;None	11;11;3;6	Bone;Liver;None;None	Distant Metastasis;Distant Metastasis;None;None	Not Available;Not Available;None;None	YES;YES;None;None	None;None;Not Available;NO	None;None;Not Available;NO	None;None;Not Available;1044	None;None;Not Available;966	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;3+	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Negative	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Positive	None;None;Not Available;Not Evaluated	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Not Available	None;None;Not Available;Negative	None;None;Not Available;Other, specify	None;None;Not Available;Locoregional Recurrence	None;None;Not Available;Breast	None;None;Not Available;YES	None;None;Not Available;Not Available	None;None;NO;YES	WITH TUMOR;WITH TUMOR;WITH TUMOR;TUMOR FREE			Not Available;Not Available;None;None			YES;YES;YES;YES		NO;NO;NO;NO	Alive;Alive;Alive;Alive	2011;2011;2015;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A152	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-C8-A12Q	FEMALE	385	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N2	M0	Stage IIIA	1		Liver	Distant Metastasis	TUMOR FREE				78	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12Q	a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	13	-28733	Not Applicable	0	2	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	NO		TCGA-C8-A12Q-F20253	84D2BF2F-915F-41A5-8B6E-DE88C2A7A96B				9		Not Available	385	Not Available		Not Available				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Liver	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			NO		NO	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Positive	Not Evaluated	7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12Q	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2	T1	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AC-A3QQ	FEMALE	734	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0 (i-)	MX	Stage IA	0	734			TUMOR FREE				54	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A3QQ	95CEF916-5545-455B-920C-773A54FC7676	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	YES	3	-19723	Not Applicable	0	34	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3QQ-F66024	FC62B467-765C-4836-B773-C315DE7A3049				1			Not Applicable	734																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	5	Close	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A3QQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	70-79%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T1c	Nipple Sparing Total Mastectomy	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-EW-A1PD	MALE	424	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	424			TUMOR FREE				61	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1PD	4dfc233b-ed03-4825-8089-e04cdee99996	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-22536	Not Applicable	0	175	Not Available	NO	TCGA-EW-A1PD-D30290;TCGA-EW-A1PD-D30289;TCGA-EW-A1PD-D30291	1681B955-E38A-4793-BD18-B508BA3EC40A;87DA1EC9-4D7A-47A4-8455-BB95C304B65C;FD142565-E97D-46EE-AB46-9AB855E32A3B	Not Available;Not Available;Not Available	8;8;8	217;405;217	112;112;112	Docetaxel;Trastuzumab;Carboplatin	Not Available;Not Available;Not Available	3;3;3	6;14;6	145;500;669	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	872;7007;3933	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PD-F29106	AEB2D7F0-8756-4DE0-9278-64F6193B5284				8		Not Available	Not Applicable	424		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	MALE	Not Available	Not Available	20-29%	Not Available	2+	Not Available	Not Available	>6.0	2.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	7	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	2	Not Available	No	A1PD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A1FJ	FEMALE	1927	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N1b	M0	Stage IIIA	0	1927			Not Available				66	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FJ	f6581eee-61b9-43d4-ab0d-ce5ce3ba1c74	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	8	-24262	1927	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	35	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	6	Not Available	No	A1FJ	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1b	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-BH-AB28	FEMALE	287	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	287			TUMOR FREE				53	Left	Not Available	Not Available	TCGA-BH-AB28	09D6E904-7184-4788-8A19-04F8C46CB13F	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	30	-19570	Not Applicable	0	185	Not Available	Not Available	TCGA-BH-AB28-D61473;TCGA-BH-AB28-D61474	54C265C0-9FA9-491F-BB0D-4D8AFD0AB2A4;5A9C6B1E-27C2-496C-8266-4D565A27C07F	Not Available;Not Available	30;30	Not Available;Not Available	122;122	Taxotere;Cytoxan	Not Applicable;Not Applicable	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-AB28-F64209	6CB9D593-9190-4C31-968A-C9D75BC2480D				25			Not Applicable	287																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Indeterminate	20	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	3	Not Available	No	AB28	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2014	2013
TCGA-AO-A126	FEMALE	3307	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	1	267.0		Locoregional Disease	TUMOR FREE				39	Right Upper Inner Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A126	cc0902fd-a2fc-4327-929e-d4219e32e1d7	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	7	-14264	Not Applicable	0	2850	Not Available	Not Available	TCGA-AO-A126-D5938;TCGA-AO-A126-D5937;TCGA-AO-A126-D5939;TCGA-AO-A126-D5940;TCGA-AO-A126-D5941	e3937ee2-ef17-48fd-b613-38d265529590;ee9c3d89-3e97-48d7-8e7c-269fe8ad0fd0;8994c71e-c50a-46fe-bd93-196c3b435d65;3d58aed6-c8a0-4506-834b-a58fa3a24e6e;9948fc14-eaff-4311-a8e0-5c0941e2316c	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	238;238;238;1795;1639	91;91;91;320;323	Methotrexate;Cyclophosphamide;Fluorouracil;Tamoxifen;Zoladex	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	8;8;8;Not Available;Not Available	40;600;600;20;Not Available	mg/m2;mg/m2;mg/m2;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1	IV;IV;IV;PO;SC	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	520;7776;7776;Not Available;Not Available	mg;mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	69	YES;NO	YES;YES	YES;YES	NO;None	TCGA-AO-A126-F5876;TCGA-AO-A126-F19402	8C48C547-31D9-439C-AFE6-E5450D782065;07D7BA23-00A6-491E-A381-1B93BB686C33	Positive;None	2+;None	Positive;None	7;12	295;None	Not Available;295	Not Applicable;Not Applicable	2850;3307	Not Available;None	267;267	Not Available;None	20-29%;None	49;None	None;Scheduled Follow-up Submission	Not Available;None	3+ Positive;None	<10%;None	>=2.0 Positive;None	0;None	31;None	Not Available;Not Available	62;None	1.3;None	Not Available;Not Available	2+;None	Negative;None	Negative;None		Not Available;0	Not Available;Not Available	Not Available;20-29%	Not Available;Positive	Not Available;Not Available	Not Available;Not Available	Not Available;<10%	Not Available;Not Available	Not Available;1.3	Not Available;Not Available	None;4 Point Scale	Not Available;Not Available	None;4 Point Scale	Not Available;Negative	Not Available;Negative	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;60-69%	Not Available;Positive	12;12	None;Not Available	None;Locoregional Disease	None;Not Available	None;YES																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	60-69%;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	>=2.2 Positive	1+	30	Not Available	74	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A126	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	ASIAN	Not Available	Local Recurrence	TCGA-AO-A126-R5877	a3a403cf-f4f1-46ae-a7b9-d614b4e1266c	1	7	421	384	Not Available	12	25	10000	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2002
TCGA-OL-A5RZ	FEMALE	679	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	MX	Stage IA	0	679			TUMOR FREE				57	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-OL-A5RZ	7E8713BD-0B17-4F09-9696-BC29707D862B	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	Unknown	16	-21038	Not Applicable	0	313	Not Available	Not Available	TCGA-OL-A5RZ-D65262;TCGA-OL-A5RZ-D65263	20672357-AAF4-4236-A2ED-742216DD61B4;70A2566A-B315-479A-82BF-250CBCAF6F3B	Not Available;Not Available	24;24	331;331	239;239	Doxorubicin;Cytoxan	Complete Response;Complete Response	9;9	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	30-39%	Unknown	Not Available	Not Available	2.0					TCGA-OL-A5RZ-F56571	1921F25F-EC28-4E7A-A12E-A445D1DDBE0D				14			Not Applicable	679																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	21.0	10.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Positive	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A5RZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1b	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2012
TCGA-EW-A1PG	FEMALE	1051	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	1051			TUMOR FREE				53	Left Lower Inner Quadrant;Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1PG	da286247-e8bb-4941-a2af-2453fe61cd02	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	18	-19464	Not Applicable	0	876	Not Available	NO	TCGA-EW-A1PG-D29645;TCGA-EW-A1PG-D29104;TCGA-EW-A1PG-D29642;TCGA-EW-A1PG-D29639;TCGA-EW-A1PG-D29649	A507200D-0651-4B04-951A-3B520607A972;252A2A60-D59F-40FC-B2AF-72551B1D46F1;5649EFA1-DE70-4DC9-AC8B-3770FB06A63D;AC1801E0-6BCE-4E2E-9CAC-53852EAA2C9C;DA69487C-E853-43D8-8FE8-325C97F99CB6	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	262;262;262;262;Not Available	157;157;157;157;263	Docetaxel;Fluorouracil;CYCLOPHOSPHAMIDE;Epirubicin;Aromasin	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	3;3;3;3;Not Available	182;910;910;182;25	mg;mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	FEC x3 then T x3;FEC x3 then T x3;FEC X3 THEN T X3;FEC x3 then T x3;Not Available	IV;IV;IV;IV;PO	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	546;2730;2730;546;Not Available	mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1PG-F29103	8BA6C3BB-BF54-4173-8FD5-BD3A864EA6EC				8		Not Available	Not Applicable	1051		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	<4.0	1.8	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	1	No	A1PG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-A8-A08H	FEMALE	0	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	0			TUMOR FREE				66	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A08H	db8d38ab-cc61-49ee-863d-40060112f2af	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24137	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08H	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-A8-A0AD	FEMALE	1157	Mixed Histology (please specify)	Breast	Alive	T1c	N0	M0	Stage I	0	1157			TUMOR FREE				83	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A0AD	af5453a9-cf1f-40de-aec4-0e0710908fb7	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-30407	Not Applicable	0	1157	Not Available	Not Available	TCGA-A8-A0AD-D37897	246120A5-AB0B-454B-B52D-6055129097FE	Not Available	6	Not Available	61	Tamoxifen	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A0AD-F40321	AA110D07-3B8D-423A-8609-0393506BEC0A				16			Not Applicable	1157																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	lobular/ductal	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0AD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-BH-A0DH	FEMALE	1156	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1156			TUMOR FREE				63	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0DH	491b6364-1223-474f-816f-e248c8c841e2	Negative	Positive	Not Available	3+	Not Available	Mastectomy NOS	Positive	Other	Not Applicable	NO	8	-23366	Not Applicable	0	1156	Not Available	Not Available	TCGA-BH-A0DH-D4521;TCGA-BH-A0DH-D4519;TCGA-BH-A0DH-D4524;TCGA-BH-A0DH-D4522	739195B2-FD02-405E-9A84-3013536F114F;3CED1251-3C25-4394-9ACA-4BE463307C37;D3845BE6-7A25-470F-A220-34434866432E;60D7BF55-6327-457F-973E-6A5BF4E8FDC3	Not Available;Not Available;Not Available;Not Available	16;16;17;17	143;Not Available;143;143	71;164;71;71	CYCLOPHOSPHAMIDE;FEMARA;TAXOTERE;DOXORUBICIN	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;Not Available;4;4	Not Available;2.5;Not Available;Not Available	Not Available;mg/day;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0DH-F4529	03118CCF-5575-4CB5-840E-2DE55AA5F8FA	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	1156	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	28	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	No	A0DH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	40-49%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DH-R4527	7A76D067-B17D-48A7-8210-123A89951ED4	1	17	233	189	Not Available	11	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-Z7-A8R6	FEMALE	3256	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	3256			TUMOR FREE				46	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-Z7-A8R6	B1D44C81-747D-471F-9093-AEB262A17975	Not Available	Positive	4 Point Scale	2+	4 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	9	-16955	Not Applicable	0	2800	Not Available	Not Available	TCGA-Z7-A8R6-D58749;TCGA-Z7-A8R6-D58750;TCGA-Z7-A8R6-D58751	A2A69EA3-72CF-46C2-B6D6-DF0A093887A5;644F7063-1BA4-4B84-99E4-012DB9AE1486;21D2B8CE-9A15-4401-936E-688113BD6678	Not Available;Not Available;Not Available	9;9;9	153;153;153	31;31;31	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	7;7;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-Z7-A8R6-F58752	05FE8EA0-A5C2-4172-8405-A7A30E1E43BF				9			Not Applicable	3256																				NO																						7					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.8	8022/3	C50.8	2+	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A8R6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	Z7	Breast	Not Applicable	Alive	2014	2005
TCGA-A2-A0T3	FEMALE	1516	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1mi	M0	Stage IB	0	1516			TUMOR FREE				37	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0T3	058dcb78-bed1-40c3-a6c2-a0cc40065531	Negative	Positive	3 Point Scale	3+	3 Point Scale	Other	Positive	Lumpectomy	Margin resection	YES	21	-13680	Not Applicable	0	456	Not Available	NO	TCGA-A2-A0T3-D9215;TCGA-A2-A0T3-D9218;TCGA-A2-A0T3-D9216;TCGA-A2-A0T3-D9214	b41bdca7-b0bf-4308-b906-1dcc9bf77b23;f9514221-8f9b-403b-99d4-e4843d0b2eb6;2a946428-c9e3-4910-8589-57d6230d7cd4;4c04520d-d4ae-4202-b00b-a2782b640207	Not Available;Not Available;Not Available;Not Available	21;21;21;21	177;Not Available;177;177	70;Not Available;70;70	Adriamycin;Tamoxifen;Cytoxan;Taxotere	Not Available;Not Available;Not Available;Not Available	2;2;2;2	6;Not Available;6;6	103;Not Available;1030;155	mg;Not Available;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;4;3;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	618;Not Available;6180;930	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.3	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0T3-F13956;TCGA-A2-A0T3-F59384	AE551901-3B41-40AC-960F-AEEC27B3CD63;7449E8A7-2B95-489D-BA42-16889AC8E023				12;12		Not Available;None	Not Applicable;Not Applicable	569;1516		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	7;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	556	Not Available	3.2	1.4	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	13	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	2	0	No	A0T3	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0T3-R9219	f00904bf-c888-403a-a5d4-2d76fcbc5378	1	21	248	203	Not Available	2	33	10440	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T1c	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2009
TCGA-E9-A1RI	FEMALE	1449	Mixed Histology (please specify)	Breast	Alive	T1c	N2	M0	Stage IIIA	0	1449			TUMOR FREE				43	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RI	dd3bfb26-b534-4917-9c4d-9fe7b6477762	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	28	-15942	Not Applicable	0	48	Not Available	NO	TCGA-E9-A1RI-D30560;TCGA-E9-A1RI-D30556;TCGA-E9-A1RI-D30562;TCGA-E9-A1RI-D46349;TCGA-E9-A1RI-D30558	7D013691-E913-4D44-BCCA-11F6C13369AB;E1C9066D-8569-4D69-A22F-3C031DD1FFD4;FEF0778A-20C4-491A-BF46-E76657C7B65F;6D4635CF-24FA-4141-B052-0F162D685C5A;5CC44B06-F81E-4106-A661-6A584D26D12B	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;6;13	78;78;Not Available;425;78	32;32;28;418;32	Doxorubicin;5-Fluorouracil;Tamoxifen;Leuprolide;Cyclophosphamide	Not Available;Not Available;Not Available;Complete Response;Not Available	4;4;4;8;2	3;1;Not Available;Not Available;3	100;1000;20;Not Available;1000	mg;mg;mg/day;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT;Not Available;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;PO;Not Available;IV	NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	300;1000;Not Available;Not Available;3000	mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;NO;Not Available	2012;2012;2012;2013;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A1RI-F30555;TCGA-E9-A1RI-F39443;TCGA-E9-A1RI-F70144	7BDF7FC0-36E3-4368-93A4-DD7C98B4B2D0;8690964A-A2FE-410B-9169-9F815F1D0A93;A958BB89-B31B-4120-984E-F4D5E8BEADEB				27;23;28		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	425;1084;1449		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	9;1;1	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2013;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	5	Not Available	No	A1RI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1RI-R30563	FF379776-F8AA-4FCF-B487-555B3031C3FE	1	12	169	137	Not Available	4	62	12400	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A09W	FEMALE	30	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIB	0	30			Not Available				70	Right Upper Inner Quadrant	Not Available	Not Available	TCGA-A8-A09W	452672e8-b6d9-45b5-bb02-e88e03e2dd66	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-25659	Not Applicable	0	30	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09W	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-A2-A4RX	FEMALE	742	Metaplastic Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	742			Unknown				67	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A4RX	D111C4AB-B39A-4A7C-8D8E-CB342BC10627	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	28	-24779	Not Applicable	0	274	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A4RX-F58491	95B990F4-B105-40DD-A286-0FC1AEB007FE				11			Not Applicable	742																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4RX	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	<10%	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2013	2012
TCGA-A7-A0CE	FEMALE	1074	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1074			TUMOR FREE				57	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A0CE	9d95a65b-e41d-4f93-92d4-99dce29ff40d	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	4	-20863	Not Applicable	0	254	Not Available	Not Available	TCGA-A7-A0CE-D3140;TCGA-A7-A0CE-D3143;TCGA-A7-A0CE-D3142	89072b52-11c9-4fe9-86c0-fff7dbaf8e8e;9464606d-3ece-43bd-aad1-7126b43626c9;30d2d91e-18e4-4adb-87e1-e9154ad7cf0e	Not Available;Not Available;Not Available	9;9;9	105;161;105	63;119;63	Adriamycin;Taxol;Cytoxan	Not Available;Not Available;Not Available	11;11;11	4;4;4	130;380;1310-1320	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	520;1520;5250	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.9	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0CE-F2071;TCGA-A7-A0CE-F39153	6C5CD45B-C966-4982-A81F-CD4385029102;EAEC135D-263E-4230-97DF-BFEB960B4161	Not Available;None	Not Available;None	Not Available;None	9;14	Not Available;None	Not Available;None	Not Applicable;Not Applicable	310;1074	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;1					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2013	FEMALE	Vysis AutoVysion System	Not Available	Not Available	PathVysion	2+	389	Not Available	3.2	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A0CE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0CE-R2979	03d6bcae-2761-4649-a609-07dd7316aa81	1	5	238	189	Not Available	11	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2009
TCGA-E2-A576	FEMALE	1043	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	MX	Stage IA	0	1043			TUMOR FREE				69	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A576	F04DCA9E-409B-4300-B11D-12243E5D361D	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	10	-25350	Not Applicable	0	578	Not Available	Not Available	TCGA-E2-A576-D48243;TCGA-E2-A576-D48244;TCGA-E2-A576-D48245	D025BAD3-CE6C-4A32-8E2E-A500F7284F31;5706041F-0C16-4D3D-AC37-E6AA13567E0B;5A282F3D-A833-4F32-B7F1-29B0C86F8E79	Not Available;Not Available;Not Available	10;10;10	Not Available;151;151	252;88;88	Arimidex;Taxotere;Cytoxan	Not Applicable;Unknown;Unknown	9;9;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E2-A576-F67575	6FD3ACAD-834B-4DE2-BD60-A40C43793BEB				6			Not Applicable	1043																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A576	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field;Primary Tumor Field	TCGA-E2-A576-R48246;TCGA-E2-A576-R48247	A51C3143-7A2E-4FF2-870E-807996C2F8B0;BB3AA3C7-55F0-43CA-A75D-F44F77A1F684	Not Available;Not Available	10;10	239;235	236;196	Unknown;Unknown	9;9	5;28	1000;5040	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2013	2011
TCGA-AO-A0JF	FEMALE	1980	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	1980			TUMOR FREE				68	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JF	f357fe19-5359-4662-8ce9-aa996132283b	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	20	-24923	Not Applicable	0	354	Not Available	Not Available	TCGA-AO-A0JF-D3207;TCGA-AO-A0JF-D3208;TCGA-AO-A0JF-D3209;TCGA-AO-A0JF-D3211;TCGA-AO-A0JF-D3206	c6fe7b1e-7d43-4f33-add3-cb45112a5a0b;957365be-dbc2-4492-98f7-f7125cb4700c;3f8e0a6f-72a8-4d35-84bf-ed2c931be832;0e86b873-98ca-4bc2-83b4-9acfddbb62a4;69646598-6e7b-4f0c-a0e9-601b648159df	Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20	155;256;353;Not Available;155	105;172;336;356;105	DOXORUBICIN;PACLITAXEL;ANASTROZOLE (ARIMIDEX);LETROZOLE (FEMARA);CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	4;12;Not Available;Not Available;4	60;80;1;2.5;600	mg/m2;mg/m2;mg/day;mg/day;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;2;2;1	IV;IV;PO;PO;IV	NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	480;1920;Not Available;Not Available;4800	mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;None;None	TCGA-AO-A0JF-F3204;TCGA-AO-A0JF-F15489;TCGA-AO-A0JF-F72115	9B204717-E586-4156-B08E-25167DC424C9;AC690AA5-8AC7-4FCD-8B92-2A1010CCFB53;704FB623-3791-4E9D-8194-3C9B34439C3B	Not Available;None;None	Not Available;None;None	Not Available;None;None	20;22;15	Not Available;None;None	Not Available;Not Available;None	Not Applicable;Not Applicable;Not Applicable	354;650;1980	Not Available;None;None	Not Available;Not Applicable;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;Scheduled Follow-up Submission;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	None;None;NO	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	None;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	Not Available;Not Available;None	9;8;4	None;Not Available;None	None;Not Available;None	None;Not Available;None	None;NO;None	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;Not Available	None;None;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE	Not Available;None;None	Not Available;None;None	Not Available;Not Available;None	Not Available;None;None	Not Available;None;None	YES;YES;YES	Not Available;None;None	YES;YES;YES	Alive;Alive;Alive	2010;2011;2015	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	2	0	No	A0JF	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A0JF-R3205	605f8f77-3566-431e-93ae-33ec0b26904a	1	6	328	299	Not Available	9	21	5272	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009
TCGA-E2-A14U	FEMALE	1318	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1318			TUMOR FREE				74	Right Upper Outer Quadrant	Other (specify)	Sentinel lymph node dissection	TCGA-E2-A14U	23B7AAEA-1119-4B10-AA1A-0AE255D2F2A6	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	6	-27389	Not Applicable	0	838	Not Available	NO	TCGA-E2-A14U-D33623	0B0A2B1B-77FF-4EEF-B070-7C3DAB61221D	Not Available	11	Not Available	129	Arimidex	Not Applicable	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14U-F33622	573201B2-5807-4344-A976-9996B93EAE55				11		Not Available	Not Applicable	1318		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	40-49%	Not Available	2+	Not Available	Not Available	Not Available	1.04	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14U	TUMOR FREE	Allred score 5+3 = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A0BL	FEMALE	2278	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	2278			TUMOR FREE				35	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0BL	92b5de82-0221-4df1-8094-80f40c0bb4fa	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	8	-12841	Not Applicable	0	1340	Not Available	NO	TCGA-BH-A0BL-D59190;TCGA-BH-A0BL-D59191;TCGA-BH-A0BL-D59192	3DFD3BA5-2A34-4B70-AC12-5D1FAFE94711;9D3B5CF6-D53E-4A6E-9E36-96AEF566A22F;A18467A5-0B9F-4D1C-97E4-44F1D31AE8F3	Not Available;Not Available;Not Available	2;2;2	142;142;240	72;72;163	Adriamycin;Cytoxan;Taxol	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0BL-F59189	3F9A600B-3723-4F22-9943-AFDBE30523C5				2			Not Applicable	2278																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0BL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-LL-A740	FEMALE	441	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	MX	Stage IA	0	441			TUMOR FREE				61	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A740	AA60FA8D-C374-40E0-AF2D-B007701E67E3	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	12	-22416	Not Applicable	0	137	Not Available	Not Available	TCGA-LL-A740-D51204;TCGA-LL-A740-D51205;TCGA-LL-A740-D65062	FFDC6873-66C3-41A3-9043-746A13AF38C6;53BF41C6-4FAA-40E5-80B2-E3ED637A4E30;25DBA480-441A-4F69-9824-94ADC2AACDB4	Not Available;Not Available;Not Available	12;12;18	164;164;255	122;122;178	ADRIAMYCIN;CYTOXAN;TAXOL	Complete Response;Complete Response;Complete Response	11;11;9	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	2.9					TCGA-LL-A740-F65059	1639524D-0C7A-4F66-8F84-322D2A41C448				18			Not Applicable	441																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	113	Not Available	3.3	1.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A740	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T1c	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-BH-A0H9	FEMALE	1247	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1247			TUMOR FREE				69	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0H9	0f64edec-0f1f-4025-8a53-75f9534f7828	Not Available	Positive	Not Available	1+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	17	-25289	Not Applicable	0	1247	Not Available	Not Available	TCGA-BH-A0H9-D4699	DA3E47E4-D137-485D-BB51-268013C132C2	Not Available	17	Not Available	101	Arimidex	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	90-99%	Not Available	Not Available	Not Available	2.98	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0H9-F4703	F47167AF-0722-4448-88DC-80918DF82E28	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	1247	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	3.43	1.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0H9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30-39%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0H9-R4701	2EBAC797-F05A-4DEA-A427-709B2D7D5B39	1	17	263	225	Not Available	11	35	6300	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-EW-A1J1	FEMALE	575	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	575			TUMOR FREE				38	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1J1	ed6cef77-1bd9-4e3b-b576-550a91e4253a	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	11	-14122	Not Applicable	0	282	Not Available	NO	TCGA-EW-A1J1-D21182;TCGA-EW-A1J1-D21576;TCGA-EW-A1J1-D21578;TCGA-EW-A1J1-D29263;TCGA-EW-A1J1-D29264	1094FF5B-1F3C-4697-9925-DD22ACA691F9;BD1F4D4A-4C61-4D48-8C60-7CAA2CA2711B;B6FC4524-6804-4773-A716-4B32CEBBA304;21F38CCA-34D8-4B6E-BFB0-AAF97BD3D511;B86DC55B-25BC-4C74-BE20-F8219FCC983D	Not Available;Not Available;Not Available;Not Available;Not Available	3;15;15;13;13	176;497;Not Available;176;176	71;276;513;71;71	Taxotere;Tamoxifen;Zoladex;Adriamycin;Cytoxan	Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;3;3	6;Not Available;Not Available;6;6	152;20;3.6;101;1015	mg;mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	TAC;TAM;Not Available;TAC;TAC	IV;PO;SC;IV;IV	NO;NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012	Not Available	90-99%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-EW-A1J1-F21181	8786A7FF-0211-4148-99E6-B23F288119FF				3		Not Available	Not Applicable	575		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	0	No	A1J1	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-EW-A1J1-R21183	C8A9D52C-E1FF-467E-A30D-5BB45741DE6E	1	3	254	209	Not Available	2	42	6,100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2010
TCGA-LL-A440	FEMALE	759	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0 (i-)	MX	Stage IA	0	759			TUMOR FREE				61	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A440	00B11CA8-8540-4A3D-B602-EC754B00230B	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-22497	Not Applicable	0	20	Not Available	Not Available	TCGA-LL-A440-D46388;TCGA-LL-A440-D46389;TCGA-LL-A440-D46390	594D9D16-EBE5-48DB-8248-895F81E52C71;DDE1F9CF-5FD6-44F3-A2FB-5DA0244330D4;33BE396B-855F-4092-A53F-628047C5B25B	Not Available;Not Available;Not Available	7;7;7	Not Available;123;123	200;60;60	ARIMIDEX;CYTOXAN;TAXOTERE	Not Applicable;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	46					TCGA-LL-A440-F46387	9524E6CE-345A-422C-963B-8ED916821299				7			Not Applicable	759																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	20	Not Available	79	1.7	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	A440	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	90-99%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T1c	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2012	2012
TCGA-E9-A1R7	FEMALE	1467	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1467			TUMOR FREE				64	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1R7	2680da86-c977-4611-b75f-df015283c023	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	28	-23397	Not Applicable	0	34	Not Available	NO	TCGA-E9-A1R7-D30603;TCGA-E9-A1R7-D71425	8895D57C-039B-4650-9D2E-7EEDF6FCE7A3;2294BAB6-88C3-4F06-BA09-D2EDFDDB7C41	Not Available;Not Available	13;25	Not Available;Not Available	25;53	Fareston;Tamoxifen	Not Available;Not Applicable	4;3	Not Available;Not Available	60;Not Available	mg/day;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	PO;Not Available	YES;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;NO	2012;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A1R7-F30602;TCGA-E9-A1R7-F62721;TCGA-E9-A1R7-F71424	00EA1897-A753-48AF-AC29-15ECF12D8DDE;D71AEB4E-FB69-4AA9-8C01-AF812A2C7AEC;AA507418-EBDE-4FAF-95FB-60332FE04D0E				24;23;25		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	645;1130;1467		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	1;7;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2014;2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1R7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A1R7-R30604	92D394C7-C929-4904-9E75-59276EFD6FA7	1	13	76	50	Not Available	4	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AC-A3HN	FEMALE	496	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	496			TUMOR FREE				87	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AC-A3HN	E37AE674-A107-4EB3-94D8-B86B0035A9F7	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	13	-32061	Not Applicable	0	21	Not Available	NO																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A3HN-F65835	3B8F9AB2-2433-441B-B393-4247E781E2F3				30			Not Applicable	496																				NO																						9					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	2	0	No	A3HN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2012	2011
TCGA-BH-A1EY	FEMALE	538	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	1	396.0	Lung	Distant Metastasis	WITH TUMOR				79	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1EY	0741b5db-4405-42ba-b63a-c6ee4f341480	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	7	-28940	538	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A1EY-F59173	4AD593DC-BD2C-44D2-A851-A2B13659DB85				2			538	Not Available																				NO																						5					Not Available	Not Available	Not Available	396	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Lung	Distant Metastasis	Liver	Not Available	Not Available	YES	WITH TUMOR						NO		NO	Dead	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	12	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A1EY	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2000
TCGA-A8-A08X	FEMALE	1308	Infiltrating Ductal Carcinoma	Breast	Alive	T4d	N3a	M0	Stage IIIC	1	366.0			TUMOR FREE				43	Left	Not Available	Not Available	TCGA-A8-A08X	f5539207-6534-4edc-a5a5-7666b5d16ba4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-15705	Not Applicable	0	1034	Not Available	Not Available	TCGA-A8-A08X-D37787;TCGA-A8-A08X-D37788;TCGA-A8-A08X-D37789;TCGA-A8-A08X-D37790;TCGA-A8-A08X-D37791;TCGA-A8-A08X-D37792	BE723714-41E5-4FCD-A43A-AF09F02ECE83;FA20A7B4-6AD1-4A7C-885A-4A7B13295649;1112F7D7-6984-4F61-85B5-5D60C66A006B;77710F3F-EECC-49E3-AA85-02773DE4D243;68CC8611-6E89-4582-9597-FCA264BEE43C;2DA191F1-8A7A-4538-A7E6-BD7F8ECA8A15	n/a;n/a;n/a;n/a;n/a;n/a	6;6;6;6;6;6	61;61;153;1249;884;Not Available	0;0;91;182;669;366	Doxorubicin;Cyclophosphamide;Paclitaxel;Trastuzumab;Vinorelbine;Tamoxifen	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A08X-F40558	84AE03E2-883C-4C00-840D-ACBADE8ECEE0				24			Not Applicable	1308																				NO																						2					Not Available	Not Available	Not Available	366	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A08X	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A08X-R38163	6525F080-30D7-4E01-A26D-B5D03967F204	Not Available	11	182	153	Complete Response	12	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3a	T4d	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-EW-A6SC	FEMALE	952	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	952			TUMOR FREE				60	Left;Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-EW-A6SC	97862B8E-9F76-4B19-A865-156A9C00FB1E	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	12	-21918	Not Applicable	0	952	Not Available	Not Available	TCGA-EW-A6SC-D71018	2A348DA5-AB1A-4268-ABFA-73790E39D18B	Not Available	18	Not Available	114	aromatase exemestane	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2015	Not Available	50-59%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-EW-A6SC-F71017	CF93EC15-3023-43A4-9CE7-8B0AFDF5AF21				12			Not Applicable	952																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2015	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A6SC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	40-49%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-EW-A6SC-R71019	C86CAA33-C1B6-417A-A173-40841EA07E68	Not Available	13	169	162	Not Available	3	10	38.5	NO	External	Not Applicable	Not Available	Not Available	Not Available	2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	Not Available	Not Available	EW	Breast	Not Applicable	Alive	2015	2012
TCGA-BH-A0HP	FEMALE	414	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N2a	M0	Stage IIIA	0	414			TUMOR FREE				65	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Inner Quadrant;Left Lower Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0HP	fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c	Not Available	Positive	Not Available	0	Not Available	Not Evaluated	Negative	Modified Radical Mastectomy	Not Applicable	NO	11	-23883	Not Applicable	0	414	Not Available	Not Available	TCGA-BH-A0HP-D4781;TCGA-BH-A0HP-D4778;TCGA-BH-A0HP-D4779;TCGA-BH-A0HP-D4777	535233BD-5A0E-4EC4-8171-96C978C4AD61;9D6BD472-15A5-46D2-9EA7-B171AC022AE4;ACE2A3F8-7C97-4502-8EED-53F76CBF9968;B29234C4-907F-4C3B-9AE1-ECF150514F2E	Not Available;Not Available;Not Available;Not Available	18;18;18;30	238;126;126;Not Available	147;63;63;347	Paclitaxel;Doxorubicin;Cyclophosphamide;Arimidex	Not Available;Not Available;Not Available;Not Available	11;11;11;11	12;4;4;Not Available	180;130;1308;1	mg;mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	IV;IV;IV;PO	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	2141;533;5347;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-Score 280	80-89%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HP-F4784	DD04D583-3871-4317-908D-8EDD22A879B7	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	414	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	No	A0HP	TUMOR FREE	H-Score 0	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0HP-R4782	2A420110-2D52-44D7-BF2D-5A5C6907AABE	1	30	330	275	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N2a	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-AN-A0FV	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE				58	Right Upper Outer Quadrant	No axillary staging	Not Available	TCGA-AN-A0FV	2e8e70f2-c781-44c2-8f12-1f8c2f536aa3	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	28	-21479	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A0FV-F68965	B6FDCFD2-3073-48EF-8C35-A799915D4467				24			Not Applicable	10																				YES																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A0FV	TUMOR FREE	Not Available	Not Available	Not Available	0	0	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-B6-A0IP	FEMALE	3926	Infiltrating Lobular Carcinoma	Breast	Dead	T1c	N0 (i-)	M0	Stage IA	0	3926			TUMOR FREE				74	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0IP	1402082d-25c9-4148-8a1e-f58450b706bb	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-27047	Not Applicable	0	3374	Not Available	Not Available																								IMAGE ANALYSIS	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-B6-A0IP-F12628;TCGA-B6-A0IP-F71501	EBCDB11A-5EE9-4B27-9CA2-4057C00D1556;6C5ADB8C-AC1E-4330-B52D-BD8A8A9B567B				2;26		Not Available;None	Not Applicable;3926	3374;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			NO;Unknown		NO;Unknown	Alive;Dead	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0IP	TUMOR FREE	IMAGE ANALYSIS	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1997
TCGA-BH-A0HY	FEMALE	1545	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	1545			TUMOR FREE				60	Left	Not Available	Not Available	TCGA-BH-A0HY	844ad251-3ee4-42f6-ad00-59a7a1670eea	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	2	-22179	Not Applicable	0	868	Not Available	NO	TCGA-BH-A0HY-D43317;TCGA-BH-A0HY-D43318;TCGA-BH-A0HY-D43319	7EC3CB4B-FC47-4903-8C56-460C10384B08;136D0D8F-953A-40A9-AB68-828686DD333B;6C77D915-C2F7-4ED7-A3BE-5658AA5B8580	Not Available;Not Available;Not Available	16;16;16	190;190;427	88;88;88	Taxotere;Carboplatin;Herceptin	Complete Response;Complete Response;Complete Response	5;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	YES;YES;YES	2013;2013;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-BH-A0HY-F19336;TCGA-BH-A0HY-F43316	AB886C18-3E2F-4605-A7DE-25582B252CF9;42F0E658-C564-4BFE-BC03-51BBA0021726				8;16		Not Available;None	Not Applicable;Not Applicable	1008;1545		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;5	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0HY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Total mastectomy with left sentinel lymph node biospy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2009
TCGA-A2-A3XW	FEMALE	1712	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1712			TUMOR FREE				42	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A3XW	C02699B5-580A-4D55-971E-F4692B2CCE57	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-15670	Not Applicable	0	1209	Not Available	NO	TCGA-A2-A3XW-D34431;TCGA-A2-A3XW-D34432;TCGA-A2-A3XW-D34433;TCGA-A2-A3XW-D34434	5DE33005-8993-4B5B-8D3A-F74A18EAE600;FBBE5DDA-17FD-4605-B38C-1F391379A514;17ED55A4-16C3-4F43-8986-3714A71F0F78;5E8166C0-1206-4A0B-9FC3-806B511A494D	Not Available;Not Available;Not Available;Not Available	15;15;15;15	139;139;223;Not Available	69;69;153;341	Adriamyicin;Cyclophosphamide;Taxol;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	8;8;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES	2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3XW-F43308;TCGA-A2-A3XW-F55843	1833A0D9-50FC-4878-803D-9D8BDDA26F14;0965C5D1-3E7F-4325-8355-E437AA49DB2B				16;16			Not Applicable;Not Applicable	1505;1712																				NO;NO																						5;1					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	1.31	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	3	0	No	A3XW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field;Regional site	TCGA-A2-A3XW-R34435;TCGA-A2-A3XW-R34436	55FB44FC-EA5B-4AB8-BA96-EFED1BD9AE21;D8B2A178-D939-450D-8DCA-F834111F718B	Not Available;Not Available	15;15	308;308	265;265	Complete Response;Complete Response	8;8	28;28	5040;5040	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2012	2009
TCGA-AQ-A54N	FEMALE	78	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	78			TUMOR FREE				51	Left Lower Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-AQ-A54N	58090433-D8D1-4499-A235-810C3E9D5B74	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	26	-18741	Not Applicable	0	78	Not Available	Not Available																								Not Available	Not Available	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AQ-A54N-F55736	80219E7C-2608-4B42-B6EC-E9DA0D3B6EB5				14			Not Applicable	78																				YES																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	A54N	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	AQ	Breast	Not Applicable	Alive	2013	2011
TCGA-A2-A4S0	FEMALE	706	Mucinous Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	706			Unknown				77	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A4S0	A53DD490-E0BA-419A-90C6-B905E241A8E5	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-28416	Not Applicable	0	271	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A4S0-F59120	CE1841D4-C855-440F-8BAD-E62CF9EE60A7				1			Not Applicable	706																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						Unknown		Unknown	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A4S0	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	90-99%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2013	2012
TCGA-BH-A209	FEMALE	3959	Medullary Carcinoma	Breast	Dead	T1c	N0	M0	Stage I	0	3959			TUMOR FREE				77	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A209	5258294f-ef5b-4091-9183-6bcc545d54b2	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	8	-28403	3959	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	12	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A209	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1996
TCGA-BH-A1FM	FEMALE	1388	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N2	M0	Stage IIIA	0	1388			Not Available				44	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FM	7eb18190-5a41-4637-9783-f81bbde499e4	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	8	-16289	1388	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	8	Not Available	No	A1FM	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	1998
TCGA-E9-A5FK	FEMALE	812	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	0	812			TUMOR FREE				60	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A5FK	B304302A-F2B9-4CD7-AB14-C21EDF7778EA	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	22	-22199	Not Applicable	0	12	Not Available	Not Available	TCGA-E9-A5FK-D56477;TCGA-E9-A5FK-D56478;TCGA-E9-A5FK-D56479	310AAC92-87DD-46B7-8666-4F20C9B2A400;DE81480C-4511-40D7-8778-F558CCA5717A;255555A4-D618-436B-9BDC-9D9FDC22430D	Not Available;Not Available;Not Available	10;10;10	200;200;200	21;21;21	Cyclophosphamide;Methotrexate;5-Fluorouracil	Complete Response;Complete Response;Complete Response	2;2;2	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A5FK-F56473;TCGA-E9-A5FK-F70209	FB6BC71D-5609-451F-A7A5-CF362F0DA12C;E5BA687C-99E5-4D48-BAD2-53A5EFF74BD1				10;30			Not Applicable;Not Applicable	447;812																				NO;NO																						2;1					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	10	Not Available	No	A5FK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	70-79%	WHITE	Unknown	Regional site	TCGA-E9-A5FK-R56480	E57FDF1C-1CD3-4800-9D55-07CDC326E434	Not Available	10	154	130	Complete Response	2	Not Available	80	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012
TCGA-A8-A085	MALE	1124	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1124			TUMOR FREE				44	Left	Not Available	Not Available	TCGA-A8-A085	3c08aabd-d5b5-4bbe-857c-38a7527b2163	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-16377	Not Applicable	0	1124	Not Available	Not Available	TCGA-A8-A085-D37772	DA0D6313-0886-4A80-817A-6FDF72104A27	n/a	6	Not Available	394	Tamoxifen	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A085-F40839	9130CB27-2E3C-4E79-B685-4C2367ADFD41				2			Not Applicable	1124																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	MALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A085	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-E9-A228	FEMALE	1285	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1285			TUMOR FREE				58	Right Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A228	b95eef8a-205f-4cf8-9d3c-ae51d406e1e0	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	2	-21294	Not Applicable	0	0	Not Available	NO	TCGA-E9-A228-D29764;TCGA-E9-A228-D29762;TCGA-E9-A228-D29763	19F31BA2-DE6B-46F0-AADB-37D011E8224C;4C597D0D-8804-43BE-BE0A-3743B29B55BF;8EE571E0-A2A2-4B47-A86B-8FFA4F553A22	Not Available;Not Available;Not Available	28;28;28	Not Available;131;131	287;35;35	Tamoxifen;Doxorubicin;Cyclophosphamide	Not Available;Not Available;Not Available	3;3;3	Not Available;4;4	20;90;900	mg/day;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2240;360;3600	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A228-F29761;TCGA-E9-A228-F65804	7CC23D2A-F635-4B8A-92F5-F30A0C403E27;9B040232-D621-4B8B-9E8A-B5499D08A9B4				28;30		Not Available;None	Not Applicable;Not Applicable	381;1285		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;9	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	2	Not Available	No	A228	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0WA	FEMALE	701	Not Available	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	701			TUMOR FREE				82	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0WA	786e8dbe-442e-4551-87b3-b4c333b04dd4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	16	-30025	Not Applicable	0	372	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0WA-F34068	B26AA90B-6D51-4807-902F-8E6B2E695140				29		Not Available	Not Applicable	701		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	3	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	Not Available	No	A0WA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-A7-A26F	FEMALE	738	Other, specify	Breast	Alive	T1	N0	M0	Stage IA	0	738			Not Available				55	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A26F	3b7b9c1e-a84c-47ed-983c-9e4b00cbf01a	Negative	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	8	-20210	Not Applicable	0	257	Not Available	NO	TCGA-A7-A26F-D15010;TCGA-A7-A26F-D15011	C3FD872C-2A13-45EF-9151-361979053F67;52516E85-91DF-4339-92FC-15606CA08875	Not Available;Not Available	11;11	140;140	77;77	Taxotere;Cytoxan	Not Available;Not Available	8;8	4;4	150;1200	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	600;4800	mg;mg	Not Available;Not Available	2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	1.8	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A26F-F29372;TCGA-A7-A26F-F38499	CE91BB2A-703B-4B86-8623-955310BB6B5A;29E46924-1FDE-481F-BD36-F129490E2FD3				16;14		Not Available;None	Not Applicable;Not Applicable	459;738		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2012	FEMALE	Not Available	Not Available	Not Available	PathVysion HER-2 DNA probe kit.	2+	330	Not Available	1.9	1.1	Not Available	Other, specify	Adenocarcinoma with squamous differentiation, metaplastic	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	Yes	A26F	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A26F-R29408	1A7DD856-99F0-40D6-90A7-1BA2202515F0	1	16	224	178	Not Available	3	33	6100	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010
TCGA-C8-A27B	FEMALE	439	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	439			TUMOR FREE				48	Left	Not Available	Not Available	TCGA-C8-A27B	f0d8a1fe-e313-44f1-99cc-b965cbeeff0e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	21	-17763	Not Applicable	0	30	Not Available	Not Available	TCGA-C8-A27B-D70782;TCGA-C8-A27B-D70783;TCGA-C8-A27B-D70784;TCGA-C8-A27B-D70785	DA6B28FB-BAD1-4A40-9E5F-0B1F39CF0496;C4415E67-02A8-44F6-A28B-1ADA98E0EFC9;AB7C57F0-657B-482F-BAD3-11C849B1AD7D;18D1F0D1-A458-40F2-B27C-6E5C94FED213	Not Available;Not Available;Not Available;Not Available	9;9;9;9	85;85;85;85	62;62;62;62	5-Flourouracil;Cyclophosphamide;Doxorubicin;Taxol	Complete Response;Complete Response;Complete Response;Complete Response	3;3;3;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2015;2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A27B-F70781	034E528F-AA4B-4323-B33B-521853E5E8E5				9			Not Applicable	439																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A27B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A14R	FEMALE	1174	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	971.0	Other, specify	New Primary Tumor	TUMOR FREE				62	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14R	4fba3deb-db94-44b5-a0f2-a575d270779e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	6	-22686	Not Applicable	0	845	Not Available	NO	TCGA-E2-A14R-D18840;TCGA-E2-A14R-D18842;TCGA-E2-A14R-D18841;TCGA-E2-A14R-D18839	02D7B362-61D3-42D6-85CD-44CEAFE39454;4742335F-157B-4689-A300-FE62F824234D;71BC8838-707A-4B8B-A57B-65DF043E1B53;1F3203CD-3D0A-40D3-95B5-5B07E4987795	Not Available;Not Available;Not Available;Not Available	24;24;24;24	131;187;145;131	89;128;145;89	Doxorubicin;Paclitaxel (Protein-Bound);Paclitaxel;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	10;10;10;10	4;3;1;4	143;610;413;1428	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;1	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	572;1832;413;5712	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	NO	YES	YES		TCGA-E2-A14R-F18838	818079A8-A928-4AC6-9779-E8A587D960DB				24		971	Not Applicable	1174		971				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	10	Other, specify	New Primary Tumor	Endometrial	YES																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14R	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-E2-A14R-R18843;TCGA-E2-A14R-R18845	71319FB6-5CE9-4A19-8D5C-34C64A295435;0DD87532-955B-43DE-A40E-7952D8993908	1;2	24;24	259;1061	210;1026	Not Available;Not Available	10;10	33;25	6040;4500	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2011;2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-A8-A07U	FEMALE	760	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	760			TUMOR FREE				66	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A07U	59bf0ce4-715a-4017-bccb-c59916e78324	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-24411	Not Applicable	0	303	Not Available	Not Available	TCGA-A8-A07U-D37854;TCGA-A8-A07U-D37855;TCGA-A8-A07U-D37856;TCGA-A8-A07U-D37857	D0CD63EE-CD6F-43C9-9FB5-FB2114055A14;8D55552F-9B8D-4002-B654-C83EED6FD35E;B2F4C015-EAF0-4448-B665-1B8C5A7B8908;B33C7BC7-4100-448C-AD46-5A4BE08C2A53	n/a;n/a;n/a;n/a	6;6;6;6	30;30;30;122	30;30;30;Not Available	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel	Unknown;Unknown;Unknown;Unknown	12;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07U-F40834	144DF477-24E5-4990-931F-2038B033AB05				2			Not Applicable	760																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07U	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A07U-R38180	0D5E6892-50BD-4919-9416-C6EA578D12B6	Not Available	11	242	212	Unknown	12	Not Available	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-B6-A402	FEMALE	2281	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	1	1516.0	Other, specify	Locoregional Recurrence	WITH TUMOR				47	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-B6-A402	75B3FE55-1A63-426E-867E-2EF52F54778D	Not Available	Negative	4 Point Scale	1+	4 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	YES	20	-17314	Not Applicable	0	1651	Not Available	Not Available	TCGA-B6-A402-D40948;TCGA-B6-A402-D40949;TCGA-B6-A402-D40950;TCGA-B6-A402-D59670	35A74783-A336-48EF-8D16-8CE8F0E6FF7D;A9104E79-C312-4005-9AF6-7BC7CCEF7C19;DE8DFC8E-AD88-486E-85C9-DEDAC34CD8AA;AA69A790-B2B4-49B2-B8C3-907251C7338C	Not Available;Not Available;Not Available;Not Available	7;7;7;3	93;93;191;2232	30;30;112;2176	Cyclophosphamide;Doxorubicin;Paclitaxel;Doxil	Partial Response;Partial Response;Partial Response;Partial Response	3;3;3;6	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2014	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-B6-A402-F59668;TCGA-B6-A402-F60751	CE3A84EC-BBCB-4860-8564-F07B7D1F291A;65F37E9F-5FDE-4D4D-BBC9-2698B4B4F03C				3;8			Not Applicable;Not Applicable	2281;2134																				NO;NO																						6;7					Not Available;YES	Not Available;NO	Not Available;Not Available	Not Available;2330	Not Available;Not Available	Not Available;4.4	Not Available;2+	Not Available;Not Available	Not Available;<10%	Not Available;Positive	Not Available;3.1	Not Available;Not Available	Not Available;<10%	Not Available;Not Available	Not Available;4.1	Not Available;2+	Not Available;3 Point Scale	Not Available;2+	Not Available;3 Point Scale	Not Available;Positive	Not Available;Negative	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;70-79%	Not Available;Negative	Not Available;Other, specify	Not Available;Locoregional Recurrence	Not Available;Lymph Node	Not Available;NO	Not Available;Not Available	NO;YES	WITH TUMOR;WITH TUMOR						YES;YES		YES;YES	Alive;Alive	2014;2014	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES	NO	Not Available	1516	Not Available	Not Available	1+	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	1+	4 Point Scale	1+	4 Point Scale	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Other, specify	Locoregional Recurrence	breast	NO	Not Available	YES	0	0	No	A402	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-B6-A402-R40853	770A2F31-3163-492C-A9D0-4F49CD54D734	Not Available	7	310	278	Unknown	3	21	5256	NO	External	Not Applicable	Not Available	Not Available	cGy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2012	2008
TCGA-E9-A3QA	FEMALE	918	Medullary Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	918			TUMOR FREE				33	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A3QA	F3CB557D-23E4-4FD1-81CA-DB1A3F56D56E	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	Not Available	30	-12142	Not Applicable	0	19	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A3QA-F66100	32054674-B4A7-45C1-AF24-7707709AD516				2			Not Applicable	918																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Not Evaluated	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A3QA	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2012	2011
TCGA-AC-A62X	FEMALE	417	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	417			TUMOR FREE				72	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AC-A62X	5B2A4F11-CA46-4974-9420-59B4820920BF	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	21	-26627	Not Applicable	0	34	Not Available	Not Available																								Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A62X-F64105	197F52A1-868A-492C-8E1B-A887CED07862				26			Not Applicable	417																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	Yes	A62X	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	BLACK OR AFRICAN AMERICAN	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2013
TCGA-E2-A1LB	FEMALE	2306	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	2306			TUMOR FREE				41	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E2-A1LB	fa176764-a76f-44c7-b97a-cd6d21e052be	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	7	-15283	Not Applicable	0	972	Not Available	NO	TCGA-E2-A1LB-D20653;TCGA-E2-A1LB-D20655;TCGA-E2-A1LB-D20651;TCGA-E2-A1LB-D20654	9B62DB92-ACF7-4884-9460-C1634758D79B;1B740152-15BF-45B7-AA8A-AC589F898590;2E9325B6-A784-44EF-8EBD-2F8B989A6248;EE4ED476-18BE-4535-BB8A-4781CC63C7E0	Not Available;Not Available;Not Available;Not Available	17;17;17;17	199;108;128;441	121;66;66;121	taxol;cytoxan;adriamycin;herceptin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	12;8;4;24	155;1206;121;496	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	02;02;01;02	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1860;4824;484;11904	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A1LB-F20650;TCGA-E2-A1LB-F70015	94F7D4C6-179E-443F-BC62-DB1D230AEA53;F04D0FA3-92DD-4833-8390-DD3333635E69				17;9		Not Available;None	Not Applicable;Not Applicable	1231;2306		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	90-99%	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	2	Not Available	No	A1LB	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-E2-A1LB-R20656	D7FD3A70-1915-43EC-BCE1-09208061AA20	01	17	287	241	Not Available	1	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2008
TCGA-B6-A0WY	FEMALE	3461	Infiltrating Ductal Carcinoma	Breast	Dead	T3	N1b	M0	Stage IIIA	1	2011.0	Bone	Distant Metastasis	WITH TUMOR				40	Left Lower Inner Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0WY	f475d460-75cd-4fe9-aa54-c90be12b4ef8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	14	-14778	3461	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	YES	NO		TCGA-B6-A0WY-F15730	3547C7D8-047E-4255-9E3B-662B6E1CBCB9				29		Not Available	3461	Not Available		2011				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Bone	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	3	Not Available	No	A0WY	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1b	T3	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1996
TCGA-E9-A243	FEMALE	612	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	1	305.0	Bone	Distant Metastasis	TUMOR FREE				52	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A243	d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	17	-19035	Not Applicable	0	43	Not Available	NO	TCGA-E9-A243-D31153;TCGA-E9-A243-D31156;TCGA-E9-A243-D31152;TCGA-E9-A243-D31154;TCGA-E9-A243-D31155;TCGA-E9-A243-D39523	0BA723FF-5046-4029-85C3-C41B010E0ED3;5335CA0B-6AEF-47D7-A8FE-D695892F85DA;144BD67A-2B2B-4DB2-A72D-AF67BE661EC0;646C3AEA-2B7C-4B5E-812C-D2539266256A;6C115212-2F46-40E5-9300-3FFAF5FD5975;617EAD96-72A4-41EE-B9EE-608F4B12E6DB	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24	235;235;235;235;235;520	53;53;53;53;53;305	5-Fluorouracil;Vincristine;5-Fluorouracil;Cyclophosphamide;Methotrexate;Pamidronate	Not Available;Not Available;Not Available;Not Available;Not Available;Stable Disease	4;4;4;4;4;1	3;1;2;5;4;Not Available	1500;4;2000;1600;100;Not Available	mg;mg;mg;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Ancillary	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4500;4;4000;8000;400;Not Available	mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;NO	2012;2012;2012;2012;2012;2013	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;None	NO;None	YES;None		TCGA-E9-A243-F31151;TCGA-E9-A243-F56656	636C7B1A-4E10-4150-B546-2EE2D23B7758;92CEDE74-3DBC-4157-911C-633BA5EDB140				20;18		305;None	Not Applicable;Not Applicable	612;Not Available		305;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Negative;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Negative;None	Not Evaluated;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Negative;None	9;2	Bone;None	Distant Metastasis;None	Not Available;None	YES;None																																	None;Not Available	WITH TUMOR;Not Available			Not Available;None			YES;Not Available		YES;Not Available	Alive;Not Available	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A243	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-E9-A243-R31157;TCGA-E9-A243-R48750	D622640B-F5A9-49CB-9B33-0A297B2BFF85;DCC746D8-2A89-4B3A-8A8B-46ABCB5A9C2F	1;Not Available	24;20	151;151	119;119	Not Available;Complete Response	4;9	25;Not Available	4500;40	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;Gy	2012;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-A7-A3J0	FEMALE	313	Mucinous Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	313			TUMOR FREE				62	Right	Sentinel node biopsy alone	Not Available	TCGA-A7-A3J0	DA70CF7E-0E61-4C72-B4C5-C408569D11B8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	13	-22672	Not Applicable	0	76	Not Available	NO	TCGA-A7-A3J0-D35966	CDDA22AF-C26F-4051-9D80-3C195030DF0E	Not Available	12	Not Available	72	Anastrazole	Not Applicable	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A3J0-F35965	B63F8878-C317-4D4A-8DA0-9A3B4ACEFEA4				12			Not Applicable	313																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A3J0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A3J0-R29282	D07FF920-EBA1-42B4-BEDE-5A3B68777BCD	1	13	63	57	Not Available	3	10	3400	NO	OTHER	Partial Breast irradiation using a SAVI catheter	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2012	2011
TCGA-EW-A1P8	FEMALE	239	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N3b	M0	Stage IIIC	1	207.0	Lung	Distant Metastasis	WITH TUMOR				58	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-EW-A1P8	359f12f9-5c41-48a4-85bc-fd7e307bf7d8	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	27	-21501	239	0	Not Available	Not Available	YES	TCGA-EW-A1P8-D29122;TCGA-EW-A1P8-D29632;TCGA-EW-A1P8-D29633	995CBFB8-E6D5-4374-A924-F0E06B3CCB01;24AB482A-B1B6-4E84-B3EA-F5F8952F6019;BE0E1D18-E1B5-4E37-AD2C-75B257D2F899	Not Available;Not Available;Not Available	8;22;22	140;140;140	40;40;40	Fluorouracil;Epirubicin;Cyclophosphamide	Not Available;Not Available;Not Available	3;3;3	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	FEC x3;FEC x3;FEC x3	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	<10%	NOT HISPANIC OR LATINO	Lung;Bone;Liver;Other, specify	skin	Not Available	Not Available	Not Available	NO		TCGA-EW-A1P8-F29121	8F96B637-28EF-44CB-901F-20EA615880C7				8		Not Available	239	Not Available		207				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Lung	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2012	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Negative	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	3 Point Scale	Not Available	3 Point Scale	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	14	Not Available	No	A1P8	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3b	T2	Not Available	NO	YES	EW	Breast	Not Applicable	Dead	2011	2010
TCGA-HN-A2OB	FEMALE	1900	Infiltrating Lobular Carcinoma	Breast	Dead	T2	N1	M0	Stage IIB	1	1543.0	Bone	Distant Metastasis	WITH TUMOR				45	Right;Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-HN-A2OB	61204CDF-3B1C-44A1-BDA6-0FEF1AC4A333	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	26	-16672	Not Applicable	0	1849	Not Available	Not Available	TCGA-HN-A2OB-D49169;TCGA-HN-A2OB-D49305;TCGA-HN-A2OB-D49307;TCGA-HN-A2OB-D49308	39B4679E-628C-435B-85C4-25B71BCB04DE;B7C4F1EB-383C-43B2-B58D-2393FE01811A;7988073B-ABA2-43A5-9498-E039E2CF2F8A;ACF2B357-EB83-4198-95BC-7128DDF3B1EE	Not Available;Not Available;Not Available;Not Available	26;30;30;30	147;147;147;210	105;105;105;168	Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel	Unknown;Unknown;Unknown;Unknown	9;9;9;9	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	Not Available	Not Evaluated	Not Available	Not Available	1.7					TCGA-HN-A2OB-F65011;TCGA-HN-A2OB-F71891	98128139-5012-4344-8CBB-E50007749352;7B121C24-0BF5-4F56-9B8F-AAC37393C325				17;1			Not Applicable;1900	1883;Not Available																				NO;NO																						9;4					Not Available;YES;YES	Not Available;NO;NO	Not Available;Not Available;Not Available	Not Available;1552;1673	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;1+;1+	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Positive;Positive	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;3+;3+	Not Available;3 Point Scale;3 Point Scale	Not Available;2+;2+	Not Available;3 Point Scale;3 Point Scale	Not Available;Negative;Negative	Not Available;Not Evaluated;Not Evaluated	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Positive;Positive	Not Available;Bone;Other, specify	Not Available;Distant Metastasis;Distant Metastasis	Not Available;Not Available;omentum	Not Available;NO;Not Available	Not Available;Not Available;Not Available	NO;YES	WITH TUMOR;Unknown						YES;YES		YES;YES	Alive;Dead	2014;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	60	Not Available	2.0	1.2	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES	NO	Not Available	1543	Not Available	Not Available	1+	Not Available	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	3+	4 Point Scale	2+	4 Point Scale	Negative	Not Available	Not Available	Not Available	Allred score=5	Not Available	Not Available	Positive	Bone	Distant Metastasis	Not Available	NO	8	YES	2	Not Available	No	A2OB	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	Not Evaluated	YES	Primary Tumor Field	TCGA-HN-A2OB-R49310	708829D0-DA92-473C-8DF3-13C6B3D1054C	Not Available	30	276	242	Unknown	9	25	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	HN	Breast	Not Applicable	Alive	2013	Not Available
TCGA-EW-A424	FEMALE	715	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N1	MX	Stage IIIA	0	715			TUMOR FREE				51	Right	Sentinel node biopsy alone	Not Available	TCGA-EW-A424	A6502F17-6BEE-4D5A-8520-06364593D39C	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-18850	Not Applicable	0	322	Not Available	Not Available	TCGA-EW-A424-D38941;TCGA-EW-A424-D38943;TCGA-EW-A424-D57613	A0C151E8-818E-4052-8F12-45E3CAC90A8C;DA732694-A93F-487C-BB75-9D25A4235E0C;B56289A2-A358-47AE-A1E7-F9C2A552156B	Not Available;Not Available;Not Available	4;4;18	181;181;Not Available	118;118;154	Docetaxel;Cyclophosphamide;Arimidex	Complete Response;Complete Response;Not Applicable	1;1;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2014	Not Available	50-59%	HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-EW-A424-F57612	9802329B-33EB-43F6-810F-6166CE0D1EC3				18			Not Applicable	715																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	1	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	1	No	A424	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	WHITE	YES	Primary Tumor Field	TCGA-EW-A424-R38939	C62AE9A3-9871-4B68-9F34-E2B47A6E9C35	Not Available	4	281	231	Complete Response	1	25	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T3	Not Available	YES	NO	EW	Breast	Not Applicable	Alive	2013	2012
TCGA-BH-A5IZ	FEMALE	567	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a		Stage IIB	0	567			TUMOR FREE				51	Left	Not Available	Not Available	TCGA-BH-A5IZ	A8A33BA9-0976-4E19-B0E9-FA5BA4D4EAA8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	Not Available	13	-18927	Not Applicable	0	98	Not Available	Not Available	TCGA-BH-A5IZ-D56581;TCGA-BH-A5IZ-D56582;TCGA-BH-A5IZ-D66934	EB4E7F2F-14F6-4609-94C9-937F41DF8521;3B0DE458-656A-4A35-8FC0-B76E3C7A33E1;E11C1618-C47C-4EA9-8EC5-B0D84CC12E53	Not Available;Not Available;Not Available	13;13;28	140;161;140	77;161;77	Adriamycin;Taxotere;Cyclophosphamide	Complete Response;Complete Response;Complete Response	2;2;10	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A5IZ-F63663	FAADBA23-9D4F-4AC4-ADB7-5E0F9CC3FF01				14			Not Applicable	567																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	Not Available	No	A5IZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Unknown	TCGA-BH-A5IZ-R56584	22DA154D-0940-4F18-A8C1-18FA728B21F1	Not Available	13	323	280	Complete Response	2	Not Available	Not Available	NO	Unknown	Not Applicable	Not Available	Not Available	Not Available	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	cM0 (i+)	N1a	T2	Not Available	YES	NO	BH	Breast	Not Applicable	Alive	2014	2012
TCGA-AR-A1AN	FEMALE	2920	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2920			TUMOR FREE				46	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AN	43029932-feb0-4658-97fa-645c1e775009	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	14	-16974	Not Applicable	0	1330	Not Available	Not Available	TCGA-AR-A1AN-D21999;TCGA-AR-A1AN-D21996;TCGA-AR-A1AN-D21998;TCGA-AR-A1AN-D21994;TCGA-AR-A1AN-D21991;TCGA-AR-A1AN-D21995	C9B603C0-0213-4B45-8199-72032C517BEA;B97F58C1-DC5F-486E-BBF6-7A8E364CB1A5;99CC0213-C42E-4C37-B846-D21F96608C60;41723CA9-81FB-486E-8E7E-5ECB2997418E;0B897029-9392-428C-B8B8-6DA05D449134;7FCC74A9-CFDF-4804-877F-E82ED18041AB	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28	Not Available;300;441;91;91;154	442;162;301;47;47;105	Anastrozole;Anastrozole;Tamoxifen;Cytoxan;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2	Not Available;Not Available;Not Available;4;4;4	1;1;20;600;60;175	mg/day;mg/day;mg/day;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	4;2;3;1;1;1	PO;PO;PO;IV;IV;IV	YES;NO;NO;NO;NO;NO	Hormone Therapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;4310;435;1250	Not Available;Not Available;Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012;2012;2012	Not Available	70-79%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AN-F21986;TCGA-AR-A1AN-F69273	875F7CBA-C219-4206-A60C-ACFF4FC1F8C9;D4512F43-4A80-4EAD-93CF-973446AA72BA				28;31		Not Available;None	Not Applicable;Not Applicable	1330;2920		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AN-R21989	467D9E15-348F-40CC-9E9C-FE3500CBD635	1	28	211	169	Not Available	2	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Wide Local Excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-E9-A227	FEMALE	975	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	975			WITH TUMOR				42	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E9-A227	89a8da07-4487-47c6-8d3c-442a87e4f632	Negative	Positive	Not Available	4+	Not Available	Other	Positive	Lumpectomy	Re-excision of original lumpectomy site	NO	28	-15602	Not Applicable	0	24	Not Available	NO	TCGA-E9-A227-D55475;TCGA-E9-A227-D55476	3A15749D-3272-4218-A622-DE1C45896D3B;A7D3378B-00F0-4BCE-9E2F-C2E4045282A9	Not Available;Not Available	7;7	197;Not Available	92;239	Taxotere;Tamoxifen	Complete Response;Not Applicable	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A227-F33186;TCGA-E9-A227-F58571	D4BCCFC5-9338-40F9-910E-E4D32F436FF8;21BBE5D6-57A3-4D50-927B-D6C087DCDAAA				7;29		Not Available;None	Not Applicable;Not Applicable	975;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	1;4	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		YES;Not Available	Alive;Not Available	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	17	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	1	Not Available	No	A227	WITH TUMOR	Not Available	Not Available	Not Available	Two-tier	Two-tier	Not Available	YES	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A227-R55477	83F17951-387D-4703-A980-57BB2DCBB075	Not Available	7	245	216	Complete Response	1	21	5256	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-BH-A0DX	FEMALE	2156	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N0	M0	Stage I	0	2156			TUMOR FREE				62	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-BH-A0DX	035cb359-eac3-484a-9e88-3ddc739440a3	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	11	-22833	Not Applicable	0	1442	Not Available	NO	TCGA-BH-A0DX-D59137;TCGA-BH-A0DX-D59138;TCGA-BH-A0DX-D59140;TCGA-BH-A0DX-D59141	174495DC-4D02-47CB-8306-FF4E876B9A7E;1FA0D545-9D52-4FDC-B43B-62C04A51EC4E;9D0C1A3D-2B12-41EB-AF5F-8A97855518FE;E8FE1855-0A33-4663-A2E3-605059890515	Not Available;Not Available;Not Available;Not Available	1;1;1;1	143;143;171;171	79;79;143;143	Taxotere;Cytoxan;Cytoxan;Methotrexate	Complete Response;Complete Response;Complete Response;Complete Response	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0DX-F59135	982B9831-0BBC-4677-99EB-6A34B28D422C				1			Not Applicable	2156																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0DX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DX-R59136	CBDB023B-245F-4480-B77C-958E1430C45A	Not Available	1	221	171	Complete Response	5	36	5040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1b	Segmental mastectomy with sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2007
TCGA-A8-A09I	FEMALE	1371	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1371			TUMOR FREE				84	Right Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A09I	1557183c-aedd-4df6-b98a-3654667f7b69	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-30711	Not Applicable	0	1006	Not Available	Not Available	TCGA-A8-A09I-D37746	331D363E-6139-4987-8F35-4A2453871C03	n/a	6	Not Available	31	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09I-F40333	75A6C6B1-5909-4715-B91F-CAAA3CBE8AD0				17			Not Applicable	1371																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A09I	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-A8-A0A4	FEMALE	396	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	396			TUMOR FREE				73	Left	Not Available	Not Available	TCGA-A8-A0A4	2cb8c866-9296-4c70-a3ea-f9a9b707895c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-26693	Not Applicable	0	396	Not Available	Not Available	TCGA-A8-A0A4-D37899;TCGA-A8-A0A4-D37900	CE92BF3F-277B-41E8-9B20-867CE5DDAC50;D8E03D97-D2C6-498F-8B32-372ACA5AB2C9	Not Available;Not Available	6;6	215;Not Available	31;215	Tamoxifen;Letrozole	Complete Response;Not Applicable	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A0A4-F40326	BE77F294-FAE5-4040-A6EA-671C8915B7F9				16			Not Applicable	396																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A0A4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-S3-A6ZH	FEMALE	641	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N3a	MX	Stage IIIC	0	641			TUMOR FREE				29	Left;Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-S3-A6ZH	EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	12	-10832	Not Applicable	0	263	Not Available	Not Available	TCGA-S3-A6ZH-D51093;TCGA-S3-A6ZH-D51095;TCGA-S3-A6ZH-D51097;TCGA-S3-A6ZH-D51098;TCGA-S3-A6ZH-D63643	4FF7C7C8-9204-4234-8E32-E4E647B7A669;9A50CE8C-5949-4FBC-9D18-2BF7A3C8FFC6;1AF804F2-0DDD-4DC3-9977-DA151A2F69AE;DCCCBA1E-1B61-46C7-A824-650991F2032E;58C4FEBB-B269-490F-9AB4-8D95373717EF	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;27	185;185;185;Not Available;Not Available	141;141;141;200;293	Adriamycin;Cytoxan;Neulasta;Taxol;TAMOXIFEN	Complete Response;Complete Response;Complete Response;Not Applicable;Not Applicable	11;11;11;11;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Ancillary;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES;YES	2013;2013;2013;2013;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	69					TCGA-S3-A6ZH-F63625;TCGA-S3-A6ZH-F68306	8AB33E9F-54C0-49A3-862C-14A9E04C144C;1E35CDDC-BA24-44AD-9A84-E53B710C9969				27;14			Not Applicable;Not Applicable	515;641																				NO;NO																						8;11					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2014;2014	FEMALE	Not Available	CAP scoring guideline 2010	Not Available	CAP scoring guideline 2010	2+	20	Not Available	79	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	21	Negative	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	14	0	No	A6ZH	TUMOR FREE	CAP scoring guideline 2010	Not Available	Not Available	Strong	Strong	YES	YES	80-89%	BLACK OR AFRICAN AMERICAN	NO	Regional site	TCGA-S3-A6ZH-R63634	AFC090C0-5CB1-47EF-B9B4-4D7AEE7ADCA5	Not Available	27	351	304	Complete Response	8	55	110	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N3a	T3	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2013	2013
TCGA-AO-A0J6	FEMALE	1140	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1140			TUMOR FREE				61	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A0J6	e9f4f373-37a5-48ad-a1a0-b0d47820111a	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	19	-22462	Not Applicable	0	775	Not Available	Not Available	TCGA-AO-A0J6-D3107;TCGA-AO-A0J6-D3105;TCGA-AO-A0J6-D3103	73049389-f0b2-42ee-8cb0-3220e24c2132;a007109f-8d09-47c0-8962-c3fdccc14bd9;56b00f1d-94c6-47aa-bfe8-3475b64b8754	Not Available;Not Available;Not Available	19;19;19	172;116;116	130;74;74	PACLITAXEL;DOXORUBICIN;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available	9;9;9	4;4;4	175;60;600	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1320;440;4400	mg;meq;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J6-F3099;TCGA-AO-A0J6-F15479	1CD5D03B-E10B-4BB5-B3E9-E49C8054290C;970D7D07-69A6-4BF8-A92E-04769BB10B85	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	775;1140	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0J6	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A0J6-R3101	485e54f5-ff71-42b8-a85c-68c5fe3c3f7e	1	19	273	241	Not Available	9	21	5240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2008
TCGA-AR-A0TW	FEMALE	3009	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1	M0	Stage IIIA	1	739.0			Not Available				50	Right Upper Outer Quadrant;Right Lower Outer Quadrant	Not Available	Not Available	TCGA-AR-A0TW	8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	10	-18263	Not Applicable	0	739	Not Available	Not Available	TCGA-AR-A0TW-D19094;TCGA-AR-A0TW-D19101;TCGA-AR-A0TW-D19103	E7E1F747-7022-4E16-A1E8-F80ECF30503E;0AA047EB-A95E-4620-BA52-2589D3AE3F8E;AA7EC35A-9A0F-46CC-B59E-CFC2A343EF76	Not Available;Not Available;Not Available	12;12;12	111;111;167	62;62;125	Doxorubicin;Cytoxan;Paclitaxel	Not Available;Not Available;Not Available	12;12;12	4;4;4	60;600;175	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	400;4050;1200	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A0TW-F18564;TCGA-AR-A0TW-F49464	30E7D95D-390D-4241-91EE-0F69147A5A9D;879D832D-C3F4-45C1-BAE3-73FE8D28964B				12;2		Not Available;None	Not Applicable;Not Applicable	1966;3009		739;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;10	Not Available;None	Not Available;None	Not Available;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	3	Not Available	No	A0TW	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-A8-A084	FEMALE	458	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	1				WITH TUMOR				81	Left	Not Available	Not Available	TCGA-A8-A084	3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	27	-29858	Not Applicable	0	458	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A084-F40838	F5462E4C-B26A-4A0D-A80C-E8B1595300E0				2			Not Applicable	458																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	WITH TUMOR						NO		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	Yes	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A084	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A084-R38151	91333E9B-66B8-4BFE-A799-B12A6394BE74	Not Available	11	Not Available	Not Available	Unknown	12	Not Available	Not Available	Not Available	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-C8-A8HR	FEMALE	408	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N2	M0	Stage IIIA	0	408			TUMOR FREE				49	Right	Axillary lymph node dissection alone	Not Available	TCGA-C8-A8HR	DCB68327-1537-4CA6-81DE-3910D0663CB8	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	29	-17921	Not Applicable	0	10	Not Available	Not Available	TCGA-C8-A8HR-D69797;TCGA-C8-A8HR-D69798;TCGA-C8-A8HR-D69799	AAB14121-BF30-4BA7-B0DE-7F26E3723D24;F6A77EA7-2ED3-4BFD-AC8F-21E9DE5FA242;33674CC5-6A4D-42DB-87A8-270B36FA8974	Not Available;Not Available;Not Available	20;20;20	237;237;237	43;43;43	5 fluorouracil;Epirubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	1;1;1	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A8HR-F69796	33528C47-968B-492E-B86C-31DC1D52F0ED				20			Not Applicable	408																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	8	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	5	Not Available	No	A8HR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	NO	YES	Not Available	ASIAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2	T3	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2014	2013
TCGA-D8-A27P	FEMALE	49	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	49			TUMOR FREE				64	Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-D8-A27P	c54d5507-bba5-4a1e-8885-3c3b1eed13c1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-23576	Not Applicable	0	23	Not Available	NO																								manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27P-F29596	0A7EBF73-2279-485B-AF1C-E49CDB81922F				26		Not Available	Not Applicable	49		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	intraoperative examination	Other method, specify:	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A27P	TUMOR FREE	manual counting	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-AR-A24U	FEMALE	3128	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N1	M0	Stage IIA	0	3128			Not Available				47	Left Upper Outer Quadrant;Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24U	241fffc8-4250-4cfa-b2e7-e68c33ae07dc	Negative	Negative	Not Available	Not Available	Not Available	Mastectomy NOS	Negative	Simple Mastectomy	Not Applicable	Not Available	26	-17523	Not Applicable	0	1623	Not Available	Not Available	TCGA-AR-A24U-D31594;TCGA-AR-A24U-D31598;TCGA-AR-A24U-D31600;TCGA-AR-A24U-D31603;TCGA-AR-A24U-D32229;TCGA-AR-A24U-D31605	DA32B961-80C8-4D77-A98B-4E9FED2AA1CE;1EA74BAA-C62D-454E-9666-8311D3957949;0F05B513-E5C7-4EBD-9FD0-00D49E148864;551E1D04-2F7A-4065-A2A5-530D95047532;3B708795-9361-4DC6-8F7A-E6C5D3BD53E6;EC9851E1-A6A6-4E59-AAF1-4F25D1B7EA80	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;23	97;97;188;111;476;476	55;55;111;111;118;118	Doxorubicin;Cytoxan;Paclitaxel;Trustuzumab;Trastuzumab;Trustuzumab	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Immunotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24U-F31590;TCGA-AR-A24U-F49473;TCGA-AR-A24U-F71738	3692FAD6-E63E-4BF1-9745-6515D89E8595;F1F5C96C-885E-427F-8C7C-3E060C82E8A4;59A7E2D3-3110-4843-96B2-AF1E57B018D9				7;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1623;2363;3128		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	25	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	2	Not Available	No	A24U	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24U-R31593	651DA6E4-2E69-451D-AB97-54875022C4F4	1	7	246	207	Not Available	5	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T1	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-EW-A2FR	FEMALE	1673	Infiltrating Ductal Carcinoma	Breast	Alive	T1b	N3a	MX	Stage IIIC	0	1673			TUMOR FREE				59	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-EW-A2FR	AF97E043-88CB-4F99-8F8B-9BCBCCCDF842	Not Available	Negative	3 Point Scale	1+	3 Point Scale	Not Available	Negative	Lumpectomy	Not Applicable	NO	12	-21628	Not Applicable	0	1120	Not Available	NO	TCGA-EW-A2FR-D32313;TCGA-EW-A2FR-D32314;TCGA-EW-A2FR-D32315;TCGA-EW-A2FR-D32316	DCEB895A-E1A5-4FD9-BE38-21E232DE5684;252D689B-BC80-47B8-B3C2-74104D012674;8A8AD4DD-2321-44FD-8088-8EC827E71D20;48579EAC-39AF-415C-B6DF-893430FC303F	Not Available;Not Available;Not Available;Not Available	23;23;23;23	76;76;76;174	34;34;34;97	Epirubicin;Fluorouracil;Cyclophosphamide;Paclitaxel	Unknown;Unknown;Unknown;Stable Disease	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	2	Not Available;None	Not Available;None	Not Available;None		TCGA-EW-A2FR-F32311;TCGA-EW-A2FR-F42056	1B368505-DA61-46F6-AA01-9AA6978FE665;7816276A-1574-408C-B73B-519C7DE42D56				23;10		Not Available;None	Not Applicable;Not Applicable	1309;1673		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	5;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	10-19%	ratio > 2.2 is positive	2+	40	Not Available	>6	3.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	19	Not Available	No	A2FR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-EW-A2FR-R32312	832B0491-C707-42CA-AFC9-E9F3E321C30E	1	23	Not Available	Not Available	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N3a	T1b	Not Available	NO	YES	EW	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A4RY	FEMALE	648	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N3a	M0	Stage IIIC	0	648			TUMOR FREE				46	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A4RY	5A53EC47-E63F-44A2-8078-87659544FB04	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	26	-17157	Not Applicable	0	268	Not Available	Not Available	TCGA-A2-A4RY-D40659;TCGA-A2-A4RY-D40660;TCGA-A2-A4RY-D40661;TCGA-A2-A4RY-D40662	1BCAA28C-A1D9-45B4-993D-DC411B983F6C;49B3D51C-F502-4AB9-9548-345C27375EA6;026BFA4A-9212-4110-83E8-783895513760;E5560868-E57D-4A2B-83C8-C2B50D5B8224	Not Available;Not Available;Not Available;Not Available	26;26;26;26	164;164;164;Not Available	58;58;58;203	Taxotere;Adriamycin;Cytoxan;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	2;2;2;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A4RY-F59208	D3984B99-34DF-4EBE-B92B-EADBB216CA0B				5			Not Applicable	648																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	18	0	No	A4RY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field;Regional site;Primary Tumor Field;Primary Tumor Field	TCGA-A2-A4RY-R40664;TCGA-A2-A4RY-R40665;TCGA-A2-A4RY-R40666;TCGA-A2-A4RY-R40667	CF487209-10D6-4BC8-80BA-3FEED723600E;6766D57B-2819-4D63-BAEA-6BE4E6712F77;E7AA083C-CCB6-4495-9409-749A30265124;A727732D-1D49-47FA-A481-F1DF8B6221E4	Not Available;Not Available;Not Available;Not Available	26;26;26;26	238;241;231;238	192;192;224;193	Complete Response;Complete Response;Complete Response;Complete Response	2;2;2;2	25;28;5;24	5000;5040;1000;4800	NO;NO;NO;NO	External;External;External;External	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	cGy;cGy;cGy;cGy	2013;2013;2013;2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T3	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2013	2012
TCGA-E2-A15O	FEMALE	289	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	NX	M0	Stage I	1	289.0		Locoregional Recurrence	TUMOR FREE				89	Left Upper Inner Quadrant	No axillary staging	Not Available	TCGA-E2-A15O	eafa45a4-2fd1-4fa3-860c-9d52ed382b7d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	14	-32583	Not Applicable	0	289	Not Available	NO	TCGA-E2-A15O-D19167;TCGA-E2-A15O-D19166;TCGA-E2-A15O-D19169;TCGA-E2-A15O-D70381	61BED00F-F2EF-4F91-8BC8-B0F1BEEEE796;6E587C05-8883-4909-BE96-852F9352E81A;ABECA7CD-0E93-4DCF-938C-350829939C31;D54F8164-4FDA-4707-A7AE-8057748B100D	Not Available;Not Available;Not Available;Not Available	16;16;16;16	289;104;Not Available;Not Available	96;48;289;289	aromasin;arimidex;femara;Femara	Not Available;Not Available;Not Available;Not Applicable	11;11;11;3	Not Available;Not Available;Not Available;Not Available	20;1;Not Available;Not Available	mg/day;mg/day;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	02;01;03;Not Available	PO;PO;PO;Not Available	NO;NO;Not Available;YES	Hormone Therapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	6000;56;Not Available;Not Available	mg;mg;mg;Not Available	Not Available;Not Available;Not Available;NO	2011;2011;2011;2015	Allred score 5+2 = 7	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A15O-F19165;TCGA-E2-A15O-F70024	0918A152-08E1-4845-90BB-A1402B7AEACB;BF01F0BA-CC2C-4473-848A-12B4C360742C				16;16		Not Available;None	Not Applicable;Not Applicable	289;289		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;YES	None;NO	None;289	None;289	None;Not Available	None;Not Available	None;1+	None;Not Available	None;Not Available	None;Positive	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;3+	None;3 Point Scale	None;3+	None;3 Point Scale	None;Negative	None;Not Evaluated	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Positive	None;Not Available	None;Locoregional Recurrence	None;Not Available	None;YES	None;Not Available	None;YES	Not Available;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	0.9	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	Yes	A15O	TUMOR FREE	Allred score 4+3 = 7	Not Available	Not Available	Allred score = 7	Allred score = 7	Not Available	NO	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	NX	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-A7-A13G	FEMALE	718	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	1	586.0	Other, specify	New Primary Tumor	TUMOR FREE				79	Left	Sentinel node biopsy alone	Not Available	TCGA-A7-A13G	6cd9baf5-bbe0-4c1e-a87f-c53b3af22890	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	16	-28969	Not Applicable	0	208	Not Available	NO	TCGA-A7-A13G-D17698;TCGA-A7-A13G-D35038	123A3E9A-D014-419E-93FC-E001C3B336B2;BEEDA94D-D6C3-4811-A18E-AA495A0EF9C3	Not Available;Not Available	24;14	Not Available;Not Available	33;33	Arimidex;Arimidex	Not Available;Not Applicable	10;9	Not Available;Not Available	1;Not Available	mg;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	1;Not Available	PO;Not Available	YES;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	376;Not Available	mg;Not Available	Not Available;NO	2011;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A7-A13G-F17696;TCGA-A7-A13G-F35039	087E9825-65B1-4984-B360-0C86EA23E197;25A9D546-BE0A-4F1D-BE67-D3D8653307F9				24;14		Not Available;None	Not Applicable;Not Applicable	348;718		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	10;9	Not Available;None	Not Available;None	Not Available;None	NO;None	None;NO	None;NO	None;586	None;586	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Other, specify	None;New Primary Tumor	None;Skin, right leg	None;YES	None;Not Available	None;YES	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	Not Available	Yes	A13G	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	50-59%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A248	FEMALE	59	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	59			TUMOR FREE				51	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A248	539bbbed-43fb-4fef-9c67-6406f58b186a	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	22	-18684	Not Applicable	0	22	Not Available	NO	TCGA-E9-A248-D31215;TCGA-E9-A248-D31213	E530CA0A-DA5E-4FBA-8E45-36898EA1D171;73DBEE28-62F4-469F-B77D-40AD347DBA5B	Not Available;Not Available	25;25	59;59	16;16	Cyclophosphamide;Doxorubicin	Not Available;Not Available	4;4	2;2	1000;100	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	2000;200	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E9-A248-F31211	A4604D3E-8204-4714-8FD3-27CD2CD423D1				25		Not Available	Not Applicable	59		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A248	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-E2-A1BC	FEMALE	501	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	501			TUMOR FREE				63	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A1BC	d8492ebd-3d94-4a4b-8de7-386526691cc2	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	NO	25	-23168	Not Applicable	0	297	Not Available	NO	TCGA-E2-A1BC-D19437	13C0F950-43CA-42DC-8E5D-A36D4B38FED8	Not Available	9	Not Available	11	Arimidex	Not Available	12	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1BC-F19427	3D5C68DA-26CB-4603-A39E-4BDB247D2704				8		Not Available	Not Applicable	501		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8524/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	Yes	A1BC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A0TU	FEMALE	709	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	709			TUMOR FREE				35	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TU	dfe6db17-cf45-488e-bd3c-b8433d7343ca	Not Available	Negative	Not Available	0	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	10	-13039	Not Applicable	0	360	Not Available	Not Available	TCGA-AR-A0TU-D19570;TCGA-AR-A0TU-D19572;TCGA-AR-A0TU-D19571	EFEB5E4B-A824-4B78-B373-603E8A1C7BBA;EE4C23A8-EDAC-4DE6-9B48-CD0BCB2D9978;8B38DA0D-2D5D-4484-BC07-F2BF3584123C	Not Available;Not Available;Not Available	15;15;15	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Doxorubicin;Docetaxel;Cytoxan	Not Available;Not Available;Not Available	12;12;12	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A0TU-F18575;TCGA-AR-A0TU-F71735	080FECF7-066F-4CB4-9E67-5ABAE2FBA3EF;3BBB4DAF-8684-4AE4-A54B-691A404D0A5D				15;30		Not Available;None	Not Applicable;Not Applicable	417;709		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	0	Not Available	No	A0TU	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-BH-A18I	FEMALE	1093	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a		Stage IIA	0	1093			TUMOR FREE				53	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A18I	9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58	Negative	Positive	Not Available	Not Available	Not Available	Modified radical mastectomy	Positive	Other	Not Applicable	Not Available	7	-19489	Not Applicable	0	220	Not Available	Not Available	TCGA-BH-A18I-D58711;TCGA-BH-A18I-D58712	62D6ACAF-3359-411A-9715-AC1D93B3EB27;B4CF288C-CBDD-493D-8CB6-198994F91639	Not Available;Not Available	22;22	220;220	121;121	Taxotere;Cytoxan	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A18I-F58710	FDFEEC48-B8F2-49EE-B102-CCF1754E0818				22			Not Applicable	1093																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.2	8500/3	C50.2	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Available	3	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	1	No	A18I	TUMOR FREE	Not Available	Not Available	Not Available	H score	H score	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	cM0 (i+)	N1a	T1c	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010
TCGA-B6-A1KC	FEMALE	1326	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1326			TUMOR FREE				67	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-B6-A1KC	1502c7d7-1535-4e56-9f34-30623acd50d5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	NO	19	-24791	Not Applicable	0	1326	Not Available	NO																								image cytometry	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A1KC-F15740	C4FFD639-1D13-4E8E-80DC-B8D3730D3F2F				29		Not Available	Not Applicable	1326		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	1	Not Available	No	A1KC	TUMOR FREE	image cytometry	Not Available	Not Available	Not Available	49 fmol/mg protein	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2011	2003
TCGA-BH-A0B0	FEMALE	2477	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	2477			TUMOR FREE				56	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0B0	66af34ea-f471-4092-aff6-9ac9a5b75b11	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-20776	Not Applicable	0	1428	Not Available	NO	TCGA-BH-A0B0-D59205;TCGA-BH-A0B0-D59206	7588271F-B241-4AE6-AE91-0065CCD2FE37;9A3AEC18-4AD6-47E3-B8CA-EA762943F950	Not Available;Not Available	2;2	194;194	82;82	Adriamycin;Cytoxan	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	YES;YES	2014;2014	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-BH-A0B0-F59204	8DFE37F5-C1F5-45C1-BCE9-70A5209079F1				2			Not Applicable	2477																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Available	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A0B0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-BH-A0B0-R59207	60C2C230-CDAF-4194-B9B2-F90127A231E7	Not Available	2	236	194	Complete Response	5	30	6000	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	left segmental mastectomy with axillary sentinel lymph node biopsy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2006
TCGA-A8-A097	FEMALE	365	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	365			TUMOR FREE				65	Left	Not Available	Not Available	TCGA-A8-A097	dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-23741	Not Applicable	0	365	Not Available	Not Available	TCGA-A8-A097-D37808;TCGA-A8-A097-D37809;TCGA-A8-A097-D37810	98353B03-FA94-480C-BB09-9F440783BCA7;E6EE618F-B8F8-4389-93CE-F97B35570AC1;ED10C356-D8E5-44B6-A777-8AF1E49CDD49	n/a;n/a;n/a	6;6;6	153;153;Not Available	61;61;31	Docetaxel;Cyclophosphamide;Tamoxifen	Complete Response;Complete Response;Not Applicable	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A097-F40553	E01ADA75-EA29-473E-8F48-7E4B21F2D04C				23			Not Applicable	365																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A097	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A097-R38168	ECEF383E-6DE5-4F26-A795-39412649FDC7	Not Available	11	184	153	Complete Response	12	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-AO-A12A	FEMALE	3112	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	3112			TUMOR FREE				47	Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A12A	99927651-34be-4795-893a-128d8a1fdb30	Not Available	Positive	Not Available	4+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	8	-17420	Not Applicable	0	2755	Not Available	Not Available	TCGA-AO-A12A-D5955;TCGA-AO-A12A-D5951;TCGA-AO-A12A-D5956;TCGA-AO-A12A-D5952;TCGA-AO-A12A-D5954	f0990117-c231-40b2-9fdd-2e0c99c53259;6e16923a-f894-4deb-96a0-7b875f5dd9c3;12495058-61d2-4d20-850f-ddfc97c9b7e8;da66efbf-8091-4e5b-b1ce-b9427f0eb0e3;b5aa7d03-a502-4ee1-97df-86d2ea4a1a5d	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	830;112;1918;112;168	186;67;831;67;126	Tamoxifen;Cyclophosphamide;Aromasin;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	Not Available;4;Not Available;4;4	20;600;25;60;175	mg/day;mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;2;1;1	PO;IV;PO;IV;IV	NO;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	58	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A12A-F5885;TCGA-AO-A12A-F19418	C93AD7CB-92B3-4437-8A76-B6F75E503D1C;BFC6614A-A948-450E-AFF8-2973C401CDF9	Not Available;None	Not Available;None	Not Available;None	8;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	2755;3112	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	>=2.0 Positive	1+	30	Not Available	61	1.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	27	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	1	No	A12A	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2003
TCGA-A8-A07B	FEMALE	1308	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1308			TUMOR FREE				69	Left Lower Outer Quadrant	Not Available	Not Available	TCGA-A8-A07B	b43e41af-1d82-4b5f-b8f1-add0510e6b86	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-25475	Not Applicable	0	1004	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A07B-F40823	4265C9DA-22B4-4682-A01B-71D9E453CB98				2			Not Applicable	1308																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A07B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-AC-A2B8	FEMALE	677	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	1	654.0	Other, specify	New Primary Tumor	Not Available				84	Right	Axillary lymph node dissection alone	Not Available	TCGA-AC-A2B8	6E126B73-D3E8-4641-A128-306F3B313E40	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	Not Available	12	-31003	Not Applicable	0	45	Not Available	NO	TCGA-AC-A2B8-D43212;TCGA-AC-A2B8-D43213	01CD233B-B68C-458C-932F-5FD7F87DCB3F;FE83C33F-CAF2-4C0F-8447-2905F8864C89	Not Available;Not Available	15;15	Not Available;Not Available	135;Not Available	Chemo, NOS;Arimidex	Complete Response;Not Applicable	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Chemotherapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A2B8-F43210	E01D57EB-5162-4BCE-8AC8-D37DDBE74B3C				15			Not Applicable	677																				NO																						5					NO	YES	672	654	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	New Primary Tumor	Rectum	YES	Not Available	YES	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2B8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-AC-A2B8-R43215	DAB5FC3E-2668-4D3F-B2AD-9411CCACBF9C	Not Available	15	122	80	Complete Response	5	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2011	2011
TCGA-A8-A086	FEMALE	396	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	396			TUMOR FREE				59	Right	Not Available	Not Available	TCGA-A8-A086	f9eb88f7-9293-46bf-ace4-a746e4ff80dc	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-21731	Not Applicable	0	396	Not Available	Not Available	TCGA-A8-A086-D37770;TCGA-A8-A086-D37771	69FDE7B7-F6E1-48E5-B4EC-553EBEA6839C;0C96C615-A569-425F-A761-07276A751736	n/a;n/a	6;6	92;92	0;0	Docetaxel;Cyclophosphamide	Complete Response;Complete Response	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A086-F40840	EB8F9F5C-FC49-4DB0-95B6-F2FC583DE891				2			Not Applicable	396																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A086	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A086-R38159	4F1BECB4-7EA6-4768-8663-1670B1C4251D	Not Available	11	153	123	Complete Response	12	Not Available	62	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-A2-A0YG	FEMALE	666	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	666			TUMOR FREE				63	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0YG	c0892598-1f7b-4f23-9cd8-731f797753d5	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	3	-23058	Not Applicable	0	404	Not Available	Not Available	TCGA-A2-A0YG-D5636;TCGA-A2-A0YG-D5637;TCGA-A2-A0YG-D5628;TCGA-A2-A0YG-D5627;TCGA-A2-A0YG-D5638;TCGA-A2-A0YG-D5639	7a5fb8b1-74dd-4cdf-a42e-10aa9ae382ad;ea67ac32-9c00-4232-aa39-39d493f18b95;310907f8-03bc-46fe-abfd-562722f26798;854cdbfa-8797-4255-ae54-9a7b1278579e;b3943b3d-4e9a-4ccc-bd23-65d88a9afc7e;a99a6cef-a2db-4dcb-aba7-24b62d65de98	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;14;14	173;232;131;131;Not Available;Not Available	173;152;68;68;Not Available;152	Taxotere;Taxol;Cytoxan;Adriamycin;Arimidex;Herceptin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	1;12;4;4;Not Available;Not Available	229;178-185;1224;122;1;255-509	mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;4;2;1;5;6	IV;IV;IV;IV;PO;IV	NO;NO;NO;NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	229;Not Available;4896;488;Not Available;Not Available	mg;Not Available;mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0YG-F16753	AE70B861-9D94-44E5-8818-90AA283FD9C6				16		Not Available	Not Applicable	666		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	14	Not Available	No	A0YG	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YG-R5625	f5aff914-e9ce-4684-9fca-5e1ed11aa6c0	1	2	303	257	Not Available	12	25	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2009
TCGA-A2-A0CR	FEMALE	3283	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	3283			TUMOR FREE				54	Left Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0CR	4CF0F639-7940-48B6-8EA1-2A3494097CDB	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	5	-20075	Not Applicable	0	2955	Not Available	NO	TCGA-A2-A0CR-D32690;TCGA-A2-A0CR-D32691;TCGA-A2-A0CR-D32692;TCGA-A2-A0CR-D32693;TCGA-A2-A0CR-D32695	D0B85F79-B3D8-4E9F-A1AA-E2C032E70AB5;A7033B5A-843E-4899-98F4-FAA742F71CB5;B04147AD-6DB7-426E-AA27-E42D79761AE0;15734CC3-5FE8-44C0-8E0B-651B026DFC80;4B109ECE-53BB-4544-A269-3DBBEFFDF432	Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7	147;147;203;300;Not Available	105;105;140;224;315	Adriamycin;Cyclophosphamide;Paclitaxel;Tamoxifen;Anastrazole	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	6;6;6;6;6	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A0CR-F42400	C3D189CF-D8DD-4B02-9DD3-68CCA1F0579F				18			Not Applicable	3283																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.2	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	1+	YES	Not Applicable	Core needle biopsy	Negative	Negative	16	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	0	No	A0CR	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	80-89%	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2004
TCGA-A8-A09B	FEMALE	365	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N1a	M0	Stage IIIB	0	365			TUMOR FREE				58	Left	Not Available	Not Available	TCGA-A8-A09B	3828b534-908e-4953-a3fb-07d01cf49c7d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-21520	Not Applicable	0	365	Not Available	Not Available	TCGA-A8-A09B-D37797;TCGA-A8-A09B-D37798;TCGA-A8-A09B-D37799;TCGA-A8-A09B-D37800;TCGA-A8-A09B-D37801	DB9805C1-DC29-4382-829A-BC707E268861;D8720C19-DA4E-4B7C-AD4B-82EFBFDBF3E2;1BC9A48C-10DD-439C-A959-4DD7B05CDF82;C0BCD5E9-32B6-4BA1-96BB-FB00CB9DA2E4;A108C623-BC80-4675-931F-301E1BA62157	n/a;n/a;n/a;n/a;n/a	6;6;6;6;6	30;30;30;122;242	30;30;30;Not Available;153	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Anastrozole	Unknown;Unknown;Unknown;Unknown;Unknown	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A09B-F40550	67B93484-7627-4EB4-82E5-189B57D36AC1				23			Not Applicable	365																				NO																						2					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A09B	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Primary Tumor Field	TCGA-A8-A09B-R38165	1528A1EE-7C4B-4B8A-AFCC-46098B902021	Not Available	11	181	153	Unknown	12	Not Available	50	NO	External	Not Applicable	Not Available	Not Available	Gy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T4b	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2009
TCGA-A2-A0CQ	FEMALE	2695	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0 (i-)	M0	Stage IA	0	2695			TUMOR FREE				62	Right	Sentinel node biopsy alone	Not Available	TCGA-A2-A0CQ	ab34a9a2-d72d-4106-94fb-118844b1b60b	Negative	Positive	Not Available	Not Available	Not Available	Lumpectomy	Positive	Lumpectomy	Not Applicable	YES	10	-22810	Not Applicable	0	2393	Not Available	Not Available	TCGA-A2-A0CQ-D1987;TCGA-A2-A0CQ-D1988;TCGA-A2-A0CQ-D1986;TCGA-A2-A0CQ-D1990	3bae8101-5295-4dd1-b21f-31ed7bf92ec2;865e1c55-d241-4076-bd9a-0bffed3475aa;664f836e-85b0-4c5f-8869-42321a27e983;71de8349-bb98-4691-8138-1cdcc08f849c	Not Available;Not Available;Not Available;Not Available	30;30;30;9	162;Not Available;162;628	99;201;99;492	Adriamycin;Arimidex;Cytoxan;AE-37	Not Available;Not Available;Not Available;Not Available	8;8;8;9	4;Not Available;4;6	104;1;1044;100	mg;mg;mg;ug	ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Not Applicable;Cancer Vaccine Trial	2;3;1;4	IV;PO;IV;Not Available	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available	416;Not Available;4176;600	mg;Not Available;mg;ug	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0CQ-F13723	3276C085-4370-48D5-9BA7-76ADDE69842D				10		Not Available	Not Applicable	2695		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A0CQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-A2-A0CQ-R1985	e74c5228-76c3-41d0-99f3-307ae0373b37	1	9	236	188	Not Available	9	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2003
TCGA-E9-A1NE	FEMALE	1088	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1088			TUMOR FREE				28	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1NE	3d676bba-154b-4d22-ab59-d4d4da051b94	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Not Available	Not Applicable	YES	23	-10564	Not Applicable	0	0	Not Available	NO	TCGA-E9-A1NE-D32914;TCGA-E9-A1NE-D32915;TCGA-E9-A1NE-D32916;TCGA-E9-A1NE-D32918	F4561048-074E-457D-A181-125FDEB51F22;84F7B524-80E6-4D79-871F-8AD30E6A9987;55ECA12D-C3E9-48D5-8BC7-77BC7D789290;ED962811-FC2D-4B99-B1B0-B0B606EC40AC	Not Available;Not Available;Not Available;Not Available	15;15;15;15	121;121;121;Not Available	10;10;10;184	Doxorubicin;Cyclophosphamide;5-Fluorouracil;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	6;6;6;6	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1NE-F29165;TCGA-E9-A1NE-F39781	714D5ED8-026F-4E91-AC35-781F105265E8;8A04ABC1-6244-42ED-B3A7-4BF655854F46				9;1		Not Available;None	Not Applicable;Not Applicable	420;1088		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;2	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8522/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	0	No	A1NE	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E9-A1NE-R29166	48473E9C-72DD-4F0A-8D3E-85B661B773F4	Not Available	9	171	141	Not Available	3	23	4600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-B6-A0RL	FEMALE	2469	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0 (i-)	M0	Stage IIA	0	2469			TUMOR FREE				60	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RL	5562455d-bbb8-46eb-a510-e8c6e1e26789	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-22238	2469	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0RL-F13796	B2545806-EF62-435D-8C96-4BE1AFC4178E				12		Not Available	2469	Not Available		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Available	16	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	0	Not Available	No	A0RL	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1993
TCGA-BH-A1FN	FEMALE	2192	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	2192			WITH TUMOR				34	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A1FN	6dd0dd7b-62ff-4fd1-a99a-b265f1a91dca	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	8	-12525	2192	0	Not Available	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	29	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	Not Available	No	A1FN	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	segmental mastectomy with axillary lymph node dissection	NO	YES	BH	Breast	Not Applicable	Dead	2011	1997
TCGA-C8-A1HO	FEMALE	375	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N3	M0	Stage IIIC	0	375			TUMOR FREE				34	Left Upper Inner Quadrant	Not Available	Not Available	TCGA-C8-A1HO	b3354b72-2637-4edc-9a95-e55801d3ac13	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Discrepancy	Not Applicable	Not Available	12	-12715	Not Applicable	0	0	Not Available	Not Available	TCGA-C8-A1HO-D70803;TCGA-C8-A1HO-D70804;TCGA-C8-A1HO-D70805	3D258720-7215-4352-8F11-753D26984EF0;25995E3D-C18A-42AE-B575-DF8521244005;957DBA00-04EE-4C3E-A23E-68E9C478CD59	Not Available;Not Available;Not Available	9;9;9	-45;-45;-45	-49;-49;-49	5-Fluorouracil;Epirubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-C8-A1HO-F70802	D4532637-AF57-4952-9398-E0DE374DD889				9			Not Applicable	375																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	Not Available	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	Not Available	Not Available	No	A1HO	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 5	Allred Score 7	Not Available	NO	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N3	T3	Not Available	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-E9-A1R4	FEMALE	186	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	186			TUMOR FREE				66	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1R4	b7a4df9a-4e25-4550-9c10-338ca1921c2f	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Applicable	NO	28	-24181	Not Applicable	0	29	Not Available	NO	TCGA-E9-A1R4-D30541;TCGA-E9-A1R4-D30538;TCGA-E9-A1R4-D30537;TCGA-E9-A1R4-D30536	3B9C6105-0363-4B73-BD5F-CE0FB88008F3;48222E9D-20E8-452B-8E46-E5FA68881243;4D26049E-F78C-4164-BDC1-E00DB74121E8;8102DE2B-8388-4BD3-8699-A8575DAE40A4	Not Available;Not Available;Not Available;Not Available	12;12;12;12	Not Available;45;45;45	12;9;9;9	Tamoxifen;5-Fluorouracil;Methotrexate;Cyclophosphamide	Not Available;Not Available;Not Available;Not Available	4;4;4;4	Not Available;2;2;2	20;2000;100;2000	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;4000;200;4000	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1R4-F30535;TCGA-E9-A1R4-F48699	33A6D6A9-9F24-4721-8CE5-F64203765025;F48BBDBA-2E52-4977-B5C5-4644216DD354				12;19		Not Available;None	Not Applicable;Not Applicable	186;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;9	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		YES;Not Available	Alive;Not Available	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Lumpectomy	Other method, specify:	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1R4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-E9-A1R4-R30543	831EC698-4241-43B9-B8DD-2281430ED0B2	1	12	155	125	Not Available	4	23	4600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-GM-A2DL	FEMALE	3519	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	3519			TUMOR FREE				50	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DL	A76774FE-7298-4D68-A2B2-C1BAD93F0C31	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	29	-18475	Not Applicable	0	2763	Not Available	NO	TCGA-GM-A2DL-D47100;TCGA-GM-A2DL-D47102	64A06228-D44D-48D4-920A-2EF984608DE9;C22DF452-BBBA-49F3-ACF1-E448627C6D68	Not Available;Not Available	22;22	1989;Not Available	158;1990	Tamoxifen;Arimidex	Complete Response;Not Applicable	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;YES	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A2DL-F47098	050D20E4-BB66-4D0F-B205-E99C63577775				22			Not Applicable	3519																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2DL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-GM-A2DL-R47099	2E8B03A4-E42D-4861-97AC-4C1D485B6DE6	Not Available	22	151	110	Complete Response	8	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2003
TCGA-A8-A082	FEMALE	549	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	549			TUMOR FREE				58	Right	Not Available	Not Available	TCGA-A8-A082	5e4187c9-98f8-4bdb-a8da-6a914e96f47a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-21338	Not Applicable	0	549	Not Available	Not Available	TCGA-A8-A082-D37887;TCGA-A8-A082-D37888;TCGA-A8-A082-D37889;TCGA-A8-A082-D37890;TCGA-A8-A082-D37891;TCGA-A8-A082-D37892	07C01032-C857-4682-B8E3-C03FA024ECB9;EFA90125-FED8-4301-A595-3CB4798D1F22;A155B75A-412B-4A2E-921A-67A737A29E6A;122E4A81-1D23-44AB-8070-1F44572B6AE8;BCB4083F-8DF9-4847-8F80-00E4A0CD49F5;03AE2E15-1D31-4DAD-8D42-434C2FF4769A	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6;6	122;122;122;92;Not Available;914	31;31;31;92;184;852	5-Fluorouracil;Epirubicin;Cyclophosphamide;Docetaxel;Letrozole;Exemestane	Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable;Complete Response	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A082-F40837	94671AF3-7174-4E0B-9B56-33FFE891B86F				2			Not Applicable	-31																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A082	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A04R	FEMALE	3709	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0 (i-)	M0	Stage IA	0	3709			TUMOR FREE				36	Left Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A04R	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	8	-13483	Not Applicable	0	2365	Not Available	Not Available	TCGA-A2-A04R-D2553;TCGA-A2-A04R-D2554;TCGA-A2-A04R-D2556;TCGA-A2-A04R-D2555;TCGA-A2-A04R-D2552	80d22cd5-ee42-4e09-b192-f6b2183cf0b3;575ace17-a333-4457-837f-9f4210296cb5;258814a0-8e67-4ac2-84ec-1353588f2f9d;59cf62c8-9052-43df-aefa-ea940996727a;7430b157-f641-4b64-86b4-38f47b845980	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	184;184;Not Available;909;45	119;119;910;399;45	CYTOXAN;Adriamycin;Anastrozole;Tamoxifen;TAXOL	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	4;4;Not Available;Not Available;1	1200;120;1;20;354	mg;mg;mg/day;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;3;5;4;1	IV;IV;PO;PO;IV	NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	4800;480;Not Available;Not Available;354	mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A2-A04R-F9327;TCGA-A2-A04R-F59315	76955B11-9319-4621-99D7-823860110AD6;C91D9225-7AD4-4F0C-9851-D37807AA970A	Not Available;None	Not Available;None	Not Available;None	21;8	Not Available;None	Not Available;None	Not Applicable;Not Applicable	2499;3709	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;5					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A04R	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	80-89%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-A2-A04R-R2557	7b76f4d4-65c9-4ff3-abef-09844e8fc56a	1	12	342	300	Not Available	10	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2004
TCGA-A8-A06Z	FEMALE	31	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	31			Not Available				84	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A06Z	2399caeb-ead2-4003-af38-809db4ac2e2b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-30984	Not Applicable	0	31	Not Available	Not Available																								Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Negative	Negative	Not Available	Not Available	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	No	A06Z	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-E9-A1RH	FEMALE	1417	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1417			TUMOR FREE				63	Right Lower Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RH	408cb583-6dc3-4698-8bd2-e284042bd5ef	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Lumpectomy	Not Applicable	NO	2	-23224	Not Applicable	0	14	Not Available	NO	TCGA-E9-A1RH-D30658;TCGA-E9-A1RH-D30656;TCGA-E9-A1RH-D30655;TCGA-E9-A1RH-D30657	E0770822-61B3-4C2B-91B4-1BD84EC0ED21;0D76DFE2-D103-4A7A-B578-BFA80C9362DC;C11A3BB8-098E-40C2-B6AC-2DAB2235186F;395299B4-0924-44F0-B3B9-48F4A1672618	Not Available;Not Available;Not Available;Not Available	13;13;13;13	205;214;214;214	11;11;11;11	5-Fluorouracil;Methotrexate;Cyclophosphamide;5-Fluorouracil	Not Available;Not Available;Not Available;Not Available	4;4;4;4	4;6;6;2	1500;100;1600;2000	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	6000;600;9600;4000	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-E9-A1RH-F30654;TCGA-E9-A1RH-F39538;TCGA-E9-A1RH-F70141	5C952C48-A87D-4BD8-8FDC-DC74E3C97E7C;8ADAFC52-311D-493C-A40D-FBC3E4824415;02098C42-1FA6-4F5D-A72C-06E338B58C37				27;24;28		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	626;1052;1417		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;NO;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	2;1;1	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2014;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A1RH	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site;Primary Tumor Field	TCGA-E9-A1RH-R30659;TCGA-E9-A1RH-R56942	9EC04972-0350-4D5B-80BC-1081E50A0DE4;F462C0FF-6B78-4FDE-A54F-8C581AB9B688	1;Not Available	13;26	107;107	63;63	Not Available;Complete Response	4;2	22;30	4400;60	NO;NO	EXTERNAL BEAM;External	Not Applicable;Not Applicable	ADJUVANT;Not Available	Not Available;Not Available	cGy;Gy	2012;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AO-A0JI	FEMALE	1528	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1	M0	Stage IIA	0	1528			TUMOR FREE				56	Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0JI	e17c565c-9857-4df3-a352-903b53093c85	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	7	-20694	Not Applicable	0	1172	Not Available	Not Available	TCGA-AO-A0JI-D5929;TCGA-AO-A0JI-D5931;TCGA-AO-A0JI-D5928;TCGA-AO-A0JI-D5930	2d6ad2f6-0769-4ee4-b690-7c424bd9fc6a;927d22e8-916f-43bb-b085-eacbf3eda2ce;cc046508-1134-4ceb-8184-57f1637e4e3e;ddd8f77f-5e9f-443d-afba-17082d2bdb03	Not Available;Not Available;Not Available;Not Available	10;10;10;10	140;Not Available;140;196	98;224;98;154	Cyclophosphamide;Arimidex (Anastrozole);Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available;Not Available	1;1;1;1	4;Not Available;4;4	600;1;60;175	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	4176;Not Available;416;1220	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JI-F5867;TCGA-AO-A0JI-F19410	94F45AAD-C6E1-4501-A451-AE8266BA9D5C;EE8F19C6-3BDA-4398-96EF-7D72609886E1	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1172;1528	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	1	No	A0JI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2007
TCGA-4H-AAAK	FEMALE	348	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	348			TUMOR FREE				50	Left;Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-4H-AAAK	6623FC5E-00BE-4476-967A-CBD55F676EA6	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	13	-18371	Not Applicable	0	158	Not Available	Not Available	TCGA-4H-AAAK-D68065;TCGA-4H-AAAK-D68067;TCGA-4H-AAAK-D68072	08F129B2-D118-4CA1-B51F-A648445EC84E;D675535D-A6A0-4634-8E6C-A5B7C8E61289;A6A3B982-CF4E-4E87-9F53-A31FE7AD6C2E	Not Available;Not Available;Not Available	13;13;13	98;98;98	27;27;27	Cyclophosphamide;Doxorubicin;5-Fluorouracil	Complete Response;Complete Response;Complete Response	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-4H-AAAK-F67414	2BC6A238-0838-44AB-9DEA-7A127FF96BEF				13			Not Applicable	348																				NO																						11					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	4	Not Available	No	AAAK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	70-79%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	YES	NO	4H	Breast	Not Applicable	Alive	2014	2013
TCGA-B6-A409	FEMALE	573	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N2a	M0	Stage IIIA	1	456.0	Lung	Distant Metastasis	WITH TUMOR				44	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-B6-A409	5362CBC4-CD28-4AFD-A8AC-1A4C2C33CAD2	Not Available	Negative	4 Point Scale	1+	4 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	20	-16178	573	0	Not Available	Not Available	Not Available	TCGA-B6-A409-D41060;TCGA-B6-A409-D41061;TCGA-B6-A409-D41062	FF0971AD-14FB-4A85-8FBB-FC306D52E376;E376E464-0759-47CF-A9BD-2B247D16DA20;2FE8275D-A6CE-4337-A4BE-E37271CD0124	Not Available;Not Available;Not Available	11;11;11	93;93;149	51;51;107	Cyclophosphamide;Doxorubicin;Paclitaxel	Unknown;Unknown;Unknown	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2013;2013;2013	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	1.8																																																																																																									FEMALE	Not Available	Not Available	10-19%	Not Available	1+	60	Not Available	2	1.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	2+	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	22	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES	YES	Not Available	456	Not Available	Not Available	1+	Not Available	<10%	Negative	Not Available	Not Available	<10%	Not Available	Not Available	1+	4 Point Scale	1+	4 Point Scale	Negative	Not Evaluated	Not Available	Not Available	Not Available	Not Available	<10%	Negative	Lung	Distant Metastasis	Not Available	NO	Not Available	YES	6	Not Available	No	A409	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1c	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2012	2008
TCGA-AO-A0JB	FEMALE	1542	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	1542			TUMOR FREE				50	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left Lower Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-AO-A0JB	3ea9412b-429e-4dcf-90cd-c53be06885a1	Not Available	Positive	Not Available	2+	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	19	-18561	Not Applicable	0	1150	Not Available	Not Available	TCGA-AO-A0JB-D3177;TCGA-AO-A0JB-D3174;TCGA-AO-A0JB-D3178;TCGA-AO-A0JB-D3176	6ffc6760-7989-43cc-a868-cacb2893c699;f1f16a87-8aa3-4ab9-8872-f3dba71b6d93;f228c0ee-6d98-4cde-b962-c60cf3e59085;c5d0586b-c47f-494b-94ac-41f12deeb702	Not Available;Not Available;Not Available;Not Available	19;19;19;19	92;Not Available;147;92	49;175;105;49	CYCLOPHOSPHAMIDE;TAMOXIFEN;PACLITAXEL;DOXORUBICIN	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;Not Available;4;4	600;20;175;60	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3680;Not Available;1080;368	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0JB-F3172;TCGA-AO-A0JB-F15485	3E04D8C6-0459-478A-8CDF-B490BF3F9A08;4E6D473B-DBDC-4AB0-B7CA-6C8E595DCB23	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	1150;1542	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A0JB	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available	Regional site	TCGA-AO-A0JB-R3175	4696646b-a422-4344-a88d-d9e532419e43	1	6	253	216	Not Available	9	28	15120	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2007
TCGA-AR-A24S	FEMALE	2976	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	2976			Not Available				61	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24S	074e8b06-3929-4896-9263-3b80ad6a355b	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	30	-22587	Not Applicable	0	1888	Not Available	Not Available	TCGA-AR-A24S-D31500;TCGA-AR-A24S-D31499	D4ADA29C-A0D8-40B4-9BC1-5C021EE0D1CA;F328D456-9B78-4357-99E0-40F41C3314CE	Not Available;Not Available	4;4	1124;126	129;32	Exemestane;Anastrozole	Not Available;Not Available	5;5	Not Available;Not Available	25;1	mg/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	2;1	PO;PO	NO;NO	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2012;2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A24S-F31496	C02A0731-B37F-4A25-87C8-C4BAE202D900				4		Not Available	Not Applicable	2976		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24S	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A24S-R31497	6158469F-BAE7-4222-BAF2-A95FF4534F27	1	4	62	55	Not Available	5	10	3850	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-BH-A0HB	FEMALE	806	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	806			TUMOR FREE				55	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0HB	0c1023c0-d2ce-4940-8047-7642f1dc3965	Not Available	Positive	Not Available	1+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	10	-20448	Not Applicable	0	806	Not Available	Not Available	TCGA-BH-A0HB-D4709;TCGA-BH-A0HB-D4710;TCGA-BH-A0HB-D4712;TCGA-BH-A0HB-D4714	6E82BA52-E171-47BE-96D0-A82FDC86A205;FF1D11E0-7156-4A41-A367-D9A6CCF223CC;7BC6F0D1-914E-49DD-897E-F07AE5696A99;73F72881-D3E3-4B35-B34A-E93F48E3254F	Not Available;Not Available;Not Available;Not Available	17;18;18;18	Not Available;134;134;893	317;71;71;162	Arimidex;Docetaxel;Cyclophosphamide;Zoledronic Acid	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;4;4;12	1;133;1068;4	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Other, specify in notes	Not Available;Not Available;Not Available;ancillary	Not Available;539;4326;48	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	H-Score 300	90-99%	Not Available	Not Available	Not Available	2.13	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0HB-F4718	557DF182-2E69-4738-AAFF-52D3BE340928	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	806	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	2.58	1.21	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0HB	TUMOR FREE	H-Score 70	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	30-39%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0HB-R4716	6E84E476-DE82-4DF3-B4A6-C0EA750613AD	1	17	221	175	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2008
TCGA-A2-A04Q	FEMALE	2385	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0 (i-)	M0	Stage IA	0	2385			TUMOR FREE				48	Right Upper Outer Quadrant;Right	Other (specify)	SLN AND NON-SLN BX	TCGA-A2-A04Q	b5fba77b-1f50-4e71-95b2-566afba4bdd7	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	10	-17660	Not Applicable	0	2179	Not Available	Not Available	TCGA-A2-A04Q-D2766;TCGA-A2-A04Q-D2764	df8339c3-f6d8-4121-a22d-949df819ce16;9f6d826b-b6b9-4f14-8640-7e859b8c7f95	Not Available;Not Available	12;12	85;85	23;43	ADRIAMYCIN;CYTOXAN	Not Available;Not Available	8;8	4;4	100-102;1000-1020	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	204;4048	mg;mg	Not Available;Not Available	2010;2010	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A2-A04Q-F9329;TCGA-A2-A04Q-F59314	B7EAC97B-63C1-4DB3-A0F0-62D03122CC88;8C018342-8251-45D4-B7B0-807B5F7BC07B	Not Available;None	Not Available;None	Not Available;None	21;8	Not Available;None	Not Available;None	Not Applicable;Not Applicable	2385;2385	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;5					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Unknown	TUMOR FREE;Unknown	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2011;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.4	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	SKIN BIOPSY	Other method, specify:	Equivocal	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A04Q	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2004
TCGA-E2-A573	FEMALE	1062	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	1062			TUMOR FREE				48	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A573	6429C443-8AC3-407F-BB9C-66420B904BBF	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	20	-17689	Not Applicable	0	677	Not Available	Not Available	TCGA-E2-A573-D44501;TCGA-E2-A573-D44502	3AF01D86-64C7-405F-887D-1A0D27831968;3A195E08-569B-4623-BF02-4176DE92D98C	Not Available;Not Available	20;20	167;167	104;104	Taxotere;Cytoxan	Complete Response;Complete Response	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Allred 0 = 0+0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	1.8					TCGA-E2-A573-F61338	E2709DF2-6524-4677-B518-338714E12666				27			Not Applicable	1062																				NO																						6					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	10-19%	Not Available	2+	200	Not Available	2.3	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A573	TUMOR FREE	Allred 0 = 0+0	Not Available	Not Available	Allred Score	Allred Score	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	YES	Primary Tumor Field	TCGA-E2-A573-R44499	400B06FE-ADCF-4256-98CF-9BA8697DB36C	Not Available	20	251	201	Complete Response	6	36	66.4	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Partial Mastectomy	NO	YES	E2	Breast	Not Applicable	Alive	2013	2011
TCGA-B6-A0RO	FEMALE	4929	Infiltrating Ductal Carcinoma	Breast	Alive	T4	N1a	M0	Stage IIIB	0	4929			TUMOR FREE				71	Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0RO	0b172e29-6166-4863-803d-a0a010887c11	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	2	-26269	Not Applicable	0	4929	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A0RO-F13799	9A962820-D315-4506-9994-96C7C5A52C5F				12		Not Available	Not Applicable	4929		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	2	Not Available	No	A0RO	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1a	T4	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1993
TCGA-BH-A0E7	FEMALE	1363	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1363			TUMOR FREE				79	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0E7	d3b9d925-ae04-4721-8bfc-50b41225bc74	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Other	Not Applicable	NO	9	-29115	Not Applicable	0	1363	Not Available	Not Available	TCGA-BH-A0E7-D4653	7F0147D6-EB47-47CD-A3B8-E8B645FAB517	Not Available	17	Not Available	26	ARIMIDEX	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	50-59%	Not Available	Not Available	Not Available	Not Available	NO	NO	NO	NO	TCGA-BH-A0E7-F4656	C4793CFE-2B14-4704-BEC5-5E9961E516CD	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	1363	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Excisional Biopsy	Negative	Not Evaluated	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A0E7	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0E7-R4655	8916C7B7-CD5F-4704-A422-9233DB47C9AA	1	17	124	74	Not Available	11	33	5940	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2006
TCGA-A8-A06T	FEMALE	1614	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a	M0	Stage IIIA	0	1614			TUMOR FREE				75	Left Upper Outer Quadrant	Not Available	Not Available	TCGA-A8-A06T	2c04a2f5-321e-4dea-8e00-268325da65cb	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-27393	Not Applicable	0	1249	Not Available	Not Available	TCGA-A8-A06T-D37762	686C3C70-6D5F-4633-B169-6268CF0EF5A7	n/a	6	Not Available	0	Anastrozole	Not Applicable	12	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available					TCGA-A8-A06T-F40816	989E9C4A-0708-4FBE-BC59-EFEB8FBA5FBB				2			Not Applicable	1614																				NO																						3					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Not Available	Positive	Positive	Not Available	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	Not Available	Not Available	Yes	A06T	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T3	Surgical Resection	NO	YES	A8	Breast	Not Applicable	Alive	2011	2007
TCGA-A2-A0CW	FEMALE	3283	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	3283			TUMOR FREE				67	Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0CW	32efa6e8-6b19-480a-9d04-ace02e93318a	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	28	-24541	Not Applicable	0	1750	Not Available	Not Available	TCGA-A2-A0CW-D7229	c36b63ba-4a02-4afd-881a-952408223aa4	Not Available	1	Not Available	156	Anastrozole	Not Available	2	Not Available	1	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-A2-A0CW-F13727;TCGA-A2-A0CW-F70690	4C41DD4D-C22A-4CDB-8415-B936FDE030FF;06E8B614-ABD0-4B06-BC35-0FD8FA585C60				13;2		Not Available;None	Not Applicable;Not Applicable	1948;3283		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	0.5	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	2	0	No	A0CW	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2011	2006
TCGA-A2-A3KD	FEMALE	1206	Mucinous Carcinoma	Breast	Alive	T3	N1mi	M0	Stage IIIA	0	1206			TUMOR FREE				47	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A3KD	BB026999-0AAB-4232-96D7-2C93B6C9691D	Close	Positive	3 Point Scale	Not Available	3 Point Scale	Mastectomy NOS	Positive	Lumpectomy	Not Applicable	YES	2	-17372	Not Applicable	0	804	Not Available	NO	TCGA-A2-A3KD-D30120;TCGA-A2-A3KD-D30119;TCGA-A2-A3KD-D30121	AB03C3FC-D1ED-4F17-8BFB-C5123D0EC3B1;02CCA825-E874-4DCB-A863-18EF85224977;042F7696-E248-4F7D-AC91-A50E35E2E99F	Not Available;Not Available;Not Available	14;14;14	190;190;Not Available	127;127;282	Taxotere;Cytoxan;Tamoxifen	Not Available;Not Available;Not Available	2;2;2	4;4;Not Available	120;962;20	mg;mg;mg/day	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	2;1;3	IV;IV;PO	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	480;3848;Not Available	mg;mg;Not Available	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3KD-F37343	F2E6F4BD-FA19-43B2-BFCD-124FE5BFF06B				3			Not Applicable	1206																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.2	Not Available	Mucinous Carcinoma	Not Applicable	No	C50.9	8480/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	1	No	A3KD	TUMOR FREE	Not Available	Not Available	Not Available	Strong	Strong	Not Available	YES	70-79%	WHITE	Not Available	Not Available	TCGA-A2-A3KD-R30122	C063B997-34B9-44F4-B7CA-6F5540ED5D27	1	14	272	222	Not Available	2	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1mi	T3	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2012	2010
TCGA-A2-A0EQ	FEMALE	2426	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	2426			TUMOR FREE				64	Left	Other (specify)	Sentinel lymph node and non-sentinel lymph node biopsy	TCGA-A2-A0EQ	2192c1db-4718-4254-ba42-3ae7f30ad5a8	Negative	Negative	Not Available	0	Not Available	Lumpectomy	Negative	Lumpectomy	Not Applicable	YES	11	-23543	Not Applicable	0	2053	Not Available	Not Available	TCGA-A2-A0EQ-D1954;TCGA-A2-A0EQ-D1957;TCGA-A2-A0EQ-D1955;TCGA-A2-A0EQ-D1956;TCGA-A2-A0EQ-D1958	51e8ec2a-d6cf-441c-9bbb-e3cc24771544;68372627-8263-45a3-8639-655764fcb576;56d1ca0d-0923-4f84-9ede-e315f87f1648;f5f84132-0ffb-472d-bf1d-c1d076a7708b;5dc02798-980f-40ea-b086-988e10bfba6d	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;9	146;586;146;167;796	84;229;84;167;679	Adriamycin;Herceptin;Cytoxan;Paclitaxel;AE-37	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;9	4;22;4;1;6	122;195-594;1218;355;500	mg;mg;mg;mg;ug	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Cancer Vaccine Trial	1;4;2;3;5	IV;IV;IV;IV;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	488;10543;4872;355;3000	mg;mg;mg;mg;ug	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0EQ-F13720	0D4DC400-90B0-4475-AECB-5547B6CA8BFF				13		Not Available	Not Applicable	2426		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	0	YES	Not Applicable	Core needle biopsy	Positive	Negative	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A0EQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-A2-A0EQ-R1959	ea9bcf48-3312-4c01-a03d-8628ec8b301d	1	12	251	203	Not Available	8	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2004
TCGA-GM-A2DO	FEMALE	2596	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	2596			TUMOR FREE				54	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DO	5FD37868-4762-4109-9DCF-6FDBAB5B645D	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	30	-19842	Not Applicable	0	1623	Not Available	NO	TCGA-GM-A2DO-D47154	C19E8E9F-4856-4D78-8214-60750D868B76	Not Available	22	2051	219	Tamoxifen	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A2DO-F47151	5EAB98B3-F7DE-4F1B-89A0-346CBBA6049E				22			Not Applicable	2596																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2DO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-GM-A2DO-R47153	F35B749C-7FAE-4842-BE1A-15F2C44A28D1	Not Available	22	218	176	Complete Response	8	Not Available	Not Available	NO	External	Not Applicable	Not Available	Not Available	Not Available	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2006
TCGA-LL-A5YN	FEMALE	447	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	447			Unknown				46	Right;Right Upper Inner Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A5YN	EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	20	-16884	Not Applicable	0	111	Not Available	Not Available	TCGA-LL-A5YN-D43375;TCGA-LL-A5YN-D43376;TCGA-LL-A5YN-D43377;TCGA-LL-A5YN-D59363	A44314A0-B6F0-45D4-811F-53215A4E052C;8DF86AE2-2A1A-48D5-B349-97263291088C;C9597303-18A1-441B-99D5-56DE1239A057;867990D7-24CC-4A86-A294-79C35DFE9907	Not Available;Not Available;Not Available;Not Available	20;20;20;9	166;166;421;Not Available	55;55;55;229	Carboplatin;Docetaxel;Trastuzumab;tamoxifen citrate	Unknown;Unknown;Unknown;Not Applicable	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	54					TCGA-LL-A5YN-F59362	043E9E03-A7CA-4DA6-BFCA-0FC75F6A5750				9			Not Applicable	447																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	20	Not Available	172	3.2	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A5YN	Unknown	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	BLACK OR AFRICAN AMERICAN	NO	Primary Tumor Field	TCGA-LL-A5YN-R59326	8260F398-2067-486D-ABC6-787644B80D64	Not Available	9	224	194	Unknown	5	22	54.72	NO	External	Not Applicable	Not Available	Not Available	Gy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2013
TCGA-A2-A0EY	FEMALE	1925	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1925			TUMOR FREE				62	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A0EY	d67cd793-2931-429a-9084-2f3c4c8be7ad	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	21	-22872	Not Applicable	0	485	Not Available	Not Available	TCGA-A2-A0EY-D1887;TCGA-A2-A0EY-D1890;TCGA-A2-A0EY-D1891;TCGA-A2-A0EY-D1893;TCGA-A2-A0EY-D1892;TCGA-A2-A0EY-D1888	1c31f4fe-aaf3-45bb-85cc-ddc5a1ed81e9;4ffd1583-1089-4c1a-9c65-3b1413b8983c;e621dfac-f2ac-4604-a5fa-520f61070b6c;8da373c9-e16f-4a58-b3ff-6c294e12787c;c5f2e97a-c397-4193-a55d-c10d91996a6b;5da60b2a-4a81-450f-8a9a-f577b0f3dc83	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	22;22;22;22;22;22	154;245;Not Available;Not Available;Not Available;154	105;183;183;329;183;105	Adriamycin;Docetaxel;Lapatinib;Arimidex;Herceptin;Cytoxan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9	4;4;Not Available;Not Available;Not Available;4	104-105;129;1000 mg daily;1 mg daily;134.4-406;1038-1050	mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;4;6;5;2	IV;IV;PO;PO;IV;IV	NO;NO;YES;YES;YES;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Hormone Therapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	418;516;Not Available;Not Available;Not Available;4176	mg;mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	60-69%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0EY-F13716	B1FF94BC-9F0B-4998-9EF9-4163BAA4F01A				10		Not Available	Not Applicable	1925		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	7.0	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Positive	23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	0	No	A0EY	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field;Regional site	TCGA-A2-A0EY-R1886;TCGA-A2-A0EY-R70741;TCGA-A2-A0EY-R70742	5148e209-8e28-494c-899a-8125f2fc630a;D655C090-1E63-49A2-B223-763B535B3287;EBA1B640-7E29-4BCF-8368-04A1FBFF1329	1;Not Available;Not Available	22;3;3	316;328;316	279;317;279	Not Available;Complete Response;Complete Response	9;3;3	28;5;28	5040;1000;5040	NO;NO;NO	EXTERNAL BEAM;External;External	Not Applicable;Not Applicable;Not Applicable	ADJUVANT;Not Available;Not Available	Not Available;Not Available;Not Available	cGy;cGy;cGy	2010;2015;2015	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2009
TCGA-A2-A3XS	FEMALE	1032	Infiltrating Ductal Carcinoma	Breast	Dead	T1	N2a	M0	Stage IIIA	1	682.0	Lung	Distant Metastasis	WITH TUMOR				62	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A2-A3XS	A78B04B4-2380-4803-963E-E4E633CD69AB	Negative	Negative	Not Available	Not Available	Not Available	Mastectomy NOS	Negative	Lumpectomy	Not Applicable	YES	15	-23000	1032	0	Not Available	Not Available	YES	TCGA-A2-A3XS-D34447;TCGA-A2-A3XS-D34449;TCGA-A2-A3XS-D34450;TCGA-A2-A3XS-D34451;TCGA-A2-A3XS-D34452;TCGA-A2-A3XS-D34453;TCGA-A2-A3XS-D34454;TCGA-A2-A3XS-D34455	B3410728-5DD2-4C46-8F60-384AE7FD0DE0;57BE30DA-D982-441F-9385-4A8F49FD6C7F;C4D6719C-2751-4CCD-A188-EC01BB23E1B0;8FC4D02E-D7CA-465A-A5DF-A4C2323A2ACC;0E43D65F-FF3E-49BB-9DEA-8C8B0BF3AD17;F4FCCE3E-BB62-4A80-909D-A1DC2198705D;055A4779-B7FE-4F15-894F-81785BED5BE4;0221663A-3CAA-42B8-B315-073962FBD6FF	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15;15;15	154;154;210;682;806;958;980;1022	112;112;167;281;695;895;874;986	Cytoxan;Adriamycin;Paclitaxel;Tamoxifen;Docetaxel;Avastin;Xeloda;Navelbine	Complete Response;Complete Response;Complete Response;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease;Clinical Progressive Disease	8;8;8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Ancillary;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	NO		TCGA-A2-A3XS-F34446	5BBB886F-91E0-431D-A6DC-E1BB89E95022				15		Not Available	1032	Not Available		682				Additional New Tumor Event							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Lung	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.3	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	0	No	A3XS	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2a	T1	Not Available	NO	YES	A2	Breast	Not Applicable	Dead	2012	2003
TCGA-A7-A56D	FEMALE	448	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	448			TUMOR FREE				84	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A56D	F062CBD0-2426-40AC-A4BE-E74AC61FA2A7	Not Available	Positive	3 Point Scale	1+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	YES	1	-30783	Not Applicable	0	177	Not Available	Not Available	TCGA-A7-A56D-D41835	80BF0AFC-29C9-4B5B-A9E4-95F4B5A4EEDC	Not Available	1	Not Available	157	Arimidex	Not Applicable	4	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A7-A56D-F50426	EEF11DEE-7878-4235-9B8C-E0F6B2BCE27A				23			Not Applicable	448																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	No	A56D	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	<10%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2013	2012
TCGA-E9-A1RD	FEMALE	34	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	34			TUMOR FREE				67	Right Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A1RD	5fe3c51f-65e2-4da6-8924-a6fae17c022d	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Modified Radical Mastectomy	Not Applicable	NO	28	-24719	Not Applicable	0	20	Not Available	NO	TCGA-E9-A1RD-D30614	559CEE81-681B-42E0-B0FF-A060CD274BE5	Not Available	13	Not Available	13	Tamoxifen	Not Available	4	Not Available	20	mg/day	ADJUVANT	Not Applicable	Not Available	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E9-A1RD-F30612;TCGA-E9-A1RD-F48702	BD35F1B7-26FB-466A-A210-63C07140D93C;8873B70A-8C47-4F12-BC51-D40E6BEA4BEE				13;19		Not Available;None	Not Applicable;Not Applicable	34;Not Available		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;YES	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	4;9	Not Available;None	Not Available;None	Not Available;None	NO;None																																	None;Not Available	TUMOR FREE;Not Available			Not Available;None			YES;Not Available		NO;Not Available	Alive;Not Available	2012;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Evaluated	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	0	Not Available	No	A1RD	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2011	2011
TCGA-AR-A0TT	FEMALE	3316	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2	M0	Stage IIIA	0	3316			Not Available				53	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TT	13ca97a1-75bb-4a49-b8c3-181e5b2c9e86	Not Available	Positive	Not Available	0	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	8	-19679	Not Applicable	0	1730	Not Available	Not Available	TCGA-AR-A0TT-D19117;TCGA-AR-A0TT-D19124;TCGA-AR-A0TT-D19121;TCGA-AR-A0TT-D19112;TCGA-AR-A0TT-D19113	29A541D6-25FE-4E6E-9273-3A8AC33916A9;59EF98F0-0F7E-49BE-A00D-AE33AE3F59D1;70A14733-C2D0-4715-8FA2-FA9E1030DC2E;AC332E3C-15EC-4568-B022-BC18DD15AC5F;3F6361BB-149D-4D35-A1E0-7968FB1EC94A	Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15	147;Not Available;376;91;91	105;385;230;48;48	Paclitaxel;Tamoxifen;Anastrozole;Doxorubicin;Cytoxan	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	4;4;4;4;4	175;20;1;60;600	mg/m2;mg/day;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;3;2;1;1	IV;PO;PO;IV;IV	NO;YES;NO;NO;NO	Chemotherapy;Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1360;Not Available;Not Available;465;4680	mg;Not Available;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011	Not Available	10-19%	Not Available	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0TT-F18576;TCGA-AR-A0TT-F49517;TCGA-AR-A0TT-F71737	5291BA86-C47C-46B6-93B4-14BB7A3F40DB;2EA565CB-7360-4D0F-B645-52EC58950B49;F362532A-12F9-4FC6-99ED-E2AA217CB5C1				15;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1730;2636;3316		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	5	Not Available	No	A0TT	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Not Available	TCGA-AR-A0TT-R19573	A3F2C813-7858-4900-AEE3-694EBB16901F	1	15	211	Not Available	Not Available	12	Not Available	Not Available	NO	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N2	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-D8-A13Y	FEMALE	1728	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0	M0	Stage IA	0	1728			TUMOR FREE				52	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A13Y	17f275c1-a0d4-487d-8f02-ea279584b4cd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	23	-19028	Not Applicable	0	264	Not Available	Not Available	TCGA-D8-A13Y-D13807;TCGA-D8-A13Y-D65312	EC2B79A5-64D5-43E1-BB6A-A4C03BD0615E;5BE46DF7-F6A7-4D7D-9ECD-B805B4C94601	Not Available;Not Available	20;22	161;161	7;7	doxorubicin;cyclophosphamide	Not Available;Not Available	6;9	4;Not Available	60;Not Available	mg/m2;Not Available	ADJUVANT;Not Available	Not Applicable;Not Applicable	4x chemotherapy+hormonotherapy;Not Available	IV;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	60;Not Available	mg/m2;Not Available	Not Available;NO	2011;2014	manual counting	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-D8-A13Y-F13806;TCGA-D8-A13Y-F72210	1EB415B3-10F0-4A5A-9621-E7D90A9C3650;F83FC2BB-608A-4335-94F9-3607FE7D1296				20;29		Not Available;None	Not Applicable;Not Applicable	362;1728		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	6;4	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Hecep Test TM DAKO	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	2	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A13Y	TUMOR FREE	manual counting	Not Available	Not Available	10-75%	10-75%	Not Available	Not Available	70-79%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A24P	FEMALE	84	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	84			Not Available				47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24P	d1fd8ed2-be13-4272-b31e-df86911db3b1	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	16	-17490	Not Applicable	0	26	Not Available	Not Available																								Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-AR-A24P-F31403	FD010A17-3FAC-4DBB-BD62-A3A5C0361049				2		Not Available	Not Applicable	84		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	NO																																		Not Available			Not Available			Not Available		Not Available	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A24P	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-AO-A0J4	FEMALE	1587	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	1587			TUMOR FREE				41	Left Upper Outer Quadrant;Left	Sentinel node biopsy alone	Not Available	TCGA-AO-A0J4	a9b7d7fe-be31-4f71-afee-c1bfdf511888	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	19	-15052	Not Applicable	0	294	Not Available	Not Available	TCGA-AO-A0J4-D2749;TCGA-AO-A0J4-D2748;TCGA-AO-A0J4-D2750	60d39515-fbed-4588-80f8-0a3c0172f94e;e8d55b3d-7228-4fe0-b888-86ebfb98dc59;1a7870eb-a79b-421d-af13-fcf0d3654788	Not Available;Not Available;Not Available	19;19;19	175;175;203	131;131;189	Doxorubicin;Cyclophasphamide;Paclitaxel	Not Available;Not Available;Not Available	9;9;9	4;4;2	60;600;175	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	400;4000;580	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J4-F2742;TCGA-AO-A0J4-F15478	D22091C4-FC26-42F1-AF72-46DADE0922AC;303D8EF0-9002-4B68-8E12-C5C5C5119275	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	294;1587	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0J4	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	BLACK OR AFRICAN AMERICAN	Not Available	Primary Tumor Field	TCGA-AO-A0J4-R2747	a5875abd-4fb2-48ad-9f4e-56c021726547	1	19	294	265	Not Available	9	21	5240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009
TCGA-B6-A0WW	FEMALE	558	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1b	MX	Stage X	1	447.0	Liver	Distant Metastasis	WITH TUMOR				58	Right Upper Inner Quadrant;Right	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0WW	f02931f8-d72a-481d-b532-8b141dab115f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	14	-21479	558	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	NO		TCGA-B6-A0WW-F15734	8CBC2A93-DCB9-4AEF-9C63-54316907C361				29		Not Available	558	Not Available		447				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	8	Liver	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			NO		YES	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Not Evaluated	Not Evaluated	18	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	5	Not Available	No	A0WW	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage X	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	MX	N1b	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1997
TCGA-B6-A0IK	FEMALE	571	Infiltrating Ductal Carcinoma	Breast	Dead	T4	N1	M0	Stage IIIB	1	489.0	Brain	Distant Metastasis	WITH TUMOR				63	Left	Not Available	Not Available	TCGA-B6-A0IK	0491063c-14a7-4104-8002-1459126332f3	Negative	Negative	Not Available	Not Available	Not Available	Modified radical mastectomy	Negative	Lumpectomy	Not Applicable	NO	2	-23150	571	0	Not Available	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	YES	YES		TCGA-B6-A0IK-F12621	5C061F46-F69E-458A-A125-056C62D4E583				2		489	571	Not Available		489				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	6	Brain	Distant Metastasis	Not Available	YES																																		WITH TUMOR			Not Available			YES		NO	Dead	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Biopsy, NOS	Other method, specify:	Not Evaluated	Not Available	14	Positive	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																	Not Available	1	Not Available	No	A0IK	WITH TUMOR	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1	T4	Not Available	NO	YES	B6	Breast	Not Applicable	Dead	2010	1994
TCGA-A2-A3Y0	FEMALE	1546	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	1546			TUMOR FREE				57	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A3Y0	174850B4-5EC2-462B-A890-89BD1716B3C2	Not Available	Positive	3 Point Scale	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	24	-21024	Not Applicable	0	859	Not Available	Not Available	TCGA-A2-A3Y0-D34570;TCGA-A2-A3Y0-D34571;TCGA-A2-A3Y0-D34587;TCGA-A2-A3Y0-D34588;TCGA-A2-A3Y0-D34589;TCGA-A2-A3Y0-D34590	9F7B7F8B-718E-4740-93BC-324EE04D01E8;FBC64FA5-C743-40B6-9565-79BFB168FF4E;27FAEC54-F24D-438B-8005-1AA132B3092A;8E48C12C-49AB-4BAE-A24E-F9DA45AAA81F;8A141947-57F7-47C1-9301-538DC497884B;7CD22268-A875-4227-AB7F-E16930C56DDC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24	137;137;247;Not Available;Not Available;Not Available	74;74;165;Not Available;Not Available;Not Available	Adriamycin;Cytoxan;Docetaxel;Arimidex;Femara;Tamoxifen	Complete Response;Complete Response;Complete Response;Complete Response;Complete Response;Not Applicable	8;8;8;8;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3Y0-F43305;TCGA-A2-A3Y0-F59118	F0E5AA9E-2FA1-4CB2-A39C-EEFDECF50948;1EF24DD9-1163-4D9E-9C00-F0FD9BB65B89				16;1			Not Applicable;Not Applicable	1167;1546																				NO;NO																						5;5					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		NO;NO	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	39	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	0	No	A3Y0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2010
TCGA-E2-A14Z	FEMALE	563	Infiltrating Ductal Carcinoma	Breast	Dead	T1c	N0	M0	Stage I	1	188.0	Liver	Distant Metastasis	WITH TUMOR				64	Left Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A14Z	d7ce6b79-f7c0-481e-9dbd-6273f01c9786	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	NO	6	-23682	Not Applicable	0	518	Not Available	NO	TCGA-E2-A14Z-D18795;TCGA-E2-A14Z-D18799;TCGA-E2-A14Z-D18796	3094D6D4-29B2-4620-ADE6-E6C60168114A;8A897AD0-3F9D-48BA-84CA-B26404B7FFBE;0F2AF5BD-F63F-4EAD-B86B-7BE2BD25AA83	Not Available;Not Available;Not Available	7;7;7	188;266;266	110;196;196	Arimidex;Carboplatin;Taxol	Not Available;Not Available;Not Available	11;11;11	Not Available;Not Available;Not Available	1;Not Available;Not Available	mg;Not Available;Not Available	ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	1;2;2	PO;Not Available;Not Available	NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	78;Not Available;Not Available	mg;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 5+3 = 8	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO		TCGA-E2-A14Z-F18790;TCGA-E2-A14Z-F18792	C99B50BB-89E6-456F-B0E0-2F621948028C;38E35F76-597F-4510-8395-8A019391EE04				4;28		Not Available;Not Available	563;563	Not Available;Not Available		188;188				Scheduled Follow-up Submission;Scheduled Follow-up Submission							Not Available;Not Available			Not Available;Not Available					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	11;11	Bone;Liver	Distant Metastasis;Distant Metastasis	Not Available;Not Available	YES;YES																																		WITH TUMOR;WITH TUMOR			Not Available;Not Available			YES;YES		YES;YES	Dead;Dead	2011;2011	FEMALE	Not Available	Not Available	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14Z	WITH TUMOR	Allred score 5+3 = 8	Not Available	Not Available	Allred score = 8	Allred score = 8	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field;Distant Recurrence	TCGA-E2-A14Z-R18793;TCGA-E2-A14Z-R18794	D536C4BC-3D79-490D-9A5B-503072DE0821;75F82406-C52F-4EF9-867B-6D2BA36FEEBF	1;2	7;7	110;359	64;236	Not Available;Not Available	11;11	33;Not Available	6040;5500	NO;NO	EXTERNAL BEAM;IMPLANTS	Not Applicable;Not Applicable	ADJUVANT;PALLIATIVE	Not Available;Not Available	cGy;cGy	2011;2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-A7-A0DC	FEMALE	906	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage IA	0	906			TUMOR FREE				63	Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A7-A0DC	cb9f5e50-f49d-4899-8895-9367afcc1015	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	4	-23294	Not Applicable	0	273	Not Available	Not Available	TCGA-A7-A0DC-D3189;TCGA-A7-A0DC-D3191;TCGA-A7-A0DC-D3187;TCGA-A7-A0DC-D3192;TCGA-A7-A0DC-D19973;TCGA-A7-A0DC-D34625	ca0fef41-cd39-4497-b295-38a48b89774c;cd2fd85e-9fad-473c-b1f1-47ec2596186b;9d5ba4cc-c114-4c1d-a59b-c3a11120136a;cbcf5f6d-0308-484f-bc64-044efa3d5e86;8404643D-1E6E-44D8-A955-3B398A0A05AF;0E08C9C8-C699-416C-AE02-F59B9358B98C	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;5;24	231;231;231;Not Available;509;Not Available	77;77;77;264;264;510	Methotrexate;Fluorouracil;Cyclophosphamide;Arimidex;Arimidex;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Unknown	11;11;11;11;1;8	8;8;8;Not Available;245;Not Available	69-71;1032-1062;1032-1062;1;1;Not Available	mg;mg;mg;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1;Not Available	IV;IV;IV;PO;PO;Not Available	NO;NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	558;8346;8346;170;245;Not Available	mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;NO	2010;2010;2010;2010;2012;2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0DC-F3193;TCGA-A7-A0DC-F40607	494F497F-FF25-4604-AC1E-12282CA0AC7E;7D70ECB9-709E-4531-B63D-60B752AA7D2A	Not Available;None	Not Available;None	Not Available;None	9;25	Not Available;None	Not Available;None	Not Applicable;Not Applicable	386;906	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;2					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;Unknown	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A0DC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-A7-A0DC-R3194	9939e1ca-953b-4e0a-a861-225fee9920c8	1	9	351	309	Not Available	11	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2009
TCGA-AR-A24V	FEMALE	3203	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	3203			Not Available				52	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A24V	3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	YES	29	-19027	Not Applicable	0	1648	Not Available	Not Available	TCGA-AR-A24V-D31619;TCGA-AR-A24V-D31620;TCGA-AR-A24V-D31622;TCGA-AR-A24V-D31623;TCGA-AR-A24V-D31624;TCGA-AR-A24V-D31625	ECA738C2-9571-4A0C-A17D-D3A9713FC600;076FC6CD-C7E1-47EF-A4D3-A1C9A5B32DB3;C613A54C-32DC-42A4-93AF-B9A4921BBF5D;A9AD5C02-19DC-42F0-B096-8FA618C4F7D3;22B76231-6512-4D60-8D8E-3E9413F870FA;B34AEFC3-E29F-4CBD-B443-2FEE1DB17665	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;21	95;95;151;178;1027;Not Available	53;53;109;109;193;1027	Doxorubicin;Cytoxan;Paclitaxel;Bevacizumab;Tamoxifen;Anastrozole	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	2012;2012;2012;2012;2012;2012	Not Available	80-89%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A24V-F31614;TCGA-AR-A24V-F49479;TCGA-AR-A24V-F71740	C1FEBD32-0A27-497D-A3F5-150E6557CF31;5C983853-8BE4-4FDF-8D26-55D45483BB03;5447AFA3-8009-4D99-80F1-BD69E437431F				7;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	1648;2596;3203		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	5;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2012;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	1	Not Available	No	A24V	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Not Available	TCGA-AR-A24V-R31617	38CC31C7-2363-4444-953E-DDAAFB7098AA	1	7	248	200	Not Available	5	33	6600	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-B6-A0X1	FEMALE	7455	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N1	M1		1	490.0	Brain	Distant Metastasis	TUMOR FREE				48	Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0X1	178b2c48-c07d-422e-ae17-8bcfd996ad51	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	NO	14	-17624	Not Applicable	0	5677	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;None	YES;None	NO;None		TCGA-B6-A0X1-F15717;TCGA-B6-A0X1-F71498	B60E0EDC-7C1B-48E9-AEA3-2D6C0B1A99DB;B774767E-92CC-4BD1-A7EE-6615FE09C623				29;26		Not Available;None	Not Applicable;7455	5677;Not Available		490;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Evaluated;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Evaluated;None	Not Evaluated;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Evaluated;None	8;3	Brain;None	Distant Metastasis;None	Not Available;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;NO		NO;NO	Alive;Dead	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	21	Negative	Indeterminate (neither Pre or Postmenopausal)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	12	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	16	Not Available	No	A0X1	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Discrepancy	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M1	N1	T2	Fine needle aspiration biopsy	NO	YES	B6	Breast	Not Applicable	Alive	2010	1994
TCGA-D8-A1XK	FEMALE	441	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	441			TUMOR FREE				55	Left Lower Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XK	97943d87-fed7-4f14-a0a7-c5bfee64c392	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	9	-20092	Not Applicable	0	326	Not Available	NO	TCGA-D8-A1XK-D30075;TCGA-D8-A1XK-D30076	A849F857-16FA-41BF-8358-A98B7681F21B;25913AF2-0E2D-4199-A59A-8CB451696BDF	Not Available;Not Available	4;2	233;128	149;65	paclitaxelum;doxorubicine+cyclophosphamide	Not Available;Not Available	2;4	12;4	80;97.2+972	mg/m2/day;mg/day	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1560;388.8+3888	mg;mg	Not Available;Not Available	2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XK-F30074	6E9797E4-9661-4BDD-9F1E-1EC2D1DB381B				4		Not Available	Not Applicable	441		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	3	Not Available	No	A1XK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XK-R30073	4AF40BF7-8C93-4618-8EA8-7F5FAAC782D9	Not Available	2	281	253	Not Available	4	45	9000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AO-A0J8	FEMALE	680	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0 (i+)	M0	Stage IIA	0	680			TUMOR FREE				61	Right Upper Outer Quadrant;Right	Sentinel node biopsy alone	Not Available	TCGA-AO-A0J8	02bf5203-f9cd-4c5a-97b4-e5584dc22325	Not Available	Positive	Not Available	3+	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	19	-22284	Not Applicable	0	277	Not Available	Not Available	TCGA-AO-A0J8-D3137;TCGA-AO-A0J8-D3138;TCGA-AO-A0J8-D3136;TCGA-AO-A0J8-D3131	7b8d5881-41d9-4c7b-ad68-60ae52734e66;9b5ca20e-c9f2-4b98-be3a-d7ddacbf8329;082d6734-1bb5-4efc-90a5-d63188cb7651;101e4937-20c7-461a-a4ce-a2e0b03c5f2d	Not Available;Not Available;Not Available;Not Available	6;19;19;19	224;Not Available;224;224	63;277;63;63	CYCLOPHOSPHAMIDE;ANASTROZOLE (ARIMIDEX);METHOTREXATE;Fluorouracil	Not Available;Not Available;Not Available;Not Available	9;9;9;9	8;Not Available;8;8	600;1;40;600	mg/m2;mg/day;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;2;1;1	IV;PO;IV;IV	NO;YES;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	8800;Not Available;560;8800	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A0J8-F3127;TCGA-AO-A0J8-F15482	BF41498F-03CE-41C2-86E8-B2A26D89DA67;7F5BA75D-9EB6-4BD5-AC2E-101D65FBEB78	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	277;680	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	9;8	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	3+ POSITIVE	<10%	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	1	No	A0J8	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AO-A0J8-R3129	7699227a-2529-4bd0-bb64-08d7ffbe4aad	1	19	281	252	Not Available	9	21	5240	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i+)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2009
TCGA-AC-A2BM	FEMALE	3022	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	MX	Stage IIB	0	3022			TUMOR FREE				41	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AC-A2BM	8159FF7B-89F4-411A-9B9C-491F1CB3EB34	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	12	-15212	Not Applicable	0	1162	Not Available	NO																								Not Available	60-69%	Not Available	Not Available	Not Available	Not Available					TCGA-AC-A2BM-F66202	DD44274C-674F-4906-827E-1411F9F99094				3			Not Applicable	3022																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Not Evaluated	Negative	13	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	1	1	No	A2BM	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	10-19%	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N1a	T2	Not Available	NO	YES	AC	Breast	Not Applicable	Alive	2011	2005
TCGA-AO-A0J9	FEMALE	1613	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	1	1066.0	Bone	Distant Metastasis	WITH TUMOR				61	Right Upper Inner Quadrant;Right Upper Outer Quadrant;Right	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A0J9	a4903de8-6cf5-4541-8ec7-065beace8b44	Negative	Positive	Not Available	4+	Not Available	Mastectomy NOS	Positive	Lumpectomy	Not Applicable	NO	19	-22642	Not Applicable	0	1256	Not Available	Not Available	TCGA-AO-A0J9-D3160;TCGA-AO-A0J9-D3155;TCGA-AO-A0J9-D3161;TCGA-AO-A0J9-D3162;TCGA-AO-A0J9-D3158;TCGA-AO-A0J9-D3164;TCGA-AO-A0J9-D3163;TCGA-AO-A0J9-D3165	45f1bb9c-2863-49b6-a2ab-f5bc422f0bd4;01d99b67-790d-4c94-82b8-faedb014d4e7;52a37453-0a2a-41e6-a1e6-b5d5bc0d512c;9943c67b-c3e6-4829-8c90-a843eae50524;e90c4e19-b755-47c9-9d5e-41881194b7ed;d1156805-edbe-42f7-9472-b3e1a3039370;faf150fa-8213-4fec-96fb-069b05d3cb0d;a55ae465-7d58-4b39-9163-396c9a4dbf15	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;19;19;19;19	141;128;204;1023;128;Not Available;1207;Not Available	141;85;161;239;85;1072;1072;1207	PACLITAXEL;CYCLOPHOSPHAMIDE;DOCETAXEL;ARIMIDEX (ANASTROZOLE);DOXORUBICIN;ZOLEDRONIC ACID;AROMASIN (EXEMESTANE);TAMOXIFEN	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9;9	1;4;3;Not Available;4;4;Not Available;Not Available	175;600;100;1;60;4;25;20	mg/m2;mg/m2;mg/m2;mg/day;mg/m2;mg;mg/day;mg/day	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;2;1;2;1;1	IV;IV;IV;PO;IV;IV;PO;PO	NO;NO;NO;NO;NO;YES;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Other, specify in notes;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;BISPHOSPHONATE;Not Available;Not Available	370;5040;630;Not Available;500;16;Not Available;Not Available	mg;mg;mg;Not Available;mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	127	YES;YES	NO;NO	YES;YES	Not Available;None	TCGA-AO-A0J9-F3151;TCGA-AO-A0J9-F15483	B970A0F3-C779-45C1-A655-7FEC777638DA;FC513014-FCB4-4F42-89F0-37A2DB946EE9	Not Available;None	Not Available;None	Not Available;None	19;22	Not Available;None	1066;1066	Not Applicable;Not Applicable	1256;1613	Not Available;None	1066;1066	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Evaluated;None		1+;1+	Not Available;Not Available	90-99%;90-99%	Positive;Positive	Not Available;Not Available	3+ POSITIVE;Not Available	<10%;Not Available	Not Available;Not Available	Not Available;Not Available	4+;Not Available	None;4 Point Scale	1+;Not Available	None;4 Point Scale	Negative;Negative	Not Evaluated;Not Available	Not Available;3 Point Scale	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	10-19%;10-19%	Positive;Positive	9;8	None;Bone	None;Distant Metastasis	None;Not Available	None;YES																																		WITH TUMOR;WITH TUMOR	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	YES;YES	Alive;Alive	2010;2011	FEMALE	Not Available	Not Available	Not Available	RATIO >EQUAL 2.0	Not Available	33	Not Available	149	1.2	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	4+	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	32	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	15	0	No	A0J9	WITH TUMOR	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	30-39%	WHITE	Not Available	Regional site	TCGA-AO-A0J9-R3154	5e4bd8f8-0619-48a2-812d-c6f0626c1e60	1	19	263	226	Not Available	9	28	11117	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2007
TCGA-AO-A124	FEMALE	3506	Other, specify	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	3506			TUMOR FREE				38	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AO-A124	b094e8b2-8ece-4b36-8025-18073a8b873c	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	YES	7	-14174	Not Applicable	0	3120	Not Available	Not Available	TCGA-AO-A124-D5932;TCGA-AO-A124-D5934;TCGA-AO-A124-D5933	7bd8d7d3-3c72-4d00-9efb-7b5cc816aae9;02906cd5-712c-423b-8684-6830cf1a7c7e;c107f6da-b6fa-47ff-b3a3-d6edac66e0f4	Not Available;Not Available;Not Available	10;10;10	126;238;126	60;147;60	Doxorubicin;Paclitaxel;Cyclophosphamide	Not Available;Not Available;Not Available	1;1;1	4;5;4	60;175;600	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	424;1600;4240	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;None	TCGA-AO-A124-F5872;TCGA-AO-A124-F19395	F53CE454-A59B-4F2B-A928-96D5BEEDECDC;4C248C62-B6C3-4222-AA49-AF4679BD9264	Not Available;None	Not Available;None	Not Available;None	7;12	Not Available;None	Not Available;Not Available	Not Applicable;Not Applicable	3120;3506	Not Available;None	Not Available;Not Applicable	Not Available;None	Not Available;None	Not Available;None	None;Scheduled Follow-up Submission	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	Not Available;None		Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	None;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	None;Not Available	None;Not Available	None;Not Available	None;NO																																		TUMOR FREE;Not Available	Not Available;None	Not Available;None	Not Available;Not Available	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2011	FEMALE	Not Available	3+ Positive	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	mucinous & Ductal	No	C50.9	8523/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A124	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	NO	YES	AO	Breast	Not Applicable	Alive	2010	2002
TCGA-A7-A0D9	FEMALE	1139	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	1139			TUMOR FREE				37	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-A7-A0D9	17baef7c-d97d-4b98-ab53-503ef856523d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	4	-13836	Not Applicable	0	160	Not Available	Not Available	TCGA-A7-A0D9-D2912;TCGA-A7-A0D9-D2916;TCGA-A7-A0D9-D2907	2a6eeaea-d6cf-4c0b-a97f-8dd3dd922972;57f1f05f-cb78-4305-9469-fe76399db912;80d0a61f-a26b-46d4-91b4-5028df32c9cb	Not Available;Not Available;Not Available	4;4;4	125;Not Available;125	62;157;62	Taxotere;Tamoxifen;Cytoxan	Not Available;Not Available;Not Available	11;11;11	4;Not Available;4	140;20;1080	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	560;4140;4320	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None	Not Available;None	TCGA-A7-A0D9-F2920;TCGA-A7-A0D9-F39771	CC7279B1-E6EC-4C7C-B5D3-1FB6ABFAA9BC;5570A0D0-8B4A-4607-B2AF-33D1B4A7EAF9	Not Available;None	Not Available;None	Not Available;None	4;1	Not Available;None	Not Available;None	Not Applicable;Not Applicable	273;1139	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None		Not Available;None		Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;2					None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	YES;YES	Not Available;None	NO;NO	Alive;Alive	2010;2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10																																	Not Available	0	0	No	A0D9	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Not Available	YES	NO	A7	Breast	Not Applicable	Alive	2010	2009
TCGA-AR-A1AP	FEMALE	2856	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0	M0	Stage I	0	2856			TUMOR FREE				80	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AP	9495f029-9882-4c9b-a557-b3aec9e91698	Negative	Positive	Not Available	Not Available	Not Available	Mastectomy NOS	Positive	Other	Not Applicable	YES	13	-29406	Not Applicable	0	1216	Not Available	Not Available	TCGA-AR-A1AP-D21795	89F5BA7B-C2F4-41AC-84D2-4EC2FC5D6F02	Not Available	27	Not Available	29	Anastrozole	Not Available	2	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2012	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AP-F21792;TCGA-AR-A1AP-F69275	32110B06-10DD-4AF4-B907-6C6F3A6F6F90;7F6FFB16-466B-42BB-BFB6-05059B1C63F7				27;31		Not Available;None	Not Applicable;Not Applicable	1216;2856		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;12	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AP	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-LL-A442	FEMALE	889	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	MX	Stage IIA	0	889			TUMOR FREE				56	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-LL-A442	3F56D67F-5A9C-4353-9408-E7F60EB6477B	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Simple Mastectomy	Not Applicable	YES	26	-20495	Not Applicable	0	109	Not Available	Not Available	TCGA-LL-A442-D36069	E1D4E54E-9B75-48FF-AF1C-506222B5E941	Not Available	17	Not Available	111	Arimidex	Not Applicable	10	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2012	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	35					TCGA-LL-A442-F46384	AB2B5DCA-684E-49C8-8594-0A66AD27B2F5				7			Not Applicable	889																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	20	Not Available	60	1.7	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	10	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	A442	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2012	2012
TCGA-BH-A0H5	FEMALE	1620	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	1620			TUMOR FREE				45	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A0H5	cab38ea8-4555-413c-b81e-4621aac4ef85	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	12	-16719	Not Applicable	0	1080	Not Available	NO	TCGA-BH-A0H5-D58731;TCGA-BH-A0H5-D58732	AE71C06F-4D9D-4EE7-B6D1-14FF06F8C6E8;C099D047-9A31-4CB6-8F0B-FEAF89B6F351	Not Available;Not Available	22;22	Not Available;Not Available	174;174	Cytoxan;Taxotere	Complete Response;Complete Response	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0H5-F58727	6C579D1F-0A86-4BC6-9C10-E56A23CDE9FB				22			Not Applicable	1620																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Available	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	Not Available	No	A0H5	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Right total mastectomy with lymph node left axillary lymph node excision	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-A2-A0CO	FEMALE	1468	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	1468			TUMOR FREE				85	Right	Axillary lymph node dissection alone	Not Available	TCGA-A2-A0CO	8E54232D-D8BB-4612-8B0E-4FEB076A60F9	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	21	-31404	Not Applicable	0	1468	Not Available	NO	TCGA-A2-A0CO-D33663;TCGA-A2-A0CO-D33664	80B1C97B-8D60-43C3-BDCE-AC0B58A11419;68699598-6953-48BB-BD8B-76AC54625819	Not Available;Not Available	12;12	512;Not Available	84;513	Tamoxifen;Arimidex	Complete Response;Unknown	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;Not Available	Hormone Therapy;Hormone Therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2012;2012	Not Available	40-49%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A0CO-F42395	D9046E4C-FEFF-41E2-BE64-6931E4173BA9				18			1468	Not Available																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	2+	YES	Not Applicable	Core needle biopsy	Negative	Negative	11	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	0	0	No	A0CO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	20-29%	WHITE	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-A2-A0CO-R33659;TCGA-A2-A0CO-R33660	D2343CBD-DC2B-49BF-89D6-6D505002D4D2;8FD8C301-7FE0-4D3A-923B-6A5A1911E753	Not Available;Not Available	12;12	127;134	93;128	Complete Response;Complete Response	7;7	Not Available;Not Available	5000;1000	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2012;2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2012	2002
TCGA-E2-A153	FEMALE	707	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	707			TUMOR FREE				51	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A153	be9bf36a-12e1-4386-addf-1686dc8b49de	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	7	-18875	Not Applicable	0	586	Not Available	NO	TCGA-E2-A153-D18954;TCGA-E2-A153-D18950;TCGA-E2-A153-D18948;TCGA-E2-A153-D18947	229BE9CD-B3B4-4B15-AA20-DFF1B19DF725;DC77A2E0-D67A-46FB-8F56-EE1F16089F98;057F6C50-9E43-4775-9A1A-00A06EB7F9B4;F3D8922B-7D20-47D4-9ECC-806723EFCE76	Not Available;Not Available;Not Available;Not Available	8;8;8;8	Not Available;196;98;98	229;112;42;42	tamoxifen;paclitaxel;doxorubicin;cyclophosphamide	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;9;4;4	20;200;120;1500	mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;2;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;1722;480;5700	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A153-F18945	3D500678-49CD-4335-9A43-AC504DE9E2B6				8		Not Available	Not Applicable	707		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	3	Not Available	No	A153	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A153-R18955	09529206-8504-42D1-A155-E1C6D5539359	1	8	294	237	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-E9-A3X8	FEMALE	926	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	926			TUMOR FREE				48	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A3X8	95873E61-AFDB-496C-9F77-3F9BEB008CDA	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	24	-17588	Not Applicable	0	23	Not Available	NO	TCGA-E9-A3X8-D41706;TCGA-E9-A3X8-D41708;TCGA-E9-A3X8-D41709;TCGA-E9-A3X8-D41710	2813ED05-F03A-4919-B4DE-12415797A897;D74CCEFE-BE26-4C75-A3ED-DE683060F21F;B42520B3-C869-4100-A31A-852F9255A6A2;05473A78-6AD8-4AFA-A02B-61BFE72F46D4	Not Available;Not Available;Not Available;Not Available	26;26;26;26	160;160;160;Not Available	14;14;14;324	Cyclophosphane;Doxorubicin;5-Fluorouracil;Tamoxifen	Complete Response;Complete Response;Complete Response;Not Applicable	3;3;3;3	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2013;2013;2013;2013	Not Available	20-29%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A3X8-F41704;TCGA-E9-A3X8-F59742	08EF0574-225F-4327-8F2D-B72B71073D9F;21FB9BF8-1169-4200-8092-32FBE1250BC1				26;20			Not Applicable;Not Applicable	478;926																				NO;NO																						3;5					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2013;2014	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Positive	Not Evaluated	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	4	0	No	A3X8	TUMOR FREE	Not Available	Not Available	Not Available	8	8	Not Available	YES	20-29%	WHITE	Not Available	Regional site	TCGA-E9-A3X8-R41711	EB81185F-05C4-4CD7-8DC8-9719C98B2E79	Not Available	26	78	52	Complete Response	3	16	40	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2012	2011
TCGA-D8-A140	FEMALE	403	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	403			Not Available				62	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-D8-A140	2585edbd-3488-4100-a4ab-a161252a31ee	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	26	-22900	Not Applicable	0	27	Not Available	Not Available	TCGA-D8-A140-D13809	CD6D1C59-F2A8-4AC6-9E8B-74835E6187BD	Not Available	20	181	27	doxorubicin+cyclophosphamid	Not Available	6	4	60 doxorubicin+ 600 CPH	Not Available	ADJUVANT	Not Applicable	4x chemotherapy	IV	NO	Chemotherapy	Not Available	60 doxorubicin+ 600 CPH	mg/m2	Not Available	2011	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A140-F13808	39F74CEF-2C48-4800-B82A-92DCBA81257C				20		Not Available	Not Applicable	403		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Hercep Test TM DAKO	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	1	Not Available	No	A140	Not Available	manual counting	Not Available	Not Available	<10%	>75%	Not Available	YES	<10%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AN-A046	FEMALE	10	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	10			TUMOR FREE				68	Right Lower Inner Quadrant	No axillary staging	Not Available	TCGA-AN-A046	dcd5860c-7e3a-44f3-a732-fe92fe3fe300	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	28	-25158	Not Applicable	0	10	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AN-A046-F68972	F3D0B69A-E347-4523-9C79-5A50FAE60BB6				24			Not Applicable	10																				NO																						12					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	0	0	No	A046	TUMOR FREE	Not Available	0	Not Available	108	205	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AN	Breast	Not Applicable	Alive	2010	2010
TCGA-E9-A5FL	FEMALE	24	Metaplastic Carcinoma	Breast	Alive	T3	N0	M0	Stage IIB	0	24			TUMOR FREE				65	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-E9-A5FL	E3935CE4-64D3-4A66-BA11-D308B844B410	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	22	-24053	Not Applicable	0	8	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E9-A5FL-F56061	20890005-DE58-433A-9DDF-39C1F4A0FDDF				24			Not Applicable	24																				YES																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						NO		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Metaplastic Carcinoma	Not Applicable	No	C50.9	8575/3	C50.9	Not Available	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	A5FL	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	Not Available	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T3	Not Available	YES	NO	E9	Breast	Not Applicable	Alive	2013	2012
TCGA-C8-A132	FEMALE	383	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	383			TUMOR FREE				56	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A132	89e867de-d30e-4bfc-a453-0a76309dabd5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	15	-20471	Not Applicable	0	13	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A132-F19090;TCGA-C8-A132-F70826	704DF98E-8B9C-4FE9-9D66-0F0709FE6144;9BDF73D9-8363-4F50-92EC-41537B282632				2;9		Not Available;None	Not Applicable;Not Applicable	57;383		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;Discrepancy		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	1	Not Available	No	A132	TUMOR FREE	Not Available	Not Available	Not Available	Allred Score 7	Allred Score 8	Not Available	YES	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Modified Radical Masectomy	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A0TP	FEMALE	4275	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	4275			Not Available				43	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A0TP	ab89bb2e-da84-4116-a8cd-49aad7bbfd4d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	YES	25	-15812	Not Applicable	0	2521	Not Available	Not Available	TCGA-AR-A0TP-D19026;TCGA-AR-A0TP-D19030	04948347-26AC-49B0-9E46-0812A85833EB;D1474BAA-9E44-4519-AAA2-B81A0B0F2E2D	Not Available;Not Available	12;12	97;97	32;32	Doxorubicin;Cytoxan	Not Available;Not Available	12;12	4;4	60;600	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	1;1	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	555;5510	mg;mg	Not Available;Not Available	2011;2011	Not Available	<10%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0TP-F17840;TCGA-AR-A0TP-F49514;TCGA-AR-A0TP-F71715	AEDD706C-7E02-4D35-9D8D-F14B61685DC5;DF520576-B6A2-4289-AA4C-EB29F269B2D6;557AE19D-DF36-4F96-AC06-278AFCD2B451				12;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	2521;3386;4275		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	Not Available;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2																																	Not Available	0	0	No	A0TP	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A0TP-R18481	B4DEB351-1554-4E4E-90E0-E4F24497D2B3	1	12	166	125	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Wide local excision	NO	YES	AR	Breast	Not Applicable	Alive	2011	2003
TCGA-E2-A3DX	FEMALE	1325	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3	M0	Stage IIIC	0	1325			TUMOR FREE				43	Right	Axillary lymph node dissection alone	Not Available	TCGA-E2-A3DX	31427699-E27A-4035-8925-6D8D6900D097	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Positive	Modified Radical Mastectomy	Not Applicable	NO	17	-15969	Not Applicable	0	217	Not Available	NO	TCGA-E2-A3DX-D35823;TCGA-E2-A3DX-D35825;TCGA-E2-A3DX-D35826;TCGA-E2-A3DX-D35827;TCGA-E2-A3DX-D35828	FB2F6144-201F-4111-AEB2-123019146F45;7F0FA9CD-0E62-4C40-8FD4-10D3CC42DF92;3D6D5170-8502-4FC1-8187-1BFE6364B6EA;82FCFACE-DFFB-46A2-B4AB-EEB1D20CF49C;53169165-315E-485D-A2BE-FAA021F7BBC2	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	105;105;196;427;Not Available	63;63;119;119;280	Doxorubicin;Cyclophosphamide;Paclitaxel;Trastuzumab;Tamoxifen	Unknown;Unknown;Unknown;Complete Response;Not Applicable	10;10;10;10;10	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO	2012;2012;2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-E2-A3DX-F35822;TCGA-E2-A3DX-F70017	664B0755-6D22-478B-8659-88B17E648B78;0009B079-7981-4E93-BEDA-673A97FF1137				9;9			Not Applicable;Not Applicable	478;1325																				NO;NO																						10;2					Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	TUMOR FREE;TUMOR FREE						YES;YES		YES;YES	Alive;Alive	2012;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7.1	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Positive	36	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1																																	Not Available	25	Not Available	No	A3DX	TUMOR FREE	Not Available	Not Available	Not Available	Allred score = 8	Allred score = 7	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A3DX-R35829	012E4A45-96F2-4842-A729-363AC3BDF8E8	Not Available	9	262	218	Complete Response	10	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2012	2011
TCGA-GM-A2DK	FEMALE	2645	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N0 (i-)	M0	Stage I	0	2645			TUMOR FREE				58	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-GM-A2DK	3A0775A0-61AE-43F2-B5F6-629A44355C2F	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Lumpectomy	Not Applicable	YES	29	-21198	Not Applicable	0	1896	Not Available	NO	TCGA-GM-A2DK-D47097	F92A5EEC-9F0D-4B49-8D7C-15E038B017EA	Not Available	22	1893	79	Arimidex	Complete Response	8	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-GM-A2DK-F47094	1C4E8267-609B-4503-AFC4-77F7B38531A0				22			Not Applicable	2645																				NO																						8					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A2DK	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	<10%	WHITE	Not Available	Primary Tumor Field	TCGA-GM-A2DK-R47095	0F34A3E2-169D-4D79-B883-9E14DADAF2DD	Not Available	22	135	93	Complete Response	8	30	60	NO	External	Not Applicable	Not Available	Not Available	Gy	2013	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1c	Not Available	NO	YES	GM	Breast	Not Applicable	Alive	2011	2005
TCGA-S3-AA10	FEMALE	586	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	586			TUMOR FREE				65	Right;Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-S3-AA10	23C31C2E-336C-4878-A476-CF8D811B4875	Not Available	Negative	3 Point Scale	Not Available	3 Point Scale	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	18	-24075	Not Applicable	0	241	Not Available	Not Available	TCGA-S3-AA10-D58351;TCGA-S3-AA10-D58352;TCGA-S3-AA10-D58354;TCGA-S3-AA10-D67781	765A1845-816A-48C0-B600-D8D63C2E7DE9;A162E470-A31A-43EF-B7CC-48C25D10E121;DFEAFB3D-F85C-4E98-96CE-3BB8DAE7C12E;DA1D7D41-7834-410C-959E-8D9D35DD679C	Not Available;Not Available;Not Available;Not Available	18;18;18;11	199;199;199;Not Available	75;75;75;265	CYTOXAN;TAXOTERE;NEULASTA;ANASTROZOLE	Complete Response;Complete Response;Complete Response;Not Applicable	4;4;4;11	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES	Chemotherapy;Chemotherapy;Ancillary;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	2014;2014;2014;2014	CAP scoring guideline 2010	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-S3-AA10-F67528;TCGA-S3-AA10-F70351;TCGA-S3-AA10-F70441	B1B67534-2F82-46FC-896D-E6CFB68E03A2;4F48B8A5-A0CB-4E1C-8ADA-12F1C6814B66;D3E73401-5961-4C83-8C9D-2E93151A962C				11;26;26			Not Applicable;Not Applicable;Not Applicable	468;523;586																				NO;NO;NO																						11;2;2					Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE						YES;YES;YES		NO;NO;NO	Alive;Alive;Alive	2014;2015;2015	FEMALE	Not Available	CAP scoring guideline 2010	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	AA10	TUMOR FREE	CAP scoring guideline 2010	Not Available	Not Available	Not Available	Not Available	YES	YES	Not Available	BLACK OR AFRICAN AMERICAN	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	S3	Breast	Not Applicable	Alive	2014	2013
TCGA-LL-A50Y	FEMALE	762	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N0	MX	Stage IIA	0	762			TUMOR FREE				84	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-LL-A50Y	91DA548B-5C64-49C3-A44A-1EF115F53311	Not Available	Positive	3 Point Scale	2+	3 Point Scale	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	8	-30934	Not Applicable	0	210	Not Available	Not Available	TCGA-LL-A50Y-D40968	AAE548CC-C906-4B50-9987-4BEAC371569C	Not Available	8	608	54	ARIMIDEX	Complete Response	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	Not Available	Not Available	NO	2013	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.5					TCGA-LL-A50Y-F50406	1D4C9AE4-C224-413E-8A94-874FE75F06CF				23			Not Applicable	762																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	167	Not Available	2.6	1.0	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Negative	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	0	Yes	A50Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	NO																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0	T2	Not Available	YES	NO	LL	Breast	Not Applicable	Alive	2013	2012
TCGA-OL-A5D8	FEMALE	973	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N0	MX	Stage IIB	0	973			TUMOR FREE				40	Left Lower Outer Quadrant	Other (specify)	axillary ultrasound	TCGA-OL-A5D8	6D4860B2-21C6-4B7B-9093-2F32700D0612	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	19	-14853	Not Applicable	0	229	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	2.25					TCGA-OL-A5D8-F55438	85CD1C5F-D1D1-4A4D-B071-233563FA3D44				10			Not Applicable	973																				NO																						1					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	20	Not Available	2	0.8	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	2	Unknown	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	Not Available	Not Available	No	A5D8	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	BLACK OR AFRICAN AMERICAN	YES																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	MX	N0	T3	Not Available	NO	YES	OL	Breast	Not Applicable	Alive	2013	2009
TCGA-BH-A0C0	FEMALE	1270	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	1270			TUMOR FREE				62	Left Upper Outer Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-BH-A0C0	7875018b-91dc-4ab1-83b0-ee3883e2816e	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	8	-23006	Not Applicable	0	1270	Not Available	Not Available	TCGA-BH-A0C0-D4514;TCGA-BH-A0C0-D4515;TCGA-BH-A0C0-D4516	7E66711C-BC10-4345-92B8-220DF4EE8F19;A22F23D5-AC34-48AE-85C2-6EE1B5E65A0C;D15BAC27-4BE3-4929-8B32-41DCA93AC97F	Not Available;Not Available;Not Available	16;16;16	Not Available;162;162	158;57;57	ARIMIDEX;CARBOPLATIN;DOCETAXEL	Not Available;Not Available;Not Available	11;11;11	Not Available;6;6	1;620;116	mg/day;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	PO;IV;IV	YES;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;3740;710	Not Available;mg/day;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	90-99%	Not Available	Not Available	Not Available	2.65	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0C0-F4518	C4A30038-2C06-4BBC-B071-677AEB2DD359	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	1270	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	40	Not Available	12.45	4.7	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available	No	A0C0	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	60-69%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0C0-R4517	E34524B4-285D-4250-BFF1-FC7F8FB4999D	1	16	249	204	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	Segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2007
TCGA-BH-A18F	FEMALE	1001	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	1001			TUMOR FREE				50	Right Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-BH-A18F	bfd49783-1767-469b-9d79-7822301c5efc	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Other	Not Applicable	Not Available	1	-18594	Not Applicable	0	268	Not Available	Not Available	TCGA-BH-A18F-D59196;TCGA-BH-A18F-D59197	9FCC797A-A7A9-48C4-8908-C2C04931C24A;60625A51-8E18-4F71-B2D7-27A2C7FB9C2C	Not Available;Not Available	2;2	189;189	101;101	Taxotere;Cytoxan	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A18F-F59193	092E4639-8456-481D-8DF3-0C60E99CDCB5				2			Not Applicable	1001																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Available	1	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A18F	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	40-49%	WHITE	Not Available	Primary Tumor Field;Regional site	TCGA-BH-A18F-R59194;TCGA-BH-A18F-R59195	489DC839-6E29-4F08-9016-7E127CE41069;808DBF60-68C3-472B-B148-479088B903AE	Not Available;Not Available	2;2	223;233	189;224	Complete Response;Complete Response	5;5	25;8	5000;1600	NO;NO	External;External	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	cGy;cGy	2014;2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	needle localized segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2011	2010
TCGA-WT-AB44	FEMALE	883	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0 (i-)	MX	Stage IA	0	883			TUMOR FREE				77	Left	No axillary staging	Not Available	TCGA-WT-AB44	5CD79093-1571-4F71-8136-0D84CCABDCAC	Not Available	Positive	3 Point Scale	3+	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	Not Available	16	Not Available	Not Applicable	0	791	Not Available	Not Available	TCGA-WT-AB44-D62427	670B2675-CB98-412D-B3C0-FE647880FDCA	Not Available	16	Not Available	31	Arimidex	Not Applicable	7	Not Available	Not Available	Not Available	Not Available	Not Applicable	Not Available	Not Available	YES	Hormone Therapy	Not Available	Not Available	Not Available	NO	2014	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-WT-AB44-F66640	0A7190BA-575B-41F4-8F55-012383288578				21			Not Applicable	883																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	0	Not Available	No	AB44	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	YES	90-99%	WHITE	YES	Primary Tumor Field	TCGA-WT-AB44-R62428	491AD153-4239-4288-A7BE-B32A0155FEB4	Not Available	16	153	92	Complete Response	7	33	6040	NO	External	Not Applicable	Not Available	Not Available	cGy	2014	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N0 (i-)	T1c	Not Available	NO	YES	WT	Breast	Not Applicable	Alive	2014	2012
TCGA-D8-A1XS	MALE	496	Other, specify	Breast	Alive	T2	N3a	M0	Stage IIIC	0	496			TUMOR FREE				48	Left Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XS	1026e0bf-5640-4fa5-b65f-4f11e8e76b18	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-17708	Not Applicable	0	50	Not Available	NO	TCGA-D8-A1XS-D29452	72D7E95D-A251-492A-ABBC-D296BC9871D3	Not Available	19	548	85	adriamycin+cyclophosphamide	Not Available	3	4	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	NO	Chemotherapy	Not Available	240+2400	mg	Not Available	2012	% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XS-F12133	49FAF5EE-952C-4CBB-A2EF-E2E972F20185				19		Not Available	Not Applicable	496		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	MALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Other, specify	Ductal/Micropapillary	No	C50.9	8507/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	28	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	25	0	No	A1XS	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XS-R29453	8FF615B0-8A31-4C2E-8FC3-C90949FBBD97	Not Available	19	258	218	Not Available	3	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A1AV	MALE	1864	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1864			Not Available				68	Left	Axillary lymph node dissection alone	Not Available	TCGA-AR-A1AV	daf62b56-6dd2-4ab7-adaa-f296bb86a0a5	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	Not Available	14	-24875	Not Applicable	0	1295	Not Available	Not Available	TCGA-AR-A1AV-D22108;TCGA-AR-A1AV-D22105;TCGA-AR-A1AV-D22104;TCGA-AR-A1AV-D22107	828B60C5-30E1-454A-BF7D-B31D23ED13CB;2A341311-F186-4BB2-9C3B-77EA76B9B7AE;E8AA4773-70EB-4FBD-AE3E-8881E5D8E348;0635BAEF-1285-40DC-820E-8805EC2E3F11	Not Available;Not Available;Not Available;Not Available	29;29;29;29	Not Available;105;105;170	175;50;50;126	Tamoxifen;Cytoxan;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available;Not Available	2;2;2;2	Not Available;4;4;4	20;600;60;175	mg/day;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	2;1;1;1	PO;IV;IV;IV	YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;5080;505;1450	Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2012;2012;2012;2012	Not Available	70-79%	HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AV-F22100;TCGA-AR-A1AV-F49475	2DF4BBA4-58D6-4FCE-A872-7337B1BC83AC;12EE7C6D-9BA2-461A-BD10-888FCEFE23B5				29;2		Not Available;None	Not Applicable;Not Applicable	1295;1864		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	2;10	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	Not Available;TUMOR FREE			Not Available;None			YES;YES		YES;YES	Alive;Alive	2012;2013	MALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	25	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	1	Not Available	No	A1AV	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	70-79%	WHITE	Not Available	Primary Tumor Field	TCGA-AR-A1AV-R22101	CE98B1FF-7DB1-4336-AA1A-8BB3B2510D22	1	29	239	194	Not Available	2	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2007
TCGA-B6-A0WT	FEMALE	5739	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	1	3862.0	Other, specify	New Primary Tumor	TUMOR FREE				61	Left Lower Inner Quadrant;Left	Axillary lymph node dissection alone	Not Available	TCGA-B6-A0WT	d7195183-9fe4-4b17-bcfd-9367d2e539ce	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	14	-22362	Not Applicable	0	5396	Not Available	Not Available																								Image Analysis	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES	NO	YES		TCGA-B6-A0WT-F15728	7B8507DD-57BE-4892-89F5-CE354094972F				29		3862	Not Applicable	5739		3862				Scheduled Follow-up Submission							Not Available			Not Available					2+	image cytometry	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Other Reporting Scale	Not Available	Other Reporting Scale	Equivocal	Negative	Not Available	Not Available	fmol/mg	image cytometry	Not Available	Positive	8	Other, specify	New Primary Tumor	right breast cancer contralateral	YES																																		TUMOR FREE			fmol/mg			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Not Evaluated	Not Evaluated	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	Not Available	No	A0WT	TUMOR FREE	Image Analysis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	4th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2010	1995
TCGA-AR-A0TQ	FEMALE	2991	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1	M0	Stage IIIA	0	2991			TUMOR FREE				27	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-AR-A0TQ	5dc1bee9-c44d-4fdc-9ae5-83426c4d6880	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	7	-9873	Not Applicable	0	1500	Not Available	Not Available	TCGA-AR-A0TQ-D19198;TCGA-AR-A0TQ-D19250;TCGA-AR-A0TQ-D19240;TCGA-AR-A0TQ-D19247;TCGA-AR-A0TQ-D19239;TCGA-AR-A0TQ-D19249;TCGA-AR-A0TQ-D19238;TCGA-AR-A0TQ-D19277;TCGA-AR-A0TQ-D19278	8FD0D2B4-23DC-43ED-BAAE-74845D09E5B9;5C21AE2A-6F50-48B8-B88B-E34B086D11D3;C1517334-59DE-4F7C-BFC3-DBF7226574CC;8BBEC5A9-8FCF-4170-ADB1-F088C1DD8B05;73DDD614-1A82-4A11-936A-F1450119F352;C7A9FEB7-335D-4E12-8111-4308158A36CF;60A907F7-7E0E-47D5-B9C2-382D8D60B445;57DEE87D-F4D7-4369-B46B-617DB56ABCD0;306F161F-8B4E-4960-AAA3-774774B68664	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12	79;482;226;93;107;226;79;1867;1864	37;254;114;93;93;100;37;233;37	Doxorubicin;Trastuzumab;Paclitaxel;Trastuzumab;Paclitaxel;Trastuzumab;Cytoxan;Exemestane;Triptorelin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12	4;13;3;Not Available;1;4;4;Not Available;Not Available	60;6;80;4;60;2;600;25;3.75	mg/m2;mg/kg;mg/m2;mg/kg;mg/m2;mg/kg;mg/m2;mg/day;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	1;1;1;1;1;1;1;2;2	IV;IV;IV;IV;IV;IV;IV;PO;IM	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	550;9720;1785;495;435;3900;5560;Not Available;270	mg;mg;mg;mg;mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011;2011;2011;2011	Not Available	10-19%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None;None	Not Available;None;None	Not Available;None;None		TCGA-AR-A0TQ-F18712;TCGA-AR-A0TQ-F49515;TCGA-AR-A0TQ-F71717	30876F63-82A1-49E6-824C-5ED620F98B30;63DB2C7C-B641-40D5-97F2-2949A3CACF0D;1FC3693E-328C-44D8-AF78-067700617492				12;2;30		Not Available;None;None	Not Applicable;Not Applicable;Not Applicable	2784;2240;2991		Not Applicable;None;None				Scheduled Follow-up Submission;None;None							Not Available;None;None			Not Available;None;None				None;Not Available;NO	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	Not Available;None;None	12;10;3	Not Available;None;None	Not Available;None;None	Not Available;None;None	NO;None;None	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Available;Not Available	None;NO;NO	TUMOR FREE;TUMOR FREE;TUMOR FREE			Not Available;None;None			YES;YES;YES		YES;YES;YES	Alive;Alive;Alive	2011;2013;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Positive	15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3																																	Not Available	2	Not Available	No	A0TQ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Regional site	TCGA-AR-A0TQ-R18715	0326E725-9461-46A7-BFFD-3D3CF96A4A0C	1	12	289	250	Not Available	12	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T3	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2006
TCGA-C8-A12M	FEMALE	358	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0 (i-)	M0	Stage IIA	0	358			TUMOR FREE				70	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A12M	dd0f8e5a-383d-4f03-bb71-0e115d4e442c	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	12	-25811	Not Applicable	0	0	Not Available	Not Available																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-C8-A12M-F19093	24695606-56F0-47DB-9B5E-AFBC4C80292D				2		Not Available	Not Applicable	358		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Patey's Surgery	Other method, specify:	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A12M	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Allred Score 8	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T2	Patey's Surgery	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-BH-A18R	FEMALE	1142	Infiltrating Ductal Carcinoma	Breast	Dead	T2b	N1	M0	Stage IIA	0	1142			TUMOR FREE				50	Right Upper Outer Quadrant	Not Available	Not Available	TCGA-BH-A18R	f6e1ec78-5ad9-4879-9b7e-262d17b166ad	Not Available	Indeterminate	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	Not Available	3	-18524	1142	0	Not Available	Not Available	NO																								Not Available	20-29%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Incisional Biopsy	Positive	Positive	15	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	10	Not Available	No	A18R	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1	T2b	Not Available	NO	YES	BH	Breast	Not Applicable	Dead	2011	2001
TCGA-AC-A6IV	FEMALE	568	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N1	MX	Stage IIB	0	568			TUMOR FREE				47	Right	Sentinel node biopsy alone	Not Available	TCGA-AC-A6IV	8E11C5EC-C15A-48D4-85AC-B7B08A9ED827	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	YES	19	-17521	Not Applicable	0	36	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-AC-A6IV-F66023	41FE4D10-71F7-4A3D-99B6-8759A24B835A				1			Not Applicable	568																				NO																						10					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		YES	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8524/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	1	Negative	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	1	1	No	A6IV	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Unknown	YES	60-69%	WHITE	Unknown																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	MX	N1	T2	Not Available	YES	NO	AC	Breast	Not Applicable	Alive	2013	2012
TCGA-BH-A0AZ	FEMALE	1919	Infiltrating Ductal Carcinoma	Breast	Alive	T3	N1a		Stage IIIA	0	1919			TUMOR FREE				47	Right	Not Available	Not Available	TCGA-BH-A0AZ	518f231c-f5f9-4a39-a97b-7fd5666d3e50	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	Not Available	27	-17465	Not Applicable	0	867	Not Available	NO	TCGA-BH-A0AZ-D58604;TCGA-BH-A0AZ-D58605;TCGA-BH-A0AZ-D58606;TCGA-BH-A0AZ-D58608	A79EE713-028A-4292-8C92-BDC9735D026F;862279A3-EF42-4533-8CE4-301C7CD7D3D8;99401709-0B70-4391-88F9-E458D2839E9E;BA304867-79FD-4DED-96AF-D5D57DA4D09C	Not Available;Not Available;Not Available;Not Available	15;15;15;15	209;209;293;482	126;126;209;126	Doxorubicin;Cytoxan;Taxol;Avastin	Complete Response;Complete Response;Complete Response;Complete Response	4;4;4;4	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	YES;YES;YES;YES	2014;2014;2014;2014	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-BH-A0AZ-F58602	40B2DDD4-6B7C-471E-AD6F-4FCF39C6E504				15			Not Applicable	1919																				NO																						4					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Alive	2014	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Available	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	1	Not Available	No	A0AZ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	cM0 (i+)	N1a	T3	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	NO	YES	BH	Breast	Not Applicable	Alive	2011	2008
TCGA-BH-A0DP	FEMALE	476	Infiltrating Lobular Carcinoma	Breast	Alive	T3	N0 (i-)	M0	Stage IIB	0	476			TUMOR FREE				60	Right	Sentinel node biopsy alone	Not Available	TCGA-BH-A0DP	14267783-5624-4fe5-ba81-9d67f1017474	Not Available	Positive	Not Available	3+	Not Available	Not Evaluated	Positive	Simple Mastectomy	Not Applicable	NO	9	-22199	Not Applicable	0	476	Not Available	Not Available	TCGA-BH-A0DP-D4536	09705E2D-CC53-4DA2-A6E5-73E70334B727	Not Available	17	Not Available	97	ARIMIDEX	Not Available	11	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	H-SCORE 280	80-89%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	TCGA-BH-A0DP-F4538	76E54C1C-F786-46BA-8C0F-D377A4642890	Not Available	Not Available	Not Available	16	Not Available	Not Available	Not Applicable	476	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		Not Available		Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11																																						TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2010	FEMALE	Not Available	Not Available	<10%	Not Available	0	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	3+	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	0	Not Available	No	A0DP	TUMOR FREE	H-SCORE 280	Not Available	Not Available	H-SCORE	H-SCORE	Not Available	Not Available	80-89%	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0DP-R4537	61E05A64-548D-49A2-82C0-BD15A10024CD	1	17	180	136	Not Available	11	30	6000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T3	Not Available	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-C8-A134	FEMALE	383	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	383			TUMOR FREE				52	Left	Axillary lymph node dissection alone	Not Available	TCGA-C8-A134	f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Other	Not Applicable	Not Available	15	-19010	Not Applicable	0	14	Not Available	Not Available	TCGA-C8-A134-D70823;TCGA-C8-A134-D70824;TCGA-C8-A134-D70825	1808C5EE-0291-4C9E-9F3F-50A3ECD730CE;3F5F3438-79BA-43E0-B135-7E37333FD8E2;BD0FF962-3C67-4CB2-880F-11E2B2F8EF7F	Not Available;Not Available;Not Available	9;9;9	41;41;41	38;38;38	5-Flourouracil;Epirubicin;Cyclophosphamide	Complete Response;Complete Response;Complete Response	3;3;3	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2015;2015;2015	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-C8-A134-F19084;TCGA-C8-A134-F70822	3331DC24-D1D5-4123-9F7F-C2F9B5AA76A9;13F00B89-54AB-41DA-BBD2-02C3D6521CCB				2;9		Not Available;None	Not Applicable;Not Applicable	34;383		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	12;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Equivocal	Not Evaluated	7	Negative	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	Not Available	Not Available	No	A134	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Modified Radical Masectomy	YES	NO	C8	Breast	Not Applicable	Alive	2011	2010
TCGA-A2-A25D	FEMALE	0	Infiltrating Lobular Carcinoma	Breast	Alive	T2	N3a	M0	Stage IIIC	0	0			TUMOR FREE				90	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-A2-A25D	3b963d72-ba5c-467b-83c9-fbdb462510a3	Not Available	Positive	Not Available	Not Available	Not Available	Not Evaluated	Negative	Lumpectomy	Not Applicable	NO	21	-32872	Not Applicable	0	0	Not Available	NO	TCGA-A2-A25D-D14497;TCGA-A2-A25D-D14498;TCGA-A2-A25D-D14499	13453903-A47B-4D8A-9288-9EE9FE596226;4E0D9B7A-4FB4-4A35-92D4-B0CF3C369CEE;A604328B-BACF-486C-9E11-4CEC7C695BC6	Not Available;Not Available;Not Available	21;21;21	Not Available;0;0	0;0;0	Tamoxifen;Exemestane;Arimidex	Not Available;Not Available;Not Available	7;7;7	Not Available;Not Available;Not Available	20;25;1	mg/day;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;3	PO;PO;PO	YES;NO;NO	Hormone Therapy;Hormone Therapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2011;2011;2011	Not Available	70-79%	NOT HISPANIC OR LATINO	Not Available	Not Available	118	Not Available	Not Available	Not Available		TCGA-A2-A25D-F30931	41B3DC6F-0AEF-40AE-966C-285FC8F9D38E				19		Not Available	Not Applicable	0		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	60	Not Available	145	1.22	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	22	Not Available	No	A25D	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Moderate using the scale of Weak, Moderate, Strong	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A25D-R14500	D849D0F0-0D55-4F6A-80A1-49A9EEDF0C27	1	21	0	0	Not Available	7	36	6640	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N3a	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2011	2010
TCGA-E2-A14Y	FEMALE	2109	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	2109			TUMOR FREE				35	Right	Sentinel node biopsy alone	Not Available	TCGA-E2-A14Y	a0576d44-9add-429b-9eeb-f7b234b7385f	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Simple Mastectomy	Not Applicable	NO	6	-13004	Not Applicable	0	688	Not Available	NO	TCGA-E2-A14Y-D18512;TCGA-E2-A14Y-D18499;TCGA-E2-A14Y-D18514;TCGA-E2-A14Y-D18513;TCGA-E2-A14Y-D18500;TCGA-E2-A14Y-D18498	A7494061-D25A-4E53-91D6-9B5DB0B5D69F;A5C3C97F-CCF1-4700-913A-C658584D28BB;BCD48E52-6804-43CF-8C55-E1980A6C15D6;67957E3D-E6D1-49EA-A0E8-11E99FB353A1;4D262684-171D-4544-A44F-60BFAC00AEAA;20803F10-4778-41BF-8D82-81E4DC7531C0	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7	547;149;Not Available;1185;384;149	190;44;548;212;44;44	Tamoxifen;Carboplatin;Fareston;Zoledronic Acid;Trastuzumab;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	Not Available;6;Not Available;Not Available;17;6	20;600;60;4;536;137	mg/day;mg;mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	3;1;5;4;2;1	PO;IV;PO;IV;IV;IV	NO;NO;YES;NO;NO;NO	Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;4092;60;48;7168;829	mg/day;mg;mg/day;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2011;2011;2011;2011;2011;2011	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-E2-A14Y-F18497;TCGA-E2-A14Y-F70401	1C861536-87ED-4A24-9C82-A5CD3A573E3B;69DD5AC7-10EB-49C5-B9C9-CCE7B1F28459				7;17		Not Available;None	Not Applicable;Not Applicable	870;2109		Not Applicable;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	11;3	Not Available;None	Not Available;None	Not Available;None	NO;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2011;2015	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Positive	5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A14Y	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-D8-A1XB	FEMALE	552	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1a	M0	Stage IIB	0	552			TUMOR FREE				62	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A1XB	d2694b09-7844-4496-865c-5d3d8cd03330	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	16	-22976	Not Applicable	0	201	Not Available	NO																								% IHC	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A1XB-F29436	D58EE9E5-C9D2-46A5-B0D5-4DE2A638DE07				19		Not Available	Not Applicable	552		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			NO		YES	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	0	No	A1XB	TUMOR FREE	%IHC	Not Available	Not Available	>75%	>75%	Not Available	YES	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-D8-A1XB-R29437	1BE82867-064E-46F8-940F-DFD8A3C07911	Not Available	19	111	74	Not Available	3	25	5000	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2012	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N1a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2010
TCGA-AR-A1AI	FEMALE	3296	Medullary Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	1	588.0	Other, specify	New Primary Tumor	TUMOR FREE				47	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-AR-A1AI	9848307d-1bd5-40c1-b655-a33297aaf74f	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-17229	Not Applicable	0	1881	Not Available	Not Available	TCGA-AR-A1AI-D22166;TCGA-AR-A1AI-D22165;TCGA-AR-A1AI-D22167	90D5DC13-564D-48CD-8C71-641D9D851628;7DC45115-BA8C-4FCF-870E-DE0B34A8BB4A;2B5F671F-53D9-4796-B9B5-CF32551C4232	Not Available;Not Available;Not Available	1;1;1	77;77;134	35;35;91	Cytoxan;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available	3;3;3	4;4;4	600;60;175	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5500;550;1520	mg;mg;mg	Not Available;Not Available;Not Available	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available;None	Not Available;None	Not Available;None		TCGA-AR-A1AI-F22164;TCGA-AR-A1AI-F69268	FC799718-A25C-425A-8D9D-1648F02C42B1;133635BC-06CC-4DDD-A045-698C61BEB38C				1;31		Not Available;None	Not Applicable;Not Applicable	1881;3296		588;None				Scheduled Follow-up Submission;None							Not Available;None			Not Available;None				None;NO	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	Not Available;None	3;12	Other, specify;None	New Primary Tumor;None	Contralateral Breast;None	YES;None	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;Not Available	None;NO	TUMOR FREE;TUMOR FREE			Not Available;None			YES;YES		NO;NO	Alive;Alive	2012;2014	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	Not Available	Not Available	Medullary Carcinoma	Not Applicable	No	C50.9	8510/3	C50.9	Not Available	YES	Not Applicable	Fine needle aspiration biopsy	Equivocal	Negative	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6																																	Not Available	0	Not Available	No	A1AI	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	AR	Breast	Not Applicable	Alive	2011	2005
TCGA-A1-A0SD	FEMALE	437	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N0	M0	Stage IIA	0	437			Not Available				59	Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-A1-A0SD	c462e422-eb8d-4daf-9897-2a9c6cbd783a	Negative	Positive	Not Available	Not Available	Not Available	Lumpectomy	Positive	Lumpectomy	Not Applicable	Not Available	7	-21793	Not Applicable	0	437	Not Available	Not Available																								Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available																																																																																																									FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	3	Positive	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	9																																	Not Available	0	0	No	A0SD	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	NO	YES	A1	Breast	Not Applicable	Alive	2011	2005
TCGA-E2-A14N	FEMALE	1434	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1	M0	Stage IIB	0	1434			TUMOR FREE				37	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-E2-A14N	752ad011-79e0-494f-9868-98bf6feb28f8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	NO	31	-13743	Not Applicable	0	1350	Not Available	NO	TCGA-E2-A14N-D19160;TCGA-E2-A14N-D19181;TCGA-E2-A14N-D19180	774B35C1-A2FE-4E38-9361-04E5C80ED934;17CBAB16-10F1-4630-8C6E-81E28038C433;9E98636D-8BD0-483C-B86A-593FAEF2D5B4	Not Available;Not Available;Not Available	17;17;17	148;148;64	64;87;64	Cyclophosphamide;Docetaxel;Doxorubicin	Not Available;Not Available;Not Available	11;11;11	5;4;1	1100;135;110	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;2;1	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5444;540;110	mg;mg;mg	Not Available;Not Available;Not Available	2011;2011;2011	Allred score 0+0 = 0	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A14N-F19154	374DA424-B865-46D4-A433-F702C840CF36				17		Not Available	Not Applicable	1434		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	<10%	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Negative	Not Evaluated	38	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	5																																	Not Available	1	Not Available	No	A14N	TUMOR FREE	Allred score 0+0 = 0	Not Available	Not Available	Allred score = 0	Allred score = 0	Not Available	YES	Not Available	WHITE	Not Available	Regional site	TCGA-E2-A14N-R19182	7722E80A-C0A5-4B7D-95C4-6BBF762D55DD	1	17	236	181	Not Available	11	28	5040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1	T2	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2007
TCGA-BH-A0BD	FEMALE	554	Infiltrating Ductal Carcinoma	Breast	Alive	T1c	N1a	M0	Stage IIA	0	554			TUMOR FREE				47	Left Upper Inner Quadrant;Left Upper Outer Quadrant;Left	Sentinel lymph node biopsy plus axillary dissection	Not Available	TCGA-BH-A0BD	b379bfb8-284e-4300-8325-85cfd6809cb8	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Other	Not Applicable	NO	4	-17275	Not Applicable	0	554	Not Available	Not Available	TCGA-BH-A0BD-D15425;TCGA-BH-A0BD-D15424;TCGA-BH-A0BD-D15426	A100360C-297C-429F-B00F-42AC189E7E5B;C55EEF50-995F-4293-B338-42772744791A;40280B62-391E-46AB-BDFE-BCF96BA2B2A7	Not Available;Not Available;Not Available	4;4;4	166;Not Available;166	61;244;61	Doxorubicin;Tamoxifen;CYCLOPHOSPHAMIDE	Not Available;Not Available;Not Available	11;11;11	6;Not Available;6	86;20;865	mg;mg/day;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	1;1;1	IV;PO;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	522;Not Available;5230	mg;Not Available;mg	Not Available;Not Available;Not Available	2010;2010;2010	H-Score-190	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-BH-A0BD-F15423	E292A040-7F71-48F6-83E4-1D0BF934EF28				4		Not Available	Not Applicable	554		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2010	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Not Evaluated	9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	11	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Evaluated	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available	No	A0BD	TUMOR FREE	H-Score-230	Not Available	Not Available	H-Score	H-Score	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-BH-A0BD-R15427	BD660DD1-5058-42E5-A3E2-C3B039B665B4	1	4	247	196	Not Available	11	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N1a	T1c	segmental mastectomy	NO	YES	BH	Breast	Not Applicable	Alive	2010	2009
TCGA-D8-A27N	FEMALE	519	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N2a	M0	Stage IIIA	0	519			TUMOR FREE				36	Right Upper Outer Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-D8-A27N	d5be2ab3-f748-480d-954b-385cf01b4c81	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Modified Radical Mastectomy	Not Applicable	NO	18	-13243	Not Applicable	0	146	Not Available	NO	TCGA-D8-A27N-D29595	7055CBBE-07D0-4F99-B7A5-FC251DAE2E28	Not Available	26	Not Available	68	taxol+adriamycin+cyclophosphamide+herceptin	Not Available	3	Not Available	60+600	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	YES	Chemotherapy	Not Available	Not Available	mg	Not Available	2012	manual counting	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-D8-A27N-F29594	3121479E-1AAE-4F1E-98CA-0ED26BDCC3CF				26		Not Available	Not Applicable	519		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		NO	Alive	2012	FEMALE	Not Available	Not Available	Not Available	Not Available	3+	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Positive	Not Evaluated	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	4	0	No	A27N	TUMOR FREE	manual counting	Not Available	Not Available	10-75%	>75%	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N2a	T2	Not Available	YES	NO	D8	Breast	Not Applicable	Alive	2011	2011
TCGA-B6-A1KN	FEMALE	4233	Infiltrating Ductal Carcinoma	Breast	Alive	T4b	N1	M0	Stage IIIB	0	4233			TUMOR FREE				57	Right Upper Inner Quadrant	Axillary lymph node dissection alone	Not Available	TCGA-B6-A1KN	271404de-24e8-43f6-806b-fb510c1124c4	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Modified Radical Mastectomy	Not Applicable	NO	19	-21183	Not Applicable	0	3330	Not Available	NO																								Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-B6-A1KN-F15738	9C9ED6D8-B891-45C3-AFFC-98008F6956BB				29		Not Available	Not Applicable	4233		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Not Evaluated	30	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	7																																	Not Available	24	Not Available	No	A1KN	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	WHITE	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	5th	Not Applicable	Not Applicable	Not Available	M0	N1	T4b	Not Available	NO	YES	B6	Breast	Not Applicable	Alive	2011	1998
TCGA-A2-A3XX	FEMALE	1439	Infiltrating Ductal Carcinoma	Breast	Dead	T2	N0	M0	Stage IIA	0	1439			TUMOR FREE				49	Left Lower Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-A2-A3XX	53886143-C1C6-40E9-88E6-E4E5E0271FC8	Not Available	Negative	Not Available	Not Available	Not Available	Not Available	Negative	Simple Mastectomy	Not Applicable	YES	15	-17981	Not Applicable	0	1168	Not Available	NO	TCGA-A2-A3XX-D34438;TCGA-A2-A3XX-D34439;TCGA-A2-A3XX-D34441	9F081506-F377-47BB-8EE6-EDE38541E7B9;588DB182-2F95-48D2-A365-0BDF34B3C1FB;B6FD1396-6FE8-44FF-A6AC-72B380261AD5	Not Available;Not Available;Not Available	15;15;15	129;129;185	80;80;143	Cyclophosphamide;Adriamycin;Paclitaxel	Complete Response;Complete Response;Complete Response	8;8;8	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2012;2012;2012	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available					TCGA-A2-A3XX-F43310	F765B888-581A-4FC9-804A-2FD66F290AF9				16			1439	Not Available																				NO																						5					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	NO	TUMOR FREE						YES		NO	Dead	2013	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.25	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A3XX	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	7th	Not Applicable	Not Applicable	Not Available	M0	N0	T2	Not Available	YES	NO	A2	Breast	Not Applicable	Alive	2012	2009
TCGA-A2-A0YC	FEMALE	990	Infiltrating Ductal Carcinoma	Breast	Alive	T2	N1mi	M0	Stage IIB	1	756.0		Locoregional Disease	TUMOR FREE				59	Right Upper Inner Quadrant	Other (specify)	Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy	TCGA-A2-A0YC	a1872011-b928-4189-ac02-e87506c20bca	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	8	-21685	Not Applicable	0	644	Not Available	Not Available	TCGA-A2-A0YC-D5677	0c6ae6c0-6396-40ca-8f21-e1d33a8e9ad0	Not Available	8	Not Available	103	Arimidex	Not Available	12	Not Available	1	mg	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	Not Available	Not Available	Not Available	2010	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	YES;YES	NO;NO	YES;YES		TCGA-A2-A0YC-F15845;TCGA-A2-A0YC-F15846	C96EBF68-77B8-4D7E-B54F-B4ACDA34E1BB;C0DCEDF1-D610-4EF2-B1BD-FA6DA338202A				30;30		756;798	Not Applicable;Not Applicable	990;990		756;798				Scheduled Follow-up Submission;Additional New Tumor Event							Not Available;Not Available			Not Available;Not Available					2+;Not Available	Not Available;Not Available	90-99%;Not Available	Positive;Positive	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Negative;Equivocal	Not Evaluated;Not Evaluated	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	90-99%;Not Available	Positive;Positive	8;8	Not Available;Bone	Locoregional Disease;Distant Metastasis	Not Available;Not Available	YES;YES																																		WITH TUMOR;WITH TUMOR			Not Available;Not Available			YES;YES		YES;YES	Alive;Alive	2011;2011	FEMALE	Not Available	Not Available	Not Available	Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified	Not Available	60	Not Available	Not Available	1.18	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Not Evaluated	Negative	3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12																																	Not Available	1	0	No	A0YC	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0YC-R5678	f101ee98-6a56-48fc-9688-d737171c8f34	1	8	78	71	Not Available	12	10	3400	NO	OTHER	Brachytherapy (Iridium 192)	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Available	M0	N1mi	T2	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2008
TCGA-E2-A1IJ	FEMALE	865	Infiltrating Lobular Carcinoma	Breast	Alive	T1c	N0	M0	Stage I	0	865			TUMOR FREE				57	Right Upper Outer Quadrant	Sentinel node biopsy alone	Not Available	TCGA-E2-A1IJ	b09643c2-ded5-4346-b3c5-90a48f88a02e	Not Available	Positive	3 Point Scale	Not Available	3 Point Scale	Not Available	Positive	Lumpectomy	Not Applicable	NO	29	-20956	Not Applicable	0	725	Not Available	NO	TCGA-E2-A1IJ-D19952	F81CA42B-439C-4C65-B16B-D4461F89A002	Not Available	21	Not Available	48	Arimidex	Not Available	12	Not Available	1	mg/day	ADJUVANT	Not Applicable	1	PO	YES	Hormone Therapy	Not Available	1	mg/day	Not Available	2011	Not Available	90-99%	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-E2-A1IJ-F19950	410FB9DE-FA2F-41B4-9C9A-584E963EA019				21		Not Available	Not Applicable	865		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	2+	Not Available	Not Available	Not Available	1.2	Not Available	Infiltrating Lobular Carcinoma	Not Applicable	No	C50.9	8520/3	C50.9	Not Available	YES	Not Applicable	Tumor resection	Equivocal	Negative	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	4																																	Not Available	0	Not Available	No	A1IJ	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	YES	90-99%	WHITE	Not Available	Primary Tumor Field	TCGA-E2-A1IJ-R19953	2BFADC86-259E-4148-BD17-F7BB8E92FE88	1	21	102	53	Not Available	12	33	6440	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2011	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage I	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0	T1c	Not Available	NO	YES	E2	Breast	Not Applicable	Alive	2011	2009
TCGA-A2-A0EO	FEMALE	2442	Infiltrating Ductal Carcinoma	Breast	Alive	T1	N0 (i-)	M0	Stage IA	0	2442			TUMOR FREE				54	Left	Sentinel node biopsy alone	Not Available	TCGA-A2-A0EO	bf88ddf5-a6d4-498c-bf7f-db9bfabff72d	Not Available	Positive	Not Available	Not Available	Not Available	Not Available	Positive	Lumpectomy	Not Applicable	YES	10	-19880	Not Applicable	0	2181	Not Available	Not Available	TCGA-A2-A0EO-D1994;TCGA-A2-A0EO-D1993;TCGA-A2-A0EO-D1995	5d5957c7-956b-45b3-981b-3030c7aac47c;2292be73-49ad-45dd-a4af-0073e6cdf61e;27d60124-9f25-4998-9bd1-d10689365a73	Not Available;Not Available;Not Available	11;11;9	Not Available;876;361	876;158;244	Exemestane;Tamoxifen;E-75	Not Available;Not Available;Not Available	8;8;9	Not Available;Not Available;4	25;10 mg twice daily;500	mg;mg;ug	ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Cancer Vaccine Trial	2;1;3	PO;PO;Not Available	YES;NO;NO	Hormone Therapy;Hormone Therapy;Immunotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;2000	Not Available;Not Available;ug	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	NOT HISPANIC OR LATINO	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available		TCGA-A2-A0EO-F13732	934A43F9-9180-48A7-BE9D-F50B3E511901				13		Not Available	Not Applicable	2442		Not Applicable				Scheduled Follow-up Submission							Not Available			Not Available					Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available	Not Available	Not Available	NO																																		TUMOR FREE			Not Available			YES		YES	Alive	2011	FEMALE	Not Available	Not Available	Not Available	Not Available	1+	Not Available	Not Available	Not Available	1.6	Not Available	Infiltrating Ductal Carcinoma	Not Applicable	No	C50.9	8500/3	C50.9	Not Available	YES	Not Applicable	Core needle biopsy	Negative	Negative	3	Close	Peri (6-12 months since last menstrual period)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	8																																	Not Available	0	0	No	A0EO	TUMOR FREE	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-A2-A0EO-R1992	9e36f785-838a-4b6a-a404-6cb8df45ea5a	1	11	137	91	Not Available	8	33	6040	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	cGy	2010	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	6th	Not Applicable	Not Applicable	Not Available	M0	N0 (i-)	T1	Not Available	NO	YES	A2	Breast	Not Applicable	Alive	2010	2003
